10-K

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2020

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to         

Commission file number 001-34569

Ellington Financial Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	26-0489289
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

53 Forest Avenue

Old Greenwich, Connecticut, 06870

(Address of Principal Executive Offices) (Zip Code)

(203) 698-1200

(Registrant's Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Stock, $0.001 par value per share	EFC	The New York Stock Exchange
6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock	EFC PR A	The New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ☐    No  ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes  ☐   No  ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☐	Accelerated Filer	☒
Non-Accelerated Filer	☐	Smaller Reporting Company	☐
		Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐  No  x

As of June 30, 2020, the last business day of the Registrant's most recently completed second fiscal quarter, the aggregate market value of the Registrant's common shares held by non-affiliates was $478,888,017 based on the closing price as reported by the New York Stock Exchange on that date.

Number of shares of the Registrant's common stock outstanding as of March 5, 2021: 43,781,684

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Registrant's definitive Proxy Statement with respect to its 2021 Annual Meeting of Stockholders to be filed not later than 120 days after the end of the Registrant's fiscal year are incorporated by reference into Part III hereof as noted therein.

Table of Contents

ELLINGTON FINANCIAL INC.

INDEX

Item No.		Form 10-K Report Page
	PART I
1.	Business	3
1A.	Risk Factors	15
1B.	Unresolved Staff Comments	59
2.	Properties	59
3.	Legal Proceedings	59
4.	Mine Safety Disclosures	59
	PART II
5.	Market for Registrant's Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities	60
6.	Selected Financial Data	62
7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	66
7A.	Quantitative and Qualitative Disclosures About Market Risk	101
8.	Financial Statements and Supplementary Data	105
9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	235
9A.	Controls and Procedures	235
9B.	Other Information	235
	PART III
10.	Directors, Executive Officers and Corporate Governance	236
11.	Executive Compensation	236
12.	Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters	236
13.	Certain Relationships and Related Transactions, and Director Independence	236
14.	Principal Accountant Fees and Services	236
	PART IV
15.	Exhibits and Financial Statement Schedules	237
16.	Form 10-K Summary	241

Table of Contents

PART I

Item 1. Business

Except where the context suggests otherwise, references in this Annual Report on Form 10-K to "EFC," "we," "us," and "our" refer to (i) Ellington Financial Inc. and its consolidated subsidiaries, including Ellington Financial Operating Partnership LLC, our operating partnership subsidiary, which we refer to as our "Operating Partnership," following our conversion to a corporation effective March 1, 2019 (our "corporate conversion"), and (ii) Ellington Financial LLC and its consolidated subsidiaries, including our Operating Partnership, before our corporate conversion. References in this Annual Report on Form 10-K to (1) "common shares" refer to (i) our common shares representing limited liability company interests, previously outstanding prior to our corporate conversion, and (ii) shares of our common stock outstanding after our corporate conversion and (2) "common shareholders" refer to (i) holders of our common shares representing limited liability company interests prior to our corporate conversion, and (ii) holders of shares of our common stock after our corporate conversion. We conduct all of our operations and business activities through our Operating Partnership. Our "Manager" refers to Ellington Financial Management LLC, our external manager, "Ellington" refers to Ellington Management Group, L.L.C. and its affiliated investment advisory firms, including our Manager, and "Manager Group" refers collectively to officers and directors of EFC, and partners and affiliates of Ellington (including families and family trusts of the foregoing). In certain instances, references to our Manager and services to be provided to us by our Manager may also include services provided by Ellington and its other affiliates from time to time.

Special Note Regarding Forward-Looking Statements

When used in this Annual Report on Form 10-K, in future filings with the Securities and Exchange Commission, or the "SEC," or in press releases or other written or oral communications, statements which are not historical in nature, including those containing words such as "believe," "expect," "anticipate," "estimate," "project," "plan," "continue," "intend," "should," "would," "could," "goal," "objective," "will," "may," "seek," or similar expressions, are intended to identify "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, or the "Securities Act," and Section 21E of the Securities Exchange Act of 1934, as amended, or the "Exchange Act," and, as such, may involve known and unknown risks, uncertainties, and assumptions.

Forward-looking statements are based on our beliefs, assumptions, and expectations of our future operations, business strategies, performance, financial condition, liquidity and prospects, taking into account information currently available to us. These beliefs, assumptions, and expectations are subject to risks and uncertainties and can change as a result of many possible events or factors, not all of which are known to us. If a change occurs, our business, financial condition, liquidity, results of operations and strategies may vary materially from those expressed or implied in our forward-looking statements. The following factors are examples of those that could cause actual results to vary from our forward-looking statements: changes in interest rates and the market value of our securities; market volatility; changes in the prepayment rates on the mortgage loans underlying the securities owned by us for which the principal and interest payments are guaranteed by a U.S. government agency or a U.S. government-sponsored entity; increased rates of default and/or decreased recovery rates on our assets; our ability to borrow to finance our assets; changes in government regulations affecting our business; our ability to maintain our exclusion from registration under the Investment Company Act of 1940, as amended, or the "Investment Company Act"; our ability to maintain our qualification as a real estate investment trust, or "REIT"; and risks associated with investing in real estate assets, including changes in business conditions and the general economy, such as those resulting from the economic effects related to the novel coronavirus (“COVID-19”) pandemic, and associated responses to the pandemic. These and other risks, uncertainties and factors, including the risk factors described under Item 1A of this Annual Report on Form 10-K, could cause our actual results to differ materially from those projected or implied in any forward-looking statements we make. All forward-looking statements speak only as of the date on which they are made. New risks and uncertainties arise over time, and it is not possible to predict those events or how they may affect us. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Our Company

We were originally formed as a Delaware limited liability company in July 2007 and commenced operations in August 2007. Through December 31, 2018, we believe that we were organized and had operated so that we qualified to be treated for U.S. federal income tax purposes as a partnership and not as an association or a publicly traded partnership taxable as a corporation. In February 2019, we elected to be taxed as a corporation for U.S. federal income tax purposes effective as of January 1, 2019, and we elected to be treated as a REIT for U.S. federal income tax purposes commencing with our taxable year ended December 31, 2019. Effective March 1, 2019, we converted to a Delaware corporation and changed our name to Ellington Financial Inc.

We acquire and manage mortgage-related, consumer-related, corporate-related, and other financial assets. Our primary objective is to generate attractive, risk-adjusted total returns for our stockholders by making investments that we believe

3

Table of Contents

compensate us appropriately for the risks associated with them. We seek to attain this objective by utilizing an opportunistic strategy. Our targeted asset classes currently include investments in the U.S. and Europe (as applicable) in the categories listed below and as described in the section captioned "Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations—Our Targeted Asset Classes." Subject to maintaining our qualification as a REIT, we expect to continue to invest in these targeted asset classes.

•residential mortgage loans, including (i) mortgage loans that are not deemed "qualified mortgage," or "QM," loans under the rules of the Consumer Financial Protection Bureau, or "non-QM loans," (ii) non-performing and re-performing residential mortgage loans, or "residential NPLs," including "legacy" (i.e. issued before the 2008 financial crisis) NPLs, and (iii) residential transition loans;

•residential mortgage-backed securities, or "RMBS," for which the principal and interest payments are guaranteed by a U.S. government agency or a U.S. government-sponsored entity, or "Agency RMBS";

•RMBS backed by U.S. residential mortgage loans for which the principal and interest payments are not guaranteed by a U.S. government agency or a U.S. government-sponsored entity, or "non-Agency RMBS"; and RMBS backed by European residential mortgage loans, or "European RMBS";

•commercial mortgage-backed securities, or "CMBS," commercial mortgage loans, and other commercial real estate debt;

•consumer loans and asset-backed securities, or "ABS," including ABS backed by consumer loans;

•collateralized loan obligations, or "CLOs";

•mortgage-related and non-mortgage-related derivatives; and

•other investments, including corporate debt and equity securities and corporate loans, and strategic investments in companies from which we purchase, or may in the future purchase, targeted assets.

Subject to maintaining our qualification as a REIT, we opportunistically utilize derivatives and other hedging instruments to hedge our interest rate, credit, and foreign currency risk.

Our investments in residential and commercial mortgage loans may consist of performing, non-performing, or sub-performing loans. In addition, we may from time to time acquire real property. We also have made, and may in the future make, investments in the debt and/or equity of other entities engaged in loan-related businesses, such as loan originators and mortgage-related entities. In connection with investments in loan originators, we may also enter into flow agreements that will allow us to purchase new loans from the loan originators in which we invest in accordance with the parameters set forth in the applicable flow agreement. We also opportunistically engage in relative value trading strategies, whereby we seek to identify and capitalize on short-term pricing disparities in various equity and/or fixed-income markets. We also opportunistically acquire and manage other types of mortgage-related and financial assets not listed above, such as mortgage servicing rights, or "MSRs," and credit risk transfer securities, or "CRTs."

Our "credit portfolio," which includes all of our assets other than Agency RMBS, has historically been the primary driver of our risk and return, and we expect that this will continue in the near to medium term. We also maintain a highly leveraged portfolio of Agency RMBS to take advantage of opportunities in that market sector, to help maintain our exclusion from registration as an investment company under the Investment Company Act, and to help maintain our qualification as a REIT. Unless we acquire very substantial amounts of whole mortgage loans or there are changes to the rules and regulations applicable to us under the Investment Company Act and/or to our qualification as a REIT, we expect that we will continue to maintain some amount of Agency RMBS. For more information on our targeted assets, see "Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations—Our Targeted Asset Classes."

Our Manager and Ellington

We are externally managed and advised by our Manager, an affiliate of Ellington, pursuant to a management agreement. Our Manager was formed solely to serve as our manager and does not have any other clients. In addition, our Manager currently does not have any employees and instead relies on the employees of Ellington to perform its obligations to us. Ellington is an investment management firm and registered investment advisor with a 26-year history of investing in a broad spectrum of mortgage-backed securities, or "MBS," and related derivatives.

The members of our management team include Michael Vranos, founder and Chief Executive Officer of Ellington, who serves as our Co-Chief Investment Officer; Laurence Penn, Vice Chairman and Chief Operating Officer of Ellington, who serves as our Chief Executive Officer and President and a member of our Board of Directors; Mark Tecotzky, Vice Chairman - Co-Head of Credit Strategies of Ellington, who serves as our Co-Chief Investment Officer; JR Herlihy, a Managing Director of Ellington, who serves as our Chief Financial Officer; Christopher Smernoff, who serves as our Chief Accounting Officer;

4

Table of Contents

Daniel Margolis, General Counsel of Ellington, who serves as our General Counsel; Vincent Ambrico, who serves as our Controller; and Jason Frank, Associate General Counsel of Ellington, who serves as our Deputy General Counsel and Secretary. Each of these individuals is an officer of our Manager.

Our Manager is responsible for administering our business activities and day-to-day operations and, pursuant to a services agreement between our Manager and Ellington, relies on the resources of Ellington to support our operations. Ellington has well-established portfolio management resources for each of our targeted asset classes and an established infrastructure supporting those resources. Through our relationship with our Manager, we benefit from Ellington's highly analytical investment processes, broad-based deal flow, extensive relationships in the financial community, financial and capital structuring skills, investment surveillance database, and operational expertise. For example, Ellington's analytic approach to the investment process involves collection of substantial amounts of data regarding historical performance of MBS collateral and MBS market transactions. Ellington analyzes this data to identify possible relationships and trends and develops financial models used to support our investment and risk management process. In addition, throughout Ellington's 26-year investing history, it has developed strong relationships with a wide range of dealers and other market participants that provide Ellington access to a broad range of trading opportunities and market information. As a result, Ellington provides us with access to a wide variety of asset acquisition and disposition opportunities and information that assist us in making asset management decisions across our targeted asset classes, which we believe provides us with a significant competitive advantage. We also benefit from Ellington's finance, accounting, operational, legal, compliance, and administrative functions.

As of December 31, 2020, Ellington had over 150 employees and had assets under management of approximately $11.3 billion, of which approximately $7.7 billion consisted of our company and Ellington Residential Mortgage REIT, a REIT listed on the New York Stock Exchange, or the "NYSE," under the ticker "EARN," that focuses its investment strategy primarily on Agency RMBS, and various hedge funds and other alternative investment vehicles that employ financial leverage, and approximately $3.6 billion consisted of accounts that do not employ financial leverage. The $11.3 billion and $7.7 billion in assets under management include approximately $1.4 billion in Ellington-managed CLOs. For these purposes, the Ellington-managed CLO figure represents the aggregate outstanding balance of CLO notes and market value of CLO equity, excluding any notes and equity held by other Ellington-managed funds and accounts.

During the first quarter of 2020, there was a worldwide outbreak of a novel coronavirus disease, or "COVID-19." In response to COVID-19, the Company's management team implemented business continuity plans, and the Company, the Manager, and Ellington continue to be fully operational in a largely work-from-home environment.

Our Strategy

We utilize an opportunistic strategy to seek to generate attractive, risk-adjusted returns. We pursue value across various types of mortgage-related, consumer-related, corporate-related, and other financial assets, through investments primarily in securities and loans.

Our strategy is adaptable to changing market environments, subject to maintaining our qualification as a REIT for U.S. federal income tax purposes and maintaining our exclusion from registration as an investment company under the Investment Company Act. As a result, although we focus on the targeted assets described in the section captioned "Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations—Our Targeted Asset Classes," our acquisition and management decisions depend on prevailing market conditions and our targeted asset classes may vary over time in response to market conditions. We may engage in a high degree of trading volume as we implement our strategy. Our Manager is authorized to follow very broad investment guidelines and, as a result, we cannot predict our portfolio composition. We expect to continue to hold certain of our targeted assets through one or more domestic taxable REIT subsidiaries, or "TRSs." As a result, a portion of the income from such assets will be subject to U.S. federal and state corporate income tax. We may change our strategy and policies without a vote of our stockholders. Moreover, although our independent directors may periodically review our investment guidelines and our portfolio, they generally do not review our proposed asset acquisitions or asset management decisions.

We believe that Ellington's capabilities allow our Manager to identify attractive assets, value these assets, monitor and forecast the performance of these assets, and opportunistically hedge our risk with respect to these assets. Ellington's continued emphasis on and development of proprietary credit, interest rate, and prepayment models, as well as other proprietary research and analytics, underscores the importance it places on a disciplined and analytical approach to fixed income investing. We leverage these skills and resources to seek to meet our investment objectives.

With respect to structured products including MBS, Ellington seeks investments across a wide range of sectors without any restriction as to ratings, structure, or position in the capital structure. Over time and through market cycles, opportunities will present themselves in varying sectors and in varying forms. By rotating between and allocating among various sectors of the structured product markets and adjusting the extent to which it hedges, Ellington believes that it is able to capitalize on the

5

Table of Contents

disparities between these sectors as well as on overall trends in the marketplace, and therefore provide better and more consistent returns for its investors. Disparities between sectors vary from time to time and are driven by a combination of factors. For example, as various structured product sectors fall in and out of favor, the relative yields that the market demands for those sectors may vary. In addition, Ellington's performance projections for certain sectors may differ from those of other market participants and such disparities will naturally cause us, from time to time, to gravitate towards certain sectors and away from others. Disparities between structured product sectors and individual securities within such sectors may also be driven by differences in collateral performance (for example, loans originated during certain periods of time when underwriting standards were generally stricter may on average perform better than loans originated during other times) and in the structure of particular investments (for example, in the timing of cash flows or the level of credit enhancement), and our Manager may believe that other market participants are overestimating or underestimating the value of these differences. Furthermore, we believe that risk management, including opportunistic portfolio hedging and prudent financing and liquidity management, is essential for consistent generation of attractive, risk-adjusted total returns across market cycles.

With respect to loans, we have tended to focus on underserved, niche market segments where inefficiencies exist, and where the segment's size or complexity could present a barrier to entry. Since the global financial crisis in 2008/2009, capital requirements and other regulations in the banking industry have curtailed bank origination and ownership of certain types of loans, and as a result, capital availability for certain loan products is lower than it was historically, thus creating better opportunities for Ellington to invest in these loan products. Ellington uses its deep network of industry relationships to source new loan investments. These relationships have generated a regular flow of investment opportunities from diversified sources, including flow agreements with certain loan origination partners. By investing opportunistically in both loans and securities, we believe that we are able to achieve attractive diversification and can take advantage of relative value across investment classes.

We believe that our Manager is uniquely qualified to implement our strategy. Our strategy is consistent with Ellington's investment approach, which is based on its distinctive strengths in sourcing, analyzing, trading, and hedging complex structured products. Furthermore, we believe that Ellington's extensive experience in buying, selling, analyzing, and structuring fixed income securities, coupled with its broad access to market information and trading flows, provides us with a steady flow of opportunities to acquire assets with favorable trade executions.

In executing our strategies, subject to maintaining our qualification as a REIT, we employ a wide variety of hedging instruments and derivative contracts. See "—Risk Management" below.

Investment Process

Our investment process benefits from the resources and professionals of our Manager and Ellington. The process is managed by an investment and risk management committee, which includes, among others, the following three officers of our Manager: Messrs. Vranos, Penn, and Tecotzky. These officers of our Manager also serve as our Co-Chief Investment Officer, Chief Executive Officer, and Co-Chief Investment Officer, respectively. The investment and risk management committee operates under investment guidelines and meets periodically to develop a set of preferences for the composition of our portfolio. The primary focus of the investment and risk management committee, as it relates to us, is to review and approve our investment policies and our portfolio holdings and related compliance with our investment policies and guidelines, and to give guidance and oversight to the various investment teams that make our day-to-day investment decisions. The investment and risk management committee has authority delegated by our Board of Directors to authorize transactions consistent with our investment guidelines.

Ellington has focused investment teams for many of our targeted asset classes. Our asset acquisition process includes sourcing and screening of asset acquisition opportunities, credit analysis, due diligence, structuring, financing, and hedging, each as appropriate, to seek attractive total returns commensurate with our risk tolerance. Our asset acquisition process is also informed by our objective to maintain our exclusion from registration as an investment company under the Investment Company Act, and to maintain our qualification as a REIT for U.S. federal income tax purposes.

Valuation of Assets

Our Manager's valuation committee directs our valuation process, which is also subject to the oversight of our independent directors. See Note 2 of the notes to consolidated financial statements included in this report for a complete discussion of our valuation process.

Risk Management

Risk management is a cornerstone of Ellington's portfolio management process. Ellington's risk management infrastructure system includes "ELLiN," a proprietary portfolio management system used by all departments at Ellington, including trading, research, risk management, finance, operations, accounting, and compliance. We benefit from Ellington's

6

Table of Contents

comprehensive risk management infrastructure and ongoing assessment of both portfolio and operational risks. In addition, we utilize derivatives and other hedging instruments to opportunistically hedge our credit, interest rate, and foreign currency risk.

Interest Rate Hedging

We opportunistically hedge our interest rate risk by using various hedging strategies to mitigate such risks, subject to maintaining our qualification as a REIT and our exclusion from registration as an investment company under the Investment Company Act. The interest rate hedging instruments that we use and may use in the future include, without limitation:

•To-Be-Announced mortgage pass-through certificates, or "TBAs";

•interest rate swaps (including floating-to-fixed, fixed-to-floating, or more complex swaps such as floating-to-inverse floating, callable or non-callable);

•collateralized mortgage obligations, or "CMOs";

•U.S. Treasury securities;

•swaptions, caps, floors, and other derivatives on interest rates;

•futures and forward contracts; and

•options on any of the foregoing.

In particular, from time to time we enter into short positions in interest rate swaps to offset the potential adverse effects that changes in interest rates would have on the value of certain of our assets and our financing costs. An interest rate swap is an agreement to exchange interest rate cash flows, calculated on a notional principal amount, at specified payment dates during the life of the agreement. Typically, one party pays a fixed interest rate and receives a floating interest rate and the other party pays a floating interest rate and receives a fixed interest rate. Each party's payment obligation is computed using a different interest rate. In an interest rate swap, the notional principal is generally not exchanged.

Credit Risk Hedging

Subject to maintaining our qualification as a REIT, we enter into credit-hedging positions in order to protect against adverse credit events with respect to certain of our credit assets. Our credit hedging portfolio can vary significantly from period to period, and can encompass a wide variety of financial instruments, including corporate debt or equity-related instruments, RMBS or CMBS-related instruments, or instruments involving other markets. Our hedging instruments can include both "single-name" instruments (i.e., instruments referencing one underlying entity or security) and hedging instruments referencing indices. We also opportunistically overlay our credit hedges with certain relative value long/short positions involving the same or similar instruments.

Foreign Currency Hedging

To the extent we hold instruments denominated in currencies other than U.S. dollars, we may enter into transactions to offset the potential adverse effects of changes in currency exchange rates, subject to maintaining our qualification as a REIT. In particular, we may use currency forward contracts and other currency-related derivatives to mitigate this risk.

Our Financing Strategies and Use of Leverage

We finance our assets with what we believe to be a prudent amount of leverage, the level of which varies from time to time based upon the particular characteristics of our portfolio, availability of financing, and market conditions. As of December 31, 2020, the majority of our debt financings consisted of repurchase agreements, or "repos." Currently, the majority of our repos are collateralized by Agency RMBS; however, we also have repo borrowings that are collateralized by our credit assets, and, from time to time, U.S. Treasury securities. In a repo, we sell an asset to a counterparty at a discounted value, or the loan amount, and simultaneously agree to repurchase the same asset from such counterparty at a specified later date at a price equal to the loan amount plus an interest factor. Despite being legally structured as sales and subsequent repurchases, repos are accounted for as collateralized borrowings. During the term of a repo, we generally receive the income and other payments distributed with respect to the underlying assets, and pay interest to the counterparty. While the proceeds of our repo financings are often used to purchase the assets subject to the transaction, our financing arrangements do not restrict our ability to use proceeds from these arrangements to support our other liquidity needs. Our repo arrangements are typically documented under the Securities Industry and Financial Markets Association's, or "SIFMA's," standard form master repurchase agreement with the ability for both parties to demand margin (i.e., to demand that the other party post additional collateral or repay a portion of the funds advanced) should the value of the underlying assets and posted collateral change. As the value of our collateral fluctuates, under most of our master repurchase agreements, we and our repo counterparties are required to post additional collateral to each other from time to time as part of the normal course of our business. Our repo financing counterparties generally have the

7

Table of Contents

right, to varying degrees, to determine the value of the underlying collateral for margining purposes, subject to the terms and conditions of our agreement with the counterparty.

In addition to using repos to finance many of our assets, we have also entered into securitization transactions, and secured borrowing facilities, to finance other assets. For those secured financings, other than repos, for which the associated transfer of assets is not accounted for as a sale, the associated borrowings are included under the captions Other secured borrowings and Other secured borrowings, at fair value, on our Consolidated Balance Sheet. In addition, we have issued senior notes, or "Senior Notes," that are unsecured and are effectively subordinated to our secured indebtedness, to the extent of the value of the collateral securing such indebtedness. Finally, we have also raised equity capital to finance acquisitions of our targeted assets, including through public offerings of our common stock and our 6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, $0.001 par value per share ("Series A Preferred Stock").

We may utilize other types of borrowings in the future, including more complex financing structures. We also may raise capital by issuing additional debt securities, additional preferred or common stock, warrants, or other securities.

Our use of leverage, especially in order to increase the amount of assets supported by our capital base, may have the effect of increasing losses when these assets underperform. Our investment policies require no minimum or maximum leverage, and our Manager's investment and risk management committee has the discretion, without the need for further approval by our Board of Directors, to change both our overall leverage and the leverage used for individual asset classes. Because our strategy is flexible, dynamic, and opportunistic, our overall leverage will vary over time. As a result, we do not have a targeted debt-to-equity ratio.

Management Agreement

We entered into a management agreement with our Manager upon our inception in August 2007, pursuant to which our Manager provides for the day-to-day management of our operations.

The management agreement, as amended, requires our Manager to manage our assets, operations, and affairs in conformity with the policies and the investment guidelines that are approved and monitored by our Board of Directors. Our Manager is under the supervision and direction of our Board of Directors. Our Manager is responsible for:

•the selection, purchase, and sale of assets in our portfolio;

•our financing and risk management activities;

•providing us with advisory services; and

•providing us with a management team, inclusive of a partially dedicated Chief Financial Officer and appropriate support personnel as necessary.

Our Manager is responsible for our day-to-day operations and performs (or causes to be performed) such services and activities relating to the management, operation, and administration of our assets and liabilities, and business as may be appropriate.

Under the management agreement, we pay our Manager a management fee quarterly in arrears, which includes a "base" component and an "incentive" component, and we reimburse certain expenses of our Manager.

The management agreement provides that 10% of each incentive fee payable to our Manager is to be paid in common shares, with the balance paid in cash; provided, however, that our Manager may, in its sole discretion, elect to receive a greater percentage of any incentive fee in the form of common shares by providing our Board of Directors with written notice of its election to receive a greater percentage of its incentive fee in common shares before the first day of the last calendar month in the quarter to which such incentive fee relates. The management agreement further provides that our Manager may not elect to receive common shares as payment of its incentive fee, other than in accordance with all applicable securities exchange rules and securities laws (including prohibitions on insider trading). The number of our common shares to be received by our Manager is based on the fair market value of those common shares, which is determined based on the average of the closing prices of our common shares as reported by the NYSE during the last calendar month of the quarter to which such incentive fee relates. Common shares delivered as payment of the incentive fee are immediately vested, provided that our Manager has agreed not to sell such common shares prior to one year after the date they are issued to our Manager, provided further, however, that this transfer restriction will immediately lapse if the management agreement is terminated.

8

Table of Contents

Base Management Fees, Incentive Fees, and Reimbursement of Expenses

Base Management Fees

Under the management agreement, we pay our Manager a base management fee quarterly in arrears in an amount equal to 1.50% per annum of the equity of the Operating Partnership (calculated in accordance with U.S Generally Accepted Accounting Principles, or "U.S. GAAP") as of the end of each fiscal quarter (before deductions for base management and incentive fees payable with respect to such fiscal quarter), provided that the equity of the Operating Partnership is adjusted to exclude one-time events pursuant to changes in U.S. GAAP, as well as non-cash charges after discussion between our Manager and our independent directors, and approval by a majority of our independent directors in the case of non-cash charges.

Incentive Fees

In addition to the base management fee, with respect to each fiscal quarter we pay our Manager an incentive fee equal to the excess, if any, of (i) the product of (A) 25% and (B) the excess of (1) our Adjusted Net Income (described below) for the Incentive Calculation Period (which means such fiscal quarter and the immediately preceding three fiscal quarters) over (2) the sum of the Hurdle Amounts (described below) for the Incentive Calculation Period, over (ii) the sum of the incentive fees already paid or payable for each fiscal quarter in the Incentive Calculation Period preceding such fiscal quarter.

For purposes of calculating the incentive fee, "Adjusted Net Income" for the Incentive Calculation Period means the net increase/(decrease) in equity resulting from operations of the Operating Partnership (or such equivalent U.S. GAAP measure based on the basis of presentation of our consolidated financial statements), after all base management fees but before any incentive fees for such period, and excluding any non-cash equity compensation expenses for such period, as reduced by any Loss Carryforward (as described below) as of the end of the fiscal quarter preceding the Incentive Calculation Period. Adjusted Net Income will be adjusted to exclude one-time events pursuant to changes in U.S. GAAP, as well as non-cash charges after discussion between our Manager and our independent directors and approval by a majority of our independent directors in the case of non-cash charges.

For purposes of calculating the incentive fee, the "Loss Carryforward" as of the end of any fiscal quarter is calculated by determining the excess, if any, of (1) the Loss Carryforward as of the end of the immediately preceding fiscal quarter over (2) the net increase in equity resulting from operations of the Operating Partnership (expressed as a positive number) or the net decrease in equity resulting from operations of the Operating Partnership (expressed as a negative number) for such fiscal quarter (or such equivalent U.S. GAAP measures as may be appropriate depending on the basis of presentation of our consolidated financial statements), as the case may be, calculated in accordance with U.S. GAAP, adjusted to exclude one-time events pursuant to changes in U.S. GAAP, as well as non-cash charges after discussion between our Manager and our independent directors and approval by a majority of our independent directors in the case of non-cash charges.

For purposes of calculating the incentive fee, the "Hurdle Amount" means, with respect to any fiscal quarter, the product of (i) one-fourth of the greater of (A) 9% and (B) 3% plus the 10-year U.S. Treasury rate for such fiscal quarter, (ii) the sum of (A) the weighted average gross proceeds per share of all common share and operating partnership unit, or "OP Unit," issuances since our inception and up to the end of such fiscal quarter, with each issuance weighted by both the number of shares and OP Units issued in such issuance and the number of days that such issued shares and OP Units were outstanding during such fiscal quarter, using a first-in first-out basis of accounting (i.e., attributing any share and OP Unit repurchases to the earliest issuances first) and (B) the result obtained by dividing (I) retained earnings attributable to common shares and OP Units at the beginning of such fiscal quarter by (II) the average number of common shares and OP Units outstanding for each day during such fiscal quarter, and (iii) the sum of (x) the average number of common shares and long term incentive plan units, or "LTIP Units," outstanding for each day during such fiscal quarter and (y) the average number of OP Units, and limited liability company interests in the Operating Partnership which are designated as LTIP Units, or "OP LTIP Units," outstanding for each day during such fiscal quarter. For purposes of determining the Hurdle Amount, issuances of common shares, OP LTIP Units and OP Units (a) as equity incentive awards, (b) to the Manager as part of its base management fee or incentive fee and (c) to the Manager or any of its affiliates in privately negotiated transactions, are excluded from the calculation. The payment of the incentive fee will be in a combination of common shares and cash, provided that at least 10% of any quarterly payment will be made in common shares.

Reimbursement of Expenses

We do not maintain an office or employ personnel. We rely on the facilities and resources of our Manager to conduct our operations. We pay all of our direct operating expenses, except those specifically required to be borne by our Manager under the management agreement. Our Manager is responsible for all costs incident to the performance of its duties under the management agreement, including compensation of Ellington's employees and other related expenses, other than our allocable portion of the costs incurred by our Manager for certain dedicated or partially dedicated employees including a Chief Financial Officer, one or more controllers, an in-house legal counsel, an investor relations professional, certain internal audit staff in

9

Table of Contents

connection with Sarbanes-Oxley compliance initiatives and certain other personnel performing duties for us, including certain personnel involved in the implementation of our more operationally intensive strategies, such as certain personnel involved in loan acquisition and loan management, based on the portion of their working time and efforts spent on our matters and subject to approval of the reimbursed amounts by the Compensation Committee of the Board of Directors. In addition, other than as expressly described in the management agreement, we are not required to pay any portion of rent, telephone, utilities, office furniture, equipment, machinery, and other office, internal and overhead expenses of our Manager and its affiliates.

Term and Termination

The management agreement has a current term that expires on December 31, 2021, and will automatically renew for a one year term on each anniversary date thereafter unless notice of non-renewal is delivered by either party to the other party at least 180 days prior to the expiration of the then current term. Our independent directors review our Manager's performance annually, and the management agreement may be terminated annually upon the affirmative vote of at least two-thirds of our independent directors, or by the affirmative vote of the holders of at least a majority of the outstanding common shares, based upon unsatisfactory performance by our Manager that is materially detrimental to us or a determination by our independent directors that the fees payable to our Manager are not fair, subject to our Manager's right to prevent a fee-based termination by accepting a mutually acceptable reduction of its fees. In the event we terminate the management agreement without cause or elect not to renew the management agreement, we will be required to pay our Manager a termination fee equal to the amount of three times the sum of (i) the average annual base management fee earned by our Manager during the 24-month period immediately preceding the date of notice of termination or non-renewal, calculated as of the end of the most recently completed fiscal quarter prior to the date of notice of termination or non-renewal and (ii) the average annual incentive fee earned by our Manager during the 24-month period immediately preceding the date of notice of termination or non-renewal, calculated as of the end of the most recently completed fiscal quarter prior to the date of notice of termination or non-renewal.

We may also terminate the management agreement without payment of the termination fee with 30 days prior written notice from our Board of Directors for cause, which is defined as:

•our Manager's continued material breach of any provision of the management agreement following a period of 30 days after written notice of such breach;

•our Manager's fraud, misappropriation of funds, or embezzlement against us;

•our Manager's gross negligence in performance of its duties under the management agreement;

•the occurrence of certain events with respect to the bankruptcy or insolvency of our Manager, including, but not limited to, an order for relief in an involuntary bankruptcy case or our Manager authorizing or filing a voluntary bankruptcy petition;

•the dissolution of our Manager; and

•certain changes of control of our Manager, including but not limited to the departure of Mr. Vranos from senior management of Ellington, whether through resignation, retirement, withdrawal, long-term disability, death or termination of employment with or without cause or for any other reason.

Our Manager may terminate the management agreement effective upon 60 days prior written notice of termination to us in the event that we default in the performance or observance of any material term, condition or covenant in the management agreement and the default continues for a period of 30 days after written notice to us specifying the default and requesting that the default be remedied in such 30-day period. In the event our Manager terminates the management agreement due to our default in the performance or observance of any material term, condition, or covenant in the management agreement, we will be required to pay our Manager the termination fee. Our Manager may also terminate the management agreement in the event we become regulated as an investment company under the Investment Company Act, with such termination deemed to occur immediately prior to such event; provided, however, that in the case of such termination, if our Manager was not at fault for our becoming regulated as an investment company under the Investment Company Act, we will be required to pay the termination fee.

Conflicts of Interest; Equitable Allocation of Opportunities

Ellington manages, and expects to continue to manage, other funds, accounts, and vehicles that have strategies that are similar to, or that overlap with, our strategy, including Ellington Residential Mortgage REIT. As of December 31, 2020, Ellington managed various funds, accounts, and other vehicles, comprising approximately $10.4 billion of assets under management (excluding our assets but including $3.6 billion of accounts that do not employ financial leverage), with strategies that are similar to, or that overlap with, our strategy. The $10.4 billion in assets under management include approximately $1.4 billion in Ellington-managed CLOs. For these purposes, the Ellington-managed CLO figure represents the aggregate outstanding balance of CLO notes and market value of CLO equity, excluding any notes and equity held by other Ellington-

10

Table of Contents

managed funds and accounts. Ellington makes available to our Manager all opportunities to acquire assets that it determines, in its reasonable and good faith judgment, based on our objectives, policies and strategies, and other relevant factors, are appropriate for us in accordance with Ellington's written investment allocation policy, it being understood that we might not participate in each such opportunity, but will on an overall basis equitably participate with Ellington's other accounts in all such opportunities. Ellington's Investment and Risk Management Committee and its Compliance Committee (headed by its Chief Compliance Officer) are responsible for monitoring the administration of, and facilitating compliance with, Ellington's investment allocation procedures and policies.

Because many of our targeted assets are typically available only in specified quantities and are also targeted assets for other Ellington accounts, Ellington often is not able to buy as much of any given asset as required to satisfy the needs of all its accounts. In these cases, Ellington's investment allocation procedures and policies typically allocate such assets to multiple accounts in proportion to their needs and available capital. Ellington may at times allocate opportunities on a preferential basis to accounts that are in a "start-up" or "ramp-up" phase. The policies permit departure from such proportional allocation under certain circumstances, including, for example, when such allocation would result in an inefficiently small amount of the security or assets being purchased for an account. In that case, the policies allow for a protocol of allocating assets so that, on an overall basis, each account is treated equitably. In addition, as part of these policies, we may be excluded from specified allocations of assets for tax, regulatory, risk management, or similar reasons.

Other policies of Ellington that our Manager applies to the management of our company include controls for:

•Cross Transactions—defined as transactions between us or one of our subsidiaries, on the one hand, and an account (other than us or one of our subsidiaries) managed by Ellington or our Manager, on the other hand. It is Ellington's policy to engage in a cross transaction only when the transaction is in the best interests of, and is consistent with the objectives and policies of, both accounts involved in the transaction. Pursuant to the terms of the management agreement, Ellington or our Manager may enter into cross transactions where it acts both on our behalf and on behalf of the other party to the transaction. Although we believe such restrictions on our Manager's ability to engage in cross transactions on our behalf mitigate many risks, cross transactions, even at market prices, may potentially create a conflict of interest between our Manager's and our officers' duties to and interests in us and their duties to and interests in the other party. Upon written notice to our Manager, we may at any time revoke our consent to our Manager's executing cross transactions. Additionally, unless approved in advance by a majority of our independent directors or pursuant to and in accordance with a policy that has been approved by a majority of our independent directors, all cross transactions must be effected at the then-prevailing market prices. Pursuant to our Manager's current policies and procedures, assets for which there are no readily observable market prices may be purchased or sold in cross transactions (i) at prices based upon third-party bids received through auction, (ii) at the average of the highest bid and lowest offer quoted by third-party dealers, or (iii) according to another pricing methodology approved by our Manager's Chief Compliance Officer.

•Principal Transactions—defined as transactions between Ellington or our Manager (or any related party of Ellington or our Manager, which includes employees of Ellington and our Manager and their families), on the one hand, and us or one of our subsidiaries, on the other hand. Certain cross transactions may also be considered principal transactions whenever our Manager or Ellington (or any related party of Ellington or our Manager, which includes employees of Ellington and our Manager and their families) have a substantial ownership interest in one of the transacting parties. Our Manager is only authorized to execute principal transactions with the prior approval of a majority of our independent directors and in accordance with applicable law. Such prior approval includes approval of the pricing methodology to be used, including with respect to assets for which there are no readily observable market prices.

•Investment in Other Ellington Accounts—pursuant to the management agreement, if we invest at issuance in the equity of any collateralized debt obligation, or "CDO," that is managed, structured, or originated by Ellington or one of its affiliates, or if we invest in any other investment fund or other investment for which Ellington or one of its affiliates receives management, origination, or structuring fees, then, unless agreed otherwise by a majority of our independent directors, the base management and incentive fees payable by us to our Manager will be reduced by (or our Manager will otherwise rebate to us) an amount equal to the applicable portion (as described in the management agreement) of any such management, origination or structuring fees.

•Split Price Executions—pursuant to the management agreement, our Manager is authorized to combine purchase or sale orders on our behalf together with orders for other accounts managed by Ellington, our Manager or their affiliates and allocate the securities or other assets so purchased or sold, on an average price basis or other fair and consistent basis, among such accounts.

Our Manager is authorized to follow very broad investment guidelines. Our independent directors will periodically review our investment guidelines and our portfolio. However, our independent directors generally will not review our proposed asset acquisitions, dispositions, or other management decisions. In addition, in conducting periodic reviews, our independent

11

Table of Contents

directors will rely primarily on information provided to them by our Manager. Furthermore, our Manager may arrange for us to use complex strategies or to enter into complex transactions that may be difficult or impossible to unwind by the time they are reviewed by our independent directors. Our Manager has great latitude within our broad investment guidelines to determine the types of assets it may decide are proper for purchase by us. The management agreement with our Manager does not restrict the ability of its officers and employees from engaging in other business ventures of any nature, whether or not such ventures are competitive with our business. We may acquire assets from entities affiliated with our Manager, even where the assets were originated by such entities. Affiliates of our Manager may also provide services to entities in which we have invested.

Our executive officers and the officers and employees of our Manager are also officers and employees of Ellington, and we compete with other Ellington accounts for access to these individuals. We have not adopted a policy that expressly prohibits our directors, officers, security holders, or affiliates from having a direct or indirect pecuniary interest in any asset to be acquired or disposed of by us or any of our subsidiaries or in any transaction to which we or any of our subsidiaries is a party or has an interest, nor do we have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. However, our code of business conduct and ethics contains a conflicts of interest policy that prohibits our directors, officers, and employees, as well as employees of our Manager who provide services to us, from engaging in any transaction that involves an actual or apparent conflict of interest with us, absent approval by the Board of Directors or except as expressly set forth above or as provided in the management agreement between us and our Manager. In addition, nothing in the management agreement binds or restricts our Manager or any of its affiliates, officers, or employees from buying, selling, or trading any securities or commodities for their own accounts or for the accounts of others for whom our Manager or any of its affiliates, officers, or employees may be acting.

Competition

In acquiring our assets, we compete with other mortgage REITs, specialty finance companies, savings and loan associations, banks, mortgage bankers, insurance companies, mutual funds, institutional investors, investment banking firms, financial institutions, governmental bodies, and other entities. Many of our competitors are significantly larger than us, have greater access to capital and other resources, and may have other advantages over us. Our competitors may include other investment vehicles managed by Ellington or its affiliates, including Ellington Residential Mortgage REIT. In addition to existing companies, other companies may be organized for similar purposes in the future, including companies focused on purchasing mortgage assets. A proliferation of such companies may increase the competition for equity capital and thereby adversely affect the market price of our common or preferred stock. An increase in the competition for sources of funding could adversely affect the availability and cost of financing, and thereby adversely affect the market price of our common or preferred stock. In addition, some of our competitors may have higher risk tolerances or different risk assessments, which could allow them to consider a wider variety of assets, or pay higher prices, than we can.

In the face of this competition, we have access to our Manager's and Ellington's professionals and their industry expertise, which may provide us with a competitive advantage and help us assess risks and determine appropriate pricing for certain potential assets. In addition, we believe that these relationships enable us to compete more effectively for attractive asset acquisition opportunities. However, we may not be able to achieve our business goals or expectations due to the competitive risks that we face.

Operating and Regulatory Structure

Tax Requirements

We elected to be taxed as a REIT under the Internal Revenue Code of 1986, as amended, or "the Code," commencing with our taxable year ended December 31, 2019. Since January 1, 2019, we have been organized in conformity with, and have operated in a manner that has enabled us to meet, the requirements for qualification as a REIT for U.S. federal income tax purposes. Provided that we maintain our qualification as a REIT, we generally will not be subject to U.S. federal income tax on our REIT taxable income that is currently distributed to our stockholders. REITs are subject to a number of organizational and operational requirements, including a requirement that they currently distribute at least 90% of their annual REIT taxable income excluding net capital gains. We cannot assure you that we will be able to comply with such requirements. Failure to qualify as a REIT in any taxable year would cause us to be subject to U.S. federal income tax on our taxable income at regular corporate rates (and any applicable state and local taxes). Even if we qualify for taxation as a REIT, we may be subject to certain U.S. federal, state, local, and non-U.S. taxes on our income. For example, any income generated by our domestic TRSs will be subject to U.S. federal, state, and local income tax. Any taxes paid by a TRS will reduce the cash available for distribution to our stockholders.

Investment Company Act Exclusions

Most of our business is conducted through various wholly-owned and majority-owned subsidiaries in a manner such that neither we nor our subsidiaries are subject to registration under the Investment Company Act. Under Section 3(a)(1) of the

12

Table of Contents

Investment Company Act, a company is deemed to be an "investment company" if:

•it is, or holds itself out as being, engaged primarily, or proposes to engage primarily, in the business of investing, reinvesting, or trading in securities (Section 3(a)(1)(A)); or

•it is engaged or proposes to engage in the business of investing, reinvesting, owning, holding, or trading in securities and does own or proposes to acquire "investment securities" having a value exceeding 40% of the value of its total assets (excluding U.S. government securities and cash) on an unconsolidated basis, or "the 40% Test" (Section 3(a)(1)(C)). "Investment securities" excludes U.S. government securities and securities of majority-owned subsidiaries that are not themselves investment companies and are not relying on the exception from the definition of investment company for private funds under Section 3(c)(1) or Section 3(c)(7) of the Investment Company Act.

We believe that we and our Operating Partnership, and a holding company subsidiary of our Operating Partnership, or the "Holding Subsidiary," will not be considered investment companies under Section 3(a)(1) of the Investment Company Act, because we and they satisfy the 40% Test and because we and they do not engage primarily (or hold ourselves or themselves out as being engaged primarily) in the business of investing, reinvesting, or trading in securities. Rather, through wholly-owned or majority-owned subsidiaries, we, our Operating Partnership, and the Holding Subsidiary are primarily engaged in the non-investment company businesses of these subsidiaries.

Our Operating Partnership currently has several subsidiaries that rely on the exclusion provided by Section 3(c)(7) of the Investment Company Act, each a "3(c)(7) subsidiary." In addition, the Holding Subsidiary currently has several 3(c)(7) subsidiaries and several subsidiaries that rely on the exclusion provided by Section 3(c)(5)(C) of the Investment Company Act, each a "3(c)(5)(C) subsidiary." While investments in 3(c)(7) subsidiaries are considered investment securities for the purposes of the 40% Test, investments in 3(c)(5)(C) subsidiaries are not considered investment securities for the purposes of the 40% Test, nor are investments in subsidiaries that rely on the exclusion provided by Section 3(a)(1)(C).

Therefore, our Operating Partnership's investments in its 3(c)(7) subsidiaries and its other investment securities cannot exceed 40% of the value of our Operating Partnership's total assets (excluding U.S. government securities and cash) on an unconsolidated basis. In addition, the Holding Subsidiary's investment in its 3(c)(7) subsidiaries and its other investment securities cannot exceed 40% of the value of our Holding Subsidiary's total assets (excluding U.S. government securities and cash) on an unconsolidated basis.

Section 3(c)(5)(C) of the Investment Company Act is designed for entities primarily engaged in the business of "purchasing or otherwise acquiring mortgages and other liens on and interests in real estate." This exclusion generally requires that at least 55% of the entity's assets on an unconsolidated basis consist of qualifying real estate assets and at least 80% of the entity's assets on an unconsolidated basis consist of qualifying real estate assets or real estate-related assets. Both the 40% Test and the requirements of the Section 3(c)(5)(C) exclusion limit the types of businesses in which we may engage and the types of assets we may hold, as well as the timing of sales and purchases of assets.

On August 31, 2011, the SEC published a concept release entitled "Companies Engaged in the Business of Acquiring Mortgages and Mortgage Related Instruments" (Investment Company Act Rel. No. 29778). This release notes that the SEC is reviewing the Section 3(c)(5)(C) exclusion relied upon by companies similar to us that invest in mortgage loans and mortgage-backed securities. There can be no assurance that the laws and regulations governing the Investment Company Act status of companies similar to ours, or the guidance from the Division of Investment Management of the SEC regarding the treatment of assets as qualifying real estate assets or real estate-related assets, will not change in a manner that adversely affects our operations as a result of this review. To the extent that the SEC staff provides more specific guidance regarding any of the matters bearing upon our exclusion from the need to register under the Investment Company Act, we may be required to adjust our strategy accordingly. Any additional guidance from the SEC staff could provide additional flexibility to us, or it could further inhibit our ability to pursue the strategies that we have chosen. Furthermore, although we intend to monitor the assets of our 3(c)(5)(C) subsidiaries regularly, there can be no assurance that any such subsidiary will be able to maintain this exclusion from registration. In that case, our investment in any such subsidiary would be classified as an investment security, and we might not be able to maintain our overall exclusion from registering as an investment company under the Investment Company Act.

If we or our subsidiaries were required to register as an investment company under the Investment Company Act, we would become subject to substantial regulation with respect to our capital structure (including our ability to use leverage), management, operations, transactions with affiliated persons (as defined in the Investment Company Act), and portfolio composition, including restrictions with respect to diversification and industry concentration and other matters. Compliance with the restrictions imposed by the Investment Company Act would require us to make material changes to our strategy which could materially adversely affect our business, financial condition and results of operations, and our ability to make distributions to our stockholders. Accordingly, to avoid that result, we may be required to adjust our strategy, which could limit

13

Table of Contents

our ability to make certain investments or require us to sell assets in a manner, at a price or at a time that we otherwise would not have chosen. This could negatively affect the value of our common or preferred stock, the sustainability of our business model and our ability to make distributions. See "Item 1A. Risk Factors—Risks Related to Our Organization and Structure—Maintenance of our exclusion from registration as an investment company under the Investment Company Act imposes significant limitations on our operations."

Investment Advisers Act of 1940

Both Ellington and our Manager are registered as investment advisers under the Investment Advisers Act of 1940, as amended, and are subject to the regulatory oversight of the Division of Investment Management of the SEC.

Human Capital Resources

We have no employees. All of our executive officers, and our dedicated or partially dedicated personnel, which include our Chief Financial Officer, Chief Accounting Officer, controller, accounting staff, in-house legal counsel, internal audit staff, and other personnel providing services to us are employees of Ellington or one or more of its affiliates. See "—Management Agreement" above.

Additional Information

A copy of this Annual Report on Form 10-K, as well as our Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any amendments to such reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act are available, free of charge, on our internet website at www.ellingtonfinancial.com. All of these reports are made available on our internet website as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Our Corporate Governance Guidelines and Code of Business Conduct and Ethics and the charters of the Audit, Compensation and Nominating and Corporate Governance Committees of our Board of Directors are also available at www.ellingtonfinancial.com and are available in print to any stockholder upon request in writing to Ellington Financial Inc., c/o Investor Relations, 53 Forest Avenue, Old Greenwich, CT 06870. The information on our website is not, and shall not be deemed to be, a part of this report or incorporated into any other filing we make with the SEC.

In addition, all of our reports filed with or furnished to the SEC can be obtained at the SEC's website at www.sec.gov.

14

Table of Contents

Item 1A. Risk Factors

Summary of Risk Factors

Risks Related To Our Business

•Difficult conditions in the mortgage and residential real estate markets as well as general market concerns may adversely affect the value of the assets in which we invest.

•The federal conservatorship of Fannie Mae and Freddie Mac and related efforts, along with any changes in laws and regulations affecting the relationship between Fannie Mae, Freddie Mac, and Ginnie Mae and the U.S. Government, may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

•Mortgage loan modification programs and future legislative action may adversely affect the value of, and the returns on, our targeted assets.

•The principal and interest payments on our non-Agency RMBS are not guaranteed by any entity, including any government entity or GSE, and therefore are subject to increased risks, including credit risk.

•Less stringent underwriting guidelines and the resultant potential for delinquencies or defaults on certain mortgage loans could lead to losses on many of the non-Agency RMBS and European RMBS that we hold.

•We rely on analytical models and other data to analyze potential asset acquisition and disposition opportunities and to manage our portfolio. Such models and other data may be incorrect, misleading or incomplete, which could cause us to purchase assets that do not meet our expectations or to make asset management decisions that are not in line with our strategy.

•Valuations of some of our assets are inherently uncertain, may be based on estimates, may fluctuate over short periods of time, and may differ from the values that would have been used if a ready market for these assets existed.

•We depend on third-party service providers, including mortgage servicers, for a variety of services related to our non-Agency RMBS, European assets, securitizations, and whole mortgage loans and loan pools. We are, therefore, subject to the risks associated with third-party service providers.

•We rely on mortgage servicers for our loss mitigation efforts, and we also may engage in our own loss mitigation efforts with respect to whole mortgage loans that we own directly. Such loss mitigation efforts may be unsuccessful or not cost effective.

•We may be affected by deficiencies in foreclosure practices of third parties, as well as related delays in the foreclosure process.

•To the extent that due diligence is conducted on potential assets, such due diligence may not reveal all of the risks associated with such assets and may not reveal other weaknesses in such assets, which could lead to losses.

•Sellers of the mortgage loans that we acquire, or that underlie the non-Agency RMBS or European RMBS in which we invest, may be unable to repurchase defective mortgage loans, which could have a material adverse effect on the value of our loans, or the loans held by the trust that issued the RMBS, and could cause shortfalls in the payments due on the RMBS or losses on the mortgage loans.

•Our assets include subordinated and lower-rated securities that generally have greater risk of loss than senior and higher-rated securities.

•Investments in second-lien mortgage loans could subject us to increased risk of losses.

•Prepayment rates can change, adversely affecting the performance of our assets.

•Increases in interest rates could negatively affect the value of our assets and increase the risk of default on our assets.

•An increase in interest rates may cause a decrease in the issuance volumes of certain of our targeted assets, which could adversely affect our ability to acquire targeted assets that satisfy our investment objectives and to generate income and pay dividends.

•Interest rate caps on the ARMs and hybrid ARMs that back our RMBS may reduce our net interest margin during periods of rising or high interest rates.

•Residential mortgage loans, including residential NPLs, non-QM loans, and residential transition loans, are subject to increased risks.

•If we subsequently resell any whole mortgage loans that we acquire, we may be required to repurchase such loans or indemnify purchasers if we breach representations and warranties.

•The commercial mortgage loans that we acquire or originate, and the mortgage loans underlying our CMBS investments, are subject to the ability of the commercial property owner to generate net income from operating the property as well as to the risks of delinquency and foreclosure.

•Our investments in CMBS are at risk of loss.

•We may not control the special servicing of the mortgage loans included in the CMBS in which we invest and, in such cases, the special servicer may take actions that could adversely affect our interests.

•A portion of our investments currently are, and in the future may be, in the form of non-performing and sub-performing commercial and residential mortgage loans, or loans that may become non-performing or sub-performing, which are subject to increased risks relative to performing loans.

•Our real estate assets and our real estate-related assets (including mortgage loans and MBS) are subject to the risks associated with real property.

•We engage in short selling transactions, which may subject us to additional risks.

•We use leverage in executing our business strategy, which may adversely affect the return on our assets and may reduce cash available for distribution to our stockholders, as well as increase losses when economic conditions are unfavorable.

•Our access to financing sources, which may not be available on favorable terms, or at all, may be limited, and our lenders and derivative counterparties may require us to post additional collateral. These circumstances may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

•A failure to comply with restrictive covenants in our financing arrangements would have a material adverse effect on us, and any future financings may require us to provide additional collateral or pay down debt.

•Our securitizations may expose us to additional risks.

•Interest rate mismatches between our assets and our borrowings may reduce our income during periods of changing interest rates, and increases in interest rates could adversely affect the value of our assets.

•The anticipated discontinuation of LIBOR and transition from LIBOR to an alternative reference rate may adversely affect the value and liquidity of the financial obligations to be held or issued by us that are linked to LIBOR.

•Our investments that are denominated in foreign currencies subject us to foreign currency risk, which may adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

•Hedging against credit events, interest rate changes, foreign currency fluctuations, and other risks may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

•Hedging instruments and other derivatives, including some credit default swaps, may not, in many cases, be traded on regulated exchanges, or may not be guaranteed or regulated by any U.S. or foreign governmental authority and involve risks and costs that could result in material losses.

•Certain of our hedging instruments are regulated by the CFTC and such regulations may adversely impact our ability to enter into such hedging instruments and cause us to incur increased costs.

•Our use of derivatives may expose us to counterparty risk.

•Our rights under our repos are subject to the effects of the bankruptcy laws in the event of the bankruptcy or insolvency of us or our lenders.

•Certain actions by the Federal Reserve could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

•We may change our investment strategy, investment guidelines, hedging strategy, and asset allocation, operational, and management policies without notice or stockholder consent, which may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to

15

Table of Contents

our stockholders. In addition, our Board of Directors may authorize us to revoke or otherwise terminate our REIT election without the approval of our stockholders.

•We operate in a highly competitive market.

•We are highly dependent on Ellington's information systems and those of third-party service providers and system failures could significantly disrupt our business, which may, in turn, materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

•Because we are highly dependent on information systems when sharing information with third party service providers, systems failures, breaches or cyber-attacks could significantly disrupt our business, which could have a material adverse effect on our results of operations and cash flows.

•Lack of diversification in the number of assets we acquire would increase our dependence on relatively few individual assets.

•The lack of liquidity in our assets may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

•We could be subject to liability for potential violations of predatory lending laws, which could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

•We may be exposed to environmental liabilities with respect to properties in which we have an interest.

•Consumer loans are subject to delinquency and loss, which could have a negative impact on our financial results.

•Increased regulatory attention and potential regulatory action on certain areas within the consumer credit or reverse mortgage businesses could have a negative impact on our reputation, or cause losses on our investments in consumer loans or our equity investment in loan originators.

•Our investments in distressed debt and equity have significant risk of loss, and our efforts to protect these investments may involve large costs and may not be successful.

•We have held and may continue to hold the debt securities, loans or equity of companies that are more likely to enter into bankruptcy proceedings or have other risks.

•We may be subject to risks associated with syndicated loans.

•We have made and may in the future make investments in companies that we do not control.

•We have invested and may in the future invest in securities in the developing CRT sector that are subject to mortgage credit risk.

Risks Related to the COVID-19 Pandemic

•The recent global outbreak of the COVID-19 pandemic has adversely affected, and could continue to adversely affect, our business, financial condition, liquidity, and results of operations.

Risks Related to our Relationship with our Manager and Ellington

•Our relationship with our Manager and Ellington poses risks to us.

•We are dependent on our Manager and certain key personnel of Ellington that are provided to us through our Manager and may not find a suitable replacement if our Manager terminates the management agreement or such key personnel are no longer available to us.

•There are conflicts of interest in our relationships with our Manager and Ellington, which could result in decisions that are not in the best interests of our shareholders.

Risks Related to Our Common Stock and Preferred Stock

•Our stockholders may not receive dividends or dividends may not grow over time.

•An increase in interest rates may have an adverse effect on the market price of our equity or debt securities and our ability to pay dividends to our stockholders.

•Investing in our securities involves a high degree of risk.

Risks Related to Our Organization and Structure

•Our certificate of incorporation, bylaws and management agreement contain provisions that may inhibit potential acquisition bids that stockholders may consider favorable, and the market price of our common stock may be lower as a result.

•There are ownership limits and restrictions on transferability in our certificate of incorporation.

•Our rights and the rights of our stockholders to take action against our directors and officers or against our Manager or Ellington are limited, which could limit your recourse in the event actions are taken that are not in your best interests.

•Our certificate of incorporation designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders' ability to obtain a favorable judicial forum for disputes with us or our directors or officers.

•Maintenance of our exclusion from registration as an investment company under the Investment Company Act imposes significant limitations on our operations.

•If we were required to register as an investment company under the Investment Company Act, we would be subject to the restrictions imposed by the Investment Company Act, which would require us to make material changes to our strategy.

U.S. Federal Income Tax Risks

•Your investment has various U.S. federal, state, and local income tax risks. Our failure to qualify as a REIT would subject us to U.S. federal, state and local income taxes, which could adversely affect the value of our common stock and would substantially reduce the cash available for distribution to our stockholders.

•Complying with REIT requirements may cause us to forego or liquidate otherwise attractive investments.

•Complying with REIT requirements may limit our ability to hedge effectively.

16

Table of Contents

If any of the following risks occurs, our business, financial condition or results of operations could be materially and adversely affected. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us, or not presently deemed material by us, may also impair our operations and performance. In connection with the forward-looking statements that appear in our periodic reports on Form 10-Q and Form 10-K, our Current Reports on Form 8-K, our press releases and our other written and oral communications, you should also carefully review the cautionary statements referred to in such reports and other communications referred to under "Special Note Regarding Forward-Looking Statements."

Risks Related To Our Business

Difficult conditions in the mortgage and residential real estate markets as well as general market concerns may adversely affect the value of the assets in which we invest.

Our business is materially affected by conditions in the residential mortgage market, the residential real estate market, the financial markets, and the economy, including inflation, energy costs, unemployment, geopolitical issues, concerns over the creditworthiness of governments worldwide and the stability of the global banking system. In particular, the residential mortgage markets in the U.S. and Europe have experienced a variety of difficulties and challenging economic conditions in the past, including defaults, credit losses, and liquidity concerns. Certain commercial banks, investment banks, insurance companies, and mortgage-related investment vehicles incurred extensive losses from exposure to the residential mortgage market as a result of these difficulties and conditions. These factors have impacted, and may in the future impact, investor perception of the risks associated with residential mortgage loans, RMBS, other real estate-related securities and various other asset classes in which we may invest. As a result, values for residential mortgage loans, RMBS, other real estate-related securities and various other asset classes in which we may invest have experienced, and may in the future experience, significant volatility. Any deterioration of the mortgage market and investor perception of the risks associated with residential mortgage loans, RMBS, other real estate-related securities, and various other assets that we acquire could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

The federal conservatorship of Fannie Mae and Freddie Mac and related efforts, along with any changes in laws and regulations affecting the relationship between Fannie Mae, Freddie Mac, and Ginnie Mae and the U.S. Government, may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

The payments we receive on our Agency RMBS depend upon a steady stream of payments on the underlying mortgages and such payments are guaranteed by the Federal National Mortgage Association, or "Fannie Mae," the Federal Home Loan Mortgage Corporation, or "Freddie Mac," or the Government National Mortgage Association, within the U.S. Department of Housing and Urban Development, or "Ginnie Mae." Fannie Mae and Freddie Mac are government-sponsored enterprises, or "GSEs," but their guarantees are not backed by the full faith and credit of the United States. Ginnie Mae, which guarantees MBS backed by federally insured or guaranteed loans primarily consisting of loans insured by the Federal Housing Administration, or "FHA," or guaranteed by the Department of Veterans Affairs, or "VA," is part of a U.S. Government agency and its guarantees are backed by the full faith and credit of the United States.

In September 2008, in response to the deteriorating financial condition of Fannie Mae and Freddie Mac, the U.S. Government placed Fannie Mae and Freddie Mac into the conservatorship of the Federal Housing Finance Agency, or "FHFA," their federal regulator, pursuant to its powers under The Federal Housing Finance Regulatory Reform Act of 2008, a part of the Housing and Economic Recovery Act of 2008. Under this conservatorship, Fannie Mae and Freddie Mac are required to reduce the amount of mortgage loans they own or for which they provide guarantees on Agency RMBS. In addition to the FHFA becoming the conservator of Fannie Mae and Freddie Mac, the U.S. Treasury entered into Preferred Stock Purchase Agreements (“PSPAs”) with the FHFA and have taken various actions intended to provide Fannie Mae and Freddie Mac with additional liquidity in an effort to ensure their financial stability.

Shortly after Fannie Mae and Freddie Mac were placed in federal conservatorship, the Secretary of the U.S. Treasury noted that the guarantee structure of Fannie Mae and Freddie Mac required examination and that changes in the structures of the entities were necessary to reduce risk to the financial system. The future roles of Fannie Mae and Freddie Mac could be significantly reduced, and the nature of their guarantees could be considerably limited relative to historical measurements or even eliminated. The substantial financial assistance provided by the U.S. Government to Fannie Mae and Freddie Mac, especially in the course of their being placed into conservatorship and thereafter, together with the substantial financial assistance provided by the U.S. Government to the mortgage-related operations of other GSEs and government agencies, such as the FHA, VA, and Ginnie Mae, has stirred debate among many federal policymakers over the continued role of the U.S. Government in providing such financial support for the mortgage-related GSEs in particular, and for the mortgage and housing markets in general.

17

Table of Contents

In May 2020, the FHFA announced new capital rules for the GSEs intended to rebuild the GSEs’ capital bases in advance of leaving conservatorship. On June 30, 2020, the proposed rule for the GSEs was published in the Federal Register, and on December 17, 2020, the final rule was published with an effective date of February 16, 2021. In January 2021, the FHFA and the U.S. Treasury agreed to modifications to the PSPAs that will permit Fannie Mae and Freddie Mac to continue to retain earnings until they satisfy the requirements of the new capital rules. However, no definitive proposals or legislation have been released or enacted with respect to ending the conservatorship, unwinding the GSEs, or materially reducing the roles of the GSEs in the U.S. mortgage market, and it is not possible at this time to predict the scope and nature of the actions that the U.S. Government will ultimately take with respect to these GSEs.

Fannie Mae, Freddie Mac, and Ginnie Mae could each be dissolved, and the U.S. Government could determine to stop providing liquidity support of any kind to the mortgage market. If Fannie Mae, Freddie Mac, or Ginnie Mae were eliminated, or their structures were to change radically, or if the U.S. Government significantly reduced its support for any or all of them, we may be unable or significantly limited in our ability to acquire Agency RMBS, which would drastically reduce the amount and type of Agency RMBS available for purchase which, in turn, could materially adversely affect our ability to maintain our exclusion from registration as an investment company under the Investment Company Act and our ability to maintain our qualification as a REIT. Moreover, any changes to the nature of the guarantees provided by, or laws affecting, Fannie Mae, Freddie Mac, and Ginnie Mae could materially adversely affect the credit quality of the guarantees, could increase the risk of loss on purchases of Agency RMBS issued by these GSEs and could have broad adverse market implications for the Agency RMBS they currently guarantee. Any action that affects the credit quality of the guarantees provided by Fannie Mae, Freddie Mac, and Ginnie Mae could materially adversely affect the value of our Agency RMBS. In addition, any market uncertainty that arises from such proposed changes could have a similar impact on us and our Agency RMBS.

In addition, we rely on our Agency RMBS as collateral for our financings under the repos that we enter into. Any decline in their value, or perceived market uncertainty about their value, would make it more difficult for us to obtain financing on our Agency RMBS on acceptable terms or at all, or to maintain compliance with the terms of any financing transactions.

Mortgage loan modification programs and future legislative action may adversely affect the value of, and the returns on, our targeted assets.

The U.S. Government, through the U.S. Treasury, FHA, and the Federal Deposit Insurance Corporation, or "FDIC," has at various points in time, including in response to the COVID-19 pandemic, and may again in the future, implement programs designed to provide homeowners with assistance in avoiding mortgage loan foreclosures. The programs may involve, among other things, the modification of mortgage loans to reduce the principal amount of the loans or the rate of interest payable on the loans, or to extend the payment terms of the loans.

Loan modification and refinance programs may adversely affect the performance of Agency and non-Agency RMBS and residential mortgage loans. In the case of non-Agency RMBS, a significant number of loan modifications with respect to a given security, including those related to principal forgiveness and coupon reduction, could negatively impact the realized yields and cash flows on such security. Similarly, principal forgiveness and/or coupon reduction could negatively impact the performance of any residential mortgage loans we own. In addition, it is also likely that loan modifications would result in increased prepayments on some RMBS. See "—Prepayment rates can change, adversely affecting the performance of our assets," below.

The U.S. Congress and various state and local legislatures may pass mortgage-related legislation that would affect our business, including legislation that would permit limited assignee liability for certain violations in the mortgage loan origination process, and legislation that would allow judicial modification of loan principal in the event of personal bankruptcy. We cannot predict whether or in what form Congress or the various state and local legislatures may enact legislation affecting our business or whether any such legislation will require us to change our practices or make changes in our portfolio in the future. These changes, if required, could materially adversely affect our business, results of operations and financial condition, and our ability to pay dividends to our stockholders, particularly if we make such changes in response to new or amended laws, regulations or ordinances in any state where we acquire a significant portion of our mortgage loans, or if such changes result in us being held responsible for any violations in the mortgage loan origination process.

The existing loan modification programs, together with future legislative or regulatory actions, including possible amendments to the bankruptcy laws, which result in the modification of outstanding residential mortgage loans and/or changes in the requirements necessary to qualify for refinancing mortgage loans with Fannie Mae, Freddie Mac, or Ginnie Mae, may adversely affect the value of, and the returns on, our assets, which could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

18

Table of Contents

The principal and interest payments on our non-Agency RMBS and any CRTs that we may purchase are not guaranteed by any entity, including any government entity or GSE, and therefore are subject to increased risks, including credit risk.

Our portfolio includes non-Agency RMBS which are backed by residential mortgage loans that do not conform to the Fannie Mae or Freddie Mac underwriting guidelines, including subprime, manufactured housing, Alt-A, prime jumbo, non-QM, and single-family-rental mortgage loans. Consequently, the principal and interest on non-Agency RMBS, unlike those on Agency RMBS, are not guaranteed by GSEs such as Fannie Mae and Freddie Mac or, in the case of Ginnie Mae, the U.S. Government.

Non-Agency RMBS are subject to many of the risks of the respective underlying mortgage loans. A residential mortgage loan is typically secured by single-family residential property and is subject to risks of delinquency and foreclosure and risk of loss. The ability of a borrower to repay a loan secured by a residential property is dependent upon the income or assets of the borrower. A number of factors, including a general economic downturn, unemployment, acts of God, pandemics such as the COVID-19 pandemic, terrorism, social unrest, and civil disturbances, may impair borrowers' abilities to repay their mortgage loans. In periods following home price declines, "strategic defaults" (decisions by borrowers to default on their mortgage loans despite having the ability to pay) also may become more prevalent. In addition, the Tax Cuts and Jobs Act, or "TCJA," reduced the mortgage interest deduction limit, eliminated the deduction for interest with respect to home equity indebtedness, with certain exceptions, and limited the state and local income and property tax deduction. These changes could reduce home affordability and adversely impact housing prices in certain regions, which could lead to an increase in defaults on the mortgage loans underlying many of our investments.

In the event of defaults under mortgage loans backing any of our non-Agency RMBS, we will bear a risk of loss of principal to the extent of any deficiency between the value of the collateral and the principal and accrued interest of the mortgage loan.

Additionally, in the event of the bankruptcy of a mortgage loan borrower, the mortgage loan to such borrower will be deemed to be secured only to the extent of the value of the underlying collateral at the time of bankruptcy (as determined by the bankruptcy court), and the lien securing the mortgage loan will be subject to the avoidance powers of the bankruptcy trustee or debtor-in-possession to the extent the lien is unenforceable under state law. Foreclosure of a mortgage loan can be an expensive and lengthy process which could have a substantial negative effect on our anticipated return on the foreclosed mortgage loan. If borrowers default on the mortgage loans backing our non-Agency RMBS and we are unable to recover any resulting loss through the foreclosure process, our business, financial condition and results of operations, and our ability to pay dividends to our stockholders, could be materially adversely affected.

Less stringent underwriting guidelines and the resultant potential for delinquencies or defaults on certain mortgage loans could lead to losses on many of the non-Agency RMBS and European RMBS that we hold.

Many of the non-Agency RMBS in which we invest are collateralized by Alt-A and subprime mortgage loans, which are mortgage loans that were originated using less stringent underwriting guidelines than those used in underwriting prime mortgage loans (mortgage loans that generally conform to Fannie Mae or Freddie Mac underwriting guidelines). In addition, we have acquired, and may acquire in the future, European RMBS, including retained tranches from European RMBS securitizations in which we have participated. These European RMBS are backed by residential mortgage loans that were typically originated using less stringent underwriting guidelines. These underwriting guidelines were more permissive as to borrower credit history or credit score, borrower debt-to-income ratio, loan-to-value ratio, and/or as to documentation (such as whether and to what extent borrower income was required to be disclosed or verified). In addition, even when specific underwriting guidelines were represented by loan originators as having been used in connection with the origination of mortgage loans, these guidelines were in many cases not followed as a result of aggressive lending practices, fraud (including borrower or appraisal fraud), or other factors. Mortgage loans that were underwritten pursuant to less stringent or looser underwriting guidelines, or that were poorly underwritten to their stated guidelines, have experienced, and should be expected to experience in the future, substantially higher rates of delinquencies, defaults, and foreclosures than those experienced by mortgage loans that were underwritten in a manner more consistent with Fannie Mae or Freddie Mac guidelines. Thus, because of the higher delinquency rates and losses associated with Alt-A, subprime mortgage loans and European mortgage loans, the performance of RMBS backed by Alt-A, subprime mortgage loans, and European mortgage loans that we may acquire could be correspondingly adversely affected, which could adversely impact our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

19

Table of Contents

We rely on analytical models and other data to analyze potential asset acquisition and disposition opportunities and to manage our portfolio. Such models and other data may be incorrect, misleading or incomplete, which could cause us to purchase assets that do not meet our expectations or to make asset management decisions that are not in line with our strategy.

Our Manager relies on the analytical models (both proprietary and third-party models) of Ellington and information and data supplied by third parties. These models and data may be used to value assets or potential asset acquisitions and dispositions and also in connection with our asset management activities. If Ellington's models and data prove to be incorrect, misleading, or incomplete, any decisions made in reliance thereon could expose us to potential risks. Our Manager's reliance on Ellington's models and data may induce it to purchase certain assets at prices that are too high, to sell certain other assets at prices that are too low, or to miss favorable opportunities altogether. Similarly, any hedging activities that are based on faulty models and data may prove to be unsuccessful.

Some of the risks of relying on analytical models and third-party data include the following:

•collateral cash flows and/or liability structures may be incorrectly modeled in all or only certain scenarios, or may be modeled based on simplifying assumptions that lead to errors;

•information about assets or the underlying collateral may be incorrect, incomplete, or misleading;

•asset, collateral or MBS historical performance (such as historical prepayments, defaults, cash flows, etc.) may be incorrectly reported, or subject to interpretation (e.g., different MBS issuers may report delinquency statistics based on different definitions of what constitutes a delinquent loan); and

•asset, collateral or MBS information may be outdated, in which case the models may contain incorrect assumptions as to what has occurred since the date information was last updated.

Some models, such as prepayment models or default models, may be predictive in nature. The use of predictive models has inherent risks. For example, such models may incorrectly forecast future behavior, leading to potential losses. In addition, the predictive models used by our Manager may differ substantially from those models used by other market participants, with the result that valuations based on these predictive models may be substantially higher or lower for certain assets than actual market prices. Furthermore, because predictive models are usually constructed based on historical data supplied by third parties, the success of relying on such models may depend heavily on the accuracy and reliability of the supplied historical data, and, in the case of predicting performance in scenarios with little or no historical precedent (such as extreme broad-based declines in home prices, deep economic recessions or depressions, or pandemics), such models must employ greater degrees of extrapolation and are therefore more speculative and of more limited reliability.

All valuation models rely on correct market data inputs. If incorrect market data is entered into even a well-founded valuation model, the resulting valuations will be incorrect. However, even if market data is input correctly, "model prices" will often differ substantially from market prices, especially for securities with complex characteristics or whose values are particularly sensitive to various factors. If our market data inputs are incorrect or our model prices differ substantially from market prices, our business, financial condition and results of operations, and our ability to pay dividends to our stockholders could be materially adversely affected.

Valuations of some of our assets are inherently uncertain, may be based on estimates, may fluctuate over short periods of time, and may differ from the values that would have been used if a ready market for these assets existed.

The values of some of the assets in our portfolio are not readily determinable. We value these assets monthly at fair value, as determined in good faith by our Manager, subject to the oversight of our Manager's valuation committee. Because such valuations are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our Manager's determinations of fair value may differ from the values that would have been used if a ready market for these assets existed or from the prices at which trades occur. Furthermore, we may not obtain third-party valuations for all of our assets. Changes in the fair value of our assets directly impact our net income through recording unrealized appreciation or depreciation of our investments and derivative instruments, and so our Manager's determination of fair value has a material impact on our net income.

While in many cases our Manager's determination of the fair value of our assets is based on valuations provided by third-party dealers and pricing services, our Manager can and does value assets based upon its judgment and such valuations may differ from those provided by third-party dealers and pricing services. Valuations of certain assets are often difficult to obtain or are unreliable. In general, dealers and pricing services heavily disclaim their valuations. Additionally, dealers and pricing services may claim to furnish valuations only as an accommodation and without special compensation, and so they may disclaim any and all liability for any direct, incidental, or consequential damages arising out of any inaccuracy or incompleteness in valuations, including any act of negligence or breach of any warranty. Depending on the complexity and

20

Table of Contents

illiquidity of an asset, valuations of the same asset can vary substantially from one dealer or pricing service to another. Higher valuations of our assets have the effect of increasing the amount of base management fees and incentive fees we pay to our Manager. Therefore, conflicts of interest exist because our Manager is involved in the determination of the fair value of our assets.

Market-based inputs are generally the preferred source of values for purposes of measuring the fair value of our assets under U.S. GAAP. However, the markets for our investments have experienced, and could in the future experience, extreme volatility, reduced transaction volume and liquidity, and disruption as a result of certain events, such as the COVID-19 pandemic, which has made, and could in the future make, it more difficult for our Manager, and for the third-party dealers and pricing services that we use, to rely on market-based inputs in connection with the valuation of our assets under U.S. GAAP. Furthermore, in determining the fair value of our assets, our Manager uses proprietary models that require the use of a significant amount of judgment and the application of various assumptions including, but not limited to, assumptions concerning future prepayment rates, interest rates, default rates and loss severities. These assumptions might be especially difficult to project accurately during periods of economic disruption. The fair value of certain of our investments may fluctuate over short periods of time, and our Manager’s determinations of fair value may differ materially from the values that would have been used if a ready market for these investments existed.

Our business, financial condition and results of operations, and our ability to pay dividends to our stockholders could be materially adversely affected if our Manager's fair value determinations of these assets were materially different from the values that would exist if a ready market existed for these assets.

We depend on third-party service providers, including mortgage servicers, for a variety of services related to our non-Agency RMBS, European assets, securitizations, and whole mortgage loans and loan pools. We are, therefore, subject to the risks associated with third-party service providers.

We depend on a variety of services provided by third-party service providers related to our non-Agency RMBS, European assets, securitizations, and whole mortgage loans and loan pools. We rely on the mortgage servicers who service the mortgage loans backing our non-Agency RMBS, our European assets, our securitizations, as well as the mortgage loans and loan pools that we own directly, to, among other things, collect principal and interest payments on the underlying mortgages and perform loss mitigation services. These mortgage servicers and other service providers to our non-Agency RMBS, European assets, and securitizations, such as trustees, bond insurance providers, due diligence vendors, and custodians, may not perform in a manner that promotes our interests. In addition, legislation that has been enacted or that may be enacted in order to reduce or prevent foreclosures through, among other things, loan modifications, may reduce the value of mortgage loans backing our non-Agency RMBS or whole mortgage loans that we acquire. Mortgage servicers may be incentivized by U.S. federal, state, or local governments to pursue such loan modifications, as well as forbearance plans and other actions intended to prevent foreclosure, even if such loan modifications and other actions are not in the best interests of the beneficial owners of the mortgage loans. In addition to legislation that creates financial incentives for mortgage loan servicers to modify loans and take other actions that are intended to prevent foreclosures, legislation has also been adopted that creates a safe harbor from liability to creditors for servicers that undertake loan modifications and other actions that are intended to prevent foreclosures. Finally, legislation has been adopted that delays the initiation or completion of foreclosure proceedings on specified types of residential mortgage loans or otherwise limits the ability of mortgage servicers to take actions that may be essential to preserve the value of the mortgage loans underlying the mortgage servicing rights. Any such limitations are likely to cause delayed or reduced collections from mortgagors and generally increase servicing costs. As a result of these legislative actions, the mortgage loan servicers on which we rely may not perform in our best interests or up to our expectations. If our third-party service providers, including mortgage servicers, do not perform as expected, our business, financial condition and results of operations, and ability to pay dividends to our stockholders may be materially adversely affected.

We rely on mortgage servicers for our loss mitigation efforts, and we also may engage in our own loss mitigation efforts with respect to whole mortgage loans that we own directly. Such loss mitigation efforts may be unsuccessful or not cost effective.

Both default frequency and default severity of mortgage loans are highly dependent on the quality of the mortgage servicer. We depend on the loss mitigation efforts of mortgage servicers and in some cases "special servicers," which are mortgage servicers who specialize in servicing non-performing loans. If mortgage servicers are not vigilant in encouraging borrowers to make their monthly payments, the borrowers are far less likely to make those payments. In addition, for the whole mortgage loans that we own directly, we may engage in our own loss mitigation efforts over and beyond the efforts of the mortgage servicers, including more hands-on mortgage servicer oversight and management, borrower refinancing solicitations, as well as other efforts. Our and our mortgage servicers' loss mitigation efforts may be unsuccessful in limiting delinquencies, defaults, and losses, or may not be cost effective, which may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders. Furthermore, our ability to accomplish such loss mitigation may be limited by the tax rules governing REITs.

21

Table of Contents

We may be affected by deficiencies in foreclosure practices of third parties, as well as related delays in the foreclosure process.

Following the global financial crisis of 2008-2009, one of the biggest risks affecting the residential mortgage loan, non-Agency RMBS, and European RMBS markets has been uncertainty around the timing and ability of servicers to foreclose on defaulted loans, so that they can liquidate the underlying properties and ultimately pass the liquidation proceeds through to RMBS holders. Given the magnitude of the 2008-2009 housing crisis, and in response to the well-publicized failures of many servicers to follow proper foreclosure procedures, mortgage servicers are being held to much higher foreclosure-related documentation standards than they previously were. However, because many mortgages have been transferred and assigned multiple times (and by means of varying assignment procedures) throughout the origination, warehouse, and securitization processes, mortgage servicers have generally had much more difficulty furnishing the requisite documentation to initiate or complete foreclosures. In addition, the COVID-19 pandemic has led, and could continue to lead, to delays in the foreclosure process, both by operation of state law (e.g., foreclosure moratoriums in certain states) and by delays in the judicial system. These circumstances have led to stalled or suspended foreclosure proceedings, and ultimately additional foreclosure-related costs. Foreclosure-related delays also tend to increase ultimate loan loss severities as a result of property deterioration, amplified legal and other costs, and other factors. Many factors delaying foreclosure, such as borrower lawsuits and judicial backlog and scrutiny, are outside of a servicer's control and have delayed, and will likely continue to delay, foreclosure processing in both judicial states (where foreclosures require court involvement) and non-judicial states. The concerns about deficiencies in foreclosure practices of servicers and related delays in the foreclosure process may impact our loss assumptions and has affected and may continue to affect the values of, and our returns on, our investments in RMBS and residential whole loans.

To the extent that due diligence is conducted on potential assets, such due diligence may not reveal all of the risks associated with such assets and may not reveal other weaknesses in such assets, which could lead to losses.

Before making an investment, our Manager may decide to conduct (either directly or using third parties) certain due diligence. There can be no assurance that our Manager will conduct any specific level of due diligence, or that, among other things, our Manager's due diligence processes will uncover all relevant facts or that any purchase will be successful, which could result in losses on these assets, which, in turn, could adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Sellers of the mortgage loans that we acquire, or that underlie the non-Agency RMBS or European RMBS in which we invest, may be unable to repurchase defective mortgage loans, which could have a material adverse effect on the value of our loans, or the loans held by the trust that issued the RMBS, and could cause shortfalls in the payments due on the RMBS or losses on the mortgage loans.

Sellers of mortgage loans that we acquire or that are sold to the trusts that issued the non-Agency RMBS or European RMBS in which we invest made various representations and warranties related to the mortgage loans sold by them to us or the trusts that issued the RMBS. If a seller fails to cure a material breach of its representations and warranties with respect to any mortgage loan in a timely manner, then we, or the trustee or the servicer of the loans, may have the right to require that the seller repurchase the defective mortgage loan (or in some cases substitute a performing mortgage loan). It is possible, however, that for financial or other reasons, the seller either may not be capable of repurchasing defective mortgage loans, or may dispute the validity of or otherwise resist its obligation to repurchase defective mortgage loans. The inability or unwillingness of a seller to repurchase defective mortgage loans from us or from a non-Agency RMBS trust or European RMBS trust in which we invest would likely cause higher rates of delinquencies, defaults, and losses for the mortgage loans we hold, or the mortgage loans backing such non-Agency RMBS or European RMBS, and ultimately greater losses for our investment in such assets.

Our assets include subordinated and lower-rated securities that generally have greater risk of loss than senior and higher-rated securities.

Certain securities that we acquire are deemed by rating agencies to have substantial vulnerability to default in payment of interest and/or principal. Other securities we acquire have the lowest quality ratings or are unrated. Many securities that we acquire are subordinated in cash flow priority to other more "senior" securities of the same securitization. The exposure to defaults on the underlying mortgages is severely magnified in subordinated securities. Certain subordinated securities ("first loss securities") absorb all losses from default before any other class of securities is at risk. Such securities therefore are considered to be highly speculative investments. Also, the risk of declining real estate values, in particular, is amplified in subordinated RMBS and CMBS, as are the risks associated with possible changes in the market's perception of the entity issuing or guaranteeing them, or by changes in government regulations and tax policies. Accordingly, the subordinated and lower-rated (or unrated) securities in which we invest may experience significant price and performance volatility relative to more senior or higher-rated securities, and they are subject to greater risk of loss than more senior or higher-rated securities which, if realized, could materially adversely affect our business, financial condition and results of operations, and our ability to

22

Table of Contents

pay dividends to our stockholders.

Investments in second lien mortgage loans could subject us to increased risk of losses.

We may invest in second-lien mortgage loans or RMBS backed by such loans. If a borrower defaults on a second-lien mortgage loan or on its senior debt (i.e., a first-lien loan, in the case of a residential mortgage loan), or in the event of a borrower bankruptcy, such loan will be satisfied only after all senior debt is paid in full. As a result, if we invest in second-lien mortgage loans and the borrower defaults, we may lose all or a significant part of our investment.

Prepayment rates can change, adversely affecting the performance of our assets.

The frequency at which prepayments (including both voluntary prepayments by borrowers and liquidations due to defaults and foreclosures) occur on mortgage loans, including those underlying our RMBS, is affected by a variety of factors, including the prevailing level of interest rates as well as economic, demographic, tax, social, legal, and other factors. Generally, borrowers tend to prepay their mortgages when prevailing mortgage rates fall below the interest rates on their mortgage loans. When borrowers prepay their mortgage loans at rates that are faster or slower than expected, it results in prepayments that are faster or slower than expected on such loans or the related RMBS. These faster or slower than expected payments may adversely affect our profitability.

We may purchase securities or loans that have a higher interest rate than the then-prevailing market interest rate. In exchange for this higher interest rate, we may pay a premium to par value to acquire the security or loan. In accordance with U.S. GAAP, we amortize this premium as an expense over the expected term of the security or loan based on our prepayment assumptions. If a security or loan is prepaid in whole or in part at a faster than expected rate, however, we must expense all or a part of the remaining unamortized portion of the premium that was paid at the time of the purchase, which will adversely affect our profitability.

We also may purchase securities or loans that have a lower interest rate than the then-prevailing market interest rate. In exchange for this lower interest rate, we may pay a discount to par value to acquire the security or loan. We accrete this discount as income over the expected term of the security or loan based on our prepayment assumptions. If a security or loan is prepaid at a slower than expected rate, however, we must accrete the remaining portion of the discount at a slower than expected rate. This will extend the expected life of our investment portfolio and result in a lower than expected yield on securities and loans purchased at a discount to par.

Prepayment rates generally increase when interest rates fall and decrease when interest rates rise. Since many RMBS, especially fixed rate RMBS, will be discount securities when interest rates are high, and will be premium securities when interest rates are low, these RMBS may be adversely affected by changes in prepayments in any interest rate environment. Prepayment rates are also affected by factors not directly tied to interest rates, and these factors are difficult to predict. Prepayments can also occur when borrowers sell their properties or when borrowers default on their mortgages and the mortgages are prepaid from the proceeds of a foreclosure sale of the underlying property and/or from the proceeds of a mortgage insurance policy or other guarantee. Fannie Mae and Freddie Mac will generally, among other conditions, purchase mortgages that are 120 days or more delinquent from the Agency RMBS pools that they have issued when the cost of guaranteed payments to security holders, including advances of interest at the security coupon rate, exceeds the cost of holding the non-performing loans in their portfolios. Consequently, prepayment rates also may be affected by conditions in the housing and financial markets, which may result in increased delinquencies on mortgage loans. Prepayment rates can also be affected by actions of the GSEs and their cost of capital, general economic conditions, and the relative interest rates on fixed and adjustable rate loans. Additionally, changes in the GSEs' decisions as to when to repurchase delinquent loans can materially impact prepayment rates on Agency RMBS.

The adverse effects of prepayments may impact us in various ways. First, particular investments may experience outright losses, as in the case of interest only securities, or "IOs," and inverse interest only securities, or "IIOs," in an environment of faster actual or anticipated prepayments. Second, particular investments may underperform relative to any hedges that our Manager may have constructed for these assets, resulting in a loss to us. In particular, prepayments (at par) may limit the potential upside of many RMBS to their principal or par amounts, whereas their corresponding hedges often have the potential for unlimited loss. Furthermore, to the extent that faster prepayment rates are due to lower interest rates, the principal payments received from prepayments will tend to be reinvested in lower-yielding assets, which may reduce our income in the long run. Therefore, if actual prepayment rates differ from anticipated prepayment rates, our business, financial condition and results of operations, and ability to pay dividends to our stockholders could be materially adversely affected.

Increases in interest rates could negatively affect the value of our assets and increase the risk of default on our assets.

Our fixed rate investments, especially most fixed rate mortgage loans, fixed rate MBS, and most MBS backed by fixed

23

Table of Contents

rate mortgage loans, decline in value when long-term interest rates increase. Even in the case of Agency RMBS, the guarantees provided by GSEs do not protect us from declines in market value caused by changes in interest rates. In the case of RMBS backed by adjustable rate mortgages, or "ARMs," increases in interest rates can lead to increases in delinquencies and defaults as borrowers become less able to make their mortgage payments following interest payment resets. Additionally, an increase in short-term interest rates would increase the amount of interest owed on our repo borrowings. See "—Interest rate mismatches between our assets and our borrowings may reduce our income during periods of changing interest rates, and increases in interest rates could adversely affect the value of our assets" below.

An increase in interest rates may cause a decrease in the issuance volumes of certain of our targeted assets, which could adversely affect our ability to acquire targeted assets that satisfy our investment objectives and to generate income and pay dividends.

Rising interest rates generally reduce the demand for mortgage loans due to the higher cost of borrowing. A reduction in the volume of mortgage loans originated may affect the volume of targeted assets available to us, which could adversely affect our ability to acquire assets that satisfy our investment objectives. If rising interest rates cause us to be unable to acquire a sufficient volume of our targeted assets with a yield that is above our borrowing cost, our ability to satisfy our investment objectives and to generate income and pay dividends to our stockholders may be materially and adversely affected.

Interest rate caps on the ARMs and hybrid ARMs that back our RMBS may reduce our net interest margin during periods of rising or high interest rates.

ARMs and hybrid ARMs (i.e., residential mortgage loans that have interest rates that are fixed for a specified period of time (typically three, five, seven or ten years) and, thereafter, adjust to a fixed increment over a specified interest rate index) are typically subject to periodic and lifetime interest rate caps. Periodic interest rate caps limit the amount an interest rate can increase during any given period. Lifetime interest rate caps limit the amount an interest rate can increase through the maturity of the loan. Our borrowings typically are not subject to similar restrictions. Accordingly, in a period of rapidly increasing interest rates, our financing costs could increase without limitation while caps could limit the interest we earn on our RMBS backed by ARMs and hybrid ARMs. This problem is magnified for ARMs and hybrid ARMs that are not fully indexed because such periodic interest rate caps prevent the coupon on the security from fully reaching the specified rate in one reset. Further, some ARMs and hybrid ARMs may be subject to periodic payment caps that result in a portion of the interest being deferred and added to the principal outstanding. As a result, we may receive less cash income on RMBS backed by ARMs and hybrid ARMs than necessary to pay interest on our related borrowings. Interest rate caps on RMBS backed by ARMs and hybrid ARMs could reduce our net interest margin if interest rates were to increase beyond the level of the caps, which could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Residential mortgage loans, including residential NPLs, non-QM loans, and residential transition loans, are subject to increased risks.

We acquire and manage residential mortgage loans. Residential mortgage loans, including residential NPLs, non-QM loans, and residential transition loans, are subject to increased risk of loss. Unlike Agency RMBS, residential mortgage loans generally are not guaranteed by the U.S. Government or any GSE, though in some cases they may benefit from private mortgage insurance. Additionally, by directly acquiring residential mortgage loans, we do not receive the structural credit enhancements that benefit senior tranches of RMBS. A residential whole mortgage loan is directly exposed to losses resulting from default. Therefore, the value of the underlying property, the creditworthiness and financial position of the borrower, and the priority and enforceability of the lien will significantly impact the value of such mortgage loan. In the event of a foreclosure, we may assume direct ownership of the underlying real estate. The liquidation proceeds upon sale of such real estate may not be sufficient to recover our cost basis in the loan, and any costs or delays involved in the foreclosure or liquidation process may increase losses.

Residential mortgage loans are also subject to property damage caused by hazards, such as earthquakes or environmental hazards, not covered by standard property insurance policies, or "special hazard risk," and to reduction in a borrower's mortgage debt by a bankruptcy court, or "bankruptcy risk." In addition, claims may be assessed against us on account of our position as a mortgage holder or property owner, including assignee liability, environmental hazards, and other liabilities. We could also be responsible for property taxes. In some cases, these liabilities may be "recourse liabilities" or may otherwise lead to losses in excess of the purchase price of the related mortgage or property.

If we subsequently resell any whole mortgage loans that we acquire, we may be required to repurchase such loans or indemnify purchasers if we breach representations and warranties.

If we subsequently resell any whole mortgage loans that we acquire, we would generally be required to make customary

24

Table of Contents

representations and warranties about such loans to the loan purchaser. Our residential mortgage loan sale agreements and terms of any securitizations into which we sell loans will generally require us to repurchase or substitute loans in the event we breach a representation or warranty given to the loan purchaser. In addition, we may be required to repurchase loans as a result of borrower fraud or in the event of early payment default on a mortgage loan. The remedies available to a purchaser of mortgage loans are generally broader than those available to us against an originating broker or correspondent. Repurchased loans are typically worth only a fraction of the original price. Significant repurchase activity could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

The commercial mortgage loans that we acquire or originate, and the mortgage loans underlying our CMBS investments, are subject to the ability of the commercial property owner to generate net income from operating the property as well as to the risks of delinquency and foreclosure.

Commercial mortgage loans are secured by commercial property and are subject to risks of delinquency and foreclosure, and risk of loss that may be greater than similar risks associated with loans made on the security of single-family residential property. The ability of a borrower to repay a loan secured by an income-producing property typically is dependent primarily upon the successful operation of such property rather than upon the existence of independent income or assets of the borrower. If the net operating income of the property is reduced, the borrower's ability to repay the loan may be impaired. Net operating income of an income-producing property can be adversely affected by, among other things:

•tenant mix;

•declines in tenant income and/or changes to tenant businesses;

•property management decisions;

•property location, condition, and design;

•new construction of competitive properties;

•changes in laws that increase operating expenses or limit rents that may be charged;

•changes in national, regional, or local economic conditions and/or specific industry segments, including the credit and securitization markets;

•declines in regional or local real estate values;

•declines in regional or local rental or occupancy rates;

•increases in interest rates, real estate tax rates, and other operating expenses;

•costs of remediation and liabilities associated with environmental conditions;

•the potential for uninsured or underinsured property losses;

•changes in governmental laws and regulations, including fiscal policies, zoning ordinances and environmental legislation, and the related costs of compliance; and

•acts of God, pandemics such as the COVID-19 pandemic, terrorist attacks, social unrest, and civil disturbances.

In the event of any default under a mortgage loan held directly by us, we will bear a risk of loss to the extent of any deficiency between the value of the collateral and our cost basis in the outstanding principal and accrued interest of the mortgage loan, and any such losses could have a material adverse effect on our cash flow from operations and our ability to pay dividends to our stockholders.

In the event of the bankruptcy of a mortgage loan borrower, the mortgage loan to such borrower will be deemed to be secured only to the extent of the value of the underlying collateral at the time of bankruptcy (as determined by the bankruptcy court), and the lien securing the mortgage loan will be subject to the avoidance powers of the bankruptcy trustee or debtor-in-possession to the extent the lien is unenforceable under state law. Foreclosure of a mortgage loan can be an expensive and lengthy process, which could have a substantial negative effect on our anticipated return on the foreclosed mortgage loan.

CMBS are secured by a single commercial mortgage loan or a pool of commercial mortgage loans. Accordingly, the CMBS we invest in are subject to all of the risks of the respective underlying commercial mortgage loans.

Our investments in CMBS are at risk of loss.

Our investments in CMBS are at risk of loss. In general, losses on real estate securing a mortgage loan included in a securitization will be borne first by the owner of the property, then by the holder of a mezzanine loan or a subordinated participation interest in a bifurcated first lien loan, or "B-Note," if any, then by the "first loss" subordinated security holder (generally, the B-piece buyer) and then by the holder of a higher-rated security. In the event of losses on mortgage loans

25

Table of Contents

included in a securitization and the subsequent exhaustion of any applicable reserve fund, letter of credit, or classes of securities junior to those in which we invest, we may not be able to recover all of our investment in the securities we purchase. In addition, if any of the real estate underlying the securitization mortgage portfolio has been overvalued by the originator, or if real estate values subsequently decline and, as a result, less collateral is available to satisfy interest and principal payments due on the related CMBS, we may incur losses. The prices of lower credit quality securities are generally less sensitive to interest rate changes than more highly rated investments, but more sensitive to adverse economic downturns or individual issuer developments.

We may not control the special servicing of the mortgage loans included in the CMBS in which we invest and, in such cases, the special servicer may take actions that could adversely affect our interests.

With respect to the CMBS in which we invest, overall control over the special servicing of the related underlying mortgage loans will be held by a "directing certificateholder" or a "controlling class representative," which is generally appointed by the holders of the most subordinate class of CMBS in such series. In connection with the servicing of the specially serviced mortgage loans, the related special servicer may, at the direction of the directing certificateholder, take actions with respect to the specially serviced mortgage loans that could adversely affect our interests. For further discussion of the risks of our reliance on special servicers, see "—We rely on mortgage servicers for our loss mitigation efforts, and we also may engage in our own loss mitigation efforts with respect to whole mortgage loans that we own directly. Such loss mitigation efforts may be unsuccessful or not cost effective" above.

A portion of our investments currently are, and in the future may be, in the form of non-performing and sub-performing commercial and residential mortgage loans, or loans that may become non-performing or sub-performing, which are subject to increased risks relative to performing loans.

A portion of our investments currently are, and in the future may be, in the form of commercial and residential whole mortgage loans, including subprime mortgage loans and non-performing and sub-performing mortgage loans, which are subject to increased risks of loss. Such loans may already be, or may become, non-performing or sub-performing for a variety of reasons, including because the underlying property is too highly leveraged or the borrower falls upon financial distress. Such non-performing or sub-performing loans may require a substantial amount of workout negotiations and/or restructuring, which may divert the attention of our Manager from other activities and entail, among other things, a substantial reduction in the interest rate, capitalization of interest payments, and a substantial write-down of the principal of the loan. However, even if such restructuring were successfully accomplished, a risk exists that the borrower will not be able or willing to maintain the restructured payments or refinance the restructured mortgage upon maturity. In addition, such modifications could affect our compliance with the tests applicable to REITs, including by increasing our distribution requirement.

In addition, certain non-performing or sub-performing loans that we acquire may have been originated by financial institutions that are or may become insolvent, suffer from serious financial stress, or are no longer in existence. As a result, the standards by which such loans were originated, the recourse to the selling institution, and/or the standards by which such loans are being serviced or operated may be adversely affected. Further, loans on properties operating under the close supervision of a mortgage lender are, in certain circumstances, subject to certain additional potential liabilities that may exceed the value of our investment.

In the future, it is possible that we may find it necessary or desirable to foreclose on some, if not many, of the loans we acquire, and the foreclosure process may be lengthy and expensive. Borrowers or junior lenders may resist mortgage foreclosure actions by asserting numerous claims, counterclaims, and defenses against us including, without limitation, numerous lender liability claims and defenses, even when such assertions may have no basis in fact, in an effort to prolong the foreclosure action and force the lender into a modification of the loan or capital structure or a favorable buy-out of the borrower's or junior lender's position. In some states, foreclosure actions can sometimes take several years or more to litigate. At any time prior to or during the foreclosure proceedings, the borrower may file, or a junior lender may cause the borrower to file, for bankruptcy, which would have the effect of staying the foreclosure actions and further delaying the foreclosure process. Foreclosure and associated litigation may create a negative public perception of the related mortgaged property, resulting in a diminution of its value. Even if we are successful in foreclosing on a loan, the liquidation proceeds upon sale of the underlying real estate may not be sufficient to recover our cost basis in the loan, resulting in a loss to us, and the borrower or junior lenders may continue to challenge whether the foreclosure process was commercially reasonable, which could result in additional costs and potential liability. Any costs or delays involved in the effectuation of a foreclosure of the loan or a liquidation of the underlying property, or defending challenges brought after the completion of a foreclosure, will further reduce the liquidation proceeds and thus increase the loss. Any such reductions could materially and adversely affect the value we realize from the loans in which we invest.

26

Table of Contents

Whether or not our Manager has participated in the negotiation of the terms of any such mortgage loans, there can be no assurance as to the adequacy of the protection of the terms of the loan, including the validity or enforceability of the loan and the maintenance of the anticipated priority and perfection of the applicable security interests. Furthermore, claims may be asserted that might interfere with enforcement of our rights. In the event of a foreclosure, we may assume direct ownership of the underlying real estate. The liquidation proceeds upon sale of such real estate may not be sufficient to recover our cost basis in the loan, resulting in a loss to us.

Commercial whole mortgage loans are also subject to special hazard risk and to bankruptcy risk. In addition, claims may be assessed against us on account of our position as mortgage holder or property owner, including assignee liability, responsibility for tax payments, environmental hazards and other liabilities. In some cases, these liabilities may be "recourse liabilities" or may otherwise lead to losses in excess of the purchase price of the related mortgage or property.

Our real estate assets and our real estate-related assets (including mortgage loans and MBS) are subject to the risks associated with real property.

We own assets secured by real estate, we own real estate directly, and may acquire additional real estate directly in the future, either through direct acquisitions or upon a default of mortgage loans. Real estate assets are subject to various risks, including:

•declines in the value of real estate;

•acts of God, including pandemics, such as the COVID-19 pandemic, earthquakes, floods, wildfires, hurricanes, mudslides, volcanic eruptions and other natural disasters, which may result in uninsured losses;

•acts of war or terrorism, including the consequences of terrorist attacks, such as those that occurred on September 11, 2001;

•adverse changes in national and local economic and market conditions;

•changes in governmental laws and regulations, fiscal policies and zoning ordinances and the related costs of compliance with laws and regulations, fiscal policies and zoning ordinances;

•costs of remediation and liabilities associated with environmental conditions such as indoor mold;

•potential liabilities for other legal actions related to property ownership including tort claims; and

•the potential for uninsured or under-insured property losses.

The occurrence of any of the foregoing or similar events may reduce our return from an affected property or asset and, consequently, materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

We engage in short selling transactions, which may subject us to additional risks.

Many of our hedging transactions, and occasionally our investment transactions, are short sales. Short selling may involve selling securities that are not owned and typically borrowing the same securities for delivery to the purchaser, with an obligation to repurchase the borrowed securities at a later date. Short selling allows the investor to profit from declines in market prices to the extent such declines exceed the transaction costs and the costs of borrowing the securities. A short sale may create the risk of an unlimited loss, in that the price of the underlying security might theoretically increase without limit, thus increasing the cost of repurchasing the securities. There can be no assurance that securities sold short will be available for repurchase or borrowing. Repurchasing securities to close out a short position can itself cause the price of the securities to rise further, thereby exacerbating the loss.

We use leverage in executing our business strategy, which may adversely affect the return on our assets and may reduce cash available for distribution to our stockholders, as well as increase losses when economic conditions are unfavorable.

We use leverage to finance our investment activities and to enhance our financial returns. Most of our leverage is in the form of short-term repos for our Agency and credit portfolio assets. Other forms of leverage include our term secured bank facilities, our securitizations, our Senior Notes, and may in the future include credit facilities, including term loans and revolving credit facilities.

Through the use of leverage, we may acquire positions with market exposure significantly greater than the amount of capital committed to the transaction. For example, by entering into repos with haircut levels, of 5%, we could theoretically leverage capital allocated to Agency RMBS by an asset-to-equity ratio of as much as 20 to 1. A haircut is the percentage discount that a repo lender applies to the market value of an asset serving as collateral for a repo borrowing, for the purpose of determining whether such repo borrowing is adequately collateralized.

27

Table of Contents

Although we may from time to time enter into certain contracts with third parties that may limit our leverage, such as certain financing arrangements with lenders, our governing documents do not specifically limit the amount of leverage that we may use. Leverage can enhance our potential returns but can also exacerbate losses. Even if an asset increases in value, if the asset fails to earn a return that equals or exceeds our cost of borrowing, the leverage will diminish our returns.

Leverage also increases the risk of our being forced to precipitously liquidate our assets. See "—Our access to financing sources, which may not be available on favorable terms, or at all, may be limited, and our lenders and derivative counterparties may require us to post additional collateral. These circumstances may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders" below.

Our access to financing sources, which may not be available on favorable terms, or at all, may be limited, and our lenders and derivative counterparties may require us to post additional collateral. These circumstances may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Our ability to fund our operations, meet financial obligations, and finance targeted asset acquisitions may be impacted by an inability to secure and maintain our financing through repurchase agreements or other borrowings with our counterparties. Because repurchase agreements are generally short-term transactions, lenders may respond to adverse market conditions in a manner that makes it more difficult for us to renew or replace on a continuous basis our maturing short-term borrowings and have, and may continue to, impose more onerous conditions when rolling such repurchase agreements.

Our lenders are primarily large global financial institutions, with exposures both to global financial markets and to more localized conditions. In addition to borrowing from large banks, we borrow from smaller non-bank financial institutions. Whether because of a global or local financial crisis or other circumstances, such as if one or more of our lenders experiences severe financial difficulties, they or other lenders could become unwilling or unable to provide us with financing, could increase the haircut required for such financing, or could increase the costs of that financing.

Moreover, we are currently party to short-term borrowings (in the form of repos) and there can be no assurance that we will be able to replace these borrowings, or "roll" them, as they mature on a continuous basis and it may be more difficult for us to obtain debt financing on favorable terms, or at all. If we are not able to renew our existing repurchase agreements or other borrowings, or arrange for new financing on terms acceptable to us, or if we default on our financial covenants (including those on our repurchase agreements, other borrowings, and our Senior Notes), are otherwise unable to access funds under our financing arrangements, or if we are required to post more collateral or face larger haircuts, we may have to dispose of assets at significantly depressed prices and at inopportune times, which could cause significant losses, and may also force us to curtail our asset acquisition activities. Similarly, if we were to move a financing from one counterparty to another that was subject to a larger haircut we would have to repay more cash to the original repurchase agreement counterparty than we would be able to borrow from the new repurchase agreement counterparty. To the extent that we might be compelled to liquidate qualifying real estate assets to repay debts, our compliance with the REIT asset tests, income tests, and distribution requirements could be negatively affected, which could jeopardize our qualification as a REIT. Losing our REIT qualification would cause us to be subject to U.S. federal income tax (and any applicable state and local taxes) on all of our income and decrease profitability and cash available to pay dividends to our stockholders. Any such forced liquidations could also materially adversely affect our ability to maintain our exclusion from registration as an investment company under the Investment Company Act.

In addition, if there is a contraction in the overall availability of financing for our assets, including if the regulatory capital requirements imposed on our lenders change, our lenders may significantly increase the cost of the financing that they provide to us, or increase the amounts of collateral they require as a condition to providing us with financing. Our lenders also have revised, and may continue to revise, their eligibility requirements for the types of assets that they are willing to finance or the terms of such financing arrangements, including increased haircuts and requiring additional cash collateral, based on, among other factors, the regulatory environment and their management of actual and perceived risk, particularly with respect to assignee liability.

Moreover, the amount of financing that we receive under our financing agreements will be directly related to our lenders’ valuation of the financed assets subject to such agreements. Typically, the master repurchase agreements that govern our borrowings under repurchase agreements grant the lender the right to reevaluate the fair market value of the financed assets subject to such repurchase agreements at any time. If a lender determines that the net decrease in the value of the portfolio of financed assets is greater in magnitude than any applicable threshold, it will generally initiate a margin call. In such cases, a lender's valuations of the financed assets may be different than the values that we ascribe to these assets and may be influenced by recent asset sales at distressed levels by forced sellers. A valid margin call requires us to transfer additional cash or qualifying assets to a lender without any advance of funds from the lender for such transfer or to repay a portion of the outstanding borrowings. If a lender under one of our repo agreements were to send us a notice of default, even if we were to dispute the validity of a margin call from the lender, such lender will have possession of the financed assets, and might still

28

Table of Contents

decide to exercise its contractual remedies. In the event of our default, our lenders or derivative counterparties can accelerate our indebtedness, terminate our derivative contracts (potentially on unfavorable terms requiring additional payments, including additional fees and costs), increase our borrowing rates, liquidate our collateral, and terminate our ability to borrow. In certain cases, a default on one repo agreement or derivative agreement (whether caused by a failure to satisfy margin calls or another event of default) can trigger "cross defaults" on other such agreements. In addition, if the market value of our derivative contracts with a derivative counterparty declines in value, we generally will be subject to a margin call by the derivative counterparty.

Significant margin calls and/or increased repo haircuts could have a material adverse effect on our results of operations, financial condition, business, liquidity, and ability to make distributions to our stockholders, and could cause the value of our capital stock to decline. During March and April of 2020, we observed that many of our financing agreement counterparties assigned lower valuations to certain of our assets, resulting in us having to pay cash or transfer additional securities to satisfy margin calls, which were higher than historical levels. In addition, during March and April of 2020 we also experienced an increase in haircuts on repurchase agreements that we rolled. A sufficiently deep and/or rapid increase in margin calls or haircuts would have an adverse impact on our liquidity.

Consequently, depending on market conditions at the relevant time, we may have to rely on additional equity issuances to meet our capital and financing needs, which may be dilutive to our stockholders, or we may have to rely on less efficient forms of debt financing that consume a larger portion of our cash flow from operations, thereby reducing funds available for our operations, future business opportunities, cash dividends to our stockholders, and other purposes. We cannot assure you that we will have access to such equity or debt capital on favorable terms (including, without limitation, cost and term) at the desired times, or at all, which may cause us to curtail our asset acquisition activities and/or dispose of assets, which could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders, or in the worst case, cause our insolvency.

A failure to comply with restrictive covenants in our financing arrangements would have a material adverse effect on us, and any future financings may require us to provide additional collateral or pay down debt.

We are subject to various restrictive covenants contained in our existing financing arrangements and may become subject to additional covenants in connection with future financings. For example, the indenture governing our Senior Notes contains covenants that, subject to a number of exceptions and adjustments, among other things: limit our ability to incur additional indebtedness; require us to maintain a minimum Net Asset Value (as defined in the indenture governing the Senior Notes); require us to maintain a ratio of Consolidated Unencumbered Assets (as defined in indenture governing the Senior Notes) to the aggregate principal amount of the outstanding Senior Notes at or above a specified threshold, and impose certain conditions on our merger or consolidation with another person. In addition, the interest rate on our Senior Notes is subject to upward adjustment based on certain changes, if any, in the ratings of the Senior Notes. Furthermore, several of our repo agreements contain financial covenants of a similar nature, including requiring us to maintain a minimum level of liquidity and a minimum level of equity.

The covenants in our financing arrangements may limit our flexibility to pursue certain investments or incur additional debt. If we fail to meet or satisfy any of these covenants, subject to certain cure provisions, as applicable, we would be in default under these agreements and our indebtedness could be declared due and payable. In addition, our lenders could terminate their commitments, require the posting of additional collateral and enforce their interests against existing collateral. We may also be subject to cross-default and acceleration rights under our financing arrangements, whereby a default (such as a failure to comply with a covenant) under one financing arrangement can trigger a default under other financing arrangements.

Our securitizations may expose us to additional risks.

In order to generate additional cash for funding new investments, we have securitized, and may in the future seek to securitize, certain of our assets, especially our loan assets. Some securitizations are treated as financing transactions for U.S. GAAP, while others are treated as sales. In a typical securitization, we convey assets to a special purpose vehicle, which then issues one or more classes of notes secured by the assets pursuant to the terms of an indenture. To the extent that we retain the most subordinated economic interests in the issuing vehicle, we would continue to be exposed to losses on the assets for as long as those retained interests remained outstanding and therefore able to absorb such losses. Furthermore, our retained interests in a securitization could be less liquid than the underlying assets themselves, and may be subject to U.S. Risk Retention Rules (See "—We, Ellington, or its affiliates may be subject to adverse legislative or regulatory changes," below) and similar European rules. Moreover, even though we might accumulate assets with a view towards possible securitization, we cannot be assured that we will be able to access the securitization market, or be able to do so under favorable terms. The inability to securitize certain segments of our portfolio, especially certain of our loan assets, could force us to resort to inferior methods of financing those assets, could force us to sell those loan assets at inopportune times, and could adversely impact our ability to grow our loan acquisition businesses.

29

Table of Contents

In addition, in anticipation of a securitization transaction, we (either alone or in conjunction with other investors, including other Ellington affiliates) have in the past, and may again in the future, provide capital to a vehicle accumulating assets for the securitization. If such a securitization is not ultimately completed, or if the assets do not perform as expected during the accumulation period, we could lose all or a portion of the capital that we provided to the vehicle. Furthermore, because we may enter into these types of transactions along with other investors, including other Ellington affiliates, there may be conflicts between us, on the one hand, and the other investors, including other Ellington affiliates, on the other hand. These accumulation vehicles typically enter into warehouse financing facilities to facilitate their accumulation of assets, and so such vehicles carry with them the additional risks associated with financial leverage and covenant compliance.

In connection with our securitizations, we generally are required to prepare disclosure documentation for investors, including term sheets and offering memoranda, which contain information regarding the securitization generally, the securities being issued, and the assets being securitized. If our disclosure documentation for a securitization is alleged or found to contain material inaccuracies or omissions, we may be liable under federal securities laws, state securities laws or other applicable laws for damages to the investors in such securitization, we may be required to indemnify the underwriters of the securitization or other parties, and/or we may incur other expenses and costs in connection with disputing these allegations or settling claims. Such liabilities, expenses, and/or losses could be significant.

We will typically be required to make representations and warranties in connection with our securitizations regarding, among other things, certain characteristics of the assets being securitized. If any of the representations and warranties that we have made concerning the assets are alleged or found to be inaccurate, we may incur expenses disputing the allegations, and we may be obligated to repurchase certain assets, which may result in losses. Even if we previously obtained representations and warranties from loan originators or other parties from whom we originally acquired the assets, such representations and warranties may not align with those that we have made for the benefit of the securitization, or may otherwise not protect us from losses (e.g., because of a deterioration in the financial condition of the party that provided representations and warranties to us).

Interest rate mismatches between our assets and our borrowings may reduce our income during periods of changing interest rates, and increases in interest rates could adversely affect the value of our assets.

Some of our assets are fixed rate or have a fixed rate component (such as RMBS backed by hybrid ARMs). This means that the interest we earn on these assets will not vary over time based upon changes in a short-term interest rate index. Although the interest we earn on our ARM loans and our RMBS backed by ARMs generally will adjust for changing interest rates, such interest rate adjustments may not occur as quickly as the interest rate adjustments to any related borrowings, and such interest rate adjustments will generally be subject to interest rate caps, which potentially could cause such RMBS to acquire many of the characteristics of fixed rate assets if interest rates were to rise above the cap levels. We generally fund our targeted assets with borrowings whose interest rates reset frequently, and as a result we generally have an interest rate mismatch between our assets and liabilities. While our interest rate hedges are intended to mitigate a portion of this mismatch, the use of interest rate hedges also introduces the risk of other interest rate mismatches and exposures, as will the use of other financing techniques. Additionally, to the extent cash flows from RMBS we hold are reinvested in new RMBS, the spread between the yields of the new RMBS and available borrowing rates may decline, which could reduce our net interest margin or result in losses.

Fixed income assets, including many RMBS, typically decline in value if interest rates increase. If long-term rates were to increase significantly, not only would the market value of these assets be expected to decline, but these assets could lengthen in duration because borrowers would be less likely to prepay their mortgages.

Interest rates are highly sensitive to many factors, including governmental monetary and tax policies, domestic and international economic and political considerations, and other factors beyond our control. During 2020, in response to the negative economic effects caused by the COVID-19 pandemic, the U.S. Federal Reserve, or the "Federal Reserve," decreased the target range for the federal funds rate from 1.50%—1.75% to 0.00%—0.25%. Prior to 2019, the Federal Reserve had been increasing the target range for the federal funds rate, from December 2015 through December 2018. The future path of interest rates is highly uncertain, and increases could occur in the near future.

While we opportunistically hedge our exposure to changes in interest rates, such hedging may be limited by our intention to remain qualified as a REIT, and we can provide no assurance that our hedges will be successful, or that we will be able to enter into or maintain such hedges. As a result, interest rate fluctuations can cause significant losses, reductions in income, and can limit the cash available to pay dividends to our stockholders.

The anticipated discontinuation of LIBOR and transition from LIBOR to an alternative reference rate may adversely affect the value and liquidity of the financial obligations to be held or issued by us that are linked to LIBOR.

30

Table of Contents

LIBOR is an indicative measure of the average interest rate at which major global banks could borrow from one another and is used extensively as a “benchmark” or “reference rate” for various financial and commercial contracts. LIBOR is quoted in multiple currencies and multiple time frames using data reported by private-sector banks.

On July 27, 2017, the U.K. Financial Conduct Authority, or the “FCA,” announced that it intends to phase out LIBOR by the end of 2021. It is unclear whether LIBOR will cease to exist at that time or whether new methods of calculating LIBOR will be established enabling LIBOR to continue to exist after 2021. On March 5, 2021, the ICE Benchmark Administration, (the current administrator of LIBOR), or the “IBA,” published a feedback statement stating that it would cease publishing USD LIBOR on December 31, 2021 for the one week and two month USD LIBOR tenors, and on June 30, 2023 for all other USD LIBOR tenors. In light of these recent announcements, the future of LIBOR at this time is uncertain and any changes in the methods by which LIBOR is determined, or any regulatory activity related to LIBOR’s phaseout, could cause LIBOR to behave differently than in the past or cease to exist. Although regulators and the IBA have made clear that the recent announcements should not be read to say that LIBOR has ceased or will cease, we cannot make assurances that LIBOR will survive in its current form, or at all.

In anticipation of the discontinuation of LIBOR in the U.S., the Alternative Reference Rates Committee, or the "ARRC," a group convened by the Federal Reserve Board and the Federal Reserve Bank of New York consisting of large U.S. financial institutions, regulators and other private and public-sector entities, has identified the Secured Overnight Financing Rate, or "SOFR," as its preferred alternative rate to take the place of US Dollar LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. Although the U.S. Treasury-backed overnight repo market is highly liquid, there is currently no robust market for determining forward-looking, SOFR term rates. Additionally, certain of our LIBOR based contracts that may be in effect at the time of LIBOR discontinuation may not contain fallback language in the event LIBOR is unavailable or may not contain fallback language that contemplates the permanent discontinuation of LIBOR. Consequently, there is uncertainty as to how our LIBOR based financial instruments may react to its discontinuation.

It also is possible that not all of our LIBOR based assets and liabilities (including our derivatives) will transition away from LIBOR at the same time, and it is possible that not all of our assets and liabilities (including our derivatives) will transition to the same alternative reference rate, in each case increasing the difficulty of hedging. Switching existing financial instruments and hedging transactions from referencing LIBOR to SOFR requires calculations of a fixed spread to account for differences between LIBOR and SOFR. Industry organizations are attempting to structure the spread calculation in a manner that minimizes the possibility of value transfer between counterparties by virtue of the transition, but there is no assurance that the calculated spread will be fair and accurate or that similar financial instruments will use the same spread. We and other market participants have less experience understanding and modeling SOFR-based assets and liabilities than LIBOR-based assets and liabilities, increasing the difficulty of investing, hedging, and risk management. The process of transition may also involve operational risks. It is also possible that no transition will occur for certain financial instruments, meaning that those instruments would continue to be subject to the weaknesses of the LIBOR calculation process and/or, as is the potential case for our Series A Preferred Stock, that the determination of LIBOR would be dependent on banks voluntarily providing quotations of LIBOR to us based on specified procedures, which an insufficient number of banks may be willing or able to do, in which case the variable rate instrument could convert to a fixed-rate instrument based on the most recent rate in effect for the instrument. At this time, it is not possible to predict the effect of any such changes, any establishment of alternative reference rates or any other reforms to LIBOR that may be implemented. The nature of such potential changes, alternative reference rates or other reforms could adversely affect the market for or value of, any securities, loans, derivatives, and other financial instruments that are based directly or indirectly on LIBOR, and as a result may adversely affect our overall financial condition and results of operations.

Our investments that are denominated in foreign currencies subject us to foreign currency risk, which may adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Our investments that are denominated in foreign currencies subject us to foreign currency risk arising from fluctuations in exchange rates between such foreign currencies and the U.S. dollar. While we currently attempt to hedge the vast majority of our foreign currency exposure, subject to maintaining our qualification as a REIT, we may not always choose to hedge such exposure, or we may not be able to hedge such exposure. To the extent that we are exposed to foreign currency risk, changes in exchange rates of such foreign currencies to the U.S. dollar may adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

31

Table of Contents

Hedging against credit events, interest rate changes, foreign currency fluctuations, and other risks may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Subject to maintaining our qualification as a REIT and maintaining our exclusion from registration as an investment company under the Investment Company Act, we opportunistically pursue various hedging strategies to seek to reduce our exposure to losses from adverse credit events, interest rate changes, foreign currency fluctuations, and other risks. Hedging against a decline in the values of our portfolio positions does not prevent losses if the values of such positions decline, nor does it eliminate the possibility of fluctuations in the value of our portfolio. Hedging transactions generally will limit the opportunity for gain should the values of our other portfolio positions increase. Further, certain hedging transactions could result in significant losses. Qualification as a REIT may require that we undertake certain hedging activities in a TRS. Our domestic TRSs are subject to U.S. federal, state, and local income tax. Moreover, at any point in time we may choose not to hedge all or a portion of our risks, and we generally will not hedge those risks that we believe are appropriate for us to take at such time, or that we believe would be impractical or prohibitively expensive to hedge. Even if we do choose to hedge certain risks, for a variety of reasons we generally will not seek to establish a perfect correlation between our hedging instruments and the risks being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. Our hedging activity will vary in scope based on the composition of our portfolio, our market views, and changing market conditions, including the level and volatility of interest rates. When we do choose to hedge, hedging may fail to protect or could materially adversely affect us because, among other things:

•our Manager may fail to correctly assess the degree of correlation between the hedging instruments and the assets being hedged;

•our Manager may fail to recalculate, re-adjust, and execute hedges in an efficient and timely manner;

•the hedging transactions may actually result in poorer overall performance for us than if we had not engaged in the hedging transactions;

•credit hedging can be expensive, particularly when the market is forecasting future credit deterioration and when markets are more illiquid;

•interest rate hedging can be expensive, particularly during periods of volatile interest rates;

•available hedges may not correspond directly with the risks for which protection is sought;

•the durations of the hedges may not match the durations of the related assets or liabilities being hedged;

•many hedges are structured as over-the-counter contracts with counterparties whose creditworthiness is not guaranteed, raising the possibility that the hedging counterparty may default on their payment obligations;

•to the extent that the creditworthiness of a hedging counterparty deteriorates, it may be difficult or impossible to terminate or assign any hedging transactions with such counterparty; and

•our hedging instruments are generally structured as derivative contracts and, as a result, are subject to additional risks such as those described above under "—Our access to financing sources, which may not be available on favorable terms, or at all, may be limited, and our lenders and derivative counterparties may require us to post additional collateral. These circumstances may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders." and below under "—Our use of derivatives may expose us to counterparty risk."

For these and other reasons, our hedging activity may materially adversely affect our business, financial condition and results of operations, our ability to pay dividends to our stockholders, and our ability to maintain our qualification as a REIT.

Hedging instruments and other derivatives, including some credit default swaps, may not, in many cases, be traded on regulated exchanges, or may not be guaranteed or regulated by any U.S. or foreign governmental authority and involve risks and costs that could result in material losses.

Hedging instruments and other derivatives, including certain types of credit default swaps, involve risk because they may not, in many cases, be traded on exchanges and may not be guaranteed or regulated by any U.S. or foreign governmental authorities. Consequently, for these instruments there may be less stringent requirements with respect to record keeping and compliance with applicable statutory and commodity and other regulatory requirements and, depending on the identity of the counterparty, applicable international requirements. Our Manager is not restricted from dealing with any particular counterparty or from concentrating any or all of its transactions with one counterparty. Furthermore, our Manager has only a limited internal credit function to evaluate the creditworthiness of its counterparties, mainly relying on its experience with such counterparties and their general reputation as participants in these markets. The business failure of a hedging counterparty with whom we enter into a hedging transaction will most likely result in a default under the agreement governing the hedging arrangement. Default by a party with whom we enter into a hedging transaction, may result in losses and may force us to re-initiate similar hedges

32

Table of Contents

with other counterparties at the then-prevailing market levels. Generally we will seek to reserve the right to terminate our hedging transactions upon a counterparty's insolvency, but absent an actual insolvency, we may not be able to terminate a hedging transaction without the consent of the hedging counterparty, and we may not be able to assign or otherwise dispose of a hedging transaction to another counterparty without the consent of both the original hedging counterparty and the potential assignee. If we terminate a hedging transaction, we may not be able to enter into a replacement contract in order to cover our risk. There can be no assurance that a liquid secondary market will exist for hedging instruments purchased or sold, and therefore we may be required to maintain any hedging position until exercise or expiration, which could adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

In addition, some portion of our hedges are cleared through a central counterparty clearinghouse, or "CCP," which we access through a futures commission merchant, or "FCM." If an FCM that holds our cleared derivatives account were to become insolvent, the CCP will make an effort to move our futures positions to an alternate FCM, though it is possible that such transfer would fail, which would result in a total cancellation of our positions in the account; in such a case, if we wished to reinstate such hedging positions, we would have to re-initiate such positions with an alternate FCM. In the event of the insolvency of an FCM that holds our cleared over-the-counter derivatives, the rules of the CCP require that its direct members submit bids to take over the portfolio of the FCM, and would further require the CCP to move our existing positions and related margin to an alternate FCM. If this were to occur, we believe that our risk of loss would be limited to the excess equity in the account at the insolvent FCM due to the "legally segregated, operationally commingled" treatment of client assets under the rules governing FCMs in respect of cleared over-the-counter derivatives. In addition, in the case of both futures and cleared over-the-counter derivatives, there could be knock-on effects of our FCM's insolvency, such as the failure of co-customers of the FCM or other FCMs of the same CCP. In such cases, there could be a shortfall in the funds available to the CCP due to such additional insolvencies and/or exhaustion of the CCP's guaranty fund that could lead to total loss of our positions in the FCM account. Finally, we face a risk of loss (including total cancellation) of positions in the account in the event of fraud by our FCM or other FCMs of the CCP, where ordinary course remedies would not apply.

The U.S. Commodity Futures Trading Commission, or "CFTC," and certain commodity exchanges have established limits referred to as speculative position limits or position limits on the maximum net long or net short position which any person or group of persons may hold or control in particular futures and options. Limits on trading in options contracts also have been established by the various options exchanges. It is possible that trading decisions may have to be modified and that positions held may have to be liquidated in order to avoid exceeding such limits. Such modification or liquidation, if required, could adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Certain of our hedging instruments are regulated by the CFTC and such regulations may adversely impact our ability to enter into such hedging instruments and cause us to incur increased costs.

We enter into interest rate swaps and credit default swaps, or "CDS," on corporations or on corporate indices, or "CDX," to hedge risks associated with our portfolio. Entities entering into such swaps are exposed to credit losses in the event of non-performance by counterparties to these transactions. Effective October 12, 2012, the CFTC issued rules regarding such swaps under the authority granted to it pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the "Dodd-Frank Act."

The rules primarily impact our trading of these instruments in two ways. First, beginning on June 10, 2013, certain newly executed swaps, including many interest rate and credit default swaps, became subject to mandatory clearing through a CCP. It is the intent of the Dodd-Frank Act that, by mandating the clearing of swaps in this manner, swap counterparty risk would not become overly concentrated in any single entity, but rather would be spread and centralized among the CCP and its members. We are not a direct member of any CCP, so we must access the CCPs through a FCM, which acts as intermediary between us and the CCP with respect to all facets of the transaction, including the posting and receipt of required collateral. If we lost access to our FCMs or CCPs, we could potentially be unable to use interest rate swaps and credit default swaps to hedge our risks.

The second way that the rules impact our trading of these instruments is the Swap Execution Facility, or "SEF," mandate, which came into effect on October 2, 2013, and requires that we execute most interest rate swaps and CDX on an electronic platform, rather than over the phone or in some other manner. If we were to lose access to our selected SEFs or we were otherwise unable to communicate with them, this would prevent us from being able to trade these instruments. If we were unable to execute our hedging trades in a timely manner, particularly in a volatile market environment, we may not be able to execute our strategies in the most advantageous manner.

In addition to subjecting our swap transactions to greater initial margin requirements and additional transaction fees charged by CCPs, FCMs, and SEFs, our swap transactions are now subjected to greater regulation by both the CFTC and the SEC. These additional fees, costs, margin requirements, documentation, and regulation could adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

33

Table of Contents

Our use of derivatives may expose us to counterparty risk.

We enter into interest rate swaps and other derivatives that have not been cleared by a CCP. If a derivative counterparty cannot perform under the terms of the derivative contract, we would not receive payments due under that agreement, we may lose any unrealized gain associated with the derivative, and the hedged liability would cease to be hedged by such instrument. If a derivative counterparty becomes insolvent or files for bankruptcy, we may also be at risk for any collateral we have pledged to such counterparty to secure our obligations under derivative contracts, and we may incur significant costs in attempting to recover such collateral.

Our rights under our repos are subject to the effects of the bankruptcy laws in the event of the bankruptcy or insolvency of us or our lenders.

In the event of our insolvency or bankruptcy, certain repos may qualify for special treatment under the U.S. Bankruptcy Code, the effect of which, among other things, would be to allow the lender to avoid the automatic stay provisions of the U.S. Bankruptcy Code and to foreclose on and/or liquidate the collateral pledged under such agreements without delay. In the event of the insolvency or bankruptcy of a lender during the term of a repo, the lender may be permitted, under applicable insolvency laws, to repudiate the contract, and our claim against the lender for damages may be treated simply as an unsecured claim. In addition, if the lender is a broker or dealer subject to the Securities Investor Protection Act of 1970, or an insured depository institution subject to the Federal Deposit Insurance Act, our ability to exercise our rights to recover our securities under a repo or to be compensated for any damages resulting from the lenders' insolvency may be further limited by those statutes. These claims would be subject to significant delay and costs to us and, if and when received, may be substantially less than the damages we actually incur.

Certain actions by the Federal Reserve could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

In response to the global financial crisis of 2008-2009 and again in response to the economic effects of the COVID-19 pandemic in 2020, the Federal Reserve announced and completed several rounds of quantitative easing, which are programs designed to expand the Federal Reserve's holdings of long-term securities by purchasing U.S. Treasury securities and/or Agency RMBS, in order to provide stability to the market. During 2020, among other actions, the Federal Reserve: (i) reduced the target range for the federal funds rate to 0.00%–0.25%; (ii) committed to purchase U.S. Treasury securities and Agency MBS without explicit limits on the amounts purchased; (iii) reduced the discount rate at its discount window; (iv) reduced the reserve requirement ratios for depository institutions to 0.00%; (v) announced its intention to continue conducting term and overnight repo operations; (vi) encouraged banks to use their capital and liquidity buffers to lend; and (vii) in coordination with other central banks, expanded U.S. dollar liquidity swap lines with foreign banks. The Federal Reserve also announced several funding and liquidity programs, including providing up to $2.3 trillion in additional loans to the market. These actions put downward pressure on interest rates and stabilized repo rates, but they could be changed and/or discontinued at any time. Long-term interest rates, including mortgage rates, also declined, which led to an increase in prepayment rates and negatively impacted the market value of many of our investments.

Among other effects, these interest rate reductions by the Federal Reserve could continue to increase prepayment rates (resulting from lower long-term interest rates, including mortgage rates), continue to impact the shape of the yield curve, and cause a narrowing of our net interest margin. If the Federal Reserve were to discontinue, modify or reverse some or all of the programs and actions it implemented in 2020 in response to the COVID-19 pandemic, such actions could have a material adverse effect on our investment portfolio and on the economy as a whole, which could adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Conversely, if the negative economic effects of the COVID-19 pandemic continue, the Federal Reserve could implement additional quantitative easing or other similar programs designed to maintain interest rates or reduce them further, which could adversely impact our business, including lowering the yields that we are able to generate on our investments.

From December 2015 through December 2018, the Federal Reserve had been increasing the target range for the federal funds rate, and interest rate increases could occur again in the near future. See "—Increases in interest rates could negatively affect the value of our assets and increase the risk of default on our assets" above. These and other actions by the Federal Reserve could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

We may change our investment strategy, investment guidelines, hedging strategy, and asset allocation, operational, and management policies without notice or stockholder consent, which may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders. In addition, our Board of Directors may authorize us to revoke or otherwise terminate our REIT election without the approval of our stockholders.

We may change our investment strategy, investment guidelines, hedging strategy, and asset allocation, operational, and

34

Table of Contents

management policies at any time without notice to or consent from our stockholders. As a result, the types or mix of assets, liabilities, or hedging transactions in our portfolio may be different from, and possibly riskier than, the types or mix of assets, liabilities, and hedging transactions that we have historically held, or that are otherwise described in this report. A change in our strategy may increase our exposure to real estate values, interest rates, and other factors. Our Board of Directors determines our investment guidelines and our operational policies, and may amend or revise our policies, including those with respect to our acquisitions, growth, operations, indebtedness, capitalization, and dividends or approve transactions that deviate from these policies without a vote of, or notice to, our stockholders. Policy or strategy changes could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Although we elected to be treated as a REIT, our Board of Directors may authorize us to revoke or otherwise terminate our REIT election, without the approval of our stockholders, at any time. These changes could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

We operate in a highly competitive market.

Our profitability depends, in large part, on our ability to acquire targeted assets at favorable prices. We compete with a number of entities when acquiring our targeted assets, including other mortgage REITs, financial companies, public and private funds, commercial and investment banks, and residential and commercial finance companies. We may also compete with (i) the Federal Reserve and the U.S. Treasury to the extent they purchase assets in our targeted asset classes and (ii) companies that partner with and/or receive financing from the U.S. Government or consumer bank deposits. Many of our competitors are substantially larger and have considerably more favorable access to capital and other resources than we do. We acquire a significant amount of our loan assets pursuant to flow agreements with various loan originators. If such originators are unable or unwilling to continue to sell loan assets to us, we may be forced to acquire such loan assets at prices that are less attractive, or acquire different assets, which could adversely impact our business, financial condition and results of operations, and our ability to pay dividends to our stockholders. Furthermore, new companies with significant amounts of capital have been formed or have raised additional capital, and may continue to be formed and raise additional capital in the future, and these companies may have objectives that overlap with ours, which may create competition for assets we wish to acquire. Some competitors may have a lower cost of funds and access to funding sources that are not available to us, such as funding from the U.S. Government. In addition, some of our competitors may have higher risk tolerances or different risk assessments, which could allow them to consider a wider variety of assets to acquire, or pay higher prices than we can. We also may have different operating constraints from those of our competitors including, among others, (i) tax-driven constraints such as those arising from our qualification as a REIT and in some cases to avoid adverse tax consequences to our stockholders, (ii) restraints imposed on us by our attempt to comply with certain exclusions from the definition of an "investment company" or other exemptions under the Investment Company Act and (iii) restraints and additional costs arising from our status as a public company. Furthermore, competition for assets in our targeted asset classes may lead to the price of such assets increasing, which may further limit our ability to generate desired returns. We cannot assure you that the competitive pressures we face will not have a material adverse effect on our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

We are highly dependent on Ellington's information systems and those of third-party service providers and system failures could significantly disrupt our business, which may, in turn, materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Our business is highly dependent on Ellington's communications and information systems and those of third-party service providers. Any failure or interruption of Ellington's or certain third-party service providers' systems or cyber-attacks or security breaches of their networks or systems could cause delays or other problems in our securities trading activities, could allow unauthorized access for purposes of misappropriating assets, stealing proprietary and confidential information, corrupting data or causing operational disruption, which could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Computer malware, ransomware, viruses, and computer hacking and phishing attacks have become more prevalent in the financial services industry and may occur on Ellington's or certain third party service providers' systems in the future. We rely heavily on Ellington's financial, accounting and other data processing systems. Although Ellington has not detected a breach to date, financial services institutions have reported breaches of their systems, some of which have been significant. Even with all reasonable security efforts, not every breach can be prevented or even detected. It is possible that Ellington or certain third-party service providers have experienced an undetected breach, and it is likely that other financial institutions have experienced more breaches than have been detected and reported. There is no assurance that we, Ellington, or certain of the third parties that facilitate our and Ellington's business activities, have not or will not experience a breach. It is difficult to determine what, if any, negative impact may directly result from any specific interruption or cyber-attacks or security breaches of Ellington's networks or systems (or the networks or systems of certain third parties that facilitate our and Ellington's business activities) or

35

Table of Contents

any failure to maintain performance, reliability and security of Ellington's or certain third-party service providers' technical infrastructure, but such computer malware, ransomware, viruses, and computer hacking and phishing attacks may negatively affect our operations.

Because we are highly dependent on information systems when sharing information with third party service providers, systems failures, breaches or cyber-attacks could significantly disrupt our business, which could have a material adverse effect on our results of operations and cash flows.

When we acquire certain investments, including residential mortgage loans and consumer loans, we may come into possession of non-public personal information that an identity thief could utilize in engaging in fraudulent activity or theft. We may share this information with third party service providers, including those interested in acquiring such loans from us or financing such loans, or with other third parties, as required or permitted by law. We may be liable for losses suffered by individuals whose personal information is stolen as a result of a breach of the security of the systems on which Ellington, or third-party service providers of ours store this information, or as a result of other mismanagement of such information, and any such liability could be material. Even if we are not liable for such losses, any breach of these systems could expose us to material costs in notifying affected individuals or other parties and providing credit monitoring services, as well as to regulatory fines or penalties. In addition, any breach of these systems could disrupt our normal business operations and expose us to reputational damage and lost business, revenues, and profits.

Lack of diversification in the number of assets we acquire would increase our dependence on relatively few individual assets.

Our management objectives and policies do not place a limit on the amount of capital used to support, or the exposure to (by any other measure), any individual asset or any group of assets with similar characteristics or risks. As a result, our portfolio may be concentrated in a small number of assets or may be otherwise undiversified, increasing the risk of loss and the magnitude of potential losses to us and our stockholders if one or more of these assets perform poorly.

For example, our portfolio of mortgage-related assets may at times be concentrated in certain property types that are subject to higher risk of foreclosure, or secured by properties concentrated in a limited number of geographic locations. To the extent that our portfolio is concentrated in any one region or type of security, downturns or other significant events or developments relating generally to such region or type of security may result in defaults on a number of our assets within a short time period, which may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

The lack of liquidity in our assets may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

We acquire assets and other instruments that are not publicly traded, including privately placed RMBS, residential and commercial mortgage loans, CLOs, consumer loans, ABS backed by consumer and commercial assets, distressed corporate debt and equity, and other private investments. As such, these assets may be subject to legal and other restrictions on resale, transfer, pledge or other disposition, or will otherwise be less liquid than publicly traded securities. Other assets that we acquire, while publicly traded, have limited liquidity on account of their complexity, turbulent market conditions, or other factors. In addition, mortgage-related assets from time to time have experienced extended periods of illiquidity, including during times of financial stress (such as during the COVID-19 pandemic), which is often the time that liquidity is most needed. Illiquid assets typically experience greater price volatility, because a ready market does not exist, and they can be more difficult to value or sell if the need arises. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our assets. We may also face other restrictions on our ability to liquidate any assets for which we or our Manager has or could be attributed with material non-public information. Furthermore, assets that are illiquid are more difficult to finance, and to the extent that we finance assets that are or become illiquid, we may lose that financing or have it reduced. If we are unable to sell our assets at favorable prices or at all, it could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

We could be subject to liability for potential violations of predatory lending laws, which could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Loan originators and servicers are required to comply with various federal, state and local laws and regulations, including anti-predatory lending laws and laws and regulations imposing certain restrictions on requirements on high cost loans. Failure of loan originators or servicers to comply with these laws, to the extent any of their loans become part of our assets, could subject us, as an assignee or purchaser of the related loans, to monetary penalties and could result in the borrowers rescinding

36

Table of Contents

the affected loans. Lawsuits have been brought in various states making claims against assignees or purchasers of high cost loans for violations of state law. Named defendants in these cases have included assignees or purchasers of certain types of loans we invest in. If the loans are found to have been originated in violation of predatory or abusive lending laws, we could incur losses, which could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

We may be exposed to environmental liabilities with respect to properties in which we have an interest.

In the course of our business, we may take title to real estate, and, if we do take title, we could be subject to environmental liabilities with respect to these properties. In such a circumstance, we may be held liable to a governmental entity or to third parties for property damage, personal injury, investigation, and clean-up costs incurred by these parties in connection with environmental contamination, or may be required to investigate or clean up hazardous or toxic substances, or chemical releases at a property. The costs associated with investigation or remediation activities could be substantial. In addition, the presence of hazardous substances may adversely affect an owner's ability to sell real estate or borrow using real estate as collateral. To the extent that an owner of an underlying property becomes liable for removal costs, the ability of the owner to make debt payments may be reduced, which in turn may materially adversely affect the value of the relevant mortgage-related assets held by us.

Consumer loans are subject to delinquency and loss, which could have a negative impact on our financial results.

We are exposed to the performance of consumer loans both through the consumer loans that we own directly, and through those consumer loans to which we are exposed indirectly through our ownership of consumer-loan-backed ABS. The ability of borrowers to repay consumer loans may be adversely affected by numerous borrower-specific factors, including unemployment, divorce, major medical expenses or personal bankruptcy. General factors, including an economic downturn, high energy costs or acts of God, pandemics such as the COVID-19 pandemic, or terrorism, may also affect the financial stability of borrowers and impair their ability or willingness to repay their loans. Whenever any of our consumer loans defaults, we are at risk of loss to the extent of any deficiency between the liquidation value of the collateral, if any, securing the loan, and the principal and accrued interest of the loan. Many of our consumer loans are unsecured, or are secured by collateral (such as an automobile) that depreciates rapidly; as a result, these loans may be at greater risk of loss than residential real estate loans. Pursuing any remaining deficiency following a default is often difficult or impractical, especially when the borrower has a low credit score, making further substantial collection efforts unwarranted. In addition, repossessing personal property securing a consumer loan can present additional challenges, including locating and taking physical possession of the collateral. We rely on servicers who service these consumer loans, to, among other things, collect principal and interest payments on the loans and perform loss mitigation services, and these servicers may not perform in a manner that promotes our interests. Since we purchase some of our consumer loans and our consumer-loan-backed ABS at a premium to the remaining unpaid principal balance, we may incur a loss when such loans are voluntarily prepaid. There can be no guarantee that we will not suffer unexpected losses on our investments as a result of the factors set out above, which could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Increased regulatory attention and potential regulatory action on certain areas within the consumer credit or reverse mortgage businesses could have a negative impact on our reputation, or cause losses on our investments in consumer loans or our equity investment in loan originators.

Certain consumer advocacy groups, media reports, and federal and state legislators have asserted that laws and regulations should be tightened to severely limit, if not eliminate, the availability of certain loan products. The consumer advocacy groups and media reports generally focus on higher cost consumer loans, which are typically made to less creditworthy borrowers, and which bear interest rates that are higher than the interest rates typically charged by lending institutions to more creditworthy consumers. These consumer advocacy groups and media reports have characterized these consumer loans as predatory or abusive. In addition, reverse mortgage loans have faced similar issues in terms of media reports and potential legislative hurdles. If the negative characterization of these types of loans becomes increasingly accepted by consumers, legislators or regulators, our reputation, as a purchaser of such loans and as an equity investor in a both a consumer loan originator and a reverse mortgage originator, could be negatively impacted. Furthermore, if legislators or regulators take action against originators of consumer loans or reverse mortgages or provide for payment relief for borrowers (which could happen, for example, because of the new presidential administration), we could incur additional losses on the consumer loans that we have purchased and/or with respect to the equity investments that we have made in a consumer loan originator and a reverse mortgage originator.

37

Table of Contents

Our investments in distressed debt and equity have significant risk of loss, and our efforts to protect these investments may involve large costs and may not be successful.

Our investments in distressed debt and equity have a significant risk of loss, and our efforts to protect these investments may involve large costs and may not be successful. We also will be subject to significant uncertainty as to when and in what manner and for what value the distressed debt or equity in which we invest will eventually be satisfied (e.g., in the case of distressed debt, through liquidation of the obligor's assets, an exchange offer or plan of reorganization involving the distressed debt securities or a payment of some amount in satisfaction of the obligation). In addition, even if an exchange offer is made or plan of reorganization is adopted with respect to distressed debt we hold, there can be no assurance that the securities or other assets received by us in connection with such exchange offer or plan of reorganization will not have a lower value or income potential than may have been anticipated when the investment was made. Moreover, any securities received by us upon completion of an exchange offer or plan of reorganization may be restricted as to resale. If we participate in negotiations with respect to any exchange offer or plan of reorganization with respect to an issuer of distressed debt, we may be restricted from disposing of such securities.

The pools of loans underlying Ellington-sponsored CLO securitizations ("Ellington-Sponsored CLOs") have historically had lower credit ratings than the loan portfolios in typical CLOs, as they allow for a higher percentage of below investment grade loans. Ellington-Sponsored CLOs have at times also experienced negative credit events in their constituent loans, credit rating downgrades of constituent loans and issued debt tranches, and failures of certain deal metrics. As a result, the risks associated with our investments in Ellington-Sponsored CLOs may be greater than those associated with our investments in other CLOs. In addition, we have in the past, and we may in the future, make equity investments in proposed Ellington-Sponsored CLO issuing entities, and we also may make loans to such entities in which we have an equity investment, to enable these entities to establish warehouse facilities for the purpose of acquiring the assets to be securitized. If the assets accumulated prior to the completion of a proposed CLO securitization experience negative credit events, decrease in value, are sold at a loss, or the proposed securitization does not occur, our equity and loan investments in such entity may experience a partial or complete loss.

We have held and may continue to hold the debt securities, loans or equity of companies that are more likely to enter into bankruptcy proceedings or have other risks.

We have held and may continue to hold the debt securities, loans or equity of companies that are more likely to experience bankruptcy or similar financial distress, such as companies that are thinly capitalized, employ a high degree of financial leverage, are in highly competitive or risky businesses, are in a start-up phase, or are experiencing losses. The bankruptcy process has a number of significant inherent risks. Many events in a bankruptcy proceeding are the product of contested matters and adversarial proceedings and are beyond the control of the creditors. A bankruptcy filing by a company whose debt or equity we have purchased may adversely and permanently affect such company. If the proceeding results in liquidation, the liquidation value of the company may have deteriorated significantly from what we believed to be the case at the time of our initial investment. The duration of a bankruptcy proceeding is also difficult to predict, and a return on investment to a creditor or equity investor can be adversely affected by delays until a plan of reorganization or liquidation ultimately becomes effective. The administrative costs in connection with a bankruptcy proceeding are frequently high and would be paid out of the debtor's estate prior to any return to creditors. Because the standards for classification of claims under bankruptcy law are vague, our influence with respect to the class of securities or other obligations we own may be lost by increases in the number and amount of claims in the same class or by different classification and treatment. In the early stages of the bankruptcy process, it is often difficult to estimate the extent of, or even to identify, any contingent claims that might be made. In addition, certain claims that have priority by law (for example, claims for taxes) may be substantial, eroding the value of any recovery by holders of other securities of the bankrupt entity.

A bankruptcy court may also re-characterize our debt investment as equity, and subordinate all or a portion of our claim to that of other creditors. This could occur even if our investment had initially been structured as senior debt, and we could lose all or a significant part of our investment.

We have made and may in the future make loans secured by, or invest in structures tied to, individual, or portfolios of, legal claims, or "litigation finance loans." There is no assurance our Manager will be able to predict several aspects of the cases underlying our investments, including to which courts and judges the cases are assigned, the development of evidence during discovery and its presentation at trial, the composition and decisions of juries, timing of the judicial process, likelihood of settlements and collectability of judgments.

In addition, we will not have the ability to control decisions made by the claimholder, defendant, or the law firm, nor can we share details of the underlying cases with our stockholders. We rely on, among other things, the advice and opinion of outside counsel and other experts in assessing potential claims and on the skills and efforts of independent law firms to litigate

38

Table of Contents

cases. There is no guarantee that the ultimate outcome of any case will be in line with a law firm's or expert's initial assessment of the validity and merit of a legal claim.

Various laws restrict the ability to assign certain legal claims or to participate in a lawyer's contingent fee interest in a claim. While we intend to analyze all relevant restrictions prior to investment, there is a risk that failure to comply with a federal, state or local law, rule or regulation could subject us to liability and jeopardize the enforceability of our investment.

We may be subject to risks associated with syndicated loans.

Under the documentation for syndicated loans, a financial institution or other entity typically is designated as the administrative agent and/or collateral agent. This agent is granted a lien on any collateral on behalf of the other lenders and distributes payments on the indebtedness as they are received. The agent is the party responsible for administering and enforcing the loan and generally may take actions only in accordance with the instructions of a majority or two-thirds in commitments and/or principal amount of the associated indebtedness. In most cases for our syndicated loan investments, we do not expect to hold a sufficient amount of the indebtedness to be able to compel any actions by the agent. Consequently, we would only be able to direct such actions if instructions from us were made in conjunction with other holders of associated indebtedness that together with us compose the requisite percentage of the related indebtedness then entitled to take action. Conversely, if holders of the required amount of the associated indebtedness other than us desire to take certain actions, such actions may be taken even if we did not support such actions. Furthermore, if a syndicated loan is subordinated to one or more senior loans made to the applicable obligor, the ability of us to exercise such rights may be subordinated to the exercise of such rights by the senior lenders. Whenever we are unable to direct such actions, the parties taking such actions may not have interests that are aligned with us, and the actions taken may not be in our best interests.

If an investment is a syndicated revolving loan or delayed drawdown loan, other lenders may fail to satisfy their full contractual funding commitments for such loan, which could create a breach of contract, result in a lawsuit by the obligor against the lenders and adversely affect the fair market value of our investment.

There is a risk that a loan agent may become bankrupt or insolvent. Such an event would delay, and possibly impair, any enforcement actions undertaken by holders of the associated indebtedness, including attempts to realize upon the collateral securing the associated indebtedness and/or direct the agent to take actions against the related obligor or the collateral securing the associated indebtedness and actions to realize on proceeds of payments made by obligors that are in the possession or control of any other financial institution. In addition, we may be unable to remove the agent in circumstances in which removal would be in our best interests. Moreover, agented loans typically allow for the agent to resign with certain advance notice, and we may not find a replacement agent on a timely basis, or at all, in order to protect our investment.

We have made and may in the future make investments in companies that we do not control.

Some of our investments in loan originators and other operating entities include, or may include, debt instruments and/or equity securities of companies that we do not control. Those investments will be subject to the risk that the company in which the investment is made may make business, financial or management decisions with which we do not agree or that the majority stakeholders or the management of such company may take risks or otherwise act in a manner that does not serve our interests. The entities in which we invest could be thinly capitalized, highly leveraged, dependent on a small number of key individuals, subject to regulatory concerns, or face other obstacles that could adversely affect the business and results of operations of any such entity. If any of the foregoing were to occur, our investments in these operating entities could be lost in their entirety, and our financial condition, results of operations and cash flow could suffer as a result.

We have invested and may in the future invest in securities in the developing CRT sector that are subject to mortgage credit risk.

We have invested and may in the future invest in credit risk transfer securities, or "CRTs." CRTs are designed to transfer a portion of the mortgage credit risk of a pool of insured or guaranteed mortgage loans from the insurer or guarantor of such loans to CRT investors. In a CRT transaction, interest and/or principal of the CRT is written off following certain credit events, such as delinquencies, defaults, and/or realized losses, on the underlying mortgage pool. To date, the vast majority of CRTs consist of risk sharing transactions issued by the GSEs, namely Fannie Mae's Connecticut Avenue Securities program, or "CAS," and Freddie Mac's Structured Agency Credit Risk program, or "STACR." These securities have historically been unsecured and subject to the credit risk of the underlying mortgage pool. In the future, Fannie Mae and Freddie Mac may issue CRTs with a variety of other structures.

39

Table of Contents

Risks Related to the COVID-19 Pandemic

The recent global outbreak of the COVID-19 pandemic has adversely affected, and could continue to adversely affect, our business, financial condition, liquidity, and results of operations.

The COVID-19 pandemic has negatively affected our business, and we believe that it could continue to do so. This pandemic caused significant volatility and disruption in the financial markets both globally and in the United States. If COVID-19 continues to spread, efforts to contain COVID-19 are unsuccessful, or the United States experiences another highly infectious or contagious disease in the future, our business, financial condition, liquidity, and results of operations could be materially and adversely affected. The ultimate severity and duration of such effects would depend on future developments that are highly uncertain and difficult to predict, including the geographic spread of the disease, the overall severity of the disease, the duration of the outbreak, the timing and effectiveness of a vaccine, the measures that may be taken by various governmental authorities in response to the outbreak (such as quarantines and travel restrictions) and the possible further impacts on the national and global economies. The continued spread of COVID-19, or an outbreak of another highly infectious or contagious disease in the future, could also negatively impact the availability of key personnel necessary to conduct our business.

Moreover, certain actions taken by U.S. or other governmental authorities that are intended to ameliorate the macroeconomic effects of the COVID-19 pandemic or an outbreak due to another highly infectious or contagious disease in the future could harm our business. Any significant decrease in economic activity or resulting decline in the markets in which we invest could also have an adverse effect on our investments in our targeted assets.

The COVID-19 pandemic and certain of the actions taken to reduce the spread of the disease, based on governmental mandates and recommendations, including restrictions on travel, restrictions on the ability of individuals to assemble in groups, and restrictions on the ability of certain businesses to operate, have resulted in lost business revenue, rapid and significant increases in unemployment, and changes in consumer behavior, all of which have materially and adversely affected the economy. As a result, there was a significant nationwide increase in loan delinquencies, forbearances, deferments, and modifications, which has increased delinquencies and losses on our loans and otherwise adversely affected our results of operations. Future outbreaks involving other highly infectious or contagious diseases could have similar adverse effects.

Our inability to access funding, or to access funding on terms that we believe are reasonable or attractive, particularly as a result of ongoing market dislocations resulting from the COVID-19 pandemic or as a result of other future outbreaks involving other highly infectious or contagious diseases, could have a material adverse effect on our financial condition.

The COVID-19 pandemic, or other future outbreaks involving other highly infectious or contagious diseases, could cause dislocations in the markets for our assets or could impair our ability to secure or maintain financing through repurchase agreements or other types of borrowings, which could have a material adverse effect on our financial condition. See “Our access to financing sources, which may not be available on favorable terms, or at all, may be limited, and our lenders and derivative counterparties may require us to post additional collateral. These circumstances may materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders” above.

We cannot predict the effect that government policies, laws, and plans adopted in response to the COVID-19 pandemic or other future outbreaks involving highly infectious or contagious diseases and resulting recessionary economic conditions will have on us.

Governments have adopted, and we expect will continue to adopt, policies, laws, and plans intended to address the COVID-19 pandemic and adverse developments in the credit, financial, and mortgage markets that it has caused. We cannot assure you that these programs will be effective, sufficient, or otherwise have a positive impact on our business. Furthermore, such programs could also have a material adverse effect on our business. It is anticipated that as a result of financial difficulties due to the COVID-19 pandemic, borrowers will continue to request forbearance or other relief with respect to their mortgage payments. In addition, across the country, moratoriums are in place in certain states to stop evictions and foreclosures in an effort to lessen the financial burden created by the COVID-19 pandemic and various states have even promulgated guidance to regulated servicers requiring them to formulate policies to assist mortgagors in need as a result of the COVID-19 pandemic. Other forbearance programs, foreclosure moratoriums or other programs or mandates may be imposed or extended, including those that will impact mortgage related assets. Moratoriums on foreclosures may significantly impair a servicer’s abilities to pursue loss mitigation strategies in a timely and effective manner, which could have a material adverse effect on our business.

40

Table of Contents

The declaration, amount, nature, and payment of future dividends on our common and preferred stock are subject to uncertainty due to market conditions, including those resulting from the COVID-19 pandemic, and future outbreaks involving other highly infectious or contagious diseases may result in similar uncertainty and market disruption.

The COVID-19 pandemic, and future outbreaks involving other highly infectious or contagious diseases may negatively impact the declaration, amount, nature, and payment of future dividends on our common and preferred stock. See “Our stockholders may not receive dividends or dividends may not grow over time” below.

The economic and market disruptions caused by the COVID-19 pandemic or by future outbreaks involving other highly infectious or contagious diseases have adversely impacted, and could continue to adversely impact, over the near and long term, the financial condition of borrowers underlying our residential mortgage loan investments, commercial mortgage loan investments, consumer loan investments, and corporate loan investments and limit our ability to grow our business.

The COVID-19 pandemic, or other future outbreaks involving other highly infectious or contagious diseases, could cause borrowers of residential mortgage loans, commercial mortgage loans, consumer loans, and corporate loans to miss payments or default on their loans. See "Residential mortgage loans, including residential NPLs, non-QM loans, and residential transition loans, are subject to increased risks," "The commercial mortgage loans that we acquire or originate, and the mortgage loans underlying our CMBS investments, are subject to the ability of the commercial property owner to generate net income from operating the property as well as to the risks of delinquency and foreclosure," "Consumer loans are subject to delinquency and loss, which could have a negative impact on our financial results," and "Our investments in distressed debt and equity have significant risk of loss, and our efforts to protect these investments may involve large costs and may not be successful" above.

Market disruptions caused by COVID-19 have made it, and could continue to make it, more difficult for the loan servicers we rely on to perform a variety of services for us, which may adversely impact our business and financial results.

The COVID-19 pandemic has made it, and could continue to make it, more difficult for loan servicers to perform a variety of services, which may adversely impact our business and financial results. As a result, we could be materially and adversely affected if a mortgage servicer is unable to adequately or successfully service our residential mortgage loans, commercial mortgage loans, and consumer loans or if any such servicer experiences financial distress. See "We rely on mortgage servicers for our loss mitigation efforts, and we also may engage in our own loss mitigation efforts with respect to whole mortgage loans that we own directly. Such loss mitigation efforts may be unsuccessful or not cost effective" above.

Our investments in loan originators could be adversely affected by the economic and market disruptions caused by the COVID-19 pandemic.

We have non-controlling equity interests in certain loan originators. The economic and market disruptions caused by the COVID-19 pandemic could adversely impact over the near and long term the business and results of operations of these entities, which in turn, could adversely impact our business and results of operations. Future outbreaks involving other highly infectious or contagious diseases could have similar adverse effects.

Market and economic disruptions caused by the COVID-19 pandemic have made, and could in the future make, it more difficult for our Manager to determine the fair value of our investments.

Market and economic disruptions caused by the COVID-19 pandemic, have made, and could in the future make, it more difficult for our Manager, and for the providers of third-party valuations that we use, to rely on market-based inputs in connection with the valuation of our assets under U.S. GAAP. The value of our common and preferred stock and our results of operations could be adversely affected if our determinations regarding the fair value of our investments were materially higher than the values that we ultimately realize upon their disposal. See “Valuations of some of our assets are inherently uncertain, may be based on estimates, may fluctuate over short periods of time, and may differ from the values that would have been used if a ready market for these assets existed” above.

Measures intended to prevent the spread of COVID-19 have disrupted our ability to operate our business.

In response to the outbreak of COVID-19 and the federal and state mandates implemented to control its spread, the vast majority of Ellington's personnel, as well as the third-party service providers that provide services to us, are working remotely. If these personnel are unable to work effectively as a result of the COVID-19 pandemic, including because of illness, quarantines, office closures, ineffective remote work arrangements, or technology failures or limitations, our operations would be adversely impacted. Further, remote work arrangements may increase the risk of cybersecurity incidents and cyber-attacks on us or our third-party service providers, which could have a material adverse effect on our business and results of operations, due to, among other things, the loss of investor or proprietary data, interruptions or delays in the operation of our business, and damage to our reputation.

41

Table of Contents

Risks Related to our Relationship with our Manager and Ellington

We are dependent on our Manager and certain key personnel of Ellington that are provided to us through our Manager and may not find a suitable replacement if our Manager terminates the management agreement or such key personnel are no longer available to us.

We do not have any employees of our own. Our officers are employees of Ellington or one or more of its affiliates. We have no separate facilities and are completely reliant on our Manager, which has significant discretion as to the implementation of our operating policies and execution of our business strategies and risk management practices. We also depend on our Manager's access to the professionals of Ellington as well as information and deal flow generated by Ellington. The employees of Ellington identify, evaluate, negotiate, structure, close, and monitor our portfolio. The departure of any of the senior officers of our Manager, or of a significant number of investment professionals of Ellington or the inability of such personnel to perform their duties due to acts of God, including pandemics such as the COVID-19 pandemic, could have a material adverse effect on our ability to achieve our objectives. We can offer no assurance that our Manager will remain our manager or that we will continue to have access to our Manager's senior management. We are subject to the risk that our Manager will terminate the management agreement or that we may deem it necessary to terminate the management agreement or prevent certain individuals from performing services for us and that no suitable replacement will be found to manage us.

The base management fee payable to our Manager is payable regardless of the performance of our portfolio, which may reduce our Manager's incentive to devote the time and effort to seeking profitable opportunities for our portfolio.

We pay our Manager substantial base management fees based on our equity capital (as defined in the management agreement) regardless of the performance of our portfolio. The base management fee takes into account the net issuance proceeds of both common and preferred stock offerings. Our Manager's entitlement to non-performance-based compensation might reduce its incentive to devote the time and effort of its professionals to seeking profitable opportunities for our portfolio, which could result in a lower performance of our portfolio and materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

Our Manager's incentive fee may induce our Manager to acquire certain assets, including speculative or high risk assets, or to acquire assets with increased leverage, which could increase the risk to our portfolio.

In addition to its base management fee, our Manager is entitled to receive an incentive fee based, in large part, upon our achievement of targeted levels of net income. In evaluating asset acquisition and other management strategies, the opportunity to earn an incentive fee based on net income may lead our Manager to place undue emphasis on the maximization of net income at the expense of other criteria, such as preservation of capital, maintaining liquidity, and/or management of credit risk or market risk, in order to achieve a higher incentive fee. Assets with higher yield potential are generally riskier or more speculative. This could result in increased risk to our portfolio.

Our Board of Directors has approved very broad investment guidelines for our Manager and will not approve each decision made by our Manager to acquire, dispose of, or otherwise manage an asset.

Our Manager is authorized to follow very broad guidelines in pursuing our strategy. While our Board of Directors periodically reviews our guidelines and our portfolio and asset-management decisions, it generally does not review all of our proposed acquisitions, dispositions, and other management decisions. In addition, in conducting periodic reviews, our Board of Directors relies primarily on information provided to them by our Manager. Furthermore, our Manager may arrange for us to use complex strategies or to enter into complex transactions that may be difficult or impossible to unwind by the time they are reviewed by our Board of Directors. Our Manager has great latitude within the broad guidelines in determining the types of assets it may decide are proper for us to acquire and other decisions with respect to the management of those assets. Poor decisions could have a material adverse effect on our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

We compete with Ellington's other accounts for access to Ellington.

Ellington has sponsored and/or currently manages accounts with a focus that overlaps with our investment focus, and expects to continue to do so in the future. Ellington is not restricted in any way from sponsoring or accepting capital from new accounts, even for investing in asset classes or strategies that are similar to, or overlapping with, our asset classes or strategies. Therefore, we compete for access to the benefits that our relationship with our Manager and Ellington provides us. For the same reasons, the personnel of Ellington and our Manager may be unable to dedicate a substantial portion of their time to managing our assets.

42

Table of Contents

We compete with other Ellington accounts for opportunities to acquire assets, which are allocated in accordance with Ellington's investment allocation policies.

Many of our targeted assets are also targeted assets of other Ellington accounts, and Ellington has no duty to allocate such opportunities in a manner that preferentially favors us. Ellington makes available to us all opportunities to acquire assets that it determines, in its reasonable and good faith judgment, based on our objectives, policies and strategies, and other relevant factors, are appropriate for us in accordance with Ellington's written investment allocation policy, it being understood that we might not participate in each such opportunity, but will on an overall basis equitably participate with Ellington's other accounts in all such opportunities.

Since many of our targeted assets are typically available only in specified quantities and are also targeted assets for other Ellington accounts, Ellington often is not able to buy as much of any asset or group of assets as would be required to satisfy the needs of all of Ellington's accounts. In these cases, Ellington's investment allocation procedures and policies typically allocate such assets to multiple accounts in proportion to their needs and available capital. As part of these policies, accounts that are in a "start-up" or "ramp-up" phase may get allocations above their proportion of available capital, which could work to our disadvantage, particularly because there are no limitations surrounding Ellington's ability to create new accounts. In addition, the policies permit departure from proportional allocations under certain circumstances, for example when such allocation would result in an inefficiently small amount of the security or assets being purchased for an account, which may also result in our not participating in certain allocations.

There are conflicts of interest in our relationships with our Manager and Ellington, which could result in decisions that are not in the best interests of our stockholders.

We are subject to conflicts of interest arising out of our relationship with Ellington and our Manager. Currently, all of our executive officers, and one of our directors, are employees of Ellington or one or more of its affiliates. As a result, our Manager and our officers may have conflicts between their duties to us and their duties to, and interests in, Ellington or our Manager. For example, Mr. Penn, our President and Chief Executive Officer and one of our directors, also serves as the President and Chief Executive Officer of, and as a member of the Board of Trustees of, Ellington Residential Mortgage REIT, and as Vice Chairman and Chief Operating Officer of Ellington. Mr. Vranos, our Co-Chief Investment Officer, also serves as the Co-Chief Investment Officer of, and as a member of the Board of Trustees of, Ellington Residential Mortgage REIT, and as Chairman of Ellington. Mr. Tecotzky, our Co-Chief Investment Officer, also serves as the Co-Chief Investment Officer of Ellington Residential Mortgage REIT, and as Vice Chairman - Co-Head of Credit Strategies of Ellington. Mr. Herlihy, our Chief Financial Officer, also serves as the Chief Operating Officer of Ellington Residential Mortgage REIT, and as a Managing Director of Ellington. Mr. Smernoff, our Chief Accounting Officer, also serves as the Chief Financial Officer of Ellington Residential Mortgage REIT.

We may acquire or sell assets in which Ellington or its affiliates have or may have an interest. Similarly, Ellington or its affiliates may acquire or sell assets in which we have or may have an interest. Although such acquisitions or dispositions may present conflicts of interest, we nonetheless may pursue and consummate such transactions. Additionally, we may engage in transactions directly with Ellington or its affiliates, including the purchase and sale of all or a portion of a portfolio asset. We may also, either directly or indirectly through an entity in which we invest, pay Ellington or an affiliate of Ellington to perform administrative services for us. Furthermore, if we securitize any of our assets, Ellington or an affiliate of Ellington may be required under the U.S. Risk Retention Rules to acquire and retain an economic interest in the credit risk of such assets. In connection with any of these transactions we may indemnify, alongside other Ellington affiliates, Ellington or its affiliates or third parties.

Acquisitions made for entities with similar objectives may be different from those made on our behalf. Ellington may have economic interests in, or other relationships with, others in whose obligations or securities we may acquire. In particular, such persons may make and/or hold an investment in securities that we acquire that may be pari passu, senior, or junior in ranking to our interest in the securities or in which partners, security holders, officers, directors, agents, or employees of such persons serve on boards of directors or otherwise have ongoing relationships. Each of such ownership and other relationships may result in securities laws restrictions on transactions in such securities and otherwise create conflicts of interest. In such instances, Ellington may, in its sole discretion, make recommendations and decisions regarding such securities for other entities that may be the same as or different from those made with respect to such securities and may take actions (or omit to take actions) in the context of these other economic interests or relationships the consequences of which may be adverse to our interests.

In deciding whether to issue additional debt or equity securities, we will rely in part on recommendations made by our Manager. While such decisions are subject to the approval of our Board of Directors, one of our directors is also an Ellington employee. Because our Manager earns base management fees that are based on the total amount of our equity capital, and earns incentive fees that are based in part on the total net income that we are able to generate, our Manager may have an incentive to

43

Table of Contents

recommend that we issue additional debt or equity securities. See "—Future offerings of debt securities, which would rank senior to our common and preferred stock upon our liquidation, and future offerings of equity securities, which could dilute our existing stockholders and, in the case of preferred equity, may be senior to our common stock for the purposes of dividend and liquidating distributions, may adversely affect the market price of our common stock."

The officers of our Manager and its affiliates devote as much time to us as our Manager deems appropriate; however, these officers may have conflicts in allocating their time and services among us and Ellington and its affiliates' accounts. During turbulent conditions in the mortgage industry, distress in the credit markets or other times when we will need focused support and assistance from our Manager and Ellington employees, other entities that Ellington advises or manages will likewise require greater focus and attention, placing our Manager and Ellington's resources in high demand. In such situations, we may not receive the necessary support and assistance we require or would otherwise receive if we were internally managed or if Ellington or its affiliates did not act as a manager for other entities.

We, directly or through Ellington, may obtain confidential information about the companies or securities in which we have invested or may invest. If we do possess confidential information about such companies or securities, there may be restrictions on our ability to dispose of, increase the amount of, or otherwise take action with respect to the securities of such companies. Our Manager's and Ellington's management of other accounts could create a conflict of interest to the extent our Manager or Ellington is aware of material non-public information concerning potential investment decisions. We have implemented compliance procedures and practices designed to ensure that investment decisions are not made while in possession of material non-public information. We cannot assure you, however, that these procedures and practices will be effective. In addition, this conflict and these procedures and practices may limit the freedom of our Manager to make potentially profitable investments, which could have an adverse effect on our operations. These limitations imposed by access to confidential information could therefore materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders.

As of December 31, 2020, the Manager Group owned approximately 8.4% of our outstanding common shares and other equity interests convertible into our common shares. In evaluating opportunities for us and other management strategies, this may lead our Manager to emphasize certain asset acquisition, disposition, or management objectives over others, such as balancing risk or capital preservation objectives against return objectives. This could increase the risks, or decrease the returns, of your investment.

The management agreement with our Manager was not negotiated on an arm's-length basis and may not be as favorable to us as if it had been negotiated with an unaffiliated third party and may be costly and difficult to terminate.

Our management agreement with our Manager was negotiated between related parties, and its terms, including fees payable, may not be as favorable to us as if it had been negotiated with an unaffiliated third party. Various potential and actual conflicts of interest may arise from the activities of Ellington and its affiliates by virtue of the fact that our Manager is controlled by Ellington.

Termination of our management agreement without cause, including termination for poor performance or non-renewal, is subject to several conditions which may make such a termination difficult and costly. The management agreement has a current term that expires on December 31, 2021, and will be automatically renewed for successive one-year terms thereafter unless notice of non-renewal is delivered by either party to the other party at least 180 days prior to the expiration of the then current term. The management agreement provides that it may be terminated by us based on performance upon the affirmative vote of at least two-thirds of our independent directors, or by a vote of the holders of at least a majority of our outstanding common stock, based either upon unsatisfactory performance by our Manager that is materially detrimental to us or upon a determination by the Board of Directors that the fees payable to our Manager are not fair, subject to our Manager's right to prevent such a termination by accepting a mutually acceptable reduction of the fees. In the event we terminate the management agreement as discussed above or elect not to renew the management agreement, we will be required to pay our Manager a termination fee equal to the amount of three times the sum of the average annual base management fee and the average annual incentive fee earned by our Manager during the 24-month period immediately preceding the date of notice of termination or non-renewal, calculated as of the end of the most recently completed fiscal quarter prior to the date of notice of termination or non-renewal. These provisions will increase the effective cost to us of terminating the management agreement, thereby adversely affecting our ability to terminate our Manager without cause.

Pursuant to the management agreement, our Manager will not assume any responsibility other than to render the services called for thereunder and will not be responsible for any action of our Board of Directors in following or declining to follow its advice or recommendations. Under the terms of the management agreement, our Manager, Ellington, and their affiliates and each of their officers, directors, members, shareholders, managers, investment and risk management committee members, employees, agents, successors and assigns, will not be liable to us for acts or omissions performed in accordance with and

44

Table of Contents

pursuant to the management agreement, except because of acts or omissions constituting bad faith, willful misconduct, gross negligence, or reckless disregard of their duties under the management agreement. In addition, we will indemnify our Manager, Ellington, and their affiliates and each of their officers, directors, members, shareholders, managers, investment and risk management committee members, employees, agents, successors and assigns, with respect to all liabilities, judgments, costs, charges, losses, expenses, and claims arising from acts or omissions of our Manager not constituting bad faith, willful misconduct, gross negligence, or reckless disregard of duties under the management agreement.

If our Manager ceases to be our Manager pursuant to the management agreement or one or more of our Manager's key personnel ceases to provide services to us, our lenders and our derivative counterparties may cease doing business with us.

If our Manager ceases to be our Manager, including upon non-renewal of our management agreement, or if one or more of our Manager's key personnel ceases to provide services to us, it could constitute an event of default or early termination event under many of our repo or derivative transaction agreements, upon which our counterparties would have the right to terminate their agreements with us. If our Manager ceases to be our Manager for any reason, including upon the non-renewal of our management agreement and we are unable to obtain or renew financing or enter into or maintain derivative transactions, our business, financial condition and results of operations, and our ability to pay dividends to our stockholders may be materially adversely affected.

Our Manager's failure to identify and acquire assets that meet our asset criteria or perform its responsibilities under the management agreement could materially adversely affect our business, financial condition and results of operations, our ability to maintain our qualification as a REIT, and our ability to pay dividends to our stockholders.

Our ability to achieve our objectives depends on our Manager's ability to identify and acquire assets that meet our asset criteria. Accomplishing our objectives is largely a function of our Manager's structuring of our investment process, our access to financing on acceptable terms, and general market conditions. Our stockholders do not have input into our investment decisions. All of these factors increase the uncertainty, and thus the risk, of investing in our common or preferred stock. The senior management team of our Manager has substantial responsibilities under the management agreement. In order to implement certain strategies, our Manager may need to hire, train, supervise, and manage new employees successfully. Any failure to manage our future growth effectively could have a material adverse effect on our business, financial condition and results of operations, our ability to maintain our qualification as a REIT, and our ability to pay dividends to our stockholders.

We do not own the Ellington brand or trademark, but may use the brand and trademark as well as our logo pursuant to the terms of a license granted by Ellington.

Ellington has licensed the "Ellington" brand, trademark, and logo to us for so long as our Manager or another affiliate of Ellington continues to act as our manager. We do not own the brand, trademark, or logo that we will use in our business and may be unable to protect this intellectual property against infringement from third parties. Ellington retains the right to continue using the "Ellington" brand and trademark. We will further be unable to preclude Ellington from licensing or transferring the ownership of the "Ellington" brand and trademark to third parties, some of whom may compete against us. Consequently, we will be unable to prevent any damage to goodwill that may occur as a result of the activities of Ellington or others.

Furthermore, in the event our Manager or another affiliate of Ellington ceases to act as our manager, or in the event Ellington terminates the license, we will be required to change our name and trademark. Any of these events could disrupt our recognition in the marketplace, damage any goodwill we may have generated, and otherwise harm our business. Finally, the license is a domestic license in the United States only and does not give us any right to use the "Ellington" brand, trademark, and logo overseas even though we are using the brand, trademark, and logo overseas. Our use of the "Ellington" brand, trademark, and logo overseas will therefore be unlicensed and could expose us to a claim of infringement.

Risks Related to Our Common Stock and Preferred Stock

Our stockholders may not receive dividends or dividends may not grow over time.

The declaration, amount, nature, and payment of any future dividends on shares of our common and preferred stock are at the sole discretion of our Board of Directors. It is possible that we may not be able to pay dividends or other distributions on shares of our common stock or on shares of our Series A Preferred Stock. Under Delaware law, cash dividends on capital stock may only be paid from “surplus” or, if there is no “surplus,” from the corporation’s net profits for the then-current or the preceding fiscal year. Unless we operate profitably, our ability to pay cash dividends on shares of our common stock and on shares of our Series A Preferred Stock would require the availability of adequate “surplus,” which is defined as the excess, if any, of our net assets (total assets less total liabilities) over our capital. Further, even if an adequate surplus is available to pay cash dividends on shares of our common stock or on shares of our Series A Preferred Stock, we may not have sufficient cash to pay dividends on shares of our common stock or shares of our Series A Preferred Stock. In addition, in order to preserve our

45

Table of Contents

liquidity, our Board of Directors may declare all or any portion of a dividend to be payable in stock, may delay the record date or payment date for any previously declared, but unpaid, dividend, convert a previously declared, but unpaid, cash dividend on our common stock to a dividend paid partially or completely in stock, or even revoke a declared, but unpaid, dividend.

Our ability to pay dividends may be impaired if any of the risks described in this Annual Report on Form 10-K, or any of our other periodic or current reports filed with the SEC, were to occur. In addition, payment of dividends depends upon our earnings, liquidity, financial condition, the REIT distribution requirements, our financial covenants, and other factors that our Board of Directors may deem relevant from time to time. We cannot assure you that our business will generate sufficient cash flow from operations or that future borrowings or other capital will be available to us in an amount sufficient to enable us to make distributions on our shares of common stock and our shares of Series A Preferred Stock, to pay our indebtedness, or to fund other liquidity needs. Our Board of Directors will continue to assess our common stock dividend rate and our preferred stock dividend payment schedule on an ongoing basis, as market conditions and our financial position continue to evolve. Our Board of Directors is under no obligation to declare any dividend distribution. We cannot assure you that we will achieve results that will allow us to pay a specified level of dividends or to increase dividends from one period to the next.

Among the factors that could materially adversely affect our business, financial condition and results of operations, and our ability to pay dividends to our stockholders are:

•our inability to realize positive or attractive returns on our portfolio, whether because of defaults in our portfolio, decreases in the value of our portfolio, or otherwise;

•margin calls or other expenditures that reduce our cash flow and impact our liquidity; and

•increases in actual or estimated operating expenses.

An increase in interest rates may have an adverse effect on the market price of our equity or debt securities and our ability to pay dividends to our stockholders.

One of the factors that investors may consider in deciding whether to buy or sell our common stock is our dividend rate (or expected future dividend rates) as a percentage of our common stock price, relative to prevailing market interest rates. Similarly, investors in our preferred equity securities or our debt securities may consider the dividend rate or yield on such securities relative to prevailing market interest rates. If market interest rates increase, prospective investors in our equity or debt securities may demand a higher dividend rate or yield on our securities or seek alternative investments paying higher dividends or interest. As a result, interest rate fluctuations and capital market conditions can affect the market price of our securities independent of the effects such conditions may have on our portfolio. For instance, if interest rates rise without an increase in our dividend rate, the market price of our common stock could decrease because potential investors may require a higher dividend yield on our common stock as market rates on interest-bearing instruments such as bonds rise. In addition, to the extent we have variable rate debt, such as our repo financings, rising interest rates would result in increased interest expense on this variable rate debt, thereby potentially adversely affecting our cash flow and our ability to service our indebtedness and pay dividends to our stockholders.

Investing in our securities involves a high degree of risk.

The assets we purchase in accordance with our objectives may result in a higher amount of risk than other alternative asset acquisition options. The assets we acquire may be highly speculative and aggressive and may be subject to a variety of risks, including credit risk, prepayment risk, interest rate risk, and market risk. As a result, an investment in our securities may not be suitable for investors with lower risk tolerance.

Risks Related To Our Organization and Structure

Our certificate of incorporation, bylaws and management agreement contain provisions that may inhibit potential acquisition bids that stockholders may consider favorable, and the market price of our common stock may be lower as a result.

Our certificate of incorporation and bylaws contain provisions that may have an anti-takeover effect and inhibit a change in our Board of Directors. These provisions include:

•allowing only our Board of Directors to fill newly created directorships resulting from any increase in the authorized number of directors and any vacancies in the Board of Directors resulting from death, resignation, retirement, disqualification, removal from office or other cause, even if the remaining directors do not constitute a quorum;

•requiring advance notice for our stockholders to nominate candidates for election to our Board of Directors or to propose business to be considered by our stockholders at a meeting of stockholders;

46

Table of Contents

•the ability of our Board of Directors to cause us to issue additional authorized but unissued shares of common stock or preferred stock without the approval of our stockholders;

•the ability of the Board of Directors to amend, modify or repeal our bylaws without the approval of our stockholders;

•restrictions on the ability of stockholders to call a special meeting without a majority of all the votes entitled to be cast at such meeting; and

• limitations on the ability of stockholders to act by written consent.

Certain provisions of the management agreement also could make it more difficult for third parties to acquire control of us by various means, including limitations on our right to terminate the management agreement and a requirement that, under certain circumstances, we make a substantial payment to our Manager in the event of a termination.

There are ownership limits and restrictions on transferability in our certificate of incorporation.

Our certificate of incorporation provides that (subject to certain exceptions described below) no person may own, or be deemed to own by virtue of the attribution provisions of the Code, more than 9.8%, in value or in number of shares, whichever is more restrictive, of the outstanding shares of any class or series of our capital stock.

Any person who acquires or attempts or intends to acquire beneficial or constructive ownership of shares of our capital stock that will or may violate any of the foregoing restrictions on transferability and ownership will be required to give written notice immediately to us, or in the case of proposed or attempted transactions will be required to give at least 15 days written notice to us, and provide us with such other information as we may request in order to determine the effect of such transfer on our status as a REIT.

Our Board of Directors, in its sole discretion, may exempt any person from the foregoing restrictions. Any person seeking such an exemption must provide to our Board of Directors such representations, covenants, and undertakings as our Board of Directors may deem appropriate. Our Board of Directors may also condition any such exemption on the receipt of a ruling from the Internal Revenue Service, or "IRS," or an opinion of counsel as it deems appropriate. Our Board of Directors has granted an exemption from this limitation to Ellington and certain affiliated entities of Ellington, subject to certain conditions.

Our rights and the rights of our stockholders to take action against our directors and officers or against our Manager or Ellington are limited, which could limit your recourse in the event actions are taken that are not in your best interests.

Our certificate of incorporation provides that each person that is or was a director, officer, employee, or agent of ours shall not be liable to us or any of our stockholders for any acts or omissions by any such person arising from the performance of their duties and obligations in connection with us, except to the extent such exemption from liability or limitation thereof is not permitted under the Delaware General Corporation Law.

In addition, our certificate of incorporation provides that we may indemnify, to the fullest extent permitted by law, each person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding (other than an action by or in our right), by reason of the fact that the person is or was a director, officer, employee, or agent of ours, against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding, if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to our best interests, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person's conduct was unlawful. Our certificate of incorporation also provides that we may indemnify, to the fullest extent permitted by law, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in our right to procure a judgment in our favor by reason of the fact that the person is or was a director, officer, employee, or agent of ours, against expenses (including attorneys' fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to our best interests, except that no indemnification may be made in respect of any claim, issue or matter as to which such person had been adjudged to be liable to us unless and only to the extent that the Court of Chancery of the State of Delaware or the court in which such action or suit was brought determines that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses. We have entered into indemnification agreements with our directors and officers implementing these indemnification provisions that obligate us to indemnify them to the maximum extent permitted by Delaware law. Such indemnification includes defense costs and expenses incurred by such officers and directors.

Our management agreement with our Manager requires us to indemnify our Manager and its affiliates against any and all claims and demands arising out of claims by third parties caused by acts or omissions of our Manager and its affiliates not constituting bad faith, willful misconduct, gross negligence, or reckless disregard of our Manager's duties under the management agreement.

47

Table of Contents

In light of the liability limitations contained in our certificate of incorporation and our management agreement with our Manager, as well as our indemnification arrangements with our directors and officers and our Manager, our and our stockholders' rights to take action against our directors, officers, and Manager are limited, which could limit your recourse in the event actions are taken that are not in your best interests.

Our certificate of incorporation designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders' ability to obtain a favorable judicial forum for disputes with us or our directors or officers.

Our certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for: any derivative action or proceeding brought on our behalf; any action asserting a claim of breach of fiduciary duty owed by any current or former director, officer or stockholder of ours to us or our stockholders; any action asserting a claim against us arising pursuant to any provision of the Delaware General Corporation Law or our certificate of incorporation or bylaws; or any action asserting a claim against us governed by the internal affairs doctrine. This choice of forum provision may limit a stockholder's ability to bring a claim in a judicial forum that the stockholder believes is favorable for disputes with us or our directors or officers, which may discourage lawsuits against us and our directors or officers. Alternatively, if a court were to find these provisions of our certificate of incorporation inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business, financial condition or results of operations.

Maintenance of our exclusion from registration as an investment company under the Investment Company Act imposes significant limitations on our operations.

We have conducted and intend to continue to conduct our operations so that neither we nor any of our subsidiaries are required to register as an investment company under the Investment Company Act. Both we and our Operating Partnership are organized as holding companies and conduct our business primarily through wholly-owned subsidiaries of our Operating Partnership. Our Operating Partnership's investments in its 3(c)(7) subsidiaries and its other investment securities cannot exceed 40% of the value of our Operating Partnership's total assets (excluding U.S. government securities and cash) on an unconsolidated basis. In addition, the Holding Subsidiary's investment in its 3(c)(7) subsidiaries and its other investment securities cannot exceed 40% of the value of our Holding Subsidiary's total assets (excluding U.S. government securities and cash) on an unconsolidated basis. These requirements limit the types of businesses in which we may engage and the assets we may hold. Our 3(c)(5)(C) subsidiaries rely on the exclusion provided by Section 3(c)(5)(C) of the Investment Company Act. Section 3(c)(5)(C) of the Investment Company Act is designed for entities "primarily engaged in the business of purchasing or otherwise acquiring mortgages and other liens on and interests in real estate." This exclusion generally requires that at least 55% of the entity's assets on an unconsolidated basis consist of qualifying real estate assets and at least 80% of the entity's assets on an unconsolidated basis consist of qualifying real estate assets or real estate-related assets. Both the 40% Test and the requirements of the Section 3(c)(5)(C) limit the types of businesses in which we may engage and the types of assets we may hold, as well as the timing of sales and purchases of those assets.

To classify the assets held by our subsidiaries as qualifying real estate assets or real estate-related assets, we rely on no-action letters and other guidance published by the SEC staff regarding those kinds of assets, as well as upon our analyses (in consultation with outside counsel) of guidance published with respect to other types of assets. There can be no assurance that the laws and regulations governing the Investment Company Act status of companies similar to ours, or the guidance from the SEC staff regarding the treatment of assets as qualifying real estate assets or real estate-related assets, will not change in a manner that adversely affects our operations. In fact, in August 2011, the SEC published a concept release in which it asked for comments on this exclusion from registration. To the extent that the SEC staff provides more specific guidance regarding any of the matters bearing upon our exclusion from the definition of an investment company under the Investment Company Act, we may be required to adjust our strategy accordingly. Any additional guidance from the SEC staff could further inhibit our ability to pursue the strategies that we have chosen. Furthermore, although we monitor the assets of our subsidiaries regularly, there can be no assurance that our subsidiaries will be able to maintain their exclusion from registration. Any of the foregoing could require us to adjust our strategy, which could limit our ability to make certain investments or require us to sell assets in a manner, at a price or at a time that we otherwise would not have chosen. This could negatively affect the value of our common or preferred stock, the sustainability of our business model, and our ability to pay dividends to our stockholders.

If we were required to register as an investment company under the Investment Company Act, we would be subject to the restrictions imposed by the Investment Company Act, which would require us to make material changes to our strategy.

If we are deemed to be an investment company under the Investment Company Act, we would be required to materially restructure our activities or to register as an investment company under the Investment Company Act, which would have a

48

Table of Contents

material adverse effect on our business, financial condition, and results of operations. In connection with any such restructuring, we may be required to sell portfolio assets at a time we otherwise might not choose to do so, and we may incur losses in connection with such sales. Further, our Manager may unilaterally terminate the management agreement if we become regulated as an investment company under the Investment Company Act. Further, if it were established that we were an unregistered investment company, there would be a risk that we would be subject to monetary penalties and injunctive relief in an action brought by the SEC, that we would be unable to enforce contracts with third parties and that third parties could seek to obtain rescission of transactions undertaken during the period it was established that we were an unregistered investment company.

U.S. Federal Income Tax Risks

Your investment has various U.S. federal, state, and local income tax risks.

We strongly urge you to consult your tax advisor concerning the effects of U.S. federal, state, and local income tax law on an investment in our common and preferred stock and on your individual tax situation.

Our failure to qualify as a REIT would subject us to U.S. federal, state and local income taxes, which could adversely affect the value of our common stock and would substantially reduce the cash available for distribution to our stockholders.

We elected to be treated as a REIT for U.S. federal income tax purposes commencing with our taxable year ended December 31, 2019. While we believe that we operated and intend to continue to operate in a manner that will enable us to meet the requirements for taxation as a REIT commencing on January 1, 2019, we cannot assure you that we will remain qualified as a REIT.

The U.S. federal income tax laws governing REITs are complex, and interpretations of the U.S. federal income tax laws governing qualification as a REIT are limited. Qualifying as a REIT requires us to meet various tests regarding the nature of our assets, our income and our earnings and profits, or "E&P" (calculated pursuant to Sections 316 and 857(d) of the Code and the regulations thereunder), the ownership of our outstanding stock, and the amount of our distributions on an ongoing basis. Our ability to satisfy the asset tests depends upon the characterization and fair market values of our assets, some of which are not precisely determinable, and for which we may not obtain independent appraisals. Our compliance with the REIT income and asset tests and the accuracy of our tax reporting to stockholders also depend upon our ability to successfully manage the calculation and composition of our gross and net taxable income, our E&P and our assets on an ongoing basis. Even a technical or inadvertent mistake could jeopardize our REIT status. Although we operated and intend to operate so as to maintain our qualification as a REIT, given the complex nature of the rules governing REITs, the ongoing importance of factual determinations, including the potential tax treatment of the investments we make, and the possibility of future changes in our circumstances, no assurance can be given that our actual results of operations for any particular taxable year will satisfy such requirements.

We also own an entity that has elected to be taxed as a REIT under the U.S. federal income tax laws, or a "Subsidiary REIT." Our Subsidiary REIT is subject to the same REIT qualification requirements that are applicable to us. If our Subsidiary REIT were to fail to qualify as a REIT, then (i) that Subsidiary REIT would become subject to regular U.S. federal, state and local corporate income tax, (ii) our interest in such Subsidiary REIT would cease to be a qualifying asset for purposes of the REIT asset tests, and (iii) it is possible that we would fail certain of the REIT asset tests, in which event we also would fail to qualify as a REIT unless we could avail ourselves of certain relief provisions. While we believe that the Subsidiary REIT has qualified as a REIT under the Code, we have joined the Subsidiary REIT in filing a "protective" TRS election under Section 856(l) of the Code for each taxable year in which we have owned an interest in the Subsidiary REIT. We cannot assure you that such "protective" TRS election would be effective to avoid adverse consequences to us. Moreover, even if the "protective" election were to be effective, the Subsidiary REIT would be subject to regular corporate income tax, and we cannot assure you that we would not fail to satisfy the requirement that not more than 20% of the value of our total assets may be represented by the securities of one or more TRSs. See "Our ownership of and relationship with our TRSs will be limited, and a failure to comply with the limits would jeopardize our REIT status and may result in the application of a 100% excise tax," below.

If we fail to qualify as a REIT in any calendar year, and do not qualify for certain statutory relief provisions, we would be required to pay U.S. federal income tax (and any applicable state and local taxes) on our taxable income at regular corporate rates, and dividends paid to our stockholders would not be deductible by us in computing our taxable income (although such dividends received by certain non-corporate U.S. taxpayers generally would be subject to a preferential rate of taxation). Further, if we fail to qualify as a REIT, we might need to borrow money or sell assets in order to pay any resulting tax. Our payment of income tax would decrease the amount of our income available for distribution to our stockholders. Furthermore, if we fail to maintain our qualification as a REIT, we no longer would be required under U.S. federal tax laws to distribute substantially all of our REIT taxable income to our stockholders. Unless our failure to qualify as a REIT was subject to relief

49

Table of Contents

under the U.S. federal tax laws, we could not re-elect to qualify as a REIT until the fifth calendar year following the year in which we failed to qualify.

Complying with REIT requirements may cause us to forego or liquidate otherwise attractive investments.

To qualify as a REIT, we must continually satisfy various tests regarding the sources of our income, the nature and diversification of our assets, the amounts we distribute to our stockholders and the ownership of our shares of beneficial interest. In order to meet these tests, we may be required to forego investments we might otherwise make and reduce or eliminate investments we made prior to the effective date of our qualification as a REIT. The tests applicable to REITs are different from the tests applicable to us in prior years when we were a partnership. Thus, we may choose not to make certain types of investments that we made in prior years or pursue certain strategies that we pursued in prior years, which could include certain hedges that would otherwise reduce certain investment risks, or we could make such investments or pursue such strategies in a TRS. Any domestic TRS will be subject to regular U.S. federal, state and local corporate income tax, which may reduce the cash available to be distributed to our stockholders as compared with prior years.

As a REIT, we may be required to pay dividends to stockholders at disadvantageous times or when we do not have funds readily available for distribution, and may be unable to pursue investments that would be otherwise advantageous to us in order to satisfy the source of income or asset diversification requirements for qualifying as a REIT. Thus, compliance with the REIT requirements may hinder our investment performance.

In particular, we must ensure that at the end of each calendar quarter, we satisfy the REIT 75% asset test, which requires that at least 75% of the value of our total assets consist of cash, cash items, government securities and qualified REIT real estate assets, including RMBS. The remainder of our investments in securities (other than government securities and qualified REIT real estate assets) generally cannot include more than 10% of the outstanding voting securities of any one issuer or more than 10% of the total value of the outstanding securities of any one issuer. In addition, in general, no more than 5% of the value of our total assets (other than government securities, TRS securities and qualified REIT real estate assets) can consist of the securities of any one issuer, and no more than 20% of the value of our total assets can be represented by securities of one or more TRSs. Generally, if we fail to comply with these requirements at the end of any calendar quarter, we must correct the failure within 30 days after the end of the calendar quarter or qualify for certain statutory relief provisions to avoid losing our REIT qualification and becoming subject to U.S. federal income tax and any applicable state and local taxes on all of our income.

In addition, we must also ensure that each taxable year we satisfy the REIT 75% and 95% gross income tests, which require that, in general, 75% of our gross income come from certain real estate-related sources and 95% of our gross income consist of gross income that qualifies for the 75% gross income test or certain other passive income sources. As a result of the requirement that we satisfy both the REIT 75% asset test and the REIT 75% and 95% gross income tests, we may be required to liquidate from our portfolio otherwise attractive investments or contribute such investments to a TRS, in which event they would be subject to regular corporate U.S. federal, state and local taxes assuming that the TRS is organized in the United States. These actions could have the effect of reducing our income and amounts available for distribution to our stockholders.

Failure to make required distributions would subject us to tax, which would reduce the cash available for distribution to our stockholders.

To qualify as a REIT, we must distribute to our stockholders each calendar year at least 90% of our REIT taxable income (including certain items of non-cash income), determined excluding any net capital gains and without regard to the deduction for dividends paid. To the extent that we satisfy the 90% distribution requirement, but distribute less than 100% of our taxable income, we will be subject to U.S. federal corporate income tax on our undistributed income. In addition, we will incur a 4% nondeductible excise tax on the amount, if any, by which our distributions in any calendar year are less than the sum of:

•85% of our REIT ordinary income for that year;

•95% of our REIT capital gain net income for that year; and

•any undistributed taxable income from prior years.

We intend to distribute our taxable income to our stockholders in a manner intended to satisfy the 90% distribution requirement and to avoid the corporate income tax. However, there is no requirement that TRSs distribute their after-tax net income to their parent REIT.

Our taxable income may substantially exceed our net income as determined based on GAAP, because, for example, realized capital losses will be deducted in determining our GAAP net income, but may not be deductible in computing our taxable income. Our Operating Partnership and certain of its subsidiaries have made an election under Section 475(f) of the Code to mark their securities to market, which may cause us to recognize taxable gains for a taxable year with respect to such

50

Table of Contents

securities without the receipt of any cash corresponding to such gains. Additionally, E&P in our foreign TRSs are taxable to us, regardless of whether such earnings are distributed. Losses in our TRSs will not reduce our taxable income, and will generally not provide any tax benefit to us, except for being carried forward against future TRS taxable income in the case of a domestic TRS. Also, our ability, or the ability of our subsidiaries, to deduct interest may be limited under Section 163(j) of the Code. In addition, we may invest in assets that generate taxable income in excess of economic income or in advance of the corresponding cash flow from the assets, or we may modify assets in a way that produces taxable income prior to or in excess of economic income. As a result of the foregoing, we may generate less cash flow than taxable income in a particular year. To the extent that we generate such non-cash taxable income in a taxable year or have limitations on our deductions, we may incur corporate income tax and the 4% nondeductible excise tax on that income if we do not distribute such income to stockholders in that year. In that event, we may be required to use cash reserves, incur debt, sell assets, make taxable distributions of our shares or debt securities or liquidate non-cash assets at rates or at times that we regard as unfavorable to satisfy the distribution requirement and to avoid corporate income tax and the 4% nondeductible excise tax in that year.

Determination of our REIT taxable income involves the application of highly technical and complex Code provisions for which only limited judicial and administrative authorities exist. If the IRS disagrees with our determination, it could affect our satisfaction of the distribution requirement. Under certain circumstances, we may be able to correct a failure to meet the distribution requirement for a year by paying "deficiency dividends" to our stockholders in a later year. We may include such deficiency dividends in our deduction for dividends paid for the earlier year. Although we may be able to avoid income tax on amounts distributed as deficiency dividends, we will be required to pay interest and a penalty to the IRS based upon the amount of any deduction we take for deficiency dividends.

Even if we qualify as a REIT, we may face other tax liabilities that reduce our cash flows.

Even if we qualify for taxation as a REIT, we may be subject to certain U.S. federal, state and local taxes on our income and assets, including taxes on any undistributed income, tax on income from some activities conducted as a result of a foreclosure, and state or local income, property and transfer taxes. In addition, our domestic TRSs will be subject to regular corporate U.S. federal, state and local taxes. Any of these taxes would decrease cash available for distributions to stockholders.

The failure of MBS subject to a repurchase agreement to qualify as real estate assets would adversely affect our ability to qualify as a REIT.

We have entered into repurchase agreements under which we nominally sell certain of our MBS to a counterparty and simultaneously enter into an agreement to repurchase the sold assets. We believe that, for U.S. federal income tax purposes, these transactions will be treated as secured debt and we will be treated as the tax owner of the MBS that are the subject of any such repurchase agreement, notwithstanding that such agreements may transfer record ownership of such assets to the counterparty during the term of the agreement. It is possible, however, that the IRS could successfully assert that we do not own the MBS during the term of the repurchase agreement, in which case we could fail to qualify as a REIT.

Uncertainty exists with respect to the treatment of our TBAs for purposes of the REIT asset and income tests.

We purchase and sell Agency RMBS through TBAs and recognize income or gains from the disposition of those TBAs, through dollar roll transactions or otherwise, and may continue to do so in the future. While there is no direct authority with respect to the qualification of TBAs as real estate assets or U.S. Government securities for purposes of the REIT 75% asset test or the qualification of income or gains from dispositions of TBAs as gains from the sale of real property or other qualifying income for purposes of the REIT 75% gross income test, we treat the GAAP value of our TBAs under which we contract to purchase to-be-announced Agency RMBS ( "long TBAs") as qualifying assets for purposes of the REIT 75% asset test, and we treat income and gains from our long TBAs as qualifying income for purposes of the REIT 75% gross income test, based on an opinion of Hunton Andrews Kurth LLP substantially to the effect that (i) for purposes of the REIT asset tests, our ownership of a long TBA should be treated as ownership of real estate assets, and (ii) for purposes of the REIT 75% gross income test, any gain recognized by us in connection with the settlement of our long TBAs should be treated as gain from the sale or disposition of an interest in mortgages on real property. Opinions of counsel are not binding on the IRS, and no assurance can be given that the IRS will not successfully challenge the conclusions set forth in such opinions. In addition, it must be emphasized that the opinion of counsel is based on various assumptions relating to our TBAs and is conditioned upon fact-based representations and covenants made by our management regarding our TBAs. No assurance can be given that the IRS would not assert that such assets or income are not qualifying assets or income. If the IRS were to successfully challenge the opinion of counsel, we could be subject to a penalty tax or we could fail to remain qualified as a REIT if a sufficient portion of our assets consists of TBAs or a sufficient portion of our income consists of income or gains from the disposition of TBAs.

51

Table of Contents

Complying with REIT requirements may limit our ability to hedge effectively.

The REIT provisions of the Code substantially limit our ability to hedge. Under these provisions, any income that we generate from transactions intended to hedge our interest rate or foreign currency risks will be excluded from gross income for purposes of the REIT 75% and 95% gross income tests if the instrument hedges (i) interest rate risk on liabilities incurred to carry or acquire real estate or (ii) risk of foreign currency fluctuations with respect to any item of income or gain that would be qualifying income under the REIT 75% or 95% gross income tests, and such instrument is properly identified under applicable Treasury Regulations. The requirements in the Treasury Regulations related to identifying hedging transactions are highly technical and complex for which only limited judicial and administrative authorities exist, and the IRS could disagree with and successfully challenge our treatment and identifications of such hedging transactions. Income from hedging transactions that are not properly identified or hedge different risks will generally constitute non-qualifying income for purposes of both the REIT 75% and 95% gross income tests and could cause us to fail to maintain our qualification as a REIT. Our aggregate gross income from such transactions, along with other gross income that does not qualify for the 95% gross income test, cannot exceed 5% of our annual gross income. As a result, we might have to limit our use of advantageous hedging techniques, and we expect to implement certain hedges through a TRS. Any hedging income earned by a domestic TRS would be subject to U.S. federal, state and local income tax at regular corporate rates. This could increase the cost of our hedging activities or expose us to greater risks associated with interest rate changes or other changes than we would otherwise want to bear. In addition, losses in our TRSs will generally not provide any tax benefit, except for being carried forward against future TRS taxable income in the case of a domestic TRS. Even if the income from certain of our hedging transactions is excluded from gross income for purposes of the REIT 75% and 95% gross income tests, such income and any loss will be taken into account in determining our REIT taxable income and our distribution requirement. If the IRS disagrees with our calculation of the amount or timing of recognition of gain or loss with respect to our hedging transactions, including the impact of our elections under Section 475(f) of the Code and the treatment of hedging expense and losses under Section 163(j) of the Code and Treasury Regulation Section 1.446-4, our distribution requirement could increase, which could require that we correct any shortfall in distributions by paying deficiency dividends to our stockholders in a later year.

Our ownership of and relationship with our TRSs will be limited, and a failure to comply with the limits would jeopardize our REIT status and may result in the application of a 100% excise tax.

A REIT may own up to 100% of the stock of one or more TRSs. A TRS may earn income that would not be qualifying income for purposes of the REIT 75% or 95% gross income tests if earned directly by the parent REIT. Both the subsidiary and the REIT must jointly elect to treat the subsidiary as a TRS. A corporation (other than a REIT) of which a TRS directly or indirectly owns more than 35% of the voting power or value of the stock will automatically be treated as a TRS. Overall, no more than 20% of the value of a REIT's total assets may consist of stock or securities of one or more TRSs. Many of the investments that we made and activities we undertook prior to our REIT election have been contributed to or will be made in one of our TRSs; thus, we hold a significant portion of our assets through, and derive a significant portion of our taxable income and gains in, TRSs. While we intend to manage our affairs so as to satisfy the requirement that no more than 20% of the value of our total assets consists of stock or securities of our TRSs, as well as the requirement that taxable income from our TRSs plus other non-qualifying gross income not exceed 25% of our total gross income, there can be no assurance that we will be able to do so in all market circumstances. Even if we are able to do so, compliance with these rules may reduce our flexibility in operating our business. In addition, the two rules may conflict with each other in that our ability to reduce the value of our TRSs below 20% of our assets by causing a TRS to distribute a dividend to us may be limited by our need to comply with the REIT 75% gross income test, which requires that, in general, 75% of our gross income come from certain real estate-related sources (and TRS dividends are not qualifying income for such test). There can be no assurance that we will be able to comply with either or both of these tests in all market conditions. Our inability to comply with both of these tests could have a material adverse effect on our business, financial condition, liquidity, results of operations, qualification as a REIT and ability to make distributions to our stockholders.

The TRS rules limit the deductibility of interest paid or accrued by a TRS to its parent REIT to assure that the TRS is subject to an appropriate level of corporate taxation. The rules also impose a 100% excise tax on certain transactions between a TRS and its parent REIT that are not conducted on an arm's-length basis. Our domestic TRSs will pay U.S. federal, state and local income tax on their taxable income (net of deductible interest expense) at regular corporate tax rates, and their after-tax net income will be available for distribution to us but is not required to be distributed to us. In certain circumstances, the ability to deduct interest expense by any TRS that we may form could be limited. In addition, losses in our domestic TRSs generally will not provide any tax benefit prior to liquidation, except for being carried forward against future TRS taxable income.

We generally structure our foreign TRSs with the intent that their income and operations will not be subject to U.S. federal, state and local income tax. If the IRS successfully challenged that tax treatment, it would reduce the amount that those foreign TRSs would have available to distribute to us. E&P in our foreign TRSs are taxable to us, and are not qualifying income

52

Table of Contents

for the purposes of the REIT 75% gross income tests, regardless of whether such earnings are distributed to us. In addition, losses in our foreign TRSs generally will not provide any tax benefit prior to liquidation.

We intend to monitor the value of and the income from our respective investments in our domestic and foreign TRSs for the purpose of ensuring compliance with TRS ownership limitations and the REIT 75% gross income test. In addition, we will review all of our transactions with our TRSs to ensure that they are entered into on arm's-length terms to avoid incurring the 100% excise tax described above. There can be no assurance, however, that we will be able to comply with the 20% limitation, the REIT 75% gross income test or avoid application of the 100% excise tax discussed above.

Our ownership limitation may restrict change of control or business combination opportunities in which our stockholders might receive a premium for their common shares.

In order for us to qualify as a REIT, no more than 50% in value of our outstanding shares may be owned, directly or indirectly, by five or fewer individuals during the last half of any calendar year. "Individuals" for this purpose include natural persons, private foundations, some employee benefit plans and trusts, and some charitable trusts. In order to help us qualify as a REIT, among other purposes, our certificate of incorporation provides that no person may own, or be deemed to own by virtue of the attribution provisions of the Code, more than 9.8%, in value or in number of shares, whichever is more restrictive, of the outstanding shares of any class or series of our capital stock.

The ownership limitation and other restrictions could have the effect of discouraging a takeover or other transaction in which holders of our common shares might receive a premium for their common shares over the then-prevailing market price or which holders might believe to be otherwise in their best interests.

Dividends payable by REITs do not qualify for the reduced tax rates available for "qualified dividend income."

The maximum U.S. federal income tax rate applicable to "qualified dividend income" paid to U.S. taxpayers taxed at individual rates is currently 20%. Common and preferred dividends payable by REITs, however, generally are not eligible for the reduced rates on qualified dividend income. Rather, for taxable years beginning prior to January 1, 2026, non-corporate taxpayers may deduct up to 20% of certain pass-through business income, including "qualified REIT dividends" (generally, dividends received by a REIT stockholder that are not designated as capital gain dividends or qualified dividend income), subject to certain limitations, resulting in an effective maximum U.S. federal income tax rate of 29.6% on such income. Although the reduced U.S. federal income tax rate applicable to qualified dividend income does not adversely affect the taxation of REITs or dividends payable by REITs, the more favorable rates applicable to regular corporate qualified dividends and the reduction in the corporate tax rate under the TCJA could cause investors who are taxed at individual rates and regulated investment companies to perceive investments in the stocks of REITs to be relatively less attractive than investments in the stocks of non-REIT corporations that pay dividends treated as qualified dividend income, which could adversely affect the value of the stock of REITs, including our common stock.

We may be subject to adverse legislative or regulatory tax changes that could reduce the market price of our common stock.

At any time, the U.S. federal income tax laws or regulations governing REITs or the administrative interpretations of those laws or regulations may be amended. We cannot predict when or if any new U.S. federal income tax law, regulation or administrative interpretation, or any amendment to any existing U.S. federal income tax law, regulation or administrative interpretation, will be adopted, promulgated or become effective and any such law, regulation or interpretation may take effect retroactively. Changes to the tax laws, with or without retroactive application, could significantly and negatively affect our stockholders or us. We cannot predict the long-term effect of any future changes on REITs or assure our stockholders that any such changes will not adversely affect the taxation of a stockholder. We and our stockholders could be adversely affected by any such change in, or any new, U.S. federal income tax law, regulation or administrative interpretation.

Our recognition of "phantom" income may reduce a stockholder's after-tax return on an investment in our common stock.

We may recognize phantom income, which is taxable income in excess of our economic income, in the earlier years that we hold certain investments in the year that we modify certain loan investments, and we may only experience an offsetting excess of economic income over our taxable income in later years, if at all. As a result, stockholders at times may be required to pay U.S. federal income tax on distributions taxable as dividends that economically represent a return of capital rather than a dividend. Taking into account the time value of money, this acceleration or increase of U.S. federal income tax liabilities may reduce a stockholder's after-tax return on his or her investment to an amount less than the after-tax return on an investment with an identical before-tax rate of return that did not generate phantom income.

53

Table of Contents

Liquidation of our assets may jeopardize our REIT qualification or may be subject to a 100% tax.

To maintain our qualification as a REIT, we must comply with requirements regarding our assets and our sources of income. If we are compelled to liquidate our assets to repay obligations to our lenders or for other reasons, we may be unable to comply with these requirements, thereby jeopardizing our qualification as a REIT, or we may be subject to a 100% tax on any resultant gain if we sell assets that are treated as inventory or property held primarily for sale to customers in the ordinary course of business.

The tax on prohibited transactions will limit our ability to engage in transactions, including certain methods of securitizing MBS, that would be treated as sales of dealer property for U.S. federal income tax purposes.

A REIT's net income from prohibited transactions is subject to a 100% tax with no offset for losses. In general, prohibited transactions are sales or other dispositions of property, other than foreclosure property, but including mortgage loans, held primarily for sale to customers in the ordinary course of business. We might be subject to this tax if we dispose of or securitize mortgage loans or MBS in a manner that was treated as dealer activity for U.S. federal income tax purposes. Therefore, in order to avoid the prohibited transactions tax, we may choose not to engage in certain sales or securitization structures, even though the transactions might otherwise be beneficial to us. Alternatively, in order to avoid the prohibited transactions tax, we may choose to implement certain transactions through a TRS.

Although we expect to avoid the prohibited transactions tax by conducting the sale of property that may be characterized as dealer property through a TRS, such TRS will be subject to federal, state and local corporate income tax and may incur a significant tax liability as a result of those sales conducted through the TRS. Moreover, no assurance can be given that the IRS will respect the transaction by which property that may be characterized as dealer property is contributed to the TRS; if such transaction is not respected, then we may be treated as having engaged in a prohibited transaction, and our net income therefrom would be subject to a 100% tax.

Our Operating Partnership has made a mark-to-market election under Section 475(f) of the Code. If the IRS challenges our application of that election, it may jeopardize our REIT qualification.

Our Operating Partnership and certain other subsidiaries have made elections under Section 475(f) of the Code to mark their securities to market. There are limited authorities under Section 475(f) of the Code as to what constitutes a trader for U.S. federal income tax purposes. Under other sections of the Code, the status of a trader in securities depends on all of the facts and circumstances, including the nature of the income derived from the taxpayer's activities, the frequency, extent and regularity of the taxpayer's securities transactions, and the taxpayer's investment intent. There can be no assurance that these subsidiaries will continue to qualify as a trader in securities eligible to make the mark-to-market election. We have not received, nor are we seeking, an opinion from counsel or a ruling from the IRS regarding our or our subsidiaries' qualification as a trader. If the qualification for, or our application of, the mark-to-market election were successfully challenged by the IRS, in whole or in part, it could, depending on the circumstances, result in retroactive (or prospective) changes in the amount or timing of gross income we recognize. Furthermore, the law is unclear as to the treatment of mark-to-market gains and losses under the various REIT tax rules, including, among others, the prohibited transaction and qualified liability hedging rules. While there is limited analogous authority, we treat any mark-to-market gains as qualifying income for purposes of the 75% gross income test to the extent that the gain is recognized with respect to a qualifying real estate asset, based on an opinion of Hunton Andrews Kurth LLP substantially to the effect that any such gains recognized with respect to assets that would produce qualifying income for purposes of the 75% and/or 95% gross income test, as applicable, if they were actually sold should be treated as qualifying income to the same extent for purposes of the 75% and/or 95% gross income test, as applicable, and any such gains should not be subject to the prohibited transaction tax. If the IRS were to successfully treat our mark-to-market gains as subject to the prohibited transaction tax or to successfully challenge the treatment or timing of recognition of our mark-to-market gains or losses with respect to our qualified liability hedges, we could owe material federal income or penalty tax or, in some circumstances, even fail to qualify as a REIT. Finally, mark-to-market gains and losses could cause volatility in the amount of our taxable income, which, in turn, could cause us to distribute more dividends to our stockholders in a particular period than would otherwise be desirable from a business perspective.

The interest apportionment rules may affect our ability to comply with the REIT asset and gross income tests.

Most of the distressed mortgage loans that we have acquired were acquired by us at a discount from their outstanding principal amount, because our pricing was generally based on the value of the underlying real estate that secures those mortgage loans. Treasury Regulation Section 1.856-5(c) (the "interest apportionment regulation") provides that if a mortgage is secured by both real property and other property, a REIT is required to apportion its annual interest income to the real property security based on a fraction, the numerator of which is the value of the real property securing the loan, determined when the REIT commits to acquire the loan, and the denominator of which is the highest "principal amount" of the loan during the year. If a mortgage is secured by both real property and personal property and the value of the personal property does not exceed 15% of

54

Table of Contents

the aggregate value of the property securing the mortgage, the mortgage is treated as secured solely by real property for this purpose. Revenue Procedure 2014-51 interprets the "principal amount" of the loan to be the face amount of the loan, despite the Code requiring taxpayers to treat any market discount, that is the difference between the purchase price of the loan and its face amount, for all purposes (other than certain withholding and information reporting purposes) as interest rather than principal.

The interest apportionment regulation applies only if the debt in question is secured both by real property and personal property. We believe that most of the mortgage loans that we acquire at a discount under the circumstances contemplated by Revenue Procedure 2014-51 are secured only by real property (including mortgage loans secured by both real property and personal property where the value of the personal property does not exceed 15% of the aggregate value of the property securing the mortgage). Accordingly, we believe that the interest apportionment regulation generally does not apply to our loans.

Nevertheless, if the IRS were to assert successfully that such mortgage loans were secured by property other than real estate, that the interest apportionment regulation applied for purposes of our REIT testing, and that the position taken in Revenue Procedure 2014-51 should be applied to our portfolio, then depending upon the value of the real property securing our loans and their face amount, and the sources of our gross income generally, we might not be able to meet the REIT 75% gross income test, and possibly the asset tests applicable to REITs. If we did not meet these tests, we could potentially either lose our REIT status or be required to pay a tax penalty to the IRS. With respect to the REIT 75% asset test, Revenue Procedure 2014-51 provides a safe harbor under which the IRS will not challenge a REIT's treatment of a loan as being a real estate asset in an amount equal to the lesser of (1) the greater of (a) the current value of the real property securing the loan or (b) the fair market value of the real property securing the loan determined as of the date the REIT committed to acquire the loan or (2) the fair market value of the loan on the date of the relevant quarterly REIT asset testing date. This safe harbor, if it applied to us, would help us comply with the REIT asset tests following the acquisition of distressed debt if the value of the real property securing the loan were to subsequently decline. If we did not meet one or more of the REIT asset tests, then we could potentially either lose our REIT status or be required to pay a tax penalty to the IRS.

Generally, our investments in residential transition loans, or "RTLs," and occasionally, our investments in small balance commercial mortgage loans, or "SBCs," will require us to make estimates about the fair value of land improvements that may be challenged by the IRS.

Generally, our investments in RTLs, and occasionally our investments in SBCs, are short term loans secured by a mortgage on real estate assets where the proceeds of the loan will be used, in part, to renovate the property. The interest from these investments will be qualifying income for purposes of the REIT income tests, provided that the loan value of the real property securing the investment is equal to or greater than the highest outstanding principal amount of the loan during any taxable year. Under the REIT provisions, where improvements will be constructed with the proceeds of the loan, the loan value of the real property is the fair value of the land and existing real property improvements plus the reasonably estimated cost of the improvements or developments (other than personal property) that will secure the loan and that are to be constructed from the proceeds of the loan. There can be no assurance that the IRS would not challenge our estimate of the loan value of the real property.

The failure of a mezzanine loan or similar debt to qualify as a real estate asset could adversely affect our ability to qualify as a REIT.

We may invest in mezzanine loans or similar debt. The IRS has provided a safe harbor for mezzanine loans but not rules of substantive law. Pursuant to the safe harbor, if a mezzanine loan meets certain requirements, it will be treated by the IRS as a real estate asset for purposes of the REIT asset tests, and interest derived from the mezzanine loan will be treated as qualifying income for purposes of the REIT 75% gross income test. We may acquire mezzanine loans or similar debt that meet most but do not meet all of the requirements of this safe harbor, and we may treat such loans as real estate assets for purposes of the REIT asset and income tests. In the event that we own a mezzanine loan or similar debt that does not meet the safe harbor, the IRS could challenge such loan's treatment as a real estate asset for purposes of the REIT asset and income tests and, if such a challenge were sustained, we could fail to qualify as a REIT.

Our qualification as a REIT and exemption from U.S. federal income tax with respect to certain assets may be dependent on the accuracy of legal opinions or advice rendered or given or statements by the issuers of assets that we acquire, and the inaccuracy of any such opinions, advice or statements may adversely affect our REIT qualification and result in significant corporate-level tax.

When purchasing securities, we may rely on opinions or advice of counsel for the issuer of such securities, or statements made in related offering documents, for purposes of determining whether such securities represent debt or equity securities for U.S. federal income tax purposes, the value of such securities, and also to what extent those securities constitute qualified real estate assets for purposes of the REIT asset tests and produce income which qualifies under the REIT 75% gross income test.

55

Table of Contents

The inaccuracy of any such opinions, advice or statements may adversely affect our REIT qualification and result in significant corporate-level tax.

If we failed in a prior year to satisfy the "qualifying income exception" under the rules for publicly traded partnerships, our income for such years could be subject to an entity-level tax, and the value of our shares could be adversely affected.

We believe, for our taxable years prior to January 1, 2019, we were organized and had operated so that we qualified to be treated as a partnership for U.S. federal income tax purposes based on the "qualifying income exception" within the meaning of Section 7704(d) of the Code. If we failed to satisfy the "qualifying income exception" for any of our prior taxable years, we would be treated as a corporation for such years for U.S. federal income tax purposes. In that event, we would be required to pay U.S. federal, state and local income tax at regular corporate rates for all of the affected years, together with interest and penalties, which would likely result in a material expense for us.

General Risk Factors

We, Ellington, or its affiliates may be subject to adverse legislative or regulatory changes.

At any time, U.S. federal, state, local, or foreign laws or regulations that impact our business, or the administrative interpretations of those laws or regulations, may be enacted or amended.

We cannot predict when or if any new law, regulation, or administrative interpretation, including those related to the Dodd-Frank Act, or any amendment to or repeal of any existing law, regulation, or administrative interpretation, will be adopted or promulgated or will become effective. Additionally, the adoption or implementation of any new law, regulation, or administrative interpretation, or any revisions in or repeals of these laws, regulations, or administrative interpretations, including those related to the Dodd-Frank Act, could cause us to change our portfolio, could constrain our strategy, or increase our costs. We could be adversely affected by any change in or any promulgation of new law, regulation, or administrative interpretation.

We, Ellington, or its affiliates may be subject to regulatory inquiries and proceedings, or other legal proceedings.

At any time, industry-wide or company-specific regulatory inquiries or proceedings can be initiated and we cannot predict when or if any such regulatory inquiries or proceedings will be initiated that involve us or Ellington or its affiliates, including our Manager. We believe that the heightened scrutiny of the financial services industry increases the risk of inquiries and requests from regulatory or enforcement agencies. For example, as discussed under the caption Item 3. Legal Proceedings, over the years, Ellington and its affiliates have received, and we expect in the future that we and they may receive, inquiries and requests for documents and information from various federal, state, and foreign regulators.

We can give no assurances that, whether the result of regulatory inquiries or otherwise, neither we nor Ellington nor its affiliates will become subject to investigations, enforcement actions, fines, penalties or the assertion of private litigation claims. If any such events were to occur, we, or our Manager's ability to perform its obligations to us under the management agreement between us and our Manager, or Ellington's ability to perform its obligations to our Manager under the services agreement between Ellington and our Manager, could be materially adversely impacted, which could in turn have a material adverse effect on our business, financial condition and results of operations, and our ability to pay dividends to our shareholders.

The market for our common stock and our preferred stock may be limited, which may adversely affect the price at which our common stock and our preferred stock trade and make it difficult to sell our common stock or our preferred stock.

While our common stock and preferred stock are listed on the NYSE, such listing does not provide any assurance as to:

•whether the market prices of our common stock and/or our preferred stock will reflect our actual financial performance;

•the liquidity of our common and our preferred stock;

•the ability of any holder to sell our common stock or our preferred stock; or

•the prices that may be obtained for our common stock or our preferred stock.

The market price and trading volume of our common stock and our preferred stock may be volatile.

The market prices of our common stock and our preferred stock may be highly volatile and could be subject to wide fluctuations. In addition, the trading volume in our common stock and our preferred stock may fluctuate and cause significant price variations to occur. We cannot assure you that the market price of our common stock or our preferred stock will not fluctuate or decline significantly in the future. Some of the factors that could negatively affect our common stock price, our

56

Table of Contents

preferred stock price, or result in fluctuations in the price or trading volume of our common stock and/or our preferred stock include:

•actual or anticipated variations in our quarterly operating results or dividends;

•changes in our earnings estimates, failure to meet earnings or operating results expectations of public market analysts and investors, or publication of research reports about us or the real estate specialty finance industry;

•increases in market interest rates that lead purchasers of our common stock or our preferred stock to demand a higher yield;

•repurchases and issuances by us of our common stock or our preferred stock;

•passage of legislation, changes in applicable law, court rulings, enforcement actions, or regulatory developments that adversely affect us or our industry;

•changes in government policies or changes in timing of implementation of government policies, including with respect to Fannie Mae, Freddie Mac, and Ginnie Mae;

•changes in market valuations of similar companies;

•adverse market reaction to any increased indebtedness we incur in the future;

•additions or departures of key management personnel;

•actions by stockholders;

•speculation in the press or investment community;

•adverse changes in global, national, regional and local economic and market conditions, including those relating to pandemics, such as the COVID-19 pandemic;

•our inclusion in, or exclusion from, various stock indices;

•our operating performance and the performance of other similar companies; and

•changes in accounting principles.

Future offerings of debt securities, which would rank senior to our common and preferred stock upon our liquidation, and future offerings of equity securities, which could dilute our existing stockholders and, in the case of preferred equity, may be senior to our common stock for the purposes of dividend and liquidating distributions, may adversely affect the market price of our common stock.

In the future, we may attempt to increase our capital resources by making additional offerings of debt or equity securities, including commercial paper, medium-term notes, senior or subordinated notes, convertible securities, and additional classes of preferred stock. If we decide to issue additional senior securities in the future, it is likely that they will be governed by an indenture or other instrument containing covenants restricting our operating flexibility. Holders of senior securities may be granted specific rights, including the right to hold a perfected security interest in certain of our assets, the right to accelerate payments due under an indenture, rights to restrict dividend payments, and rights to require approval to sell assets. Additionally, any convertible or exchangeable securities that we issue in the future may have rights, preferences, and privileges more favorable than those of our then-outstanding securities and could dilute our existing stockholders. We and, indirectly, our stockholders, will bear the cost of issuing and servicing such securities. Upon liquidation, holders of our debt securities and preferred stock, and lenders with respect to other borrowings will receive a distribution of our available assets prior to the holders of our common stock. Additional equity offerings, including offerings of our common or preferred stock or other securities convertible into our common stock, may dilute the holdings of our existing stockholders or reduce the market price of our existing equity securities, or both. We cannot predict the effect, if any, of future sales of our common or preferred stock or other securities convertible into our common stock, or the availability of such securities for future sales, on the market price of our common stock. Sales of substantial amounts of our common or preferred stock or other securities convertible into our common stock, or the perception that such sales could occur, may adversely affect the prevailing market price for our common stock. Our preferred stock has a preference on liquidating distributions and a preference on dividend payments that could limit our ability to make a dividend distribution to the holders of our common stock. Because our decision to issue securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing, or nature of our future offerings. Thus, holders of our securities bear the risk of our future offerings reducing the market price of our securities and, in the case of holders of our equity securities, diluting their holdings.

57

Table of Contents

Certain provisions of Delaware law may inhibit potential acquisition bids that stockholders may consider favorable, and the market price of our common stock may be lower as a result.

We are a Delaware corporation, and Section 203 of the Delaware General Corporation Law applies to us. In general, Section 203 prevents an "interested stockholder" (as defined below) from engaging in a "business combination" (as defined in the statute) with us for three years following the date that person becomes an interested stockholder unless one or more of the following occurs:

•before that person became an interested stockholder, our board of directors approved the transaction in which the interested stockholder became an interested stockholder or approved the business combination;

•upon completion of the transaction that resulted in the interested stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) stock held by directors who are also officers of our company and by employee stock plans that do not provide employees with the right to determine confidentially whether shares held under the plan will be tendered in a tender or exchange offer; and

•following the transaction in which that person became an interested stockholder, the business combination is approved by our board of directors and authorized at a meeting of stockholders by the affirmative vote of the holders of at least two-thirds of our outstanding voting stock not owned by the interested stockholder.

The statute defines "interested stockholder" as any person that is the owner of 15% or more of our outstanding voting stock or is an affiliate or associate of us and was the owner of 15% or more of our outstanding voting stock at any time within the three-year period immediately before the date of determination.

These provisions may delay, deter or prevent a change in control of our company, even if a proposed transaction is at a premium over the then current market price for our common stock. Further, these provisions may apply in instances where some stockholders consider a transaction beneficial to them. As a result, our stock price may be negatively affected by these provisions.

Failure to procure adequate funding and capital would adversely affect our results and may, in turn, negatively affect the value of our common shares and our ability to pay dividends to our stockholders.

We depend upon the availability of adequate funding and capital for our operations. To maintain our status as a REIT, we are required to distribute to our stockholders at least 90% of our REIT taxable income annually, determined excluding any net capital gains and without regard to the deduction for dividends paid. As a result, we are not able to retain much or any of our earnings for new investments. We cannot assure you that any, or sufficient, funding or capital will be available to us in the future on terms that are acceptable to us. In the event that we cannot obtain sufficient funding and capital on acceptable terms, there may be a negative impact on the value of our shares of common stock and our ability to pay dividends to our stockholders, and you may lose part or all of your investment.

58

Table of Contents

Item 1B. Unresolved Staff Comments

None.

Item 2. Properties

We do not own any properties. Our principal offices are located in leased space at 53 Forest Avenue, Old Greenwich, CT 06870. The offices of our Manager and Ellington are at the same location. As part of our management agreement, our Manager is responsible for providing offices necessary for all operations, and accordingly, all lease responsibilities belong to our Manager.

Item 3. Legal Proceedings

Neither we nor Ellington nor its affiliates (including our Manager) are currently subject to any legal proceedings that we or our Manager consider material. Nevertheless, we and Ellington and its affiliates operate in highly regulated markets that currently are under regulatory scrutiny, and over the years, Ellington and its affiliates have received, and we expect in the future that we and they may receive, inquiries and requests for documents and information from various federal, state and foreign regulators.

We and Ellington cannot provide any assurance that, whether the result of regulatory inquiries or otherwise, neither we nor Ellington nor its affiliates will become subject to investigations, enforcement actions, fines, penalties or the assertion of private litigation claims or that, if any such events were to occur, they would not materially adversely affect us. For a discussion of these and other related risks, see "Part I, Item 1A. Risk Factors—We, Ellington, or its affiliates may be subject to regulatory inquiries and proceedings, or other legal proceedings" of this Annual Report on Form 10-K.

Item 4. Mine Safety Disclosures

Not applicable.

59

Table of Contents

PART II

Item 5. Market for Registrant's Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common shares have been listed on the NYSE under the symbol "EFC" since October 8, 2010.

Holders of Our Common Stock

Based upon a review of a securities position listing as of March 5, 2021, we had an aggregate of 124 holders of record and holders of our common stock who are nominees for an undetermined number of beneficial owners.

Dividends

While we have historically paid dividends to our common stockholders on a monthly (prior to April 2019, on a quarterly) basis, the declaration of dividends to holders of our common stockholders and the amount of such dividends are at the sole discretion of our Board of Directors. In setting our dividends, our Board of Directors takes into account, among other things, our earnings, liquidity, financial condition, the REIT distribution requirements, our financial covenants, and other factors that our Board of Directors may deem relevant from time to time. In addition, in order to preserve our liquidity, our Board of Directors may declare all or any portion of a dividend to be payable in stock, may delay the record date or payment date for any previously declared, but unpaid, dividend, convert a previously declared, but unpaid, cash dividend on our common stock to a dividend paid partially or completely in stock, or even revoke a declared, but unpaid, dividend. Furthermore, it is possible that some of our future financing arrangements could contain provisions restricting our ability to pay dividends. In addition, our ability to pay dividends is subject to certain restrictions under the Delaware General Corporation Law, or the "DGCL." Under the DGCL, cash dividends on capital stock may only be paid from “surplus” or, if there is no “surplus,” from the corporation’s net profits for the then-current or the preceding fiscal year.

We cannot assure you that we will pay any future dividends to our stockholders and previously declared dividends are not intended to be indicative of the amount and timing of future dividends, if any.

Unregistered Sales of Equity Securities

Pursuant to our 2017 Plan, on December 17, 2020, we granted 32,809 OP LTIP Units to certain of our partially dedicated employees. The OP LTIP Units are subject to forfeiture restrictions that will lapse with respect to 18,211 of the OP LTIP Units on December 17, 2021 and 14,598 of the OP LTIP Units on December 17, 2022. Once vested, the OP LTIP Units may be converted at the election of the holder, or at any time at our election, into OP Units on a one-for-one basis. Subject to certain conditions, the OP Units are redeemable by the holder for an equivalent number of shares of our common stock or, at our election, for the cash value of such shares of our common stock. Such grants were exempt from the registration requirements of the Securities Act based on the exemption provided in Section 4(a)(2) of the Securities Act.

Issuer Purchases of Equity Securities

None.

60

Table of Contents

Performance

This performance graph is furnished and shall not be deemed filed with the SEC or subject to Section 18 of the Exchange Act, nor shall it be deemed incorporated by reference in any of our filings under the Securities Act.

The following graph provides a comparison of the cumulative total return on our common shares to the cumulative total return on the Standard & Poor's 500 Composite Stock Price Index, or the "S&P 500," and the FTSE National Association of Real Estate Investment Trusts Mortgage REIT Index, or the "FTSE NAREIT MREIT." The comparison is for the period from December 31, 2015 to December 31, 2020, and assumes in each case, a $100 investment on December 31, 2015 and the reinvestment of dividends.

The actual cumulative total returns shown on the graph above are as follows:

	December 31,
	2015		2016		2017		2018		2019		2020
Ellington Financial Inc.	$	100.00	$	103.50	$	108.00	$	126.69	$	167.77	$	151.28
S&P 500	100.00		111.95		136.38		130.39		172.92		204.72
FTSE NAREIT MREIT	100.00		122.83		147.09		143.23		173.69		141.36

The performance information above has been obtained from sources believed to be reliable, but neither its accuracy nor its completeness can be guaranteed. The historical information set forth above is not necessarily indicative of future performance. Accordingly, we do not make or endorse any predictions as to future share performance.

61

Table of Contents

Item 6. Selected Financial Data

The following table presents selected consolidated financial information as of and for the years ended December 31, 2020, 2019, 2018, 2017, and 2016. The consolidated financial information presented below as of and for the years ended December 31, 2020, 2019, and 2018, has been derived from our audited financial statements included elsewhere in this Annual Report on Form 10-K. The consolidated financial information as of and for the years ended December 31, 2017 and 2016, was derived from our historical audited consolidated financial statements not included in this Annual Report on Form 10-K.

Since the information presented below is only selected financial data and does not provide all of the information contained in our historical consolidated financial statements included elsewhere in this Annual Report on Form 10-K, including the related notes, you should read it in conjunction with "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations," and our historical consolidated financial statements, including the related notes to our consolidated financial statements, included in this Annual Report on Form 10-K.

As detailed in Note 2 of the notes to our consolidated financial statements for the year ended December 31, 2020, effective January 1, 2019, as a result of our prospective application of a change in accounting, as required under ASC 946-10-25-2, we have determined that the presentation of our consolidated financial statements for periods beginning after December 31, 2018 are not comparable to the consolidated financial statements previously prepared for prior periods for which we applied ASC 946, Financial Services—Investment Companies ("ASC 946"); as a result, the financial statements for periods beginning after December 31, 2018 are shown separately from the financial statements for prior periods.

Condensed Consolidated Statement of Operations

	Year Ended December 31,
	2020		2019
(In thousands, except per share amounts)
Net Interest Income
Interest income	$	173,531	$	159,901
Interest expense	(61,665)		(78,479)
Total net interest income	111,866		81,422
Other Income (Loss)
Realized and unrealized gains (losses) on securities and loans, net	(31,743)		41,693
Realized and unrealized gains (losses) on financial derivatives, net	(30,532)		(36,250)
Realized and unrealized gains (losses) on real estate owned, net	(634)		1,048
Other, net	(2,298)		5,350
Total other income (loss)	(65,207)		11,841
Expenses
Base management fee to affiliate (Net of fee rebates of $1,051 and $1,967, respectively)(1)	11,508		7,988
Incentive fee to affiliate	—		116
Other investment related expenses	18,144		17,777
Other operating expense	15,186		12,856
Total expenses	44,838		38,737
Net Income (Loss) before Income Tax Expense (Benefit) and Earnings (Losses) from Investments in Unconsolidated Entities	1,821		54,526
Income tax expense (benefit)	11,377		1,558
Earnings (losses) from investments in unconsolidated entities	37,933		10,209
Net Income (Loss)	28,377		63,177
Net income (loss) attributable to non-controlling interests	3,369		5,244
Dividends on preferred stock	7,763		1,466
Net Income (Loss) Attributable to Common Stockholders	$	17,245	$	56,467
Net Income (Loss) per Share of Common Stock:
Basic and Diluted	$	0.39	$	1.76

(1)See Note 13 of the notes to the consolidated financial statements for the year ended December 31, 2020, for further details on management fee rebates.

62

Table of Contents

	Year Ended December 31,
	2018		2017		2016
(In thousands except per share amounts)
Investment Income:
Interest income	$	131,027	$	89,629	$	74,344
Other income	4,014		4,331		5,841
Total investment income	135,041		93,960		80,185
Expenses:
Base management fee (Net of fee rebates of $1,380, $332, and $0 respectively)(1)	7,573		9,056		10,065
Incentive fee	715		—		—
Interest expense	56,707		31,120		16,306
Other investment related expenses	16,954		9,754		8,070
Other operating expense	9,967		8,862		9,979
Total expenses	91,916		58,792		44,420
Net Investment Income	43,125		35,168		35,765
Net Realized and Unrealized Gain (Loss) on Investments, Financial Derivatives, and Foreign Currency Transactions/Translation:
Net realized and change in net unrealized gain (loss) on investments	(526)		11,298		(5,304)
Net change in net unrealized gain (loss) on other secured borrowings	758		—		—
Net realized and change in net unrealized gain (loss) on financial derivatives, excluding currency hedges	4,454		(11,727)		(46,722)
Net realized and change in net unrealized gain (loss) on financial derivatives—currency hedges	5,040		(6,946)		2,513
Net foreign currency gain (loss)	(2,940)		8,171		(1,954)
Net Realized and Change in Net Unrealized Gain (Loss) on Investments, Financial Derivatives, and Foreign Currency Transactions/Translation	6,786		796		(51,467)
Net Increase (Decrease) in Equity Resulting from Operations	49,911		35,964		(15,702)
Less: Net Increase in Equity Resulting From Operations Attributable to Non-controlling Interests	3,235		1,983		305
Net Increase (Decrease) in Shareholders' Equity Resulting from Operations	$	46,676	$	33,981	$	(16,007)
Net Increase (Decrease) in Shareholders' Equity Resulting from Operations per share	$	1.52	$	1.04	$	(0.48)

(1)See Note 9 of the notes to the consolidated financials for the year ended December 31, 2018 for further details on management fee rebates.

63

Table of Contents

Condensed Consolidated Balance Sheet

	As of December 31,
	2020		2019
(In thousands, except share amounts)
Assets
Cash and cash equivalents(1)	$	111,647	$	72,302
Restricted cash(1)	175		175
Securities, at fair value(1)	1,514,185		2,449,941
Loans, at fair value(1)	1,453,480		1,412,426
Investments in unconsolidated entities, at fair value(1)	141,620		71,850
Real estate owned(1)	23,598		30,584
Financial derivatives—assets, at fair value	15,479		16,788
Reverse repurchase agreements	38,640		73,639
Due from brokers(1)	63,147		79,829
Investment related receivables(1)	49,317		123,120
Other assets(1)	2,575		7,563
Total Assets	3,413,863		4,338,217
Liabilities
Securities sold short, at fair value	38,642		73,409
Repurchase agreements(1)	1,496,931		2,445,300
Financial derivatives—liabilities, at fair value	24,553		27,621
Due to brokers	5,059		2,197
Investment related payables(1)	4,754		66,133
Other secured borrowings(1)	51,062		150,334
Other secured borrowings, at fair value(1)	754,921		594,396
Senior notes, net	85,561		85,298
Base management fee payable to affiliate	3,178		2,663
Incentive fee payable to affiliate	—		116
Dividends payable	5,738		6,978
Interest payable(1)	3,233		7,320
Accrued expenses and other liabilities(1)	18,659		7,753
Total Liabilities	2,492,291		3,469,518
Commitments and contingencies (Note 21)
Equity
Preferred stock, par value $0.001 per share, 100,000,000 shares authorized; 6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable; 4,600,000 shares issued and outstanding ($115,000 liquidation preference)	111,034		111,034
Common stock, par value $0.001 per share, 100,000,000 shares authorized; 43,781,684 and 38,647,943 shares issued and outstanding	44		39
Additional paid-in-capital	915,658		821,747
Retained earnings (accumulated deficit)	(141,521)		(103,555)
Total Stockholders' Equity	885,215		829,265
Non-controlling interests(1)	36,357		39,434
Total Equity	921,572		868,699
Total Liabilities and Equity	$	3,413,863	$	4,338,217
SUPPLEMENTAL PER SHARE INFORMATION:
Book Value Per Common Share(2)	$	17.59	$	18.48

(1)Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

(2)Based on total stockholders' equity less the aggregate liquidation preference of the Company's preferred stock outstanding.

64

Table of Contents

Condensed Consolidated Statement of Assets, Liabilities, and Equity

	As of December 31,
	2018		2017		2016
(In thousands except per share amounts)
Cash and cash equivalents	$	44,656	$	47,233	$	123,274
Restricted cash	425		425		655
Investments at fair value	2,939,311		2,071,707		1,505,026
Financial derivatives–assets, at fair value	20,001		28,165		35,595
Repurchase agreements	61,274		155,949		184,819
Receivable for securities sold	780,826		476,000		445,112
Due from brokers	71,794		140,404		93,651
Other assets	53,212		73,458		25,063
Total assets	3,971,499		2,993,341		2,413,195
Investments sold short at fair value	850,577		642,240		584,896
Financial derivatives–liabilities, at fair value	20,806		36,273		18,687
Reverse repurchase agreements	1,498,849		1,209,315		1,033,581
Payable for securities purchased	5,553		202,703		85,168
Other secured borrowings	488,411		57,909		24,086
Other secured borrowings, at fair value	114,100		125,105		—
Senior notes, net	297,948		84,771		—
Due to brokers	85,035		1,721		12,780
Other liabilities	15,050		12,343		9,220
Total liabilities	3,376,329		2,372,380		1,768,418
Equity	595,170		620,961		644,777
Less: Non-controlling interests	31,337		20,862		7,116
Shareholders' Equity	$	563,833	$	600,099	$	637,661
Shareholders' equity per common share	$	18.92	$	19.15	$	19.75
Shareholders' equity per common share, diluted	$	18.92	$	18.85	$	19.46

65

Table of Contents

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

Executive Summary

We invest in a diverse array of real-estate-related and other financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, or "RMBS," commercial mortgage-backed securities, or "CMBS," consumer loans and asset-backed securities, or "ABS," including ABS backed by consumer loans, collateralized loan obligations, or "CLOs," non-mortgage- and mortgage-related derivatives, equity investments in loan origination companies, and other strategic investments. We are externally managed and advised by our Manager, an affiliate of Ellington. Ellington is a registered investment adviser with a 26-year history of investing in the Agency and credit markets.

We conduct all of our operations and business activities through the Operating Partnership. As of December 31, 2020, we have an ownership interest of approximately 98.7% in the Operating Partnership. The remaining ownership interest of approximately 1.3% in the Operating Partnership represents the interests in the Operating Partnership that are owned by an affiliate of our Manager, our directors, and certain current and former Ellington employees and their related parties, and is reflected in our financial statements as a non-controlling interest.

Our primary objective is to generate attractive, risk-adjusted total returns for our stockholders. We seek to attain this objective by utilizing an opportunistic strategy to make investments, without restriction as to ratings, structure, or position in the capital structure, that we believe compensate us appropriately for the risks associated with them rather than targeting a specific yield. Our evaluation of the potential risk-adjusted return of any potential investment typically involves weighing the potential returns of such investment under a variety of economic scenarios against the perceived likelihood of the various scenarios. Potential investments subject to greater risk (such as those with lower credit ratings and/or those with a lower position in the capital structure) will generally require a higher potential return to be attractive in comparison to investment alternatives with lower potential return and a lower degree of risk. However, at any particular point in time, depending on how we perceive the market's pricing of risk both generally and across sectors, we may favor higher-risk assets or we may favor lower-risk assets, or a combination of the two, in the interests of portfolio diversification or other considerations.

Through December 31, 2020, our credit portfolio, which includes all of our investments other than RMBS for which the principal and interest payments are guaranteed by a U.S. government agency or a U.S. government-sponsored entity, or "Agency RMBS," has been the primary driver of our risk and return, and we expect that this will continue in the near- to medium-term. For more information on our targeted assets, see "—Our Targeted Asset Classes" below. We believe that Ellington's capabilities allow our Manager to identify attractive assets in these classes, value these assets, monitor and forecast the performance of these assets, and opportunistically hedge our risk with respect to these assets.

We continue to maintain a highly leveraged portfolio of Agency RMBS to take advantage of opportunities in that market sector, to help maintain our exclusion from registration as an investment company under the Investment Company Act, and to help maintain our qualification as a REIT. Unless we acquire very substantial amounts of whole mortgage loans or there are changes to the rules and regulations applicable to us under the Investment Company Act and/or to our qualification as a REIT, we expect that we will continue to maintain some amount of Agency RMBS.

The strategies that we employ are intended to capitalize on opportunities in the current market environment. Subject to maintaining our qualification as a REIT, we intend to adjust our strategies to changing market conditions by shifting our asset allocations across various asset classes as credit and liquidity trends evolve over time. We believe that this flexibility, combined with Ellington's experience, will help us generate more consistent returns on our capital throughout changing market cycles.

Subject to maintaining our qualification as a REIT, we opportunistically hedge our credit risk, interest rate risk, and foreign currency risk; however, at any point in time we may choose not to hedge all or a portion of these risks, and we will generally not hedge those risks that we believe are appropriate for us to take at such time, or that we believe would be impractical or prohibitively expensive to hedge.

We also use leverage in our credit strategy, albeit significantly less leverage than that used in our Agency RMBS strategy. Through December 31, 2020, we financed the vast majority of our Agency RMBS assets, and a portion of our credit assets, through repurchase agreements, which we sometimes refer to as "repos," which we account for as collateralized borrowings. We expect to continue to finance the vast majority of our Agency RMBS through the use of repos. In addition to financing assets through repos, we also enter into other secured borrowing transactions, which are accounted for as collateralized borrowings, to finance certain of our loan assets. We have also obtained, through the securitization markets, term financing for certain of our non-qualified mortgage, or "non-QM," loans, certain of our consumer loans, and certain of our leveraged corporate loans. Additionally, we have issued unsecured long-term debt.

As of December 31, 2020, outstanding borrowings under repos and Total other secured borrowings (which include Other secured borrowings and Other secured borrowings, at fair value, as presented on our Consolidated Balance Sheet) were $2.3

66

Table of Contents

billion, of which approximately 40%, or $921.9 million, relates to our Agency RMBS holdings. The remaining outstanding borrowings relate to our credit portfolio.

As of December 31, 2020, we also had $86.0 million outstanding of unsecured long-term debt, maturing in September of 2022, or the "Senior Notes." The Senior Notes bear interest at a rate of 5.50%, subject to adjustment based on changes, if any, in the ratings of the Senior Notes. The indenture governing the Senior Notes contains a number of covenants, including several financial covenants. The Senior Notes were issued in connection with an exchange of our previously issued unsecured long-term debt (the "Old Senior Notes") on February 13, 2019 (the "Note Exchange"), in connection with our intended election to be taxed as a REIT. At the time of the Note Exchange, the Senior Notes were rated A by Egan-Jones Rating Company1.

1A rating is not a recommendation to buy, sell or hold securities. Ratings may be subject to revision or withdrawal at any time by the assigning rating organization. Each rating should be evaluated independently of any other rating.

See Note 11 of the notes to our consolidated financial statements for further detail on the Senior Notes and the Note Exchange.

As of December 31, 2020, our book value per share of common stock, calculated using Total Stockholders' Equity less the aggregate liquidation preference of outstanding preferred stock, was $17.59. Our debt-to-equity ratio was 2.6:1 as of December 31, 2020. Our debt-to-equity ratio does not account for liabilities other than debt financings and does not include debt associated with securitization transactions accounted for as sales. Our recourse debt-to-equity ratio was 1.6:1 as of December 31, 2020.

On January 24, 2020, we completed a follow-on offering of 5,290,000 shares of our common stock, of which 690,000 shares were issued pursuant to the exercise of the underwriters' option. The issuance and sale of such common shares generated net proceeds, after underwriters' discount and offering costs, of $95.3 million.

During the year ended December 31, 2020 we repurchased 290,050 shares of our common stock at an average price per share of $10.54 and a total cost of $3.1 million. In addition to making discretionary repurchases, we from time to time use 10b5-1 plans to increase the number of trading days available to implement these repurchases.

We elected to be taxed as a REIT under the Internal Revenue Code of 1986, as amended, or "the Code," commencing with our taxable year ended December 31, 2019. Provided that we maintain our qualification as a REIT, we generally will not be subject to U.S. federal, state, and local income tax on our REIT taxable income that is currently distributed to our stockholders. Any taxes paid by a domestic taxable REIT subsidiary, or "TRS," will reduce the cash available for distribution to our stockholders. REITs are subject to a number of organizational and operational requirements, including a requirement that they currently distribute at least 90% of their annual REIT taxable income excluding net capital gains.

On February 28, 2019, we filed a certificate of conversion with the Secretary of State of the State of Delaware (the "Secretary of State") to convert from a Delaware limited liability company to a Delaware corporation (the "Conversion") and change our name to Ellington Financial Inc. (the "Corporation"). The Conversion became effective on March 1, 2019, and upon effectiveness, each of our existing common shares representing limited liability company interests, no par value, converted into one issued and outstanding, fully paid and nonassessable share of common stock, $0.001 par value per share, of the Corporation.

Our Targeted Asset Classes

Our targeted asset classes currently include investments in the U.S. and Europe (as applicable) in the categories listed below. Subject to maintaining our qualification as a REIT, we expect to continue to invest in these targeted asset classes. Also, we expect to continue to hold certain of our targeted assets through one or more TRSs. As a result, a portion of the income from such assets will be subject to U.S. federal corporate income tax.

67

Table of Contents

Asset Class		Principal Assets
Agency RMBS	.	Whole pool pass-through certificates;
	.	Partial pool pass-through certificates;
	.	Agency collateralized mortgage obligations, or "CMOs," including interest only securities, or "IOs," principal only securities, or "POs," inverse interest only securities, or "IIOs"; and
CLOs	.	Retained tranches from CLO securitizations, including participating in the accumulation of the underlying assets for such securitization by providing capital to the vehicle accumulating assets; and
	.	Other CLO debt and equity tranches.
CMBS and Commercial Mortgage Loans	.	CMBS; and
	.	Commercial mortgage loans and other commercial real estate debt.
Consumer Loans and ABS	.	Consumer loans;
	.	ABS, including ABS backed by consumer loans; and
	.	Retained tranches from securitizations to which we have contributed assets.
Mortgage-Related Derivatives	.	To-Be-Announced mortgage pass-through certificates, or "TBAs";
	.	Credit default swaps, or "CDS," on individual RMBS, on the ABX, CMBX and PrimeX indices and on other mortgage-related indices; and
	.	Other mortgage-related derivatives.
Non-Agency RMBS	.	RMBS backed by prime jumbo, Alt-A, non-QM, manufactured housing, and subprime mortgages;
	.	RMBS backed by fixed rate mortgages, Adjustable rate mortgages, or "ARMs," Option-ARMs, and Hybrid ARMs;
	.	RMBS backed by mortgages on single-family-rental properties;
	.	RMBS backed by first lien and second lien mortgages;
	.	Investment grade and non-investment grade securities;
	.	Senior and subordinated securities;
	.	IOs, POs, IIOs, and inverse floaters;
	.	Collateralized debt obligations, or "CDOs";
	.	RMBS backed by European residential mortgages, or "European RMBS"; and
	.	Retained tranches from securitizations in which we have participated.
Residential Mortgage Loans	.	Residential non-performing mortgage loans, or "NPLs";
	.	Re-performing loans, or "RPLs," which generally are loans that were modified and/or formerly NPLs where the borrower has resumed making payments in some form or amount;
	.	Residential "transition loans," such as residential bridge loans and residential "fix-and-flip" loans;
	.	Non-QM loans; and
	.	Retained tranches from securitizations to which we have contributed assets.
Other	.	Real estate, including commercial and residential real property;
	.	Strategic debt and/or equity investments in loan originators and mortgage-related entities;
	.	Corporate debt and equity securities and corporate loans;
	.	Mortgage servicing rights, or "MSRs";
	.	Credit risk transfer securities, or "CRTs"; and
	.	Other non-mortgage-related derivatives.

68

Table of Contents

Agency RMBS

Our Agency RMBS assets consist primarily of whole pool (and to a lesser extent, partial pool) pass-through certificates, the principal and interest of which are guaranteed by a federally chartered corporation, such as the Federal National Mortgage Association, or "Fannie Mae," the Federal Home Loan Mortgage Corporation, or "Freddie Mac," or the Government National Mortgage Association, within the U.S. Department of Housing and Urban Development, or "Ginnie Mae," and which are backed by ARMs, Hybrid ARMs, or fixed-rate mortgages. In addition to investing in pass-through certificates which are backed by traditional mortgages, we have also invested in Agency RMBS backed by reverse mortgages. Reverse mortgages are mortgage loans for which neither principal nor interest is due until the borrower dies, the home is sold, or other trigger events occur. Mortgage pass-through certificates are securities representing undivided interests in pools of mortgage loans secured by real property where payments of both interest and principal, plus prepaid principal, on the securities are made monthly to holders of the security, in effect "passing through" monthly payments made by the individual borrowers on the mortgage loans that underlie the securities, net of fees paid to the issuer/guarantor and servicers of the securities. Whole pool pass-through certificates are mortgage pass-through certificates that represent the entire ownership of (as opposed to merely a partial undivided interest in) a pool of mortgage loans.

Our Agency RMBS assets are typically concentrated in specified pools. Specified pools are fixed-rate Agency pools consisting of mortgages with special characteristics, such as mortgages with low loan balances, mortgages backed by investor properties, mortgages originated through the government-sponsored "Making Homes Affordable" refinancing programs, and mortgages with various other characteristics. Our Agency strategy also includes RMBS that are backed by ARMs or Hybrid ARMs and reverse mortgages, and CMOs, including IOs, POs, and IIOs.

CLOs

CLOs are a form of asset-backed security collateralized by syndicated corporate loans. We have retained, and may retain in the future, tranches from CLO securitizations for which we have participated in the accumulation of the underlying assets, typically by providing capital to a vehicle accumulating assets for such CLO securitization. Such vehicles may enter into warehouse financing facilities in order to facilitate such accumulation. Securitizations can effectively provide us with long-term, locked-in financing on the related collateral pool, with an effective cost of funds well below the expected yield on the collateral pool. Our CLO holdings may include both debt and equity interests.

CMBS

We acquire CMBS, which are securities collateralized by mortgage loans on commercial properties. The majority of CMBS issued are fixed rate securities backed by fixed rate loans made to multiple borrowers on a variety of property types, though single-borrower CMBS and floating rate CMBS have also been issued.

The majority of CMBS utilize senior/subordinate structures, similar to those found in non-Agency RMBS. Subordination levels vary so as to provide for one or more AAA credit ratings on the most senior classes, with less senior securities rated investment grade and non-investment grade, including a first loss component which is typically unrated. This first loss component is commonly referred to as the "B-piece," which is the most subordinated (and therefore highest yielding and riskiest) tranche of a CMBS securitization. Much of our focus within the CMBS sector has been on B-pieces, but we also acquire other CMBS with more senior credit priority.

Commercial Mortgage Loans and Other Commercial Real Estate Debt

We acquire commercial mortgage loans, which are loans secured by liens on commercial properties, including hotel, industrial, multi-family, office and retail properties. Loans may be fixed or floating rate and will generally have maturities ranging from one to ten years. We typically acquire first lien loans but may also acquire subordinated loans. As of December 31, 2020, all of our commercial mortgage loans were first lien loans. Commercial real estate debt typically limits the borrower's right to freely prepay for a period of time through provisions such as prepayment fees, lockout, yield maintenance, or defeasance provisions. Some of the commercial mortgage loans that we acquire may be non-performing, underperforming, or otherwise distressed; these loans are typically acquired at a discount both to their unpaid principal balances and to the value of the underlying real estate.

We also participate in the origination of "bridge" loans, which have shorter terms and higher interest rates than more traditional commercial mortgage loans. Bridge loans are typically secured by properties in transition, where the borrower is in the process of either re-developing or stabilizing operations at the property. Properties securing these loans may include multi-family, retail, office, industrial, and other commercial property types.

Within both our loan acquisition and loan origination strategies, we generally focus on smaller balance loans and/or loan packages that are less-competitively-bid. These loans typically have balances that are less than $20 million, and are secured by

69

Table of Contents

real estate and, in some cases, a personal guarantee from the borrower.

Consumer Loans and ABS

We acquire U.S. consumer whole loans and ABS, including ABS backed by U.S. consumer loans. Our U.S. consumer loan portfolio primarily consists of unsecured loans, but also includes secured auto loans. We are currently purchasing newly originated consumer loans under flow agreements with originators, as well as seasoned consumer loans in the secondary market, and we continue to evaluate new opportunities.

TBAs and Other Mortgage-Related Derivatives

In addition to investing in specified pools of Agency RMBS, we utilize TBA transactions, whereby we agree to purchase or sell, for future delivery, Agency RMBS with certain principal and interest terms and certain types of underlying collateral, but the particular Agency RMBS to be delivered is not identified until shortly before the TBA settlement date. TBAs are liquid and have quoted market prices and represent the most actively traded class of mortgage-backed securities, or "MBS." TBA trading is based on the assumption that mortgage pools that are eligible to be delivered at TBA settlement are fungible and thus the specific mortgage pools to be delivered do not need to be explicitly identified at the time a trade is initiated.

We generally engage in TBA transactions for purposes of managing certain risks associated with our investment strategies. Other than with respect to TBA transactions entered into by our TRSs, most of our TBA transactions are treated for tax purposes as hedging transactions used to hedge indebtedness incurred to acquire or carry real estate assets, or "qualifying liability hedges." The principal risks that we use TBAs to mitigate are interest rate and yield spread risks. For example, we may hedge the interest rate and/or yield spread risk inherent in our long Agency RMBS by taking short positions in TBAs that are similar in character. Alternatively, we may opportunistically engage in TBA transactions because we find them attractive in their own right, from a relative value perspective or otherwise. For accounting purposes, in accordance with generally accepted accounting principles in the United States of America, or "U.S. GAAP," we classify TBA transactions as derivatives.

We also take long and short positions in various other mortgage-related derivative instruments, including mortgage-related credit default swaps. A credit default swap is a credit derivative contract in which one party (the protection buyer) pays an ongoing periodic premium (and often an upfront payment as well) to another party (the protection seller) in return for compensation for default (or similar credit event) by a reference entity. In this case, the reference entity can be an individual MBS or an index of several MBS, such as an ABX, PrimeX, or CMBX index. Payments from the protection seller to the protection buyer typically occur if a credit event takes place. A credit event can be triggered by, among other things, the reference entity's failure to pay its principal obligations or a severe ratings downgrade of the reference entity.

Non-Agency RMBS

We acquire non-Agency RMBS backed by prime jumbo, Alt-A, non-QM, manufactured housing, subprime residential, and single-family-rental mortgage loans. Our non-Agency RMBS holdings can include investment-grade and non-investment grade classes, including non-rated classes.

Non-Agency RMBS are generally debt obligations issued by private originators of, or investors in, residential mortgage loans. Non-Agency RMBS generally are issued as CMOs and are backed by pools of whole mortgage loans or by mortgage pass-through certificates. Non-Agency RMBS generally are securitized in senior/subordinated structures, or in excess spread/over-collateralization structures. In senior/subordinated structures, the subordinated tranches generally absorb all losses on the underlying mortgage loans before any losses are borne by the senior tranches. In excess spread/over-collateralization structures, losses are first absorbed by any existing over-collateralization, then borne by subordinated tranches and excess spread, which represents the difference between the interest payments received on the mortgage loans backing the RMBS and the interest due on the RMBS debt tranches, and finally by senior tranches and any remaining excess spread.

We also have acquired, and may acquire in the future, European RMBS, including retained tranches from European RMBS securitizations in which we have participated.

Residential Mortgage Loans

Our residential mortgage loans include newly originated non-QM loans, residential transition loans, as well as legacy residential NPLs and RPLs. A non-QM loan is not necessarily high-risk, or subprime, but is instead a loan that does not conform to the complex Qualified Mortgage, or "QM," rules of the Consumer Financial Protection Bureau. For example, many non-QM loans are made to creditworthy borrowers who cannot provide traditional documentation for income, such as borrowers who are self-employed. There is also demand from certain creditworthy borrowers for loans above the QM 43% debt-to-income ratio limit that still meet all ability-to-repay standards. We hold an equity investment in a non-QM originator,

70

Table of Contents

and to date we have purchased the vast majority of our non-QM loans from this originator, although we could potentially purchase a greater share of non-QM loans from other sources in the future.

The residential transition loans that we originate or purchase include: (i) "fix and flip" loans, which are made to real estate investors for the purpose of acquiring residential homes, making value-add improvements to such homes, and reselling the newly rehabilitated homes for a potential profit, and (ii) loans made to real estate investors for a "business purpose," such as purchasing a rental investment property, financing or refinancing a fully rehabilitated home awaiting sale, or securing short-term financing pending qualification for longer-term lower-rate financing. Our residential transition loans are secured by non-owner occupied properties, and are typically structured as fixed-rate, interest-only loans with terms to maturity between 6 and 24 months. Our underwriting guidelines focus on both the "as is" and "as repaired" property values, borrower experience as a real estate investor, and asset verification.

We remain active in the market for residential NPLs and RPLs. The market for large residential NPL and RPL pools has remained highly concentrated, with the great majority having traded to only a handful of large players who typically securitize the residential NPLs and RPLs that they purchase. As a result, we have continued to focus our acquisitions on less-competitively-bid, and more attractively-priced mixed legacy pools sourced from motivated sellers.

Other Investment Assets

Our other investment assets include real estate, including residential and commercial real property, strategic debt and/or equity investments in loan originators, corporate debt and equity securities, corporate loans, which can include litigation finance loans, CRTs, and other non-mortgage-related derivatives. We do not typically purchase real property directly; rather, our real estate ownership usually results from foreclosure activity with respect to our acquired residential and commercial loans. We have made investments in loan originators and other related entities in the form of debt and/or equity and, to date, our investments have represented non-controlling interests. We have also entered into flow agreements with certain of the loan originators in which we have invested. We have not yet acquired mortgage servicing rights directly, but we may do so in the future.

Hedging Instruments

Interest Rate Hedging

We opportunistically hedge our interest rate risk by using various hedging strategies, subject to maintaining our qualification as a REIT. The interest rate hedging instruments that we use and may use in the future include, without limitation:

•TBAs;

•interest rate swaps (including floating-to-fixed, fixed-to-floating, floating-to-floating, or more complex swaps such as floating-to-inverse floating, callable or non-callable);

•CMOs;

•U.S. Treasury securities;

•swaptions, caps, floors, and other derivatives on interest rates;

•futures and forward contracts; and

•options on any of the foregoing.

Because fluctuations in short-term interest rates may expose us to fluctuations in the spread between the interest we earn on our investments and the interest we pay on our borrowings, we may seek to manage such exposure by entering into short positions in interest rate swaps. An interest rate swap is an agreement to exchange interest rate cash flows, calculated on a notional principal amount, at specified payment dates during the life of the agreement. Typically, one party pays a fixed interest rate and receives a floating interest rate and the other party pays a floating interest rate and receives a fixed interest rate. Each party's payment obligation is computed using a different interest rate. In an interest rate swap, the notional principal is generally not exchanged.

Credit Risk Hedging

We enter into credit-hedging positions in order to protect against adverse credit events with respect to our credit investments, subject to maintaining our qualification as a REIT. Our credit hedging portfolio can vary significantly from period to period, and can encompass a wide variety of financial instruments, including corporate debt or equity-related instruments, RMBS- or CMBS-related instruments, or instruments involving other markets. Our hedging instruments can include both "single-name" instruments (i.e., instruments referencing one underlying entity or security) and hedging instruments referencing indices.

71

Table of Contents

Currently, our credit hedges consist primarily of financial instruments tied to corporate credit, such as CDS on corporate bond indices, short positions in and CDS on corporate bonds; and positions involving exchange traded funds, or "ETFs," of corporate bonds. Our credit hedges also currently include CDS tied to individual MBS or an index of several MBS, such as CDS on CMBS indices, or "CMBX."

Foreign Currency Hedging

To the extent that we hold instruments denominated in currencies other than U.S. dollars, we may enter into transactions to offset the potential adverse effects of changes in currency exchange rates, subject to maintaining our qualification as a REIT. In particular, we may use currency forward contracts and other currency-related derivatives to mitigate this risk.

Trends and Recent Market Developments

Market Overview

•After lowering the target range for the federal funds rate three times in 2019, the U.S. Federal Reserve, or "Federal Reserve," elected to maintain its target range of 1.50%–1.75% at its January 2020 meeting, but noted concerns about the spread of the novel coronavirus disease ("COVID-19") in its minutes. As the first quarter of 2020 progressed and COVID-19 spread, economic activity declined as countries around the world implemented social-distancing restrictions; unemployment claims surged and GDP growth forecasts were revised downward as the market began to price in a global recession. In March, macroeconomic conditions worsened, and financial markets experienced extreme volatility and dislocations. In response, the Federal Reserve implemented two emergency interest rate cuts totaling 150 basis points, resumed its asset purchases at an unprecedented pace, added additional liquidity to repo markets, and formed several credit facilities to stabilize markets. The White House and U.S. Congress passed three rounds of stimulus packages, culminating in the $2 trillion CARES Act on March 27th, the largest emergency spending bill in history. In April, the Federal Reserve expanded many of its stimulus programs to provide up to $2.3 trillion in additional capital. Similarly, central banks and governments around the globe responded swiftly and aggressively with interest rate cuts, quantitative easing programs, and stimulus packages.

While these efforts were successful in stabilizing markets, the negative economic impact of COVID-19 persisted, and the Federal Reserve continued its accommodative monetary policy throughout the rest of 2020, including maintaining its target range of 0.00%–0.25% for the federal funds rate; purchasing significant amounts of U.S. Treasury securities, Agency RMBS, and other eligible collateral pursuant to the asset purchase programs it outlined earlier in the year; and extending or expanding several of its liquidity support programs. At its final meeting of 2020, in December, the Federal Reserve noted that "the COVID-19 pandemic is causing tremendous human and economic hardship across the United States and around the world. Economic activity and employment have continued to recover but remain well below their levels at the beginning of the year." The Federal Reserve reiterated that it "is committed to using its full range of tools to support the U.S. economy in this challenging time, thereby promoting its maximum employment and price stability goals." The Federal Reserve also directed the Open Market Desk to increase its holdings of Treasury securities by $80 billion per month, and of Agency RMBS by $40 billion per month.

Finally, just prior to year end 2020, Congress and the administration approved an additional $900 billion of COVID-related stimulus and economic aid.

•Interest rates dropped dramatically during the first quarter of 2020, as the spread of COVID-19 prompted a flight to safety. Between February 12th and March 9th, the 10-year U.S. Treasury yield plummeted 109 basis points to a record low of 0.54%, before rebounding to 1.19% less than two weeks later, and then declining to 0.67% as of March 31st. U.S. Treasury yields fell across the yield curve over the course of the quarter, with yields on 3-month Treasury bills down 148 basis points, yields on the 2-year U.S. Treasury down 132 basis points, and yields on the 10-year U.S. Treasury down 125 basis points. On March 9th, the MOVE index, which measures U.S. interest rate volatility, reached its highest point since the 2008-2009 financial crisis.

During the second and third quarters, interest rate volatility subsided considerably and U.S. Treasury yields continued to hover near all-time lows. During this six-month period, the 10-year U.S. Treasury yield traded in a remarkably tight 39-basis-point rage, compared to a 134-basis-point range in the first quarter. At September 30th, the 10-year U.S. Treasury yield was 0.68%, virtually unchanged from March 31st and only 14 basis points above the record low reached in March. After reaching its highest point since the 2008–2009 financial crisis in March, the MOVE index had reverted to pre-COVID-19 levels by mid-April and continued to decline through the third quarter, hitting an all-time low at the end of September.

During the fourth quarter, long-term interest rates rose modestly and the U.S. Treasury yield curve steepened, with the 10-year U.S. Treasury yield increasing 23 basis points to finish the year at 0.91%, and the 2-year U.S. Treasury yield

72

Table of Contents

up just 1 basis point to 0.12%. The yield spread between the 2-year and 10-year U.S. Treasury increased to 79 basis points from 56 basis points at the end of the third quarter. The MOVE index increased modestly in October, before reverting to lower levels in November and December.

•Mortgage rates declined during each quarter of 2020, setting new all-time lows at several points during the year. Over the course of the year, the Freddie Mac survey 30-year mortgage declined 107 basis points to 2.67% at December 31, 2020. Refinancing applications surged with the declining mortgage rates. On March 6th, the Mortgage Bankers Association's Refinance Index, which measures refinancing application volumes, increased 79% to its highest level since April 2009. Although refinancing applications declined after March, they remained elevated throughout the year, at levels not seen since 2013. Overall Fannie Mae 30-year MBS prepayments increased steadily during the year, from a CPR of 17.0 in December 2019 to an 8-year high of 37.2 CPR in October 2020, before finishing the year at 35.6 CPR.

•In connection with the Federal Reserve actions, LIBOR rates, which drive many of our financing costs, declined sharply during the first half of 2020. Between December 31, 2019, and June 30, 2020, one-month LIBOR declined 160 basis points to 0.16%, and three-month LIBOR fell 161 basis points to 0.30%. LIBOR rates remained low during the second half of the year, with one-month LIBOR finishing the year at 0.14% and three-month LIBOR at 0.24%.

•U.S. real GDP declined at an annualized rate of 5.0% in the first quarter and then 31.4% in the second quarter, reflecting the negative impact of the COVID-19 pandemic and associated measures to contain it. The GDP growth rate bounced back in the third quarter, increasing at estimated annualized rates of 33.4%, before slowing in the fourth quarter to an estimated annualized rate of 4.1%.

•The sudden and significant decline in economic activity and implementation of social-distancing restrictions caused unemployment claims to rise significantly in 2020. U.S. employers reported a reduction of 701,000 jobs in March, and unemployment claims surged to 38.5 million in the second quarter. The unemployment rate spiked to 11.1% at June 30th, from 4.4% at March 31st. Unemployment claims totaled 14.1 million in the third quarter and 10.3 million in the fourth quarter, both down significantly from the second quarter but still well above historical averages. The unemployment rate dropped to 6.7% at December 31st, down from 7.8% at September 30th, 11.1% at June 30th and 14.8% at the April 30th peak. However, the U.S. lost 140,000 jobs in December, the first month of net job losses since the spring, which muddled the outlook going forward.

•With the economic slowdown and spike in unemployment, forbearance rates on residential mortgages rose during the first half of 2020. According to the Mortgage Bankers Association, the total forbearance rate increased most significantly during the month of April, from 2.7% as of March 29th to 7.5% as of April 26th, before rising further to 8.5% as of May 31st, plateauing during June, and then finishing the second quarter at 8.4%. Forbearance rates on residential mortgages declined steadily during the third and fourth quarters, driven by the economic recovery and an improving employment picture, even as many stimulus measures expired. According to the Mortgage Bankers Association, the total forbearance rate decreased from 8.4% at the end of June, to 6.9% at the end of September, and to 5.5% as of January 3, 2021.

•Yield spreads on most fixed income assets widened sharply in the first half of March. For Agency RMBS, the heightened levels of interest rate volatility, together with concerns of a liquidity crunch in the private sector, exacerbated fundamental concerns about a surge in prepayments from the decline in mortgage rates; while for credit assets, the negative macroeconomic developments raised concerns about a potential surge in future credit losses within many sectors. Across virtually all credit-sensitive fixed income asset classes, repo financing stresses and sharp declines in asset prices severely reduced liquidity, and prompted forced selling from many market participants experiencing liquidity problems, which further contributed to price declines and yield spread widening. This selling was particularly acute in structured credit assets, but even Agency RMBS, despite their creditworthiness, experienced significant yield spread widening in sympathy. As described above, central banks and governments around the globe responded swiftly and aggressively with interest rate cuts, quantitative easing programs, and stimulus packages; these actions succeeded in stabilizing markets for the balance of 2020.

•The Bloomberg Barclays US MBS Index ("BB MBS Index") generated a positive return for each quarter of 2020, finishing the year with a 3.87% return, but a slight negative excess return (on a duration-adjusted basis) of (0.17)% relative to the Bloomberg Barclays U.S. Treasury Index. Notably, during the extreme market volatility experienced in March, the intra-month negative excess return reached an extreme of (2.22)% as of March 19th, before actions by the Federal Reserve caused yield spreads on Agency RMBS to retighten. Additionally, after underperforming in the first quarter, pay-ups on Agency specified pools performed exceptionally well during the rest of 2020.

•For the first quarter, the Bloomberg Barclays US Corporate Bond Index ("BB IG Index") generated a loss of 3.63% and a negative excess return of (13.50)%, while the Bloomberg Barclays U.S. Corporate High Yield Bond Index ("BB HY Index") generated a loss of (12.68)% and a negative excess return of (17.03)%. Each index generated both positive returns and positive excess returns during each of the subsequent three quarters, however. For the full year, the BB IG

73

Table of Contents

Index generated a 9.89% return, and a positive excess return of 0.49%; while the BB HY Index generated a 7.11% return and positive excess return of 2.25%.

•During the first quarter, U.S. equities had their worst quarter since the 2008–2009 financial crisis, with the Dow Jones Industrial Average ("DJIA") declining 23%, the S&P down 20%, and the NASDAQ down 14%. Stock markets were highly volatile during the quarter, as the S&P 500 declined 34% between February 19th and March 23rd, and then increased 18% over the next three days. Because of rapid price declines that tripped market "circuit breakers," trading was halted temporarily on the major U.S. stock exchanges on four trading days during the quarter. The CBOE Volatility Index, which measures expected moves in the S&P 500 index, registered an all-time high of 82.69 on March 16th. London's FTSE 100 declined 25%, while the MSCI World global equity index declined 21%.

Despite the continuing negative economic impacts of COVID-19, U.S. equities rebounded dramatically in the second quarter, with the DJIA and S&P 500 indexes posting their biggest quarterly gains since 1998 and offsetting most of the losses suffered in March, amidst optimism over the reopening of the economy, possible additional stimulus measures, and advances on COVID-19 treatments and a possible vaccine. The DJIA rose 17.8% and the S&P 500 rose 20.0% quarter over quarter, while the tech-heavy NASDAQ composite index increased 30.6%. Equity volatility declined during the second quarter, but remained higher than pre-COVID-19 levels. The CBOE Volatility Index steadily declined for most of the second quarter, finishing at 30.43 at June 30th. Meanwhile, London's FTSE 100 index increased 8.8% quarter over quarter, while the MSCI World global equity index rebounded by 18.8% over the same period.

The strong performance of equities continued into the second half of the year, driven by record-low interest rates, expectations of additional stimulus, advances on a possible COVID-19 vaccine, as well as continued outperformance by the tech sector.

In July, the tech-heavy NASDAQ composite index closed at an all-time high, while in August, the S&P 500 reversed all of its losses for the year and reached a new all-time high as well. Performance waned in September amidst a tech selloff and dimming hopes for new stimulus, but U.S. equities still posted a strong third quarter. Quarter over quarter, the S&P 500 rose 8.5%, the DJIA 7.6%, and the NASDAQ 11%. The CBOE Volatility Index, which measures expected moves in the S&P 500 index, increased moderately in September but remained at levels well below those seen in March and April. Meanwhile, London's FTSE 100 index decreased 4.9% and the MSCI World global equity index rose 7.5%, over the same period.

In the second half of October, U.S. equities slumped and equity volatility increased in response to fading stimulus hopes and an accelerating number of COVID-19 cases. However, in November and December, stocks rallied following the U.S. presidential election and in response to advances in the development of COVID-19 vaccines as well as the passage of an additional stimulus package. During December, each of the S&P 500, DJIA, and NASDAQ indexes set fresh new highs; and for the full year, these indexes gained 16%, 7%, and 44%, respectively. After rising in October, the VIX volatility index declined steadily into year end.

74

Table of Contents

Portfolio Overview and Outlook

The following tables summarize the Company's investment portfolio as of December 31, 2020 and 2019.

Credit Portfolio(1)

	December 31, 2020				December 31, 2019
($ in thousands)	Fair Value		% of Total Long Credit Portfolio		Fair Value		% of Total Long Credit Portfolio
Dollar Denominated:
CLOs(2)	$	181,229	8.3	%	$	172,802	8.5	%
CMBS	117,652		5.4	%	124,693		6.2	%
Commercial mortgage loans and REO(3)(4)	269,287		12.4	%	320,926		15.8	%
Consumer loans and ABS backed by consumer loans(2)	112,077		5.1	%	238,193		11.7	%
Corporate debt and equity and corporate loans	12,606		0.6	%	20,987		1.0	%
Debt and equity investments in loan origination entities	79,536		3.7	%	41,393		2.1	%
Non-Agency RMBS	154,492		7.1	%	113,342		5.6	%
Residential mortgage loans and REO(3)	1,188,731		54.7	%	933,870		46.1	%
Non-Dollar Denominated:
CLOs(2)	6,108		0.3	%	5,722		0.3	%
CMBS	—		—	%	175		—	%
Consumer loans and ABS backed by consumer loans	306		—	%	549		—	%
Corporate debt and equity	28		—	%	30		—	%
RMBS(5)	51,388		2.4	%	55,156		2.7	%
Total Long Credit Portfolio	$	2,173,440	100.0	%	$	2,027,838	100.0	%
Less: Non-retained tranches of consolidated securitization trusts	739,670				584,246
Total Long Credit Portfolio excluding non-retained tranches of consolidated securitization trusts	$	1,433,770			$	1,443,592

(1)This information does not include U.S. Treasury securities, interest rate swaps, TBA positions, or other hedge positions.

(2)Includes equity investments in securitization-related vehicles.

(3)REO is not considered a financial instrument and, as a result, is included at the lower of cost or fair value, as discussed in Note 2 of the notes to consolidated financial statements for the year ended December 31, 2020.

(4)Includes investments in unconsolidated entities holding small balance commercial mortgage loans and REO.

(5)Includes an investment in an unconsolidated entity holding European RMBS.

Agency RMBS Portfolio

	December 31, 2020				December 31, 2019
($ in thousands)	Fair Value		% of Long Agency Portfolio		Fair Value		% of Long Agency Portfolio
Long Agency RMBS:
Fixed Rate	$	807,704	84.2	%	$	1,758,882	90.8	%
Floating Rate	6,454		0.7	%	10,002		0.5	%
Reverse Mortgages	97,629		10.2	%	132,800		6.9	%
IOs	47,656		4.9	%	35,279		1.8	%
Total Long Agency RMBS	$	959,443	100.0	%	$	1,936,963	100.0	%

As the year began, we grew our credit and Agency portfolios as we deployed the proceeds from our common equity offering that closed in January. In March 2020, in light of the heightened levels of market volatility and systemic liquidity risk associated with the outbreak of the COVID-19 pandemic, we strategically reduced the size of our Agency portfolio significantly, in order to lower our leverage and enhance our liquidity position. By reducing our Agency portfolio in an orderly and measured way, we avoided forced asset sales. As a result of these sales, our total long Agency RMBS portfolio decreased by 48% to $1.016 billion as of March 31, 2020, from $1.937 billion as of December 31, 2019.

75

Table of Contents

During the market turbulence of March 2020, we also substantially suspended new investments in our credit strategies. Excluding non-retained tranches of our consolidated non-QM securitization trusts (in the amount of $540.3 million and $584.2 million, as of March 31, 2020 and December 31, 2019, respectively), our total long credit portfolio was essentially unchanged at $1.457 billion as of March 31, 2020, as compared to $1.444 billion as of December 31, 2019. In the credit portfolio, net new purchases during January and February were roughly offset by asset paydowns, asset payoffs, and net reductions in the valuation of the credit portfolio related to the market dislocations in March.

High levels of market distress continued into April, and during that month, we further reduced the size of our Agency portfolio, and only resumed very limited purchase and sale activity in our credit portfolio. Beginning in May and June, with the markets stabilized, we fully resumed our investment activity in our credit and Agency portfolios.

As the year progressed, we maintained the approximate sizes of both the Agency and credit portfolios, as we chose to keep our debt-to-equity ratios relatively low and liquidity high in light of the ongoing economic uncertainty. Our total long Agency RMBS portfolio decreased 5.6% to $959.4 million as of December 31, 2020, from $1.016 billion as of March 31, 2020. Excluding non-retained tranches of our consolidated non-QM securitization trusts, our total long credit portfolio declined slightly to $1.434 billion as of December 31, 2020, as compared to $1.457 billion as of March 31, 2020; new acquisitions of non-QM loans and purchases of non-Agency RMBS, most of which occurred at depressed prices after the market selloff in March and April, were roughly offset by two non-QM loan securitizations, net pay-offs in our small balance commercial mortgage portfolio, as well as a smaller consumer loan portfolio, driven by pay-offs and a securitization completed in the fourth quarter.

As of December 31, 2020, we had cash and cash equivalents of $111.6 million, along with unencumbered assets of approximately $442.5 million.

Credit Portfolio Performance Summary

In March 2020, the market turmoil associated with the COVID-19 pandemic caused significant volatility, price declines and yield spread widening across virtually all credit assets. As a result, we incurred considerable mark-to-market losses in the first quarter. We also received margin calls under our financing arrangements and under our derivative contracts that were higher than typical historical levels. In contrast, prices in many credit-sensitive fixed income sectors rebounded in the second quarter, generating significant net realized and unrealized gains on our credit assets, and our margin calls reverted to more typical levels. We satisfied all margin calls during both periods.

As the year progressed, prices on our credit assets began to recover, financing markets continued to normalize, and our credit portfolio generated excellent results, driven by strong net interest income and significant mark-to-market gains across the portfolio. During the final three quarters of the year, we had large gains on our non-QM loans, non-Agency RMBS, and CMBS, all markets where there had been substantial distressed selling during the first quarter, followed by a sharp rebound in prices and liquidity thereafter. In addition, our small balance commercial mortgage loan, consumer loan, and residential transition mortgage loan portfolios exhibited resilient credit performance throughout the year, generated strong returns on equity, and also returned capital quickly for redeployment. Finally, we benefited from excellent results from our strategic investments in loan originators.

Our credit hedges were profitable during the first quarter of 2020, as markets sold off, and then were a drag on returns during the balance of the year as credit prices recovered. Overall for the year, the credit hedges had only a minor impact on our results.

Economic Impacts of COVID-19

Although most of our assets have recovered meaningfully since the market selloff of the first quarter, we still anticipate eventual principal losses on certain of our credit assets as a result of the economic impacts of COVID-19. The effects of these anticipated principal losses are reflected in earnings through unrealized and realized gains (losses) on securities and loans on our Consolidated Statement of Operations, as we elect the fair value option on our securities and loans.

Furthermore, as has been widely reported, there has been a significant nationwide increase in loan delinquencies, forbearances, deferments, and modifications, and we saw the effects of this in some of our portfolios during the year. However, these effects moderated considerably during the second half of 2020.

•Non-QM Loan Portfolio—Since the onset of the COVID-19 pandemic, we have worked with the servicer of our non-QM loans to develop a process to document and verify hardship due to the COVID-19 pandemic. We use this information to determine the suitability for a borrower to be granted forbearance, typically for a term lasting three months. We have also worked with the servicer to develop a process to evaluate the possible loss mitigation options in the event that a borrower, at the end of the forbearance period, cannot fully repay the forborne payments. Such options may include various repayment plans, deferment plans, rate and/or term modifications, short sales, and principal reduction modifications.

76

Table of Contents

As of December 31, 2020, non-QM loans with an unpaid principal balance of $14.9 million, or 1.4% of our non-QM loan portfolio, were in forbearance; 13.4% of these loans in forbearance continued to make their regular payments and were current under the terms of their notes despite being in forbearance plans as of December 31, 2020.

•Small Balance Commercial Mortgage Loan Portfolio—In our small balance commercial mortgage loan portfolio, we have granted short-term interest deferments to certain borrowers, with such deferred interest capitalized and added to the outstanding principal balance of the loan. In certain other cases, we have granted loan modifications to permit the use of cash reserves to pay interest due on the loan. As of December 31, 2020, small balance commercial mortgage loans with an unpaid principal balance of $45.4 million, or 21.3%, of our small balance commercial mortgage loan portfolio that were current prior to March 2020, have entered into a deferment or modification agreement; all such loans were performing under the terms of such agreements as of December 31, 2020.

•Consumer Loan Portfolio—As of December 31, 2020, we have also seen a decrease in loan deferments in our consumer loan portfolio. As of December 31, 2020, consumer loans with a unpaid principal balance of $10.3 million of our consumer loan portfolio had entered into a deferment plan at some point since March 2020, 77% of which (based on unpaid principal balance) had been entered into prior to June 30, 2020. As of December 31, 2020, of the loans that had entered into a deferment plan, we had received payments on 86.1% of them, based on unpaid principal balance.

•Residential Transition Loan Portfolio—In our residential transition loan portfolio, we had no loans subject to forbearance, deferment, or modification plans as of December 31, 2020.

Supplemental Credit Portfolio Information

The table below details certain information regarding the Company's investments in commercial mortgage loans as of December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield(2)		Life (Years)(3)
Commercial mortgage loans, held-for-investment(1)	$	253,868	$	1,375	$	255,243	$	479	$	(1,447)	$	254,275	8.25	%	8.09	%	0.6

(1)Includes our allocable portion of small-balance commercial loans, based on our ownership percentage, held in variable interest entities. Our equity investments in such variable interest entities are included in Investments in unconsolidated entities, at fair value on the Consolidated Balance Sheet.

(2)Excludes commercial mortgage loans, in non-accrual status, with a fair value of $34.7 million.

(3)Expected average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

The table below summarizes our interests in commercial mortgage loans by property type of the underlying real estate collateral, as a percentage of total outstanding unpaid principal balance, as of December 31, 2020:

Property Type	December 31, 2020
Multifamily	23.2	%
Hotel(1)	20.7	%
Industrial(1)	19.0	%
Mixed Use	13.4	%
Retail	10.5	%
Other(1)	13.2	%
	100.0	%

(1)Includes our allocable portion of small-balance commercial loans, based on our ownership percentage, held in variable interest entities. Our equity investments in such variable interest entities are included in Investments in unconsolidated entities, at fair value on the Consolidated Balance Sheet.

77

Table of Contents

Agency RMBS Portfolio Performance Summary

In March 2020, a precipitous decline in interest rates and high levels of interest rate volatility generated net realized and unrealized losses on our interest rate hedges, and while our Agency RMBS did appreciate in price, they significantly underperformed our hedges, as yield spreads widened on Agency pools across the board. Furthermore, TBAs outperformed specified pools during the first quarter, depressing pay-ups on our specified pool portfolio. As a result, we experienced a significant net loss on our Agency strategy for the first quarter. Pay-ups are price premiums for specified pools relative to their TBA counterparts, and generally reflect, among other factors, the prepayment protection that specified pools provide.

During the second quarter, asset purchases by the Federal Reserve continued to be significant, and the liquidity stresses of the first quarter subsided. Our Agency strategy performed exceptionally well during the second quarter, driven by significantly higher pay-ups on our specified pools. Pay-ups on specified pools expanded as investors sought prepayment protection amidst record-low mortgage rates and increasing actual and projected prepayment rates. Our Agency strategy also benefited from the appreciation of our reverse mortgage pools, driven by strong investor demand and a recovery in yield spreads after the distress in March.

Our Agency strategy continued to perform well in the second half of 2020, driven by continued strong price performance from our specified pools and wide net interest margins. During most of 2020, mortgage rates declined and actual and expected prepayment rates rose, which benefited pay-ups on our prepayment-protected specified pools. Average pay-ups on our specified pools increased to 2.05% as of December 31, 2020, from 1.10%2 as of December 31, 2019.

2Conformed to current period calculation methodology.

As the year progressed, we also increased our holdings of long TBAs held for investment, which we concentrated in current coupon production. These investments performed well, driven by Federal Reserve purchasing activity. We continued to hedge interest rate risk in our Agency strategy, through the use of interest rate swaps, and short positions in TBAs, U.S. Treasury securities, and futures.

As of December 31, 2020 and 2019, the weighted average net pass-through rate on our fixed-rate specified pools was 3.7% and 4.0%, respectively. Portfolio turnover for our Agency strategy, as measured by sales and excluding paydowns, was approximately 125% for the year ended December 31, 2020.

We expect to continue to target specified pools that, taking into account their particular composition and based on our prepayment projections, should: (1) generate attractive yields relative to other Agency RMBS and U.S. Treasury securities, (2) have less prepayment sensitivity to government policy shocks, and/or (3) create opportunities for trading gains once the market recognizes their value, which for newer pools may come only after several months, when actual prepayment experience can be observed. We believe that our research team, proprietary prepayment models, and extensive databases remain essential tools in our implementation of this strategy.

The following table summarizes the prepayment rates for our portfolio of fixed-rate specified pools (excluding those backed by reverse mortgages) for the three-month periods ended December 31, 2020, September 30, 2020, June 30, 2020, March 31, 2020, and December 31, 2019.

	Three-Month Period Ended
	December 31, 2020	September 30, 2020	June 30, 2020	March 31, 2020	December 31, 2019
Three-Month Constant Prepayment Rates(1)	24.4%	22.0%	21.1%	20.1%	19.9%

(1)Excludes Agency fixed-rate RMBS without any prepayment history.

78

Table of Contents

The following table provides details about the composition of our portfolio of fixed-rate specified pools (excluding those backed by reverse mortgages) as of December 31, 2020 and 2019:

		December 31, 2020					December 31, 2019(1)
	Coupon (%)	Current Principal		Fair Value		Weighted Average Loan Age (Months)	Current Principal		Fair Value		Weighted Average Loan Age (Months)
		(In thousands)					(In thousands)
Fixed-rate Agency RMBS:
15-year fixed-rate mortgages:
	2.50–2.99	$	20,248	$	21,476	46	$	125,526	$	127,080	65
	3.00–3.49	13,714		14,405		20	68,037		70,097		62
	3.50–3.99	22,820		24,505		60	109,362		113,943		44
	4.00–4.49	6,878		7,366		51	5,453		5,764		58
	4.50–4.99	4,215		4,462		124	6,258		6,522		113
Total 15-year fixed-rate mortgages		67,875		72,214		51	314,636		323,406		58
20-year fixed-rate mortgages:
	2.50–2.99	48,350		51,466		2	—		—		—
	4.00–4.49	1,204		1,292		31	—		—		—
	4.50–4.99	577		652		85	804		877		73
Total 20-year fixed-rate mortgages		50,131		53,410		4	804		877		73
30-year fixed-rate mortgages:
	2.50–2.99	29,043		30,753		3	13,991		13,867		3
	3.00–3.49	122,851		130,817		18	39,267		40,308		18
	3.50–3.99	133,713		145,590		46	281,921		293,968		24
	4.00–4.49	169,080		184,495		48	482,388		507,707		28
	4.50–4.99	101,664		112,481		48	280,885		299,042		21
	5.00–5.49	63,240		70,533		46	235,034		252,500		18
	5.50–5.99	5,083		5,845		61	21,041		22,618		21
	6.00–6.49	1,347		1,566		90	4,235		4,589		42
Total 30-year fixed-rate mortgages		626,021		682,080		40	1,358,762		1,434,599		23
Total fixed-rate Agency RMBS		$	744,027	$	807,704	38	$	1,674,202	$	1,758,882	30

(1)Conformed to current period methodology.

Our net Agency premium as a percentage of the fair value of our specified pool holdings is one metric that we use to measure the overall prepayment risk of our specified pool portfolio. Net Agency premium represents the total premium (excess of market value over outstanding principal balance) on our specified pool holdings less the total premium on related net short TBA positions. The lower our net Agency premium, the less we believe that our specified pool portfolio is exposed to market-wide increases in Agency RMBS prepayments. Our net Agency premium as a percentage of fair value of our specified pool holdings was approximately 4.8% and 2.6% as of December 31, 2020 and 2019, respectively. These figures take into account the net short TBA positions that we use to hedge our specified pool holdings, which had a notional value of $383.6 million and a fair value of $412.2 million as of December 31, 2020, as compared to a notional value of $1.093 billion and a fair value of $1.139 billion as of December 31, 2019. Excluding these TBA hedging positions, our Agency premium as a percentage of fair value was approximately 7.9% and 5.0% as of December 31, 2020 and 2019, respectively. Our Agency premium percentage and net Agency premium percentage may fluctuate from period to period based on a variety of factors, including market factors such as interest rates and mortgage rates, and, in the case of our net Agency premium percentage, based on the degree to which we hedge prepayment risk with short TBA positions. We believe that our focus on purchasing pools with specific prepayment characteristics provides a measure of protection against prepayments.

79

Table of Contents

Financing

The following table details our borrowings outstanding and debt-to-equity ratios as of December 31, 2020 and 2019:

	As of
($ in thousands)	December 31, 2020		December 31, 2019
Recourse(1) Borrowings:
Repurchase Agreements	$	1,364,090	$	2,150,282
Other Secured Borrowings	37,372		47,814
Senior Notes, at par	86,000		86,000
Total Recourse Borrowings	$	1,487,462	$	2,284,096
Debt-to-Equity Ratio Based on Total Recourse Borrowings(1)	1.6:1		2.6:1
Debt-to-Equity Ratio Based on Total Recourse Borrowings Excluding U.S. Treasury Securities	1.6:1		2.6:1
Non-Recourse(2) Borrowings:
Repurchase Agreements	$	132,841	$	295,018
Other Secured Borrowings	13,690		102,520
Other Secured Borrowings, at fair value(3)	754,921		594,396
Total Recourse and Non-Recourse Borrowings	$	2,388,914	$	3,276,030
Debt-to-Equity Ratio Based on Total Recourse and Non-Recourse Borrowings	2.6:1		3.8:1
Debt-to-Equity Ratio Based on Total Recourse and Non-Recourse Borrowings Excluding U.S. Treasury Securities	2.6:1		3.8:1

(1)As of December 31, 2020 and 2019, excludes borrowings at certain unconsolidated entities that are recourse to us. Including such borrowings, our debt-to-equity ratio based on total recourse borrowings was 1.6:1 and 2.7:1 as of December 31, 2020 and 2019, respectively.

(2)All of our non-recourse borrowings are secured by collateral. In the event of default under a non-recourse borrowing, the lender has a claim against the collateral but not any of the Operating Partnership's other assets. In the event of default under a recourse borrowing, the lender's claim is not limited to the collateral (if any).

(3)Relates to our non-QM loan securitizations, where we have elected the fair value option on the related debt.

Our debt-to-equity ratio including repos, Total other secured borrowings, and our Senior Notes, but excluding repos on U.S. Treasury securities, was 2.6:1 and 3.8:1 as of December 31, 2020 and 2019, respectively. Excluding repos on U.S. Treasury securities, our recourse debt-to-equity ratio decreased to 1.6:1 as of December 31, 2020, from 2.6:1 as of December 31, 2019. In March, in light of the heightened levels of market volatility and systemic liquidity risk associated with the outbreak of the COVID-19 pandemic, we strategically reduced the size of our Agency portfolio significantly, in order to lower our leverage and enhance our liquidity position. We chose to keep our leverage ratios relatively low and liquidity high during the rest of 2020, in light of the ongoing economic uncertainty.

Our debt-to-equity ratio may fluctuate period over period based on portfolio management decisions, market conditions, capital markets activities, and the timing of security purchase and sale transactions.

Our financing costs include interest expense related to our repo borrowings, Total other secured borrowings, and Senior Notes. The interest rates on our repo borrowings and Other secured borrowings are generally based on, or correlated with, LIBOR. For the year ended December 31, 2020, our average cost of funds decreased significantly to 2.25%, compared to 3.18% for the year ended December 31, 2019. The year-over-year decline in our average cost of funds was due to the declines in short-term interest rates over the course of 2020.

Critical Accounting Estimates

We adopted ASC 946 upon commencement of operations in August 2007, and applied U.S. GAAP for investment companies. In connection with our internal restructuring and our intention to qualify as a REIT for the year ended December 31, 2019, we have determined that, effective January 1, 2019, we no longer qualified for investment company accounting in accordance with ASC 946-10-25, and prospectively discontinued its use. We elected the fair value option for, and therefore we will continue to measure at fair value, those of our assets and liabilities for which such election is permitted, as provided for under ASC 825, Financial Instruments ("ASC 825").

Our consolidated financial statements include the accounts of Ellington Financial Inc., its Operating Partnership, its subsidiaries, and variable interest entities, or "VIEs," for which the Company is deemed to be the primary beneficiary. All intercompany balances and transactions have been eliminated. Certain of our critical accounting policies require us to make

80

Table of Contents

estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. We believe that all of the decisions and assessments upon which our consolidated financial statements are based were reasonable at the time made based upon information available to us at that time. We rely on the experience of our Manager and Ellington and analysis of historical and current market data in order to arrive at what we believe to be reasonable estimates. See Note 2 of the notes to our consolidated financial statements for a complete discussion of our significant accounting policies. We have identified our most critical accounting policies to be the following:

Valuation: For financial instruments that are traded in an "active market," the best measure of fair value is the quoted market price. However, many of our financial instruments are not traded in an active market. Therefore, management generally uses third-party valuations when available. If third-party valuations are not available, management uses other valuation techniques, such as the discounted cash flow methodology. Summary descriptions, for various categories of financial instruments, of the valuation methodologies management uses in determining fair value of our financial instruments are detailed in Note 2 of the notes to our consolidated financial statements. Management utilizes such methodologies to assign a good faith fair value (the estimated price that, in an orderly transaction at the valuation date, would be received to sell an asset, or paid to transfer a liability, as the case may be) to each such financial instrument.

See the notes to our consolidated financial statements for more information on valuation techniques used by management in the valuation of our assets and liabilities.

Purchases and Sales of Investments and Investment Income: Purchase and sales transactions are generally recorded on trade date. Realized and unrealized gains and losses are calculated based on identified cost. We generally amortize premiums and accrete discounts on our fixed-income investments using the effective interest method.

See the notes to our consolidated financial statements for more information on the assumptions and methods that we use to amortize purchase premiums and accrete purchase discounts.

Income Taxes: We made an election to be taxed as a REIT for U.S. federal income tax purposes commencing with our taxable year ended December 31, 2019. As a REIT, we generally are not subject to corporate-level federal and state income tax on net income we distribute to our stockholders within the prescribed timeframes. To qualify as a REIT, we must meet a number of organizational and operational requirements, including distributing at least 90% of our taxable income to our stockholders. Even if we qualify as a REIT, we may be subject to certain federal, state, local and foreign taxes on our income and property, and to federal income and excise taxes on our undistributed taxable income. If we fail to qualify as a REIT, and do not qualify for certain statutory relief provisions, we will be subject to U.S. federal, state, and local income taxes and may be precluded from qualifying as a REIT for the four taxable years following the year in which we fail to qualify as a REIT.

We elected to treat certain domestic and foreign subsidiaries as TRSs, and may in the future elect to treat other current or future subsidiaries as TRSs. In general, a TRS may hold assets and engage in activities that we cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. A domestic TRS may, but is not required to, declare dividends to us; such dividends will be included in our taxable income/(loss) and may necessitate a distribution to our stockholders. Conversely, if we retain earnings at the level of a domestic TRS, such earnings will increase the book equity of the consolidated entity. A domestic TRS is subject to U.S. federal, state, and local corporate income taxes. We have elected and may elect in the future to treat certain of our foreign corporate subsidiaries as TRSs and, accordingly, taxable income generated by these TRSs may not be subject to U.S. federal, state, and local corporate income taxation, but generally will be included in our income on a current basis as Subpart F income, whether or not distributed. However, certain of our foreign subsidiaries may be subject to income taxes in the relevant foreign jurisdictions. Our financial results are generally not expected to reflect provisions for current or deferred income taxes, except for any activities conducted through one or more TRSs that are subject to corporate income taxation.

We follow the authoritative guidance on accounting for and disclosure of uncertainty on tax positions, which requires management to determine whether a tax position is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For uncertain tax positions, the tax benefit to be recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We did not have any unrecognized tax benefits resulting from tax positions related to the current period or our open tax years. In the normal course of business, we may be subject to examination by federal, state, local, and foreign jurisdictions, where applicable, for the current period and our open tax years. We may take positions with respect to certain tax issues which depend on legal interpretation of facts or applicable tax regulations. Should the relevant tax regulators successfully challenge any such positions, we might be found to have a tax liability that has not been recorded in the accompanying consolidated financial statements. Also, management's conclusions regarding the authoritative guidance may be subject to review and adjustment at a later date based on changing tax laws, regulations, and interpretations

81

Table of Contents

thereof.

See the notes to our consolidated financial statements for additional details on income taxes.

Recent Accounting Pronouncements

Refer to the notes to our consolidated financial statements for a description of relevant recent accounting pronouncements.

Financial Condition

The following table summarizes the fair value our investment portfolio(1) as of December 31, 2020 and December 31, 2019.

(In thousands)	December 31, 2020		December 31, 2019
Long:
Credit:
Dollar Denominated:
CLO(2)	$	181,229	$	172,802
CMBS	117,652		124,693
Commercial Mortgage Loans and REO(3)(4)	269,287		320,926
Consumer Loans and ABS backed by Consumer Loans(2)	112,077		238,193
Corporate Debt and Equity and Corporate Loans	12,606		20,987
Equity Investments in Loan Origination Entities	79,536		41,393
Non-Agency RMBS	154,492		113,342
Residential Mortgage Loans and REO(3)	1,188,731		933,870
Non-Dollar Denominated:
CLO(2)	6,108		5,722
CMBS	—		175
Consumer Loans and ABS backed by Consumer Loans	306		549
Corporate Debt and Equity	28		30
RMBS(5)	51,388		55,156
Agency:
Fixed-Rate Specified Pools	807,704		1,758,882
Floating-Rate Specified Pools	6,454		10,002
IOs	47,656		35,279
Reverse Mortgage Pools	97,629		132,800
Total Long	$	3,132,883	$	3,964,801
Short:
Credit:
Dollar Denominated:
Corporate Debt and Equity	$	(218)	$	(471)
Government Debt:
Dollar Denominated	—		(62,994)
Non-Dollar Denominated	(38,424)		(9,944)
Total Short	$	(38,642)	$	(73,409)

(1)For more detailed information about the investments in our portfolio, please see the notes to consolidated financial statements.

(2)Includes equity investments in securitization-related vehicles.

(3)REO is not eligible to elect the fair value option as described in Note 2 of the notes to consolidated financial statements and, as a result, is included at the lower of cost or fair value.

(4)Includes investments in unconsolidated entities holding small balance commercial mortgage loans and REO.

(5)Includes an investment in an unconsolidated entity holding European RMBS.

82

Table of Contents

The following table summarizes our financial derivatives portfolio(1)(2) as of December 31, 2020.

	Notional						Net Fair Value
(In thousands)	Long		Short		Net
Mortgage-Related Derivatives:
CDS on MBS and MBS Indices	$	874	$	(13,846)	$	(12,972)	$	2,401
Total Net Mortgage-Related Derivatives							2,401
Corporate-Related Derivatives:
CDS on Corporate Bonds and Corporate Bond Indices	67,779		(121,197)		(53,418)		(3,765)
Total Return Swaps on Corporate Bond Indices and Corporate Debt(3)	4,161		—		4,161		(475)
Warrants(4)	1,897		—		1,897		36
Total Net Corporate-Related Derivatives							(4,204)
Interest Rate-Related Derivatives:
TBAs	149,990		(504,067)		(354,077)		37
Interest Rate Swaps	253,423		(408,295)		(154,872)		(6,655)
U.S. Treasury Futures(5)	1,900		(178,500)		(176,600)		(374)
Total Interest Rate-Related Derivatives							(6,992)
Other Derivatives:
Foreign Currency Forwards(6)	—		(22,330)		(22,330)		(279)
Total Net Other Derivatives							(279)
Net Total							$	(9,074)

(1)For more detailed information about the financial derivatives in our portfolio, please refer to Note 8 of the notes to consolidated financial statements.

(2)In the table above, fair value of certain derivative transactions are shown on a net basis. The accompanying financial statements separate derivative transactions as either assets or liabilities. As of December 31, 2020, derivative assets and derivative liabilities were $15.5 million and $(24.6) million, respectively, for a net fair value of $(9.1) million, as reflected in "Net Total" above.

(3)Notional value represents the face amount of the underlying asset.

(4)Notional represents the maximum number of shares available to be purchased upon exercise.

(5)Notional value represents the total face amount of U.S. Treasury securities underlying all contracts held. As of December 31, 2020, a total of 19 long and 1,558 short U.S. Treasury futures contracts were held.

(6)Short notional value represents U.S. Dollars to be received by us at the maturity of the forward contract.

83

Table of Contents

The following table summarizes our financial derivatives portfolio(1)(2) as of December 31, 2019.

	Notional						Net Fair Value
(In thousands)	Long		Short		Net
Mortgage-Related Derivatives:
CDS on MBS and MBS Indices	$	1,039	$	(70,656)	$	(69,617)	$	4,062
Total Net Mortgage-Related Derivatives							4,062
Corporate-Related Derivatives:
CDS on Corporate Bonds and Corporate Bond Indices	131,137		(262,885)		(131,748)		(10,616)
Total Return Swaps on Corporate Bond Indices and Corporate Debt(3)	7,359		(17,560)		(10,201)		(589)
Total Net Corporate-Related Derivatives							(11,205)
Interest Rate-Related Derivatives:
TBAs	40,100		(1,093,730)		(1,053,630)		(416)
Interest Rate Swaps	305,723		(732,961)		(427,238)		(3,251)
U.S. Treasury Futures(4)	—		(16,000)		(16,000)		148
Eurodollar Futures(5)	—		(14,000)		(14,000)		(45)
Total Interest Rate-Related Derivatives							(3,564)
Other Derivatives:
Foreign Currency Forwards(6)	—		(26,211)		(26,211)		(126)
Total Net Other Derivatives							(126)
Net Total							$	(10,833)

(1)For more detailed information about the financial derivatives in our portfolio, please refer to Note 8 of the notes to consolidated financial statements for the year ended December 31, 2019.

(2)In the table above, fair value of certain derivative transactions are shown on a net basis. The accompanying financial statements separate derivative transactions as either assets or liabilities. As of December 31, 2019, derivative assets and derivative liabilities were $16.8 million and $(27.6) million, respectively, for a net fair value of $(10.8) million, as reflected in "Net Total" above.

(3)Notional value represents the face amount of the underlying asset.

(4)Notional value represents the total face amount of U.S. Treasury securities underlying all contracts held. As of December 31, 2019, a total of 160 short U.S. Treasury futures contracts were held.

(5)Every $1,000,000 in notional value represents one contract.

Short notional value represents U.S. Dollars to be received by us at the maturity of the forward contract

As of December 31, 2020, our Consolidated Balance Sheet reflected total assets of $3.4 billion and total liabilities of $2.5 billion. As of December 31, 2019, our Consolidated Balance Sheet reflected total assets of $4.3 billion and total liabilities of $3.5 billion. Our investments in securities, loans, and unconsolidated entities, financial derivatives, and real estate owned included in total assets were $3.1 billion and $4.0 billion as of December 31, 2020 and 2019, respectively. Our investments in securities sold short and financial derivatives included in total liabilities were $63.2 million and $101.0 million as of December 31, 2020 and 2019, respectively. As of December 31, 2020, investments in securities sold short consisted principally of short positions in sovereign bonds. As of December 31, 2019, investments in securities sold short consisted principally of short positions in sovereign bonds and U.S. Treasury securities. We primarily use short positions in sovereign bonds and U.S. Treasury securities to hedge the risk of rising interest rates and foreign currency risk.

Typically, we hold a net short position in TBAs. The amounts of net short TBAs, as well as of other hedging instruments, may fluctuate according to the size of our investment portfolio as well as according to how we view market dynamics as favoring the use of one hedging instrument or another. As of December 31, 2020 and 2019, we had a net short notional TBA position of $0.4 billion and $1.1 billion, respectively. The size of the net short notional TBA position declined primarily because we reduced our TBA short positions in connection with our strategic reduction of the size of our Agency specified pool portfolio in March, and because we increased the amount of long TBAs held for investment.

For a more detailed discussion of our investment portfolio, see "—Trends and Recent Market Developments—Portfolio Overview and Outlook" above.

We use mortgage-related credit derivatives primarily to hedge credit risk in certain credit strategies, although we also take net long positions in certain CDS on RMBS and CMBS indices. Our CDS on individual RMBS represent "single-name" positions whereby we have synthetically purchased credit protection on specific non-Agency RMBS bonds. As there is no longer an active market for CDS on individual RMBS, our portfolio in this sector continues to run off. We also use CDS on

84

Table of Contents

corporate bond indices, options thereon, and various other instruments as a means to hedge credit risk. As market conditions change, especially as the pricing of various credit hedging instruments changes in relation to our outlook on future credit performance, we continuously re-evaluate both the extent to which we hedge credit risk and the particular mix of instruments that we use to hedge credit risk.

We may hold long and/or short positions in corporate bonds or equities. Our long and short positions in corporate bonds or equities may serve as outright investments or portfolio hedges.

We use a variety of instruments to hedge interest rate risk in our portfolio, including non-derivative instruments such as U.S. Treasury securities and sovereign debt instruments, and derivative instruments such as interest rate swaps, TBAs, Eurodollar and U.S. Treasury futures, and options on the foregoing. The mix of instruments that we use to hedge interest rate risk may change materially from one period to the next.

We have also entered into foreign currency forward and futures contracts in order to hedge risks associated with foreign currency fluctuations.

We have entered into repos to finance many of our assets. We account for our repos as collateralized borrowings. As of December 31, 2020 indebtedness outstanding on our repos was approximately $1.5 billion. As of December 31, 2020, our assets financed with repos consisted of Agency RMBS of $947.0 million and credit assets of $884.2 million. As of December 31, 2020, outstanding indebtedness under repos was $921.9 million for Agency RMBS and $575.1 million for credit assets. As of December 31, 2019 indebtedness outstanding on our repos was approximately $2.4 billion. As of December 31, 2019, our assets financed with repos consisted of Agency RMBS of $1.9 billion and credit assets of $830.3 million. As of December 31, 2019, outstanding indebtedness under repos was $1.9 billion for Agency RMBS and $580.8 million for credit assets. Our repos bear interest at rates that have historically moved in close relationship to LIBOR.

In addition to our repos, as of December 31, 2020 we had Total other secured borrowings of $806.0 million, used to finance $906.4 million of non-QM loans, consumer loans and ABS backed by consumer loans, and small balance commercial loans. This compares to Total other secured borrowings of $744.7 million as of December 31, 2019, used to finance $843.4 million of non-QM loans and REO, and consumer loans and ABS backed by consumer loans. In addition to our secured borrowings, we had $86.0 million of Senior Notes outstanding as of both December 31, 2020 and 2019.

As of December 31, 2020 and 2019 our debt-to-equity ratio was 2.6:1 and 3.8:1, respectively. Excluding repos on U.S. Treasury securities, our recourse debt-to-equity ratio was 1.6:1 as of December 31, 2020 as compared to 2.6:1 as of December 31, 2019. See the discussion in "—Liquidity and Capital Resources" below for further information on our borrowings.

Equity

As of December 31, 2020, our equity increased by approximately $52.9 million to $921.6 million from $868.7 million as of December 31, 2019. The increase principally consisted of net income of $28.4 million, net proceeds from the issuance of common stock of $95.3 million, and contributions from our non-controlling interests of $8.3 million. These increases were partially offset by common and preferred dividends of $63.8 million, distributions to non-controlling interests of $13.0 million, and payments to repurchase shares of common stock of $3.1 million. Stockholders' equity, which excludes the non-controlling interests related to the minority interest in the Operating Partnership as well as the minority interests of our joint venture partners, was $885.2 million as of December 31, 2020.

85

Table of Contents

Results of Operations for the Years Ended December 31, 2020, 2019, and 2018

The following table summarizes our results of operations for the years ended December 31, 2020 and 2019:

	Year Ended
(In thousands except per share amounts)	December 31, 2020		December 31, 2019
Interest Income (Expense)
Interest income	$	173,531	$	159,901
Interest expense	(61,665)		(78,479)
Net interest income	111,866		81,422
Other Income (Loss)
Realized and unrealized gains (losses) on securities and loans, net	(31,743)		41,693
Realized and unrealized gains (losses) on financial derivatives, net	(30,532)		(36,250)
Realized and unrealized gains (losses) on real estate owned, net	(634)		1,048
Other, net	(2,298)		5,350
Total other income (loss)	(65,207)		11,841
Expenses
Base management fee to affiliate (Net of fee rebates of $1,051 and $1,967, respectively)(1)	11,508		7,988
Incentive fee to affiliate	—		116
Other investment related expenses	18,144		17,777
Other operating expenses	15,186		12,856
Total expenses	44,838		38,737
Net Income (Loss) before Income Tax Expense (Benefit) and Earnings (Losses) from Investments in Unconsolidated Entities	1,821		54,526
Income tax expense (benefit)	11,377		1,558
Earnings (losses) from investments in unconsolidated entities	37,933		10,209
Net Income (Loss)	28,377		63,177
Net income (loss) attributable to non-controlling interests	3,369		5,244
Dividends on preferred stock	7,763		1,466
Net Income (Loss) Attributable to Common Stockholders	$	17,245	$	56,467
Net Income (Loss) Per Common Share	$	0.39	$	1.76

(1)See Note 13 of the notes to the consolidated financial statements for the year ended December 31, 2020, for further details on management fee rebates.

86

Table of Contents

The following table summarizes our results of operations for the year ended December 31, 2018:

(In thousands except per share amounts)	Year Ended December 31, 2018
Investment Income:
Interest income	$	131,027
Other income	4,014
Total investment income	135,041
Expenses:
Base management fee to affiliate (Net of fee rebates of $1,380)	7,573
Incentive fee to affiliate	715
Interest expense	56,707
Other investment related expenses	16,954
Other operating expenses	9,967
Total expenses	91,916
Net Investment Income	43,125
Net Realized and Unrealized Gain (Loss) on Investments, Financial Derivatives, and Foreign Currency Transactions/Translation:
Net realized and change in net unrealized gain (loss) on investments	(526)
Net realized and change in net unrealized gain (loss) on other secured borrowings	758
Net realized and change in net unrealized gain (loss) on financial derivatives, excluding currency hedges	4,454
Net realized and change in net unrealized gain (loss) on financial derivatives—currency hedges	5,040
Net foreign currency gain (loss)	(2,940)
Net Realized and Change in Net Unrealized Gain (Loss) on Investments, Financial Derivatives, and Foreign Currency Transactions/Translation	6,786
Net Increase (Decrease) in Equity Resulting from Operations	49,911
Less: Net Increase (Decrease) in Equity Resulting from Operations Attributable to Non-controlling Interests	3,235
Net Increase (Decrease) in Shareholders' Equity Resulting from Operations	$	46,676
Net Increase (Decrease) in Shareholders' Equity Resulting from Operations per share	$	1.52

Core Earnings

In connection with our conversion to a REIT effective as of January 1, 2019 (the "REIT Conversion"), we began to include the calculation of Core Earnings starting with the three-month period ended March 31, 2019. Prior to the REIT Conversion, we did not calculate Core Earnings. We calculate Core Earnings as U.S. GAAP net income (loss) as adjusted for: (i) realized and unrealized gain (loss) on securities and loans, REO, financial derivatives (excluding periodic settlements on interest rate swaps), other secured borrowings, at fair value, and foreign currency transactions; (ii) incentive fee to affiliate; (iii) Catch-up Premium Amortization Adjustment (as defined below); (iv) non-cash equity compensation expense; (v) provision for income taxes; and (vi) certain other income or loss items that are of a non-recurring nature. For certain investments in unconsolidated entities, we include the relevant components of net operating income in Core Earnings. The Catch-up Premium Amortization Adjustment is a quarterly adjustment to premium amortization triggered by changes in actual and projected prepayments on our Agency RMBS (accompanied by a corresponding offsetting adjustment to realized and unrealized gains and losses). The adjustment is calculated as of the beginning of each quarter based on our then-current assumptions about cashflows and prepayments, and can vary significantly from quarter to quarter.

Core Earnings is a supplemental non-GAAP financial measure. We believe that the presentation of Core Earnings provides a consistent measure of operating performance by excluding the impact of gains and losses and other adjustments listed above from operating results. We believe that Core Earnings provides information useful to investors because it is a metric that we use to assess our performance and to evaluate the effective net yield provided by our portfolio. In addition, we believe that presenting Core Earnings enables our investors to measure, evaluate, and compare our operating performance to that of our peers. However, because Core Earnings is an incomplete measure of our financial results and differs from net income (loss) computed in accordance with U.S. GAAP, it should be considered as supplementary to, and not as a substitute for, net income (loss) computed in accordance with U.S. GAAP.

87

Table of Contents

The following table reconciles, for the years ended December 31, 2020 and 2019, Core Earnings to the line on the our Consolidated Statement of Operations entitled Net Income (Loss), which we believe is the most directly comparable U.S. GAAP measure.

	Year Ended
(In thousands, except per share amounts)	December 31, 2020		December 31, 2019
Net income (loss)	$	28,377	$	63,177
Income tax expense (benefit)	11,377		1,558
Net income (loss) before income tax expense (benefit)	39,754		64,735
Adjustments:
Realized (gains) losses on securities and loans, net	5,960		12,785
Realized (gains) losses on financial derivatives, net	31,521		30,912
Realized (gains) losses on real estate owned, net	(15)		(2,327)
Unrealized (gains) losses on securities and loans, net	25,783		(54,478)
Unrealized (gains) losses on financial derivatives, net	(989)		5,338
Unrealized (gains) losses on real estate owned, net	649		1,279
Other realized and unrealized (gains) losses, net(1)	7,703		829
Net realized gains (losses) on periodic settlements of interest rate swaps	(2,038)		1,695
Net unrealized gains (losses) on accrued periodic settlements of interest rate swaps	219		(764)
Incentive fee to affiliate	—		116
Non-cash equity compensation expense	722		475
Negative (positive) component of interest income represented by Catch-up Premium Amortization Adjustment	4,523		4,660
Debt issuance costs related to Other secured borrowings, at fair value	3,894		3,536
Non-recurring expenses(2)	174		1,333
(Earnings) losses from investments in unconsolidated entities(3)	(34,664)		(5,561)
Total Core Earnings	83,196		64,563
Dividends on preferred stock	7,763		1,466
Core Earnings attributable to non-controlling interests	4,532		4,883
Core Earnings Attributable to Common Stockholders	$	70,901	$	58,214
Core Earnings Attributable to Common Stockholders, per share	$	1.63	$	1.82

(1)Includes realized and unrealized gains (losses) on foreign currency and unrealized gain (loss) on other secured borrowings, at fair value, included in Other, net, on the Consolidated Statement of Operations.

(2)For 2020, non-recurring expenses consisted of expensed deferred offering costs; for 2019, non-recurring expenses consisted primarily of professional fees related to the REIT Conversion.

(3)Adjustment represents, for certain investments in unconsolidated entities, the net realized and unrealized gains and losses of the underlying investments of such entities.

Results of Operations for the Years Ended December 31, 2020 and 2019

Net Income (Loss) Attributable to Common Stockholders

For the year ended December 31, 2020 we had net income (loss) attributable to common stockholders of $17.2 million compared to $56.5 million for the year ended December 31, 2019. The year-over-year decrease in our results of operations was primarily due to net realized and unrealized losses on securities and loans, partially offset by an increase in net interest income and earnings from investments in unconsolidated entities for the year ended December 31, 2020.

Interest Income

Interest income was $173.5 million for the year ended December 31, 2020, as compared to $159.9 million for the year ended December 31, 2019. Interest income for both periods included coupon payments received and accrued on our holdings, the net accretion and amortization of purchase discounts and premiums on those holdings, and interest on our cash balances, including those balances held by our counterparties as collateral.

88

Table of Contents

For the year ended December 31, 2020, interest income from our credit portfolio was $144.6 million, as compared to $120.3 million for the year ended December 31, 2019. This year-over-year increase was primarily due to the larger size of the credit portfolio for the year ended December 31, 2020, partially offset by lower average asset yields on this portfolio.

For the year ended December 31, 2020, interest income from our Agency RMBS was $28.0 million, as compared to $37.4 million for the year ended December 31, 2019. This year-over-year decrease was due to the smaller size of the Agency portfolio, as well as lower average asset yields, for the year ended December 31, 2020.

The following table details our interest income, average holdings of yield-bearing assets, and weighted average yield based on amortized cost for the years ended December 31, 2020 and 2019:

	Credit(1)						Agency(1)						Total(1)
(In thousands)	Interest Income		Average Holdings		Yield		Interest Income		Average Holdings		Yield		Interest Income		Average Holdings		Yield
Year ended December 31, 2020	$	144,603	$	1,943,650	7.44	%	$	28,012	$	1,121,737	2.50	%	$	172,615	$	3,065,387	5.63	%
Year ended December 31, 2019	$	120,342	$	1,415,358	8.50	%	$	37,372	$	1,331,654	2.81	%	$	157,714	$	2,747,012	5.74	%

(1)Amounts exclude interest income on cash and cash equivalents (including when posted as margin) and long positions in U.S. Treasury securities. Also excludes long holdings of corporate securities that represent components of certain relative value trading strategies.

Some of the variability in our interest income and portfolio yields is due to the Catch-up Premium Amortization Adjustment. For the years ended December 31, 2020 and 2019, we had a negative Catch-up Premium Amortization Adjustment of approximately $(4.5) million and $(4.7) million, respectively, which decreased our interest income. Excluding the Catch-up Premium Amortization Adjustment, the weighted average yield of our Agency portfolio and our total portfolio was 2.90% and 5.78%, respectively, for the year ended December 31, 2020. Excluding the Catch-up Premium Amortization Adjustment, the weighted average yield of our Agency portfolio and our total portfolio was 3.16% and 5.91%, respectively, for the year ended December 31, 2019.

Interest Expense

Interest expense primarily includes interest on funds borrowed under repos and Total other secured borrowings, interest on our Senior Notes, coupon interest on securities sold short, the related net accretion and amortization of purchase discounts and premiums on those short holdings, and interest on our counterparties' cash collateral held by us. Our total interest expense decreased to $61.7 million for the year ended December 31, 2020, as compared to $78.5 million for the year ended December 31, 2019. Although average borrowings increased year over year, interest expense declined as a result of a significant decrease in borrowing rates on our both our Agency and credit assets.

The table below summarizes the components of interest expense for the years ended December 31, 2020 and 2019.

	Year Ended
(In thousands)	December 31, 2020		December 31, 2019
Repos and Total other secured borrowings	$	56,005	72,702
Senior Notes (1)	4,993		4,968
Securities sold short (2)	471		746
Other (3)	196		63
Total	$	61,665	78,479

(1)Amount includes the related amortization of debt issuance costs. For the year ended December 31, 2020, amount includes interest expense on the Senior Notes. For the year ended December 31, 2019, amount includes interest expense on the Senior Notes and the Old Senior Notes.

(2)Amount includes the related net accretion and amortization of purchase discounts and premiums.

(3)Primarily includes interest expense on our counterparties' cash collateral held by us.

89

Table of Contents

The following table summarizes our aggregate secured borrowings, which, other than Other secured borrowings, at fair value, carry interest rates that are based on, or correlated with, LIBOR, including repos and Total other secured borrowings, for the years ended December 31, 2020 and 2019.

	Year Ended
	December 31, 2020						December 31, 2019
Collateral for Secured Borrowing	Average Borrowings		Interest Expense		Average Cost of Funds		Average Borrowings		Interest Expense		Average Cost of Funds
(In thousands)
Credit(1)	$	1,387,152	$	44,106	3.18	%	$	1,041,209	$	41,932	4.03	%
Agency RMBS	1,099,416		11,895		1.08	%	1,241,957		30,703		2.47	%
Subtotal(1)	2,486,568		56,001		2.25	%	2,283,166		72,635		3.18	%
U.S. Treasury Securities	408		4		0.91	%	2,771		67		2.40	%
Total	$	2,486,976	$	56,005	2.25	%	$	2,285,937	$	72,702	3.18	%
Average One-Month LIBOR					0.52	%					2.22	%
Average Six-Month LIBOR					0.69	%					2.32	%

(1)Excludes U.S. Treasury Securities.

Among other instruments, we use interest rate swaps to hedge against the risk of rising interest rates. If we were to include as a component of our cost of funds the amortization of upfront payments and the actual and accrued periodic payments on our interest rate swaps used to hedge our assets, our total average cost of funds would increase to 2.35% for the year ended December 31, 2020 and decrease to 3.11% for the year ended December 31, 2019. Excluding the Catch-up Premium Amortization Adjustment, our net interest margin, defined as the yield on our portfolio of yield-bearing targeted assets less our cost of funds (including amortization of upfront payments and actual and accrued periodic payments on interest rate swaps as described above), was 3.43% and 2.80% for the years ended December 31, 2020 and 2019, respectively. These metrics do not include costs associated with other instruments that we use to hedge interest rate risk, such as TBAs and futures.

Base Management Fees

For the year ended December 31, 2020, the gross base management fee, which is based on total equity at the end of each quarter, was $12.6 million, and our Manager credited us with rebates on our base management fee of $1.1 million, resulting in a net base management fee of $11.5 million. For the year ended December 31, 2019, the gross base management fee was $10.0 million, and our Manager credited us with rebates on our base management fee of $2.0 million, resulting in a net base management fee of $8.0 million. For each period, the base management fee rebates related to those of our CLO investments for which Ellington or one of its affiliates earned CLO management fees. The year-over-year increase in the net base management fee was due to our larger capital base at the end of each quarter in 2020 as compared to each respective quarter end in 2019.

Incentive Fees

In addition to the base management fee, our Manager is also entitled to a quarterly incentive fee if our performance (as measured by adjusted net income, as defined in the management agreement) over the relevant rolling four quarter calculation period exceeds a defined return hurdle for the period. Incentive fee incurred for the year ended December 31, 2019 was $0.1 million; no incentive fee was incurred for the year ended December 31, 2020, since on a rolling four quarter basis, our income did not exceed the prescribed hurdle amount. Because our operating results can vary materially from one period to another, incentive fee expense can be highly variable.

Other Investment Related Expenses

Other investment related expenses consist of servicing fees on our mortgage and consumer loans, as well as various other expenses and fees directly related to our financial assets and certain financial liabilities carried at fair value. For the years ended December 31, 2020 and 2019 other investment related expenses were $18.1 million and $17.8 million, respectively. The increase in other investment related expenses was primarily due to year-over-year increases in debt issuance costs related to our non-QM loan securitizations and servicing expenses on our consumer loan portfolios, partially offset by a decrease in various other expenses related to our residential and commercial mortgage loan and REO portfolios.

Other Operating Expenses

Other operating expenses consist of professional fees, compensation expense related to our dedicated or partially dedicated personnel, and various other operating expenses necessary to run our business. Other operating expenses exclude

90

Table of Contents

management and incentive fees, interest expense, and other investment related expenses. Other operating expenses were $15.2 million for the year ended December 31, 2020 as compared to $12.9 million for the year ended December 31, 2019. The increase in other operating expenses for the year ended December 31, 2020 was primarily due to an increase in fund administration expenses, the recognition of Delaware corporate franchise tax, and compensation expense.

Other Income (Loss)

Other income (loss) consists of net realized and unrealized gains (losses) on securities and loans, financial derivatives, and real estate owned. Other, net, another component of Other income (loss), includes rental income and income related to loan originations, as well as realized gains (losses) on foreign currency transactions and unrealized gains (losses) on foreign currency remeasurement and Other Secured Borrowings, at fair value. For the year ended December 31, 2020, other income (loss) was $(65.2) million, consisting primarily of net realized and unrealized losses of $(31.7) million on our securities and loans and net realized and unrealized losses on our financial derivatives of $(30.5) million. Net realized and unrealized losses of $(31.7) million on our securities and loans primarily resulted from net realized and unrealized losses on CLOs, CMBS, and consumer loans and ABS backed by consumer loans, partially offset by net realized and unrealized gains on Agency RMBS and non-QM loans. These net realized and unrealized losses were primarily incurred during the first quarter of 2020, and were driven by to the market and economic disruptions caused by the COVID-19 pandemic. Net realized and unrealized losses of $(30.5) million on our financial derivatives were primarily related to net realized and unrealized losses on interest rate swaps, TBAs, futures, forwards, and total return swaps, as interest rates declined significantly during the year, partially offset by net realized and unrealized gains on CDS on asset-backed indices, CDS on corporate bond indices, and CDS on corporate bonds.

For the year ended December 31, 2019, other income was $11.8 million, consisting primarily of net realized and unrealized gains of $41.7 million on our securities and loans, gains included in Other, net of $5.4 million, and net realized and unrealized gains of $1.0 million on our real estate owned, partially offset by net realized and unrealized losses of $(36.3) million on our financial derivatives. Net realized and unrealized gains of $41.7 million on our securities and loans primarily resulted from net realized and unrealized gains on Agency RMBS, residential mortgage loans, and non-Agency RMBS and CMBS, partially offset by net realized and unrealized losses on CLOs, consumer loans, and corporate debt and equity. Net realized and unrealized losses of $(36.3) million on our financial derivatives was primarily related to net realized and unrealized losses on interest rate swaps, TBAs, futures, CDS on corporate bond indices, and CDS on asset-backed indices, partially offset by net realized and unrealized gains on forwards.

Income Tax Expense (Benefit)

Income tax expense was $11.4 million for the year ended December 31, 2020, as compared to $1.6 million for the year ended December 31, 2019. The increase in income tax expense for the year ended December 31, 2020 was primarily due to an increase in deferred tax liabilities related to unrealized gains on investments held in a domestic TRS.

Earnings (Losses) from Investments in Unconsolidated Entities

We have elected the fair value option for our equity investments in unconsolidated entities. Earnings (losses) from investments in unconsolidated entities was $37.9 million for the year ended December 31, 2020, as compared to $10.2 million for the year ended December 31, 2019. The increase in Earnings (losses) from investments in unconsolidated entities was primarily due to unrealized gains on our investments in loan originators.

Results of Operations for the Years Ended December 31, 2019 and 2018

Net Income (Loss) Attributable to Common Stockholders

For the year ended December 31, 2019 we had net income (loss) attributable to common stockholders of $56.5 million. We had interest income of $159.9 million, interest expense of $78.5 million, total other income (loss) of $11.8 million, earnings from investments in unconsolidated entities of $10.2 million, income tax expense of $1.6 million, total operating expenses of $38.7 million, net income attributable to non-controlling interests of $5.2 million, and dividends on preferred stock of $1.5 million.

Summary of Net Increase in Shareholders' Equity from Operations

For the year ended December 31, 2018 we had a net increase in shareholders' equity resulting from operations of $46.7 million. We had interest income of $131.0 million, other income of $4.0 million, net realized and unrealized gains of $6.8 million, and total expenses of $91.9 million, less net increase (decrease) in equity resulting from operations attributable to non-controlling interests of $3.2 million.

91

Table of Contents

Interest Income

Interest income was $159.9 million for the year ended December 31, 2019, as compared to $131.0 million for the year ended December 31, 2018. Interest income for both periods included coupon payments received and accrued on our holdings, the net accretion and amortization of purchase discounts and premiums on those holdings, and interest on our cash balances, including those balances held by our counterparties as collateral.

For the year ended December 31, 2019, interest income from our credit portfolio was $120.3 million, as compared to $91.6 million for the year ended December 31, 2018. This period-over-period increase was primarily due to the larger size of the credit portfolio for the year ended December 31, 2019, as well as higher average asset yields on this portfolio.

For the year ended December 31, 2019, interest income from our Agency RMBS was $37.4 million, as compared to $31.1 million for the year ended December 31, 2018. This year-over-year increase was primarily due to the larger size of the Agency portfolio for the year ended December 31, 2019, partially offset by lower average asset yields on this portfolio.

The following table details our interest income, average holdings of yield-bearing assets, and weighted average yield based on amortized cost for the years ended December 31, 2019 and 2018:

	Credit(1)						Agency(1)						Total(1)
(In thousands)	Interest Income		Average Holdings		Yield		Interest Income		Average Holdings		Yield		Interest Income		Average Holdings		Yield
Year ended December 31, 2019	$	120,342	$	1,415,358	8.50	%	$	37,372	$	1,331,654	2.81	%	$	157,714	$	2,747,012	5.74	%
Year ended December 31, 2018	$	91,624	$	1,139,460	8.04	%	$	31,115	$	960,090	3.24	%	$	122,739	$	2,099,550	5.85	%

(1)Amounts exclude interest income on cash and cash equivalents (including when posted as margin) and long positions in U.S. Treasury securities. Also excludes long holdings of corporate securities that represent components of certain relative value trading strategies.

Some of the variability in our interest income and portfolio yields is due to the Catch-up Premium Amortization Adjustment. For the year ended December 31, 2019, we had a negative Catch-up Premium Amortization Adjustment of approximately $(4.7) million, which decreased our interest income. Excluding the Catch-up Premium Amortization Adjustment, the weighted average yield of our Agency portfolio and our total portfolio was 3.16% and 5.91%, respectively, for the year ended December 31, 2019. By comparison, for the year ended December 31, 2018 the Catch-up Premium Amortization Adjustment decreased interest income by approximately $(0.1) million, which slightly decreased our interest income. Excluding the Catch-up Premium Amortization Adjustment, the weighted average yield of our Agency portfolio and our total portfolio was 3.26% and 5.85%, respectively for the year ended December 31, 2018.

Interest Expense

Interest expense primarily includes interest on funds borrowed under repos and Total other secured borrowings, interest on our Senior Notes, coupon interest on securities sold short, the related net accretion and amortization of purchase discounts and premiums on those short holdings, and interest on our counterparties' cash collateral held by us. Our total interest expense increased to $78.5 million for the year ended December 31, 2019, as compared to $56.7 million for the year ended December 31, 2018. The year-over-year increase was primarily due to (i) an increase in our total borrowings, in connection with the growth of our portfolio, (ii) higher average rates on our repo and Other secured borrowings, and (iii) a higher proportion of our credit-related borrowings consisting of borrowings used to finance loan assets, which typically have higher borrowing costs than securities.

92

Table of Contents

The table below summarizes the components of interest expense for the years ended December 31, 2019 and 2018.

	For the Year Ended
(In thousands)	December 31, 2019		December 31, 2018
Repos and Total other secured borrowings	$	72,702	46,280
Senior Notes (1)	4,968		4,778
Securities sold short (2)	746		5,116
Other (3)	63		533
Total	$	78,479	56,707

(1)Amount includes the related amortization of debt issuance costs. For the year ended December 31, 2019, amount includes interest expense on the Senior Notes and the Old Senior Notes. For the year ended December 31, 2018, amount includes interest expense on the Old Senior Notes.

(2)Amount includes the related net accretion and amortization of purchase discounts and premiums.

(3)Primarily includes interest expense on our counterparties' cash collateral held by us, and reverse repos with negative interest rates, which can occur when we borrow certain bonds that we have sold short.

The following table summarizes our aggregate secured borrowings, which, other than Other secured borrowings, at fair value, carry interest rates that are based on, or correlated with, LIBOR, including repos and Total other secured borrowings, for the years ended December 31, 2019 and 2018.

	For the Year Ended
	December 31, 2019						December 31, 2018
Collateral for Secured Borrowing	Average Borrowings		Interest Expense		Average Cost of Funds		Average Borrowings		Interest Expense		Average Cost of Funds
(In thousands)
Credit(1)	$	1,041,209	$	41,932	4.03	%	$	747,283	$	27,317	3.66	%
Agency RMBS	1,241,957		30,703		2.47	%	882,388		18,593		2.11	%
Subtotal(1)	2,283,166		72,635		3.18	%	1,629,671		45,910		2.82	%
U.S. Treasury Securities	2,771		67		2.40	%	18,349		370		2.02	%
Total	$	2,285,937	$	72,702	3.18	%	$	1,648,020	$	46,280	2.81	%
Average One-Month LIBOR					2.22	%					2.02	%
Average Six-Month LIBOR					2.32	%					2.49	%

(1)Excludes U.S. Treasury Securities.

Among other instruments, we use interest rate swaps to hedge against the risk of rising interest rates. If we were to include as a component of our cost of funds the amortization of upfront payments and the actual and accrued periodic payments on our interest rate swaps used to hedge our assets, our total average cost of funds would decrease to 3.11% for the year ended December 31, 2019 and to 2.73% for the year ended December 31, 2018. Excluding the Catch-up Premium Amortization Adjustment, our net interest margin, defined as the yield on our portfolio of yield-bearing targeted assets less our cost of funds (including amortization of upfront payments and actual and accrued periodic payments on interest rate swaps as described above), was 2.80% and 3.12% for the years ended December 31, 2019 and 2018, respectively. These metrics do not include costs associated with other instruments that we use to hedge interest rate risk, such as TBAs and futures.

Base Management Fees

For the year ended December 31, 2019, the gross base management fee, which is based on total equity at the end of each quarter, was $10.0 million, and our Manager credited us with rebates on our base management fee of $2.0 million, resulting in a net base management fee of $8.0 million. For the year ended December 31, 2018, the gross base management fee was $9.0 million, and our Manager credited us with rebates on our base management fee of $1.4 million, resulting in a net base management fee of $7.6 million. For each period, the base management fee rebates related to those of our CLO investments for which Ellington or one of its affiliates earned CLO management fees. The year-over-year increase in the net base management fee was primarily due to our larger capital base in the second half of 2019 partially offset by the year-over-year increase in the fee rebate from our Manager.

Incentive Fees

In addition to the base management fee, our Manager is also entitled to a quarterly incentive fee if our performance (as measured by adjusted net income, as defined in the management agreement) over the relevant rolling four quarter calculation period exceeds a defined return hurdle for the period. Incentive fee incurred for the years ended December 31, 2019 and 2018

93

Table of Contents

was $0.1 million and $0.7 million, respectively. Because our operating results can vary materially from one period to another, incentive fee expense can be highly variable.

Other Investment Related Expenses

Other investment related expenses consist of servicing fees on our mortgage and consumer loans, as well as various other expenses and fees directly related to our financial assets and certain financial liabilities carried at fair value. For the years ended December 31, 2019 and 2018 other investment related expenses were $17.8 million and $17.0 million, respectively. The increase in other investment related expenses was primarily due to an increase in debt issuance costs related to Other secured borrowings, at fair value, given that we completed two non-QM securitizations during 2019 as compared to just one in 2018, and to a lesser extent, an increase in servicing expenses on our larger loan portfolios. These increases were partially offset by a decrease in dividend expense on common stock sold short.

Other Operating Expenses

Other operating expenses consist of professional fees, compensation expense related to our dedicated or partially dedicated personnel, and various other operating expenses necessary to run our business. Other operating expenses exclude management and incentive fees, interest expense, and other investment related expenses. Other operating expenses were $12.9 million for the year ended December 31, 2019 as compared to $10.0 million for the year ended December 31, 2018. The increase in other operating expenses for the year ended December 31, 2019 was primarily due to an increase in professional fees related to our REIT Conversion and an increase in compensation expense.

Other Income (Loss)

Other income (loss) consists of net realized and unrealized gains (losses) on securities and loans, financial derivatives, and real estate owned. Other, net, another component of Other income (loss), includes rental income and income related to loan origination, as well as realized gains (losses) on foreign currency transactions and unrealized gains (losses) on foreign currency remeasurement and Other Secured Borrowings, at fair value. For the year ended December 31, 2019, other income was $11.8 million, consisting primarily of net realized and unrealized gains of $41.7 million on our securities and loans, gains included in Other, net of $5.4 million, and net realized and unrealized gains of $1.0 million on our real estate owned, partially offset by net realized and unrealized losses of $(36.3) million on our financial derivatives. Net realized and unrealized gains of $41.7 million on our securities and loans primarily resulted from net realized and unrealized gains on Agency RMBS, residential mortgage loans, and non-Agency RMBS and CMBS, partially offset by net realized and unrealized losses on CLOs, consumer loans, and corporate debt and equity. Net realized and unrealized losses of $(36.3) million on our financial derivatives was primarily related to net realized and unrealized losses on interest rate swaps, TBAs, futures, CDS on corporate bond indices, and CDS on asset-backed indices, partially offset by net realized and unrealized gains on forwards.

Net Realized and Unrealized Gains (Losses) on Investments

During the year ended December 31, 2018, we had net realized and unrealized losses on investments of $(0.5) million. Included in these investments are short positions in TBAs, U.S. Treasury securities, and sovereign securities, used primarily to hedge interest rate and/or prepayment risk with respect to our other investment holdings.

Net realized and unrealized losses on investments of $(0.5) million for the year ended December 31, 2018 resulted principally from net realized and unrealized losses on Agency RMBS, U.S. CLOs, and European RMBS, partially offset by net realized and unrealized gains on TBAs, CMBS, listed and non-listed equity investments, and European non-performing loans.

Net Realized and Unrealized Gains and (Losses) on Financial Derivatives

During the year ended December 31, 2018, we had net realized and unrealized gains on our financial derivatives of $9.5 million. Our financial derivatives consisted of interest rate derivatives, used primarily to hedge interest rate risk, and of credit derivatives and total return swaps, both used primarily to hedge credit risk, but also for non-hedging purposes. Our derivatives also included foreign currency forwards and futures, used to hedge foreign currency risk. Our interest rate derivatives were primarily in the form of net short positions in interest rate swaps, Eurodollar futures, and U.S. Treasury Note futures.

Net realized and unrealized gains of $9.5 million on our financial derivatives for the year ended December 31, 2018 resulted primarily from net gains on our total return swaps, interest rate swaps, and CDS on corporate bond indices, partially offset by net realized and unrealized losses on credit default swaps on asset-backed indices. Net realized and unrealized gains on our foreign currency hedges more than offset the net foreign exchange transaction and translation losses. Translation and transaction net losses were incurred in connection with our non-dollar denominated European assets.

94

Table of Contents

Liquidity and Capital Resources

Liquidity refers to our ability to meet our cash needs, including repaying our borrowings, funding and maintaining positions in our targeted assets, making distributions in the form of dividends, and other general business needs. Our short-term (one year or less) and long-term liquidity requirements include acquisition costs for assets we acquire, payment of our base management fee and incentive fee, compliance with margin requirements under our repos, reverse repos, and financial derivative contracts, repayment of repo borrowings and other secured borrowings to the extent we are unable or unwilling to extend such borrowings, payment of our general operating expenses, payment of interest payments on our Senior Notes, and payment of our dividends. Our capital resources primarily include cash on hand, cash flow from our investments (including principal and interest payments received on our investments and proceeds from the sale of investments), borrowings under repos and other secured borrowings, and proceeds from equity and debt offerings. We expect that these sources of funds will be sufficient to meet our short-term and long-term liquidity needs.

The following summarizes our borrowings under repos by remaining maturity:

(In thousands)	December 31, 2020				December 31, 2019
Remaining Days to Maturity	Outstanding Borrowings		% of Total		Outstanding Borrowings		% of Total
30 Days or Less	$	303,351	20.3	%	$	528,545	21.6	%
31 - 60 Days	469,695		31.4	%	848,878		34.7	%
61 - 90 Days	327,012		21.8	%	733,575		30.0	%
91 - 120 Days	89,931		6.0	%	10,270		0.4	%
121 - 150 Days	69,104		4.6	%	7,460		0.3	%
151 - 180 Days	70,920		4.7	%	34,580		1.4	%
181 - 360 Days	72,670		4.9	%	186,661		7.7	%
> 360 Days	94,248		6.3	%	95,331		3.9	%
	$	1,496,931	100.0	%	$	2,445,300	100.0	%

Repos involving underlying investments that were sold prior to December 31, 2020 for settlement following December 31, 2020, are shown using their original maturity dates even though such repos may be expected to be terminated early upon settlement of the sale of the underlying investment. 

The amounts borrowed under our repo agreements are generally subject to the application of "haircuts." A haircut is the percentage discount that a repo lender applies to the market value of an asset serving as collateral for a repo borrowing, for the purpose of determining whether such repo borrowing is adequately collateralized. As of December 31, 2020, the weighted average contractual haircut applicable to the assets that serve as collateral for our outstanding repo borrowings (excluding repo borrowings related to U.S. Treasury securities) was 33.0% with respect to credit assets, 6.0% with respect to Agency RMBS assets, and 19.1% overall. As of December 31, 2019 these respective weighted average contractual haircuts were 29.3%, 5.0%, and 12.3%. The increase in the weighted average contractual haircuts for both our credit assets and our Agency RMBS was primarily due to volatile market conditions and market-wide liquidity stresses resulting from the COVID-19 pandemic. Although this increase in financing haircuts has not yet been shown to be temporary, market haircut levels as of the end of the fourth quarter were noticeably lower than those observed in early April 2020. Additionally, a portion of the increase in the weighted average contractual haircut on our overall portfolio is due to the lower share of our overall portfolio represented by Agency RMBS.

We expect to continue to borrow funds in the form of repos as well as other similar types of financings. The terms of our repo borrowings are predominantly governed by master repurchase agreements, which generally conform to the terms in the standard master repurchase agreement as published by the Securities Industry and Financial Markets Association as to repayment and margin requirements. In addition, each lender may require that we include supplemental terms and conditions to the standard master repurchase agreement. Typical supplemental terms and conditions include the addition of or changes to provisions relating to margin calls, net asset value requirements, cross default provisions, certain key person events, changes in corporate structure, and requirements that all controversies related to the repurchase agreement be litigated in a particular jurisdiction. These provisions may differ for each of our repo lenders.

As of December 31, 2020 and 2019, we had $1.5 billion and $2.4 billion, respectively, of borrowings outstanding under our repos. As of December 31, 2020, the remaining terms on our repos ranged from 4 days to 516 days, with a weighted average remaining term of 94 days. Our repo borrowings were with a total of 24 counterparties as of December 31, 2020. As of December 31, 2020, our repos had a weighted average borrowing rate of 1.20%. As of December 31, 2020, our repos had interest rates ranging from 0.20% to 5.00%. As of December 31, 2019, the remaining terms on our repos ranged from 2 days to

95

Table of Contents

882 days, with a weighted average remaining term of 91 days. Our repo borrowings were with a total of 28 counterparties as of December 31, 2019. As of December 31, 2019, our repos had a weighted average borrowing rate of 2.37%. As of December 31, 2019, our repos had interest rates ranging from 0.15% to 5.20%. Investments transferred as collateral under repos had an aggregate fair value of $1.8 billion and $2.8 billion as of December 31, 2020 and 2019, respectively.

The interest rates of our repos have historically moved in close relationship to short-term LIBOR rates, and in some cases are explicitly indexed to short-term LIBOR rates and reset accordingly. It is expected that amounts due upon maturity of our repos will be funded primarily through the roll/re-initiation of repos and, if we are unable or unwilling to roll/re-initiate our repos, through free cash and proceeds from the sale of securities.

During March and early April, the market turmoil associated with the COVID-19 pandemic caused significant volatility, price declines and yield spread widening across virtually all credit assets. As a result, we incurred considerable mark-to-market losses in the first quarter, which resulted in our receipt of margin calls under our financing arrangements and under our derivative contracts that were higher than typical historical levels. While we were able to roll our repos in an orderly manner, haircuts and borrowing rates were generally higher, and maturities generally shorter. In contrast, prices in many credit-sensitive fixed income sectors rebounded in the second quarter, generating significant net realized and unrealized gains on our credit assets, and our margin calls reverted to more typical levels. By the end of the second quarter, the market for standard repo financing of securities had largely returned to pre-March levels. We satisfied all margin calls during both periods.

Over the course of 2020, we made substantial progress extending and improving our sources of financing and leverage. Following the market volatility of the spring, we also obtained term financing for numerous loan assets that we had previously held unfinanced. In addition to adding new financing facilities and extending the terms of other financing facilities, we completed three loan securitizations during the year.

The following table details total outstanding borrowings, average outstanding borrowings, and the maximum outstanding borrowings at any month end for each quarter under repos for the past twelve quarters:

Quarter Ended	Borrowings Outstanding at Quarter End		Average Borrowings Outstanding		Maximum Borrowings Outstanding at Any Month End
	(In thousands)
December 31, 2020	$	1,496,931	$	1,408,935	$	1,496,931
September 30, 2020	1,439,984		1,368,191		1,551,147
June 30, 2020(1)	1,294,549		1,520,985		1,542,577
March 31, 2020(2)	2,034,225		2,440,982		2,485,496
December 31, 2019(3)	2,445,300		2,119,394		2,445,300
September 30, 2019	2,056,422		1,796,310		2,056,422
June 30, 2019	1,715,506		1,769,909		1,962,866
March 31, 2019	1,550,016		1,471,592		1,550,016
December 31, 2018	1,498,849		1,509,819		1,595,118
September 30, 2018	1,636,039		1,534,490		1,672,077
June 30, 2018	1,421,506		1,398,813		1,471,052
March 31, 2018	1,330,943		1,269,297		1,330,943

(1)During this quarter, we continued to lower leverage and improve our liquidity given the uncertainty as a result of the COVID-19 pandemic.

(2)In March 2020, in response to significant volatility and heightened risks in the financial markets as a result of the spread of COVID-19, we significantly reduced our outstanding borrowings to lower leverage and increase our liquidity.

(3)At the end of 2019 we increased the size of both our Credit and Agency portfolios which we subsequently financed through repos.

In addition to our borrowings under repos, we have entered into various other types of transactions to finance certain of our investments, including non-QM loans and REO, and consumer loans and ABS backed by consumer loans; such transactions are accounted for as collateralized borrowings. As of December 31, 2020 and 2019, we had outstanding borrowings related to such transactions in the amount of $806.0 million and $744.7 million, respectively, which is reflected under the captions "Other secured borrowings" and "Other secured borrowings, at fair value" on the Consolidated Balance Sheet. As of December 31, 2020, the fair value of non-QM loans, consumer loans and ABS backed by consumer loans, and small balance commercial mortgage loans collateralizing our Total other secured borrowings was $906.4 million. As of December 31, 2019, the fair value of non-QM loans and REO and consumer loans and ABS backed by consumer loans collateralizing our Total other secured borrowings was $843.4 million. See Note 11 in the notes to our consolidated financial statements for the year ended December 31, 2020, for further information on our other secured borrowings.

96

Table of Contents

As of both December 31, 2020 and 2019, we had $86.0 million outstanding of Senior Notes, maturing in September 2022 and bearing interest at a rate of 5.50%, subject to adjustment based on changes, if any, in the ratings of the Senior Notes. These Senior Notes were issued on February 13, 2019 in connection with the Note Exchange. See Note 11 in the notes to our consolidated financial statements for the year ended December 31, 2020, for further detail on the Senior Notes.

As of December 31, 2020, we had an aggregate amount at risk under our repos with 24 counterparties of approximately $363.1 million, and as of December 31, 2019, we had an aggregate amount at risk under our repos with 28 counterparties of approximately $348.4 million. Amounts at risk represent the excess, if any, for each counterparty of the fair value of collateral held by such counterparty over the amounts outstanding under repos. If the amounts outstanding under repos with a particular counterparty are greater than the collateral held by the counterparty, there is no amount at risk for the particular counterparty. Amount at risk as of December 31, 2020 and 2019 does not include approximately $4.2 million and $5.1 million, respectively, of net accrued interest receivable, which is defined as accrued interest on securities held as collateral less interest payable on cash borrowed.

Our derivatives are predominantly subject to bilateral collateral arrangements or clearing in accordance with the Dodd-Frank Act. We may be required to deliver or receive cash or securities as collateral upon entering into derivative transactions. Changes in the relative value of derivative transactions may require us or the counterparty to post or receive additional collateral. Entering into derivative contracts involves market risk in excess of amounts recorded on our balance sheet. In the case of cleared derivatives, the clearinghouse becomes our counterparty and the future commission merchant acts as an intermediary between us and the clearinghouse with respect to all facets of the related transaction, including the posting and receipt of required collateral.

As of December 31, 2020, we had an aggregate amount at risk under our derivative contracts, excluding TBAs, with eight counterparties of approximately $11.2 million. We also had $7.2 million of initial margin for cleared over-the-counter, or "OTC," derivatives posted to central clearinghouses as of that date. As of December 31, 2019, we had an aggregate amount at risk under our derivatives contracts, excluding TBAs, with ten counterparties of approximately $26.4 million. We also had $14.2 million of initial margin for cleared OTC derivatives posted to central clearinghouses as of that date. Amounts at risk under our derivatives contracts represent the excess, if any, for each counterparty of the fair value of our derivative contracts plus our collateral held directly by the counterparty less the counterparty's collateral held by us. If a particular counterparty's collateral held by us is greater than the aggregate fair value of the financial derivatives plus our collateral held directly by the counterparty, there is no amount at risk for the particular counterparty.

We purchase and sell TBAs and Agency pass-through certificates on a when-issued or delayed delivery basis. The delayed delivery for these securities means that these transactions are more prone to market fluctuations between the trade date and the ultimate settlement date, and therefore are more vulnerable, especially in the absence of margining arrangements with respect to these transactions, to increasing amounts at risk with the applicable counterparties. As of December 31, 2020, in connection with our forward settling TBA and Agency pass-through certificates, we had an aggregate amount at risk with six counterparties of approximately $4.1 million. As of December 31, 2019, in connection with our forward settling TBA and Agency pass-through certificates, we had an aggregate amount at risk with nine counterparties of approximately $4.2 million. Amounts at risk in connection with our forward settling TBA and Agency pass-through certificates represent the excess, if any, for each counterparty of the net fair value of the forward settling transactions plus our collateral held directly by the counterparty less the counterparty's collateral held by us. If a particular counterparty's collateral held by us is greater than the aggregate fair value of the forward settling transactions plus our collateral held directly by the counterparty, there is no amount at risk for the particular counterparty.

We held cash and cash equivalents of approximately $111.6 million and $72.3 million as of December 31, 2020 and 2019, respectively.

On June 13, 2018, our Board of Directors approved the adoption of a share repurchase program under which we are authorized to repurchase up to 1.55 million shares of common stock. The program, which is open-ended in duration, allows us to make repurchases from time to time on the open market or in negotiated transactions, including under 10b5-1 plans. Repurchases are at our discretion, subject to applicable law, share availability, price and our financial performance, among other considerations. In addition to making discretionary repurchases, we from time to time use 10b5-1 plans to increase the number of trading days available to implement these repurchases.

During the year ended December 31, 2020, we repurchased 290,050 shares at an average price per share of $10.54 and a total cost of $3.1 million. From inception of the current repurchase plan through March 5, 2021, we repurchased 701,965 shares at an average price per share of $13.36 and a total cost of $9.4 million, and have authorization to repurchase an additional 848,035 common shares.

97

Table of Contents

On April 3, 2019, we commenced an "at-the-market" offering program, or "ATM program," by entering into equity distribution agreements with third party sales agents under which we are authorized to offer and sell shares of common stock from time to time with a maximum aggregate gross offering price of up to $150 million. Through January 21, 2020 we did not issue any shares of common stock under the ATM program. Effective January 21, 2020, we terminated the ATM program.

On January 24, 2020, we completed a follow-on offering of 5,290,000 shares of our common stock, of which 690,000 shares were issued pursuant to the exercise of the underwriters' option. The issuance and sale of such common shares generated net proceeds, after underwriters' discount and offering costs, of $95.3 million.

We may declare dividends based on, among other things, our earnings, our financial condition, the REIT qualification requirements of the Internal Revenue Code of 1986, as amended, our working capital needs and new opportunities. The declaration of dividends to our stockholders and the amount of such dividends are at the discretion of our Board of Directors.

The following table sets forth the dividend distributions authorized by the Board of Directors payable to common stockholders and holders of Convertible Non-controlling Interest Units (as defined in Note 2 of the notes to consolidated financial statements) for the periods indicated below:

Year Ended December 31, 2020

Declaration Date	Dividend Per Share		Dividend Amount		Record Date	Payment Date
			(In thousands)
January 8, 2020	$	0.15	$	6,699	January 31, 2020	February 25, 2020
February 7, 2020	0.15		6,699		February 28, 2020	March 25, 2020
March 6, 2020	0.15		6,658		March 31, 2020	April 27, 2020
April 7, 2020	0.08		3,551		April 30, 2020	May 26, 2020
May 7, 2020	0.08		3,551		May 29, 2020	June 25, 2020
June 5, 2020	0.09		3,995		June 30, 2020	July 27, 2020
July 8, 2020	0.09		3,995		July 31, 2020	August 25, 2020
August 7, 2020	0.09		3,995		August 31, 2020	September 25, 2020
September 8, 2020	0.09		3,997		September 30, 2020	October 26, 2020
October 7, 2020	0.09		3,997		October 30, 2020	November 25, 2020
November 2, 2020	0.10		4,441		November 30, 2020	December 28, 2020
December 7, 2020	0.10		4,445		December 31, 2020	January 25, 2021

Year Ended December 31, 2019

Declaration Date	Dividend Per Share		Dividend Amount		Record Date	Payment Date
			(In thousands)
February 14, 2019	$	0.41	$	12,496	March 1, 2019	March 15, 2019
March 11, 2019	0.14		4,267		March 29, 2019	April 25, 2019
April 5, 2019	0.14		4,267		April 30, 2019	May 28, 2019
May 7, 2019	0.14		4,267		May 31, 2109	June 25, 2019
June 7, 2019	0.14		4,267		June 28, 2019	July 25, 2019
July 8, 2019	0.14		4,831		July 31, 2019	August 26, 2019
August 7, 2019	0.14		4,831		August 30, 2019	September 25, 2019
September 9, 2019	0.14		4,833		September 30, 2019	October 25, 2019
October 7, 2019	0.14		4,833		October 31, 2019	November 25, 2019
November 7, 2019	0.14		5,421		November 29, 2019	December 26, 2019
December 6, 2019	0.14		5,512		December 31, 2019	January 27, 2020

On January 8, 2021, the Board of Directors approved a dividend in the amount of $0.10 per share of common stock payable on February 25, 2021 to stockholders of record as of January 29, 2021. On February 5, 2021, the Board of Directors approved a dividend in the amount of $0.10 per share of common stock payable on March 25, 2021 to stockholders of record as of February 26, 2021.

98

Table of Contents

The following table sets forth the dividend distributions authorized by the Board of Directors payable to holders of our Series A Preferred Stock:

Declaration Date	Dividend Per Share		Dividend Amount		Record Date	Payment Date
			(In thousands)
December 13, 2019	$	0.459380	$	2,113	December 31, 2019	January 30, 2020
April 7, 2020	0.421875		1,941		April 17, 2020	April 30, 2020
July 8, 2020	0.421875		1,941		July 20, 2020	July 30, 2020
October 7, 2020	0.421875		1,941		October 19, 2020	October 30, 2020

On January 8, 2021, the Board of Directors approved a dividend in the amount of $0.421875 per share of Series A Preferred Stock payable on February 1, 2021 to stockholders of record as of January 19, 2021.

For the year ended December 31, 2020, our operating activities provided net cash in the amount of $119.5 million and our investing activities provided net cash in the amount of $507.3 million. Our repo activity used to finance many of our investments (including repayments of amounts borrowed under our repos) used net cash of $919.4 million. We received $485.8 million in proceeds from the issuance of Total other secured borrowings and we used $179.6 million for principal payments on Other secured borrowings. Thus our operating and investing activities, when combined with our repo financings and Other secured borrowings (net of repayments), provided net cash of $13.6 million for the year ended December 31, 2020. We received proceeds from the issuance of common stock, net of offering costs paid, of $95.3 million and contributions from non-controlling interests provided cash of $9.8 million. We used $65.0 million to pay dividends, $11.3 million for distributions to non-controlling interests (our joint venture partners), and $3.1 million to repurchase common stock. As a result there was an increase in our cash holdings of $39.3 million, from $72.5 million as of December 31, 2019 to $111.8 million as of December 31, 2020.

For the year ended December 31, 2019, our operating activities provided net cash in the amount of $79.2 million and our investing activities used net cash in the amount of $1.665 billion. Our repo activity used to finance many of our investments (including repayments of amounts borrowed under our repos) provided net cash of $1.171 billion. We received $348.3 million in proceeds from the issuance of Total other secured borrowings and we used $124.0 million for principal payments on Total other secured borrowings. Thus our operating and investing activities, when combined with our repo financings and Other secured borrowings (net of repayments), used net cash of $189.5 million for the year ended December 31, 2019. We received proceeds from the issuance of common and preferred stock, net of offering costs paid, of $267.4 million and contributions from non-controlling interests provided cash of $27.7 million. We used $54.3 million to pay dividends, $23.1 million for distributions to non-controlling interests (our joint venture partners), and $0.8 million to repurchase common stock. As a result there was an increase in our cash holdings of $27.4 million, from $45.1 million as of December 31, 2018 to $72.5 million as of December 31, 2019.

For the year ended December 31, 2018, our operating activities used net cash in the amount of $494.2 million, and our reverse repo activity used to finance many of our investments (including repayments of amounts borrowed under our reverse repo agreements) provided net cash of $409.7 million. We received $201.9 million in proceeds from the issuance of Total other secured borrowings, net of certain expenses related to these issuances, and we used $43.8 million for principal payments on Other secured borrowings. Thus our operating activities, when combined with our reverse repo financings, Total other secured borrowings (net of repayments and certain expenses related to the issuance of debt), provided net cash of $73.6 million for the year ended December 31, 2018. In addition, contributions from non-controlling interests provided cash of $21.5 million. We used $50.7 million to pay dividends, $23.9 million for distributions to non-controlling interests (our joint venture partners), and $23.1 million to repurchase common shares. As a result there was a decrease in our cash holdings of $2.6 million, from $47.7 million as of December 31, 2017 to $45.1 million as of December 31, 2018.

Based on our current portfolio, amount of free cash on hand, debt-to-equity ratio, and current and anticipated availability of credit, we believe that our capital resources will be sufficient to enable us to meet anticipated short-term and long-term liquidity requirements. However, the unexpected inability to finance our Agency RMBS portfolio would create a serious short-term strain on our liquidity and would require us to liquidate much of that portfolio, which in turn would require us to restructure our portfolio to maintain our exclusion from registration as an investment company under the Investment Company Act and to maintain our qualification as a REIT. Steep declines in the values of our credit assets financed using repos, or in the values of our derivative contracts, would result in margin calls that would significantly reduce our free cash position. Furthermore, a substantial increase in prepayment rates on our assets financed by repos could cause a temporary liquidity shortfall, because we are generally required to post margin on such assets in proportion to the amount of the announced principal paydowns before the actual receipt of the cash from such principal paydowns. If our cash resources are at any time insufficient to satisfy our liquidity requirements, we may have to sell assets or issue additional debt or equity securities.

99

Table of Contents

In March 2020, as a result of significant declines in asset prices and general price volatility, we received margin calls under our financing arrangements and under our derivative contracts that were higher than typical historical levels. During the second and third quarters, prices for most credit assets stabilized and market volatility subsided, and as a result, our margin calls reverted to more typical levels. We satisfied all margin calls during these periods.

Although we may from time to time enter into financing arrangements that limit our leverage, our investment guidelines do not limit the amount of leverage that we may use, and we believe that the appropriate leverage for the particular assets we hold depends on the credit quality and risk of those assets, as well as the general availability and terms of stable and reliable financing for those assets.

Contractual Obligations and Commitments

We are a party to a management agreement with our Manager. Pursuant to that agreement, our Manager is entitled to receive a base management fee, an incentive fee, reimbursement of certain expenses and, in certain circumstances, a termination fee. Such fees and expenses do not have fixed and determinable payments. For a description of the management agreement provisions, see Note 13 of the notes to our consolidated financial statements the year ended December 31, 2020.

The following table summarizes our contractual obligations at December 31, 2020:

(In thousands)	Less than One Year		1-3 Years		3-5 Years		More than Five Years		Total
Reverse repurchase agreements	$	1,402,683	$	94,248	$	—	$	—	$	1,496,931
Interest expense on repurchase agreements, based on rates at December 31, 2020(1)	4,112		3,510		—		—		7,622
Senior Notes	4,730		90,730		—		—		95,460
Payable for securities purchased and financial derivatives	4,754		—		—		—		4,754
Total	1,416,279		188,488		—		—		1,604,767

(1)Includes accrued interest expense on repurchase agreements at December 31, 2020 of $1.5 million which is included in Interest payable on the Consolidated Balance Sheet.

The above table excludes repayment obligations related to our Total other secured borrowings. These repayment obligations have been excluded from the above table since the timing of their actual maturities is based on the timing of the repayments of the underlying consumer and mortgage loans that collateralize them rather than a stated contractual maturity. Consumer and mortgage loans are subject to prepayment by borrowers and such prepayments are inherently difficult to predict. In addition, other secured borrowings related to our non-QM loan securitizations are subject to our optional redemption rights as described in Note 10 of the notes to consolidated financial statements for the year ended December 31, 2020.

The following table details our projected payments under our obligations related to our Total other secured borrowings as of December 31, 2020.

(In thousands)	Less than One Year		1-3 Years		3-5 Years		More than Five Years		Total
Total other secured borrowings	$	370,933	$	458,245	$	—	$	—	$	829,178
Interest expense on Total other secured borrowings, based on rates at December 31, 2020	38,203		30,736						68,939
Total	409,136		488,981		—		—		898,117

We enter into repos with third-party broker-dealers whereby we sell a security to such broker-dealer at an agreed-upon purchase price at the initiation of the repo and agree to repurchase such security at predetermined repurchase price and termination date, thus providing the broker-dealer with an implied interest rate on the funds initially transferred to us by the broker-dealer. We enter into reverse repos with third-party broker-dealers whereby we purchase a security under an agreement to resell at an agreed-upon price and date. In general, we most often enter into reverse repo transactions in order to effectively borrow securities that we can then deliver to counterparties to whom we have made short sales of the same securities. The implied interest rates on the repos and reverse repos we enter into are based upon competitive market rates at the time of initiation. Repos and reverse repos that are conducted with the same counterparty may be reported on a net basis if they meet the requirements of ASC 210-20, Balance Sheet, Offsetting. See "—Liquidity and Capital Resources" for a summary of our borrowings on repos. As of December 31, 2020 and 2019 there were no repos or reverse repos reported on a net basis on the Consolidated Balance Sheet.

100

Table of Contents

We have numerous contractual obligations and commitments related to our outstanding borrowings (see Note 11 of the notes to our consolidated financial statements for the year ended December 31, 2020) and related to our financial derivatives (see Note 8 of the notes to our consolidated financial statements for the year ended December 31, 2020).

See Note 21 of the notes to our consolidated financial statements as of December 31, 2020 for further detail on our other contractual obligations and commitments.

Off-Balance Sheet Arrangements

As of December 31, 2020, we did not have any material relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. Further, we have not guaranteed any obligations of unconsolidated entities nor do we have any commitment to provide funding to any such entities that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or resources that would be material to an investor in our securities. As such, we are not materially exposed to any market, credit, liquidity, or financing risk that could arise if we had engaged in such relationships.

At December 31, 2020 we have not entered into any repurchase agreements for which delivery of the borrowed funds is not scheduled until after period end.

Inflation

Virtually all of our assets and liabilities are interest rate sensitive in nature. As a result, interest rates and other factors influence our performance far more so than does inflation. Changes in interest rates do not necessarily correlate with inflation rates or changes in inflation rates. Our activities and balance sheet are measured with reference to historical cost and/or fair market value without considering inflation.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

The primary components of our market risk at December 31, 2020 are related to credit risk, prepayment risk, and interest rate risk. We seek to actively manage these and other risks and to acquire and hold assets that we believe justify bearing those risks, and to maintain capital levels consistent with those risks.

Credit Risk

We are subject to credit risk in connection with many of our assets, especially non-Agency RMBS, CMBS, residential and commercial mortgage loans, corporate debt investments including CLOs and investments in securitization warehouses, and consumer loans.

Credit losses on real estate loans can occur for many reasons, including, but not limited to, poor origination practices, fraud, faulty appraisals, documentation errors, poor underwriting, legal errors, poor servicing practices, weak economic conditions, decline in the value of homes, businesses or commercial properties, special hazards, earthquakes and other natural events, such as the COVID-19 pandemic, or an outbreak of another highly infectious or contagious disease, over-leveraging of the borrower on a property, reduction in market rents and occupancies and poor property management services, changes in legal protections for lenders, reduction in personal income, job loss, and personal events such as divorce or health problems. Property values are subject to volatility and may be affected adversely by a number of factors, including, but not limited to, national, regional, and local economic conditions (which may be adversely affected by industry slowdowns and other factors), local real estate conditions (such as an oversupply of housing), changes or continued weakness in specific industry segments, construction quality, age and design, demographic factors, and retroactive changes to building or similar codes.

The ability of borrowers to repay consumer loans may be adversely affected by numerous borrower-specific factors, including unemployment, divorce, major medical expenses or personal bankruptcy. General factors, including an economic downturn, high energy costs or acts of God or terrorism, pandemics such as the COVID-19 pandemic or another highly infectious or contagious disease, may also affect the financial stability of borrowers and impair their ability or willingness to repay their loans. Whenever any of our consumer loans defaults, we are at risk of loss to the extent of any deficiency between the liquidation value of the collateral, if any, securing the loan, and the principal and accrued interest of the loan. Many of our consumer loans are unsecured, or are secured by collateral (such as an automobile) that depreciates rapidly; as a result, these loans may be at greater risk of loss than residential real estate loans.

Our corporate investments, especially our lower-rated or unrated CLO investments, corporate equity, and our investments in loan originators, have significant risk of loss, and our efforts to protect these investments may involve substantial costs and may not be successful. The risk of loss with respect to these investments has been, and will likely continue to be, exacerbated

101

Table of Contents

by the COVID-19 pandemic. We also will be subject to significant uncertainty as to when and in what manner and for what value the corporate debt in which we directly or indirectly invest will eventually be satisfied (e.g., through liquidation of the obligor's assets, an exchange offer or plan of reorganization involving the debt securities or a payment of some amount in satisfaction of the obligation). In addition, these investments could involve loans to companies that are more likely to experience bankruptcy or similar financial distress, such as companies that are thinly capitalized, employ a high degree of financial leverage, are in highly competitive or risky businesses, are in a start-up phase, or are experiencing losses.

Similarly, we are exposed to the risk of potential credit losses on the other assets in our credit portfolio. For many of our investments, the two primary components of credit risk are default risk and severity risk.

Default Risk

Default risk is the risk that a borrower fails to make scheduled principal and interest payments on a mortgage loan or other debt obligation. We may attempt to mitigate our default risk by, among other things, opportunistically entering into credit default swaps and total return swaps. These instruments can reference various MBS indices, corporate bond indices, or corporate entities. We often rely on third-party servicers to mitigate our default risk, but such third-party servicers may have little or no economic incentive to mitigate loan default rates.

Severity Risk

Severity risk is the risk of loss upon a borrower default on a mortgage loan or other secured or unsecured debt obligation. Severity risk includes the risk of loss of value of the property or other asset, if any, securing the mortgage loan or debt obligation, as well as the risk of loss associated with taking over the property or other asset, if any, including foreclosure costs. We often rely on third-party servicers to mitigate our severity risk, but such third-party servicers may have little or no economic incentive to mitigate loan loss severities. In the case of mortgage loans, such mitigation efforts may include loan modification programs and prompt foreclosure and property liquidation following a default. Many of our consumer loans are unsecured, or are secured by collateral (such as an automobile) that depreciates rapidly; as a result, these loans may be at greater risk of loss than residential real estate loans. Pursuing any remaining deficiency following a default on a consumer loan is often difficult or impractical, especially when the borrower has a low credit score, making further substantial collection efforts unwarranted. In addition, repossessing personal property securing a consumer loan can present additional challenges, including locating and taking physical possession of the collateral. We rely on servicers who service these consumer loans, to, among other things, collect principal and interest payments on the loans and perform loss mitigation services, and these servicers may not perform in a manner that promotes our interests. In the case of corporate debt, if a company declares bankruptcy, the bankruptcy process has a number of significant inherent risks. Many events in a bankruptcy proceeding are the product of contested matters and adversarial proceedings and are beyond the control of the creditors. A bankruptcy filing by a company whose debt we have purchased may adversely and permanently affect such company. If the proceeding results in liquidation, the liquidation value of the company may have deteriorated significantly from what we believed to be the case at the time of our initial investment. The duration of a bankruptcy proceeding is also difficult to predict, and our return on investment can be adversely affected by delays until a plan of reorganization or liquidation ultimately becomes effective. A bankruptcy court may also re-characterize our debt investment as equity, and subordinate all or a portion of our claim to that of other creditors. This could occur even if our investment had initially been structured as senior debt.

Prepayment Risk

Prepayment risk is the risk of change, whether an increase or a decrease, in the rate at which principal is returned in respect of fixed-income assets in our portfolio, including both through voluntary prepayments and through liquidations due to defaults and foreclosures. Most significantly, our portfolio is exposed to the risk of changes in prepayment rates of mortgage loans, including the mortgage loans underlying our RMBS, and changes in prepayment rates of certain of our consumer loan holdings. This rate of prepayment is affected by a variety of factors, including the prevailing level of interest rates as well as economic, demographic, tax, social, legal, and other factors. Changes in prepayment rates will have varying effects on the different types of securities in our portfolio, and we attempt to take these effects into account in making asset management decisions. Additionally, increases in prepayment rates may cause us to experience losses on our interest only securities and inverse interest only securities, as those securities are extremely sensitive to prepayment rates. Prepayment rates, besides being subject to interest rates and borrower behavior, are also substantially affected by government policy and regulation. For example, the government sponsored HARP program, which was designed to encourage mortgage refinancings, was a steady contributor to Agency RMBS prepayment speeds from its inception in 2009 until its expiration at the end of 2018. Mortgage rates declined significantly during 2020, and remain very low by historical standards. As a result, prepayments continue to represent a meaningful risk, especially with respect to our Agency RMBS.

102

Table of Contents

Interest Rate Risk

Interest rates are highly sensitive to many factors, including governmental monetary and tax policies, domestic and international economic and political considerations, and other factors beyond our control. We are subject to interest rate risk in connection with most of our assets and liabilities. For some securities in our portfolio, the coupon interest rates on, and therefore also the values of, such securities are highly sensitive to interest rate movements, such as inverse floating rate RMBS, which benefit from falling interest rates. Our repurchase agreements generally carry interest rates that are determined by reference to LIBOR or similar short-term benchmark rates for those same periods. Whenever one of our fixed-rate repo borrowings matures, it will generally be replaced with a new fixed-rate repo borrowing based on market interest rates prevailing at such time. Subject to maintaining our qualification as a REIT and our exclusion from registration under the Investment Company Act, we opportunistically hedge our interest rate risk by entering into interest rate swaps, TBAs, U.S. Treasury securities, Eurodollar futures, U.S. Treasury futures, and other instruments. In general, such hedging instruments are used to mitigate the interest rate risk arising from the mismatch between the duration of our financed assets and the duration of the liabilities used to finance such assets. The majority of this mismatch currently relates to our Agency RMBS.

The following sensitivity analysis table shows the estimated impact on the value of our portfolio segregated by certain identified categories as of December 31, 2020, assuming a static portfolio and immediate and parallel shifts in interest rates from current levels as indicated below.

(In thousands)	Estimated Change for a Decrease in Interest Rates by								Estimated Change for an Increase in Interest Rates by
	50 Basis Points				100 Basis Points				50 Basis Points				100 Basis Points
Category of Instruments	Market Value		% of Total Equity		Market Value		% of Total Equity		Market Value		% of Total Equity		Market Value		% of Total Equity
Agency RMBS	$	6,082	0.66	%	$	9,132	0.99	%	$	(9,114)	(0.99)	%	$	(21,259)	(2.31)	%
Non-Agency RMBS, CMBS, ABS and Loans	6,490		0.70	%	13,950		1.51	%	(5,520)		(0.60)	%	(10,069)		(1.09)	%
U.S. Treasury Securities, and Interest Rate Swaps, Options, and Futures	(8,773)		(0.95)	%	(17,858)		(1.94)	%	8,461		0.92	%	16,609		1.80	%
Mortgage-Related Derivatives	—		—	%	1		—	%	—		—	%	1		—	%
Corporate Securities and Derivatives on Corporate Securities	7		—	%	5		—	%	(16)		—	%	(42)		—	%
Repurchase Agreements, Reverse Repurchase Agreements, and Senior Notes	(754)		(0.08)	%	(566)		(0.06)	%	1,676		0.18	%	3,938		0.43	%
Total	$	3,052	0.33	%	$	4,664	0.50	%	$	(4,513)	(0.49)	%	$	(10,822)	(1.17)	%

The preceding analysis does not show sensitivity to changes in interest rates for instruments for which we believe that the effect of a change in interest rates is not material to the value of the overall portfolio and/or cannot be accurately estimated. In particular, this analysis excludes certain of our holdings of corporate securities and derivatives on corporate securities, and reflects only sensitivity to U.S. interest rates.

Our analysis of interest rate risk is derived from Ellington's proprietary models as well as third-party information and analytics. Many assumptions have been made in connection with the calculations set forth in the table above and, as such, there can be no assurance that assumed events will occur or that other events will not occur that would affect the outcomes. For example, for each hypothetical immediate shift in interest rates, assumptions have been made as to the response of mortgage prepayment rates, the shape of the yield curve, and market volatilities of interest rates; each of the foregoing factors can significantly and adversely affect the fair value of our interest rate-sensitive instruments.

The above analysis utilizes assumptions and estimates based on management's judgment and experience, and relies on financial models, which are inherently imperfect; in fact, different models can produce different results for the same securities. While the table above reflects the estimated impacts of immediate parallel interest rate increases and decreases on specific categories of instruments in our portfolio, we actively trade many of the instruments in our portfolio, and therefore our current or future portfolios may have risks that differ significantly from those of our December 31, 2020 portfolio estimated above. Moreover, the impact of changing interest rates on fair value can change significantly when interest rates change by a greater amount than the hypothetical shifts assumed above. Furthermore, our portfolio is subject to many risks other than interest rate risks, and these additional risks may or may not be correlated with changes in interest rates. For all of the foregoing reasons and others, the table above is for illustrative purposes only and actual changes in interest rates would likely cause changes in the

103

Table of Contents

actual fair value of our portfolio that would differ from those presented above, and such differences might be significant and adverse. See "—Special Note Regarding Forward-Looking Statements."

104

Table of Contents

Item 8. Financial Statements and Supplementary Data

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2020 AND 2019 AND FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019
Report of Independent Registered Public Accounting Firm	106
Consolidated Balance Sheet	108
Consolidated Statement of Operations	109
Consolidated Statement of Changes in Equity	110
Consolidated Statement of Cash Flows	111
Notes to Consolidated Financial Statements	114
CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2018 AND FOR THE YEAR ENDED DECEMBER 31, 2018
Report of Independent Registered Public Accounting Firm	180
Consolidated Statement of Assets, Liabilities, and Equity	181
Consolidated Condensed Schedule of Investments	182
Consolidated Statement of Operations	195
Consolidated Statement of Changes in Equity	197
Consolidated Statement of Cash Flows	197
Notes to Consolidated Financial Statements	199

105

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of Ellington Financial Inc.

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheet of Ellington Financial Inc. and its subsidiaries (the “Company”) as of December 31, 2020 and 2019, and the related consolidated statements of operations, of changes in equity and of cash flows for the years then ended, including the related notes and the schedule of mortgage loans on real estate as of and for the year ended December 31, 2020 appearing under Item 15(a)(2) (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Annual Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

106

Table of Contents

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Valuation of Certain Investments in Securities, Loans and Unconsolidated Entities that are Determined Based on Management’s Internal Valuation Techniques

As described in Notes 2 and 3 to the consolidated financial statements, the Company’s investments in securities at fair value, loans at fair value and investments in unconsolidated entities at fair value were $1.5 billion, $1.5 billion and $0.1 billion, respectively as of December 31, 2020. The Company elected the fair value option for those of its assets for which such election is permitted, including its investments in securities, loans, and investments in unconsolidated entities. Management generally uses third party valuations when available. If third-party valuations are not available, management uses other valuation techniques, such as a discounted cash flow methodology. Management’s estimate of fair value may be based on several assumptions, including but not limited to management’s estimates of yield, projected collateral prepayments, projected collateral losses, projected collateral recoveries, recovery amount, and recovery timeline, as applicable. For certain investments in unconsolidated entities, an equity price-to-book assumption is also considered. Fair value measurements are impacted by the interrelationships of these assumptions.

The principal considerations for our determination that performing procedures relating to the valuation of certain investments in securities, loans and unconsolidated entities that are determined based on management’s internal valuation techniques is a critical audit matter are (i) the significant judgment by management in determining the fair value of these investments, which in turn led to (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating audit evidence related to the valuation of these investments and the interrelated assumptions related to yield, projected collateral prepayments, projected collateral losses, projected collateral recoveries, recovery amount, recovery timeline, and equity price-to-book, as applicable; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s valuation of certain investments in securities, loans, and unconsolidated entities, including controls over management’s comparison of internally developed fair values to fair values obtained from third-party pricing providers. These procedures also included, among others, developing an independent range of fair value estimates, which included (i) testing the completeness and accuracy of data provided by management; (ii) comparing management’s estimate of fair value to independent sources, where available; and (iii) for a sample of investments, the involvement of professionals with specialized skill and knowledge to assist in developing an independent range of estimates of fair value by independently developing assumptions related to yield, projected collateral prepayments, projected collateral losses, projected collateral recoveries, recovery amount, recovery timeline, and equity price-to-book assumptions, as applicable.

/s/PricewaterhouseCoopers LLP

New York, New York

March 16, 2021

We have served as the Company’s auditor since 2007.

107

Table of Contents

ELLINGTON FINANCIAL INC.

CONSOLIDATED BALANCE SHEET

	December 31, 2020		December 31, 2019
(In thousands, except share amounts)	Expressed in U.S. Dollars
Assets
Cash and cash equivalents(1)	$	111,647	$	72,302
Restricted cash(1)	175		175
Securities, at fair value(1)(2)	1,514,185		2,449,941
Loans, at fair value(1)(2)	1,453,480		1,412,426
Investments in unconsolidated entities, at fair value(1)	141,620		71,850
Real estate owned(1)(2)	23,598		30,584
Financial derivatives—assets, at fair value	15,479		16,788
Reverse repurchase agreements	38,640		73,639
Due from brokers(1)	63,147		79,829
Investment related receivables(1)	49,317		123,120
Other assets(1)	2,575		7,563
Total Assets	$	3,413,863	$	4,338,217
Liabilities
Securities sold short, at fair value	$	38,642	$	73,409
Repurchase agreements(1)	1,496,931		2,445,300
Financial derivatives—liabilities, at fair value	24,553		27,621
Due to brokers	5,059		2,197
Investment related payables(1)	4,754		66,133
Other secured borrowings(1)	51,062		150,334
Other secured borrowings, at fair value(1)	754,921		594,396
Senior notes, net	85,561		85,298
Base management fee payable to affiliate	3,178		2,663
Incentive fee payable to affiliate	—		116
Dividends payable	5,738		6,978
Interest payable(1)	3,233		7,320
Accrued expenses and other liabilities(1)	18,659		7,753
Total Liabilities	2,492,291		3,469,518
Commitments and contingencies (Note 21)
Equity
Preferred stock, par value $0.001 per share, 100,000,000 shares authorized; 6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable; 4,600,000 shares issued and outstanding, respectively ($115,000 liquidation preference)	111,034		111,034
Common stock, par value $0.001 per share, 100,000,000 shares authorized; 43,781,684 and 38,647,943 shares issued and outstanding, respectively	44		39
Additional paid-in-capital	915,658		821,747
Retained earnings (accumulated deficit)	(141,521)		(103,555)
Total Stockholders' Equity	885,215		829,265
Non-controlling interests(1)	36,357		39,434
Total Equity	921,572		868,699
Total Liabilities and Equity	$	3,413,863	$	4,338,217

(1)Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

(2)Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

See Notes to Consolidated Financial Statements

108

Table of Contents

ELLINGTON FINANCIAL INC.

CONSOLIDATED STATEMENT OF OPERATIONS

	Year Ended
	December 31, 2020		December 31, 2019
(In thousands, except per share amounts)
Net Interest Income
Interest income	$	173,531	$	159,901
Interest expense	(61,665)		(78,479)
Total net interest income	111,866		81,422
Other Income (Loss)
Realized gains (losses) on securities and loans, net	(5,960)		(12,785)
Realized gains (losses) on financial derivatives, net	(31,521)		(30,912)
Realized gains (losses) on real estate owned, net	15		2,327
Unrealized gains (losses) on securities and loans, net	(25,783)		54,478
Unrealized gains (losses) on financial derivatives, net	989		(5,338)
Unrealized gains (losses) on real estate owned, net	(649)		(1,279)
Other, net	(2,298)		5,350
Total other income (loss)	(65,207)		11,841
Expenses
Base management fee to affiliate (Net of fee rebates of $1,051 and $1,967, respectively)(1)	11,508		7,988
Incentive fee to affiliate	—		116
Investment related expenses:
Servicing expense	9,139		8,632
Debt issuance costs related to Other secured borrowings, at fair value	3,894		3,536
Other	5,111		5,609
Professional fees	5,005		4,853
Compensation expense	3,776		3,649
Other expenses	6,405		4,354
Total expenses	44,838		38,737
Net Income (Loss) before Income Tax Expense (Benefit) and Earnings (Losses) from Investments in Unconsolidated Entities	1,821		54,526
Income tax expense (benefit)	11,377		1,558
Earnings (losses) from investments in unconsolidated entities	37,933		10,209
Net Income (Loss)	28,377		63,177
Net income (loss) attributable to non-controlling interests	3,369		5,244
Dividends on preferred stock	7,763		1,466
Net Income (Loss) Attributable to Common Stockholders	$	17,245	$	56,467
Net Income (Loss) per Share of Common Stock:
Basic and Diluted	$	0.39	$	1.76

(1)See Note 13 for further details on management fee rebates.

See Notes to Consolidated Financial Statements

109

Table of Contents

ELLINGTON FINANCIAL INC.

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

			Common Stock			Additional Paid-in Capital		Retained Earnings/(Accumulated Deficit)		Total Stockholders' Equity		Non-controlling Interest		Total Equity
	Preferred Stock		Shares	Par Value
(In thousands, except share amounts)				Expressed in U.S. Dollars
BALANCE, January 1, 2019	$	—	29,796,601	$	—	$	665,356	$	(101,523)	$	563,833	$	31,337	$	595,170
Share conversion(1)			—	30		(30)		—		—		—		—
Net income (loss)								57,933		57,933		5,244		63,177
Net proceeds from the issuance of common stock(2)			8,855,000	9		156,319				156,328				156,328
Net proceeds from the issuance of preferred stock(2)	111,034									111,034				111,034
Contributions from non-controlling interests												27,650		27,650
Common dividends(3)								(58,499)		(58,499)		(1,325)		(59,824)
Preferred dividends(4)								(1,466)		(1,466)				(1,466)
Distributions to non-controlling interests												(23,063)		(23,063)
Conversion of non-controlling interest units to shares of common stock			47,167	—		812				812		(812)		—
Adjustment to non-controlling interests						(392)				(392)		392		—
Repurchase of shares of common stock			(50,825)	—		(782)				(782)				(782)
Share-based long term incentive plan unit awards						464				464		11		475
BALANCE, December 31, 2019	$	111,034	38,647,943	$	39	$	821,747	$	(103,555)	$	829,265	$	39,434	$	868,699
Net income (loss)								25,008		25,008		3,369		28,377
Net proceeds from the issuance of common stock(2)			5,290,000	5		95,287				95,292		—		95,292
Shares of common stock issued in connection with incentive fee payment			637	—		12				12		—		12
Contributions from non-controlling interests												8,270		8,270
Common dividends(3)								(55,211)		(55,211)		(812)		(56,023)
Preferred dividends(4)								(7,763)		(7,763)		—		(7,763)
Distributions to non-controlling interests												(12,958)		(12,958)
Conversion of non-controlling interest units to shares of common stock			133,154	—		2,437				2,437		(2,437)		—
Adjustment to non-controlling interests			—	—		(1,480)				(1,480)		1,480		—
Repurchase of shares of common stock			(290,050)	—		(3,056)				(3,056)				(3,056)
Share-based long term incentive plan unit awards			—	—		711				711		11		722
BALANCE, December 31, 2020	$	111,034	43,781,684	$	44	$	915,658	$	(141,521)	$	885,215	$	36,357	$	921,572

(1)See Note 1 for further details on the share conversion.

(2)Net of underwriters' discounts and offering costs.

(3)For the years ended December 31, 2020 and 2019, dividends totaling $1.26 and $1.81, respectively, per share of common stock and convertible unit outstanding, were declared.

(4)For the years ended December 31, 2020 and 2019, dividends totaling $1.265625 and $0.45938, respectively, per share of preferred stock was declared.

See Notes to Consolidated Financial Statements

110

Table of Contents

ELLINGTON FINANCIAL INC.

CONSOLIDATED STATEMENT OF CASH FLOWS

	Year Ended
	December 31, 2020		December 31, 2019
(In thousands)	Expressed in U.S. Dollars
Cash Flows from Operating Activities:
Net income (loss)	$	28,377	$	63,177
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Amortization of premiums and accretion of discounts, net	41,681		48,132
Realized (gains) losses on securities and loans, net	5,960		12,785
Realized (gains) losses on financial derivatives, net	31,521		30,912
Realized (gains) losses on real estate owned, net	(15)		(2,327)
Unrealized (gains) losses on securities and loans, net	25,783		(54,478)
Unrealized (gains) losses on financial derivatives, net	(989)		5,338
Unrealized (gains) losses on real estate owned, net	649		1,279
Unrealized (gains) losses other, net	9,562		645
Realized (gains) losses other, net—foreign currency transaction	173		2,392
Unrealized (gains) losses other, net—foreign currency translation	(1,720)		(3,310)
Amortization of deferred debt issuance costs	263		263
Shares issued in connection with incentive fee payment	12		—
Share-based long term incentive plan unit expense	722		475
Interest income related to consolidated securitization trust	(21,800)		(16,034)
Interest expense related to consolidated securitization trust	21,020		15,136
Debt issuance costs related to Other secured borrowings, at fair value	1,749		1,381
(Earnings) losses from investments in unconsolidated entities	(37,933)		(10,209)
Changes in operating asset and liabilities:
(Increase) decrease in interest and principal receivable	5,223		(15,449)
(Increase) decrease in other assets	1,077		(3,663)
Increase (decrease) in base management fee payable to affiliate	515		919
Increase (decrease) in incentive fee payable to affiliate	(116)		116
Increase (decrease) in interest payable	(3,798)		161
Increase (decrease) in accrued expenses and other liabilities	11,590		1,607
Net cash provided by (used in) operating activities	$	119,506	$	79,248

See Notes to Consolidated Financial Statements

111

Table of Contents

ELLINGTON FINANCIAL INC.
CONSOLIDATED STATEMENT OF CASH FLOWS (CONTINUED)
	Year Ended
	December 31, 2020		December 31, 2019
(In thousands)	Expressed in U.S. Dollars
Cash Flows from Investing Activities:
Purchase of securities	$	(1,346,245)	$	(3,057,372)
Purchase of loans	(852,261)		(1,040,006)
Capital improvements of real estate owned	(153)		(240)
Proceeds from disposition of securities	1,888,099		1,838,182
Proceeds from disposition of loans	25,414		28,878
Contributions to investments in unconsolidated entities	(34,624)		(42,124)
Distributions from investments in unconsolidated entities	30,644		49,758
Proceeds from disposition of real estate owned	9,889		24,059
Proceeds from principal payments of securities	362,987		275,221
Proceeds from principal payments of loans	443,640		304,953
Proceeds from securities sold short	268,294		645,553
Repurchase of securities sold short	(310,559)		(650,576)
Payments on financial derivatives	(115,418)		(90,057)
Proceeds from financial derivatives	84,597		58,578
Payments made on reverse repurchase agreements	(7,586,769)		(7,050,581)
Proceeds from reverse repurchase agreements	7,622,670		7,038,216
Due from brokers, net	16,443		6,483
Due to brokers, net	619		(3,458)
Net cash provided by (used in) investing activities	507,267		(1,664,533)
Cash Flows from Financing Activities:
Net proceeds from the issuance of common stock(1)	95,537		156,742
Net proceeds from the issuance of preferred stock(1)	—		111,378
Offering costs paid	(253)		(712)
Repurchase of common stock	(3,056)		(782)
Dividends paid	(65,026)		(54,312)
Contributions from non-controlling interests	9,848		27,650
Distributions to non-controlling interests	(11,301)		(23,063)
Proceeds from issuance of Other secured borrowings	57,863		97,642
Principal payments on Other secured borrowings	(67,325)		(61,408)
Borrowings under repurchase agreements	4,138,940		9,047,746
Repayments of repurchase agreements	(5,059,445)		(7,862,227)
Proceeds from issuance of Other secured borrowings, at fair value	427,959		250,666
Repayment of Other secured borrowings, at fair value	(112,253)		(62,608)
Due from brokers, net	49		(13,676)
Due to brokers, net	1,035		(355)
Net cash provided by (used in) financing activities	(587,428)		1,612,681
Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash	39,345		27,396
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	72,477		45,081
Cash, Cash Equivalents, and Restricted Cash, End of Period	$	111,822	$	72,477

See Notes to Consolidated Financial Statements

112

Table of Contents

ELLINGTON FINANCIAL INC.
CONSOLIDATED STATEMENT OF CASH FLOWS (CONTINUED)
	Year Ended
	December 31, 2020		December 31, 2019
(In thousands)	Expressed in U.S. Dollars
Supplemental disclosure of cash flow information:
Interest paid	$	65,751	$	78,754
Income tax paid	543		189
Dividends payable	5,738		6,978
Shares issued in connection with incentive fee payment (non-cash)	12		—
Share-based long term incentive plan unit awards (non-cash)	722		475
Contributions from non-controlling interests (non-cash)	2,340		—
Distributions to non-controlling interests (non-cash)	(2,340)		—
Transfers from mortgage loans to real estate owned (non-cash)	3,384		22,577
Transfers from mortgage loans to investments in unconsolidated entities (non-cash)	10,833		—
Purchase of investments (non-cash)	—		(2,975)
Contributions to investments in non-consolidated entities (non-cash)	(17,023)		—
Distributions from investments in unconsolidated entities (non-cash)	—		2,975
Purchase of loans (non-cash)	(6,670)		—
Principal payments on Other secured borrowings, at fair value (non-cash)	(193,575)		(119,683)
Proceeds received from Other secured borrowings, at fair value (non-cash)	28,818		227,428
Principal payments on Other secured borrowings (non-cash)	(96,480)		—
Proceeds from issuance of Other secured borrowings (non-cash)	6,670		—
Proceeds from principal payments of investments (non-cash)	193,575		119,683
Proceeds from the disposition of loans (non-cash)	113,791		—
Repayments of repurchase agreements (non-cash)	(27,864)		(226,945)
Repayment of senior notes (non-cash)	—		(86,000)
Issuance of senior notes (non-cash)	—		86,000

(1)Net of underwriters' discounts.

See Notes to Consolidated Financial Statements

113

Table of Contents

ELLINGTON FINANCIAL INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2020

1. Organization and Investment Objective

Ellington Financial Inc., formerly known as Ellington Financial LLC, was originally formed as a Delaware limited liability company on July 9, 2007 and commenced operations on August 17, 2007. On February 28, 2019, Ellington Financial LLC filed a certificate of conversion with the Secretary of State of the State of Delaware (the "Secretary") to convert from a Delaware limited liability company to a Delaware corporation (the "Conversion") and change its name to Ellington Financial Inc. The Conversion became effective on March 1, 2019, and upon effectiveness, each of Ellington Financial LLC's existing common shares representing limited liability company interests, no par value, converted into one issued and outstanding, fully paid and nonassessable share of common stock, $0.001 par value per share, of Ellington Financial Inc. In connection with the Conversion, Ellington Financial Inc.'s Board of Directors (the "Board of Directors") approved Ellington Financial Inc.'s Certificate of Incorporation (which was also filed with the Secretary) and Bylaws.

Ellington Financial Operating Partnership LLC (the "Operating Partnership"), a 98.7% owned consolidated subsidiary of Ellington Financial Inc., was formed as a Delaware limited liability company on December 14, 2012 and commenced operations on January 1, 2013. All of Ellington Financial Inc.'s operations and business activities are conducted through the Operating Partnership. Ellington Financial Inc., the Operating Partnership, and their consolidated subsidiaries are hereafter collectively referred to as the "Company." All intercompany accounts are eliminated in consolidation.

The Company conducts its operations to qualify and be taxed as a real estate investment trust, or "REIT," under the Internal Revenue Code of 1986, as amended (the "Code"), and has elected to be taxed as a corporation effective January 1, 2019. The Company has elected to be taxed as a REIT for U.S. federal income tax purposes. In anticipation of the Company's intended election to be taxed as a REIT under the Code beginning with its 2019 taxable year (the "REIT Election"), the Company implemented an internal restructuring as of December 31, 2018. As part of this restructuring, the Company moved certain of its non-REIT-qualifying investments and financial derivatives to taxable REIT subsidiaries or, "TRSs," and disposed of certain of its investments in non-REIT-qualifying investments and financial derivatives.

The Company invests in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, or "RMBS," commercial mortgage-backed securities, or "CMBS," consumer loans and asset-backed securities, or "ABS," including ABS backed by consumer loans, collateralized loan obligations, or "CLOs," non-mortgage- and mortgage-related derivatives, equity investments in loan origination companies, and other strategic investments.

Ellington Financial Management LLC (the "Manager") is an SEC-registered investment adviser that serves as the Manager to the Company pursuant to the terms of its Seventh Amended and Restated Management Agreement (the "Management Agreement"), which was approved by the Board of Directors effective March 13, 2018. The Manager is an affiliate of Ellington Management Group, L.L.C. ("Ellington"), an investment management firm that is registered as both an investment adviser and a commodity pool operator. In accordance with the terms of the Management Agreement, the Manager implements the investment strategy and manages the business and operations on a day-to-day basis for the Company and performs certain services for the Company, subject to oversight by the Board of Directors.

COVID-19 Impact

During the first quarter of 2020, there was a worldwide outbreak of a novel coronavirus disease, or "COVID-19." The outbreak was declared a pandemic by the World Health Organization and numerous countries, including the United States, have responded by instituting quarantines or lockdowns, imposing restrictions on travel, restrictions on the ability of individuals to assemble in groups, and restrictions on the ability of certain businesses to operate, all of which have resulted in significant disruptions in the U.S. and global economies. In mid-March 2020, adverse economic conditions related to the COVID-19 pandemic began to impact the Company's financial position and results of operations. The COVID-19 pandemic has contributed to volatility, dislocations in the financial markets, and illiquidity. As a result, during the first quarter of 2020 the Company received margin calls under its repurchase agreements that were higher than typical historical levels. During the remainder of 2020, prices for most credit assets, which are assets for which the principal and interest payments are not guaranteed by a U.S. government agency or a U.S. government-sponsored entity, stabilized, and market volatility subsided, and as a result our margin calls reverted to more typical levels. We satisfied all margin calls during the year ended December 31, 2020.

Actions by the U.S. Federal Reserve starting in the second half of March 2020 helped stabilize the market for certain assets, including RMBS for which the principal and interest payments are guaranteed by a U.S. government agency or a U.S. government-sponsored entity, or "Agency RMBS," and investment-grade corporate bonds, while other sectors, including non-investment-grade CMBS and CLOs, noticeably lagged. In light of the heightened levels of market volatility and systemic liquidity risk experienced during the first quarter of 2020, the Company proactively reduced the size of its Agency RMBS

114

Table of Contents

portfolio, thereby bolstering its liquidity and lowering its leverage, and it maintained a smaller Agency RMBS portfolio through the rest of 2020. Beginning in the second quarter, the Company resumed making new credit and Agency RMBS investments, but continued to maintain a higher cash balance and lower debt-to-equity ratio than prior to the outbreak of COVID-19.

The Company's management team implemented business continuity plans, and the Company, the Manager, and Ellington continue to be fully operational in a largely work-from-home environment.

2. Significant Accounting Policies

(A) Basis of Presentation: The Company's consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, or "U.S. GAAP," and Regulation S-X. The consolidated financial statements include the accounts of the Company, the Operating Partnership, its subsidiaries, and variable interest entities, or "VIEs," for which the Company is deemed to be the primary beneficiary. All intercompany balances and transactions have been eliminated. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and those differences could be material (particularly in light of the significant volatility, lack of pricing transparency, and market dislocations that have been caused by the COVID-19 pandemic, and associated responses to the pandemic). In management's opinion, all material adjustments considered necessary for a fair statement of the Company's consolidated financial statements have been included and are only of a normal recurring nature.

The Company adopted ASC 946, Financial Services—Investment Companies ("ASC 946") upon its commencement of operations in August 2007, and applied U.S. GAAP for investment companies. In connection with the Company's internal restructuring and the Company's intention to qualify as a REIT for the year ended December 31, 2019, the Company determined that, effective January 1, 2019, it no longer qualified for investment company accounting in accordance with ASC 946-10-25, and has prospectively discontinued its use. The Company elected the fair value option, or "FVO," for, and therefore the Company continued to measure at fair value, those of its assets and liabilities it had previously measured at fair value and for which such election is permitted, as provided for under ASC 825, Financial Instruments ("ASC 825"). Due to the prospective application of a change in accounting as required under ASC 946-10-25-2, the Company determined that the presentation of its consolidated financial statements for periods beginning after December 31, 2018 are not comparable to the consolidated financial statements previously prepared for prior periods for which the Company applied ASC 946. As a result, the Company has provided separate consolidated financial statements for applicable prior periods in Item 8 of this Annual Report on Form 10-K.

Reclassification and Presentation

Effective January 1, 2019, the Company prospectively discontinued its application of ASC 946. Upon its change in status, the following significant changes and elections were made:

•Investments in securities are now accounted for in accordance with ASC 320, Investments—Debt and Equity Securities ("ASC 320");

•The Company elected the FVO as provided for under ASC 825-10-25-4 for all eligible financial instruments for which the Company had previously measured at fair value, including investments in securities, loans, financial derivatives, and certain of the Company's secured borrowings. As a result, all changes in the fair value of such financial instruments will continue to be recorded in earnings on the Company's Consolidated Statement of Operations;

•Real estate owned, or "REO," is not eligible for the FVO election. As a result, REO is carried at the lower of cost or fair value. The Company's cost basis in any REO that was previously measured at fair value under ASC 946 was adjusted on January 1, 2019 to equal the fair value of such investment as of December 31, 2018;

•The Company elected not to designate its financial derivatives as hedging instruments in accordance with ASC 815, Derivatives and Hedging ("ASC 815"). As a result, all changes in the fair value of financial derivatives will continue to be recorded in earnings on the Company's Consolidated Statement of Operations;

•Forward settling to-be-announced mortgage-backed-securities, or "TBAs," are no longer classified as investments. TBAs will be classified as financial derivatives, with the difference between the forward contract price and the market value of the TBA position as of the reporting date included in Unrealized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations; and

•The Company is required to account for certain of its equity investments under ASC 323-10, Investments—Equity Method and Joint Ventures ("ASC 323-10"). The Company has elected the FVO for such equity investments and changes in fair value will be reported in Earnings (losses) from investments in unconsolidated entities, on the Consolidated Statement of Operations.

115

Table of Contents

The discontinuation of the Company's application of ASC 946 prospectively changed the presentation of the Company's consolidated financial statements. The most significant changes were:

•The Consolidated Statement of Assets, Liabilities, and Equity has been changed to a Consolidated Balance Sheet;

•The Consolidated Condensed Schedule of Investments has been removed;

•The Consolidated Statement of Operations is no longer presented in the format required under ASC 946. The Company will present the Consolidated Statement of Operations as required under U.S. GAAP for operating companies. A Consolidated Statement of Other Comprehensive Income (Loss) will be presented, if and when applicable;

•The Consolidated Statement of Cash Flows has been changed, and now includes a section for investing activities;

•Certain footnotes have been changed to reflect conformity with applicable U.S. GAAP for operating companies;

•The Company re-evaluated its interests in all entities to determine whether they are variable interests, and re-evaluated its investments, including it investments in partially owned entities, to determine if they are VIEs, as required under ASC 810, Consolidation ("ASC 810"). The Company also re-evaluated consolidation considerations for all of its investments in VIEs and partially owned entities, as required under ASC 810. Applicable disclosures related to VIEs have been included in these notes to consolidated financial statements;

•Securities/loans sold under agreements to be repurchased at an agreed-upon price and date, which were formerly referred to as "reverse repurchase agreements," are now referred to as "repurchase agreements";

•Securities/loans purchased under agreements to resell at an agreed-upon price and date, which were formerly referred to as "repurchase agreements," are now referred to as "reverse repurchase agreements"; and

•The financial highlights disclosures, which are not required under U.S. GAAP for operating companies, have been removed.

(B) Valuation: The Company applies ASC 820-10, Fair Value Measurement ("ASC 820") to its holdings of financial instruments. ASC 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:

•Level 1—inputs to the valuation methodology are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Currently, the types of financial instruments the Company generally includes in this category are listed equities and exchange-traded derivatives;

•Level 2—inputs to the valuation methodology other than quoted prices included in Level 1 are observable for the asset or liability, either directly or indirectly. Currently, the types of financial instruments that the Company generally includes in this category are Agency RMBS, U.S. Treasury securities and sovereign debt, certain non-Agency RMBS, CMBS, CLOs, corporate debt, and actively traded derivatives such as interest rate swaps, foreign currency forwards, and other over-the-counter derivatives; and

•Level 3—inputs to the valuation methodology are unobservable and significant to the fair value measurement. The types of financial instruments that the Company generally includes in this category are certain RMBS, CMBS, CLOs, ABS, credit default swaps, or "CDS," on individual ABS, and total return swaps on distressed corporate debt, in each case where there is less price transparency. Also included in this category are residential and commercial mortgage loans, consumer loans, and private corporate debt and equity investments.

For certain financial instruments, the various inputs that management uses to measure fair value may fall into different levels of the fair value hierarchy. For each such financial instrument, the determination of which category within the fair value hierarchy is appropriate is based on the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the various inputs that management uses to measure fair value, with the highest priority given to inputs that are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets (Level 1), and the lowest priority given to inputs that are unobservable and significant to the fair value measurement (Level 3). The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. The Company may use valuation techniques consistent with the market and income approaches to measure the fair value of its financial instruments. The market approach uses third-party valuations and information obtained from market transactions involving identical or similar financial instruments. The income approach uses projections of the future economic benefit of an instrument to determine its fair value, such as in the discounted cash flow methodology. The inputs or methodology used for valuing financial instruments are not necessarily an indication of the risk associated with investing in these financial instruments. The leveling of each financial instrument is reassessed at the end of each period. Transfers between levels of the fair value hierarchy are assumed to occur at the end of the reporting period.

116

Table of Contents

Summary Valuation Techniques

For financial instruments that are traded in an "active market," the best measure of fair value is the quoted market price. However, many of the Company's financial instruments are not traded in an active market. Therefore, management generally uses third-party valuations when available. If third-party valuations are not available, management uses other valuation techniques, such as the discounted cash flow methodology. The following are summary descriptions, for various categories of financial instruments, of the valuation methodologies management uses in determining fair value of the Company's financial instruments in such categories. Management utilizes such methodologies to assign a fair value (the estimated price that, in an orderly transaction at the valuation date, would be received to sell an asset, or paid to transfer a liability, as the case may be) to each such financial instrument.

For mortgage-backed securities, or "MBS," TBAs, CLOs, and corporate debt and equity, management seeks to obtain at least one third-party valuation, and often obtains multiple valuations when available. Management has been able to obtain third-party valuations on the vast majority of these instruments and expects to continue to solicit third-party valuations in the future. Management generally values each financial instrument at the average of third-party valuations received and not rejected as described below. Third-party valuations are not binding, management may adjust the valuations it receives (e.g., downward adjustments for odd lots), and management may challenge or reject a valuation when, based on its validation criteria, management determines that such valuation is unreasonable or erroneous. Furthermore, based on its validation criteria, management may determine that the average of the third-party valuations received for a given financial instrument does not result in what management believes to be the fair value of such instrument, and in such circumstances management may override this average with its own good faith valuation. The validation criteria may take into account output from management's own models, recent trading activity in the same or similar instruments, and valuations received from third parties. The use of proprietary models requires the use of a significant amount of judgment and the application of various assumptions including, but not limited to, assumptions concerning future prepayment rates and default rates. Given their relatively high level of price transparency, Agency RMBS pass-throughs are typically classified as Level 2. Non-Agency RMBS, CMBS, Agency interest only and inverse interest only RMBS, CLOs, and corporate bonds are generally classified as either Level 2 or Level 3 based on analysis of available market data and/or third-party valuations. The Company's investments in distressed corporate debt can be in the form of loans as well as total return swaps on loans. These investments, as well as related non-listed equity investments, are generally designated as Level 3 assets. Valuations for total return swaps are typically based on prices of the underlying loans received from third-party pricing services. Private equity investments are generally classified as Level 3. Furthermore, the methodology used by the third-party valuation providers is reviewed at least annually by management, so as to ascertain whether such providers are utilizing observable market data to determine the valuations that they provide.

For residential and commercial mortgage loans and consumer loans, management determines fair value by taking into account both external pricing data, which includes third-party valuations, and internal pricing models. Management has obtained third-party valuations on the majority of these investments and expects to continue to solicit third-party valuations in the future. In determining fair value for non-performing mortgage loans, management evaluates third-party valuations, if applicable, as well as management's estimates of the value of the underlying real estate, using information including general economic data, broker price opinions, or "BPOs," recent sales, property appraisals, and bids. In determining fair value for performing mortgage loans and consumer loans, management evaluates third-party valuations, if applicable, as well as discounted cash flows of the loans based on market assumptions. Cash flow assumptions typically include projected default and prepayment rates and loss severities, and may include adjustments based on appraisals and BPOs. Mortgage and consumer loans are classified as Level 3.

The Company has securitized certain mortgage loans that are not deemed "qualified mortgage," or "QM," loans under the rules of the Consumer Financial Protection Bureau, or "non-QM loans." The Company's securitized non-QM loans are held as part of a collateralized financing entity, or "CFE." A CFE is a VIE that holds financial assets, issues beneficial interests in those assets, and has no more than nominal equity, and for which the issued beneficial interests have contractual recourse only to the related assets of the CFE. ASC 810 allows the Company to elect to measure both the financial assets and financial liabilities of the CFE using the more observable of the fair value of the financial assets and the fair value of the financial liabilities of the CFE. The Company has elected the FVO for initial and subsequent recognition of the debt issued by its consolidated securitization trusts and has determined that each consolidated securitization trust meets the definition of a CFE; see Note 10 "Securitization Transactions—Residential Mortgage Loan Securitizations" for further discussion on the Company's securitization trusts. The Company has determined the inputs to the fair value measurement of the financial liabilities of each of its CFEs to be more observable than those of the financial assets and, as a result, has used the fair value of the financial liabilities of each of the CFEs to measure the fair value of the financial assets of each of the CFEs. The fair value of the debt issued by each CFE is typically valued using both external pricing data, which includes third-party valuations, and internal pricing models. The securitized non-QM loans, which are assets of the CFEs, are included in Loans, at fair value, on the Company's Consolidated Balance Sheet. The debt issued by the CFEs is included in Other secured borrowings, at fair value, on the Company's Consolidated Balance Sheet. Unrealized gains (losses) from changes in fair value of Other secured borrowings,

117

Table of Contents

at fair value, are included in Other, net, on the Company's Consolidated Statement of Operations. The securitized non-QM loans and the debt issued by the Company's CFEs are both classified as Level 3.

For financial derivatives with greater price transparency, such as CDS on asset-backed indices, CDS on corporate indices, certain options on the foregoing, and total return swaps on publicly traded equities or indices, market-standard pricing sources are used to obtain valuations; these financial derivatives are generally classified as Level 2. Interest rate swaps, swaptions, and foreign currency forwards are typically valued based on internal models that use observable market data, including applicable interest rates and foreign currency rates in effect as of the measurement date; the model-generated valuations are then typically compared to counterparty valuations for reasonableness. These financial derivatives are also generally classified as Level 2. Financial derivatives with less price transparency, such as CDS on individual ABS, are generally valued based on internal models, and are classified as Level 3. In the case of CDS on individual ABS, the valuation process typically starts with an estimation of the value of the underlying ABS. In valuing its financial derivatives, the Company also considers the creditworthiness of both the Company and its counterparties, along with collateral provisions contained in each financial derivative agreement.

Investments in private operating entities, such as loan originators, are valued based on available metrics, such as relevant market multiples and comparable company valuations, company specific-financial data including actual and projected results, and independent third party valuation estimates. These investments are classified as Level 3.

The Company's repurchase and reverse repurchase agreements are carried at cost, which approximates fair value. Repurchase and reverse repurchase agreements are classified as Level 2, based on the adequacy of the collateral and their short term nature.

The Company's valuation process, including the application of validation criteria, is directed by the Manager's Valuation Committee (the "Valuation Committee"), and overseen by the Company's audit committee. The Valuation Committee includes senior level executives from various departments within the Manager, and each quarter, the Valuation Committee reviews and approves the valuations of the Company's financial instruments. The valuation process also includes a monthly review by the Company's third-party administrator. The goal of this review is to replicate various aspects of the Company's valuation process based on the Company's documented procedures.

Because of the inherent uncertainty of valuation, the estimated fair value of the Company's financial instruments may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to the Company's consolidated financial statements.

(C) Accounting for Securities: Purchases and sales of investments in securities are generally recorded on trade date, and realized and unrealized gains and losses are calculated based on identified cost. Investments in securities are recorded in accordance with ASC 320 or ASC 325-40, Beneficial Interests in Securitized Financial Assets ("ASC 325-40"). The Company generally classifies its securities as available-for-sale. The Company has chosen to elect the FVO pursuant to ASC 825 for its investments in securities. Electing the FVO allows the Company to record changes in fair value in the Consolidated Statement of Operations, as a component of Unrealized gains (losses) on securities and loans, net, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all investment activities will be recorded in a similar manner.

Many of the Company's investments in securities, such as MBS and CLOs, are issued by entities that are deemed to be VIEs. For the majority of such investments, the Company has determined it is not the primary beneficiary of such VIEs and therefore has not consolidated such VIEs. The Company's maximum risk of loss in these unconsolidated VIEs is generally limited to the fair value of the Company's investment in the VIE.

The Company evaluates its investments in interest only securities to determine whether they meet the requirements for classification as financial derivatives under ASC 815. For interest only securities, where the holder is entitled only to a portion of the interest payments made on the mortgages underlying certain MBS, and inverse interest only securities, which are interest only securities whose coupon has an inverse relationship to its benchmark rate, such as LIBOR, the Company has determined that such investments do not meet the requirements for treatment as financial derivatives and are classified as securities.

Periods after January 1, 2020—For periods subsequent to the Company's application of the principles of ASU 2016-13, Financial Instruments—Credit Losses ("ASU 2016-13"), as discussed below, the Company evaluates the cost basis of its investments in securities on at least a quarterly basis, under ASC 326-30, Financial Instruments—Credit Losses: Available-for-Sale Debt Securities ("ASC 326-30"). When the fair value of a security is less than its amortized cost basis as of the balance sheet date, the security's cost basis is considered impaired. The Company must evaluate the decline in the fair value of the impaired security and determine whether such decline resulted from a credit loss or non-credit related factors. In its assessment of whether a credit loss exists, the Company compares the present value of estimated future cash flows of the impaired security

118

Table of Contents

with the amortized cost basis of such security. The estimated future cash flows reflect those that a "market participant" would use and typically include assumptions related to fluctuations in interest rates, prepayment speeds, default rates, collateral performance, and the timing and amount of projected credit losses, as well incorporating observations of current market developments and events. Cash flows are discounted at an interest rate equal to the current yield used to accrete interest income. If the present value of estimated future cash flows is less than the amortized cost basis of the security, an expected credit loss exists and is included in Unrealized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations. If it is determined as of the financial reporting date that all or a portion of a security's cost basis is not collectible, then the Company will recognize a realized loss to the extent of the adjustment to the security's cost basis. This adjustment to the amortized cost basis of the security is reflected in Net realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

Periods prior to January 1, 2020—For periods prior to the Company's adoption of ASU 2016-13, the Company evaluated the cost basis of its investments in securities for other-than-temporary impairment, or "OTTI," on at least a quarterly basis.

When the fair value of a security was less than its amortized cost basis as of the balance sheet date, the security's cost basis was considered impaired, and the impairment was designated as either temporary or other-than-temporary. When a security's cost basis was impaired, an OTTI was considered to have occurred if (i) the Company intended to sell the security, (ii) it was more likely than not that the Company would have been required to sell the security before recovery of its amortized cost basis, or (iii) the Company did not expect to recover the security's amortized cost basis, even if the Company did not intend to sell the security and it was not more likely than not that the Company would have been required to sell the security. Additionally, for securities accounted for under ASC 325-40, an impairment of the cost basis was recorded when there was an adverse change in the expected cash flows to be received and the fair value of the security was less than its carrying amount. Any resulting OTTI adjustments made to the cost basis of the security were reflected in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

(D) Accounting for Loans: The Company's loan portfolio primarily consists of residential mortgage, commercial mortgage, and consumer loans. The Company's loans are accounted for under ASC 310-10, Receivables, and are classified as held-for-investment when the Company has the intent and ability to hold such loans for the foreseeable future or to maturity/payoff. When the Company has the intent to sell loans, such loans will be classified as held-for-sale. Mortgage loans held-for-sale are accounted for under ASC 948-310, Financial services—mortgage banking. The Company may aggregate its loans into pools based on common risk characteristics at purchase. The Company has chosen to elect the FVO pursuant to ASC 825 for its loan portfolios. Loans are recorded at fair value on the Consolidated Balance Sheet and changes in fair value are recorded in earnings on the Consolidated Statement of Operations as a component of Unrealized gains (losses) on securities and loans, net. The Company generates income from fees on certain loans, generally commercial mortgage loans, that it originates and holds for investment, including origination and exit fees. Such fee income is recorded when earned and included in Other, net on the Consolidated Statement of Operations. Transfers between held-for-investment and held-for-sale occur once the Company's intent to sell the loans changes.

For residential and commercial mortgage loans, the Company generally accrues interest payments. Such loans are typically moved to non-accrual status if the loan becomes 90 days or more delinquent. The Company does not accrue interest payments on its consumer loans; interest payments are recorded upon receipt. Once consumer loans are more than 120 days past due, the Company will generally charge off such loans. The Company evaluates its charged-off loans and determines collectibility, if any, on such loans.

The Company evaluates the collectibility of both interest and principal on each of its loan investments and whether the cost basis of the loan is impaired. A loan's cost basis is impaired when, based on current information and market developments, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. When a loan's cost basis is impaired, the Company does not record an allowance for loan loss as it elected the FVO on all of its loan investments.

Periods after January 1, 2020—For periods subsequent to the Company's application of the principles of ASU 2016-13, in its assessment of whether a credit loss exists, the Company compares the present value of the amount expected to be collected on the impaired loan with the amortized cost basis of such loan. If the present value of the amount expected to be collected on the impaired loan is less than the amortized cost basis of such loan, an expected credit loss exists and is included in Unrealized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations. If it is determined as of the financial reporting date that all or a portion of a loan's cost basis is not collectible, then the Company will recognize a realized loss to the extent of the adjustment to the loan's cost basis. This adjustment to the amortized cost basis of the loan is reflected in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

119

Table of Contents

Periods prior to January 1, 2020—For periods prior to the Company's application of the principles of ASU 2016-13, the Company recognized impairments through an adjustment to the amortized cost basis; the Company recognized a realized loss in the period such adjustment was made, which is included in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

(E) Interest Income: The Company amortizes premiums and accretes discounts on its debt securities. Coupon interest income on fixed-income investments is generally accrued based on the outstanding principal balance or notional value and the current coupon rate.

For debt securities that are deemed to be of high credit quality at the time of purchase (generally Agency RMBS, exclusive of interest only securities), premiums and discounts are amortized/accreted into interest income over the life of such securities using the effective interest method. For such securities whose cash flows vary depending on prepayments, an effective yield retroactive to the time of purchase is periodically recomputed based on actual prepayments and changes in projected prepayment activity, and a catch-up adjustment, or "Catch-up Premium Amortization Adjustment," is made to amortization to reflect the cumulative impact of the change in effective yield.

For debt securities (generally non-Agency RMBS, CMBS, ABS, CLOs, and interest only securities) that are deemed not to be of high credit quality at the time of purchase, interest income is recognized based on the effective interest method. For purposes of estimating future expected cash flows, management uses assumptions including, but not limited to, assumptions for future prepayment rates, default rates, and loss severities (each of which may in turn incorporate various macro-economic assumptions, such as future housing prices, GDP growth rates, and unemployment rates). These assumptions are re-evaluated not less than quarterly. Changes in projected cash flows may result in prospective changes in the yield/interest income recognized on such securities based on the updated expected future cash flows.

For each loan purchased with the expectation that both interest and principal will be paid in full, the Company generally amortizes or accretes any premium or discount over the life of the loan utilizing the effective interest method. However, based on current information and market developments, the Company re-assesses the collectibility of interest and principal, and generally designates a loan as in non-accrual status either when any payments have become 90 or more days past due, or when, in the opinion of management, it is probable that the Company will be unable to collect either interest or principal in full. Once a loan is designated as in non-accrual status, as long as principal is still expected to be collectible in full, interest payments are recorded as interest income only when received (i.e., under the cash basis method); accruals of interest income are only resumed when the loan becomes contractually current and performance is demonstrated to be resumed. However, if principal is not expected to be collectible in full, the cost recovery method is used (i.e., no interest income is recognized, and all payments received—whether contractually interest or principal—are applied to cost).

Periods after January 1, 2020—Certain of the Company's debt securities and loans, at the date of acquisition, have experienced or are expected to experience more-than-insignificant deterioration in credit quality since origination. For periods subsequent to the Company's application of the principles of ASU 2016-13, if at the date of acquisition for a particular asset the Company projects a significant difference between contractual cash flows and expected cash flows, it establishes an initial estimate for credit losses as an upward adjustment to the acquisition cost of the asset for the purpose of calculating interest income using the effective yield method.

Periods prior to January 1, 2020—Prior to the Company's application of the principles of ASU 2016-13, for each loan acquired that had evidence of credit deterioration since origination and the expectation that either principal or interest would not be paid in full, interest income was generally recognized using the effective interest method for so long as the cash flows could be reasonably estimated. Here, instead of amortizing the purchase discount (i.e., the excess of the unpaid principal balance over the purchase price) over the life of the loan, the Company effectively amortized the accretable yield (i.e., the excess of the Company's estimate of the total cash flows to be collected over the life of the loan over the purchase price). Not less than quarterly, the Company updated its estimate of the cash flows expected to be collected over the life of the loan, and applied revised yields prospectively.

In estimating future cash flows on the Company's debt securities, there are a number of assumptions that are subject to significant uncertainties and contingencies, including, in the case of MBS, assumptions relating to prepayment rates, default rates, loan loss severities, and loan repurchases. These estimates require the use of a significant amount of judgment.

(F) Investments in unconsolidated entities: The Company has made and may in the future make non-controlling equity investments in various entities, such as loan originators. Such investments are generally in the form of preferred and/or common equity, or membership interests. In certain cases, the Company can exercise significant influence over the entity (e.g. by having representation on the entity's board of directors) but the requirements for consolidation under ASC 810 are not met; in such cases the Company is required to account for such equity investments under ASC 323-10. The Company has chosen to elect the FVO pursuant to ASC 825 for its investments in unconsolidated entities, which, in management's view, more appropriately

120

Table of Contents

reflects the results of operations for a particular reporting period, as all investment activities will be recorded in a similar manner. The period change in fair value of the Company's investments in unconsolidated entities is recorded on the Consolidated Statement of Operations in Earnings (losses) from investments in unconsolidated entities.

(G) REO: When the Company obtains possession of real property in connection with a foreclosure or similar action, the Company de-recognizes the associated mortgage loan according to ASU 2014-04, Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure ("ASU 2014-04"). Under the provisions of ASU 2014-04, the Company is deemed to have received physical possession of real estate property collateralizing a mortgage loan when it obtains legal title to the property upon completion of a foreclosure or when the borrower conveys all interest in the property to it through a deed in lieu of foreclosure or similar legal agreement. The Company's initial cost basis in REO is equal to the fair value of the real estate associated with the foreclosed mortgage loan, less expected costs to sell. REO valuations are reflected at the lower of cost or fair value. The fair value of such REO is typically based on management's estimates which generally use information including general economic data, BPOs, recent sales, property appraisals, and bids, and takes into account the expected costs to sell the property. REO recorded at fair value on a non-recurring basis are classified as Level 3.

(H) Securities Sold Short: The Company may purchase or engage in short sales of U.S. Treasury securities and sovereign debt to mitigate the potential impact of changes in interest rates and/or foreign exchange rates on the performance of its portfolio. When the Company sells securities short, it typically satisfies its security delivery settlement obligation by borrowing or purchasing the security sold short from the same or a different counterparty. When borrowing a security sold short from a counterparty, the Company generally is required to deliver cash or securities to such counterparty as collateral for the Company's obligation to return the borrowed security. The Company has chosen to elect the FVO pursuant to ASC 825 for its securities sold short. Electing the FVO allows the Company to record changes in fair value in the Consolidated Statement of Operations, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all securities activities will be recorded in a similar manner. As such, securities sold short are recorded at fair value on the Consolidated Balance Sheet and the period change in fair value is recorded in current period earnings on the Consolidated Statement of Operations as a component of Unrealized gains (losses) on securities and loans, net. A realized gain or loss will be recognized upon the termination of a short sale if the market price is less or greater than the original sale price. Such realized gain or loss is recorded on the Company's Consolidated Statement of Operations in Realized gains (losses) on securities and loans, net.

(I) Financial Derivatives: The Company enters into various types of financial derivatives subject to its investment guidelines, which include restrictions associated with maintaining qualification as a REIT. The Company's financial derivatives are predominantly subject to bilateral collateral arrangements or clearing in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the "Dodd-Frank Act." The Company may be required to deliver or receive cash or securities as collateral upon entering into derivative transactions. In addition, changes in the value of derivative transactions may require the Company or the counterparty to post or receive additional collateral. In the case of cleared derivatives, the clearinghouse becomes the Company's counterparty and a futures commission merchant acts as an intermediary between the Company and the clearinghouse with respect to all facets of the related transaction, including the posting and receipt of required collateral. Cash collateral received by the Company is included in Due to brokers, on the Consolidated Balance Sheet. Conversely, cash collateral posted by the Company is included in Due from brokers, on the Consolidated Balance Sheet. The types of derivatives primarily utilized by the Company are swaps, TBAs, futures, options, and forwards.

Swaps: The Company may enter into various types of swaps, including interest rate swaps, credit default swaps, and total return swaps. The primary risk associated with the Company's interest rate swap activity is interest rate risk. The primary risk associated with the Company's credit default swaps and total return swaps is credit risk.

The Company is subject to interest rate risk exposure in the normal course of pursuing its investment objectives. Primarily to help mitigate interest rate risk, the Company enters into interest rate swaps. Interest rate swaps are contractual agreements whereby one party pays a floating interest rate on a notional principal amount and receives a fixed-rate payment on the same notional principal, or vice versa, for a fixed period of time. Interest rate swaps change in value with movements in interest rates. The Company also enters into interest rate swaps whereby the Company pays one floating rate and receives a different floating rate, or "basis swaps."

The Company enters into credit default swaps. A credit default swap is a contract under which one party agrees to compensate another party for the financial loss associated with the occurrence of a "credit event" in relation to a "reference amount" or notional value of a "reference asset" (usually a bond, loan, or an index or basket of bonds or loans). The definition of a credit event may vary from contract to contract. A credit event may occur (i) when the reference asset (or underlying asset, in the case of a reference asset that is an index or basket) fails to make scheduled principal or interest payments to its holders, (ii) with respect to credit default swaps referencing mortgage/asset-backed securities and indices, when the reference asset (or underlying asset, in the case of a reference asset that is an index or basket) is downgraded below a certain rating level, or

121

Table of Contents

(iii) with respect to credit default swaps referencing corporate entities and indices, upon the bankruptcy of the obligor of the reference asset (or underlying obligor, in the case of a reference asset that is an index). The Company typically writes (sells) protection to take a "long" position with respect to the underlying reference assets, or purchases (buys) protection to take a "short" position with respect to the underlying reference assets or to hedge exposure to other investment holdings.

The Company enters into total return swaps in order to take a "long" or "short" position with respect to an underlying reference asset. The Company is subject to market price volatility of the underlying reference asset. A total return swap involves commitments to pay interest in exchange for a market-linked return based on a notional value. To the extent that the total return of the corporate debt, security, group of securities or index underlying the transaction exceeds or falls short of the offsetting interest obligation, the Company will receive a payment from or make a payment to the counterparty.

Swaps change in value with movements in interest rates, credit quality, or total return of the reference securities. During the term of swap contracts, changes in value are recognized as unrealized gains or losses on the Consolidated Statement of Operations. When a contract is terminated, the Company realizes a gain or loss equal to the difference between the proceeds from (or cost of) the closing transaction and the Company's basis in the contract, if any. Periodic payments or receipts required by swap agreements are recorded as unrealized gains or losses when accrued and realized gains or losses when received or paid. Upfront payments paid and/or received by the Company to open swap contracts are recorded as an asset and/or liability on the Consolidated Balance Sheet and are recorded as a realized gain or loss on the termination date.

TBA Securities: The Company transacts in the forward settling TBA market. A TBA position is a forward contract for the purchase ("long position") or sale ("short position") of Agency RMBS at a predetermined price, face amount, issuer, coupon, and maturity on an agreed-upon future delivery date. For each TBA contract and delivery month, a uniform settlement date for all market participants is determined by the Securities Industry and Financial Markets Association. The specific Agency RMBS to be delivered into the contract at the settlement date are not known at the time of the transaction. The Company typically does not take delivery of TBAs, but rather enters into offsetting transactions and settles the associated receivable and payable balances with its counterparties. The Company uses TBAs to mitigate interest rate risk, usually by taking short positions. The Company also invests in TBAs as a means of acquiring additional exposure to Agency RMBS, or for speculative purposes, including holding long positions.

TBAs are accounted for by the Company as financial derivatives. The difference between the forward contract price and the market value of the TBA position as of the reporting date is included in Unrealized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations.

Futures Contracts: A futures contract is an exchange-traded agreement to buy or sell an asset for a set price on a future date. The Company enters into Eurodollar and/or U.S. Treasury security futures contracts to hedge its interest rate risk. The Company may also enter into various other futures contracts, including equity index futures and foreign currency futures. Initial margin deposits are made upon entering into futures contracts and can generally be either in the form of cash or securities. During the period the futures contract is open, changes in the value of the contract are recognized as unrealized gains or losses by marking-to-market to reflect the current market value of the contract. Variation margin payments are made or received periodically, depending upon whether unrealized losses or gains are incurred. When the contract is closed, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Options: The Company may purchase or write put or call options contracts or enter into swaptions. The Company enters into options contracts typically to help mitigate overall market, credit, or interest rate risk depending on the type of options contract. However, the Company also enters into options contracts from time to time for speculative purposes. When the Company purchases an options contract, the option asset is initially recorded at an amount equal to the premium paid, if any, and is subsequently marked-to-market. Premiums paid for purchasing options contracts that expire unexercised are recognized on the expiration date as realized losses. If an options contract is exercised, the premium paid is subtracted from the proceeds of the sale or added to the cost of the purchase to determine whether the Company has realized a gain or loss on the related transaction. When the Company writes an options contract, the option liability is initially recorded at an amount equal to the premium received, if any, and is subsequently marked-to-market. Premiums received for writing options contracts that expire unexercised are recognized on the expiration date as realized gains. If an options contract is exercised, the premium received is subtracted from the cost of the purchase or added to the proceeds of the sale to determine whether the Company has realized a gain or loss on the related investment transaction. When the Company enters into a closing transaction, the Company will realize a gain or loss depending upon whether the amount from the closing transaction is greater or less than the premiums paid or received. The Company may also enter into options contracts that contain forward-settling premiums. In this case, no money is exchanged upfront. Instead, the agreed-upon premium is paid by the buyer upon expiration of the option, regardless of whether or not the option is exercised.

122

Table of Contents

Forward Currency Contracts: A forward currency contract is an agreement between two parties to purchase or sell a specific quantity of currency with the delivery and settlement at a specific future date and exchange rate. During the period the forward currency contract is open, changes in the value of the contract are recognized as unrealized gains or losses. When the contract is settled, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Financial derivative assets are included in Financial derivatives—assets, at fair value, on the Consolidated Balance Sheet. Financial derivative liabilities are included in Financial derivatives—liabilities, at fair value, on the Consolidated Balance Sheet. The Company has chosen to elect the FVO pursuant to ASC 825 for its financial derivatives. Electing the FVO allows the Company to record changes in fair value in the Consolidated Statement of Operations, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all securities activities will be recorded in a similar manner. Changes in unrealized gains and losses on financial derivatives are included in Unrealized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations. Realized gains and losses on financial derivatives are included in Realized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations.

(J) Cash and Cash Equivalents: Cash and cash equivalents include cash and short term investments with original maturities of three months or less at the date of acquisition. Cash and cash equivalents typically include amounts held in interest bearing overnight accounts and amounts held in money market funds, and these balances generally exceed insured limits. The Company holds its cash at institutions that it believes to be highly creditworthy. Restricted cash represents cash that the Company can use only for specific purposes. See Note 18 for further discussion of restricted cash balances.

(K) Repurchase Agreements: The Company enters into repurchase agreements with third-party broker-dealers whereby it sells securities under agreements to be repurchased at an agreed-upon price and date. The Company accounts for repurchase agreements as collateralized borrowings, with the initial sale price representing the amount borrowed, and with the future repurchase price consisting of the amount borrowed plus interest, at the implied interest rate of the repurchase agreement, on the amount borrowed over the term of the repurchase agreement. The interest rate on a repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. When the Company enters into a repurchase agreement, the lender establishes and maintains an account containing cash and/or securities having a value not less than the repurchase price, including accrued interest, of the repurchase agreement. Repurchase agreements are carried at their contractual amounts, which approximate fair value as the debt is short-term in nature.

(L) Reverse Repurchase Agreements: The Company enters into reverse repurchase agreement transactions whereby it purchases securities under agreements to resell at an agreed-upon price and date. In general, securities received pursuant to reverse repurchase agreements are delivered to counterparties of short sale transactions. The interest rate on a reverse repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. Assets held pursuant to reverse repurchase agreements are reflected as assets on the Consolidated Balance Sheet. Reverse repurchase agreements are carried at their contractual amounts, which approximates fair value due to their short-term nature.

Repurchase and reverse repurchase agreements that are conducted with the same counterparty may be reported on a net basis if they meet the requirements of ASC 210-20, Balance Sheet Offsetting. There are no repurchase and reverse repurchase agreements reported on a net basis in the Company's consolidated financial statements.

(M) Transfers of Financial Assets: The Company enters into transactions whereby it transfers financial assets to third parties. Upon such a transfer of financial assets, the Company will sometimes retain or acquire interests in the related assets. The Company evaluates transferred assets pursuant to ASC 860-10, Transfers of Financial Assets, or "ASC 860-10," which requires that a determination be made as to whether a transferor has surrendered control over transferred financial assets. That determination must consider the transferor's continuing involvement in the transferred financial asset, including all arrangements or agreements made contemporaneously with, or in contemplation of, the transfer, even if they were not entered into at the time of the transfer. When a transfer of financial assets does not qualify as a sale, ASC 860-10 requires the transfer to be accounted for as a secured borrowing with a pledge of collateral. ASC 860-10 is a standard that requires the Company to exercise significant judgment in determining whether a transaction should be recorded as a "sale" or a "financing."

(N) Variable Interest Entities: VIEs are entities in which: (i) the equity investors do not have the characteristics of a controlling financial interest, or (ii) there is insufficient equity to permit the entity to finance its activities without additional subordinated financial support from other parties. Consolidation of a VIE is required by the entity that is deemed to be the primary beneficiary of the VIE. The Company evaluates all of its interests in VIEs for consolidation under ASC 810. The primary beneficiary is generally the party with both (i) the power to direct the activities of the VIE that most significantly

123

Table of Contents

impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant to the VIE.

When the Company has an interest in an entity that has been determined to be a VIE, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The Company will only consolidate a VIE for which it has concluded it is the primary beneficiary. To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE's economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes (i) identifying the activities that most significantly impact the VIE's economic performance; and (ii) identifying which party, if any, has power over those activities. To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, it considers all of its economic interests, including debt and/or equity investments, as well as other arrangements deemed to be variable interests in the VIE. These assessments to determine whether the Company is the primary beneficiary require significant judgment. In instances where the Company and its related parties have interests in a VIE, the Company considers whether there is a single party in the related party group that meets the criteria to be deemed the primary beneficiary. If one party within the related party group meets such criteria, that reporting entity would be deemed to be the primary beneficiary of the VIE and no further analysis is needed. If no party within the related party group on its own meets the criteria to be deemed the primary beneficiary, but the related party group as a whole meets such criteria, the determination of the primary beneficiary within the related party group requires significant judgment. The Company performs analysis, which is based upon qualitative as well as quantitative factors, such as the relationship of the VIE to each of the members of the related party group, as well as the significance of the VIE's activities to those members, with the objective of determining which party is most closely associated with the VIE.

The Company performs ongoing reassessments of (i) whether any entities previously evaluated have become VIEs, based on certain events, and therefore subject to assessment to determine whether consolidation is appropriate, and (ii) whether changes in the facts and circumstances regarding the Company's involvement with a VIE causes its consolidation conclusion regarding the VIE to change. See Note 9 and Note 13 for further information on the Company's consolidated VIEs.

The Company's maximum amount at risk is generally limited to the Company's investment in the VIE. The Company is generally not contractually required to provide and has not provided any form of financial support to the VIEs.

The Company holds beneficial interests in certain securitization trusts that are considered VIEs. The beneficial interests in these securitization trusts are represented by certificates issued by the trusts. The securitization trusts have been structured as pass-through entities that receive principal and interest payments on the underlying collateral and distribute those payments to the certificate holders, which include both third-party investors and the Company. The certificates held by the Company typically include some or all of the most subordinated tranches. The assets held by the trusts are restricted in that they can only be used to fulfill the obligations of the related trust. In certain cases, the design and structure of the securitization trust is such that the Company effectively retains control of the assets as well as the activities that most significantly impact the economic performance of the trust. In such cases, the Company is determined to be the primary beneficiary, and the Company consolidates the trust and all intercompany transactions are eliminated in consolidation. In cases where the Company does not effectively retain control of the assets of, or have the power to direct the activities that most significantly impact the economic performance of, the related trust, it does not consolidate the trust. See Note 10 for further discussion of the Company's securitization trusts.

(O) Offering Costs/Underwriters' Discount: Offering costs and underwriters' discount are generally charged against stockholders' equity upon the completion of a capital raise. Offering costs typically include legal, accounting, and other fees associated with the cost of raising capital.

(P) Debt Issuance Costs: Debt issuance costs associated with debt for which the Company has elected the FVO are expensed at the issuance of the debt, and are included in Investment related expenses—Other on the Consolidated Statement of Operations. Costs associated with the issuance of debt for which the Company has not elected the FVO are deferred and amortized over the life of the debt, which approximates the effective interest rate method, and are included in Interest expense on the Consolidated Statement of Operations. Deferred debt issuance costs are presented on the Consolidated Balance Sheet as a direct deduction from the related debt liability, unless such deferred debt issuance costs are associated with borrowing facilities that are expected to have a future benefit, such as giving the Company the ability to access additional borrowings over the contractual term of the debt, in which case such deferred debt issuance costs are included in Other assets on the Consolidated Balance Sheet. Debt issuance costs include legal and accounting fees, purchasers' or underwriters' discount, as well as other fees associated with the cost of the issuance of the related debt.

(Q) Expenses: Expenses are recognized as incurred on the Consolidated Statement of Operations.

124

Table of Contents

(R) Investment Related Expenses: Investment related expenses consist of expenses directly related to specific financial instruments. Such expenses generally include dividend expense on common stock sold short, servicing fees and corporate and escrow advances on mortgage and consumer loans, and various other expenses and fees related directly to the Company's financial instruments. The Company has elected the FVO for its investments, and as a result all investment related expenses are expensed as incurred and included in Investment related expenses on the Consolidated Statement of Operations.

(S) Investment Related Receivables: Investment related receivables on the Company's Consolidated Balance Sheet includes receivables for securities sold and interest and principal receivable on securities and loans.

(T) Long Term Incentive Plan Units: Long term incentive plan units of the Operating Partnership ("OP LTIP Units") have been issued to certain Ellington personnel dedicated or partially dedicated to the Company, certain of the Company's directors, as well as the Manager. Costs associated with OP LTIP Units issued to dedicated or partially dedicated personnel, or to the Company's directors, are measured as of the grant date based on the Company's closing stock price on the New York Stock Exchange and are amortized over the vesting period in accordance with ASC 718-10, Compensation—Stock Compensation. The vesting periods for OP LTIP Units are typically one year from issuance for non-executive directors, and are typically one year to two years from issuance for dedicated or partially dedicated personnel.

(U) Non-controlling interests: Non-controlling interests include interests in the Operating Partnership represented by units convertible into shares of the Company's common stock ("Convertible Non-controlling Interests"). Convertible Non-controlling Interests include both the OP LTIP Units and those common units ("OP Units") of the Operating Partnership not held by the Company (collectively, the "Convertible Non-controlling Interest Units"). Non-controlling interests also include the interests of joint venture partners in certain of our consolidated subsidiaries. The joint venture partners' interests are not convertible into shares of the Company's common stock. The Company adjusts the Convertible Non-controlling Interests to align their carrying value with their share of total outstanding Operating Partnership units, including both the OP Units held by the Company and the Convertible Non-controlling Interests. Any such adjustments are reflected in Adjustment to non-controlling interests, on the Consolidated Statement of Changes in Equity. See Note 15 for further discussion of non-controlling interests.

(V) Dividends: Dividends payable on shares of common stock and Convertible Non-controlling Interest Units are recorded on the declaration date.

(W) Shares Repurchased: Shares of common stock that are repurchased by the Company subsequent to issuance are immediately retired upon settlement and decrease the total number of shares of common stock issued and outstanding. The cost of such repurchases is charged against Additional paid-in-capital on the Company's Consolidated Balance Sheet.

(X) Earnings Per Share ("EPS"): Basic EPS is computed using the two class method by dividing net income (loss) after adjusting for the impact of Convertible Non-controlling Interests which are participating securities, by the weighted average number of shares of common stock outstanding calculated including Convertible Non-controlling Interests. Because the Company's Convertible Non-controlling Interests are participating securities, they are included in the calculation of both basic and diluted EPS.

(Y) Foreign Currency: The functional currency of the Company is U.S. dollars. Assets and liabilities denominated in foreign currencies are remeasured into U.S. dollars at current exchange rates at the following dates: (i) assets, liabilities, and unrealized gains/losses—at the valuation date; and (ii) income, expenses, and realized gains/losses—at the accrual/transaction date. The Company isolates the portion of realized and change in unrealized gain (loss) resulting from changes in foreign currency exchange rates on investments and financial derivatives from the fluctuations arising from changes in fair value of investments and financial derivatives held. Changes in realized and change in unrealized gain (loss) due to foreign currency are included in Other, net, on the Consolidated Statement of Operations.

The Company's reporting currency is U.S. Dollars. If the Company has investments in unconsolidated entities that have a functional currency other than U.S. Dollars, the fair value is translated to U.S. dollars using the current exchange rate at the valuation date. The cumulative translation adjustment, if any, associated with the Company's investments in unconsolidated entities is recorded in accumulated other comprehensive income (loss), a component of consolidated stockholders' equity.

(Z) Income Taxes: The Company has elected to be taxed as a REIT under Sections 856 through 860 of the Code. As a REIT, the Company is generally not subject to corporate-level federal and state income tax on net income it distributes to its stockholders within the prescribed timeframes. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including distributing at least 90% of its annual taxable income to stockholders. Even if the Company qualifies as a REIT, it may be subject to certain federal, state, local and foreign taxes on its income and property, and to federal income and excise taxes on its undistributed taxable income. If the Company fails to qualify as a REIT, and does not qualify for

125

Table of Contents

certain statutory relief provisions, it will be subject to U.S. federal, state, and local income taxes and may be precluded from qualifying as a REIT for the four taxable years following the year in which the Company fails to qualify as a REIT.

As a REIT, if the Company fails to distribute in any calendar year (subject to specific timing rules for certain dividends paid in January) at least the sum of (i) 85% of its ordinary income for such year, (ii) 95% of its capital gain net income for such year, and (iii) any undistributed taxable income from the prior year, the Company would be subject to a non-deductible 4% excise tax on the excess of such required distribution over the sum of (i) the amounts actually distributed and (ii) the amounts of income retained and on which the Company has paid corporate income tax.

The Company elected to treat certain domestic and foreign subsidiaries as TRSs, and may in the future elect to treat other current or future subsidiaries as TRSs. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. A domestic TRS may, but is not required to, declare dividends to the Company; such dividends will be included in the Company's taxable income/(loss) and may necessitate a distribution to the Company's stockholders. Conversely, if the Company retains earnings at the level of a domestic TRS, such earnings will increase the book equity of the consolidated entity. A domestic TRS is subject to U.S. federal, state, and local corporate income taxes. The Company has elected and may elect in the future to treat certain of its foreign corporate subsidiaries as TRSs and, accordingly, taxable income generated by these TRSs may not be subject to U.S. federal, state, and local corporate income taxation, but generally will be included in the Company's income on a current basis as Subpart F income, whether or not distributed. However, certain of the Company's foreign subsidiaries may be subject to income taxes in the relevant foreign jurisdictions. The Company's financial results are generally not expected to reflect provisions for current or deferred income taxes, except for any activities conducted through one or more TRSs that are subject to corporate income taxation.

The Company follows the authoritative guidance on accounting for and disclosure of uncertainty on tax positions, which requires management to determine whether a tax position of the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For uncertain tax positions, the tax benefit to be recognized is measured as the largest amount of benefit that is more than 50% likely to be realized upon ultimate settlement. The Company did not have any unrecognized tax benefits resulting from tax positions related to the current period or its open tax years. In the normal course of business, the Company may be subject to examination by federal, state, local, and foreign jurisdictions, where applicable, for the current period and its open tax years. The Company may take positions with respect to certain tax issues which depend on legal interpretation of facts or applicable tax regulations. Should the relevant tax regulators successfully challenge any of such positions, the Company might be found to have a tax liability that has not been recorded in the accompanying consolidated financial statements. Also, management's conclusions regarding the authoritative guidance may be subject to review and adjustment at a later date based on changing tax laws, regulations, and interpretations thereof.

(AA) Recent Accounting Pronouncements: In August 2018, the Financial Accounting Standards Board, or "FASB," issued ASU 2018-13, Fair Value Measurement—Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement ("ASU 2018-13"). This amends ASC 820 to remove or modify various current disclosure requirements related to fair value measurement. Additionally, ASU 2018-13 requires certain additional disclosures around fair value measurement. ASU 2018-13 is effective for annual periods beginning after December 15, 2019 and interim periods within those years, with early adoption permitted. Entities are permitted to early adopt any removed or modified disclosures and delay adoption of the additional disclosures until their effective date. The adoption of ASU 2018-13 did not have a material impact on the Company's consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, which introduced a new model related to the accounting for credit losses on financial assets subject to credit losses and measured at amortized cost and certain off-balance sheet credit exposures. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2016-13 amends the guidance which required an OTTI charge only when fair value is below the amortized cost of an asset. The length of time the fair value of an available-for-sale debt security has been below the amortized cost will no longer impact the determination of whether a credit loss exists; as a result, there is no longer an other-than-temporary impairment model. In addition, credit losses on available-for-sale debt securities will now be limited to the difference between the security's amortized cost basis and its fair value. This new debt security model will also require the use of an allowance to record estimated credit losses. While generally not applicable for financial assets for which the fair value option has been elected, the Company has applied the principles of ASU 2016-13 as described above. The adoption of ASU 2016-13 did not have a material impact on the Company's consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform—Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"), which provides optional guidance for a limited period meant to ease the potential burden in accounting for, or recognizing the effects of, reform to LIBOR and certain other reference rates. The

126

Table of Contents

standard is effective for all entities beginning on March 12, 2020 and may be elected over time. However, ASU 2020-04 is only applicable to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform, and that were entered into or evaluated prior to January 1, 2023. The Company is currently evaluating the impact that the adoption of ASU 2020-04 would have on its consolidated financial statements.

3. Valuation

The tables below reflect the value of the Company's Level 1, Level 2, and Level 3 financial instruments that are measured at fair value on a recurring basis as of December 31, 2020 and 2019:

December 31, 2020:

Description	Level 1		Level 2		Level 3		Total
	(In thousands)
Assets:
Securities, at fair value:
Agency RMBS	$	—	$	947,780	$	11,663	$	959,443
Non-Agency RMBS	—		76,276		127,838		204,114
CMBS	—		54,505		63,148		117,653
CLOs	—		70,171		111,100		181,271
Asset-backed securities, backed by consumer loans	—		—		44,925		44,925
Corporate debt securities	—		1,107		4,082		5,189
Corporate equity securities	—		—		1,590		1,590
Loans, at fair value:
Residential mortgage loans	—		—		1,187,069		1,187,069
Commercial mortgage loans	—		—		213,031		213,031
Consumer loans	—		—		47,525		47,525
Corporate loans	—		—		5,855		5,855
Investment in unconsolidated entities, at fair value	—		—		141,620		141,620
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	—		—		347		347
Credit default swaps on asset-backed indices	—		2,184		—		2,184
Credit default swaps on corporate bond indices	—		3,420		—		3,420
Interest rate swaps	—		8,519		—		8,519
TBAs	—		962		—		962
Total return swaps	—		—		9		9
Warrants	—		36		—		36
Futures	2		—		—		2
Total assets	$	2	$	1,164,960	$	1,959,802	$	3,124,764

127

Table of Contents

Description	Level 1		Level 2		Level 3		Total
(continued)	(In thousands)
Liabilities:
Securities sold short, at fair value:
Government debt	$	—	$	(38,424)	$	—	$	(38,424)
Corporate debt securities	—		(218)		—		(218)
Financial derivatives–liabilities, at fair value:
Credit default swaps on asset-backed indices	—		(130)		—		(130)
Credit default swaps on corporate bonds	—		(747)		—		(747)
Credit default swaps on corporate bond indices	—		(6,438)		—		(6,438)
Interest rate swaps	—		(15,174)		—		(15,174)
TBAs	—		(925)		—		(925)
Futures	(376)		—		—		(376)
Forwards	—		(279)		—		(279)
Total return swaps	—		—		(484)		(484)
Other secured borrowings, at fair value	—		—		(754,921)		(754,921)
Total liabilities	$	(376)	$	(62,335)	$	(755,405)	$	(818,116)

December 31, 2019:

Description	Level 1		Level 2		Level 3		Total
	(In thousands)
Assets:
Securities, at fair value:
Agency RMBS	$	—	$	1,917,059	$	19,904	$	1,936,963
Non-Agency RMBS	—		76,969		89,581		166,550
CMBS	—		95,063		29,805		124,868
CLOs	—		125,464		44,979		170,443
Asset-backed securities, backed by consumer loans	—		—		48,610		48,610
Corporate debt securities	—		—		1,113		1,113
Corporate equity securities	—		—		1,394		1,394
Loans, at fair value:
Residential mortgage loans	—		—		932,203		932,203
Commercial mortgage loans	—		—		274,759		274,759
Consumer loans	—		—		186,954		186,954
Corporate loans	—		—		18,510		18,510
Investment in unconsolidated entities, at fair value	—		—		71,850		71,850
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	—		—		993		993
Credit default swaps on asset-backed indices	—		3,319		—		3,319
Credit default swaps on corporate bonds	—		2		—		2
Credit default swaps on corporate bond indices	—		5,599		—		5,599
Interest rate swaps	—		5,468		—		5,468
TBAs	—		596		—		596
Total return swaps	—		—		620		620
Futures	148		—		—		148
Forwards	—		43		—		43
Total assets	$	148	$	2,229,582	$	1,721,275	$	3,951,005

128

Table of Contents

Description	Level 1		Level 2		Level 3		Total
(continued)	(In thousands)
Liabilities:
Securities sold short, at fair value:
Government debt	$	—	$	(72,938)	$	—	$	(72,938)
Corporate debt securities	—		(471)		—		(471)
Financial derivatives–liabilities, at fair value:
Credit default swaps on asset-backed indices	—		(250)		—		(250)
Credit default swaps on corporate bonds	—		(1,693)		—		(1,693)
Credit default swaps on corporate bond indices	—		(14,524)		—		(14,524)
Interest rate swaps	—		(8,719)		—		(8,719)
TBAs	—		(1,012)		—		(1,012)
Futures	(45)		—		—		(45)
Forwards	—		(169)		—		(169)
Total return swaps	—		(773)		(436)		(1,209)
Other secured borrowings, at fair value	—		—		(594,396)		(594,396)
Total liabilities	$	(45)	$	(100,549)	$	(594,832)	$	(695,426)

129

Table of Contents

The following tables identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2020 and 2019:

December 31, 2020:

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
	(In thousands)
Non-Agency RMBS	$	70,619	Market Quotes	Non Binding Third-Party Valuation	$	9.53		$	204.61		$	85.70
	57,219		Discounted Cash Flows
	127,838			Yield(1)	0.7		%	52.6		%	7.4		%
				Projected Collateral Prepayments	—		%	99.1		%	45.3		%
				Projected Collateral Losses	0.4		%	72.6		%	18.4		%
				Projected Collateral Recoveries	—		%	79.1		%	16.8		%
Non-Agency CMBS	53,199		Market Quotes	Non Binding Third-Party Valuation	$	4.79		$	98.00		$	65.20
	9,949		Discounted Cash Flows
	63,148			Yield	3.7		%	26.3		%	8.7		%
				Projected Collateral Prepayments	—		%	—		%	—		%
				Projected Collateral Losses	0.7		%	10.7		%	3.6		%
				Projected Collateral Recoveries	72.4		%	96.1		%	90.6		%
CLOs	102,910		Market Quotes	Non Binding Third-Party Valuation	$	2.00		$	330.00		$	88.66
	8,190		Discounted Cash Flows
	111,100			Yield	3.4		%	35.4		%	10.5		%
				Projected Collateral Prepayments	41.2		%	97.7		%	65.7		%
				Projected Collateral Losses	1.7		%	28.9		%	11.2		%
				Projected Collateral Recoveries	0.6		%	15.2		%	7.9		%
Agency interest only RMBS	4,844		Market Quotes	Non Binding Third-Party Valuation	$	1.91		$	18.91		$	8.38
	6,819		Option Adjusted Spread ("OAS")
	11,663			LIBOR OAS(2)(3)	297			2,886			914
				Projected Collateral Prepayments	8.3		%	100.0		%	75.9		%
ABS backed by consumer loans	97		Market Quotes	Non Binding Third-Party Valuation	$	96.51		$	98.43		$	97.33
	44,828		Discounted Cash Flows
	44,925			Yield	12.6		%	27.5		%	15.6		%
				Projected Collateral Prepayments	0.0		%	11.6		%	7.7		%
				Projected Collateral Losses	1.0		%	21.1		%	17.1		%
Corporate debt and equity	5,672		Discounted Cash Flows	Yield	8.1		%	10.8		%	9.7		%
Performing and re-performing residential mortgage loans	338,265		Discounted Cash Flows	Yield	2.5		%	28.5		%	5.4		%
	15,659		Recent Transactions	Transaction Price	$	60.00		$	103.88		$	103.44
	353,924

130

Table of Contents

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
(continued)	(In thousands)
Securitized residential mortgage loans(4)(5)	$	783,162	Market Quotes	Non Binding Third-Party Valuation	$	5.34		$	105.61		$	100.22
	18,182		Discounted Cash Flows
	801,343			Yield	—		%	38.7		%	4.4		%
Non-performing residential mortgage loans	31,802		Discounted Cash Flows	Yield	1.2		%	41.0		%	12.1		%
				Recovery Amount	0.9		%	1713.0		%	30.6		%
				Months to Resolution	0.0			106.6			30.0
Performing commercial mortgage loans	181,545		Discounted Cash Flows	Yield	3.7		%	9.7		%	8.1		%
Non-performing commercial mortgage loans	31,486		Discounted Cash Flows	Yield	8.6		%	14.6		%	10.8		%
				Recovery Amount	100.0		%	102.4		%	100.8		%
				Months to Resolution	1.8			5.8			3.7
Consumer loans	47,525		Discounted Cash Flows	Yield	7.8		%	28.1		%	11.2		%
				Projected Collateral Prepayments	0.0		%	36.0		%	17.3		%
				Projected Collateral Losses	0.9		%	86.6		%	9.4		%
Corporate loans	5,855		Market Quotes	Non Binding Third-Party Valuation	$	100.00		$	100.00		$	100.00
				Yield	21.1		%	21.1		%	21.1		%
Investment in unconsolidated entities	141,620		Enterprise Value	Equity Price-to-Book(6)	1.0x			6.2x			1.4x
Total return swaps—asset	9		Discounted Cash Flows	Yield	22.0		%	22.0		%	22.0		%
Credit default swaps on asset-backed securities	347		Net Discounted Cash Flows	Projected Collateral Prepayments	32.7		%	39.7		%	38.1		%
				Projected Collateral Losses	6.6		%	10.8		%	8.9		%
				Projected Collateral Recoveries	13.9		%	18.1		%	15.6		%
Total return swaps—liability	(484)		Discounted Cash Flows	Yield	16.8%			16.8%			16.8%
Other secured borrowings, at fair value(4)	(754,921)		Market Quotes	Non Binding Third-Party Valuation	$	85.37		$	105.61		$	102.04
				Yield	1.6%			3.0%			2.6%
				Projected Collateral Prepayments	—%			75.3%			48.7%

(1)For the range minimum, the range maximum, and the weighted average yield, excludes non-Agency RMBS with a negative yield, with a total fair value of $0.3 million. Including these securities the weighted average yield was 7.3%.

(2)Shown in basis points.

(3)For range minimum, range maximum, and the weighted average of LIBOR OAS, excludes Agency interest only securities with a negative LIBOR OAS, with a total fair value of $4.5 million. Including these securities the weighted average was 396 basis points.

(4)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFEs as discussed in Note 2.

(5)Includes $26.4 million of non-performing securitized residential mortgage loans.

(6)Represents an estimation of where market participants might value an enterprise on a price-to-book basis.

131

Table of Contents

December 31, 2019(1):

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
	(In thousands)
Non-Agency RMBS	$	38,754	Market Quotes	Non Binding Third-Party Valuation	$	6.68		$	144.79		$	86.21
	50,827		Discounted Cash Flows
	89,581			Yield(2)	0.5		%	65.1		%	8.1		%
				Projected Collateral Prepayments	0.8		%	76.5		%	53.1		%
				Projected Collateral Losses	0.1		%	48.9		%	17.7		%
				Projected Collateral Recoveries	—		%	32.4		%	6.5		%
Non-Agency CMBS	29,630		Market Quotes	Non Binding Third-Party Valuation	$	5.08		$	80.72		$	64.73
	175		Discounted Cash Flows
	29,805			Yield	3.7		%	15.7		%	7.6		%
				Projected Collateral Prepayments	—		%	100.0		%	0.6		%
				Projected Collateral Losses	—		%	3.0		%	0.2		%
				Projected Collateral Recoveries	—		%	10.6		%	2.0		%
CLOs	38,220		Market Quotes	Non Binding Third-Party Valuation	$	40.00		$	96.00		$	73.98
	6,759		Discounted Cash Flows
	44,979			Yield	3.2		%	41.9		%	14.0		%
				Projected Collateral Prepayments	48.5		%	88.3		%	83.2		%
				Projected Collateral Losses	4.7		%	36.4		%	8.8		%
				Projected Collateral Recoveries	3.7		%	15.1		%	5.7		%
Agency interest only RMBS	3,753		Market Quotes	Non Binding Third-Party Valuation	$	1.36		$	16.61		$	5.11
	16,151		Option Adjusted Spread ("OAS")
	19,904			LIBOR OAS(3)(4)	93			3,527			583
				Projected Collateral Prepayments	12.3		%	100.0		%	70.5		%
ABS backed by consumer loans	139		Market Quotes	Non Binding Third-Party Valuation	$	95.47		$	96.78		$	96.12
	48,471		Discounted Cash Flows
	48,610			Yield	3.8		%	34.2		%	12.7		%
				Projected Collateral Prepayments	0.0		%	11.2		%	9.7		%
				Projected Collateral Losses	0.6		%	18.0		%	15.4		%
Corporate debt and equity	2,507		Discounted Cash Flows	Yield	7.2		%	10.0		%	8.8		%
Performing and re-performing residential mortgage loans	289,672		Discounted Cash Flows	Yield	0.4		%	19.5		%	6.3		%
Securitized residential mortgage loans(5)(6)	621,762		Market Quotes	Non Binding Third-Party Valuation	$	2.56		$	100.45		$	98.23
	6,653		Discounted Cash Flows
	628,415			Yield	3.2		%	4.3		%	3.6		%

132

Table of Contents

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
(Continued)	(In thousands)
Non-performing residential mortgage loans	$	14,116	Discounted Cash Flows	Yield	1.0		%	26.6		%	9.2		%
				Recovery Amount	28.0		%	464.3		%	94.3		%
				Months to Resolution	1.1			165.4			56.3
Performing commercial mortgage loans	248,214		Discounted Cash Flows	Yield	7.7		%	16.6		%	8.8		%
Non-performing commercial mortgage loans	26,545		Discounted Cash Flows	Yield	9.8		%	14.7		%	12.4		%
				Recovery Amount	100.0		%	100.0		%	100.0		%
				Months to Resolution	1.1			23.0			11.4
Consumer loans	186,954		Discounted Cash Flows	Yield	6.7		%	19.6		%	9.4		%
				Projected Collateral Prepayments	0.0		%	44.2		%	16.0		%
				Projected Collateral Losses	3.7		%	84.5		%	8.6		%
Corporate loans	6,010		Market Quotes	Non Binding Third-Party Valuation	$	100.00		$	100.00		$	100.00
	12,500		Discounted Cash Flows
	18,510			Yield	15.0		%	21.0		%	17.8		%
Investment in unconsolidated entities	71,850		Enterprise Value	Equity Price-to-Book(7)	1.0x			4.7x			1.4x
Total return swaps—asset	620		Discounted Cash Flows	Yield	8.5		%	27.7		%	11.5		%
Credit default swaps on asset-backed securities	993		Net Discounted Cash Flows	Projected Collateral Prepayments	35.4		%	42.0		%	37.3		%
				Projected Collateral Losses	4.2		%	12.4		%	10.2		%
				Projected Collateral Recoveries	10.0		%	18.2		%	15.3		%
Total return swaps—liability	(436)		Discounted Cash Flows	Yield	27.7%			27.7%			27.7%
Other secured borrowings, at fair value(5)	(594,396)		Market Quotes	Non Binding Third-Party Valuation	97.77			100.45			100.61
				Yield	2.9%			4.0%			3.3%
				Projected Collateral Prepayments	—%			96.6%			57.2%

(1)Conformed to current period presentation.

(2)For the range minimum, the range maximum, and the weighted average yield, excludes non-Agency RMBS with a negative yield, with a total fair value of $0.6 million. Including these securities the weighted average yield was 8.0%.

(3)Shown in basis points.

(4)For range minimum, range maximum, and the weighted average of LIBOR OAS, excludes Agency interest only securities with a negative LIBOR OAS, with a total fair value of $0.3 million. Including these securities the weighted average was 576 basis points.

(5)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFEs as discussed in Note 2.

(6)Includes $1.5 million of non-performing securitized residential mortgage loans.

(7)Represent an estimation of where market participants might value an enterprise on a price-to-book basis.

Third-party non-binding valuations are validated by comparing such valuations to internally generated prices based on the Company's models and, when available, to recent trading activity in the same or similar instruments.

For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread ("LIBOR OAS") valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to

133

Table of Contents

(b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset. The Company considers the expected timeline to resolution in the determination of fair value for its non-performing commercial and residential mortgage loans.

Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, for instruments subject to prepayments and credit losses, such as non-Agency RMBS and consumer loans and ABS backed by consumer loans, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such credit default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.

The tables below includes a roll-forward of the Company's financial instruments for the years ended December 31, 2020 and 2019 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.

Year Ended December 31, 2020

(In thousands)	Beginning Balance as of  December 31, 2019		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/Payments(1)		Sales/Issuances(2)		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of  December 31, 2020
Assets:
Securities, at fair value:
Agency RMBS	$	19,904	$	(7,903)	$	722	$	3,175	$	8,307	$	(5,046)	$	1,083	$	(8,579)	$	11,663
Non-Agency RMBS	89,581		1,557		1,009		(1,283)		64,362		(40,841)		17,425		(3,972)		127,838
CMBS	29,805		813		62		(2,477)		52,915		(38,553)		20,583		—		63,148
CLOs	44,979		2,185		(8,862)		(13,132)		48,120		(6,747)		53,052		(8,495)		111,100
Asset-backed securities backed by consumer loans	48,610		(4,986)		(138)		(1,245)		30,899		(28,215)		—		—		44,925
Corporate debt securities	1,113		—		914		1,068		5,668		(4,681)		—		—		4,082
Corporate equity securities	1,394		—		7		(165)		366		(12)		—		—		1,590
Loans, at fair value:
Residential mortgage loans	932,203		(6,445)		(165)		11,593		594,397		(344,514)		—		—		1,187,069
Commercial mortgage loans	274,759		128		135		(166)		121,844		(183,669)		—		—		213,031
Consumer loans	186,954		(24,586)		(4,843)		(2,891)		141,245		(248,354)		—		—		47,525
Corporate loan	18,510		—		—		—		1,445		(14,100)		—		—		5,855
Investments in unconsolidated entities, at fair value	71,850		—		424		37,509		61,589		(29,752)		—		—		141,620
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	993		—		(5,451)		5,402		24		(621)		—		—		347
Total return swaps	620		—		288		(611)		126		(414)		—		—		9
Total assets, at fair value	$	1,721,275	$	(39,237)	$	(15,898)	$	36,777	$	1,131,307	$	(945,519)	$	92,143	$	(21,046)	$	1,959,802
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps	$	(436)	$	—	$	(551)	$	(48)	$	592	$	(41)	$	—	$	—	$	(484)
Other secured borrowings, at fair value	(594,396)		—		—		(9,576)		305,828		(456,777)		—		—		(754,921)
Total liabilities, at fair value	$	(594,832)	$	—	$	(551)	$	(9,624)	$	306,420	$	(456,818)	$	—	$	—	$	(755,405)

134

Table of Contents

(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities.

(2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities.

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at December 31, 2020, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2020. For Level 3 financial instruments held by the Company at December 31, 2020, change in net unrealized gain (loss) of $(33.3) million, $8.6 million, $37.1 million, $0.5 million, $(0.5) million, and $(9.6) million, for the year ended December 31, 2020 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively.

At December 31, 2020, the Company transferred $21.0 million of assets from Level 3 to Level 2 and $92.1 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

Year Ended December 31, 2019

(In thousands)	Beginning Balance as of  January 1, 2019		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/ Payments(1)		Sales/ Issuances(2)		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of  December 31, 2019
Assets:
Securities, at fair value:
Agency RMBS	$	7,293	$	(3,464)	$	(1,787)	$	808	$	13,818	$	(1,306)	$	5,370	$	(828)	$	19,904
Non-Agency RMBS	91,291		270		5,636		(3,654)		21,512		(33,664)		15,354		(7,164)		89,581
CMBS	803		16		180		(246)		31,464		(5,271)		2,859		—		29,805
CLOs	14,915		(268)		(3,190)		2,329		25,531		(5,112)		11,984		(1,210)		44,979
Asset-backed securities backed by consumer loans	22,800		(2,520)		(891)		873		42,137		(13,789)		—		—		48,610
Corporate debt securities	6,318		22		(1,341)		188		11,024		(15,098)		—		—		1,113
Corporate equity securities	1,534		—		(1,807)		205		1,462		—		—		—		1,394
Loans, at fair value:
Residential mortgage loans	496,830		(6,081)		1,466		8,800		661,813		(230,625)		—		—		932,203
Commercial mortgage loans	195,301		(282)		2,412		(2,083)		175,689		(96,278)		—		—		274,759
Consumer loans	183,961		(28,521)		(6,291)		3,000		183,994		(149,189)		—		—		186,954
Corporate loan	—		36		—		(36)		18,510		—		—		—		18,510
Investment in unconsolidated entities, at fair value	72,298		—		1,545		8,664		42,173		(52,830)		—		—		71,850
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	1,472		—		528		(479)		33		(561)		—		—		993
Total return swaps	—		—		160		620		—		(160)		—		—		620
Total assets, at fair value	$	1,094,816	$	(40,792)	$	(3,380)	$	18,989	$	1,229,160	$	(603,883)	$	35,567	$	(9,202)	$	1,721,275
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps	$	—	$	—	$	(15)	$	(436)	$	15	$	—	$	—	$	—	$	(436)
Other secured borrowings, at fair value	(297,948)		—		—		(502)		182,291		(478,237)		—		—		(594,396)
Total liabilities, at fair value	$	(297,948)	$	—	$	(15)	$	(938)	$	182,306	$	(478,237)	$	—	$	—	$	(594,832)

(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities.

(2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities.

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3

135

Table of Contents

financial instruments held by the Company at December 31, 2019, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2019. For Level 3 financial instruments held by the Company at December 31, 2019, change in net unrealized gain (loss) of $2.4 million, $11.5 million, $5.2 million, $0.1 million, $(0.4) million, and $0.1 million, for the year ended December 31, 2019 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively.

At December 31, 2019, the Company transferred $9.2 million of assets from Level 3 to Level 2 and $35.6 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

The following table summarizes the estimated fair value of all other financial instruments not measured at fair value on a recurring basis as of December 31, 2020 and 2019:

	As of
	December 31, 2020				December 31, 2019
(In thousands)	Fair Value		Carrying Value		Fair Value		Carrying Value
Other financial instruments
Assets:
Cash and cash equivalents	$	111,647	$	111,647	$	72,302	$	72,302
Restricted cash	175		175		175		175
Due from brokers	63,147		63,147		79,829		79,829
Reverse repurchase agreements	38,640		38,640		73,639		73,639
Liabilities:
Repurchase agreements	1,496,931		1,496,931		2,445,300		2,445,300
Other secured borrowings	51,062		51,062		150,334		150,334
Senior notes, net	86,000		85,561		88,365		85,298
Due to brokers	5,059		5,059		2,197		2,197

Cash and cash equivalents generally includes cash held in interest bearing overnight accounts, for which fair value equals the carrying value, and investments which are liquid in nature, such as investments in money market accounts or U.S. Treasury Bills, for which fair value equals the carrying value; such assets are considered Level 1. Restricted cash includes cash held in a segregated account for which fair value equals the carrying value; such assets are considered Level 1. Due from brokers and Due to brokers include collateral transferred to or received from counterparties, along with receivables and payables for open and/or closed derivative positions. These receivables and payables are short term in nature and any collateral transferred consists primarily of cash; fair value of these items is approximated by carrying value and such items are considered Level 1. The Company's reverse repurchase agreements, repurchase agreements, and other secured borrowings are carried at cost, which approximates fair value due to their short term nature. Reverse repurchase agreements, repurchase agreements, and other secured borrowings are classified as Level 2 based on the adequacy of the collateral and their short term nature. Senior notes, net are considered Level 3 liabilities given the relative unobservability of the most significant inputs to valuation estimation as well as the lack of trading activity of these instruments. As of December 31, 2020 and 2019, the estimated fair value of the Company's Senior notes was based on a third-party valuation.

136

Table of Contents

4. Investment in Securities

The Company's securities portfolio primarily consists of Agency RMBS, non-Agency RMBS, CMBS, CLOs, ABS backed by consumer loans, and corporate debt and equity. The following tables detail the Company's investment in securities as of December 31, 2020 and 2019.

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Current Principal		Unamortized Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon(1)		Yield		Life (Years)(2)
Long:
Agency RMBS:
15-year fixed-rate mortgages	$	67,875	$	2,543	$	70,418	$	1,832	$	(36)	$	72,214	3.30	%	1.83	%	3.24
20-year fixed-rate mortgages	50,131		3,097		53,228		182		—		53,410		2.57	%	1.08	%	4.46
30-year fixed-rate mortgages	626,021		30,738		656,759		25,765		(444)		682,080		3.99	%	2.35	%	4.17
Adjustable rate mortgages	6,171		159		6,330		124		—		6,454		3.66	%	2.27	%	3.42
Reverse mortgages	89,383		5,152		94,535		3,123		(29)		97,629		3.97	%	2.37	%	4.60
Interest only securities	n/a		n/a		43,406		5,808		(1,558)		47,656		3.36	%	10.01	%	4.85
Non-Agency RMBS	321,842		(131,083)		190,759		15,880		(5,549)		201,090		3.15	%	6.40	%	5.46
CMBS	188,085		(61,763)		126,322		1,655		(16,910)		111,067		2.71	%	7.47	%	8.09
Non-Agency interest only securities	n/a		n/a		8,123		1,792		(305)		9,610		1.17	%	18.85	%	3.49
CLOs	n/a		n/a		208,907		2,563		(30,199)		181,271		3.67	%	8.50	%	3.50
ABS backed by consumer loans	69,646		(24,936)		44,710		221		(6)		44,925		11.95	%	18.57	%	1.11
Corporate debt	27,083		(23,187)		3,896		1,296		(3)		5,189		2.13	%	6.75	%	3.10
Corporate equity	n/a		n/a		1,604		376		(390)		1,590		n/a		n/a		n/a
Total Long	1,446,237		(199,280)		1,508,997		60,617		(55,429)		1,514,185		3.84	%	4.88	%	4.45
Short:
Corporate debt	(200)		(1)		(201)		—		(17)		(218)		5.09	%	4.67	%	6.42
European sovereign bonds	(37,804)		3,163		(34,641)		—		(3,783)		(38,424)		0.23	%	0.06	%	3.11
Total Short	(38,004)		3,162		(34,842)		—		(3,800)		(38,642)		0.26	%	0.09	%	3.13
Total	$	1,408,233	$	(196,118)	$	1,474,155	$	60,617	$	(59,229)	$	1,475,543	3.92	%	4.77	%	4.49

(1)Weighted average coupon represents the weighted average coupons of the securities, rather than, in the case of collateralized securities, the coupon rates or loan rates on the underlying collateral.

(2)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

137

Table of Contents

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Current Principal		Unamortized Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon(1)		Yield		Life (Years)(2)
Long:
Agency RMBS:
15-year fixed-rate mortgages	$	314,636	$	6,369	$	321,005	$	2,604	$	(203)	$	323,406	3.05	%	2.28	%	3.05
20-year fixed-rate mortgages	804		49		853		24		—		877		4.62	%	2.99	%	4.80
30-year fixed-rate mortgages	1,358,762		64,846		1,423,608		13,821		(2,830)		1,434,599		4.20	%	2.95	%	6.63
Adjustable rate mortgages	9,651		315		9,966		90		(54)		10,002		3.99	%	2.03	%	4.09
Reverse mortgages	122,670		8,133		130,803		2,023		(26)		132,800		4.43	%	2.78	%	6.67
Interest only securities	n/a		n/a		34,044		1,624		(389)		35,279		2.81	%	9.27	%	3.86
Non-Agency RMBS	274,353		(122,685)		151,668		12,549		(1,081)		163,136		3.41	%	7.25	%	5.31
CMBS	185,417		(67,961)		117,456		2,990		(480)		119,966		3.31	%	6.62	%	8.94
Non-Agency interest only securities	n/a		n/a		6,517		1,817		(18)		8,316		1.10	%	8.18	%	4.14
CLOs	n/a		n/a		169,238		4,219		(3,014)		170,443		5.05	%	9.62	%	4.75
ABS backed by consumer loans	67,080		(19,154)		47,926		1,596		(912)		48,610		12.17	%	14.00	%	1.22
Corporate debt	22,125		(21,241)		884		229		—		1,113		—	%	—	%	0.33
Corporate equity	n/a		n/a		1,242		152		—		1,394		n/a		n/a		n/a
Total Long	2,355,498		(151,329)		2,415,210		43,738		(9,007)		2,449,941		4.15	%	4.09	%	5.88
Short:
Corporate debt	(450)		(6)		(456)		—		(15)		(471)		5.44	%	5.21	%	4.90
U.S. Treasury securities	(63,140)		381		(62,759)		63		(298)		(62,994)		1.76	%	1.87	%	6.11
European sovereign bonds	(9,759)		133		(9,626)		—		(318)		(9,944)		0.77	%	0.12	%	1.58
Total Short	(73,349)		508		(72,841)		63		(631)		(73,409)		1.65	%	1.66	%	5.49
Total	$	2,282,149	$	(150,821)	$	2,342,369	$	43,801	$	(9,638)	$	2,376,532	4.23	%	4.01	%	5.90

(1)Weighted average coupon represents the weighted average coupons of the securities, rather than, in the case of collateralized securities, the coupon rates or loan rates on the underlying collateral.

(2)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

138

Table of Contents

The following tables detail weighted average life of the Company's Agency RMBS as of December 31, 2020 and 2019.

December 31, 2020:

($ in thousands)	Agency RMBS						Agency Interest Only Securities
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(2)		Fair Value		Amortized Cost		Weighted Average Coupon(2)
Less than three years	$	139,059	$	135,844	4.15	%	$	8,143	$	7,314	3.99	%
Greater than three years and less than seven years	770,173		742,946		3.79	%	32,669		29,362		3.74	%
Greater than seven years and less than eleven years	2,555		2,480		3.01	%	5,165		5,063		1.04	%
Greater than eleven years	—		—		—	%	1,679		1,667		0.83	%
Total	$	911,787	$	881,270	3.84	%	$	47,656	$	43,406	3.36	%

(1)Expected average lives of RMBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

December 31, 2019:

($ in thousands)	Agency RMBS						Agency Interest Only Securities
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(2)		Fair Value		Amortized Cost		Weighted Average Coupon(2)
Less than three years	$	188,593	$	187,099	3.39	%	$	9,011	$	8,611	3.35	%
Greater than three years and less than seven years	961,839		953,031		4.25	%	25,334		24,512		2.66	%
Greater than seven years and less than eleven years	713,862		708,805		3.89	%	934		921		1.90	%
Greater than eleven years	37,390		37,300		3.51	%	—		—		—	%
Total	$	1,901,684	$	1,886,235	4.02	%	$	35,279	$	34,044	2.81	%

(1)Expected average lives of RMBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

The following tables detail weighted average life of the Company's long non-Agency RMBS, CMBS, and CLOs and other securities as of December 31, 2020 and 2019.

December 31, 2020:

($ in thousands)	Non-Agency RMBS and CMBS						Non-Agency IOs						CLOs and Other Securities(2)
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)
Less than three years	$	58,350	$	54,339	3.39	%	$	5,163	$	3,754	0.92	%	$	89,235	$	90,869	7.73	%
Greater than three years and less than seven years	114,815		109,161		3.45	%	4,447		4,369		1.37	%	139,830		163,670		3.69	%
Greater than seven years and less than eleven years	109,519		123,782		2.74	%	—		—		—	%	2,320		2,974		1.14	%
Greater than eleven years	29,473		29,799		1.46	%	—		—		—	%	—		—		—	%
Total	$	312,157	$	317,081	2.98	%	$	9,610	$	8,123	1.17	%	$	231,385	$	257,513	5.09	%

(1)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Other Securities includes asset-backed securities, backed by consumer loans and corporate debt.

(3)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

139

Table of Contents

December 31, 2019:

($ in thousands)	Non-Agency RMBS and CMBS						Non-Agency IOs						CLOs and Other Securities(2)
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)
Less than three years	$	50,120	$	48,213	2.73	%	$	439	$	401	1.37	%	$	54,446	$	54,090	11.11	%
Greater than three years and less than seven years	87,436		79,326		4.42	%	7,877		6,116		1.08	%	157,384		155,651		5.38	%
Greater than seven years and less than eleven years	127,533		123,924		3.31	%	—		—		—	%	8,336		8,307		—	%
Greater than eleven years	18,013		17,661		0.81	%	—		—		—	%	—		—		—	%
Total	$	283,102	$	269,124	3.37	%	$	8,316	$	6,517	1.10	%	$	220,166	$	218,048	6.60	%

(1)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Other Securities includes asset-backed securities, backed by consumer loans, corporate debt, and U.S. Treasury securities.

(3)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

The following tables detail the components of interest income by security type for the years ended December 31, 2020 and 2019:

	Year Ended
(In thousands)	December 31, 2020						December 31, 2019
Security Type	Coupon Interest		Net Amortization		Interest Income		Coupon Interest		Net Amortization		Interest Income
Agency RMBS	$	59,987	$	(31,975)	$	28,012	$	62,103	$	(24,731)	$	37,372
Non-Agency RMBS and CMBS	15,257		5,775		21,032		13,855		2,782		16,637
CLOs	14,103		3,529		17,632		15,857		(1,599)		14,258
Other securities(1)	11,545		(4,986)		6,559		7,157		(2,468)		4,689
Total	$	100,892	$	(27,657)	$	73,235	$	98,972	$	(26,016)	$	72,956

(1)Other securities includes ABS backed by consumer loans, corporate debt securities, and U.S. Treasury securities.

For the years ended December 31, 2020 and 2019, the Catch-Up Premium Amortization Adjustment was $(4.5) million and $(4.7) million, respectively.

The following tables present proceeds from sales and the resulting realized gains and (losses) of the Company's securities for the years ended December 31, 2020 and 2019.

	Year Ended
(In thousands)	December 31, 2020								December 31, 2019(1)
Security Type	Proceeds(2)		Gross Realized Gains		Gross Realized Losses(3)		Net Realized Gain (Loss)		Proceeds(2)		Gross Realized Gains		Gross Realized Losses(3)		Net Realized Gain (Loss)
Agency RMBS	$	1,439,413	$	16,260	$	(3,481)	$	12,779	$	1,010,251	$	9,006	$	(2,254)	$	6,752
Non-Agency RMBS and CMBS	145,323		13,692		(4,187)		9,505		184,725		12,552		(4,869)		7,683
CLOs	46,632		1,122		(4,251)		(3,129)		62,063		1,286		(816)		470
Other securities(4)	188,152		1,662		(9)		1,653		636,886		1,113		2		1,115
Total	$	1,819,520	$	32,736	$	(11,928)	$	20,808	$	1,893,925	$	23,957	$	(7,937)	$	16,020

(1)Conformed to current period presentation.

(2)Includes proceeds on sales of securities not yet settled as of period end.

(3)Excludes realized losses of $(17.7) million and $(28.7) million, for the years ended December 31, 2020 and 2019, respectively, related to adjustments to the cost basis of certain securities for which the Company has determined all or a portion of such securities cost basis to be uncollectible.

(4)Other securities includes ABS backed by consumer loans, corporate debt and equity, exchange-traded equity, and U.S. Treasury securities.

140

Table of Contents

The following table presents the fair value and gross unrealized losses of our long securities, excluding those where there are expected credit losses as of the balance sheet date in relation to such securities' cost bases, by length of time that such securities have been in an unrealized loss position at December 31, 2020.

December 31, 2020:

(In thousands)	Less than 12 Months				Greater than 12 Months				Total
Security Type	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Agency RMBS	$	126,926	$	(981)	$	832	$	(44)	$	127,758	$	(1,025)
Non-Agency RMBS and CMBS	20,474		(2,616)		2,599		(348)		23,073		(2,964)
CLOs	5,279		(753)		1,196		(1,131)		6,475		(1,884)
Other securities(1)	1,107		(8)		—		—		1,107		(8)
Total	$	153,786	$	(4,358)	$	4,627	$	(1,523)	$	158,413	$	(5,881)

(1)Other securities includes ABS backed by consumer loans and corporate debt and equity securities.

The following table presents the fair value and gross unrealized losses of our long securities by length of time that such securities have been in an unrealized loss position at December 31, 2019.

December 31, 2019:

(In thousands)	Less than 12 Months				Greater than 12 Months				Total
Security Type	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Agency RMBS	$	328,968	$	(1,503)	$	125,095	$	(1,999)	$	454,063	$	(3,502)
Non-Agency RMBS and CMBS	88,495		(880)		27,218		(699)		115,713		(1,579)
CLOs	37,354		(1,911)		9,245		(1,103)		46,599		(3,014)
Other securities(1)	16,562		(852)		1,380		(60)		17,942		(912)
Total	$	471,379	$	(5,146)	$	162,938	$	(3,861)	$	634,317	$	(9,007)

(1)Other securities includes ABS backed by consumer loans, corporate debt and equity, and U.S. Treasury securities.

As described in Note 2, the Company evaluates the cost basis of its securities for impairment on at least a quarterly basis. As of December 31, 2020, the Company had expected future credit losses, which it tracks for purposes of calculating interest income, of $24.9 million related to adverse changes in estimated future cash flows on its securities, primarily due to the economic impact of the COVID-19 pandemic. Certain of the Company's securities, at the date of acquisition, have experienced or are expected to experience more-than-insignificant deterioration in credit quality since origination and the Company has established an initial estimate for credit losses on such securities; as of December 31, 2020, the estimated credit losses on such securities was $2.6 million. As of December 31, 2020, the Company determined for certain securities that a portion of such securities cost basis is not collectible; for the year ended December 31, 2020, the Company recognized realized losses on these securities of $(17.7) million, which are reflected in Net realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

For the year ended December 31, 2019, the Company recognized an impairment charge of $28.7 million on the cost basis of its securities, which is included in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

141

Table of Contents

5. Investment in Loans

The Company invests in various types of loans, such as residential mortgage, commercial mortgage, consumer, and corporate loans. As discussed in Note 2, the Company has elected the FVO for its investments in loans. The following table is a summary of the Company's investments in loans as of December 31, 2020 and 2019:

	As of
(In thousands)	December 31, 2020				December 31, 2019
Loan Type	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
Residential mortgage loans	$	1,150,303	$	1,187,069	$	911,705	$	932,203
Commercial mortgage loans	212,716		213,031		277,870		274,759
Consumer loans	48,180		47,525		179,743		186,954
Corporate loans	5,855		5,855		18,415		18,510
Total	$	1,417,054	$	1,453,480	$	1,387,733	$	1,412,426

The Company is subject to credit risk in connection with its investments in loans. The two primary components of credit risk are default risk, which is the risk that a borrower fails to make scheduled principal and interest payments, and severity risk, which is the risk of loss upon a borrower default on a mortgage loan or other secured or unsecured loan. Severity risk includes the risk of loss of value of the property or other asset, if any, securing the loan, as well as the risk of loss associated with taking over the property or other asset, if any, including foreclosure costs. Credit risk in our loan portfolio can be amplified by exogenous shocks impacting our borrowers such as man-made or natural disasters, including the COVID-19 pandemic.

The following table provides details, by accrual status, for loans that are 90 days or more past due as of December 31, 2020 and 2019:

	As of
	December 31, 2020				December 31, 2019
(In thousands)	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
90 days or more past due—non-accrual status
Residential mortgage loans	$	64,509	$	60,381	$	22,092	$	19,401
Commercial mortgage loans	44,233		44,052		28,936		26,545
Consumer loans	1,015		930		5,633		5,225

Residential Mortgage Loans

The tables below detail certain information regarding the Company's residential mortgage loans as of December 31, 2020 and 2019.

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield		Life (Years)(1)
Residential mortgage loans, held-for-investment(2)	$	1,150,303	$	14,263	$	1,164,566	$	27,892	$	(5,389)	$	1,187,069	6.19	%	5.60	%	1.90

(1)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

(2)Includes $801.3 million of non-QM loans that have been securitized and are held in consolidated securitization trusts. Such loans had $24.8 million and $(0.1) million of gross unrealized gains and gross unrealized losses, respectively; such unrealized gains (losses) are included on the Company's Consolidated Statement of Operations in Unrealized gains (losses) on securities and loans, net. See Residential Mortgage Loan Securitizations in Note 10 for additional information.

142

Table of Contents

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield		Life (Years)(1)
Residential mortgage loans, held-for-investment(2)	$	911,705	$	9,354	$	921,059	$	13,082	$	(1,938)	$	932,203	6.44	%	5.79	%	1.90

(1)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

(2)Includes $628.4 million of non-QM loans that have been securitized and are held in consolidated securitization trusts. Such loans had $11.3 million and $(0.1) million of gross unrealized gains and gross unrealized losses, respectively; such unrealized gains (losses) are included on the Company's Consolidated Statement of Operations in Unrealized gains (losses) on securities and loans, net. See Residential Mortgage Loan Securitizations in Note 10 for additional information.

The table below summarizes the geographic distribution of the real estate collateral underlying the Company's residential mortgage loans as a percentage of total outstanding unpaid principal balance as of December 31, 2020 and 2019:

Property Location by U.S. State	December 31, 2020		December 31, 2019
California	43.1	%	46.6	%
Florida	14.8	%	11.9	%
Texas	10.2	%	11.9	%
Colorado	3.1	%	3.2	%
Massachusetts	2.6	%	2.9	%
Oregon	2.2	%	2.2	%
Arizona	2.0	%	2.4	%
Nevada	1.9	%	1.6	%
Illinois	1.8	%	1.7	%
Utah	1.7	%	1.9	%
New York	1.6	%	1.3	%
Washington	1.4	%	1.6	%
New Jersey	1.4	%	1.1	%
Georgia	1.3	%	0.7	%
North Carolina	1.1	%	0.8	%
Maryland	1.0	%	1.1	%
Other	8.8	%	7.1	%
	100.0	%	100.0	%

The following table presents information on the Company's residential mortgage loans by re-performing or non-performing status, as of December 31, 2020 and 2019.

	As of
	December 31, 2020				December 31, 2019
(In thousands)	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
Re-performing	$	18,120	$	16,741	$	27,663	$	25,323
Non-performing	62,009		58,169		17,757		15,580

As described in Note 2, the Company evaluates the cost basis of its residential mortgage loans for impairment on at least a quarterly basis. At December 31, 2020, the Company had expected future credit losses, which it tracks for purposes of calculating interest income, of $2.2 million related to adverse changes in estimated future cash flows on its residential mortgage loans, primarily due to the economic impact of the COVID-19 pandemic. Certain of the Company's residential mortgage loans, at the date of acquisition, have experienced or are expected to experience more-than-insignificant deterioration in credit quality since origination and the Company has established an initial estimate for credit losses on such loans; as of December 31, 2020, the estimated credit losses on such loans was $0.2 million. The Company has determined for certain of its residential mortgage loans that a portion of such loans' cost basis is not collectible; for the year ended December 31, 2020, the Company recognized realized losses on these loans of $(0.8) million, which are reflected in Net realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

143

Table of Contents

For the year ended December 31, 2019, the Company recognized an impairment charge of $0.9 million on the cost basis of its residential mortgage loans, which is included in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

As of December 31, 2020 and 2019, the Company had residential mortgage loans that were in the process of foreclosure with a fair value of $14.9 million and $10.9 million, respectively.

Commercial Mortgage Loans

The tables below detail certain information regarding the Company's commercial mortgage loans as of December 31, 2020 and 2019:

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield(1)		Life (Years)(2)
Commercial mortgage loans, held-for-investment	$	212,716	$	290	$	213,006	$	479	$	(454)	$	213,031	8.38	%	8.28	%	0.62

(1)Excludes non-performing commercial mortgage loans, in non-accrual status, with a fair value of $31.5 million.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield(1)		Life (Years)(2)
Commercial mortgage loans, held-for-investment	$	277,870	$	(3,302)	$	274,568	$	253	$	(62)	$	274,759	7.65	%	8.58	%	1.07

(1)Excludes commercial mortgage loans, held at par in non-accrual status, with a fair value of $10.7 million.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

The table below summarizes the geographic distribution of the real estate collateral underlying the Company's commercial mortgage loans as a percentage of total outstanding unpaid principal balance as of December 31, 2020 and 2019:

Property Location by U.S. State	December 31, 2020		December 31, 2019
Florida	23.8	%	31.7	%
New York	15.2	%	17.7	%
Connecticut	11.2	%	8.2	%
Missouri	7.9	%	4.6	%
Ohio	7.3	%	—	%
California	5.9	%	—	%
Massachusetts	6.1	%	4.7	%
New Jersey	5.8	%	13.3	%
Arizona	4.3	%	3.8	%
Virginia	4.2	%	6.8	%
Indiana	2.8	%	2.1	%
North Carolina	2.2	%	1.8	%
Nevada	1.9	%	1.5	%
Tennessee	—	%	1.5	%
Illinois	1.4	%	1.2	%
Other	—	%	1.1	%
	100.0	%	100.0	%

144

Table of Contents

As of December 31, 2020, the Company had three non-performing commercial mortgage loans with an unpaid principal balance and fair value of $31.8 million and $31.5 million, respectively. As of December 31, 2019, the Company had three non-performing commercial mortgage loans with an unpaid principal balance and fair value of $28.9 million and $26.5 million, respectively.

As described in Note 2, the Company evaluates the cost basis of its commercial mortgage loans for impairment on at least a quarterly basis. At December 31, 2020, the expected future credit losses, which it tracks for purposes of calculating interest income, of $0.4 million related to adverse changes in estimated future cash flows on its commercial mortgage loans. For the year ended December 31, 2019, the Company did not recognize any impairment charge on the cost basis of its commercial mortgage loans.

As of December 31, 2020 the Company had one commercial mortgage loan with a fair value of $10.5 million that was in the process of foreclosure. As of December 31, 2019, the Company had two commercial mortgage loans with a fair value of $16.0 million that were in the process of foreclosure.

Consumer Loans

The tables below detail certain information regarding the Company's consumer loans as of December 31, 2020 and 2019:

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value(1)		Life (Years)(2)	Delinquency (Days)
Consumer loans, held-for-investment	$	48,180	$	72	$	48,252	$	1,160	$	(1,887)	$	47,525	1.04	7

(1)Includes $0.6 million of charged-off loans for which the Company has determined that it is probable the servicer will be able to collect principal and interest.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value(1)		Life (Years)(2)	Delinquency (Days)
Consumer loans, held-for-investment	$	179,743	$	5,027	$	184,770	$	2,561	$	(377)	$	186,954	0.82	4

(1)Includes $0.6 million of charged-off loans for which the Company has determined that it is probable the servicer will be able to collect principal and interest.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

The table below provides details on the delinquency status as a percentage of total unpaid principal balance of the Company's consumer loans, which the Company uses as an indicator of credit quality, as of December 31, 2020 and 2019:

Days Past Due	December 31, 2020		December 31, 2019
Current	90.4	%	95.3	%
30-59 Days	3.4	%	2.1	%
60-89 Days	3.3	%	1.4	%
90-119 Days	2.8	%	1.2	%
>120 Days	0.1	%	—	%
	100.0	%	100.0	%

During the years ended December 31, 2020 and 2019, the Company charged off $20.9 million and $19.0 million, respectively, of unpaid principal balance of consumer loans that were greater than 120 days delinquent. As of both December 31, 2020 and 2019, the Company held charged-off consumer loans with an aggregate fair value of $0.6 million for which the Company has determined that it is probable the servicer will be able to collect principal and interest.

145

Table of Contents

As described in Note 2, the Company evaluates the cost basis of its consumer loans for impairment on at least a quarterly basis. At December 31, 2020, the Company had expected future credit losses, which it tracks for purposes of calculating interest income, of $2.9 million on its consumer loans. The Company has determined for certain of its consumer loans that a portion of such loans' cost basis is not collectible; for the year ended December 31, 2020, the Company recognized realized losses on these loans of $3.2 million.

For the year ended December 31, 2019, the Company recognized an impairment charge of $6.3 million on the cost basis of its consumer loan pools, which is included in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

Corporate Loans

The tables below detail certain information regarding the Company's corporate loans as of December 31, 2020 and 2019:

December 31, 2020:

					Weighted Average
($ in thousands)	Unpaid Principal Balance		Fair Value		Rate		Remaining Term (Years)
Corporate loans, held-for-investment(1)	$	5,855	$	5,855	20.00	%	1.75

(1)See Note 21 for further details on the Company's unfunded commitments related to certain of its corporate loans.

December 31, 2019:

					Weighted Average
($ in thousands)	Unpaid Principal Balance		Fair Value		Rate		Remaining Term (Years)
Corporate loans, held-for-investment(1)(2)	$	18,415	$	18,510	17.62	%	0.87

(1)See Note 13 for further details on the Company's transactions involving a loan originator in which the Company also holds an equity investment.

(2)See Note 21 for further details on the Company's unfunded commitments related to certain of its corporate loans.

6. Investments in Unconsolidated Entities

The Company has various equity investments in entities where it has the ability to exert significant influence over such entity, but does not control such entity. In these cases the criteria for consolidation have not been met and the Company is required to account for such investments under ASC 323-10; the Company has elected the FVO for its investments in unconsolidated entities. As of December 31, 2020 and 2019, the Company's investments in unconsolidated entities had an aggregate fair value of $141.6 million and $71.9 million, respectively, which is included on the Consolidated Balance Sheet in Investments in unconsolidated entities, at fair value. For the years ended December 31, 2020 and 2019, the Company recognized $37.9 million and $10.2 million, respectively, in Earnings (losses) from investments in unconsolidated entities, on its Consolidated Statement of Operations, primarily related to its investment in loan originators. As of December 31, 2020 and 2019, the Company had non-controlling equity interests in three loan originators with an aggregate fair value of $79.5 million and $40.6 million, respectively. Certain of the entities that the Company accounts for under ASC 323-10 are deemed to be VIEs, and the maximum amount at risk is generally limited to the Company's investment in the VIE. As of December 31, 2020 and 2019, the fair value of the Company's investments in unconsolidated entities that have been deemed to be VIEs was $13.6 million and $28.5 million.

146

Table of Contents

The following table provides details about the Company's investments in unconsolidated entities as of December 31, 2020 and 2019:

		Percentage Ownership of Unconsolidated Entity
Investment in Unconsolidated Entity	Form of Investment	December 31, 2020	December 31, 2019
Longbridge Financial, LLC(1)	Preferred shares	49.7%	49.7%
LendSure Mortgage Corp.(1)(2)	Common shares	49.9%	49.9%
Elizon TCG SBC 2017-1(1)	Membership Interest	36.0%	—%
Jepson Holdings Limited(1)	Membership Interest	30.1%	30.1%
Elizon DB 2015-1 LLC(1)(3)(4)	Membership Interest	8.9%	3.5%
Elizon AFG 2018-1 LLC(1)(3)(5)	Membership Interest	—%	13.4%
Other(6)(7)	Various	7.4%–56.3%	7.7%–51.0%

(1)See Note 13 for additional details on the Company's related party transactions.

(2)Excludes investment in warrants convertible into non-voting common shares; including such warrants the Company's additional non-voting stake in the entity was 15.0% as of December 31, 2020. See Note 13 Related Party Transactions—Transactions Involving Certain Loan Originators for additional information.

(3)The Company has evaluated this entity and determined that it meets the definition of a VIE. The Company evaluated its interest in the VIE and determined that the Company does not have the power to direct the activities of the VIE and does not have control of the underlying assets, where applicable. As a result, the Company determined that it is not the primary beneficiary of this VIE and therefore has not consolidated the VIE.

(4)As discussed in Note 13 Related Party Transactions—Participation in Multi-Borrower Financing Facilities, the Company and the Affiliated Entities (as defined in Note 13) each consolidate their segregated silos of the Joint Entity (as defined in Note 13). The Company's effective percentage ownership before the effects of consolidation of both its and the Affiliated Entities' respective segregated silos of the Joint Entity, was 58.2% and 70.4% as of December 31, 2020 and 2019, respectively.

(5)As discussed in Note 13 Related Party Transactions—Participation in Multi-Borrower Financing Facilities, the Company and the Affiliated Entities each consolidate their segregated silos of the Joint Entity. The Company's effective percentage ownership before the effects of consolidation of both its and the Affiliated Entities' respective segregated silos of the Joint Entity, was 48.7% as of December 31, 2019.

(6)Includes interest in Consumer Risk Retention Vehicle, as defined in Note 10—Participation in Multi-Seller Consumer Loan Securitization. The Company has evaluated this entity and determined that it does not meet the definition of a VIE. The Company evaluated its interest in the entity under the voting interest model outlined in ASC 810, and has determined that the Company does not control this entity. As a result, the Company has not consolidated the entity. See Note 10 for additional details on the Company's securitization transactions.

(7)Includes interest in warehouse facilities; see Note 13—Participation in CLO Transactions, for additional details.

The following table provides a summary of the combined financial position of the unconsolidated entities as of December 31, 2020 and 2019, in which the Company has an investment:

	December 31, 2020		December 31, 2019
	(In thousands)
Assets
Investments in securities, loans, MSRs, and REO(1)	$	424,475	$	560,949
Other assets	117,746		65,580
Total assets	$	542,221	$	626,529
Liabilities
Borrowings	$	215,792	$	387,910
Other liabilities	30,801		28,134
Total liabilities	246,593		416,044
Equity	295,628		210,485
Total liabilities and equity	$	542,221	$	626,529

(1)Includes investments carried as the lower of cost or fair value as well as investments where the unconsolidated entity has elected the FVO.

147

Table of Contents

The following table provides a summary of the combined results of operations of the unconsolidated entities as of December 31, 2020 and 2019, in which the Company has an investment:

	Year Ended December 31, 2020		Year Ended December 31, 2019
			(In thousands)
Net Interest Income
Interest income	$	10,935	$	30,587
Interest expense	(9,243)		(13,316)
Total net interest income	1,692		17,271
Other Income (Loss)
Realized and unrealized gains (losses) on securities, loans, MSRs, and REO, net	44,362		40,901
Other, net	44,031		31,848
Total other income (loss)	88,393		72,749
Total expenses	65,492		58,018
Net income (loss) before income tax expense	24,593		32,002
Income tax expense (benefit)	776		979
Net Income (Loss)	$	23,817	$	31,023

7. Real Estate Owned

As discussed in Note 2, the Company obtains possession of REO as a result of foreclosures on the associated mortgage loans. The following tables detail activity in the Company's carrying value of REO for the years ended December 31, 2020 and 2019:

	Year Ended
	December 31, 2020			December 31, 2019
	Number of Properties	Carrying Value		Number of Properties	Carrying Value
		(In thousands)			(In thousands)
Beginning Balance (December 31, 2019 and January 1, 2019, respectively)	15	$	30,584	20	$	30,778
Transfers from mortgage loans	10	3,384		8	22,577
Capital expenditures and other adjustments to cost		191			240
Adjustments to record at the lower of cost or fair value		(1,053)			(1,002)
Disposals	(12)	(9,508)		(13)	(22,009)
Ending Balance (December 31, 2020 and 2019, respectively)	13	$	23,598	15	$	30,584

During the year ended December 31, 2020, the Company sold twelve REO properties, realizing a net gain (loss) of approximately $15 thousand. During the year ended December 31, 2019, the Company sold thirteen REO properties, realizing a net gain (loss) of approximately $2.3 million. Such realized gains (losses) are included in Realized gains (losses) on real estate owned, net, on the Company's Consolidated Statement of Operations. As of December 31, 2020 and 2019 all of the Company's REO had been obtained as a result of obtaining physical possession through foreclosure. As of December 31, 2020 and 2019, the Company had REO measured at fair value on a non-recurring basis of $22.4 million and $19.4 million, respectively.

148

Table of Contents

8. Financial Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages certain risks associated with its investments and borrowings, including interest rate, credit, liquidity, and foreign exchange rate risk primarily by managing the amount, sources, and duration of its investments and borrowings, and through the use of derivative financial instruments. The Company's derivative financial instruments are used to manage differences in the amount, timing, and duration of its known or expected cash receipts and its known or expected cash payments principally related to its investments and borrowings.

The following table details the fair value of the Company's holdings of financial derivatives as of December 31, 2020 and 2019:

	December 31, 2020		December 31, 2019
(In thousands)
Financial derivatives–assets, at fair value:
TBA securities purchase contracts	$	961	$	90
TBA securities sale contracts	1		506
Fixed payer interest rate swaps	125		3,914
Fixed receiver interest rate swaps	8,394		1,554
Credit default swaps on asset-backed securities	347		993
Credit default swaps on asset-backed indices	2,184		3,319
Credit default swaps on corporate bonds	—		2
Credit default swaps on corporate bond indices	3,420		5,599
Total return swaps	9		620
Futures	2		148
Forwards	—		43
Warrants	36		—
Total financial derivatives–assets, at fair value	15,479		16,788
Financial derivatives–liabilities, at fair value:
TBA securities sale contracts	$	(925)	$	(1,012)
Fixed payer interest rate swaps	(15,109)		(8,513)
Fixed receiver interest rate swaps	(65)		(206)
Credit default swaps on asset-backed indices	(130)		(250)
Credit default swaps on corporate bonds	(747)		(1,693)
Credit default swaps on corporate bond indices	(6,438)		(14,524)
Total return swaps	(484)		(1,209)
Futures	(376)		(45)
Forwards	(279)		(169)
Total financial derivatives–liabilities, at fair value	(24,553)		(27,621)
Total	$	(9,074)	$	(10,833)

149

Table of Contents

Interest Rate Swaps

The following tables provide information about the Company's fixed payer interest rate swaps as of December 31, 2020 and 2019:

December 31, 2020:

					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	17,500	$	(231)	2.75	%	0.24	%	0.22
2022	96,533		(1,535)		1.19		0.22		1.14
2023	146,012		(4,770)		1.50		0.23		2.42
2025	66,503		(1,034)		0.73		0.21		4.75
2026	11,216		(458)		1.23		0.25		5.50
2027	9,732		60		0.49		0.24		6.48
2028	16,644		(2,169)		2.39		0.24		7.32
2029	22,744		(2,289)		1.94		0.23		8.61
2030	13,015		(369)		1.13		0.22		9.29
2035	500		15		0.78		0.09		14.81
2036	1,100		(47)		1.45		0.25		15.13
2040	500		20		0.90		0.09		19.82
2049	5,796		(2,208)		2.89		0.23		28.02
2050	500		31		0.98		0.09		29.82
Total	$	408,295	$	(14,984)	1.39	%	0.23	%	3.82

December 31, 2019:

					Weighted Average
Maturity	Notional Amount(1)		Fair Value(1)		Pay Rate(2)(3)		Receive Rate(2)		Remaining Years to Maturity(4)
	(In thousands)
2020	$	68,607	$	(234)	1.74	%	1.93	%	0.24
2021	268,929		(419)		1.73		1.95		1.64
2022	31,350		9		1.65		1.93		2.14
2023	101,012		(1,265)		2.06		1.91		3.29
2024	13,000		99		1.56		1.89		4.90
2025	12,800		(24)		n/a		n/a		5.22
2026	59,902		1,946		1.24		1.94		6.50
2028	32,942		(1,634)		2.40		1.93		8.34
2029	136,838		(2,018)		2.02		1.96		9.61
2030	685		(32)		2.38		1.90		10.90
2036	1,100		87		1.45		1.94		16.14
2049	5,796		(1,114)		2.89		2.09		29.03
Total	$	732,961	$	(4,599)	1.83	%	1.94	%	4.31

(1)Includes forward-starting interest rate swaps with a notional amount of $20.9 million and fair value of $(41) thousand.

(2)Excludes forward-starting interest rate swaps.

(3)Including forward-starting interest rate swaps the total weighted average pay rate was 1.83%.

(4)Includes forward-starting interest rate swaps, all of which start within six months of period end.

150

Table of Contents

The following tables provide information about the Company's fixed receiver interest rate swaps as of December 31, 2020 and 2019:

December 31, 2020:

					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	12,950	$	205	0.24	%	1.75	%	0.71
2022	103,974		1,413		0.22		1.07		1.48
2023	48,657		2,209		0.24		2.00		2.26
2024	86,342		4,567		0.22		1.65		3.73
2035	500		(14)		0.09		0.74		14.81
2040	500		(20)		0.09		0.84		19.82
2050	500		(31)		0.09		0.90		29.82
Total	$	253,423	$	8,329	0.22	%	1.48	%	2.48

December 31, 2019:

					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	181,950	$	(49)	1.89	%	1.67	%	1.84
2022	53,974		441		1.91		1.85		2.17
2023	48,657		709		1.92		2.00		3.26
2024	11,342		306		2.09		2.33		4.23
2029	9,800		(59)		1.91		1.78		9.77
Total	$	305,723	$	1,348	1.91	%	1.78	%	2.47

151

Table of Contents

Credit Default Swaps

The following table provides information about the Company's credit default swaps as of December 31, 2020 and 2019:

	As of
	December 31, 2020					December 31, 2019
Type(1)	Notional		Fair Value		Weighted Average Remaining Term (Years)	Notional		Fair Value		Weighted Average Remaining Term (Years)
($ in thousands)
Asset:
Long:
Credit default swaps on asset-backed indices	$	395	$	5	16.99	$	695	$	10	23.80
Credit default swaps on corporate bonds	—		—		—	430		2		0.47
Credit default swaps on corporate bond indices	67,779		3,296		2.52	130,707		5,547		2.42
Short:
Credit default swaps on asset-backed securities	(957)		347		14.70	(2,640)		993		15.63
Credit default swaps on asset-backed indices	(12,888)		2,179		39.61	(63,515)		3,309		38.40
Credit default swaps on corporate bond indices	(2,173)		124		2.97	(1,997)		52		3.97
Liability:
Long:
Credit default swaps on asset-backed indices	479		(130)		32.36	344		(145)		29.35
Short:
Credit default swaps on asset-backed indices	(1)		—		29.00	(4,501)		(105)		40.31
Credit default swaps on corporate bonds	(8,400)		(747)		4.17	(10,800)		(1,693)		3.92
Credit default swaps on corporate bond indices	(110,624)		(6,438)		2.78	(250,088)		(14,524)		2.51
	$	(66,390)	$	(1,364)	10.25	$	(201,365)	$	(6,554)	14.88

(1)Long notional represents contracts where the Company has written protection and short notional represents contracts where the Company has purchased protection.

152

Table of Contents

Futures

The following table provides information about the Company's long and short positions in futures as of December 31, 2020 and 2019:

	As of
	December 31, 2020					December 31, 2019
Description	Notional Amount		Fair Value		Remaining Months to Expiration	Notional Amount		Fair Value		Remaining Months to Expiration
	(In thousands)					(In thousands)
Assets:
Short Contracts:
U.S. Treasury futures	$	(300)	$	2	2.70	$	—	$	—	—
Liabilities:
Long Contracts:
U.S. Treasury futures	1,900		(9)		2.70	—		—		—
Short Contracts:
U.S. Treasury futures	(178,200)		(367)		2.94	(16,000)		148		2.77
Eurodollar futures	—		—		—	(14,000)		(45)		4.05
Total, net	$	(176,600)	$	(374)	2.94	$	(30,000)	$	103	3.37

Warrants

The following table provides information about the Company's warrants contracts to purchase shares as of December 31, 2020 and 2019:

	December 31, 2020				As of December, 31, 2019
Description	Number of Shares Underlying Warrant	Fair Value		Remaining Years to Expiration	Number of Shares Underlying Warrant	Fair Value		Remaining Years to Expiration
	(In thousands)				(In thousands)
Warrants	1,897	$	36	2.40	1,515	$	—	2.82

TBAs

The Company transacts in the forward settling TBA market. Pursuant to these TBA transactions, the Company agrees to purchase or sell, for future delivery, Agency RMBS with certain principal and interest terms and certain types of underlying collateral, but the particular Agency RMBS to be delivered is not identified until shortly before the TBA settlement date. TBAs are generally liquid, have quoted market prices, and represent the most actively traded class of MBS. The Company uses TBAs to mitigate interest rate risk, usually by taking short positions. The Company also invests in TBAs as a means of acquiring additional exposure to Agency RMBS, or for investment purposes, including holding long positions.

The Company does not generally take delivery of TBAs; rather, it settles the associated receivable and payable with its trading counterparties on a net basis. Transactions with the same counterparty for the same TBA that result in a reduction of the position are treated as extinguished.

153

Table of Contents

As of December 31, 2020 and 2019, the Company had outstanding TBA purchase and sale contracts as follows:

	December 31, 2020								December 31, 2019
TBA Securities	Notional Amount(1)		Cost Basis(2)		Market Value(3)		Net Carrying Value(4)		Notional Amount(1)		Cost Basis(2)		Market Value(3)		Net Carrying Value(4)
(In thousands)
Purchase contracts:
Assets	$	149,990	$	155,008	$	155,969	$	961	$	40,100	$	40,585	$	40,675	$	90
Liabilities	—		—		—		—		—		—		—		—
	149,990		155,008		155,969		961		40,100		40,585		40,675		90
Sale contracts:
Assets	(4,400)		(4,765)		(4,764)		1		(319,981)		(332,080)		(331,574)		506
Liabilities	(499,667)		(531,034)		(531,959)		(925)		(773,749)		(806,568)		(807,580)		(1,012)
	(504,067)		(535,799)		(536,723)		(924)		(1,093,730)		(1,138,648)		(1,139,154)		(506)
Total TBA securities, net	$	(354,077)	$	(380,791)	$	(380,754)	$	37	$	(1,053,630)	$	(1,098,063)	$	(1,098,479)	$	(416)

(1)Notional amount represents the principal balance of the underlying Agency RMBS.

(2)Cost basis represents the forward price to be paid (received) for the underlying Agency RMBS.

(3)Market value represents the current market value of the underlying Agency RMBS (on a forward delivery basis) as of period end.

(4)Net carrying value represents the difference between the market value of the TBA contract as of period end and the cost basis, and is reported in Financial derivatives-assets, at fair value and Financial derivatives-liabilities, at fair value on the Consolidated Balance Sheet.

Gains and losses on the Company's derivative contracts for the years ended December 31, 2020 and 2019 are summarized in the tables below:

Year Ended December 31, 2020:

Derivative Type	Primary  Risk Exposure	Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps		Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)		Net Realized Gains (Losses) on Financial Derivatives(1)		Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps		Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)		Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)
(In thousands)
Interest rate swaps	Interest Rate	$	(2,038)	$	(17,060)	$	(19,098)	$	219	$	(6,597)	$	(6,378)
Credit default swaps on asset-backed securities	Credit			(5,452)		(5,452)				5,402		5,402
Credit default swaps on asset-backed indices	Credit			6,486		6,486				2,691		2,691
Credit default swaps on corporate bond indices	Credit			1,502		1,502				(712)		(712)
Credit default swaps on corporate bonds	Credit			285		285				486		486
Total return swaps	Credit			(2,057)		(2,057)				114		114
TBAs	Interest Rate			(4,624)		(4,624)				454		454
Futures	Interest Rate			(7,447)		(7,447)				(477)		(477)
Forwards	Currency			(1,004)		(1,004)				(153)		(153)
Warrants	Equity Market/Credit			—		—				(377)		(377)
Options	Credit			(100)		(100)				—		—
Total		$	(2,038)	$	(29,471)	$	(31,509)	$	219	$	831	$	1,050

(1)Includes realized gain/(loss) on transactions involving foreign-currency-denominated financial derivatives in the amount of $12 thousand for the year ended December 31, 2020, which is included on the Consolidated Statement of Operations in Other, net.

(2)Includes foreign currency remeasurement on financial derivatives in the amount of $61 thousand for the year ended December 31, 2020, which is included on the Consolidated Statement of Operations in Other, net.

154

Table of Contents

Year Ended December 31, 2019:

Derivative Type	Primary  Risk Exposure	Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps		Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)		Net Realized Gains (Losses) on Financial Derivatives(1)		Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps		Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)		Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)
(In thousands)
Interest rate swaps	Interest Rate	$	1,695	$	(876)	$	819	$	(764)	$	(5,778)	$	(6,542)
Credit default swaps on asset-backed securities	Credit			528		528				(479)		(479)
Credit default swaps on asset-backed indices	Credit			(1,883)		(1,883)				(1,848)		(1,848)
Credit default swaps on corporate bond indices	Credit			(5,262)		(5,262)				(1,364)		(1,364)
Credit default swaps on corporate bonds	Credit			(708)		(708)				1,007		1,007
Total return swaps	Equity Market/Credit			(1,460)		(1,460)				(584)		(584)
TBAs	Interest Rate			(15,755)		(15,755)				4,026		4,026
Futures	Interest Rate/Currency			(7,924)		(7,924)				458		458
Forwards	Currency			813		813				(12)		(12)
Options	Interest Rate			(35)		(35)				1		1
Total		$	1,695	$	(32,562)	$	(30,867)	$	(764)	$	(4,573)	$	(5,337)

(1)Includes realized gain/(loss) on transactions involving foreign-currency-denominated financial derivatives in the amount of $45 thousand for the year ended December 31, 2019, which is included on the Consolidated Statement of Operations in Other, net.

(2)Includes foreign currency remeasurement on financial derivatives in the amount of $1 thousand for the year ended December 31, 2019, which is included on the Consolidated Statement of Operations in Other, net.

The table below details the average notional values of the Company's financial derivatives, using absolute value of month end notional values, for the years ended December 31, 2020 and 2019:

Derivative Type	Year Ended December 31, 2020		Year Ended December 31, 2019
(In thousands)
Interest rate swaps	$	1,009,110	$	731,941
TBAs	713,634		973,331
Credit default swaps	277,990		399,316
Total return swaps	6,975		39,434
Futures	149,538		167,708
Options	1,500		19,825
Forwards	26,413		30,930
Warrants	1,570		2,222

From time to time the Company enters into credit derivative contracts for which the Company sells credit protection ("written credit derivatives"). As of December 31, 2020 and 2019, all of the Company's open written credit derivatives were credit default swaps on either mortgage/asset-backed indices (ABX and CMBX indices) or corporate bond indices (CDX), collectively referred to as credit indices, or on individual corporate bonds, for which the Company receives periodic payments at fixed rates from credit protection buyers, and is obligated to make payments to the credit protection buyer upon the occurrence of a "credit event" with respect to underlying reference assets.

155

Table of Contents

Written credit derivatives held by the Company at December 31, 2020 and 2019 are summarized below:

Credit Derivatives	December 31, 2020		December 31, 2019
(In thousands)
Fair Value of Written Credit Derivatives, Net	$	3,171	$	5,414
Fair Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties (1)	—		(3,248)
Notional Value of Written Credit Derivatives (2)	68,653		132,176
Notional Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties (1)	—		(81,637)

(1)Offsetting transactions with third parties include purchased credit derivatives which have the same reference obligation.

(2)The notional value is the maximum amount that a seller of credit protection would be obligated to pay, and a buyer of credit protection would receive, upon occurrence of a "credit event." Movements in the value of credit default swap transactions may require the Company or the counterparty to post or receive collateral. Amounts due or owed under credit derivative contracts with an International Swaps and Derivatives Association, or "ISDA," counterparty may be offset against amounts due or owed on other credit derivative contracts with the same ISDA counterparty. As a result, the notional value of written credit derivatives involving a particular underlying reference asset or index has been reduced (but not below zero) by the notional value of any contracts where the Company has purchased credit protection on the same reference asset or index with the same ISDA counterparty.

A credit default swap on a credit index or a corporate bond typically terminates at the stated maturity date in the case of corporate indices or bonds, or, in the case of ABX and CMBX indices, the date that all of the reference assets underlying the index are paid off in full, retired, or otherwise cease to exist. Implied credit spreads may be used to determine the market value of such contracts and are reflective of the cost of buying/selling credit protection. Higher spreads would indicate a greater likelihood that a seller will be obligated to perform (i.e., make protection payments) under the contract. In situations where the credit quality of the underlying reference assets has deteriorated, the percentage of notional values that would be paid up front to enter into a new such contract ("points up front") is frequently used as an indication of credit risk. Credit protection sellers entering the market in such situations would expect to be paid points up front corresponding to the approximate fair value of the contract. For the Company's written credit derivatives that were outstanding at December 31, 2020 and 2019, implied credit spreads on such contracts ranged between 40.0 and 274.8 basis points and 10.9 and 440.0 basis points, respectively. Excluded from these spread ranges are contracts outstanding for which the individual spread is greater than 2,000 basis points. The Company believes that these contracts would be quoted based on estimated points up front. The total fair value of contracts with individual implied credit spreads in excess of 2,000 basis points was $(0.1) million as of both December 31, 2020 and December 31, 2019. Estimated points up front on these contracts as of December 31, 2020 ranged between 56.2 and 85.2 and as of December 31, 2019 estimated points up front on these contracts was 57.0. Total net up-front payments (paid) or received relating to written credit derivatives outstanding at December 31, 2020 and 2019 were $(2.0) million and $(3.3) million, respectively.

156

Table of Contents

9. Consolidated VIEs

As discussed in Note 2, the Company has interests in entities that it has determined to be VIEs. The following table summarizes the assets and liabilities of the Company's consolidated VIEs that are included on the Company's Consolidated Balance Sheet as of December 31, 2020 and 2019.

(In thousands)	December 31, 2020 (1)		December 31, 2019 (1)
Assets
Cash and cash equivalents	$	701	$	6,016
Restricted cash	175		175
Securities, at fair value	44,523		47,923
Loans, at fair value	1,435,067		1,393,916
Investments in unconsolidated entities, at fair value	6,345		5,641
Real estate owned	23,598		30,584
Investment related receivables	24,824		28,668
Other assets	2,001		6,191
Total Assets	$	1,537,234	$	1,519,114
Liabilities
Repurchase agreements	$	275,019	$	302,791
Investment related payables	—		3,275
Other secured borrowings	51,062		150,334
Other secured borrowings, at fair value	754,921		594,396
Interest payable	776		1,247
Accrued expenses and other liabilities	1,103		2,279
Total Liabilities	1,082,881		1,054,322
Total Stockholders' Equity	430,554		440,394
Non-controlling interests	23,799		24,400
Total Equity	454,353		464,794
Total Liabilities and Equity	$	1,537,234	$	1,519,116

(1)See Note 10 and Note 13 for additional information on the Company's consolidated VIEs.

10. Securitization Transactions

Participation in CLO Transactions

Since June 2017, an affiliate of Ellington has sponsored four CLO securitization transactions (the "Ellington-sponsored CLO Securitizations"), collateralized by corporate loans and managed by an affiliate of Ellington (the "CLO Manager"). Ellington, the Company, several other affiliates of Ellington, and in certain cases, third parties, participated in the Ellington-sponsored CLO Securitizations (collectively, the "CLO Co-Participants").

Pursuant to each Ellington-sponsored CLO Securitization, a newly formed securitization trust (each a "CLO Issuer") issued various classes of notes, which were in turn sold to unrelated third parties and the applicable CLO Co-Participants.

The CLO Issuers are each deemed to be a VIE. The Company evaluates its interests in the CLO Issuers under ASC 810, and while the Company retains credit risk in each of the securitization trusts through its beneficial ownership of a portion of the subordinated interests of each of the securitization trusts, which are the first to absorb credit losses on the securitized assets, the Company does not retain control of these assets or the power to direct the activities of the CLO Issuers that most significantly impact the CLO Issuers' economic performance. As a result, the Company determined that it is not the primary beneficiary of the CLO Issuers, and therefore the Company has not consolidated the CLO Issuers. The Company's maximum amount at risk is limited to the Company's investment in each of the CLO Issuers. As of December 31, 2020 and 2019, the fair value of the Company's investment in the notes issued by the CLO Issuers was $17.3 million and $39.7 million, respectively.

See Note 13 for further details on the Company's participation in CLO transactions.

157

Table of Contents

Residential Mortgage Loan Securitizations

Since November 2017, the Company, through certain wholly owned subsidiaries (each, a "Sponsor"), has sponsored several securitizations of non-QM loans. In each case, the applicable Sponsor transferred a pool of non-QM loans (each, a Collateral Pool") to a wholly owned entity (each, a "Depositor") and on the closing date such loans were deposited into newly created securitization trusts (collectively, the "Issuing Entities"). Pursuant to the securitizations, the Issuing Entities issued various classes of mortgage pass-through certificates (the "Certificates") which are backed by the cash flows from the underlying non-QM loans.

Under the Dodd-Frank Act, sponsors of securitizations are generally required to retain at least 5% of the economic interest in the credit risk of the securitized assets (the "Risk Retention Rules"). In order to comply with the Risk Retention Rules, in each securitization, the applicable Sponsor purchased and intends to hold, at a minimum, the requisite amount of the most subordinated classes of Certificates and the excess cash flow certificates. The applicable Sponsor also purchased the Certificates entitled to excess servicing fees in each securitization, while the remaining classes of Certificates were purchased by unrelated parties.

Notwithstanding that the Certificates carry final scheduled distribution dates of October 25, 2047 or later, the applicable Depositor may, at its sole option, purchase all of the outstanding Certificates (an "Optional Redemption") following the earlier of (1) the applicable anniversary of the closing date (typically two or three years) of the respective securitization or (2) the date on which the aggregate unpaid principal balance of the applicable Collateral Pool has declined below 30% of the aggregate unpaid principal balance of the applicable Collateral Pool as of the date as of which such loans were originally transferred to the applicable Issuing Entity. The purchase price that the Depositor is required to pay in connection with an Optional Redemption is equal to the sum of the unpaid principal balance of each class of Certificates as of the redemption date and any accrued and unpaid interest thereon. In light of these Optional Redemption rights held by the applicable Depositor, the transfers of non-QM loans to each of the Issuing Entities do not qualify as sales under ASC 860-10.

In the event that certain breaches of representations or warranties are discovered with respect to any underlying non-QM loans, the Company could be required to repurchase or replace such loans.

Each Sponsor also serves as the servicing administrator of its respective securitization, for which it is entitled to receive a monthly fee equal to one-twelfth of the product of (a) 0.03% and (b) the unpaid principal balance of the underlying non-QM loans as of the first day of the related due period. Each Sponsor in its role as servicing administrator provides direction and consent for certain loss mitigation activities to the third-party servicer of the underlying non-QM loans. In certain circumstances, the servicing administrator will be required to reimburse the servicer for principal and interest advances and servicing advances made by the servicer.

In light of the Company's retained interests in each of the securitizations, together with the Optional Redemption rights and the Company's ability to direct the third-party servicer regarding certain loss mitigation activities, the Company is deemed to be the primary beneficiary of the Issuing Entities, which are VIEs, and has consolidated the Issuing Entities. Interest income from these loans and the expenses related to the servicing of these loans are included in Interest income and Investment related expenses—Servicing expense, respectively, on the Consolidated Statement of Operations.

The Issuing Entities each meet the definition of a CFE as defined in Note 2, and as a result the assets of each of the Issuing Entities have been valued using the fair value of the liabilities of the respective Issuing Entity, as such liabilities have been assessed to be more observable than such assets.

The debt of the Issuing Entities is included in Other secured borrowings, at fair value, on the Consolidated Balance Sheet and is shown net of the Certificates held by the Company. In November 2020, the Company exercised its Optional Redemption right with respect to Ellington Financial Mortgage Trust 2018-1. In November 2019, the Company exercised its Optional Redemption right with respect to Ellington Financial Mortgage Trust 2017-1.

158

Table of Contents

The following table details the Company's outstanding consolidated residential mortgage loan securitizations:

Issuing Entity	Closing Date	Principal Balance of Loans Transferred to the Depositor		Total Face Amount of Certificates Issued
		(In thousands)
Ellington Financial Mortgage Trust 2019-1	6/19	$	226,913	$	226,913	(1)
Ellington Financial Mortgage Trust 2019-2	11/19	267,255		267,255		(2)
Ellington Financial Mortgage Trust 2020-1	6/20	259,273		259,273		(3)
Ellington Financial Mortgage Trust 2020-2	11/20	219,732		219,732		(4)

(1)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 6.1% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.2 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(2)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 6.4% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.7 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(3)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 8.0% of the fair value of all Certificates issued. Additionally, the Sponsor purchased another subordinated class of Certificates with an aggregate value equal to 3.5% of the fair value of all Certificates issued as of the settlement date. Finally, the Sponsor also purchased, for an aggregate purchase price of $1.9 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(4)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 7.6% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.4 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

The following table details the assets and liabilities of the consolidated securitization trusts included in the Company's Consolidated Balance Sheet as of December 31, 2020 and 2019:

(In thousands)	December 31, 2020		December 31, 2019
Assets:
Loans, at fair value	$	801,343	$	628,415
Real estate owned	—		658
Investment related receivables	15,544		10,409
Liabilities:
Other secured borrowings, at fair value	754,921		594,396

Participation in Multi-Seller Consumer Loan Securitization

In November 2020, the Company participated in a securitization whereby the Company, together with another entity managed by Ellington (the "Consumer Co-Participant"), sold consumer loans with an aggregate unpaid principal balance of approximately $205.1 million to a newly formed securitization trust (the "Consumer Securitization Issuer"). Of the $205.1 million in loans sold to the Consumer Securitization Issuer, the Company's share was 56.3% while the Consumer Co-Participant's share was 43.7%. The transfer was accounted for as a sale in accordance with ASC 860-10. Pursuant to the securitization, the Consumer Securitization Issuer issued senior and subordinated notes in the principal amounts of $158.4 million and $35.2 million, respectively. Trust certificates representing beneficial ownership of the Issuer were also issued. In connection with the transaction, and through a jointly owned newly formed entity (the "Consumer Risk Retention Vehicle"), the Company and the Consumer Co-Participant acquired certain of the subordinated notes as well as the trust certificates in the Issuer. The Company and the co-participant acquired 56.3% and 43.7%, respectively, of the interests in the Consumer Risk Retention Vehicle. As of December 31, 2020, the Company's total interest in the Consumer Risk Retention Vehicle, for which the Company has elected the FVO, was 56.3% or $19.1 million, and is included on the Consolidated Balance Sheet in Investments in unconsolidated entities, at fair value.

The notes and trust certificates issued by the Consumer Securitization Issuer are backed by the cash flows from the underlying consumer loans. If there are breaches of representations and warranties with respect to any underlying consumer loans, the Company could, under certain circumstances, be required to repurchase or replace such loans. Absent such breaches, the Company has no obligation to repurchase or replace any underlying consumer loans that become delinquent or otherwise default. In addition, another affiliate of Ellington acts as the administrator for the securitization and is paid a monthly fee for its services.

159

Table of Contents

The Consumer Securitization Issuer is deemed to be a VIE. The Company has evaluated its interest in the Consumer Securitization Issuer under ASC 810, and while the Company retains credit risk in the securitization trust through its beneficial ownership of most of the subordinated interests of the securitization trust, which are the first to absorb credit losses on the securitized assets, neither the Company nor the Consumer Risk Retention Vehicle retains control of these assets or the power to direct the activities of the Consumer Securitization Issuer that most significantly impact the Consumer Securitization Issuer's economic performance. As a result, the Company determined that neither the Company nor the Consumer Risk Retention Vehicle is the primary beneficiary of the Consumer Securitization Issuer, and therefore the Company has not consolidated the Consumer Securitization Issuer. Additionally, the Company evaluated its interest in the Consumer Risk Retention Vehicle, which does not meet the criteria to be deemed a VIE, under the voting interest model provided by ASC 810 and determined the Company does not control the Consumer Risk Retention Vehicle. As a result, the Company has not consolidated the Consumer Risk Retention Vehicle.

11. Borrowings

Secured Borrowings

The Company's secured borrowings consist of repurchase agreements, Other secured borrowings, and Other secured borrowings, at fair value. As of December 31, 2020 and 2019, the Company's total secured borrowings were $2.3 billion and $3.2 billion, respectively.

Repurchase Agreements

The Company enters into repurchase agreements. A repurchase agreement involves the sale of an asset to a counterparty together with a simultaneous agreement to repurchase the transferred asset or similar asset from such counterparty at a future date. The Company accounts for its repurchase agreements as collateralized borrowings, with the transferred assets effectively serving as collateral for the related borrowing. The Company's repurchase agreements typically range in term from 30 to 180 days, although the Company also has repurchase agreements that provide for longer or shorter terms. The principal economic terms of each repurchase agreement—such as loan amount, interest rate, and maturity date—are typically negotiated on a transaction-by-transaction basis. Other terms and conditions, such as those relating to events of default, are typically governed under the Company's master repurchase agreements. Absent an event of default, the Company maintains beneficial ownership of the transferred securities during the term of the repurchase agreement and receives the related principal and interest payments. Interest rates on these borrowings are generally fixed based on prevailing rates corresponding to the terms of the borrowings, and for most repurchase agreements, interest is generally paid at the termination of the repurchase agreement, at which time the Company may enter into a new repurchase agreement at prevailing market rates with the same counterparty, repay that counterparty and possibly negotiate financing terms with a different counterparty, or choose to no longer finance the related asset. Some repurchase agreements provide for periodic payments of interest, such as monthly payments. In response to a decline in the fair value of the transferred securities, whether as a result of changes in market conditions, security paydowns, or other factors, repurchase agreement counterparties will typically make a margin call, whereby the Company will be required to post additional securities and/or cash as collateral with the counterparty in order to re-establish the agreed-upon collateralization requirements. In the event of increases in fair value of the transferred securities, the Company can generally require the counterparty to post collateral with it in the form of cash or securities. The Company is generally permitted to sell or re-pledge any securities posted by the counterparty as collateral; however, upon termination of the repurchase agreement, or other circumstance in which the counterparty is no longer required to post such margin, the Company must return to the counterparty the same security that had been posted.

At any given time, the Company seeks to have its outstanding borrowings under repurchase agreements with several different counterparties in order to reduce the exposure to any single counterparty. The Company had outstanding borrowings under repurchase agreements with 24 counterparties as of December 31, 2020 as compared to 28 counterparties as of December 31, 2019.

As of December 31, 2020, remaining days to maturity on the Company's open repurchase agreements ranged from 4 days to 516 days. Interest rates on the Company's open repurchase agreements ranged from 0.20% to 5.00% as of December 31, 2020. As of December 31, 2019, remaining days to maturity on the Company's open repurchase agreements ranged from 2 days to 882 days. Interest rates on the Company's open repurchase agreements ranged from 0.15% to 5.20% as of December 31, 2019.

160

Table of Contents

The following table details the Company's outstanding borrowings under repurchase agreements for Agency RMBS and credit assets (which can include non-Agency RMBS, CMBS, CLOs, consumer loans, corporate debt, residential mortgage loans, and commercial mortgage loans and REO), by remaining maturity as of December 31, 2020 and 2019:

	December 31, 2020					December 31, 2019
			Weighted Average					Weighted Average
Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity
Agency RMBS:	(In thousands)					(In thousands)
30 Days or Less	$	265,556	0.28	%	17	$	511,996	2.08	%	17
31-60 Days	385,141		0.25	%	44	744,387		1.93	%	47
61-90 Days	174,586		0.28	%	70	594,738		1.96	%	76
91-120 Days	—		—	%	—	10,270		2.24	%	93
121-150 Days	2,692		0.27	%	126	—		—	%	—
151-180 Days	59,857		0.32	%	162	3,082		2.67	%	171
181-360 Days	34,030		0.32	%	252	—		—	%	—
Total Agency RMBS	921,862		0.27	%	57	1,864,473		1.98	%	48
Credit:
30 Days or Less	37,795		2.11	%	17	16,549		3.38	%	25
31-60 Days	84,554		2.23	%	50	104,491		3.14	%	48
61-90 Days	152,426		2.11	%	75	138,837		3.03	%	73
91-120 Days	89,931		2.47	%	106	—		—	%	—
121-150 Days	66,412		4.75	%	125	7,460		3.89	%	123
151-180 Days	11,063		2.27	%	165	31,498		3.87	%	173
181-360 Days	38,640		2.90	%	289	186,661		3.80	%	250
> 360 Days	94,248		2.99	%	447	95,331		4.52	%	678
Total Credit Assets	575,069		2.69	%	155	580,827		3.61	%	229
Total	$	1,496,931	1.20	%	94	$	2,445,300	2.37	%	91

Repurchase agreements involving underlying investments that the Company sold prior to period end, for settlement following period end, are shown using their original maturity dates even though such repurchase agreements may be expected to be terminated early upon settlement of the sale of the underlying investment.

As of December 31, 2020 and 2019, the fair value of investments transferred as collateral under outstanding borrowings under repurchase agreements was $1.831 billion and $2.763 billion, respectively. Collateral transferred under outstanding borrowings under repurchase agreements as of December 31, 2020 and 2019 include investments in the amount of $1.4 million and $64.7 million, respectively, that were sold prior to period end but for which such sale had not yet settled. In addition, as of December 31, 2020 the Company posted net cash collateral of $28.9 million to its counterparties. As of December 31, 2019, the Company posted net cash collateral of $31.0 million, as well as posting additional securities with a fair value of $0.2 million, to its counterparties.

Amount at risk represents the excess, if any, for each counterparty of the fair value of collateral held by such counterparty over the amounts outstanding under repurchase agreements. As of both December 31, 2020 and 2019, there was no single counterparty for which the amount at risk relating to our repurchase agreements was greater than 10% of total equity.

Other Secured Borrowings

In February 2018, the Company entered into agreements to finance a portfolio of unsecured loans through a recourse secured borrowing facility. The facility has a term ending in February 2021. The facility accrues interest on a floating-rate basis. As of December 31, 2020 and 2019, the Company had outstanding borrowings under this facility in the amount of $8.7 million and $16.0 million, respectively, which is included under the caption Other secured borrowings, on the Company's Consolidated Balance Sheet. The effective interest rate, inclusive of related deferred financing costs, was 2.30% and 3.85% as of December 31, 2020 and 2019. As of December 31, 2020 and 2019, the fair value of unsecured loans collateralizing this borrowing was $11.5 million and $22.3 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of December 31, 2020, the Company was in compliance with all of its covenants.

161

Table of Contents

The Company has a non-recourse secured borrowing facility that is used to finance a portfolio of unsecured loans. The facility included a reinvestment period ending in February 2021 (or earlier following an early amortization event), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. Following the reinvestment period, the facility will begin to amortize based on the collections from the underlying loans. The facility accrues interest on a floating rate basis. As of December 31, 2020 and 2019, the Company had outstanding borrowings under this facility in the amount of $7.0 million and $102.5 million, respectively, which is included under the caption Other secured borrowings, on the Company's Consolidated Balance Sheet. The effective interest rate on this facility, inclusive of related deferred financing costs, was 2.25% and 4.01%, as of December 31, 2020 and 2019, respectively. As of December 31, 2020 and 2019, the fair value of unsecured loans collateralizing this borrowing was $31.8 million and $144.1 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of December 31, 2020, the Company was in compliance with all of its covenants.

In December 2019, the Company entered into an agreement to finance a portfolio of ABS backed by consumer loans through a recourse secured borrowing facility. The facility includes a revolving borrowing period ending in June 2021 (or earlier following a trigger event), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. Following the revolving borrowing period, the facility amortizes, with a final termination date in June 2023. The facility accrues interest on a floating rate basis. As of December 31, 2020 and 2019, the Company had outstanding borrowings under this facility in the amount of $28.7 million and $31.8 million, respectively, which is included under the caption Other secured borrowings, on the Company's Consolidated Balance Sheet.The effective interest rate on this facility, inclusive of related deferred financing costs, was 5.22% and 5.23% as of December 31, 2020 and 2019, respectively. As of December 31, 2020 and 2019, the fair value of ABS backed by consumer loans collateralizing this borrowing was $44.5 million and $47.9 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of December 31, 2020, the Company was in compliance with all of its covenants.

The Company has completed securitization transactions, as discussed in Note 10, whereby it financed portfolios of non-QM loans. As of December 31, 2020 and 2019, the fair value of the Company's outstanding liabilities associated with these securitization transactions was $754.9 million and $594.4 million, respectively, representing the fair value of the securitization trust certificates held by third parties as of such date, and is included on the Company's Consolidated Balance Sheet in Other secured borrowings, at fair value. The weighted average coupon of the Certificates held by third parties was 2.43% and 3.19% as of December 31, 2020 and 2019, respectively. As of December 31, 2020, the fair value of non-QM loans held in the consolidated securitization trusts was $801.3 million. As of December 31, 2019, the fair value of non-QM loans and the carrying value of REO was $629.1 million.

In March 2020, the Company entered into a participation agreement with an unrelated third-party, the "Junior Participant," whereby the Company transferred to the Junior Participant an interest in a small balance commercial mortgage loan, the "Partial Loan," (together with the Company's interest, the "Whole Commercial Loan"). The Partial Loan is subordinate to the interest in the loan held by the Company. In accordance with ASC 860-10, the Partial Loan transferred to the Junior Participant does not meet the definition of a participating interest and, as a result, the Company does not recognize the transfer of the Partial Loan to the Junior Participant as a sale. The Company has recorded the Whole Commercial Loan in Loans, at fair value, on the Consolidated Balance Sheet. As of December 31, 2020, the fair value of the Whole Commercial Loan was $17.3 million. The Company's liability to the Junior Participant as of December 31, 2020 was $6.7 million and is included in Other secured borrowings on the Company's Consolidated Balance Sheet. Under the terms of the participation agreement, the Junior Participant is entitled to a portion of the cashflows of the underlying commercial mortgage loan.

Unsecured Borrowings

Senior Notes

On August 18, 2017, the Company issued $86.0 million in aggregate principal amount of unsecured senior notes (the "Old Senior Notes"). The total net proceeds to the Company from the issuance of the Old Senior Notes was approximately $84.7 million, after deducting debt issuance costs. The Old Senior Notes had an interest rate of 5.25%, subject to adjustment based on changes in the ratings, if any, of the Old Senior Notes. On February 13, 2019, in connection with the REIT Election, the Company exchanged all $86.0 million in principal amount of the Old Senior Notes for new unsecured long-term debt jointly and severally co-issued by certain of its consolidated subsidiaries and fully guaranteed by the Company (the "Senior Notes"). At any time, the Company is permitted to add others of its consolidated subsidiaries as co-issuers of the Senior Notes. The Senior Notes bear interest at a rate of 5.50%, subject to adjustment based on changes, if any, in the ratings of the Senior Notes. Interest on the Senior Notes is payable semi-annually in arrears on March 1 and September 1 of each year. The Senior Notes mature on September 1, 2022. The Company may redeem the Senior Notes, at its option, in whole or in part, prior to March 1, 2022 at a price equal to 100% of the principal amount thereof, plus the applicable "make-whole" premium as of the applicable date of redemption. At any time on or after March 1, 2022, the Company may redeem the Senior Notes, in whole or in part, at a redemption price equal to 100% of the aggregate principal amount of the Senior Notes to be redeemed, plus accrued and unpaid

162

Table of Contents

interest. The Senior Notes are carried at amortized cost. There are a number of covenants, including several financial covenants, associated with the Senior Notes. As of both December 31, 2020 and 2019, the Company was in compliance with all of its covenants.

The Company amortizes debt issuance costs over the life of the associated debt; the amortized portion of debt issuance costs is included in Interest expense on the Consolidated Statement of Operations. The Senior Notes have an effective interest rate of 5.80%, inclusive of debt issuance costs.

The Senior Notes are unsecured and are effectively subordinated to secured indebtedness of the Company, to the extent of the value of the collateral securing such indebtedness.

Schedule of Principal Repayments

The following table details the Company's principal repayment schedule, over the next 5 years, for outstanding borrowings as of December 31, 2020:

Year	Repurchase Agreements(1)		Other Secured Borrowings(2)		Senior Notes(1)		Total
(In thousands)
Next Twelve Months	$	1,402,683	$	370,933	$	—	$	1,773,616
Year 2	94,248		236,976		86,000		417,224
Year 3	—		221,269		—		221,269
Year 4	—		—		—		—
Year 5	—		—		—		—
Total	$	1,496,931	$	829,178	$	86,000	$	2,412,109

(1)Reflects the Company's contractual principal repayment dates.

(2)Includes $778.1 million of expected principal repayments related to the Company's consolidated residential mortgage loan securitizations, which are projected based upon the underlying assets' expected repayments and may be prior to the stated contractual maturities.

12. Income Taxes

The Company has elected to be taxed as a REIT under the Code. A REIT is generally not subject to U.S. federal, state, and local income tax on the portion of its income that is distributed to its owners if it distributes at least 90% of its REIT taxable income within the prescribed time frames, determined without regard to the deduction for dividends paid and excluding any net capital gains. The Company intends to operate in a manner which will allow it to continue to meet the requirements for qualification as a REIT. Accordingly, Ellington Financial Inc. does not believe that it will be subject to U.S. federal, state, and local income tax on the portion of its net taxable income that is distributed to its stockholders as long as certain asset, income, and share ownership tests are met.

Cash dividends declared by the Company that do not exceed its current or accumulated earnings and profits will be considered ordinary income to stockholders for income tax purposes unless all or a portion of a dividend is designated by the Company as a capital gain dividend. Distributions in excess of the Company's current and accumulated earnings and profits will be characterized as return of capital or capital gains.

The following table details the tax characteristics of the Company's dividends declared on its shares of common and preferred stock for the years ended December 31, 2020 and 2019.

	Year Ended
Tax Characteristic	December 31, 2020		December 31, 2019
Ordinary income	58.2	%	85.0	%
Return of capital	37.9	%	9.4	%
Capital gains	3.9	%	5.6	%
	100.0	%	100.0	%

Certain foreign and domestic subsidiaries of the Company have elected to be treated as TRSs and therefore are taxed as corporations for U.S. federal, state, and local income tax purposes. To the extent that those entities incur, or are expected to incur, U.S. federal, state, or local income taxes, or foreign income taxes, such taxes are recorded in the Company's consolidated financial statements.

163

Table of Contents

In response to the negative economic impact of the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act, or the "CARES Act," was signed into law on March 27, 2020, and provided for significant stimulus spending and included numerous tax provisions. As of December 31, 2020, there was no material impact on the Company's tax provision as a result of the CARES Act; however, the Company continues to monitor and evaluate the impact of the CARES Act and other COVID-19-related legislation.

The Company accounts for income taxes in accordance with ASC 740, Income Taxes, or "ASC 740." Deferred income taxes reflect the net tax effects of temporary differences that may exist between the carrying amounts of assets and liabilities under U.S. GAAP and the carrying amounts used for income tax purposes. For the years ended December 31, 2020 and 2019, the Company recorded an income tax expense of $11.4 million and $1.6 million, respectively. The increase in income tax expense for the year ended December 31, 2020, was primarily due to an increase in deferred tax liabilities related to unrealized gains on investments held in a domestic TRS.

The following table summarizes the Company's income tax provision for the years ended December 31, 2020 and 2019.

	As of
(In thousands)	December 31, 2020		December 31, 2019
Current income tax provision
Federal	$	38	$	185
State	602		293
Total current income tax provision, net	640		478
Deferred income tax provision
Federal	6,638		1,080
State	4,099		—
Total deferred income tax provision, net	10,737		1,080
Total income tax provision	$	11,377	$	1,558

The following table details the components of the Company's net deferred tax asset (liability) at December 31, 2020 and 2019.

	As of
(In thousands)	December 31, 2020		December 31, 2019
Deferred tax asset
Net operating loss available for carry-back and carry-forward	$	1,937	$	3,907
Basis difference for investments	1,481		669
Valuation allowance	—		(157)
Deferred tax asset	3,419		4,419
Deferred tax liability
Basis difference for investments	(15,525)		(5,484)
Deferred tax liability	(15,525)		(5,484)
Net deferred tax asset (liability)	$	(12,106)	$	(1,065)

The following table details the reconciliation between the Company's U.S. federal and state statutory income tax rate and the effective tax rate for the years ended December 31, 2020 and 2019.

	Year Ended
	December 31, 2020		December 31, 2019
Federal statutory rate	21.00	%	21.00	%
State statutory rate, net of federal benefit	11.83	%	0.45	%
Income attributable to non-controlling interests	(1.78)	%	(1.28)	%
REIT earnings not subject to corporate taxes	(2.43)	%	(17.76)	%
Effective tax rate	28.62	%	2.41	%

Based on its analysis of any potential uncertain income tax positions, the Company concluded it did not have any uncertain tax positions that meet the recognition or measurement criteria of ASC 740 as of December 31, 2020 and 2019.

164

Table of Contents

13. Related Party Transactions

The Company is party to the Management Agreement (which may be amended from time to time), pursuant to which the Manager manages the assets, operations, and affairs of the Company, in consideration of which the Company pays the Manager management and incentive fees. The descriptions of the Base Management Fees and Incentive Fees are detailed below.

Base Management Fees

The Operating Partnership pays the Manager 1.50% per annum of total equity of the Operating Partnership calculated in accordance with U.S. GAAP as of the end of each fiscal quarter (before deductions for base management fees and incentive fees payable with respect to such fiscal quarter), provided that total equity is adjusted to exclude one-time events pursuant to changes in U.S. GAAP, as well as non-cash charges after discussion between the Manager and the Company's independent directors, and approval by a majority of the Company's independent directors in the case of non-cash charges.

Pursuant to the Management Agreement, if the Company invests at issuance in the equity of any collateralized debt obligation that is managed, structured, or originated by Ellington or one of its affiliates, or if the Company invests in any other investment fund or other investment for which Ellington or one of its affiliates receives management, origination, or structuring fees, then, unless agreed otherwise by a majority of the Company's independent directors, the base management and incentive fees payable by the Company to its Manager will be reduced by an amount equal to the applicable portion (as described in the Management Agreement) of any such management, origination, or structuring fees.

For the year ended December 31, 2020, the total base management fee incurred was $11.5 million, consisting of $12.6 million of total gross base management fee incurred, less $1.1 million of management fee rebates. For the year ended December 31, 2019, the total base management fee incurred was $8.0 million consisting of $10.0 million of total gross base management fee incurred, less $2.0 million of management fee rebates. See "—Participation in CLO Transactions" below for details on management fee rebates.

Incentive Fees

The Manager is entitled to receive a quarterly incentive fee equal to the positive excess, if any, of (i) the product of (A) 25% and (B) the excess of (1) Adjusted Net Income (described below) for the Incentive Calculation Period (which means such fiscal quarter and the immediately preceding three fiscal quarters) over (2) the sum of the Hurdle Amounts (described below) for the Incentive Calculation Period, over (ii) the sum of the incentive fees already paid or payable for each fiscal quarter in the Incentive Calculation Period preceding such fiscal quarter.

For purposes of calculating the incentive fee, "Adjusted Net Income" for the Incentive Calculation Period means the net increase in equity from operations of the Operating Partnership, after all base management fees but before any incentive fees for such period, and excluding any non-cash equity compensation expenses for such period, as reduced by any Loss Carryforward (as described below) as of the end of the fiscal quarter preceding the Incentive Calculation Period.

For purposes of calculating the incentive fee, the "Loss Carryforward" as of the end of any fiscal quarter is calculated by determining the excess, if any, of (1) the Loss Carryforward as of the end of the immediately preceding fiscal quarter over (2) the Company's net increase in equity from operations (expressed as a positive number) or net decrease in equity from operations (expressed as a negative number) of the Operating Partnership for such fiscal quarter. As of both December 31, 2020 and 2019, there was no Loss Carryforward.

For purposes of calculating the incentive fee, the "Hurdle Amount" means, with respect to any fiscal quarter, the product of (i) one-fourth of the greater of (A) 9% and (B) 3% plus the 10-year U.S. Treasury rate for such fiscal quarter, (ii) the sum of (A) the weighted average gross proceeds per share of all common stock and OP Unit issuances since inception of the Company and up to the end of such fiscal quarter, with each issuance weighted by both the number of shares of common stock and OP Units issued in such issuance and the number of days that such issued shares of common stock and OP Units were outstanding during such fiscal quarter, using a first-in first-out basis of accounting (i.e. attributing any share of common stock and OP Unit repurchases to the earliest issuances first) and (B) the result obtained by dividing (I) retained earnings attributable to shares of common stock and OP Units at the beginning of such fiscal quarter by (II) the average number of shares of common stock and OP Units outstanding for each day during such fiscal quarter, and (iii) the sum of (x) the average number of shares of common stock and long term incentive plan units of the Company outstanding for each day during such fiscal quarter, and (y) the average number of Convertible Non-controlling Interests outstanding for each day during such fiscal quarter. For purposes of determining the Hurdle Amount, issuances of common stock, and Convertible Non-controlling Interests (a) as equity incentive awards, (b) to the Manager as part of its base management fee or incentive fee and (c) to the Manager or any of its affiliates in privately negotiated transactions, are excluded from the calculation. The payment of the incentive fee will be in a combination

165

Table of Contents

of shares of common stock and cash, provided that at least 10% of any quarterly payment will be made in shares of common stock.

The Company did not accrue an incentive fee for the year ended December 31, 2020, since on a rolling four quarter basis, the Company's income did not exceed the prescribed hurdle amount. Total incentive fee incurred for the year ended December 31, 2019 was $0.1 million.

Termination Fees

The Management Agreement requires the Company to pay a termination fee to the Manager in the event of (1) the Company's termination or non-renewal of the Management Agreement without cause or (2) the Company's termination of the Management Agreement based on unsatisfactory performance by the Manager that is materially detrimental to the Company or (3) the Manager's termination of the Management Agreement upon a default by the Company in the performance of any material term of the Management Agreement. Such termination fee will be equal to the amount of three times the sum of (i) the average annual quarterly base management fee amounts paid or payable with respect to the two 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal and (ii) the average annual quarterly incentive fee amounts paid or payable with respect to the two 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal.

Expense Reimbursement

Under the terms of the Management Agreement the Company is required to reimburse the Manager for operating expenses related to the Company that are incurred by the Manager, including expenses relating to legal, accounting, due diligence, other services, and all other costs and expenses. The Company's reimbursement obligation is not subject to any dollar limitation. Expenses will be reimbursed in cash within 60 days following delivery of the expense statement by the Manager; provided, however, that such reimbursement may be offset by the Manager against amounts due to the Company from the Manager. The Company will not reimburse the Manager for the salaries and other compensation of the Manager's personnel except that the Company will be responsible for expenses incurred by the Manager in employing certain dedicated or partially dedicated personnel as further described below.

The Company reimburses the Manager for the allocable share of the compensation, including, without limitation, wages, salaries, and employee benefits paid or reimbursed, as approved by the Compensation Committee of the Board of Directors to certain dedicated or partially dedicated personnel who spend all or a portion of their time managing the Company's affairs, based upon the percentage of time devoted by such personnel to the Company's affairs. In their capacities as officers or personnel of the Manager or its affiliates, such personnel will devote such portion of their time to the Company's affairs as is necessary to enable the Company to operate its business.

For the years ended December 31, 2020 and 2019, the Company reimbursed the Manager $9.9 million and $10.9 million, respectively, for previously incurred operating expenses. As of December 31, 2020 and 2019, the outstanding payable to the Manager for operating expenses was $2.5 million and $2.0 million, respectively, which are included in Accrued expenses and other liabilities on the Consolidated Balance Sheet.

Transactions Involving Certain Loan Originators

As of December 31, 2020 and 2019, the loan originators in which the Company holds equity investments represent related parties. Transactions that have been entered into with these related party mortgage originators are summarized below.

The Company is a party to a mortgage loan purchase and sale flow agreement, with a mortgage originator in which the Company holds a non-controlling equity investment, whereby the Company purchases residential mortgage loans that satisfy certain specified criteria. The Company has also provided a $5.0 million line of credit to the mortgage originator. Under the terms of this line of credit, the Company has agreed to make advances to the mortgage originator solely for the purpose of funding specifically identified residential mortgage loans designated for sale to the Company. To the extent the advances are drawn by the mortgage originator, it must pay interest, at a rate of 15% per annum, on the outstanding balance of each advance from the date the advance is made until such advance is repaid in full. The mortgage originator is required to repay advances in full no later than two business days following the date that the Company purchases the related residential mortgage loans from the mortgage originator. As of both December 31, 2020 and December 31, 2019, there were no advances outstanding. The Company has also entered into two agreements whereby it guarantees the performance of such mortgage originator under third-party master repurchase agreements. See Note 21, Commitments and Contingencies, for further information on the Company's guarantees of the third-party borrowing arrangements. Additionally, in August 2020, the Company entered into a commitment agreement whereby the Company committed to purchase $150 million of residential mortgage loans that meet specified criteria, or the "Commitment Agreement." As of December 31, 2020, the Company had purchased the entire $150 million of eligible

166

Table of Contents

residential mortgage loans under the terms of the Commitment Agreement. In connection with the Commitment Agreement, the Company also entered into an agreement whereby the Company would be entitled to receive warrants proportionally as it satisfied its purchase commitment under the Commitment Agreement to purchase a maximum of 9.329 million shares of non-voting common stock. As of December 31, 2020, the Company has received warrants for the maximum 9.329 million shares; such warrants have a fair value of $3.6 million as of December 31, 2020 and are included in Investments in unconsolidated entities on the Consolidated Balance Sheet.

The Company, through a related party of Ellington, or the "Loan Purchaser," is a party to a consumer loan purchase and sale flow agreement with a consumer loan originator in which the Company holds an investment in preferred stock and warrants to purchase additional preferred stock, whereby the Loan Purchaser purchases consumer loans that satisfy certain specified criteria. The Company has investments in participation certificates related to consumer loans titled in the name of the Loan Purchaser. Through its participation certificates, the Company has beneficial interests in the loan cash flows, net of servicing-related fees and expenses. The total fair value of the Company's participation certificates was $44.5 million and $47.9 million as of December 31, 2020 and 2019, respectively.

In May 2019 the Company entered into a note purchase agreement whereby it agreed to lend up to $5.0 million to a mortgage originator ("the Initial Note") in which the Company also holds a non-controlling equity investment. The Initial Note carried an interest rate of 15% per annum on the outstanding balance. In July and December 2019, the Company amended the note purchase agreement whereby it agreed to lend an additional $5.0 million and $2.5 million, respectively, (the "Additional Notes") to the mortgage originator. The Additional Notes each carried an interest rate of 18% per annum. As of December 31, 2019, the aggregate outstanding balance on the Initial Note and the Additional Notes was $12.5 million. In January 2020, the Initial Note and the Additional Notes were repaid. The Initial Note and the Additional Notes are classified as Corporate loans and included in Loans, at fair value on the Consolidated Balance Sheet.

Consumer, Residential, and Commercial Loan Transactions with Affiliates

The Company purchases certain of its consumer loans through an affiliate, or the "Purchasing Entity." The Purchasing Entity has entered into purchase agreements, open-ended in duration, with third party consumer loan originators whereby it has agreed to purchase eligible consumer loans. The amount of loans purchased under these purchase agreements is dependent on, among other factors, the amount of loans originated in any given period by the selling originators. The Company and certain other affiliates of Ellington have entered into agreements with the Purchasing Entity whereby the Company and each of those other affiliates of Ellington have agreed to purchase their allocated portion (subject to monthly determination based on available capital and other factors) of the eligible loans acquired by the Purchasing Entity under each purchase agreement. Immediately after the Purchasing Entity purchases beneficial interests in the loans, the Company and other affiliates of Ellington purchase such beneficial interests from the Purchasing Entity, at the same price paid by the Purchasing Entity. During the years ended December 31, 2020 and 2019, the Company purchased loans under these agreements with an aggregate principal balance of $115.7 million and $134.4 million, respectively. As of December 31, 2020 and 2019, the estimated remaining contingent purchase obligations of the Company under these purchase agreements was approximately $13.0 million and $287.1 million, respectively, in principal balance.

The Company's beneficial interests in the consumer loans purchased through the Purchasing Entity are evidenced by participation certificates issued by trusts that hold legal title to the loans. These trusts are owned by a related party of Ellington and were established to hold such loans. Through its participation certificates, the Company participates in the cash flows of the underlying loans held by each trust. The total amount of consumer loans underlying the Company's participation certificates and held in the related party trusts was $45.1 million and $185.4 million as of December 31, 2020 and 2019, respectively.

The Company has beneficial interests in residential mortgage loans and REO held in a trust owned by a related party of Ellington. Through these beneficial interests, the Company participates in the cash flows of the underlying loans held by such trust. The total amount of residential mortgage loans and REO underlying the Company's beneficial interests and held in the related party trust was $387.4 million and $304.8 million as of December 31, 2020 and 2019, respectively.

The Company is a co-investor in certain small balance commercial mortgage loans with several other investors, including an unrelated third party and various affiliates of Ellington. These loans are beneficially owned by a consolidated subsidiary of the Company. As of December 31, 2020 and 2019, the aggregate fair value of the small balance commercial loans was $34.0 million and $29.5 million, respectively. As of December 31, 2020, the non-controlling interests held by the unrelated third party and the Ellington affiliates were $4.1 million and $8.9 million, respectively. As of December 31, 2019, the non-controlling interests held by the unrelated third party and the Ellington affiliates were $3.6 million and $7.0 million, respectively. As of December 31, 2019, the Company had a payable to an Ellington affiliate in the amount of $0.7 million, which is included in Accrued expenses and other liabilities on the Consolidated Balance Sheet. The Company did not have any payables to or receivables from the Ellington affiliates as of December 31, 2020.

167

Table of Contents

The Company is also a co-investor in certain small balance commercial mortgage loans and REO with other investors, including various unrelated third parties and various affiliates of Ellington. Each co-investor in a particular loan has an interest in the limited liability company that owns such loan or REO. As of December 31, 2020 and 2019, the aggregate fair value of the Company's investments in the jointly owned limited liability companies was approximately $33.9 million and $17.3 million, respectively. Such investments are included in Investments in unconsolidated entities, on the Consolidated Balance Sheet.

The consumer, residential mortgage, and certain commercial mortgage loans that are the subject of the foregoing loan transactions are held in trusts, each of which the Company has determined to be a VIE. The Company has evaluated each of these VIEs and determined that the Company has the power to direct the activities of each VIE that most significantly impact such VIE's economic performance and the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. As a result the Company has determined it is the primary beneficiary of each of these VIEs and has consolidated each VIE.

Equity Investment in Unconsolidated Entity

The Company was a co-investor, together with other affiliates of Ellington, in Jepson Holdings Limited, the parent of an entity (the "Right Holder Entity") that held a call right (the "Call Right") to a European mortgage loan securitization (the "Initial Securitization"). The Right Holder Entity issued notes (the "Right Holder Notes") to the Company and its affiliates, and to an unrelated third party.

In March 2019, the Right Holder Entity assigned the Call Right to a newly formed entity, which exercised the Call Right and re-securitized the underlying European mortgage loan assets of the Initial Securitization through a new securitization trust (the "New Securitization"). In exchange for assigning the Call Right, the Right Holder Entity received a combination of (i) cash and (ii) certain notes issued by the New Securitization (the "New Securitization Notes"). The Right Holder Entity fully repaid the unrelated third party's Right Holder Note with a combination of cash and New Securitization Notes. The Right Holder Notes held by the Company and its affiliates were also fully repaid with cash and New Securitization Notes. Certain of the New Securitization Notes were distributed to the Company and its affiliates on a pro rata basis. The Right Holder Entity is expected to continue to hold certain of the New Securitization Notes in order to comply with European risk retention rules. As of December 31, 2020 and 2019, the Company's equity investment in Jepson Holdings Limited had a fair value of $1.8 million and $1.9 million, respectively. See Note 6 for additional details on this equity investment.

Participation in Multi-Borrower Financing Facilities

The Company is a co-participant with certain other entities managed by Ellington or its affiliates (the "Affiliated Entities") in various entities (each, a "Joint Entity"), which were formed in order to facilitate the financing of small balance commercial mortgage loans, residential mortgage loans, and REO (collectively, the "Mortgage Loan and REO Assets"), through repurchase agreements. Each Joint Entity has a master repurchase agreement with a particular financing counterparty.

In connection with the financing of the Mortgage Loan and REO Assets under repurchase agreements, each of the Company and the Affiliated Entities transferred certain of their respective Mortgage Loan and REO Assets to one of the Joint Entities in exchange for its pro rata share of the financing proceeds that the respective Joint Entity received from the financing counterparty. While the Company's Mortgage Loan and REO Assets were transferred to the Joint Entity, the Company's Mortgage Loan and REO Assets and the related debt were not derecognized for financial reporting purposes, in accordance with ASC 860-10, because the Company continued to retain the risks and rewards of ownership of its Mortgage Loan and REO Assets. As of December 31, 2020 and 2019, the Joint Entities had aggregate outstanding issued debt under the repurchase agreements in the amount of $192.3 million and $350.6 million, respectively. The Company's segregated silo of this debt as of December 31, 2020 and 2019 was $116.1 million and $174.4 million, respectively, and is included under the caption Repurchase agreements on the Company's Consolidated Balance Sheet. To the extent that there is a default under the repurchase agreements, all of the assets of each respective Joint Entity, including those beneficially owned by any non-defaulting owners of such Joint Entity, could be used to satisfy the outstanding obligations under such repurchase agreement. As of both December 31, 2020 and 2019, no party to any of the repurchase agreements was in default.

Each of the Joint Entities has been determined to be a VIE. The Company has evaluated each of these VIEs and determined that it continued to retain the risks and rewards of ownership of certain of the Mortgage Loan and REO Assets, where such Mortgage Loan and REO Assets and the related debt are segregated for the Company and each of the Affiliated Entities. On account of the segregation of certain of each co-participant's assets and liabilities within each of the Joint Entities, as well as the retention by each co-participant of control over its segregated Mortgage Loan and REO Assets within the Joint Entities, the Company has determined that it is the primary beneficiary of, and has consolidated its segregated silo of assets and liabilities within, each of the Joint Entities. See Note 9 and Note 11 for additional information.

168

Table of Contents

Participation in CLO Transactions

As discussed in Note 10, the Company participated in a number of CLO securitization transactions, all managed by the CLO Manager.

The CLO Manager is entitled to receive management and incentive fees in accordance with the respective management agreements between the CLO Manager and the respective CLO Issuers. In accordance with the Management Agreement, the Manager rebates to the Company the portion of the management fees payable by each CLO Issuer to the CLO Manager that are allocable to the Company's participating interest in the unsecured subordinated notes issued by such CLO Issuer. For the years ended December 31, 2020 and 2019, the amount of such management fee rebates was $1.1 million and $2.0 million, respectively.

In addition, from time to time, the Company along with various other affiliates of Ellington, and in certain cases various third parties, advance funds in the form of loans ("Initial Funding Loans") to securitization vehicles to enable them to establish warehouse facilities for the purpose of acquiring the assets to be securitized. Pursuant to the terms of the warehouse facilities and the Initial Funding Loans, the applicable securitization trust is required, at the closing of each respective CLO securitization, first to repay the warehouse facility, then to repay the Initial Funding Loans, and then to distribute interest earned, net of any necessary reserves and/or interest expense, and the aggregate realized or unrealized gains, if any, on assets purchased into the warehouse facility. In the event that such CLO securitization fails to close, the assets held by the respective securitization vehicle would, subject to a cure period, be liquidated. As of December 31, 2020 and 2019, the Company's investment in such warehouse facilities was $6.1 million and $8.1 million, respectively, which are included on the Consolidated Balance Sheet in Investments in unconsolidated entities.

During the years ended December 31, 2020 and 2019, the Company purchased various underperforming corporate debt and equity securities from certain of the Ellington-sponsored CLO Securitizations at market prices determined through the procedures set forth in the indentures of the respective Ellington-sponsored CLO Securitization. The total amount of such debt and equity securities purchased during the years ended December 31, 2020 and 2019 was $1.6 million and $8.8 million, respectively.

14. Long-Term Incentive Plan Units

OP LTIP Units subject to the Company's incentive plans are generally exercisable by the holder at any time after vesting. Each OP LTIP Unit is convertible into an OP Unit on a one-for-one basis. Subject to certain conditions, the OP Units are redeemable by the holder for an equivalent number of shares of common stock of the Company or for the cash value of such shares of common stock, at the Company's election. Costs associated with the OP LTIP Units issued under the Company's incentive plans are measured as of the grant date and expensed ratably over the vesting period. Total expense associated with OP LTIP Units issued under the Company's incentive plans for the years ended December 31, 2020 and 2019 was $0.7 million and $0.5 million, respectively.

On March 4, 2020, the Company's Board of Directors authorized the issuance of 14,811 OP LTIP Units to certain of Ellington's personnel dedicated to the Company pursuant to the Company's 2017 Equity Incentive Plan.

On September 10, 2020, the Company's Board of Directors authorized the issuance of 22,840 OP LTIP Units to certain of its directors pursuant to the Company's 2017 Equity Incentive Plan.

On December 17, 2020, the Company's Board of Directors authorized the issuance of 32,809 OP LTIP Units to certain of Ellington's personnel dedicated to the Company pursuant to the Company's 2017 Equity Incentive Plan.

169

Table of Contents

The below table details unvested OP LTIP Units as of December 31, 2020:

Grant Recipient	Number of OP LTIP Units Granted	Grant Date	Vesting Date(1)
Directors:
	22,840	September 10, 2020	September 9, 2021
Dedicated or partially dedicated personnel:
	10,067	December 13, 2019	December 13, 2021
	18,211	December 17, 2020	December 17, 2021
	9,834	March 4, 2020	December 31, 2021
	14,598	December 17, 2020	December 17, 2022
Total unvested OP LTIP Units at December 31, 2020	75,550

(1)Date at which such OP LTIP Units will vest and become non-forfeitable.

The following tables summarize issuance and exercise activity of OP LTIP Units for the years ended December 31, 2020 and 2019:

	Year Ended
	December 31, 2020			December 31, 2019
	Manager	Director/ Employee	Total	Manager	Director/ Employee	Total
OP LTIP Units Outstanding (December 31, 2019 and January 1, 2019, respectively)	365,518	180,198	545,716	375,000	146,371	521,371
Granted	—	70,460	70,460	—	37,437	37,437
Exercised	—	(3,638)	(3,638)	(9,482)	(3,610)	(13,092)
OP LTIP Units Outstanding (December 31, 2020 and 2019, respectively)	365,518	247,020	612,538	365,518	180,198	545,716
OP LTIP Units Unvested and Outstanding (December 31, 2020 and 2019, respectively)	—	75,550	75,550	—	46,128	46,128
OP LTIP Units Vested and Outstanding (December 31, 2020 and 2019, respectively)	365,518	171,470	536,988	365,518	134,070	499,588

There were an aggregate of 1,761,212 and 1,832,309 shares of common stock of the Company underlying awards, including OP LTIP Units, available for future issuance under the Company's 2017 Equity Incentive Plan as of December 31, 2020 and 2019, respectively.

15. Non-controlling Interests

Operating Partnership

Non-controlling interests include the Convertible Non-controlling Interests in the Operating Partnership owned by an affiliate of our Manager, our directors, and certain current and former Ellington employees and their related parties. On December 31, 2018, the Company redeemed 503,988 outstanding long term incentive plan units of the Company and exchanged them on a one-for-one basis for OP LTIP Units. Income allocated to Convertible Non-controlling Interests is based on the non-controlling interest owners' ownership percentage of the Operating Partnership during the period, calculated using a daily weighted average of all shares of common stock of the Company and Convertible Non-controlling Interests outstanding during the period. Holders of Convertible Non-controlling Interests are entitled to receive the same distributions that holders of shares of common stock of the Company receive. Convertible Non-controlling Interests are non-voting with respect to matters as to which holders of common stock of the Company are entitled to vote.

On March 2, 2020, certain related parties of current Ellington employees converted 129,516 OP Units into shares of common stock.

170

Table of Contents

As December 31, 2020, the Convertible Non-controlling Interests consisted of the outstanding 612,538 OP LTIP Units and 48,409 OP Units, and represented an interest of approximately 1.3% in the Operating Partnership. As December 31, 2019, the Convertible Non-controlling Interests consisted of the outstanding 545,716 OP LTIP Units and 177,925 OP Units, and represented an interest of approximately 1.6% in the Operating Partnership. As of December 31, 2020 and 2019, non-controlling interests related to all outstanding Convertible Non-controlling Interests was $11.7 million and $13.4 million, respectively.

Joint Venture Interests

Non-controlling interests also include the interests of joint venture partners in various consolidated subsidiaries of the Company. These subsidiaries hold the Company's investments in certain commercial mortgage loans and REO. The joint venture partners participate in the income, expense, gains and losses of such subsidiaries as set forth in the related operating agreements of the subsidiaries. The joint venture partners make capital contributions to the subsidiaries as new approved investments are purchased by the subsidiaries, and are generally entitled to distributions when investments are sold or otherwise disposed of. As of December 31, 2020 and 2019, the joint venture partners' interests in subsidiaries of the Company were $24.5 million and $25.9 million, respectively.

The joint venture partners' interests are not convertible into shares of common stock of the Company or OP Units, nor are the joint venture partners entitled to receive distributions that holders of shares of common stock of the Company receive.

16. Equity

Preferred Stock

The Company has authorized 100,000,000 shares of preferred stock, $0.001 par value per share. As of both December 31, 2020 and 2019, there were 4,600,000 shares of 6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, $0.001 par value per share ("Series A Preferred Stock") outstanding.

The Company's Series A Preferred Stock ranks senior to its common stock and Convertible Non-controlling Interests with respect to the payment of dividends and the distribution of assets upon a voluntary or involuntary liquidation, dissolution or winding up of the Company. Additionally, the Company's Series A Preferred Stock has no stated maturity and is not subject to any sinking fund or mandatory redemption. The Series A Preferred Stock is not redeemable by the Company prior to October 30, 2024, except under circumstances where it is necessary to allow the Company to maintain its qualification as a REIT for U.S. federal income tax purposes and except in certain instances upon the occurrence of a change of control. Holders of the Company's Series A Preferred Stock generally do not have any voting rights.

Holders of the Series A Preferred Stock are entitled to receive cumulative cash dividends (i) from and including the original issue date to, but excluding, October 30, 2024, at a fixed rate equal to 6.750% per annum of the $25.00 per share liquidation preference and (ii) from and including October 30, 2024, at a floating rate equal to three-month LIBOR plus a spread of 5.196% per annum of the $25.00 per share liquidation preference. Dividends are payable quarterly in arrears on or about the 30th day of each January, April, July, and October, commencing with the first dividend payment on January 30, 2020, which the Board of Directors declared in December 2019. As of December 31, 2020 and 2019, the total amount of cumulative preferred dividends in arrears was $1.3 million and $1.5 million, respectively.

171

Table of Contents

Common Stock

The Company has authorized 100,000,000 shares of common stock, $0.001 par value per share. The Board of Directors may authorize the issuance of additional shares, subject to the approval of the holders of at least a majority of the shares of common stock then outstanding present in person or represented by proxy at a meeting of the stockholders. As of December 31, 2020 and 2019, there were 43,781,684 and 38,647,943, respectively, shares of common stock outstanding.

On January 24, 2020, the Company completed a follow-on offering of 5,290,000 shares of its common stock, of which 690,000 shares were issued pursuant to the exercise of the underwriters' option. The issuance and sale of the 5,290,000 shares of common stock generated net proceeds, after underwriters' discount and offering costs, of $95.3 million.

The following table summarizes issuance, repurchase, and other activity with respect to the Company's common stock for the years ended December 31, 2020 and 2019:

	Year Ended
	December 31, 2020	December 31, 2019
Shares of Common Stock Outstanding (12/31/2019 and 1/1/2019, respectively)	38,647,943	29,796,601
Share Activity:
Shares of common stock issued	5,290,000	8,855,000
Shares of common stock issued in connection with incentive fee payment	637	—
Shares of common stock repurchased	(290,050)	(50,825)
OP LTIP Units exercised	—	13,092
OP Units exercised	133,154	34,075
Shares of Common Stock Outstanding (12/31/2020 and 12/31/2019, respectively)	43,781,684	38,647,943

If all Convertible Non-controlling Interests that have been previously issued were to become fully vested and exchanged for shares of common stock as of December 31, 2020 and 2019, the Company's issued and outstanding shares of common stock would increase to 44,442,631 and 39,371,584 shares, respectively.

On June 13, 2018, the Board of Directors approved the adoption of a share repurchase program under which the Company is authorized to repurchase up to 1.55 million shares of common stock. The program, which is open-ended in duration, allows the Company to make repurchases from time to time on the open market or in negotiated transactions, including under Rule 10b5-1 plans. Repurchases are at the Company's discretion, subject to applicable law, share availability, price and financial performance, among other considerations. During the year ended December 31, 2020, the Company repurchased 290,050 shares at an average price per share of $10.54 and a total cost of $3.1 million. During the year ended December 31, 2019, the Company repurchased 50,825 shares at an average price per share of $15.39 and a total cost of $0.8 million. From inception of the current repurchase plan through December 31, 2020, the Company repurchased 701,965 shares at an average price per share of $13.36 and a total cost of $9.4 million.

172

Table of Contents

17. Earnings Per Share

The components of the computation of basic and diluted EPS are as follows:

	Year Ended
(In thousands except share amounts)	December 31, 2020		December 31, 2019
Net income (loss) attributable to common stockholders	$	17,245	$	56,467
Add: Net income (loss) attributable to Convertible Non-controlling Interests(1)	(3)		1,305
Net income (loss) attributable to common stockholders and Convertible Non-controlling Interests	17,242		57,772
Dividends Paid:
Common stockholders	(55,211)		(58,499)
Convertible Non-controlling Interests	(812)		(1,325)
Total dividends paid to common stockholders and Convertible Non-controlling Interests	(56,023)		(59,824)
Undistributed (Distributed in excess of) earnings:
Common stockholders	(37,966)		(2,032)
Convertible Non-controlling Interests	(815)		(20)
Total undistributed (distributed in excess of) earnings attributable to common stockholders and Convertible Non-controlling Interests	$	(38,781)	$	(2,052)
Weighted average shares outstanding (basic and diluted):
Weighted average shares of common stock outstanding	43,486,336		32,067,768
Weighted average Convertible Non-controlling Interest Units outstanding	635,245		732,456
Weighted average shares of common stock and Convertible Non-controlling Interest Units outstanding	44,121,581		32,800,224
Basic earnings per share of common stock and Convertible Non-controlling Interest Unit:
Distributed	$	1.26	$	1.81
Undistributed (Distributed in excess of)	(0.87)		(0.05)
	$	0.39	$	1.76
Diluted earnings per share of common stock and Convertible Non-controlling Interest Unit:
Distributed	$	1.26	$	1.81
Undistributed (Distributed in excess of)	(0.87)		(0.05)
	$	0.39	$	1.76

(1)For the years ended December 31, 2020 and 2019, excludes net income (loss) of $3.4 million and $3.9 million, respectively, attributable to joint venture partners, which have non-participating interests as described in Note 15.

18. Restricted Cash

The Company is required to maintain a specific cash balance in a segregated account pursuant to a flow consumer loan purchase and sale agreement. As of both December 31, 2020 and 2019, the Company's restricted cash balance related to the flow consumer loan purchase and sale agreement was $0.2 million.

19. Offsetting of Assets and Liabilities

The Company generally records financial instruments at fair value as described in Note 2. Financial instruments are generally recorded on a gross basis on the Consolidated Balance Sheet. In connection with the vast majority of its derivative, reverse repurchase and repurchase agreements, and the related trading agreements, the Company and its counterparties are required to pledge collateral. Cash or other collateral is exchanged as required with each of the Company's counterparties in connection with open derivative positions, and reverse repurchase and repurchase agreements.

173

Table of Contents

The following tables present information about certain assets and liabilities representing financial instruments as of December 31, 2020 and 2019. The Company has not entered into master netting agreements with any of its counterparties. Certain of the Company's reverse repurchase and repurchase agreements and financial derivative transactions are governed by underlying agreements that generally provide a right of net settlement, as well as a right of offset in the event of default or in the event of a bankruptcy of either party to the transaction.

December 31, 2020:

Description	Amount of Assets (Liabilities) Presented in the Consolidated Balance Sheet(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount
(In thousands)
Assets
Financial derivatives–assets	$	15,479	$	(12,579)	$	—	$	(1,404)	$	1,496
Reverse repurchase agreements	38,640		(38,640)		—		—		—
Liabilities
Financial derivatives–liabilities	(24,553)		12,579		—		10,694		(1,280)
Repurchase agreements	(1,496,931)		1,496,931		(28,884)		28,884		—

(1)In the Company's Consolidated Balance Sheet, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.

(2)For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's repurchase agreements as of December 31, 2020 was $1.8 billion. As of December 31, 2020, total cash collateral on financial derivative assets and liabilities excludes excess net cash collateral pledged (received) of $4.5 million and $10.3 million, respectively.

(3)When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a particular asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.

December 31, 2019:

Description	Amount of Assets (Liabilities) Presented in the Consolidated Balance Sheet(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount
(In thousands)
Assets
Financial derivatives–assets	$	16,788	$	(12,755)	$	—	$	(807)	$	3,226
Reverse repurchase agreements	73,639		(73,639)		—		—		—
Liabilities
Financial derivatives–liabilities	(27,621)		12,755		—		12,233		(2,633)
Repurchase agreements	(2,445,300)		73,639		2,340,656		31,005		—

(1)In the Company's Consolidated Balance Sheet, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.

(2)For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's repurchase agreements as of December 31, 2019 was $2.8 billion. As of December 31, 2019, total cash collateral on financial derivative assets and liabilities excludes excess net cash collateral pledged of $4.3 million and $23.4 million, respectively.

(3)When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a particular asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.

174

Table of Contents

20. Counterparty Risk

The Company is exposed to concentrations of counterparty risk. It seeks to mitigate such risk by diversifying its exposure among various counterparties, when appropriate. The following table summarizes the Company's exposure to counterparty risk as of December 31, 2020 and 2019.

December 31, 2020:

	Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)
	(In thousands)
Cash and cash equivalents	$	111,647	8	40.1	%
Collateral on repurchase agreements held by dealers(2)	1,860,059		24	15.3	%
Due from brokers	63,147		22	28.9	%
Receivable for securities sold(3)	1,416		2	94.5	%

(1)Each counterparty is a large creditworthy financial institution.

(2)Includes securities, loans, and REO as well as cash posted as collateral for repurchase agreements.

(3)Included in Investment related receivables on the Consolidated Balance Sheet.

December 31, 2019:

	Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)
	(In thousands)
Cash and cash equivalents	$	72,302	11	42.2	%
Collateral on repurchase agreements held by dealers(2)	2,793,696		28	13.8	%
Due from brokers	79,829		24	30.9	%
Receivable for securities sold(3)	69,995		5	62.3	%

(1)Each counterparty is a large creditworthy financial institution.

(2)Includes securities, loans, and REO as well as cash posted as collateral for repurchase agreements.

(3)Included in Investment related receivables on the Consolidated Balance Sheet.

175

Table of Contents

21. Commitments and Contingencies

The Company provides current directors and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the Company.

In the normal course of business the Company may also enter into contracts that contain a variety of representations, warranties, and general indemnifications. The Company's maximum exposure under these arrangements, including future claims that may be made against the Company that have not yet occurred, is unknown. The Company has not incurred any costs to defend lawsuits or settle claims related to these indemnification agreements. As of both December 31, 2020 and 2019, the Company has no liabilities recorded for these agreements.

The Company's maximum risk of loss from credit events on its securities (excluding Agency securities, which are guaranteed by the issuing government agency or government-sponsored enterprise), loans, and investments in unconsolidated entities is limited to the amount paid for such investment.

Commitments and Contingencies Related to Investments in Residential Mortgage Loans

In connection with certain of the Company's investments in residential mortgage loans, the Company has unfunded commitments in the amount of $4.7 million and $5.2 million as of December 31, 2020 and 2019, respectively.

Commitments and Contingencies Related to Investments in Mortgage Loan Originators

In connection with certain of its investments in mortgage loan originators, the Company has outstanding commitments and contingencies as described below.

As described in Note 13, the Company is party to a flow mortgage loan purchase and sale agreement with a mortgage loan originator. The Company has entered into two agreements whereby it guarantees the performance of this mortgage loan originator under master repurchase agreements. The Company's maximum guarantees are capped at $25.0 million. As of December 31, 2020 and 2019, the mortgage loan originator had $5.3 million and $0.4 million, respectively, of outstanding borrowings under the agreements guaranteed by the Company. The Company's obligations under these arrangements are deemed to be guarantees under ASC 460-10. The Company has elected the FVO for its guarantees, which are included in Accrued expenses and other liabilities on the Consolidated Balance Sheet. As of both December 31, 2020 and 2019, the estimated fair value of such guarantees was insignificant.

Commitments and Contingencies Related to Corporate Loans

The Company has investments in certain corporate loans whereby the borrowers can request additional funds under the respective agreements. As of December 31, 2020 and 2019 the Company had unfunded commitments related to such investments in the amount of $0.1 million and $1.9 million, respectively.

176

Table of Contents

22. Condensed Quarterly Financial Data (Unaudited)

Detailed below is unaudited quarterly financial data for the years ended December 31, 2020 and 2019.

	Three Month Period Ended
	March 31, 2020		June 30, 2020		September 30, 2020		December 31, 2020
(In thousands except per share amounts)
Net Interest Income
Interest income	$	52,108	$	39,281	$	43,075	$	39,067
Interest expense	(22,090)		(14,686)		(12,937)		(11,952)
Total net interest income	30,018		24,595		30,138		27,115
Other Income (Loss)
Realized gains (losses) on securities and loans, financial derivatives, and real estate owned, net	204		(27,927)		(192)		(9,551)
Unrealized gains (losses) on securities and loans, financial derivatives, and real estate owned, net	(144,079)		52,057		24,032		42,547
Other, net	1,679		(435)		(2,747)		(795)
Total other income (loss)	(142,196)		23,695		21,093		32,201
Expenses
Base management fee to affiliate (Net of fee rebates of $507, $145, $201, and $198, respectively)(1)	2,443		2,906		2,981		3,178
Incentive fee to affiliate	—		—		—		—
Investment related expenses:
Servicing expense	2,531		2,493		2,379		1,736
Debt issuance costs related to Other secured borrowings, at fair value	—		2,075		—		1,819
Other	1,423		707		1,199		1,782
Professional fees	1,277		1,333		1,209		1,186
Compensation expense	788		941		1,085		962
Other expenses	1,752		1,497		1,625		1,531
Total expenses	10,214		11,952		10,478		12,194
Net Income (Loss) before Income Tax Expense and Earnings from Investments in Unconsolidated Entities	(122,392)		36,338		40,753		47,122
Income tax expense (benefit)	(547)		1,542		2,494		7,888
Earnings from investments in unconsolidated entities	(6,497)		5,643		11,443		27,344
Net Income (Loss)	(128,342)		40,439		49,702		66,578
Net income (loss) attributable to non-controlling interests	(885)		1,220		1,559		1,475
Dividends on preferred stock	1,941		1,941		1,940		1,941
Net Income (Loss) Attributable to Common Stockholders	$	(129,398)	$	37,278	$	46,203	$	63,162
Net Income (Loss) per Share of Common Stock:
Basic and Diluted (2)	$	(3.04)	$	0.85	$	1.06	$	1.44

(1)See Note 13 for further details on management fee rebates.

(2)For the year ended December 31, 2020 the sum of EPS for the four quarters of the year does not equal EPS as calculated for the entire year (see Note 17) as a result of changes in the number of shares of common stock outstanding during the year due to both issuances and repurchases of shares of common stock, as EPS is calculated using average shares of common stock outstanding during the period.

177

Table of Contents

	Three Month Period Ended
	March 31, 2019		June 30, 2019		September 30, 2019		December 31, 2019
(In thousands except per share amounts)
Net Interest Income
Interest income	$	36,016	$	38,547	$	39,985	$	45,353
Interest expense	(17,618)		(19,702)		(19,954)		(21,205)
Total net interest income	18,398		18,845		20,031		24,148
Other Income (Loss)
Realized gains (losses) on securities and loans, financial derivatives, and real estate owned, net	(16,950)		(12,327)		(4,827)		(7,266)
Unrealized gains (losses) on securities and loans, financial derivatives, and real estate owned, net	20,452		13,300		7,970		6,139
Other, net	2,002		1,808		539		1,001
Total other income (loss)	5,504		2,781		3,682		(126)
Expenses
Base management fee to affiliate (Net of fee rebates of $447, $508, $503, and $509, respectively)(1)	1,722		1,661		1,942		2,663
Incentive fee to affiliate	—		—		—		116
Investment related expenses:
Servicing expense	2,393		2,244		1,940		2,055
Debt issuance costs related to Other secured borrowings, at fair value	—		1,671		—		1,865
Other	1,083		1,238		1,347		1,941
Professional fees	1,956		1,178		698		1,021
Compensation expense	1,072		903		712		962
Other expenses	985		1,053		1,156		1,160
Total expenses	9,211		9,948		7,795		11,783
Net Income (Loss) before Income Tax Expense and Earnings from Investments in Unconsolidated Entities	14,691		11,678		15,918		12,239
Income tax expense (benefit)	—		376		2		1,180
Earnings from investments in unconsolidated entities	1,797		2,354		2,796		3,262
Net Income (Loss)	16,488		13,656		18,712		14,321
Net income (loss) attributable to non-controlling interests	1,080		1,012		1,419		1,733
Dividends on preferred stock	—		—		—		1,466
Net Income (Loss) Attributable to Common Stockholders	$	15,408	$	12,644	$	17,293	$	11,122
Net Income (Loss) per Share of Common Stock:
Basic and Diluted (2)	$	0.52	$	0.43	$	0.53	$	0.31

(1)See Note 13 for further details on management fee rebates.

(2)For the year ended December 31, 2019 the sum of EPS for the four quarters of the year does not equal EPS as calculated for the entire year (see Note 17) as a result of changes in the number of shares of common stock outstanding during the year due to issuances of shares of common stock, as EPS is calculated using average shares of common stock outstanding during the period.

178

Table of Contents

23. Subsequent Events

On January 8, 2021, the Board of Directors approved a dividend in the amount of $0.10 per share of common stock payable on February 25, 2021 to stockholders of record as of January 29, 2021 and a dividend in the amount of $0.421875 per share of Series A Preferred Stock payable on February 1, 2021 to stockholders of record as of January 19, 2021.

On February 5, 2021, the Board of Directors approved a dividend in the amount of $0.10 per share of common stock payable on March 25, 2021 to stockholders of record as of February 26, 2021.

179

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of Ellington Financial Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated statement of assets, liabilities, and equity, including the consolidated condensed schedule of investments, of Ellington Financial LLC and its subsidiaries (the "Company") as of December 31, 2018, and the related consolidated statements of operations, of changes in equity and of cash flows for the year then ended, including the related notes (collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2018, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.

Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/ PricewaterhouseCoopers LLP

New York, New York

March 14, 2019

We have served as the Company's auditor since 2007.

180

ELLINGTON FINANCIAL LLC

CONSOLIDATED STATEMENT OF ASSETS, LIABILITIES, AND EQUITY

	December 31, 2018
(In thousands except share amounts)	Expressed in U.S. Dollars
ASSETS
Cash and cash equivalents	$	44,656
Restricted cash	425
Investments, financial derivatives, and repurchase agreements:
Investments, at fair value (Cost – $2,970,306)	2,939,311
Financial derivatives–assets, at fair value (Net cost – $22,526)	20,001
Repurchase agreements, at fair value (Cost – $61,274)	61,274
Total investments, financial derivatives, and repurchase agreements	3,020,586
Due from brokers	71,794
Receivable for securities sold and financial derivatives	780,826
Interest and principal receivable	37,676
Other assets	15,536
Total Assets	$	3,971,499
LIABILITIES
Investments and financial derivatives:
Investments sold short, at fair value (Proceeds – $844,604)	$	850,577
Financial derivatives–liabilities, at fair value (Net proceeds – $19,019)	20,806
Total investments and financial derivatives	871,383
Reverse repurchase agreements	1,498,849
Due to brokers	5,553
Payable for securities purchased and financial derivatives	488,411
Other secured borrowings (Proceeds – $114,100)	114,100
Other secured borrowings, at fair value (Proceeds – $298,706)	297,948
Senior notes, net	85,035
Accounts payable and accrued expenses	5,723
Base management fee payable to affiliate	1,744
Interest and dividends payable	7,159
Other liabilities	424
Total Liabilities	3,376,329
EQUITY	595,170
TOTAL LIABILITIES AND EQUITY	$	3,971,499
Commitments and contingencies (Note 17)
ANALYSIS OF EQUITY:
Common shares, no par value, 100,000,000 shares authorized;
(29,796,601 shares issued and outstanding)	$	563,833
Additional paid-in capital – Long term incentive plan units	—
Total Shareholders' Equity	563,833
Non-controlling interests	31,337
Total Equity	$	595,170
PER SHARE INFORMATION:
Common shares	$	18.92

See Notes to Consolidated Financial Statements

181

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS

AT DECEMBER 31, 2018

Current Principal/Number of Shares		Description	Rate	Maturity	Fair Value
(In thousands)					Expressed in U.S. Dollars
Cash Equivalents—Money Market Funds (2.09%) (a) (b)
North America
Funds
$	12,460	Various	2.31% - 2.34%		$	12,460
Total Cash Equivalents—Money Market Funds (Cost $12,460)					$	12,460

Long Investments (493.86%) (a) (b) (ad)
Mortgage-Backed Securities (300.21%)
Agency Securities (243.66%) (c)
Fixed Rate Agency Securities (230.23%)
Principal and Interest - Fixed Rate Agency Securities (148.68%)
North America
Mortgage-related—Residential
$	143,523	Federal National Mortgage Association Pools (30 Year)	4.00%	9/39 - 11/48	$	147,395
111,109		Federal Home Loan Mortgage Corporation Pools (30 Year)	4.00%	11/41 - 12/48	114,104
82,189		Federal National Mortgage Association Pools (30 Year)	3.50%	9/42 - 2/48	82,450
74,478		Government National Mortgage Association Pools (30 Year)	4.50%	9/46 - 1/49	77,266
65,892		Federal National Mortgage Association Pools (30 Year)	4.50%	10/41 - 12/48	68,853
51,362		Government National Mortgage Association Pools (30 Year)	4.00%	7/45 - 5/48	52,544
46,026		Government National Mortgage Association Pools (30 Year)	5.00%	2/48 - 12/48	48,245
45,670		Federal Home Loan Mortgage Corporation Pools (30 Year)	4.50%	9/43 - 10/48	47,583
42,663		Federal National Mortgage Association Pools (15 Year)	3.50%	3/28 - 3/32	43,241
38,420		Federal National Mortgage Association Pools (30 Year)	5.00%	10/35 - 8/48	40,652
32,106		Government National Mortgage Association Pools (30 Year)	3.50%	12/42 - 12/47	32,253
25,082		Federal Home Loan Mortgage Corporation Pools (30 Year)	3.50%	1/42 - 3/48	25,185
21,807		Government National Mortgage Association Pools (30 Year)	5.50%	4/48 - 12/48	23,207
10,899		Federal National Mortgage Association Pools (15 Year)	3.00%	4/30 - 9/32	10,895
8,275		Federal Home Loan Mortgage Corporation Pools (15 Year)	3.50%	9/28 - 12/32	8,389
7,287		Federal Home Loan Mortgage Corporation Pools (Other)	3.50%	4/43 - 9/46	7,316
6,096		Federal Home Loan Mortgage Corporation Pools (30 Year)	5.00%	7/44 - 10/48	6,423
5,728		Federal National Mortgage Association Pools (15 Year)	4.00%	6/26 - 5/31	5,823
5,023		Federal National Mortgage Association Pools (30 Year)	5.50%	10/39 - 6/48	5,342
4,547		Federal National Mortgage Association Pools (Other)	5.00%	9/43 - 1/44	4,772
4,394		Federal National Mortgage Association Pools (Other)	4.00%	12/47	4,478
3,408		Government National Mortgage Association Pools (30 Year)	6.00%	5/48 - 11/48	3,666
2,773		Federal Home Loan Mortgage Corporation Pools (30 Year)	3.00%	7/43 - 6/45	2,722
2,603		Federal National Mortgage Association Pools (30 Year)	3.00%	1/42 - 6/45	2,556
2,508		Government National Mortgage Association Pools (30 Year)	3.75%	7/47	2,537
2,348		Federal Home Loan Mortgage Corporation Pools (Other)	4.50%	5/44	2,432
2,343		Federal Home Loan Mortgage Corporation Pools (15 Year)	3.00%	4/30	2,342
2,177		Federal National Mortgage Association Pools (15 Year)	4.50%	4/26	2,265
2,025		Federal National Mortgage Association Pools (Other)	4.50%	5/41	2,079
1,677		Federal Home Loan Mortgage Corporation Pools (30 Year)	5.50%	8/33 - 5/48	1,786
1,478		Federal National Mortgage Association Pools (20 Year)	4.00%	12/33	1,526

See Notes to Consolidated Financial Statements

182

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONTINUED)

AT DECEMBER 31, 2018

Current Principal/Notional Value		Description	Rate	Maturity	Fair Value
(In thousands)					Expressed in U.S. Dollars
(continued)
$	976	Federal Home Loan Mortgage Corporation Pools (20 Year)	4.50%	12/33	$	1,021
886		Federal Home Loan Mortgage Corporation Pools (15 Year)	4.00%	2/29	897
651		Federal Home Loan Mortgage Corporation Pools (30 Year)	6.00%	5/40	697
710		Government National Mortgage Association Pools (30 Year)	3.00%	11/42	695
588		Federal National Mortgage Association Pools (30 Year)	6.00%	9/39 - 2/40	631
524		Government National Mortgage Association Pools (30 Year)	2.49%	10/43	496
109		Federal National Mortgage Association Pools (30 Year)	3.28%	6/42	106
					884,870
Interest Only - Fixed Rate Agency Securities (1.77%)
North America
Mortgage-related—Residential
17,505		Government National Mortgage Association	4.00%	2/45 - 6/45	2,828
10,446		Federal National Mortgage Association	4.50%	12/20 - 6/44	1,223
4,768		Government National Mortgage Association	6.00%	6/38 - 8/39	978
5,949		Government National Mortgage Association	4.50%	6/39 - 7/44	808
3,401		Federal National Mortgage Association	5.50%	10/39	749
3,612		Government National Mortgage Association	5.50%	11/43	623
3,642		Federal Home Loan Mortgage Corporation	3.50%	12/32	515
3,560		Federal National Mortgage Association	4.00%	5/39 - 11/43	513
2,659		Federal National Mortgage Association	5.00%	1/38 - 5/40	463
5,122		Federal Home Loan Mortgage Corporation	5.00%	11/38	402
3,749		Federal Home Loan Mortgage Corporation	5.50%	1/39 - 9/39	336
1,613		Federal National Mortgage Association	6.00%	1/40	274
1,463		Federal Home Loan Mortgage Corporation	4.50%	7/43	254
2,291		Federal National Mortgage Association	3.00%	9/41	203
3,043		Government National Mortgage Association	5.00%	5/37 - 5/41	181
842		Government National Mortgage Association	4.75%	7/40	160
					10,510
TBA - Fixed Rate Agency Securities (79.78%)
North America
Mortgage-related—Residential
299,455		Government National Mortgage Association (30 Year)	5.00%	1/19	311,515
122,003		Federal National Mortgage Association (30 Year)	4.00%	1/19	124,376
21,540		Federal Home Loan Mortgage Corporation (30 Year)	3.50%	1/19	21,529
10,579		Government National Mortgage Association (30 Year)	5.50%	1/19	11,058
4,800		Government National Mortgage Association (30 Year)	3.00%	1/19	4,727
1,660		Federal Home Loan Mortgage Corporation (15 Year)	3.00%	1/19	1,655
					474,860
Total Fixed Rate Agency Securities (Cost $1,388,115)					1,370,240

See Notes to Consolidated Financial Statements

183

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONTINUED)

AT DECEMBER 31, 2018

Current Principal/Notional Value		Description	Rate	Maturity	Fair Value
(In thousands)					Expressed in U.S. Dollars
Floating Rate Agency Securities (13.43%)
Principal and Interest - Floating Rate Agency Securities (10.24%)
North America
Mortgage-related—Residential
$	52,532	Government National Mortgage Association Pools	4.39% - 4.67%	7/61 - 12/67	$	55,475
3,515		Federal National Mortgage Association Pools	2.70% - 4.69%	9/35 - 5/45	3,650
1,808		Federal Home Loan Mortgage Corporation Pools	3.49% - 4.72%	6/37 - 5/44	1,846
					60,971
Interest Only - Floating Rate Agency Securities (3.19%)
North America
Mortgage-related—Residential
228,763		Other Government National Mortgage Association	0.38% - 5.64%	6/31 - 10/66	10,772
70,568		Other Federal National Mortgage Association	1.13% - 5.50%	6/33 - 11/46	4,880
48,699		Other Federal Home Loan Mortgage Corporation	1.55% - 4.19%	3/36 - 1/44	3,256
5,220		Resecuritization of Government National Mortgage Association (d)	2.21%	8/60	98
					19,006
Total Floating Rate Agency Securities (Cost $81,873)					79,977
Total Agency Securities (Cost $1,469,988)					1,450,217
Private Label Securities (56.55%)
Principal and Interest - Private Label Securities (55.33%)
North America (27.62%)
Mortgage-related—Residential
227,479		Various	0.00%-24.56%	5/19 - 3/47	149,273
Mortgage-related—Commercial
37,171		Various	2.80% - 3.29%	3/49 - 5/61	15,137
Total North America (Cost $153,769)					164,410
Europe (27.71%)
Mortgage-related—Residential
183,154		Various	0.00% - 5.50%	6/25 - 12/52	149,425
Mortgage-related—Commercial
24,978		Various	0.38% - 4.29%	10/20 - 8/45	15,482
Total Europe (Cost $172,661)					164,907
Total Principal and Interest - Private Label Securities (Cost $326,430)					329,317

See Notes to Consolidated Financial Statements

184

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONTINUED)

AT DECEMBER 31, 2018

Current Principal/Notional Value		Description	Rate	Maturity	Fair Value
(In thousands)					Expressed in U.S. Dollars
Interest Only - Private Label Securities (1.22%)
North America
Mortgage-related—Residential
$	30,842	Various	0.00% - 2.00%	12/30 - 9/47	$	3,941
Mortgage-related—Commercial
41,707		Various	1.25% - 2.00%	3/49 - 5/61	3,289
Total Interest Only - Private Label Securities (Cost $5,189)					7,230
Other Private Label Securities (0.00%)
North America
Mortgage-related—Commercial
—		Various	—%	7/45 - 5/61	—
Total Other Private Label Securities (Cost $0)					—
Total Private Label Securities (Cost $331,619)					336,547
Total Mortgage-Backed Securities (Cost $1,801,607)					1,786,764
Collateralized Loan Obligations (20.82%)
North America (20.82%) (e)
269,224		Various	0.00%-10.54%	4/20- 10/2118	123,893
Total North America (Cost $139,424)					123,893
Total Collateralized Loan Obligations (Cost $139,424)					123,893
Consumer Loans and Asset-backed Securities backed by Consumer Loans (34.74%) (f)
North America (34.59%)
Consumer (g) (h)
233,602		Various	5.31%-76.50%	1/19 - 12/23	205,877
Total North America (Cost $211,221)					205,877
Europe (0.15%)
Consumer
3,540		Various	—%	12/30	884
Total Europe (Cost $761)					884
Total Consumer Loans and Asset-backed Securities backed by Consumer Loans (Cost $211,982)					206,761

See Notes to Consolidated Financial Statements

185

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONTINUED)

AT DECEMBER 31, 2018

Current Principal/Number of Properties			Rate	Maturity	Fair Value
(In thousands)					Expressed in U.S. Dollars
Corporate Debt (3.76%)
North America (1.95%)
Communications
$	938	Various	—%	5/22	$	824
Consumer
3,342		Various	6.69%	1/27	3,141
Energy
2,080		Various	4.63%	9/21	1,877
Industrial
1,755		Various	3.75%	12/21	1,742
Technology
4,570		Various	0.00% - 4.38%	5/20 - 5/22	4,002
Total North America (Cost $11,949)					11,586
Europe (1.81%)
Consumer
20,574		Various	—%	1/19	—
Financial
11,235		Various	0.00%-16.00%	10/20 - 11/22	10,806
Total Europe (Cost $12,319)					10,806
Total Corporate Debt (Cost $24,268)					22,392
Secured Notes (1.83%) (n)
North America
Mortgage-related—Residential
17,608		Various	5.00%	11/57	10,917
Total Secured Notes (Cost $12,138)					10,917
Mortgage Loans (118.96%) (f)
North America
Mortgage-related—Commercial (j)
235,459		Various	4.31%-12.74%	3/19 - 10/37	211,185
Mortgage-related—Residential (k) (m)
493,248		Various	2.00%-15.00%	3/19 - 12/58	496,830
Total Mortgage Loans (Cost $703,366)					708,015
Real Estate Owned (5.80%) (f) (l)
North America
Real estate-related
5		Single-Family Houses			1,296
18		Commercial Properties			33,204
Total Real Estate Owned (Cost $35,371)					34,500

See Notes to Consolidated Financial Statements

186

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONTINUED)

AT DECEMBER 31, 2018

Current Principal/Number of Shares			Rate	Maturity	Fair Value
(In thousands)					Expressed in U.S. Dollars
Common Stock (0.37%)
North America (0.37%)
Consumer
24		Exchange Traded Equity			$	25
Financial
213		Exchange Traded Equity			2,175
Total North America (Cost $2,482)					2,200
Total Corporate Equity Investments (Cost $2,482)					2,200
Corporate Equity Investments (7.36%)
North America (7.36%)
Communications
7		Non-Exchange Traded Corporate Equity			97
Consumer
n/a		Non-Controlling Equity Interest in Limited Liability Company (i)			4,045
3,000		Non-Exchange Traded Preferred Equity Investment in Consumer Loan Originators (n)			3,000
1,540		Non-Exchange Traded Corporate Equity			—
Diversified
144		Non-Exchange Traded Corporate Equity			1,433
Mortgage-related—Commercial (n)
n/a		Non-Controlling Equity Interest in Limited Liability Company			1,147
Mortgage-related—Residential (n)
23		Non-Exchange Traded Preferred Equity Investment in Mortgage Originators			27,317
9,818		Non-Exchange Traded Common Equity Investment in Mortgage Originators			6,750
Total North America (Cost $39,587)					43,789
Europe (0.00%)
Consumer
125		Non-Exchange Traded Corporate Equity			—
Financial
—		Non-Exchange Traded Corporate Equity			4
Total Europe (Cost $5)					4
Total Corporate Equity Investments (Cost $39,592)					43,793
U.S. Treasury Securities (0.01%)
North America
Government
$	75	U.S. Treasury Note	2.75%	4/23	76
Total U.S. Treasury Securities (Cost $76)					76
Total Long Investments (Cost $2,970,306)					$	2,939,311

See Notes to Consolidated Financial Statements

187

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONTINUED)

AT DECEMBER 31, 2018

Current Principal		Description	Rate	Maturity	Fair Value
(In thousands)					Expressed in U.S. Dollars
Repurchase Agreements (10.30%) (a) (b) (o)
$	13,854	JP Morgan Securities LLC	3.25%	1/19	$	13,854
		Collateralized by Par Value $13,600
		U.S. Treasury Note, Coupon 2.88%,
		Maturity Date 11/21
10,712		JP Morgan Securities LLC	3.15%	1/19	10,712
		Collateralized by Par Value $10,451
		U.S. Treasury Note, Coupon 2.88%,
		Maturity Date 10/23
10,365		JP Morgan Securities LLC	(0.75)%	1/19	10,365
		Collateralized by Par Value $10,102
		Sovereign Government Bond, Coupon 0.75%
		Maturity Date 7/21
9,379		JP Morgan Securities LLC	(0.65)%	1/19	9,379
		Collateralized by Par Value $9,161
		Sovereign Government Bond, Coupon 2.75%,
		Maturity Date 4/19
3,562		JP Morgan Securities LLC	3.05%	1/19	3,562
		Collateralized by Par Value $3,400
		U.S. Treasury Note, Coupon 3.13%,
		Maturity Date 11/28
2,884		JP Morgan Securities LLC	2.95%	1/19	2,884
		Collateralized by Par Value $2,800
		U.S. Treasury Note, Coupon 2.88%,
		Maturity Date 8/28
2,098		Bank of America Securities	2.90%	1/19	2,098
		Collateralized by Par Value $2,062
		U.S. Treasury Note, Coupon 2.88%,
		Maturity Date 11/23
1,975		Bank of America Securities	2.90%	1/19	1,975
		Collateralized by Par Value $1,939
		U.S. Treasury Note, Coupon 2.75%,
		Maturity Date 8/23
1,710		Barclays Capital Inc	(1.65)%	1/19	1,710
		Collateralized by Par Value $1,900
		Exchange-Traded Corporate Debt, Coupon 5.95%,
		Maturity Date 12/26
1,369		Bank of America Securities	3.05%	1/19	1,369
		Collateralized by Par Value $1,355
		U.S. Treasury Note, Coupon 2.75%,
		Maturity Date 4/23
957		Morgan Stanley	(2.15)%	1/19	957
		Collateralized by Par Value $1,000
		Exchange-Traded Corporate Debt, Coupon 5.95%,
		Maturity Date 12/26

See Notes to Consolidated Financial Statements

188

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONTINUED)

AT DECEMBER 31, 2018

Current Principal		Description	Rate	Maturity	Fair Value
(In thousands)					Expressed in U.S. Dollars
(continued)
$	797	Barclays Capital Inc	(0.75)%	1/19	$	797
		Collateralized by Par Value $1,200
		Exchange-Traded Corporate Debt, Coupon 9.88%,
		Maturity Date 2/24
531		Barclays Capital Inc	(1.25)%	1/19	531
		Collateralized by Par Value $800
		Exchange-Traded Corporate Debt, Coupon 9.88%,
		Maturity Date 2/24
525		RBC Capital Markets LLC	2.05%	1/19	525
		Collateralized by Par Value $500
		Exchange-Traded Corporate Debt, Coupon 5.75%,
		Maturity Date 10/22
469		Bank of America Securities	3.05%	1/19	469
		Collateralized by Par Value $463
		U.S. Treasury Note, Coupon 2.63%,
		Maturity Date 6/23
87		Societe Generale	(1.85)%	1/19	87
		Collateralized by Par Value $100
		Exchange-Traded Corporate Debt, Coupon 5.95%,
		Maturity Date 12/26
Total Repurchase Agreements (Cost $61,274)					$	61,274

Investments Sold Short (-142.91%) (a) (b)
TBA - Fixed Rate Agency Securities Sold Short (-129.87%) (p)
North America
Mortgage-related—Residential
$	(156,590)	Federal National Mortgage Association (30 year)	4.50%	1/19	$	(162,119)
(117,590)		Government National Mortgage Association (30 year)	4.50%	1/19	(121,637)
(107,397)		Federal Home Loan Mortgage Corporation (30 year)	4.00%	1/19	(109,465)
(87,817)		Federal National Mortgage Association (30 year)	5.00%	1/19	(91,971)
(86,893)		Government National Mortgage Association (30 year)	4.00%	1/19	(88,994)
(76,912)		Federal National Mortgage Association (30 year)	3.50%	1/19	(76,891)
(32,260)		Government National Mortgage Association (30 year)	3.50%	1/19	(32,484)
(26,530)		Federal National Mortgage Association (15 year)	3.50%	1/19	(26,859)
(24,841)		Federal Home Loan Mortgage Corporation (30 year)	4.50%	1/19	(25,707)
(16,557)		Federal National Mortgage Association (30 year)	3.00%	1/19	(16,153)
(13,450)		Federal National Mortgage Association (15 year)	3.00%	1/19	(13,426)
(6,860)		Federal National Mortgage Association (30 year)	5.50%	1/19	(7,258)
Total TBA - Fixed Rate Agency Securities Sold Short (Proceeds -$766,777)					(772,964)

See Notes to Consolidated Financial Statements

189

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONTINUED)

AT DECEMBER 31, 2018

Current Principal/Number of Shares		Description	Rate	Maturity	Fair Value
(In thousands)					Expressed in U.S. Dollars
Government Debt Sold Short (-9.10%)
North America (-5.85%)
Government
$	(13,600)	U.S. Treasury Note	2.88%	11/21	$	(13,754)
(10,451)		U.S. Treasury Note	2.88%	10/23	(10,631)
(3,400)		U.S. Treasury Note	3.13%	11/28	(3,528)
(2,800)		U.S. Treasury Note	2.88%	8/28	(2,844)
(2,062)		U.S. Treasury Note	2.88%	11/23	(2,098)
(1,939)		U.S. Treasury Note	2.75%	8/23	(1,962)
Total North America (Proceeds -$34,410)					(34,817)
Europe (-3.25%)
Government
(19,006)		European Sovereign Bond	0.75% - 2.75%	4/19 - 7/21	(19,334)
Total Europe (Proceeds -$19,545)					(19,334)
Total Government Debt Sold Short (Proceeds -$53,955)					(54,151)
Common Stock Sold Short (-2.84%)
North America
Financial
(277)		Exchange Traded Equity			(16,933)
Total Common Stock Sold Short (Proceeds -$17,164)					(16,933)
Corporate Debt Sold Short (-1.10%)
North America
Communications
(1,730)		Various	4.25%	9/23	(1,734)
Consumer
(500)		Various	5.75%	10/22	(500)
Energy
(2,000)		Various	9.88%	2/24	(1,230)
Financial
(3,600)		Various	4.70% - 5.95%	12/26 - 6/27	(2,810)
Technology
(288)		Various	4.95%	4/23	(255)
Total Corporate Debt Sold Short (Proceeds -$6,708)					(6,529)
Total Investments Sold Short (Proceeds -$844,604)					$	(850,577)

See Notes to Consolidated Financial Statements

190

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONTINUED)

AT DECEMBER 31, 2018

	Primary Risk Exposure	Notional Value		Range of Expiration Dates	Fair Value
(In thousands)					Expressed in U.S.Dollars
Financial Derivatives–Assets (3.36%) (a) (b)
Swaps (3.36%)
Long Swaps:
Credit Default Swaps on Corporate Bond Indices (q)	Credit	$	47,815	6/19 - 6/23	$	733
Credit Default Swaps on Asset-Backed Indices (q)	Credit	689		12/37	7
Interest Rate Swaps (r)	Interest Rates	29,198		1/19 - 2/19	61
North America
Credit Default Swaps on Corporate Bonds (q)
Basic Materials	Credit	4		12/22	—
Communications	Credit	3,090		12/20 - 12/23	18
Consumer	Credit	10,655		6/20 - 12/23	868
Financial	Credit	930		12/23	104
Industrial	Credit	485		12/23	13
Total Credit Default Swaps on Corporate Bonds					1,003
Short Swaps:
Credit Default Swaps on Asset-Backed Indices (s)	Credit	(56,207)		5/46 - 11/59	8,085
Interest Rate Swaps (t)	Interest Rates	(353,741)		3/20 - 12/45	7,163
North America
Credit Default Swaps on Asset-Backed Securities (s)
Mortgage-related—Residential	Credit	(3,186)		6/35 - 12/35	1,472
Credit Default Swaps on Corporate Bonds (s)
Basic Materials	Credit	(2,074)		12/21 - 12/23	25
Communications	Credit	(906)		12/21 - 12/23	226
Consumer	Credit	(2,065)		3/20	30
Energy	Credit	(7,610)		6/19 - 6/23	950
Technology	Credit	(4,070)		6/20 - 6/22	239
Total Credit Default Swaps on Corporate Bonds					1,470
Total Return Swaps (u)
Financial	Equity Market	(17,740)		7/19 - 10/19	1
Total Total Return Swaps					1
Total Swaps (Net cost $22,524)					19,995
Options (0.00%)
Purchased Options:
Interest Rate Caps (w)	Interest Rates	51,545		5/19	—
Total Options (Cost $2)					—

See Notes to Consolidated Financial Statements

191

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONTINUED)

AT DECEMBER 31, 2018

	Primary Risk Exposure	Notional Value		Range of Expiration Dates	Fair Value
(In thousands)					Expressed in U.S.Dollars
Futures (0.00%)
Short Futures:
U.S. Treasury Note Futures (x)	Interest Rates	$	(151,600)	3/19	$	—
Total Futures					—
Forwards (0.00%)
Short Forwards:
Currency Forwards (aa)	Interest Rates	(802)		3/19	6
Total Forwards					6
Total Financial Derivatives–Assets (Net cost $22,526)					$	20,001
Financial Derivatives–Liabilities (-3.50%) (a) (b)
Swaps (-3.42%)
Long Swaps:
Credit Default Swaps on Asset-Backed Indices (q)	Credit	$	14,838	3/49 - 11/60	$	(2,125)
Credit Default Swaps on Corporate Bond Indices (q)	Credit	2,330		12/23	(1,467)
Interest Rate Swaps (r)	Interest Rates	113,809		6/21 - 1/29	(1,987)
North America
Credit Default Swaps on Corporate Bonds (q)
Basic Materials	Credit	2,000		12/23	(25)
Communications	Credit	2,313		6/22 - 12/23	(396)
Consumer	Credit	3,741		3/20 - 6/21	(62)
Energy	Credit	5,144		6/20 - 6/23	(1,885)
Technology	Credit	1,953		6/20 - 6/23	(114)
Total Credit Default Swaps on Corporate Bonds					(2,482)
Recovery Swaps (v)
Consumer	Credit	2,600		6/19	(8)
Total Recovery Swaps					(8)

See Notes to Consolidated Financial Statements

192

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONTINUED)

AT DECEMBER 31, 2018

	Primary Risk Exposure	Notional Value		Range of Expiration Dates	Fair Value
(In thousands)					Expressed in U.S.Dollars
Short Swaps:
Interest Rate Swaps (t)	Interest Rates	$	(71,672)	5/20 - 11/28	$	(1,406)
Interest Rate Basis Swaps (z)	Interest Rates	(12,900)		6/19	(4)
Credit Default Swaps on Corporate Bond Indices (s)	Credit	(279,163)		6/19 - 12/23	(10,090)
Total Return Swaps (ab)	Credit	(11,230)		3/19	(6)
North America
Credit Default Swaps on Corporate Bonds (s)
Basic Materials	Credit	(1,180)		12/19	(57)
Communications	Credit	(3,910)		12/19 - 12/23	(11)
Consumer	Credit	(12,830)		6/19 - 12/23	(567)
Financial	Credit	(930)		12/23	(104)
Industrial	Credit	(485)		12/23	(13)
Technology	Credit	(1,160)		6/19	(4)
Total Credit Default Swaps on Corporate Bonds					(756)
Total Swaps (Net proceeds -$19,019)					(20,331)
Futures (-0.06%)
Short Futures:
Eurodollar Futures (ac)	Interest Rates	(98,000)		3/19 - 6/20	(53)
Currency Futures (y)	Interest Rates	(47,931)		3/19	(302)
Total Futures					(355)
Forwards (-0.02%)
Short Forwards:
Currency Forwards (aa)	Interest Rates	(16,497)		3/19	(120)
Total Forwards					(120)
Total Financial Derivatives–Liabilities (Net proceeds -$19,019)					$	(20,806)

See Notes to Consolidated Financial Statements

193

ELLINGTON FINANCIAL LLC

CONSOLIDATED CONDENSED SCHEDULE OF INVESTMENTS (CONCLUDED)

AT DECEMBER 31, 2018

(a)See Note 2 and Note 3 in Notes to Consolidated Financial Statements.

(b)Classification percentages are based on Total Equity.

(c)At December 31, 2018, the Company's long investments guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, and the Government National Mortgage Association, represented 93.99%, 42.12%, and 107.55% of Total Equity, respectively.

(d)Private trust 100% backed by interest in Government National Mortgage Association collateralized mortgage obligation certificates.

(e)Includes investment in collateralized loan obligation notes in the amount of $50.8 million that were issued and are managed by related parties of the Company. See Note 9 to the Notes to Consolidated Financial Statements.

(f)Loans and real estate owned are beneficially owned by the Company through participation certificates in the various trusts that hold such investments. See Note 9 to the Notes to Consolidated Financial Statements.

(g)Includes investments in participation certificates related to loans titled in the name of a related party of Ellington Management Group, L.L.C. Through its participation certificates, the Company has beneficial interests in the loan cash flows, net of servicing-related fees and expenses. At December 31, 2018 loans for which the Company has beneficial interests in the net cash flows, totaled $21.9 million. See Note 9 to the Notes to Consolidated Financial Statements.

(h)Includes investments in participation certificates related to loans held in a trust owned by a related party of Ellington Management Group, L.L.C. Through its participation certificates, the Company participates in the cash flows of the underlying loans held by the trust. At December 31, 2018 loans held in the related party trust for which the Company has participating interests in the cash flows, totaled $181.5 million. See Note 9 to the Notes to Consolidated Financial Statements.

(i)Represents the Company's beneficial interest in an entity, which is co-owned by an affiliate of Ellington Management Group, L.L.C. The entity owns subordinated notes issued by, as well as trust certificates representing ownership of, a securitization trust. See Note 6 and Note 9 to the Notes to Consolidated Financial Statements.

(j)Includes non-performing commercial mortgage loans in the amount of $47.3 million whereby principal and/or interest is past due and a maturity date is not applicable.

(k)As of December 31, 2018, the Company had residential mortgage loans that were in the process of foreclosure with a fair value of $9.1 million.

(l)Number of properties not shown in thousands, represents actual number of properties owned.

(m)Includes $314.2 million of non-qualified mortgage loans that have been securitized and are held in a consolidated securitization trusts. See Note 6 to the Notes to Consolidated Financial Statements.

(n)Represents the Company's investment in a related party. See Note 9 to the Notes to Consolidated Financial Statements.

(o)In general, securities received pursuant to repurchase agreements were delivered to counterparties in short sale transactions.

(p)At December 31, 2018, the Company's short investments guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, and the Government National Mortgage Association, represented 66.31%, 22.71%, and 40.85% of Total Equity, respectively.

(q)For long credit default swaps, the Company sold protection.

(r)For long interest rate swap contracts, the Company pays a floating rate and receives a fixed rate.

(s)For short credit default swaps, the Company purchased protection.

(t)For short interest rate swap contracts, the Company pays a fixed rate and receives a floating rate.

(u)Notional value represents number of underlying shares multiplied by the closing price of the underlying security.

(v)For long recovery swaps the Company receives a specified recovery rate in exchange for the actual recovery rate on the underlying.

(w)Notional value represents the amount on which interest payments are calculated to the extent the market interest rate exceeds the rate cap on the contract.

(x)Notional value represents the total face amount of U.S. Treasury securities underlying all contracts held. As of December 31, 2018, a total of 1,516 contracts were held.

(y)Notional value represents the total face amount of foreign currency underlying all contracts held; as of December 31, 2018, 411 contracts were held.

(z)Represents interest rate "basis" swaps whereby the Company pays one floating rate and receives a different floating rate.

(aa)Notional value represents U.S. Dollars to be received by the Company at the maturity of the forward contract.

(ab)Notional value represents the number of underlying index units multiplied by the reference price.

(ac)Every $1,000,000 in notional value represents one contract.

(ad)The table below shows the Company's long investment ratings from Moody's, Standard and Poor's, or Fitch, as well as the Company's long investments that were unrated but guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association. Ratings tend to be a lagging credit indicator; as a result, the credit quality of the Company's long investment holdings may be lower than the credit quality implied based on the ratings listed below. In situations where an investment has a split rating, the lowest provided rating is used. The ratings descriptions include ratings qualified with a "+," "-," "1," "2," or "3."

Rating Description	Percent of Equity
Unrated but Agency-Guaranteed	243.66	%
Aaa/AAA/AAA	0.01	%
Aa/AA/AA	0.63	%
A/A/A	4.73	%
Baa/BBB/BBB	1.84	%
Ba/BB/BB or below	46.34	%
Unrated	196.65	%

See Notes to Consolidated Financial Statements

194

ELLINGTON FINANCIAL LLC

CONSOLIDATED STATEMENT OF OPERATIONS

	Year Ended December 31, 2018
(In thousands except per share amounts)
INVESTMENT INCOME
Interest income(1)	$	131,027
Other income	4,014
Total investment income	135,041
EXPENSES
Base management fee to affiliate (Net of fee rebates of $1,380)(2)	7,573
Incentive fee to affiliate	715
Interest expense(1)	56,707
Other investment related expenses
Servicing expense	7,715
Debt issuance costs related to Other secured borrowings, at fair value	1,647
Other	7,592
Professional fees	3,902
Administration fees	734
Compensation expense	2,233
Insurance expense	487
Directors' fees and expenses	298
Share-based long term incentive plan unit expense	415
Other expenses	1,898
Total expenses	91,916
NET INVESTMENT INCOME	43,125
NET REALIZED AND CHANGE IN NET UNREALIZED GAIN (LOSS) ON INVESTMENTS, FINANCIAL DERIVATIVES, AND FOREIGN CURRENCY TRANSACTIONS/TRANSLATION
Net realized gain (loss) on:
Investments	25,421
Financial derivatives, excluding currency hedges	(2,639)
Financial derivatives—currency hedges	4,475
Foreign currency transactions	4,131
	31,388
Change in net unrealized gain (loss) on:
Investments	(25,947)
Other secured borrowings	758
Financial derivatives, excluding currency hedges	7,093
Financial derivatives—currency hedges	565
Foreign currency translation	(7,071)
	(24,602)
NET REALIZED AND CHANGE IN NET UNREALIZED GAIN (LOSS) ON INVESTMENTS, OTHER SECURED BORROWINGS, FINANCIAL DERIVATIVES, AND FOREIGN CURRENCY TRANSACTIONS/TRANSLATION	6,786

See Notes to Consolidated Financial Statements

195

ELLINGTON FINANCIAL LLC
CONSOLIDATED STATEMENT OF OPERATIONS (CONTINUED)
	Year Ended December 31, 2018
NET INCREASE IN EQUITY RESULTING FROM OPERATIONS	$	49,911
LESS: NET INCREASE IN EQUITY RESULTING FROM OPERATIONS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS	3,235
NET INCREASE IN SHAREHOLDERS' EQUITY RESULTING FROM OPERATIONS	$	46,676
NET INCREASE IN SHAREHOLDERS' EQUITY RESULTING FROM OPERATIONS PER SHARE:
Basic and Diluted	$	1.52

(1)Includes interest income and interest expense of a consolidated securitization trust of $6.0 million and $3.6 million, respectively, for the year ended December 31, 2018. See Note 6 for further details on the Company's consolidated securitization trust.

(2)See Note 9 for further details on management fee rebates.

See Notes to Consolidated Financial Statements

196

ELLINGTON FINANCIAL LLC

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

	Year Ended December 31, 2018
	Shareholders' Equity		Non-controlling Interest		Total Equity
(In thousands)	Expressed in U.S. Dollars
BEGINNING EQUITY (December 31, 2017)	$	600,099	$	20,862	$	620,961
CHANGE IN EQUITY RESULTING FROM OPERATIONS
Net investment income					43,125
Net realized gain (loss) on investments, financial derivatives, and foreign currency transactions					31,388
Change in net unrealized gain (loss) on investments, other secured borrowings, financial derivatives, and foreign currency translation					(24,602)
Net increase (decrease) in equity resulting from operations	46,676		3,235		49,911
CHANGE IN EQUITY RESULTING FROM TRANSACTIONS
Shares issued in connection with incentive fee payment	71				71
Contributions from non-controlling interests			21,532		21,532
Dividends(1)	(50,388)		(348)		(50,736)
Distributions to non-controlling interests			(23,853)		(23,853)
Adjustment to non-controlling interest	(369)		369		—
Share-based long term incentive plan unit redemption and distribution	(9,537)		9,537		—
Shares repurchased	(23,131)				(23,131)
Share-based long term incentive plan unit awards	412		3		415
Net increase (decrease) in equity from transactions	(82,942)		7,240		(75,702)
Net increase (decrease) in equity	(36,266)		10,475		(25,791)
ENDING EQUITY (December 31, 2018)	$	563,833	$	31,337	$	595,170

(1)For the year ended December 31, 2018, dividends totaling $1.64 per common share and convertible unit outstanding, were declared.

See Notes to Consolidated Financial Statements

197

ELLINGTON FINANCIAL LLC

CONSOLIDATED STATEMENT OF CASH FLOWS

	Year Ended December 31, 2018
(In thousands)	Expressed in U.S. Dollars
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH:
NET INCREASE IN EQUITY RESULTING FROM OPERATIONS	$	49,911
Cash flows provided by (used in) operating activities:
Reconciliation of the net increase (decrease) in equity resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss on investments, financial derivatives, and foreign currency transactions	(25,368)
Change in net unrealized (gain) loss on investments, other secured borrowings, financial derivatives, and foreign currency translation	26,318
Amortization of premiums and accretion of discounts (net)	45,895
Purchase of investments	(3,350,398)
Proceeds from disposition of investments	1,868,532
Proceeds from principal payments of investments	497,858
Proceeds from investments sold short	2,674,841
Repurchase of investments sold short	(2,457,148)
Payments on financial derivatives	(119,490)
Proceeds from financial derivatives	121,904
Amortization of deferred debt issuance costs	263
Shares issued in connection with incentive fee payment	71
Share-based long term incentive plan unit expense	415
Interest income related to consolidated securitization trust(1)	(4,697)
Interest expense related to consolidated securitization trust(1)	4,313
Debt issuance costs related to Other secured borrowings, at fair value(1)	1,647
Repurchase agreements	94,675
(Increase) decrease in assets:
Receivable for securities sold and financial derivatives	(304,826)
Due from brokers	68,610
Interest and principal receivable	(7,988)
Other assets	28,234
Increase (decrease) in liabilities:
Due to brokers	3,832
Payable for securities purchased and financial derivatives	285,708
Accounts payable and accrued expenses	1,838
Other liabilities	(17)
Interest and dividends payable	1,255
Base management fee payable to affiliate	(369)
Net cash provided by (used in) operating activities	(494,181)

See Notes to Consolidated Financial Statements

198

ELLINGTON FINANCIAL LLC
CONSOLIDATED STATEMENT OF CASH FLOWS (CONTINUED)
	Year Ended December 31, 2018
(In thousands)	Expressed in U.S. Dollars
Cash flows provided by (used in) financing activities:
Contributions from non-controlling interests	$	21,532
Shares repurchased	(23,131)
Dividends paid	(50,736)
Distributions to non-controlling interests	(23,853)
Proceeds from issuance of Other secured borrowings	100,010
Principal payments on Other secured borrowings	(43,819)
Proceeds from issuance of Other secured borrowings, at fair value	102,706
Debt issuance costs related to Other secured borrowings, at fair value	(775)
Borrowings under reverse repurchase agreements	8,078,468
Repayments of reverse repurchase agreements	(7,668,798)
Net cash provided by (used in) financing activities	491,604
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	(2,577)
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, BEGINNING OF PERIOD	47,658
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, END OF PERIOD	$	45,081
Supplemental disclosure of cash flow information:
Interest paid	$	55,649
Shares issued in connection with incentive fee payment	71
Share-based long term incentive plan unit awards (non-cash)	415
Aggregate TBA trade activity (buys + sells) (non-cash)	29,752,907
Purchase of investments (non-cash)	(17,424)
Proceeds from principal payments of investments (non-cash)	49,731
Proceeds from the disposition of investments (non-cash)	17,424
Proceeds received from Other secured borrowings, at fair value (non-cash)	120,625
Principal payments on Other secured borrowings, at fair value (non-cash)	(49,731)
Repayments of reverse repurchase agreements (non-cash)	(120,136)
Expenses from issuance of other secured borrowings at fair value (non-cash)	(872)
Share-based long term incentive plan unit redemption (non-cash)	(9,537)
Contribution from non-controlling interests (non-cash)	9,537

(1)Related to non-qualified mortgage securitization transactions. See Note 6 for further details.

See Notes to Consolidated Financial Statements

199

ELLINGTON FINANCIAL LLC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2018

1. Organization and Investment Objective

Ellington Financial LLC was formed as a Delaware limited liability company on July 9, 2007 and commenced operations on August 17, 2007. Ellington Financial Operating Partnership LLC (the "Operating Partnership"), a 97.6% owned consolidated subsidiary of Ellington Financial LLC, was formed as a Delaware limited liability company on December 14, 2012 and commenced operations on January 1, 2013. All of the Company's operations and business activities are conducted through the Operating Partnership. Ellington Financial LLC, the Operating Partnership, and their consolidated subsidiaries are hereafter collectively referred to as the "Company." All intercompany accounts are eliminated in consolidation.

The Company invests in a diverse array of financial assets, including residential mortgage-backed securities, or "RMBS," commercial mortgage-backed securities, or "CMBS," residential and commercial mortgage loans, consumer loans and asset-backed securities, or "ABS," backed by consumer loans, collateralized loan obligations, or "CLOs," non-mortgage and mortgage-related derivatives, equity investments in loan origination companies, and other strategic investments.

Ellington Financial Management LLC ("EFM" or the "Manager") is an SEC-registered investment adviser and a registered commodity pool operator that serves as the Manager to the Company pursuant to the terms of its seventh amended and restated management agreement (the "Management Agreement"). EFM is an affiliate of Ellington Management Group, L.L.C., ("Ellington") an investment management firm that is registered as both an investment adviser and a commodity pool operator. In accordance with the terms of the Management Agreement, the Manager implements the investment strategy and manages the business and operations on a day-to-day basis for the Company and performs certain services for the Company, subject to oversight by the Company's Board of Directors ("Board of Directors").

2. Significant Accounting Policies

(A) Basis of Presentation: The Company's consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, or "U.S. GAAP," for investment companies, ASC 946, Financial Services—Investment Companies ("ASC 946"). The Company has determined that it meets the definition of an investment company under ASC 946. ASC 946 requires, among other things, that investments be reported at fair value in the financial statements. Additionally under ASC 946 the Company generally will not consolidate its interest in any company other than in its subsidiaries that qualify as investment companies under ASC 946. The consolidated financial statements include the accounts of the Company, the Operating Partnership, and its subsidiaries. They also include certain securitization trusts which are designed to facilitate specific financing activities of the Company and represent a direct extension of the Company's business activities. All intercompany balances and transactions have been eliminated. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and those differences could be material.

(B) Valuation: The Company applies ASC 820-10, Fair Value Measurement ("ASC 820-10"), to its holdings of financial instruments. ASC 820-10 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:

•Level 1—inputs to the valuation methodology are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Currently, the types of financial instruments the Company generally includes in this category are listed equities, exchange-traded derivatives, and cash equivalents;

•Level 2—inputs to the valuation methodology other than quoted prices included in Level 1 are observable for the asset or liability, either directly or indirectly. Currently, the types of financial instruments that the Company generally includes in this category are Agency RMBS, U.S. Treasury securities and sovereign debt, certain non-Agency RMBS and CMBS, CLOs, and corporate debt, and actively traded derivatives, such as interest rate swaps and foreign currency forwards, and certain other over-the-counter derivatives; and

•Level 3—inputs to the valuation methodology are unobservable and significant to the fair value measurement. The types of financial instruments that the Company generally includes in this category are certain RMBS, CMBS, and CLOs, ABS, credit default swaps, or "CDS," on individual ABS, distressed corporate debt, and total return swaps on distressed corporate debt, in each case where there is less price transparency. Also included in this category are residential and commercial mortgage loans, consumer loans, non-listed equities, private corporate debt and equity investments, secured notes, and Other secured borrowings, at fair value.

200

For certain financial instruments, the various inputs that management uses to measure fair value for such financial instrument may fall into different levels of the fair value hierarchy. In such cases, the determination of which category within the fair value hierarchy is appropriate for such financial instrument is based on the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the various inputs that management uses to measure fair value with the highest priority to inputs that are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets (Level 1) and the lowest priority to inputs that are unobservable and significant to the fair value measurement (Level 3). The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. The Company may use valuation techniques consistent with the market and income approaches to measure the fair value of its assets and liabilities. The market approach uses third-party valuations and information obtained from market transactions involving identical or similar assets or liabilities. The income approach uses projections of the future economic benefit of an instrument to determine its fair value, such as in the discounted cash flow methodology. The inputs or methodology used for valuing financial instruments are not necessarily an indication of the risk associated with investing in these financial instruments. The leveling of each financial instrument is reassessed at the end of each period.

Summary Valuation Techniques

For financial instruments that are traded in an "active market," the best measure of fair value is the quoted market price. However, many of the Company's financial instruments are not traded in an active market. Therefore, management generally uses third-party valuations when available. If third-party valuations are not available, management uses other valuation techniques, such as the discounted cash flow methodology. The following are summary descriptions, for various categories of financial instruments, of the valuation methodologies management uses in determining fair value of the Company's financial instruments in such categories. Management utilizes such methodologies to assign a good faith fair value (the estimated price that, in an orderly transaction at the valuation date, would be received to sell an asset, or paid to transfer a liability, as the case may be) to each such financial instrument.

For mortgage-backed securities, or "MBS," including To Be Announced MBS, or "TBAs," CLOs, and distressed and non-distressed corporate debt and equity, management seeks to obtain at least one third-party valuation, and often obtains multiple valuations when available. Management has been able to obtain third-party valuations on the vast majority of these instruments and expects to continue to solicit third-party valuations in the future. Management generally values each financial instrument at the average of third-party valuations received and not rejected as described below. Third-party valuations are not binding, and while management generally does not adjust the valuations it receives, management may challenge or reject a valuation when, based on its validation criteria, management determines that such valuation is unreasonable or erroneous. Furthermore, based on its validation criteria, management may determine that the average of the third-party valuations received for a given instrument does not result in what management believes to be the fair value of such instrument, and in such circumstances management may override this average with its own good faith valuation. The validation criteria may take into account output from management's own models, recent trading activity in the same or similar instruments, and valuations received from third parties. The use of proprietary models requires the use of a significant amount of judgment and the application of various assumptions including, but not limited to, assumptions concerning future prepayment rates and default rates. Valuations for fixed-rate RMBS pass-throughs issued by a U.S. government agency or government-sponsored enterprise are typically based on observable pay-up data (pay-ups are price premiums for specified categories of fixed-rate pools relative to their TBA counterparts) or models that use observable market data, such as interest rates and historical prepayment speeds, and are validated against third-party valuations. Given their relatively high level of price transparency, Agency RMBS pass-throughs are typically designated as Level 2 assets. Non-Agency MBS, Agency interest only and inverse interest only RMBS, and CLOs are generally classified as either Level 2 or Level 3 based on analysis of available market data and/or third-party valuations. The Company's investments in distressed corporate debt can be in the form of loans as well as total return swaps on loans. These investments, as well as related non-listed equity investments, are generally designated as Level 3 assets. Valuations for total return swaps are typically based on prices of the underlying loans received from widely used third-party pricing services. Investments in non-distressed corporate bonds are generally also valued based on prices received from third-party pricing services, and many of these bonds, because they are very liquid with readily observable data, are generally classified as Level 2 holdings. Furthermore, the methodology used by the third-party valuation providers is reviewed at least annually by management, so as to ascertain whether such providers are utilizing observable market data to determine the valuations that they provide.

For residential and commercial mortgage loans, consumer loans, and real estate owned properties, or "REO," management determines fair value by taking into account both external pricing data, when available, and internal pricing models. Non-performing mortgage loans and REO are typically valued based on management's estimates of the value of the underlying real estate, using information including general economic data, broker price opinions, or "BPOs," recent sales, property appraisals, and bids. Performing mortgage loans and consumer loans are typically valued using discounted cash flows based on market assumptions. Cash flow assumptions typically include projected default and prepayment rates and loss severities, and may

201

include adjustments based on appraisals and BPOs. Mortgage and consumer loans and REO properties are classified as Level 3 assets.

Securitized mortgage loans that are not deemed "qualified mortgage," or "QM," loans under the rules of the Consumer Financial Protection Bureau, or "non-QM loans," are held as part of a collateralized financing entity, or "CFE." A CFE is a variable interest entity, or "VIE," that holds financial assets, issues beneficial interests in those assets, and has no more than nominal equity, and for which the issued beneficial interests have contractual recourse only to the related assets of the CFE. ASC 810, Consolidation ("ASC 810"), allows the Company to elect to measure both the financial assets and financial liabilities of the CFE using the more observable of the fair value of the financial assets and the fair value of the financial liabilities of the CFE. The Company has elected the fair value option for initial and subsequent recognition of the debt issued by its consolidated securitization trust and has determined such trust meets the definition of a CFE; see Note 6 for further discussion on the Company's securitization trusts. The Company has determined the inputs to the fair value measurement of the financial liabilities of its CFE to be more observable than those of the financial assets and, as a result, has used the fair value of the financial liabilities of the CFE to measure the fair value of the financial assets of the CFE. The fair value of the debt issued by the CFE is typically valued using discounted cash flows and other market data. The securitized non-QM loans, which are assets of the CFE, are included in Investments, at fair value on the Company's Consolidated Statement of Assets, Liabilities, and Equity. The debt issued by the CFE is included in Other secured borrowings, at fair value, on the Company's Consolidated Statement of Assets, Liabilities, and Equity. The securitized non-QM loans and the debt issued by the Company's CFE are both designated as Level 3 financial instruments.

For financial derivatives with greater price transparency, such as CDS on asset-backed indices, CDS on corporate indices, certain options on the foregoing, and total return swaps on publicly traded equities, market-standard pricing sources are used to obtain valuations; these financial derivatives are generally designated as Level 2 instruments. Interest rate swaps, swaptions, and foreign currency forwards are typically valued based on internal models that use observable market data, including applicable interest rates and foreign currency rates in effect as of the measurement date; the model-generated valuations are then typically compared to counterparty valuations for reasonableness. These financial derivatives are also generally designated as Level 2 instruments. Financial derivatives with less price transparency, such as CDS on individual ABS, are generally valued based on internal models, and are typically designated as Level 3 instruments. In the case of CDS on individual ABS, the valuation process typically starts with an estimation of the value of the underlying ABS. In valuing its derivatives, the Company also considers the creditworthiness of both the Company and its counterparties, along with collateral provisions contained in each derivative agreement.

Investments in private operating entities, such as loan originators, are valued based on available metrics, such as relevant market multiples and comparable company valuations, company specific-financial data including actual and projected results and independent third party valuation estimates. These investments are designated as Level 3 assets.

The Company's repurchase agreements are carried at fair value based on their contractual amounts as the debt is short-term in nature. The Company's reverse repurchase agreements are carried at cost, which approximates fair value. Repurchase and reverse repurchase agreements are classified as Level 2 assets and liabilities based on the adequacy of the collateral and their short term nature.

The Company's valuation process, including the application of validation criteria, is overseen by the Manager's Valuation Committee ("Valuation Committee"). The Valuation Committee includes senior level executives from various departments within the Manager, and each quarter, the Valuation Committee reviews and approves the valuations of the Company's investments. The valuation process also includes a monthly review by the Company's third-party administrator. The goal of this review is to replicate various aspects of the Company's valuation process based on the Company's documented procedures.

Because of the inherent uncertainty of valuation, the estimated fair value of the Company's financial instruments may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to the Company's consolidated financial statements.

(C) Purchase and Sales of Investments and Investment Income: Purchases and sales of investments are generally recorded on trade date, and realized and unrealized gains and losses are calculated based on identified cost. The Company amortizes premiums and accretes discounts on its debt investments. Coupon interest income on fixed-income investments is generally accrued based on the outstanding principal balance or notional value and the current coupon interest rate.

For Agency RMBS and debt securities that are deemed to be of high credit quality at the time of purchase, premiums and discounts are amortized into interest income over the life of such securities using the effective interest method. For securities whose cash flows vary depending on prepayments, an effective yield retroactive to the time of purchase is periodically recomputed based on actual prepayments and changes in projected prepayment activity, and a catch-up adjustment is made to amortization to reflect the cumulative impact of the change in effective yield.

202

For debt securities (including non-Agency MBS) that are deemed not to be of high credit quality at the time of purchase, interest income is recognized based on the effective interest method. For purposes of determining the effective interest rate, management estimates the future expected cash flows of its investment holdings based on assumptions including, but not limited to, assumptions for future prepayment rates, default rates, and loss severities (each of which may in turn incorporate various macro-economic assumptions, such as future housing prices). These assumptions are re-evaluated not less than quarterly. Principal write-offs are generally treated as realized losses. Changes in projected cash flows, as applied to the current amortized cost of the security, may result in a prospective change in the yield/interest income recognized on such securities.

For each loan purchased with the expectation that both interest and principal will be paid in full, the Company generally amortizes or accretes any premium or discount over the life of the loan utilizing the effective interest method. However, on at least a quarterly basis based on current information and events, the Company re-assesses the collectibility of interest and principal, and designates a loan as impaired either when any payments have become 90 or more days past due, or when, in the opinion of management, it is probable that the Company will be unable to collect either interest or principal in full. Once a loan is designated as impaired, as long as principal is still expected to be collectible in full, interest payments are recorded as interest income only when received (i.e., under the cash basis method); accruals of interest income are only resumed when the loan becomes contractually current and performance is demonstrated to be resumed. However, if principal is not expected to be collectible in full, the cost recovery method is used (i.e., no interest income is recognized, and all payments received—whether contractually interest or principal—are applied to cost).

For each loan purchased with evidence of credit deterioration since origination and the expectation that either principal or interest will not be paid in full, interest income is generally recognized using the effective interest method for as long as the cash flows can be reasonably estimated. Here, instead of amortizing the purchase discount (i.e., the excess of the unpaid principal balance over the purchase price) over the life of the loan, the Company effectively amortizes the accretable yield (i.e., the excess of the Company's estimate of the total cash flows to be collected over the life of the loan over the purchase price). Not less than quarterly, the Company updates its estimate of the cash flows expected to be collected over the life of the loan, and revised yields are prospectively applied. To the extent that cash flows cannot be reasonably estimated, these loans are generally accounted for under the cost recovery method.

For certain groups of consumer loans that the Company considers as having sufficiently homogeneous characteristics, the Company aggregates such loans into pools, and accounts for each such pool as a single asset. The pool is then treated analogously to a debt security deemed not to be of high credit quality, in that (i) the aggregate premium or discount for the pool is amortized or accreted into interest income based on the pool's effective interest rate; (ii) the effective interest rate is determined based on the net expected cash flows of the pool, taking into account estimates of prepayments, defaults, and loss severities; and (iii) estimates are updated not less than quarterly and revised yields are prospectively applied.

In estimating future cash flows on the Company's debt investments, there are a number of assumptions that will be subject to significant uncertainties and contingencies, including, in the case of MBS, assumptions relating to prepayment rates, default rates, loan loss severities, and loan repurchases. These estimates require the use of a significant amount of judgment.

The Company receives dividend income on certain of its equity investments and rental income on certain of its REO properties. These items of income are included on the Consolidated Statement of Operations in, "Other income."

(D) Cash and Cash Equivalents: Cash and cash equivalents include cash and short term investments with original maturities of three months or less at the date of acquisition. Cash and cash equivalents typically include amounts held in an interest bearing overnight account and amounts held in money market funds, and these balances generally exceed insured limits. The Company holds its cash at institutions that it believes to be highly creditworthy. Restricted cash represents cash that the Company can use only for specific purposes. The Company's investments in money market funds are included in the Consolidated Condensed Schedule of Investments. See Note 15 for further discussion of restricted cash balances.

(E) Financial Derivatives: The Company enters into various types of financial derivatives. The Company's financial derivatives are predominantly subject to bilateral collateral arrangements or clearing in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. The Company may be required to deliver or receive cash or securities as collateral upon entering into derivative transactions. In addition, changes in the relative value of derivative transactions may require the Company or the counterparty to post or receive additional collateral. In the case of cleared derivatives, the clearinghouse becomes the Company's counterparty and a futures commission merchant acts as an intermediary between the Company and the clearinghouse with respect to all facets of the related transaction, including the posting and receipt of required collateral. Cash collateral received by the Company is reflected on the Consolidated Statement of Assets, Liabilities, and Equity as "Due to Brokers." Conversely, cash collateral posted by the Company is reflected as "Due from Brokers" on the Consolidated Statement of Assets, Liabilities, and Equity. The major types of derivatives utilized by the Company are swaps, futures, options, and forwards.

203

Swaps: The Company may enter into various types of swaps, including interest rate swaps, credit default swaps, and total return swaps. The primary risk associated with the Company's interest rate swap activity is interest rate risk. The primary risk associated with the Company's credit default swaps is credit risk and the primary risks associated with the Company's total return swap activity are equity market risk and credit risk.

The Company is subject to interest rate risk exposure in the normal course of pursuing its investment objectives. Primarily to help mitigate interest rate risk, the Company enters into interest rate swaps. Interest rate swaps are contractual agreements whereby one party pays a floating interest rate on a notional principal amount and receives a fixed-rate payment on the same notional principal, or vice versa, for a fixed period of time. Interest rate swaps change in value with movements in interest rates.

The Company enters into credit default swaps. A credit default swap is a contract under which one party agrees to compensate another party for the financial loss associated with the occurrence of a "credit event" in relation to a "reference amount" or notional value of a credit obligation (usually a bond, loan, or a basket of bonds or loans). The definition of a credit event may vary from contract to contract. A credit event may occur (i) when the underlying reference asset(s) fails to make scheduled principal or interest payments to its holders, (ii) with respect to credit default swaps referencing mortgage/asset-backed securities and indices, when the underlying reference obligation is downgraded below a certain rating level, or (iii) with respect to credit default swaps referencing corporate entities and indices, upon the bankruptcy of the underlying reference obligor. The Company typically writes (sells) protection to take a "long" position or purchases (buys) protection to take a "short" position with respect to underlying reference assets or to hedge exposure to other investment holdings.

The Company enters into total return swaps in order to take a "long" or "short" position with respect to an underlying reference asset. The Company is subject to market price volatility of the underlying reference asset. A total return swap involves commitments to pay interest in exchange for a market-linked return based on a notional value. To the extent that the total return of the corporate debt, security, group of securities or index underlying the transaction exceeds or falls short of the offsetting interest obligation, the Company will receive a payment from or make a payment to the counterparty.

Swaps change in value with movements in interest rates, credit quality, or total return of the reference securities. During the term of swap contracts, changes in value are recognized as unrealized gains or losses. When a contract is terminated, the Company realizes a gain or loss equal to the difference between the proceeds from (or cost of) the closing transaction and the Company's basis in the contract, if any. Periodic payments or receipts required by swap agreements are recorded as unrealized gains or losses when accrued and realized gains or losses when received or paid. Upfront payments paid and/or received by the Company to open swap contracts are recorded as an asset and/or liability on the Consolidated Statement of Assets, Liabilities, and Equity and are recorded as a realized gain or loss on the termination date.

Futures Contracts: A futures contract is an exchange-traded agreement to buy or sell an asset for a set price on a future date. The Company enters into Eurodollar and/or U.S. Treasury security futures contracts to hedge its interest rate risk. The Company may also enter into various other futures contracts, including equity index futures and foreign currency futures. Initial margin deposits are made upon entering into futures contracts and can generally be either in the form of cash or securities. During the period the futures contract is open, changes in the value of the contract are recognized as unrealized gains or losses by marking-to-market to reflect the current market value of the contract. Variation margin payments are made or received periodically, depending upon whether unrealized losses or gains are incurred. When the contract is closed, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Options: The Company may purchase or write put or call options contracts or enter into swaptions. The Company enters into options contracts typically to help mitigate overall market, credit, or interest rate risk depending on the type of options contract. However, the Company also enters into options contracts from time to time for speculative purposes. When the Company purchases an options contract, the option asset is initially recorded at an amount equal to the premium paid, if any, and is subsequently marked-to-market. Premiums paid for purchasing options contracts that expire unexercised are recognized on the expiration date as realized losses. If an options contract is exercised, the premium paid is subtracted from the proceeds of the sale or added to the cost of the purchase to determine whether the Company has realized a gain or loss on the related transaction. When the Company writes an options contract, the option liability is initially recorded at an amount equal to the premium received, if any, and is subsequently marked-to-market. Premiums received for writing options contracts that expire unexercised are recognized on the expiration date as realized gains. If an options contract is exercised, the premium received is subtracted from the cost of the purchase or added to the proceeds of the sale to determine whether the Company has realized a gain or loss on the related investment transaction. When the Company enters into a closing transaction, the Company will realize a gain or loss depending upon whether the amount from the closing transaction is greater or less than the premiums paid or received. The Company may also enter into options contracts that contain forward-settling premiums. In this case, no money

204

is exchanged upfront. Instead the agreed-upon premium is paid by the buyer upon expiration of the option, regardless of whether or not the option is exercised.

Forward Currency Contracts: A forward currency contract is an agreement between two parties to purchase or sell a specific quantity of currency with the delivery and settlement at a specific future date and exchange rate. During the period the forward currency contract is open, changes in the value of the contract are recognized as unrealized gains or losses. When the contract is settled, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Commitments to Purchase Residential Mortgage Loans: The Company has entered into forward purchase commitments under flow agreements, whereby the Company commits to purchasing the loans based on pre-defined underwriting guidelines and at stated interest rates. Actual loan purchases are contingent upon successful loan closings. These commitments to purchase mortgage loans are classified as derivatives on the Company's Consolidated Statement of Assets, Liabilities, and Equity and are, therefore, recorded as assets or liabilities measured at fair value. Until the purchase commitment expires or the underlying loan closes, changes in the estimated fair value of such commitments are recognized as unrealized gains or losses in the Consolidated Statement of Operations.

Financial derivatives disclosed on the Consolidated Condensed Schedule of Investments include: credit default swaps on asset-backed securities, credit default swaps on asset-backed indices, credit default swaps on corporate bond indices, credit default swaps on corporate bonds, interest rate swaps, total return swaps, futures contracts, foreign currency forwards, options contracts.

Financial derivative assets are included in Financial derivatives—assets, at fair value on the Consolidated Statement of Assets, Liabilities, and Equity. Financial derivative liabilities are included in Financial derivatives—liabilities, at fair value on the Consolidated Statement of Assets, Liabilities, and Equity. In addition, financial derivative contracts are summarized by type on the Consolidated Condensed Schedule of Investments.

(F) Investments Sold Short: When the Company sells securities short, it typically satisfies its security delivery settlement obligation by obtaining the security sold short from the same or a different counterparty. The Company generally is required to deliver cash or securities as collateral to the counterparty for the Company's obligation to return the borrowed security. The amount by which the market value of the obligation falls short of or exceeds the proceeds from the short sale is treated as an unrealized gain or loss, respectively. A realized gain or loss will be recognized upon the termination of a short sale if the market price is less or greater than the proceeds originally received.

(G) Reverse Repurchase Agreements: The Company enters into reverse repurchase agreements with third-party broker-dealers whereby it sells securities under agreements to be repurchased at an agreed-upon price and date. The Company accounts for reverse repurchase agreements as collateralized borrowings, with the initial sale price representing the amount borrowed, and with the future repurchase price consisting of the amount borrowed plus interest, at the implied interest rate of the reverse repurchase agreement, on the amount borrowed over the term of the reverse repurchase agreement. The interest rate on a reverse repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. When the Company enters into a reverse repurchase agreement, the lender establishes and maintains an account containing cash and/or securities having a value not less than the repurchase price, including accrued interest, of the reverse repurchase agreement. Reverse repurchase agreements are carried at their contractual amounts, which approximate fair value as the debt is short-term in nature.

(H) Repurchase Agreements: The Company enters into repurchase agreement transactions whereby it purchases securities under agreements to resell at an agreed-upon price and date. In general, securities received pursuant to repurchase agreements are delivered to counterparties of short sale transactions. The interest rate on a repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. Assets held pursuant to repurchase agreements are reflected as assets on the Consolidated Statement of Assets, Liabilities, and Equity. Repurchase agreements are carried at fair value based on their contractual amounts as the debt is short-term in nature.

Repurchase and reverse repurchase agreements that are conducted with the same counterparty may be reported on a net basis if they meet the requirements of ASC 210-20, Balance Sheet Offsetting. There are no repurchase and reverse repurchase agreements reported on a net basis in the Company's consolidated financial statements.

(I) Transfers of Financial Assets: The Company enters into transactions whereby it transfers financial assets to third parties. Upon such a transfer of financial assets, the Company will sometimes retain or acquire interests in the related assets. The Company evaluates transferred assets pursuant to ASC 860-10, Transfers of Financial Assets, or "ASC 860-10," which requires that a determination be made as to whether a transferor has surrendered control over transferred financial assets. That

205

determination must consider the transferor's continuing involvement in the transferred financial asset, including all arrangements or agreements made contemporaneously with, or in contemplation of, the transfer, even if they were not entered into at the time of the transfer. When a transfer of financial assets does not qualify as a sale, ASC 860-10 requires the transfer to be accounted for as a secured borrowing with a pledge of collateral. ASC 860-10 is a standard that requires the Company to exercise significant judgment in determining whether a transaction should be recorded as a "sale" or a "financing."

(J) When-Issued/Delayed Delivery Securities: The Company may purchase or sell securities on a when-issued or delayed delivery basis. Securities purchased or sold on a when-issued basis are traded for delivery beyond the normal settlement date at a stated price or yield, and no income accrues to the purchaser prior to settlement. Purchasing or selling securities on a when-issued or delayed delivery basis involves the risk that the market price or yield at the time of settlement may be lower or higher than the agreed-upon price or yield, in which case a realized loss may be incurred.

The Company transacts in the forward settling TBA market. The Company typically does not take delivery of TBAs, but rather settles the associated receivable and payable with its trading counterparties on a net basis. Transactions with the same counterparty for the same TBA that result in a reduction of the position are treated as extinguished. The market value of the securities that the Company is required to purchase pursuant to a TBA transaction may decline below the agreed-upon purchase price. Conversely, the market value of the securities that the Company is required to sell pursuant to a TBA transaction may increase above the agreed upon sale price. As part of its TBA activities, the Company may "roll" its TBA positions, whereby the Company may sell (buy) securities for delivery (receipt) in an earlier month and simultaneously contract to repurchase (sell) similar, but not identical, securities at an agreed-upon price on a fixed date in a later month (with the later-month price typically lower than the earlier-month price). The Company accounts for its TBA transactions (including those related to TBA rolls) as purchases and sales.

(K) REO: When the Company obtains possession of real property in connection with a foreclosure or similar action, the Company de-recognizes the associated mortgage loan according to ASU 2014-04, Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure ("ASU 2014-04"). Under the provisions of ASU 2014-04, the Company is deemed to have received physical possession of real estate property collateralizing a mortgage loan when it obtains legal title to the property upon completion of a foreclosure or when the borrower conveys all interest in the property to it through a deed in lieu of foreclosure or similar legal agreement. The Company holds all REO at fair value.

(L) Investments in Operating Entities: The Company has made and may in the future make non-controlling investments in operating entities such as loan originators. Investments in such operating entities may be in the form of preferred and/or common equity, debt, or some other form of investment. The Company carries its investments in such entities at fair value. In cases where the operating entity provides services to the Company, the Company is required to use the equity method of accounting.

(M) Variable Interest Entities: VIEs are entities in which: (i) the equity investors do not have the characteristics of a controlling financial interest, or (ii) there is insufficient equity to permit the entity to finance its activities without additional subordinated financial support from other parties. The Company holds beneficial interests in securitization trusts that are considered VIEs. The beneficial interests in these securitization trusts are represented by certificates issued by the trusts. The securitization trusts have been structured as pass-through entities that receive principal and interest payments on the underlying collateral and distribute those payments to the certificate holders, which include both third-party investors and the Company. The certificates held by the Company typically include some or all of the most subordinated tranches. The assets held by the trusts are restricted in that they can only be used to fulfill the obligations of the related trust. In certain cases the design and structure of the securitization trust is such that the Company effectively retains control of the assets as well as the activities that most significantly impact the economic performance of the trust; in such cases the trust is considered a direct extension of the Company's business, and the Company consolidates the trust. In cases where the Company does not effectively retain control of the assets of, or the activities that most significantly impact the economic performance of, the related trust, it does not consolidate the trust. See Note 6 for further discussion of the Company's securitization trusts.

(N) Offering Costs/Underwriters' Discount: Offering costs and underwriters' discount are charged against shareholders' equity. Offering costs typically include legal, accounting, printing, and other fees associated with the cost of raising capital.

(O) Debt Issuance Costs: Debt issuance costs associated with debt for which the Company has elected the fair value option are expensed at the issuance of the debt, and are included in Other investment related expenses on the Consolidated Statement of Operations. Costs associated with the issuance of debt for which the Company has not elected the fair value option are amortized over the life of the debt, which approximates the effective interest rate method, and are included in Interest expense on the Consolidated Statement of Operations. Deferred debt issuance costs are presented on the Consolidated Statement of Assets, Liabilities, and Equity as a direct deduction from the related debt liability, unless such deferred debt issuance costs are associated with borrowing facilities that are expected to have a future benefit, such as giving the Company

206

the ability to access additional borrowings over the contractual term of the debt, in which case such deferred debt issuance costs are included in Other Assets on Consolidated Statement of Assets, Liabilities, and Equity. Debt issuance costs include legal and accounting fees, purchasers' or underwriters' discount, as well as other fees associated with the cost of the issuance of the related debt.

(P) Expenses: Expenses are recognized as incurred on the Consolidated Statement of Operations.

(Q) Other Investment Related Expenses: Other investment related expenses consist of expenses directly related to specific financial instruments. Such expenses generally include dividend expense on common stock sold short, servicing fees and corporate and escrow advances on mortgage and consumer loans, and various other expenses and fees related directly to the Company's financial instruments. Other investment related expenses are recognized as incurred on the Consolidated Statement of Operations; dividend expense on common stock sold short is recognized on the ex-dividend date.

(R) LTIP Units: Long term incentive plan units of the Company ("LTIP Units") and long term incentive plan units of the Operating Partnership ("OP LTIP Units") have been issued to the Company's dedicated or partially dedicated personnel and certain of its directors as well as the Manager. Costs associated with LTIP Units and OP LTIP Units issued to dedicated or partially dedicated personnel, or to its directors, are measured as of the grant date based on the closing stock price on the New York Stock Exchange and are amortized over the vesting period in accordance with ASC 718-10, Compensation—Stock Compensation. The vesting periods for LTIP Units and OP LTIP Units are typically one year from issuance for directors, and are typically one year to two years from issuance for dedicated or partially dedicated personnel.

(S) Non-controlling interests: Non-controlling interests include interests in the Operating Partnership represented by units convertible into the Company's common shares ("Convertible Non-controlling Interests"). Convertible Non-controlling Interests include both the OP LTIP Units and those common units ("OP Units") of the Operating Partnership not held by the Company. Non-controlling interests also include the interests of joint venture partners in certain of our consolidated subsidiaries. The joint venture partners' interests are not convertible into the Company's common shares. The Company adjusts the Convertible Non-controlling Interests to align their carrying value with their share of total outstanding Operating Partnership units, including both the OP Units held by the Company and the Convertible Non-controlling Interests. Any such adjustments are reflected in "Adjustment to non-controlling interest" on the Consolidated Statement of Changes in Equity. See Note 11 for further discussion of non-controlling interests.

(T) Dividends: Dividends payable by the Company are recorded on the ex-dividend date. Dividends are typically declared and paid on a quarterly basis in arrears.

(U) Shares Repurchased: Common shares that are repurchased by the Company subsequent to issuance are immediately retired upon settlement and decrease the total number of shares outstanding and issued.

(V) Earnings Per Share ("EPS"): Basic EPS is computed using the two class method by dividing net increase (decrease) in shareholders' equity resulting from operations after adjusting for the impact of LTIP Units which are participating securities, by the weighted average number of common shares outstanding calculated including LTIP Units. Because the Company's LTIP Units are participating securities, they are included in the calculation of basic and diluted EPS. Convertible Non-controlling Interests are also participating securities and, accordingly, are included in the calculation of both basic and diluted EPS.

(W) Foreign Currency: Assets and liabilities denominated in foreign currencies are translated into U.S. dollars at current exchange rates at the following dates: (i) assets, liabilities, and unrealized gains/losses—at the valuation date; and (ii) income, expenses, and realized gains/losses—at the accrual/transaction date. The Company isolates the portion of realized and change in unrealized gain (loss) resulting from changes in foreign currency exchange rates on investments and financial derivatives from the fluctuations arising from changes in fair value of investments and financial derivatives held. Changes in realized and change in unrealized gain (loss) due to foreign currency are included in Foreign currency transactions and Foreign currency translation, respectively, on the Consolidated Statement of Operations.

(X) Income Taxes: The Company is treated as a partnership for U.S. federal income tax purposes. Certain of the Company's subsidiaries are not consolidated for U.S. federal income tax purposes, but are also treated as partnerships. In general, partnerships are not subject to entity-level tax on their income, but the income of a partnership is taxable to its owners on a flow-through basis. In addition, certain subsidiaries of the Company have elected to be treated as corporations for U.S. federal income tax purposes, and one has elected to be taxed as a real estate investment trust, or "REIT."

The Company follows the authoritative guidance on accounting for and disclosure of uncertainty on tax positions, which requires management to determine whether a tax position of the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For uncertain tax positions, the tax benefit to be recognized is measured as the largest amount

207

of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company did not have any additions to unrecognized tax benefits resulting from tax positions related either to the current period or to 2017, 2016, or 2015 (its open tax years), and no reductions resulting from tax positions of prior years or due to settlements, and thus had no unrecognized tax benefits or reductions since inception. The Company does not expect any change in unrecognized tax benefits within the next fiscal year. There were no amounts accrued for tax penalties or interest as of or during the periods presented in these consolidated financial statements.

The Company may take positions with respect to certain tax issues which depend on legal interpretation of facts or applicable tax regulations. Should the relevant tax regulators successfully challenge any of such positions, the Company might be found to have a tax liability that has not been recorded in the accompanying consolidated financial statements. Also, management's conclusions regarding ASC 740-10 may be subject to review and adjustment at a later date based on factors including, but not limited to, further implementation guidance from the Financial Accounting Standards Board, or "FASB," and ongoing analyses of tax laws, regulations and interpretations thereof.

(Y) Recent Accounting Pronouncements: In August 2018, the Financial Accounting Standards Board, or "FASB," issued ASU 2018-13, Fair Value Measurement—Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement ("ASU 2018-13"). This amends ASC 820, Fair Value Measurement, to remove or modify various current disclosure requirements related to fair value measurement. Additionally ASU 2018-13 requires certain additional disclosures around fair value measurement. ASU 2018-13 is effective for annual periods beginning after December 15, 2019 and interim periods within those years, with early adoption permitted. Entities are permitted to early adopt any removed or modified disclosures and delay adoption of the additional disclosures until their effective date. The Company has elected to early adopt the removal and modification of various disclosure requirements in accordance with ASU 2018-13; early adoption has not had a material impact on the Company's consolidated financial statements. The Company has elected not to early adopt the additional disclosure requirements. The adoption of additional disclosures, as required under ASU 2018-13, is not expected to have a material impact on the Company's consolidated financial statements.

In June 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation—Improvements to Nonemployee Share-Based Payment Accounting ("ASU 2018-07"). This amends ASC 718, Compensation—Stock Compensation, to simplify several aspects of accounting for nonemployee share-based payment transactions. ASU 2018-07 is effective for annual periods beginning after December 15, 2019 and interim periods beginning after December 15, 2020, with early adoption permitted. The adoption of ASU 2018-07 is not expected to have a material impact on the Company's consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows—Restricted Cash ("ASU 2016-18"). This amends ASC 230, Statement of Cash Flows, to require that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash and restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. ASU 2016-18 became effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU 2016-18 did not have a material impact on the Company's consolidated financial statements.

208

3. Valuation

The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2018:

Description	Level 1		Level 2		Level 3		Total
	(In thousands)
Assets:
Cash equivalents	$	12,460	$	—	$	—	$	12,460
Investments, at fair value-
Agency residential mortgage-backed securities	$	—	$	1,442,924	$	7,293	$	1,450,217
U.S. Treasury securities	—		76		—		76
Private label residential mortgage-backed securities	—		211,348		91,291		302,639
Private label commercial mortgage-backed securities	—		33,105		803		33,908
Commercial mortgage loans	—		—		211,185		211,185
Residential mortgage loans	—		—		496,830		496,830
Collateralized loan obligations	—		108,978		14,915		123,893
Consumer loans and asset-backed securities backed by consumer loans	—		—		206,761		206,761
Corporate debt	—		16,074		6,318		22,392
Secured notes	—		—		10,917		10,917
Real estate owned	—		—		34,500		34,500
Common stock	2,200		—		—		2,200
Corporate equity investments	—		—		43,793		43,793
Total investments, at fair value	2,200		1,812,505		1,124,606		2,939,311
Financial derivatives–assets, at fair value-
Credit default swaps on asset-backed securities	—		—		1,472		1,472
Credit default swaps on corporate bond indices	—		733		—		733
Credit default swaps on corporate bonds	—		2,473		—		2,473
Credit default swaps on asset-backed indices	—		8,092		—		8,092
Total return swaps	—		1		—		1
Interest rate swaps	—		7,224		—		7,224
Forwards	—		6		—		6
Total financial derivatives–assets, at fair value	—		18,529		1,472		20,001
Repurchase agreements, at fair value	—		61,274		—		61,274
Total investments, financial derivatives–assets, and repurchase agreements, at fair value	$	2,200	$	1,892,308	$	1,126,078	$	3,020,586
Liabilities:
Investments sold short, at fair value-
Agency residential mortgage-backed securities	$	—	$	(772,964)	$	—	$	(772,964)
Government debt	—		(54,151)		—		(54,151)
Corporate debt	—		(6,529)		—		(6,529)
Common stock	(16,933)		—		—		(16,933)
Total investments sold short, at fair value	(16,933)		(833,644)		—		(850,577)

209

Description	Level 1		Level 2		Level 3		Total
(continued)	(In thousands)
Financial derivatives–liabilities, at fair value-
Credit default swaps on corporate bond indices	$	—	$	(11,557)	$	—	$	(11,557)
Credit default swaps on corporate bonds	—		(3,246)		—		(3,246)
Credit default swaps on asset-backed indices	—		(2,125)		—		(2,125)
Interest rate swaps	—		(3,397)		—		(3,397)
Total return swaps	—		(6)		—		(6)
Futures	(355)		—		—		(355)
Forwards	—		(120)		—		(120)
Total financial derivatives–liabilities, at fair value	(355)		(20,451)		—		(20,806)
Other secured borrowings, at fair value	—		—		(297,948)		(297,948)
Total investments sold short, financial derivatives–liabilities, and other secured borrowings, at fair value	$	(17,288)	$	(854,095)	$	(297,948)	$	(1,169,331)

The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2018:

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
	(In thousands)
Private label residential mortgage-backed securities	$	36,945	Market Quotes	Non Binding Third-Party Valuation	$	17.42		$	178.00		$	78.31
Collateralized loan obligations	5,828		Market Quotes	Non Binding Third-Party Valuation	2.64			375.00			167.78
Corporate debt, non-exchange traded corporate equity, and secured notes	13,976		Market Quotes	Non Binding Third-Party Valuation	9.69			91.00			59.18
Private label commercial mortgage-backed securities	576		Market Quotes	Non Binding Third-Party Valuation	5.93			6.36			6.14
Agency interest only residential mortgage-backed securities	744		Market Quotes	Non Binding Third-Party Valuation	1.70			9.12			5.64
Private label residential mortgage-backed securities	54,346		Discounted Cash Flows	Yield	3.5		%	66.1		%	10.7		%
				Projected Collateral Prepayments	16.0		%	92.1		%	50.4		%
				Projected Collateral Losses	0.0		%	23.1		%	8.7		%
				Projected Collateral Recoveries	1.5		%	14.6		%	7.3		%
				Projected Collateral Scheduled Amortization	6.1		%	61.8		%	33.6		%
											100.0		%
Private label commercial mortgage-backed securities	227		Discounted Cash Flows	Yield	3.4		%	3.4		%	3.4		%
				Projected Collateral Losses	2.0		%	2.0		%	2.0		%
				Projected Collateral Recoveries	6.6		%	6.6		%	6.6		%
				Projected Collateral Scheduled Amortization	91.4		%	91.4		%	91.4		%
											100.0		%
Corporate debt and non-exchange traded corporate equity	4,793		Discounted Cash Flows	Yield	17.5		%	17.5		%	17.5		%

210

(continued)	Fair Value		Valuation  Technique	Unobservable Input	Range				Weighted Average
Description					Min		Max
	(In thousands)
Collateralized loan obligations	$	9,087	Discounted Cash Flows	Yield	12.6	%	103.1	%	26.7	%
				Projected Collateral Prepayments	8.1	%	88.4	%	65.2	%
				Projected Collateral Losses	3.7	%	40.8	%	13.5	%
				Projected Collateral Recoveries	4.2	%	38.0	%	11.9	%
				Projected Collateral Scheduled Amortization	3.5	%	13.5	%	9.4	%
									100.0	%
Consumer loans and asset-backed securities backed by consumer loans	206,761		Discounted Cash Flows	Yield	7.0	%	18.3	%	8.5	%
				Projected Collateral Prepayments	0.0	%	45.9	%	33.5	%
				Projected Collateral Losses	2.6	%	84.8	%	9.1	%
				Projected Collateral Scheduled Amortization	15.2	%	96.6	%	57.4	%
									100.0	%
Performing commercial mortgage loans	163,876		Discounted Cash Flows	Yield	8.0	%	22.5	%	9.6	%
Non-performing commercial mortgage loans and commercial real estate owned	80,513		Discounted Cash Flows	Yield	9.6	%	27.4	%	13.2	%
				Months to Resolution	3.0		16.0		7.9
Performing residential mortgage loans	171,367		Discounted Cash Flows	Yield	2.7	%	12.9	%	6.0	%
Securitized residential mortgage loans(1)	314,202		Discounted Cash Flows	Yield	4.3	%	4.6	%	4.6	%
Non-performing residential mortgage loans and residential real estate owned	12,557		Discounted Cash Flows	Yield	4.3	%	25.1	%	11.3	%
				Months to Resolution(2)	1.9		42.2		27.8
Credit default swaps on asset-backed securities	1,472		Net Discounted Cash Flows	Projected Collateral Prepayments	33.6	%	42.0	%	36.5	%
				Projected Collateral Losses	11.1	%	15.6	%	12.8	%
				Projected Collateral Recoveries	10.3	%	18.7	%	15.8	%
				Projected Collateral Scheduled Amortization	32.0	%	36.5	%	34.9	%
									100.0	%
Agency interest only residential mortgage-backed securities	6,549		Option Adjusted Spread ("OAS")	LIBOR OAS(3)	211		3,521		677
				Projected Collateral Prepayments	37.7	%	100.0	%	66.2	%
				Projected Collateral Scheduled Amortization	0.0	%	62.3	%	33.8	%
									100.0	%
Non-exchange traded common equity investment in mortgage-related entity	6,750		Enterprise Value	Equity Price-to-Book(4)	3.3x		3.3x		3.3x
Non-exchange traded preferred equity investment in mortgage-related entity	27,317		Enterprise Value	Equity Price-to-Book(4)	1.1x		1.1x		1.1x
Non-exchange traded preferred equity investment in loan origination entity	3,000		Recent Transactions	Transaction Price	N/A		N/A		N/A
Non-controlling equity interest in limited liability company	5,192		Discounted Cash Flows	Yield(5)	12.9%		16.1%		15.4%
Other secured borrowings, at fair value(1)	(297,948)		Discounted Cash Flows	Yield	3.9%		4.4%		4.3%

(1)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFE as discussed in Note 2.

(2)Excludes certain loans that are re-performing.

211

(3)Shown in basis points.

(4)Represent an estimation of where market participants might value an enterprise on a price-to-book basis.

(5)Represents the significant unobservable inputs used to fair value the financial instruments of the limited liability company. The fair value of such financial instruments is the largest component of the valuation of the limited liability company as a whole.

Third-party non-binding valuations are validated by comparing such valuations to internally generated prices based on the Company's models and to recent trading activity in the same or similar instruments.

For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread ("OAS") valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to (b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset. The Company considers the expected timeline to resolution in the determination of fair value for its non-performing commercial and residential mortgage loans.

Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, for instruments subject to prepayments and credit losses, such as non-Agency RMBS and consumer loans and ABS backed by consumer loans, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such credit default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.

212

The tables below include a roll-forward of the Company's financial instruments for the year ended December 31, 2018 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.

Level 3—Fair Value Measurement Using Significant Unobservable Inputs:

Year Ended December 31, 2018

(In thousands)	Ending Balance as of  December 31, 2017		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/ Payments		Sales/ Issuances		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of  December 31, 2018
Assets:
Investments, at fair value-
Agency residential mortgage-backed securities	$	6,173	$	(2,233)	$	(10)	$	175	$	2,753	$	(1,169)	$	2,616	$	(1,012)	$	7,293
Private label residential mortgage-backed securities	101,297		383		1,838		(2,135)		75,685		(78,487)		7,074		(14,364)		91,291
Private label commercial mortgage-backed securities	12,347		(243)		2,229		2,120		1,481		(16,896)		—		(235)		803
Commercial mortgage loans	108,301		790		1,146		1,944		149,053		(50,049)		—		—		211,185
Residential mortgage loans	182,472		(1,965)		1,011		(34)		402,235		(86,889)		—		—		496,830
Collateralized loan obligations	24,911		(351)		317		(2,268)		33,549		(33,115)		3,959		(12,087)		14,915
Consumer loans and asset-backed securities backed by consumer loans	135,258		(29,320)		8,415		(1,092)		228,354		(134,854)		—		—		206,761
Corporate debt	23,947		56		241		(964)		7,665		(17,688)		—		(6,939)		6,318
Secured notes	—		870		—		(1,221)		11,268		—		—		—		10,917
Real estate owned	26,277		—		(653)		(1,003)		12,793		(2,914)		—		—		34,500
Corporate equity investments	37,465		—		1,671		8,299		12,708		(16,350)		—		—		43,793
Total investments, at fair value	658,448		(32,013)		16,205		3,821		937,544		(438,411)		13,649		(34,637)		1,124,606
Financial derivatives–assets, at fair value-
Credit default swaps on asset-backed securities	3,140		—		(687)		715		102		(1,798)		—		—		1,472
Total financial derivatives– assets, at fair value	3,140		—		(687)		715		102		(1,798)		—		—		1,472
Total investments and financial derivatives–assets, at fair value	$	661,588	$	(32,013)	$	15,518	$	4,536	$	937,646	$	(440,209)	$	13,649	$	(34,637)	$	1,126,078
Liabilities:
Other secured borrowings, at fair value	$	(125,105)	$	—	$	—	$	758	$	49,731	$	(223,332)	$	—	$	—	$	(297,948)
Total other secured borrowings, at fair value	$	(125,105)	$	—	$	—	$	758	$	49,731	$	(223,332)	$	—	$	—	$	(297,948)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at December 31, 2018, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2018. For Level 3 financial instruments held by the Company at December 31, 2018, change in net unrealized gain (loss) of $5.3 million, $(0.6) million, and $0.8 million, for the year ended December 31, 2018 relate to investments, financial derivatives–assets, and other secured borrowings, at fair value, respectively.

At December 31, 2018, the Company transferred $34.6 million of securities from Level 3 to Level 2 and $13.6 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

Not included in the disclosures above are the Company's other financial instruments, which are carried at cost and include, Cash, Due from brokers, Due to brokers, Reverse repurchase agreements, Other secured borrowings, and the Company's unsecured long-term debt, or the "Senior Notes," which is reflected on the Consolidated Statement of Assets,

213

Liabilities, and Equity in Senior notes, net. Cash includes cash held in various accounts including an interest bearing overnight account for which fair value equals the carrying value; such assets are considered Level 1 assets. Due from brokers and Due to brokers include collateral transferred to or received from counterparties, along with receivables and payables for open and/or closed derivative positions. These receivables and payables are short term in nature and any collateral transferred consists primarily of cash; carrying value of these items approximates fair value and such items are considered Level 1 assets and liabilities. The Company's reverse repurchase agreements and Other secured borrowings are carried at cost, which approximates fair value due to their short term nature. Reverse repurchase agreements and Other secured borrowings are considered Level 2 assets and liabilities based on the adequacy of the associated collateral and their short term nature. The Company estimates the fair value of the Senior Notes at $86.0 million as of December 31, 2018. The Senior Notes are considered Level 3 liabilities given the relative unobservability of the most significant inputs to valuation estimation as well as the lack of trading activity of these instruments.

4. To Be Announced RMBS

In addition to investing in pools of Agency RMBS, the Company transacts in the forward settling TBA market. Pursuant to these TBA transactions, the Company agrees to purchase or sell, for future delivery, Agency RMBS with certain principal and interest terms and certain types of underlying collateral, but the particular Agency RMBS to be delivered is not identified until shortly before the TBA settlement date. TBAs are liquid and have quoted market prices and represent the most actively traded class of MBS. The Company accounts for its TBAs as purchases and sales and uses TBAs primarily for hedging purposes, typically in the form of short positions. However, the Company may also invest in TBAs for speculative purposes, including holding long positions. Overall, the Company typically holds a net short position.

The Company does not generally take delivery of TBAs; rather, it settles the associated receivable and payable with its trading counterparties on a net basis. Transactions with the same counterparty for the same TBA that result in a reduction of the position are treated as extinguished. The fair value of the Company's long positions in TBA contracts are reflected on the Consolidated Condensed Schedule of Investments under TBA–Fixed-Rate Agency Securities and the fair value of the Company's positions in TBA contracts sold short are reflected on the Consolidated Condensed Schedule of Investments under TBA–Fixed-Rate Agency Securities Sold Short. The payables and receivables related to the Company's TBA securities are included on the Consolidated Statement of Assets, Liabilities, and Equity in Payable for securities purchased and Receivable for securities sold, respectively.

The below table details TBA assets, liabilities, and the respective related payables and receivables as of December 31, 2018:

(In thousands)	As of December 31, 2018
Assets:
TBA securities, at fair value (Current principal: $460,037)	$	474,860
Receivable for securities sold relating to unsettled TBA sales	766,574
Liabilities:
TBA securities sold short, at fair value (Current principal: -$753,697)	$	(772,964)
Payable for securities purchased relating to unsettled TBA purchases	(473,386)
Net short TBA securities, at fair value	(298,104)

214

5. Financial Derivatives

Gains and losses on the Company's derivative contracts for the year ended December 31, 2018 are summarized in the table below:

		Year Ended December 31, 2018
Derivative Type	Primary Risk Exposure	Net Realized Gain/(Loss)(1)		Change in Net Unrealized Gain/(Loss)(2)
(In thousands)
Credit default swaps on asset-backed securities	Credit	$	(687)	$	715
Credit default swaps on asset-backed indices	Credit	(2,293)		2,013
Credit default swaps on corporate bond indices	Credit	(1,983)		3,540
Credit default swaps on corporate bonds	Credit	2,993		(2,648)
Total return swaps	Equity Market/Credit	3,844		(5)
Interest rate swaps	Interest Rate	(985)		3,648
Futures	Interest Rate/Currency	162		108
Forwards	Currency	923		359
Options	Interest Rate/ Equity Market	(63)		77
Total		$	1,911	$	7,807

(1)Includes gain/(loss) on foreign currency transactions on derivatives in the amount of $0.1 million for the year ended December 31, 2018, which is included on the Consolidated Statement of Operations in Realized gain (loss) on foreign currency transactions.

(2)Includes foreign currency translation on derivatives in the amount of $0.1 million for the year ended December 31, 2018, which is included on the Consolidated Statement of Operations in Change in net unrealized gain (loss) on foreign currency translation.

The table below details the average notional values of the Company's financial derivatives, using absolute value of month end notional values, for the year ended December 31, 2018:

Derivative Type	Year Ended December 31, 2018
	(In thousands)
Interest rate swaps	$	1,059,756
Credit default swaps	566,805
Total return swaps	53,603
Futures	201,295
Options	99,891
Forwards	45,522

From time to time the Company enters into credit derivative contracts for which the Company sells credit protection ("written credit derivatives"). As of December 31, 2018 all of the Company's open written credit derivatives were credit default swaps on either mortgage/asset-backed indices (ABX and CMBX indices) or corporate bond indices (CDX), collectively referred to as credit indices, or on individual corporate bonds, for which the Company receives periodic payments at fixed rates from credit protection buyers, and is obligated to make payments to the credit protection buyer upon the occurrence of a "credit event" with respect to underlying reference assets.

Written credit derivatives held by the Company at December 31, 2018 are summarized below:

Credit Derivatives	December 31, 2018
(In thousands)
Fair Value of Written Credit Derivatives, Net	$	(4,339)
Fair Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties(1)	(284)
Notional Value of Written Credit Derivatives (2)	98,586
Notional Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties (1)	(41,134)

(1)Offsetting transactions with third parties include purchased credit derivatives which have the same reference obligation.

215

(2)The notional value is the maximum amount that a seller of credit protection would be obligated to pay, and a buyer of credit protection would receive, upon occurrence of a "credit event." Movements in the value of credit default swap transactions may require the Company or the counterparty to post or receive collateral. Amounts due or owed under credit derivative contracts with an International Swaps and Derivatives Association, or "ISDA," counterparty may be offset against amounts due or owed on other credit derivative contracts with the same ISDA counterparty. As a result, the notional value of written credit derivatives involving a particular underlying reference asset or index has been reduced (but not below zero) by the notional value of any contracts where the Company has purchased credit protection on the same reference asset or index with the same ISDA counterparty.

A credit default swap on a credit index or a corporate bond typically terminates at the stated maturity date in the case of corporate indices or bonds, or, in the case of ABX and CMBX indices, the date that all of the reference assets underlying the index are paid off in full, retired, or otherwise cease to exist. Implied credit spreads may be used to determine the market value of such contracts and are reflective of the cost of buying/selling credit protection. Higher spreads would indicate a greater likelihood that a seller will be obligated to perform (i.e., make protection payments) under the contract. In situations where the credit quality of the underlying reference assets has deteriorated, the percentage of notional values that would be paid up front to enter into a new such contract ("points up front") is frequently used as an indication of credit risk. Credit protection sellers entering the market in such situations would expect to be paid points up front corresponding to the approximate fair value of the contract. For the Company's written credit derivatives that were outstanding at December 31, 2018, implied credit spreads on such contracts ranged between 42.6 and 815.1 basis points. Excluded from this spread range are contracts outstanding for which the individual spread is greater than 2,000 basis points. The Company believes that these contracts would be quoted based on estimated points up front. The total fair value of contracts with individual implied credit spreads in excess of 2,000 basis points was $(1.0) million as of December 31, 2018. Estimated points up front on these contracts as of December 31, 2018 ranged between 36.9 and 75.2 points. Total net up-front payments (paid) or received relating to written credit derivatives outstanding at December 31, 2018 were $(2.0) million.

6. Securitization Transactions

Participation in Multi-Seller Consumer Loan Securitization

In August 2016, the Company participated in a securitization transaction whereby the Company, together with another entity managed by Ellington (the "co-participant"), sold consumer loans with an aggregate unpaid principal balance of approximately $124 million to a newly formed securitization trust (the "Issuer"). Of the $124 million in loans sold to the Issuer, the Company's share was 51% while the co-participant's share was 49%. The transfer was accounted for as a sale in accordance with ASC 860-10. As a result of the sale the Company recognized a realized loss in the amount of $(0.1) million. Pursuant to the securitization, the Issuer issued senior and subordinated notes in the principal amount of $87 million and $18.7 million, respectively. Trust certificates representing beneficial ownership of the Issuer were also issued. In connection with the transaction, and through a jointly owned newly formed entity (the "Acquiror"), the Company and the co-participant acquired all of the subordinated notes as well as the trust certificates in the Issuer. The Company and the co-participant acquired 51% and 49%, respectively, of the interests in the Acquiror. During 2017, at the co-participant's direction, the Acquiror sold the portion of the subordinated notes beneficially owned by the co-participant, and in 2018, the Acquiror sold the remaining portion of the subordinated notes which were beneficially owned by the Company, and as a result as of December 31, 2018, the Company's total interest in the Acquiror was approximately 62%. The Company's interest in the Acquiror is accounted for as a beneficial interest and is included on the Consolidated Condensed Schedule of Investments in Corporate Equity Investments.

The notes and trust certificates issued by the Issuer are backed by the cash flows from the underlying consumer loans. If there are breaches of representations and warranties with respect to any underlying consumer loans, the Company could, under certain circumstances, be required to purchase or replace such loans. Absent such breaches, the Company has no obligation to repurchase or replace any underlying consumer loans that become delinquent or otherwise default. Cash flows collected on the underlying consumer loans are distributed to service providers to the trust, noteholders, and trust certificate holders in accordance with the contractual priority of payments. In addition, another affiliate of Ellington (the "Administrator"), acts as the administrator for the securitization and is paid a monthly fee for its services.

While the Company retains credit risk in the securitization trust through its beneficial ownership of the most subordinated interests of the securitization trust, which are the first to absorb credit losses on the securitized assets, the Company does not retain control of these assets or the power to direct the activities of the Issuer that most significantly impact the Issuer's economic performance. See Note 9 for further details on the Company's participation in the multi-seller consumer loan securitization.

Participation in CLO Transactions

Since June 2017, an affiliate of Ellington sponsored three CLO securitization transactions (the "CLO I Securitization," the "CLO II Securitization," and the "CLO III Securitization"; collectively, the "Ellington-sponsored CLO Securitizations"), collateralized by corporate loans and managed by an affiliate of Ellington (the "CLO Manager"). Ellington, the Company,

216

several other affiliates of Ellington, and, in the case of the CLO II Securitization and the CLO III Securitization, several third parties, participated in the Ellington-sponsored CLO Securitizations (collectively, the "CLO Co-Participants").

Pursuant to each Ellington-sponsored CLO Securitization, a newly formed securitization trust (the "CLO I Issuer," the "CLO II Issuer," and the "CLO III Issuer"; collectively, the "CLO Issuers") issued various classes of notes, which were in turn sold to unrelated third parties and the applicable CLO Co-Participants. The notes issued by each CLO Issuer are backed by the cash flows from the underlying corporate loans (including loans to be purchased during a reinvestment period); these cash flows are applied in accordance with the contractual priority of payments.

In the case of the CLO I Securitization, the Company and one CLO Co-Participant transferred corporate loans with a fair value of approximately $62.0 million and $141.7 million, respectively, to the CLO I Issuer in exchange for cash. The Company has no obligation to repurchase or replace securitized corporate loans that subsequently become delinquent or are otherwise in default, and the transfer by the Company was accounted for as a sale in accordance with ASC 860-10. As a result of the sale, the Company recognized a realized gain in the amount of $0.2 million.

In the case of the CLO II Securitization and the CLO III Securitization, the Company, along with certain other CLO Co-Participants, advanced funds in the form of loans (the "Advances") to the applicable CLO Issuers prior to the CLO pricing date to enable it to establish warehouse facilities for the purpose of acquiring the assets to be securitized. Pursuant to their terms, the Advances are required to be repaid at the closing of the respective securitization.

In each Ellington-sponsored CLO Securitization, the Company and each of the applicable CLO Co-Participants purchased various classes of notes issued by the corresponding CLO Issuer. In accordance with the Company's accounting policy for recording certain investment transactions on trade date, these purchases were recorded on the CLO pricing date rather than the CLO closing date. In addition, in the case of each of the CLO I Securitization and the CLO II Securitization, the Company and the CLO Co-Participants also funded a newly formed entity (the "CLO I Risk Retention Vehicle" and the "CLO II Risk Retention Vehicle") to purchase a sufficient portion of the unsecured subordinated notes issued by the applicable CLO Issuer so as to comply with risk retention rules (the "Risk Retention Rules") under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as further described below.

With respect to each Ellington-sponsored CLO Securitization, the Company subsequently sold a portion of the notes that it had originally purchased. As of December 31, 2018, the Company did not have an ownership interest in the CLO I Risk Retention Vehicle.

Under the Risk Retention Rules, sponsors of securitizations are generally required to retain at least 5% of the economic interest in the credit risk of the securitized assets. However, in February 2018, the U.S. Court of Appeals for the District of Columbia Circuit, or the "Court of Appeals," ruled that open-market CLO securitizations are exempt from the Risk Retention Rules, as long as certain requirements are met, and in April 2018 the Court of Appeals gave effect to this ruling. As a result, Risk Retention Rules no longer apply to managers of open-market CLOs, and those managers are now permitted to sell the interests in existing open-market CLOs that were originally retained in order to comply with the Risk Retention Rules, as long as those securitizations meet the requirements for exemption. After the decision by the Court of Appeals, the CLO Manager determined that the CLO II Securitization met the requirements for exemption from the Risk Retention Rules and subsequently distributed, in-kind, the subordinated notes held in the CLO II Risk Retention Vehicle to the CLO Co-Participants pro rata based on each CLO Co-Participant's respective ownership percentage of the CLO II Risk Retention Vehicle. The subordinated notes distributed to the Company from the CLO II Risk Retention Vehicle had a face amount of $5.6 million. Such notes had a fair value of $4.3 million as of December 31, 2018 and are included on the Company's Consolidated Condensed Schedule of Investments in Collateralized Loan Obligations and in the table below. The Manager of CLO III Securitization was not required to establish a risk retention vehicle because the transaction closed subsequent to the effectiveness of the ruling by the Court of Appeals.

In August 2018, the CLO I Issuer optionally redeemed all of the notes issued by the CLO I Securitization. Simultaneously with this optional redemption, the CLO I Issuer issued various classes of new notes, which were in turn sold to unrelated third parties and to the applicable CLO Co-Participants ("the Reset CLO I Securitization"). These new notes are backed by the cash flows from the underlying corporate loans (including loans to be purchased during a reinvestment period); these cash flows are applied in accordance with the contractual priority of payments. The CLO Manager determined that the Reset CLO I Securitization met the requirements for exemption from the Risk Retention Rules. As a result, the CLO Manager commenced liquidation of the CLO I Risk Retention Vehicle, and all of the liquidation proceeds have been distributed to the applicable CLO Co-Participants. As of December 31, 2018, the Company has received $5.7 million in liquidation proceeds from the CLO I Risk Retention Vehicle.

While the Company retains credit risk in each of the Ellington-sponsored CLO Securitizations through its beneficial ownership of the most subordinated interests of each of the securitization trusts, which are the first to absorb credit losses on the

217

securitized assets, the Company does not retain control of these assets nor does it have the power to direct the activities of the CLO Issuers that most significantly impact the CLO Issuers' economic performance.

The following table details the Company's investments in notes issued by the Ellington-sponsored CLO Securitizations:

CLO Issuer(1)	CLO Pricing Date	CLO Closing Date	Total Face Amount of Notes Issued		Face Amount of Notes Initially Purchased			Aggregate Purchase Price		Notes Held(2) as of
										December 31, 2018
($ in thousands)
CLO I Issuer(3)(4)	5/17	6/17	$	373,550	$	36,606	(5)	$	35,926	$	—
CLO I Issuer(4)	8/18	8/18	461,840		36,579		(5)	25,622		16,973		(6)
CLO II Issuer	12/17	1/18	452,800		18,223		(7)	16,621		14,721		(6)
CLO III Issuer	6/18	7/18	407,100		35,480		(7)	32,394		19,071		(8)

(1)

(1)The Company does not have the power to direct the activities of the CLO Issuers that most significantly impact their economic performance.

(2)Included on the Company's Consolidated Condensed Schedule of Investments in Collateralized Loan Obligations.

(3)Excludes the Company's equity investment in the CLO I Risk Retention Vehicle, as discussed above.

(4)In August 2018, the notes originally issued by the CLO I Issuer in 2017 were fully redeemed, and the CLO I Issuer simultaneously issued new notes in conjunction with this full redemption.

(5)The Company purchased secured and unsecured subordinated notes.

(6)Includes secured and unsecured subordinated notes.

(7)The Company purchased secured senior and secured and unsecured subordinated notes.

(8)Includes secured senior and secured and unsecured subordinated notes.

See Note 9 for further details on the Company's participation in CLO transactions.

Residential Mortgage Loan Securitizations

Since November 2017, the Company, through its wholly owned subsidiary, Ellington Financial REIT TRS LLC (the "Sponsor"), has sponsored two securitizations of non-QM loans. In each case, the Sponsor transferred non-QM loans to a wholly owned, newly created entity (the "Depositor") and on the closing date such loans were deposited into newly created securitization trusts (Ellington Financial Mortgage Trust 2017-1 and Ellington Financial Mortgage Trust 2018-1, collectively the "Issuing Entities"). Pursuant to the securitizations, the Issuing Entities issued various classes of mortgage pass-through certificates (the "Certificates") which are backed by the cash flows from the underlying non-QM loans. As detailed further in the table below, in order to comply with the Risk Retention Rules, in each securitization the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates. The Sponsor also purchased the Certificates entitled to excess servicing fees in each securitization, while the remaining classes of Certificates were purchased by unrelated parties.

The Certificates issued in November 2017 and 2018 have final scheduled distribution dates of October 25, 2047 and October 25, 2058, respectively. However, the Depositor may, with respect to each securitization, at its sole option, purchase all of the outstanding Certificates (an "Optional Redemption") following the earlier of (1) the two year anniversary of the closing date of such securitization or (2) the date on which the aggregate unpaid principal balance of the underlying non-QM loans has declined below 30% of the aggregate unpaid principal balance of the underlying non-QM loans as of the date as of which such loans were originally transferred to the applicable Issuing Entity. The purchase price that the Depositor is required to pay in connection with an Optional Redemption is equal to the sum of the unpaid principal balance of each class of Certificates as of the redemption date and any accrued and unpaid interest thereon. In light of these Optional Redemption rights held by the Depositor, the transfers of non-QM loans to each of the Issuing Entities do not qualify as sales under ASC 860, Transfers and Servicing.

In the event that certain breaches of representations or warranties are discovered with respect to any underlying non-QM loans, the Company could be required to repurchase or replace such loans.

The Sponsor also serves as the servicing administrator of each securitization and as such, is entitled to receive a monthly fee equal to one-twelfth of the product of (a) 0.03% and (b) the unpaid principal balance of the underlying non-QM loans as of the first day of the related due period. The Sponsor in its role as servicing administrator provides direction and consent for certain loss mitigation activities to the third-party servicer of the underlying non-QM loans. In certain circumstances, the servicing administrator will be required to reimburse the servicer for principal and interest advances and servicing advances made by the servicer.

In light of the Company's retained interests in each of the securitizations, together with the Optional Redemption rights and the Company's ability to direct the third-party servicer regarding certain loss mitigation activities, the Issuing Entities are

218

deemed to be an extension of the Company's business. The non-QM loans held by the Issuing Entities are included on the Consolidated Condensed Schedule of Investments in Mortgage Loans. Interest income from these loans and the expenses related to the servicing of these loans are included in Interest income and Other investment related expenses—Servicing expense, respectively, on the Consolidated Statement of Operations.

The Issuing Entities each meet the definition of a CFE as defined in Note 2, and as a result the assets of the Issuing Entities have been valued using the fair value of the liabilities of the Issuing Entities, as such liabilities have been assessed to be more observable than such assets.

The debt of the Issuing Entities is included in Other secured borrowings, at fair value on the Consolidated Statement of Assets, Liabilities, and Equity and is shown net of the Certificates held by the Company.

The following table details the residential mortgage loan securitizations:

Issuing Entity	Closing Date	Principal Balance of Loans Transferred to the Depositor		Total Face Amount of Certificates Issued
		(In thousands)
Ellington Financial Mortgage Trust 2017-1	11/15/2017	$	141,233	$	141,233	(1)
Ellington Financial Mortgage Trust 2018-1	11/13/2018	232,518		232,518		(2)

(1)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value equal to 5.1% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $0.7 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(2)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value equal to 5.7% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.3 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

The following table details the assets and liabilities of the consolidated securitization trusts included in the Company's Consolidated Statement of Assets, Liabilities, and Equity as of December 31, 2018:

	As of
(In thousands)	December 31, 2018
Assets:
Investments, at fair value	$	314,202
Interest and dividends receivable	3,527
Liabilities:
Interest and dividends payable	103
Other secured borrowings, at fair value	297,948

7. Borrowings

Secured Borrowings

The Company's secured borrowings consist of reverse repurchase agreements, Other secured borrowings, and Other secured borrowings, at fair value. As of December 31, 2018 the Company's total secured borrowings were $1.911 billion.

Reverse Repurchase Agreements

The Company enters into reverse repurchase agreements. A reverse repurchase agreement involves the sale of an asset to a counterparty together with a simultaneous agreement to repurchase the transferred asset or similar asset from such counterparty at a future date. The Company accounts for its reverse repurchase agreements as collateralized borrowings, with the transferred assets effectively serving as collateral for the related borrowing. The Company's reverse repurchase agreements typically range in term from 30 to 180 days, although the Company also has reverse repurchase agreements that provide for longer or shorter terms. The principal economic terms of each reverse repurchase agreement—such as loan amount, interest rate, and maturity date—are typically negotiated on a transaction-by-transaction basis. Other terms and conditions, such as those relating to events of default, are typically governed under the Company's master repurchase agreements. Absent an event of default, the Company maintains beneficial ownership of the transferred securities during the term of the reverse repurchase agreement and receives the related principal and interest payments. Interest rates on these borrowings are generally fixed based on prevailing rates corresponding to the terms of the borrowings, and for most reverse repurchase agreements, interest is generally paid at the termination of the reverse repurchase agreement, at which time the Company may enter into a new reverse repurchase agreement at prevailing market rates with the same counterparty, repay that counterparty and possibly negotiate

219

financing terms with a different counterparty, or choose to no longer finance the related asset. Some reverse repurchase agreements provide for periodic payments of interest, such as monthly payments. In response to a decline in the fair value of the transferred securities, whether as a result of changes in market conditions, security paydowns, or other factors, reverse repurchase agreement counterparties will typically make a margin call, whereby the Company will be required to post additional securities and/or cash as collateral with the counterparty in order to re-establish the agreed-upon collateralization requirements. In the event of increases in fair value of the transferred securities, the Company can generally require the counterparty to post collateral with it in the form of cash or securities. The Company is generally permitted to sell or re-pledge any securities posted by the counterparty as collateral; however, upon termination of the reverse repurchase agreement, or other circumstance in which the counterparty is no longer required to post such margin, the Company must return to the counterparty the same security that had been posted.

At any given time, the Company seeks to have its outstanding borrowings under reverse repurchase agreements with several different counterparties in order to reduce the exposure to any single counterparty. The Company had outstanding borrowings under reverse repurchase agreements with 23 counterparties as of December 31, 2018.

At December 31, 2018, approximately 21% of open reverse repurchase agreements were with one counterparty. As of December 31, 2018 remaining days to maturity on the Company's open reverse repurchase agreements ranged from 2 days to 871 days. Interest rates on the Company's open reverse repurchase agreements ranged from 0.23% to 6.07% as of December 31, 2018.

The following table details the Company's outstanding borrowings under reverse repurchase agreements for Agency RMBS, credit assets (which include non-Agency MBS, CLOs, consumer loans, corporate debt, residential mortgage loans, and commercial mortgage loans and REO), and U.S. Treasury securities, by remaining maturity as of December 31, 2018:

(In thousands)	December 31, 2018
			Weighted Average
Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity
Agency RMBS:
30 Days or Less	$	245,956	2.46	%	17
31-60 Days	415,379		2.58	%	46
61-90 Days	255,421		2.74	%	76
91-120 Days	506		3.31	%	91
Total Agency RMBS	917,262		2.59	%	47
Credit:
30 Days or Less	30,426		2.55	%	22
31-60 Days	189,937		3.32	%	48
61-90 Days	93,202		3.21	%	74
121-150 Days	26,222		4.60	%	123
151-180 Days	9,491		4.64	%	166
181-360 Days	91,730		4.54	%	316
> 360 Days	140,306		5.15	%	636
Total Credit Assets	581,314		3.98	%	240
U.S. Treasury Securities:
30 Days or Less	273		3.10	%	2
Total U.S. Treasury Securities	273		3.10	%	2
Total	$	1,498,849	3.13	%	122

Reverse repurchase agreements involving underlying investments that the Company sold prior to period end, for settlement following period end, are shown using their original maturity dates even though such reverse repurchase agreements may be expected to be terminated early upon settlement of the sale of the underlying investment.

As of December 31, 2018, the fair value of investments transferred as collateral under outstanding borrowings under reverse repurchase agreements was $1.79 billion. Collateral transferred under outstanding borrowings as of December 31, 2018 include investments in the amount of $86.7 million that were sold prior to period end but for which such sale had not yet

220

settled. In addition the Company posted net cash collateral of $17.0 million and additional securities with a fair value of $0.2 million as of December 31, 2018 to its counterparties.

As of December 31, 2018, there were no counterparties for which the amount at risk relating to our repurchase agreements was greater than 10% of total equity.

Other Secured Borrowings

In February 2018, the Company entered into agreements to finance a portfolio of unsecured loans through a recourse secured borrowing facility. The facility includes a one year revolving period (or earlier following an early amortization event or event of default), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. After the revolving period ends, the facility has a two-year term ending in February 2021. The facility accrues interest on a floating rate basis. As of December 31, 2018, the Company had outstanding borrowings under this facility in the amount of $13.2 million which is included under the caption Other secured borrowings, on the Company's Consolidated Statement of Assets, Liabilities, and Equity, and the effective interest rate, inclusive of related deferred financing costs, was 4.72%. As of December 31, 2018, the fair value of unsecured loans collateralizing this borrowing was $20.3 million.

In December 2017, the Company amended its non-recourse secured borrowing facility that is used to finance a portfolio of unsecured loans. The facility includes a reinvestment period ending in December 2019 (or earlier following an early amortization event), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. Following the reinvestment period, the facility will begin to amortize based on the collections from the underlying loans. The facility accrues interest on a floating rate basis. As of December 31, 2018 the Company had outstanding borrowings under this facility in the amount of $101.0 million which is included under the caption Other secured borrowings, on the Company's Consolidated Statement of Assets, Liabilities, and Equity, and the effective interest rate on this facility, inclusive of related deferred financing costs, was 4.68% as of December 31, 2018. As of December 31, 2018 the fair value of unsecured loans collateralizing this borrowing was $149.0 million.

The Company has completed securitization transactions, as discussed in Note 6, whereby it financed portfolios of non-QM loans. As of December 31, 2018 the fair value of the Company's outstanding liabilities associated with these securitization transactions were $297.9 million, representing the fair value of the securitization trust certificates held by third parties as of such date, and is included on Company's Consolidated Statement of Assets, Liabilities, and Equity in Other Secured Borrowings, at fair value. The weighted average coupon on the Certificates held by third parties was 3.72% as of December 31, 2018. As of December 31, 2018 the fair value of non-QM loans held in the securitization trusts were $314.2 million.

Unsecured Borrowings

Senior Notes

On August 18, 2017, the Company issued $86.0 million in aggregate principal amount of Senior Notes. The total net proceeds to the Company from the issuance of the Senior Notes was approximately $84.7 million, after deducting debt issuance costs. The Senior Notes bear an interest rate of 5.25%, subject to adjustment based on changes in the ratings, if any, of the Senior Notes. Interest on the Senior notes is payable semi-annually in arrears on March 1 and September 1 of each year. The Senior Notes mature on September 1, 2022. The Company may redeem the Senior Notes, at its option, in whole or in part, prior to March 1, 2022 at a price equal to 100% of the principal amount thereof, plus the applicable "make-whole" premium as of the applicable date of redemption. At any time on or after March 1, 2022, the Company may redeem the Senior Notes, in whole or in part, at a redemption price equal to 100% of the aggregate principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest. The Senior Notes are carried at amortized cost. There are a number of covenants, including several financial covenants, associated with the Senior Notes. As of December 31, 2018 the Company was in compliance with all of its covenants.

The Company amortizes debt issuance costs over the life of the associated debt; the amortized portion of debt issuance costs is included in Interest expense on the Consolidated Statement of Operations. The Senior Notes have an effective interest rate of 5.55%, inclusive of debt issuance costs.

The Senior Notes are unsecured and are effectively subordinated to secured indebtedness of the Company, to the extent of the value of the collateral securing such indebtedness.

221

Schedule of Principal Repayments

The following table details the Company's principal repayment schedule for outstanding borrowings as of December 31, 2018:

Year	Reverse Repurchase Agreements(1)		Other Secured Borrowings(2)		Senior Notes(1)		Total
(In thousands)
2019	$	1,358,542	$	194,135	$	—	$	1,552,677
2020	78,530		205,198		—		283,728
2021	61,776		13,150		—		74,926
2022	—		—		86,000		86,000
2023	—		—		—		—
Total	$	1,498,848	$	412,483	$	86,000	$	1,997,331

(1)Reflects the Company's contractual principal repayment dates.

(2)Reflects the Company's expected principal repayment dates.

8. Income Taxes

The Company has certain subsidiaries that have elected to be treated as corporations for U.S. federal, state, and local income tax purposes. The Company accounts for income taxes in accordance with ASC 740, Income Taxes. Deferred income taxes reflect the net tax effects of temporary differences that may exist between the carrying amounts of assets and liabilities under U.S. GAAP and the amounts used for income tax purposes. As of December 31, 2018, one of the Company's domestic TRS's had a net operating loss carry-forward, resulting in a gross deferred tax asset, which has been fully reserved through a valuation allowance.

9. Related Party Transactions

The Company is party to a Management Agreement (which may be amended from time to time), pursuant to which the Manager manages the assets, operations, and affairs of the Company, in consideration of which the Company pays the Manager management and incentive fees. Effective March 13, 2018, the Board of Directors approved a Seventh Amended and Restated Management Agreement between the Company and the Manager. The descriptions of the Base Management Fees and Incentive Fees are detailed below.

Base Management Fees

The Operating Partnership pays the Manager 1.50% per annum of total equity of the Operating Partnership calculated in accordance with U.S. GAAP as of the end of each fiscal quarter (before deductions for base management fees and incentive fees payable with respect to such fiscal quarter), provided that total equity is adjusted to exclude one-time events pursuant to changes in U.S. GAAP, as well as non-cash charges after discussion between the Manager and the Company's independent directors, and approval by a majority of the Company's independent directors in the case of non-cash charges.

Pursuant to the Company's management agreement, if the Company invests at issuance in the equity of any collateralized debt obligation that is managed, structured, or originated by Ellington or one of its affiliates, or if the Company invests in any other investment fund or other investment for which Ellington or one of its affiliates receives management, origination, or structuring fees, then, unless agreed otherwise by a majority of the Company's independent directors, the base management and incentive fees payable by the Company to its Manager will be reduced by an amount equal to the applicable portion (as described in the management agreement) of any such management, origination, or structuring fees.

Summary information—For the year ended December 31, 2018 the total base management fee incurred, net of fee rebates, was $7.6 million.

Incentive Fees

The Manager is entitled to receive a quarterly incentive fee equal to the positive excess, if any, of (i) the product of (A) 25% and (B) the excess of (1) Adjusted Net Income (described below) for the Incentive Calculation Period (which means such fiscal quarter and the immediately preceding three fiscal quarters) over (2) the sum of the Hurdle Amounts (described below) for the Incentive Calculation Period, over (ii) the sum of the incentive fees already paid or payable for each fiscal quarter in the Incentive Calculation Period preceding such fiscal quarter.

222

For purposes of calculating the incentive fee, "Adjusted Net Income" for the Incentive Calculation Period means the net increase in equity from operations of the Operating Partnership, after all base management fees but before any incentive fees for such period, and excluding any non-cash equity compensation expenses for such period, as reduced by any Loss Carryforward (as described below) as of the end of the fiscal quarter preceding the Incentive Calculation Period.

For purposes of calculating the incentive fee, the "Loss Carryforward" as of the end of any fiscal quarter is calculated by determining the excess, if any, of (1) the Loss Carryforward as of the end of the immediately preceding fiscal quarter over (2) the Company's net increase in equity from operations (expressed as a positive number) or net decrease in equity from operations (expressed as a negative number) of the Operating Partnership for such fiscal quarter. As of December 31, 2018, there was a Loss Carryforward of $2.1 million.

For purposes of calculating the incentive fee, the "Hurdle Amount" means, with respect to any fiscal quarter, the product of (i) one-fourth of the greater of (A) 9% and (B) 3% plus the 10-year U.S. Treasury rate for such fiscal quarter, (ii) the sum of (A) the weighted average gross proceeds per share of all common share and OP Unit issuances since inception of the Company and up to the end of such fiscal quarter, with each issuance weighted by both the number of shares and OP Units issued in such issuance and the number of days that such issued shares and OP Units were outstanding during such fiscal quarter, using a first-in first-out basis of accounting (i.e. attributing any share and OP Unit repurchases to the earliest issuances first) and (B) the result obtained by dividing (I) retained earnings attributable to common shares and OP Units at the beginning of such fiscal quarter by (II) the average number of common shares and OP Units outstanding for each day during such fiscal quarter, (iii) the sum of (x) the average number of common shares and LTIP Units outstanding for each day during such fiscal quarter, and (y) the average number of OP Units and OP LTIP Units outstanding for each day during such fiscal quarter. For purposes of determining the Hurdle Amount, issuances of common shares, OP LTIP Units, and OP Units (a) as equity incentive awards, (b) to the Manager as part of its base management fee or incentive fee and (c) to the Manager or any of its affiliates in privately negotiated transactions, are excluded from the calculation. The payment of the incentive fee will be in a combination of common shares and cash, provided that at least 10% of any quarterly payment will be made in common shares.

Summary information—Total incentive fee incurred for the year ended December 31, 2018 was $0.7 million.

Termination Fees

The Management Agreement requires the Company to pay a termination fee to the Manager in the event of (1) the Company's termination or non-renewal of the Management Agreement without cause or (2) the Company's termination of the Management Agreement based on unsatisfactory performance by the Manager that is materially detrimental to the Company or (3) the Manager's termination of the Management Agreement upon a default by the Company in the performance of any material term of the Management Agreement. Such termination fee will be equal to the amount of three times the sum of (i) the average annual Quarterly Base Management Fee Amounts paid or payable with respect to the two 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal and (ii) the average annual Quarterly Incentive Fee Amounts paid or payable with respect to the two 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal.

Expense Reimbursement

Under the terms of the Management Agreement the Company is required to reimburse the Manager for operating expenses related to the Company that are incurred by the Manager, including expenses relating to legal, accounting, due diligence, other services, and all other costs and expenses. The Company's reimbursement obligation is not subject to any dollar limitation. Expenses will be reimbursed in cash within 60 days following delivery of the expense statement by the Manager; provided, however, that such reimbursement may be offset by the Manager against amounts due to the Company from the Manager. The Company will not reimburse the Manager for the salaries and other compensation of the Manager's personnel except that the Company will be responsible for expenses incurred by the Manager in employing certain dedicated or partially dedicated personnel as further described below.

The Company reimburses the Manager for the allocable share of the compensation, including, without limitation, wages, salaries, and employee benefits paid or reimbursed, as approved by the Compensation Committee of the Board of Directors to certain dedicated or partially dedicated personnel who spend all or a portion of their time managing the Company's affairs, based upon the percentage of time devoted by such personnel to the Company's affairs. In their capacities as officers or personnel of the Manager or its affiliates, such personnel will devote such portion of their time to the Company's affairs as is necessary to enable the Company to operate its business.

For the year ended December 31, 2018 the Company reimbursed the Manager $6.5 million for previously incurred operating and compensation expenses.

223

Equity Investments in Certain Mortgage Originators

As of December 31, 2018, the mortgage originators in which the Company holds equity investments represent related parties. Transactions that have been entered into with these related party mortgage originators are summarized below.

The Company is a party to a mortgage loan purchase and sale flow agreement, with a mortgage originator in which the Company holds an investment in common stock, whereby the Company purchases residential mortgage loans that satisfy certain specified criteria. The Company has also provided a $5.0 million line of credit to the mortgage originator. Under the terms of this line of credit, the Company has agreed to make advances to the mortgage originator solely for the purpose of funding specifically identified residential mortgage loans designated for sale to the Company. To the extent the advances are drawn by the mortgage originator, it must pay interest, at a rate of 15% per annum, on the outstanding balance of each advance from the date the advance is made until such advance is repaid in full. The mortgage originator is required to repay advances in full no later than two business days following the date the Company purchases the related residential mortgage loans from the mortgage originator. As of December 31, 2018, there were no advances outstanding. The Company has also entered into two agreements whereby it guarantees the performance of such mortgage originator under third-party borrowing arrangements. See Note 17, Commitments and Contingencies, for further information on the Company's guarantees of the third-party borrowing arrangements.

Consumer, Residential, and Commercial Loan Transactions with Affiliates

The Company, through a related party of Ellington, or the "Loan Purchaser," is a beneficiary to a consumer loan purchase and sale flow agreement whereby the Loan Purchaser purchases consumer loans that satisfy certain specified criteria. The Company has investments in participation certificates related to consumer loans titled in the name of the Loan Purchaser. Through its participation certificates, the Company has beneficial interests in the loan cash flows, net of servicing-related fees and expenses. The total fair value of the Company's beneficial interests in the net cash flows was $21.9 million as of December 31, 2018 and is included on the Company's Consolidated Condensed Schedule of Investments in Consumer Loans and Asset-backed Securities backed by Consumer Loans. In addition, the Company also holds an investment in preferred stock and warrants to purchase additional preferred stock of the consumer loan originator that sells consumer loans to the Loan Purchaser.

The Company purchases certain of its consumer loans through an affiliate, or the "Purchasing Entity." The Purchasing Entity has entered into purchase agreements, open-ended in duration, with third party consumer loan originators whereby it has agreed to purchase eligible consumer loans. The amount of loans purchased under these purchase agreements is dependent on, among other factors, the amount of loans originated in any given period by the selling originators. The Company and other affiliates of Ellington have entered into agreements with the Purchasing Entity whereby the Company and each of the affiliates have agreed to purchase their allocated portion (subject to monthly determination based on available capital and other factors) of the eligible loans acquired by the Purchasing Entity under each purchase agreement. Immediately after the Purchasing Entity purchases beneficial interests in the loans, the Company and other affiliates purchase such beneficial interests from the Purchasing Entity, at the same price paid by the Purchasing Entity. During the year ended December 31, 2018, the Company purchased loans under these agreements with an aggregate principal balance of $166.3 million. As of December 31, 2018, the estimated remaining contingent purchase obligations of the Company under these purchase agreements was approximately $263.5 million in principal balance.

The Company's beneficial interests in the consumer loans purchased through the Purchasing Entity are evidenced by participation certificates issued by trusts that hold legal title to the loans. These trusts are owned by a related party of Ellington and were established to hold such loans. Through its participation certificates, the Company participates in the cash flows of the underlying loans held by each trust. The total amount of consumer loans held in the related party trusts, for which the Company has participating interests in the net cash flows, was $181.5 million as of December 31, 2018 and is included on the Company's Consolidated Condensed Schedule of Investments in Consumer Loans and Asset-backed Securities backed by Consumer Loans.

The Company has investments in participation certificates related to residential mortgage loans and REO held in a trust owned by another related party of Ellington. Through its participation certificates, the Company participates in the cash flows of the underlying loans held by such trust. The total amount of residential mortgage loans and REO held in the related party trust, for which the Company has participating interests in the net cash flows, and the residential mortgage loans previously held in the related party trust that now reside in the securitization trusts as described in Note 6 was $498.1 million as of December 31, 2018 and is included on the Company's Consolidated Condensed Schedule of Investments in Mortgage Loans as well as Real Estate Owned.

The Company is a co-investor in certain small balance commercial mortgage loans with several other investors, including an unrelated third party and various affiliates of Ellington. These loans are beneficially owned by a consolidated subsidiary of

224

the Company. As of December 31, 2018, the aggregate fair value of these loans was $25.3 million and the non-controlling interests held by the unrelated third party and the various Ellington affiliates were $1.4 million and $4.1 million, respectively.

The Company is also a co-investor in certain small balance commercial mortgage loans with other investors, including unrelated third parties and various affiliates of Ellington. Each co-investor has an interest in a limited liability company that owns the loans. As of December 31, 2018 the Company's ownership percentage of the jointly owned limited liability company was approximately 15% and had a fair value of $1.1 million, which is included on the Company's Consolidated Condensed Schedule of Investments in Corporate Equity Investments.

The Company is also a co-investor, together with other affiliates of Ellington, in the parent of an entity (the "Holding Entity"), that holds a call right to a securitization. The Holding Entity issued notes to the Company and its affiliates, and to an unrelated third party. As of December 31, 2018 the notes held by the Company had a fair value of $10.9 million, which are included on the Company's Consolidated Condensed Schedule of Investments in Secured Notes.

Participation in Multi-Borrower Financing Facilities

The Company is a co-participant with certain other entities managed by Ellington (the "Affiliated Entities") in two entities (each, a "Jointly Owned Entity"), which were formed in order to facilitate the financing of small balance commercial mortgage loans and REO (collectively, "SBC Assets"). Each Jointly Owned Entity has a reverse repurchase agreement with a particular financing counterparty.

From time to time, when the Company and/or the Affiliated Entities wish to finance an SBC Asset through one of the Jointly Owned Entities, Ellington submits such SBC Asset for approval to the financing counterparty for such Jointly Owned Entity. Upon obtaining such approval, the Company and/or the Affiliated Entities, as the case may be, transfers such SBC Assets to the Jointly Owned Entity in exchange for its pro rata share of the financing proceeds that the Jointly Owned Entity receives from the financing counterparty. While the Company transferred certain SBC Assets to the Jointly Owned Entities, such SBC Assets and the related debt were not derecognized for financial reporting purposes, in accordance with ASC 860-10, because the Company continued to retain the risks and rewards of ownership of its SBC Assets. As of December 31, 2018 , the Jointly Owned Entities have outstanding issued debt under the reverse repurchase agreements in the amount of $149.0 million. The Company's portion of this debt as of December 31, 2018 was $77.0 million and is included under the caption Reverse repurchase agreements on the Company's Consolidated Statement of Assets, Liabilities, and Equity. To the extent that there is a default under one of these reverse repurchase agreements, all of the assets of the applicable Jointly Owned Entity, including those assets beneficially owned by any non-defaulting owners of such Jointly Owned Entity, could be used to satisfy the outstanding obligations under such reverse repurchase agreement. As of December 31, 2018, no party to either of the reverse repurchase agreements was in default. There was no receivable from the Jointly Owned Entities as of December 31, 2018.

Multi-Seller Consumer Loan Securitization

In December 2016, in order to facilitate the financing of the Company's share of the subordinated note held by the Acquiror, the Company entered into a repurchase agreement with the Acquiror (the "Acquiror Repurchase Agreement") whereby the Company's share of the subordinated note held by the Acquiror was transferred to the Company as collateral under the Acquiror Repurchase Agreement. The Company then re-hypothecated this collateral to a third-party lending institution pursuant to a reverse repurchase agreement (the "Reverse Agreement"). The Acquiror Repurchase Agreement is included on the Company's Consolidated Statement of Assets, Liabilities and Equity under the caption, Repurchase agreements, at fair value and on its Consolidated Condensed Schedule of Investments. The Company's obligation under the Reverse Agreement is included on its Consolidated Statement of Assets, Liabilities and Equity under the caption, Reverse repurchase agreements. In December 2018, the Acquiror sold the Company's share of the subordinated note, and as a result as of December 31, 2018 there were no amounts outstanding amounts under the Acquiror Repurchase Agreement or the Reverse Agreement. See Note 6 for details of the Company's participation in the multi-seller consumer loan securitization.

Participation in CLO Transactions

As discussed in Note 6, the Company participated in various CLO securitization transactions, all managed by the CLO Manager.

The CLO Manager is entitled to receive management and incentive fees in accordance with the respective management agreements between the CLO Manager and the respective CLO Issuers. In accordance with the Company's Management Agreement, the Manager rebates to the Company the portion of the management fees payable by each CLO Issuer to the CLO Manager that are allocable to the Company's participating interest in the unsecured subordinated notes issued by such CLO Issuer. For the year ended December 31, 2018 the amount of such fee rebates was $1.4 million, respectively.

225

In addition, from time to time, the Company along with various other affiliates of Ellington, and in certain cases various third parties, advance funds in the form of loans ("Initial Funding Loans") to securitization vehicles to enable them to establish warehouse facilities for the purpose of acquiring the assets to be securitized. Pursuant to the terms of the warehouse facilities and the Initial Funding Loans, the applicable securitization trust is required, at the closing of each respective CLO securitization, first to repay the warehouse facility, then to repay the Initial Funding Loans, and then to distribute interest earned, net of any necessary reserves and/or interest expense, and the aggregate realized or unrealized gains, if any, on assets purchased into the warehouse facility. In the event that such CLO securitization fails to close, the assets held by the respective securitization vehicle would, subject to a cure period, be liquidated. As of December 31, 2018 the Company's loan receivable related to the warehouse facility in operation at such time was in the amount of $11.6 million and is included on the Consolidated Statement of Assets, Liabilities and Equity in Other assets. Each loan receivable from these warehouse facilities is considered a Level 3 asset and its carrying value approximates fair value due to its short term nature and the adequacy of the assets acquired into the warehouse.

In July 2018, the Company purchased two loans from the CLO I Securitization, at the fair market price. The loans purchased by the Company had a face amount of $2.9 million. The Company subsequently sold one of the loans and the remaining loan had a fair value of $1.6 million at December 31, 2018 and is included on the Company's Consolidated Condensed Schedule of Investments in Corporate Debt.

10. Long-Term Incentive Plan Units

LTIP Units and OP LTIP Units held pursuant to the Company's incentive plans are generally exercisable by the holder at any time after vesting. Each LTIP Unit is convertible into one common share. Each OP LTIP Unit is convertible into an OP Unit on a one-for-one basis. Subject to certain conditions, the OP Units are redeemable by the holder for an equivalent number of common shares of the Company or for the cash value of such common shares, at the Company's election. Costs associated with the LTIP Units and the OP LTIP Units issued under the Company's incentive plans are measured as of the grant date and expensed ratably over the vesting period. Total expense associated with LTIP Units and OP LTIP Units issued under the Company's incentive plans for the year ended December 31, 2018 was $0.4 million.

On March 7, 2018, the Company's Board of Directors authorized the issuance of 1,723 LTIP Units to certain of its partially dedicated employees pursuant to the Company's 2017 Equity Incentive Plan. These LTIP Units will vest and become non-forfeitable on March 7, 2019.

On September 12, 2018, the Company's Board of Directors authorized the issuance of 14,440 LTIP Units to certain of its directors pursuant to the Company's 2017 Equity Incentive Plan. These LTIP Units will vest and become non-forfeitable on September 11, 2019.

On December 11, 2018, the Company's Board of Directors authorized the issuance of 17,383 OP LTIP Units to certain of its partially dedicated employees pursuant to the Company's 2017 Equity Incentive Plan. These OP LTIP Units will vest and become non-forfeitable on December 11, 2019 with respect to 8,692 OP LTIP Units and December 11, 2020 with respect to 8,691 OP LTIP Units.

On December 31, 2018, the Company redeemed all 503,988 outstanding LTIP Units which it had originally issued under its incentive plans, with each LTIP unitholder receiving in exchange an equal number of OP LTIP Units (the "Redemption Transaction").

The below table details unvested OP LTIP Units as of December 31, 2018:

Grant Recipient	Number of OP LTIP Units	Grant Date	Vesting Date(1)
Directors:
	14,440	September 12, 2018	September 11, 2019
Partially dedicated employees:
	8,692	December 11, 2018	December 11, 2019
	8,691	December 11, 2018	December 11, 2020
	1,723	March 7, 2018	March 7, 2019
	5,886	December 12, 2017	December 12, 2019
Total unvested OP LTIP Units at December 31, 2018	39,432

(1)Date at which such OP LTIP Units will vest and become non-forfeitable.

226

The following table summarizes issuance and exercise activity of LTIP Units and OP LTIP Units for the year ended December 31, 2018:

	Year Ended December 31, 2018
	Manager	Director/ Employee	Total
LTIP Units and OP LTIP Units Outstanding (December 31, 2017)	375,000	116,159	491,159
Granted	—	33,546	33,546
Exercised	—	(3,334)	(3,334)
LTIP Units and OP LTIP Units Outstanding (December 31, 2018)	375,000	146,371	521,371
LTIP Units and OP LTIP Units Vested and Outstanding (December 31, 2018)	375,000	106,939	481,939

As of December 31, 2018, there were an aggregate of 1,874,223 common shares underlying awards, including OP LTIP Units, available for future issuance under the Company's 2017 Equity Incentive Plan.

11. Non-controlling Interests

Operating Partnership

Non-controlling interests include the Convertible Non-controlling Interests in the Operating Partnership owned by an affiliate of our Manager, our directors, and certain current and former Ellington employees and their related parties. These interests consist of OP Units and OP LTIP Units. On January 1, 2013, 212,000 OP Units were purchased by the initial non-controlling interest member. On December 11, 2018, the Company issued 17,383 OP LTIP Units to certain officers of the Company. On December 31, 2018, the Company redeemed 503,988 LTIP Units and distributed 503,988 OP LTIP Units to non-controlling interest members pursuant to the Redemption Transaction. Income allocated to these non-controlling interests is based on the non-controlling interest owners' ownership percentage of the Operating Partnership during the quarter, calculated using a daily weighted average of all common shares and convertible units outstanding during the quarter. Holders of OP Units and OP LTIP Units are entitled to receive the same distributions that holders of common shares receive, and OP Units are convertible into common shares on a one-for-one basis, subject to specified limitations. Each OP LTIP Unit is convertible into an OP Unit on a one-for-one basis. OP Units and OP LTIP Units are non-voting with respect to matters as to which common shareholders are entitled to vote. As December 31, 2018, the Convertible Non-controlling Interests consisted of the outstanding 521,371 OP LTIP Units and 212,000 OP Units, and represented an interest of approximately 2.4% in the Operating Partnership. As of December 31, 2018 non-controlling interests related to the outstanding 521,371 OP LTIP Units and the outstanding 212,000 OP Units was $13.9 million.

Joint Venture Interests

Non-controlling interests also include the interests of joint venture partners in various consolidated subsidiaries of the Company. The subsidiaries hold the Company's investments in certain commercial mortgage loans and REO. These joint venture partners participate in the income, expense, gains and losses of such subsidiaries as set forth in the related operating agreements of the subsidiaries. These joint venture partners make capital contributions to the subsidiaries as new approved investments are purchased by the subsidiaries, and are generally entitled to distributions when investments are sold or otherwise disposed of. As of December 31, 2018 these joint venture partners' interests in subsidiaries of the Company were $17.3 million.

These joint venture partners' interests are not convertible into common shares of the Company or OP Units, nor are these joint venture partners entitled to receive distributions that holders of common shares of the Company receive.

12. Common Share Capitalization

During the year ended December 31, 2018 the Board of Directors authorized dividends totaling $1.64 per share. Total dividends paid during the year ended December 31, 2018 were $50.7 million, respectively.

The following table summarizes issuance, repurchase, and other activity with respect to the Company's common shares for the year ended December 31, 2018:

	Year Ended December 31, 2018
Common Shares Outstanding (December 31, 2017)	31,335,938
Share Activity:
Shares repurchased	(1,547,148)

227

Director LTIP Units exercised	3,334
Shares issued in connection with incentive fee payment	4,477
Common Shares Outstanding (December 31, 2018)	29,796,601

If all LTIP Units, OP LTIP Units, and OP Units that have been previously issued were to become fully vested and exchanged for common shares as of December 31, 2018 the Company's issued and outstanding common shares would increase to 30,529,972.

On June 13, 2018, the Company's Board of Directors approved the adoption of a share repurchase program under which the Company is authorized to repurchase up to 1.55 million common shares. The program, which is open-ended in duration, allows the Company to make repurchases from time to time on the open market or in negotiated transactions, including under Rule 10b5-1 plans. Repurchases are at the Company's discretion, subject to applicable law, share availability, price and its financial performance, among other considerations. This program superseded the program that was previously adopted on February 6, 2018. During the year ended December 31, 2018, the Company repurchased 1,547,148 common shares at an average price per share of $14.95 and a total cost of $23.1 million. As of December 31, 2018, the Company had repurchased 361,090 common shares at an average price per share of $15.34 and a total cost of $5.5 million under the current share repurchase program.

13. Earnings Per Share

The components of the computation of basic and diluted EPS were as follows:

	Year Ended December 31, 2018
(In thousands except share amounts)
Net increase (decrease) in shareholders' equity resulting from operations	$	46,676
Add: Net increase (decrease) in equity resulting from operations attributable to participating non-controlling interests(1)	319
Net increase (decrease) in equity resulting from operations related to common shares, LTIP Unit holders, and participating non-controlling interests	46,995
Net increase (decrease) in shareholders' equity resulting from operations available to common share and LTIP Unit holders:
Net increase (decrease) in shareholders' equity resulting from operations–common shares	45,922
Net increase (decrease) in shareholders' equity resulting from operations–LTIP Units	753
Dividends Paid:
Common shareholders	(49,576)
LTIP Unit holders	(812)
Non-controlling interests	(348)
Total dividends paid to common shareholders, LTIP Unit holders, and non-controlling interests	(50,736)
Undistributed (Distributed in excess of) earnings:
Common shareholders	(3,653)
LTIP Unit holders	(59)
Non-controlling interests	(29)
Total undistributed (distributed in excess of) earnings attributable to common shareholders, LTIP Unit holders, and non-controlling interests	$	(3,741)
Weighted average shares outstanding (basic and diluted):
Weighted average common shares outstanding	30,297,401
Weighted average participating LTIP Units	496,962
Weighted average non-controlling interest units	212,000
Basic earnings per common share:
Distributed	$	1.64
Undistributed (Distributed in excess of)	(0.12)
	$	1.52
Diluted earnings per common share:

228

Distributed	$	1.64
Undistributed (Distributed in excess of)	(0.12)
	$	1.52

(1)For the year ended December 31, 2018, excludes net increase (decrease) in equity resulting from operations of $2.9 million attributable to joint venture partners, which have non-participating interests as described in Note 11.

14. Counterparty Risk

As of December 31, 2018, investments with an aggregate value of approximately $1.79 billion were held with dealers as collateral for various reverse repurchase agreements. The investments held as collateral include securities in the amount of $86.7 million that were sold prior to period end but for which such sale had not yet settled as of December 31, 2018.

The following table details the percentage of such collateral held by counterparties who hold greater than 15% of the aggregate $1.79 billion in collateral for various reverse repurchase agreements as of December 31, 2018. In addition to the below, unencumbered investments, on a settlement date basis, of approximately $13.3 million were held in custody at the Bank of New York Mellon Corporation as of December 31, 2018.

Dealer	% of Total Collateral on Reverse Repurchase Agreements
Royal Bank of Canada	19%

The following table details the percentage of collateral amounts held by dealers who hold greater than 15% of the Company's Due from Brokers, included as of December 31, 2018:

Dealer	% of Total Due from Brokers
Morgan Stanley	37%
J.P. Morgan Securities LLC	30%

The following table details the percentage of amounts held by dealers who hold greater than 15% of the Company's Receivable for securities sold as of December 31, 2018:

Dealer	% of Total Receivable for Securities Sold
J.P. Morgan Securities LLC	25%
Bank of America Securities	26%
CS First Boston Limited	34%

In addition, the Company held cash and cash equivalents of $44.7 million as of December 31, 2018. The below table details the concentration of cash and cash equivalents held by each counterparty:

Counterparty	As of December 31, 2018
Bank of New York Mellon Corporation	64%
Deutsche Bank Securities	5%
Bank of America Securities	2%
Morgan Stanley Institutional Liquidity Fund—Government Portfolio	10%
BlackRock Liquidity Funds FedFund Portfolio	9%
Goldman Sachs Financial Square Funds—Government Fund	9%
Lakeland Bank Inc.	1%

15. Restricted Cash

The Company is required to maintain certain cash balances with counterparties and/or unrelated third parties for various activities and transactions.

229

The Company is required to maintain a specific cash balance in a segregated account pursuant to a flow consumer loan purchase and sale agreement. The Company is also required to maintain a specific minimum cash balance in connection with its subsidiary that holds various state mortgage origination licenses.

The below table details the Company's restricted cash balances included in Restricted cash on the Consolidated Statement of Assets, Liabilities, and Equity as of December 31, 2018.

	December 31, 2018
	(In thousands)
Restricted cash balance related to:
Minimum account balance required for regulatory purposes	$	250
Flow consumer loan purchase and sale agreement	175
Total	$	425

16. Offsetting of Assets and Liabilities

The Company records financial instruments at fair value as described in Note 2. All financial instruments are recorded on a gross basis on the Consolidated Statement of Assets, Liabilities, and Equity. In connection with the vast majority of its derivative, repurchase and reverse repurchase agreements, and the related trading agreements, the Company and its counterparties are required to pledge collateral. Cash or other collateral is exchanged as required with each of the Company's counterparties in connection with open derivative positions, and repurchase and reverse repurchase agreements.

The following tables present information about certain assets and liabilities representing financial instruments as of December 31, 2018. The Company has not entered into master netting agreements with any of its counterparties. Certain of the Company's repurchase and reverse repurchase agreements and financial derivative transactions are governed by underlying agreements that generally provide a right of offset in the event of default or in the event of a bankruptcy of either party to the transaction.

December 31, 2018:

Description	Amount of Assets (Liabilities) Presented in the Consolidated Statements of Assets, Liabilities, and Equity(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount
(In thousands)
Assets
Financial derivatives–assets	$	20,001	$	(10,910)	$	—	$	(2,514)	$	6,577
Repurchase agreements	61,274		(61,274)		—		—		—
Liabilities
Financial derivatives–liabilities	(20,806)		10,910		—		9,896		—
Reverse repurchase agreements	(1,498,849)		61,274		1,420,601		16,974		—

(1)

(1)In the Company's Consolidated Statement of Assets, Liabilities, and Equity, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.

(2)For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's reverse repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's reverse repurchase agreements as of December 31, 2018 were $1.79 billion. As of December 31, 2018 total cash collateral on financial derivative assets excludes excess net cash collateral pledged of $0.1 million. As of December 31, 2018 total cash collateral on financial derivative liabilities excludes excess cash collateral pledged of $16.4 million.

(3)When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a specific asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.

17. Commitments and Contingencies

The Company provides current directors and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the Company.

In the normal course of business the Company may also enter into contracts that contain a variety of representations,

230

warranties, and general indemnifications. The Company's maximum exposure under these arrangements, including future claims that may be made against the Company that have not yet occurred, is unknown. The Company has not incurred any costs to defend lawsuits or settle claims related to these indemnification agreements. As of December 31, 2018, the Company has no liabilities recorded for these agreements.

Commitments and Contingencies Related to Investments in Residential Mortgage Loans

In connection with certain of the Company's investments in residential mortgage loans, the Company has unfunded commitments in the amount of $1.0 million as of December 31, 2018.

Commitments and Contingencies Related to Investments in Mortgage Originators

In connection with certain of its investments in mortgage originators, the Company has outstanding commitments and contingencies as described below.

As described in Note 9, Related Party Transactions, the Company is party to a flow mortgage loan purchase and sale agreement with a mortgage originator. The Company has entered into two agreements whereby it guarantees the performance of this mortgage originator under master repurchase agreements. The Company's maximum guarantees are capped at $25.0 million. As of December 31, 2018 the mortgage originator had $2.9 million outstanding borrowings under these agreements guaranteed by the Company. The Company's obligation under these arrangements are deemed to be guarantees under ASC 460-10 and are carried at fair value and included in Other Liabilities on the Consolidated Statement of Assets, Liabilities, and Equity. As of December 31, 2018 the estimated fair value of such guarantees was zero.

18. Financial Highlights

Results of Operations for a Share Outstanding Throughout the Periods:

	Year Ended December 31, 2018
Beginning Shareholders' Equity Per Share (December 31, 2017)	$	19.15
Net Investment Income	1.42
Net Realized/Unrealized Gains (Losses)	0.23
Results of Operations Attributable to Equity	1.65
Less: Results of Operations Attributable to Non-controlling Interests	(0.11)
Results of Operations Attributable to Shareholders' Equity(1)	1.54
Dividends Paid to Common Shareholders	(1.64)
Weighted Average Share Impact on Dividends Paid (2)	(0.03)
Accretive (Dilutive) Effect of Share Issuances (Net of Offering Costs), Share Repurchases, and Adjustments to Non-controlling Interest	(0.10)
Ending Shareholders' Equity Per Share (December 31, 2018)(3)	$	18.92
Shares Outstanding, end of period	29,796,601

(1)Calculated based on average common shares outstanding and can differ from the calculation for EPS (See Note 13).

(2)Per share impact on dividends paid relating to share issuances/repurchases during the period as well as dividends paid to LTIP and OP Unit holders.

(3)If all LTIP Units and OP Units previously issued were vested and exchanged for common shares as of December 31, 2018 shareholders' equity per share would be $18.92.

Total Return:

The Company calculates its total return two ways, one based on its reported net asset value and the other based on its publicly traded share price.

The following table illustrates the Company's total return for the periods presented based on net asset value:

Net Asset Value Based Total Return for a Shareholder: (1)

	Year Ended December 31, 2018(2)
Total Return	7.38%

(1)Total return is calculated assuming reinvestment of distributions at shareholders' equity per share during the period.

(2)The Company redeemed all 503,988 of its outstanding LTIP Units which it had originally issued under its incentive plans, with each LTIP unitholder receiving in exchange an equal number of OP LTIP Units. While this activity did not affect fully diluted net asset value per common share, it did cause a

231

1.66% decline in net asset value per common share. The Company's total return for the year ended December 31, 2018 before the effect of this activity was 9.19%.

Market Based Total Return for a Shareholder:

For the year ended December 31, 2018 the Company's market based total return based on the closing price as reported by the New York Stock Exchange was 17.30%. Calculation of market based total return assumes the reinvestment of dividends at the closing price as reported by the New York Stock Exchange as of the ex-date.

Net Investment Income Ratio to Average Equity: (1)

	Year Ended December 31, 2018
Net Investment Income	7.04%

(1)Average equity is calculated using month end values.

Expense Ratios to Average Equity: (1)

	Year Ended December 31, 2018
Operating expenses, before interest expense and other investment related expenses	(2.86)%
Incentive fee	(0.12)%
Interest expense and other investment related expenses	(12.03)%
Total Expenses	(15.01)%

(1)Average equity is calculated using month end values.

232

19. Condensed Quarterly Financial Data (Unaudited)

Detailed below is unaudited quarterly financial data for the year ended December 31, 2018.

	Three Month Period Ended
	March 31, 2018		June 30, 2018		September 30, 2018		December 31, 2018
(In thousands except per share amounts)
INVESTMENT INCOME
Interest income(1)	$	28,092	$	31,941	$	35,300	$	35,694
Other income	716		1,094		1,046		1,157
Total investment income	28,808		33,035		36,346		36,851
EXPENSES
Base management fee to affiliate(2)	1,978		2,021		1,830		1,744
Incentive fee to affiliate	—		291		424		—
Interest expense(1)	11,562		13,383		15,678		16,083
Other investment related expenses	2,952		3,771		4,384		4,201
Other operating expenses	2,074		2,578		2,352		4,609
Total expenses	18,566		22,044		24,668		26,637
NET INVESTMENT INCOME	10,242		10,991		11,678		10,214
NET REALIZED AND CHANGE IN NET UNREALIZED GAIN (LOSS) ON INVESTMENTS, OTHER SECURED BORROWINGS, FINANCIAL DERIVATIVES, AND FOREIGN CURRENCY TRANSACTIONS/TRANSLATION
Net realized gain (loss) on investments, financial derivatives, and foreign currency transactions	13,051		(1,343)		10,102		9,578
Change in net unrealized gain (loss) on investments, other secured borrowings, financial derivatives, and foreign currency translation	(1,969)		12,536		(14,306)		(20,862)
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS, OTHER SECURED BORROWINGS, FINANCIAL DERIVATIVES, AND FOREIGN CURRENCY	11,082		11,193		(4,204)		(11,284)
NET INCREASE (DECREASE) IN EQUITY RESULTING FROM OPERATIONS	21,324		22,184		7,474		(1,070)
LESS: NET INCREASE IN EQUITY RESULTING FROM OPERATIONS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS	285		991		813		1,147
NET INCREASE (DECREASE) IN SHAREHOLDERS' EQUITY RESULTING FROM OPERATIONS	$	21,039	$	21,193	$	6,661	$	(2,217)
NET INCREASE (DECREASE) IN SHAREHOLDERS' EQUITY RESULTING FROM OPERATIONS PER SHARE:
Basic and Diluted (3)	$	0.67	$	0.69	$	0.22	$	(0.07)

(1)Includes interest income and interest expense of a consolidated securitization trust of $1.3 million and $0.9 million, respectively, for the three-month period ended March 31, 2018. Includes interest income and interest expense of a consolidated securitization trust of $1.3 million and $0.8 million, respectively, for the three-month period ended June 30, 2018. Includes interest income and interest expense of a consolidated securitization trust of $1.3 million and $0.7 million, respectively, for the three-month period ended September 30, 2018. Includes interest income and interest expense of a consolidated securitization trust of $2.1 million and $1.2 million, respectively, for the three-month period ended December 31, 2018. See Note 6 for further details on the Company's consolidated securitization trusts.

(2)Net of management fee rebate of $0.3 million, $0.3 million, $0.4 million, and $0.4 million, for the each of the three-month periods ended March 31, 2018, June 30, 2018, September 30, 2018, and December 31, 2018, respectively. See Note 9 for further details on management fee rebates.

(3)For the year ended December 31, 2018 the sum of EPS for the four quarters of the year does not equal EPS as calculated for the entire year (see Note 13) as a result of changes in shares during the year due to repurchases of common shares, as EPS is calculated using average shares outstanding during the period.

233

20. Subsequent Events

On February 13, 2019, the Company announced that it will elect to be taxed as a REIT for U.S. federal income tax purposes for the taxable year ending December 31, 2019. To facilitate this planned election, it has elected to be taxed as a corporation for U.S. federal income tax purposes effective January 1, 2019.

Also on February 13, 2019, the Company exchanged $86 million of 5.50% Senior Notes due 2022 (the "New Senior Notes") for its existing 5.25% senior notes due 2022 (the "Existing Senior Notes"). The New Senior Notes were jointly and severally issued by two of the Company's subsidiaries and fully guaranteed by the Company. The indenture governing the New Senior Notes contains a number of covenants, including several financial covenants.

On February 14, 2019, the Company's Board of Directors approved a dividend in the amount of $0.41 per share payable on March 15, 2019 to shareholders of record as of March 1, 2019.

On February 28, 2019, the Company filed a certificate of conversion with the Secretary of State of the State of Delaware (the "Secretary of State") to convert from a Delaware limited liability company to a Delaware corporation (the "Conversion") and change its name to Ellington Financial Inc. (the "Corporation"). The Conversion became effective on March 1, 2019, and upon effectiveness, each of the Company's existing common shares representing limited liability company interests, no par value, converted into one issued and outstanding, fully paid and nonassessable share of common stock, $0.001 par value per share, of the Corporation. In connection with the Conversion, the Board approved the Company's Certificate of Incorporation, which the Company also filed with the Secretary of State, and the Company's Bylaws.

On March 11, 2019, the Company's Board of Directors approved a dividend in the amount of $0.14 per share payable on April 25, 2019 to stockholders of record as of March 29, 2019.

In connection with the Conversion and the Company's plan to qualify as a REIT for the year ending December 31, 2019, effective January 1, 2019 the Company no longer qualifies for investment company accounting in accordance with ASC 946 and will discontinue its use prospectively. The Company will continue to measure its qualifying assets and liabilities at fair value by electing the fair value option where applicable.

234

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management as appropriate to allow timely decisions regarding required disclosures. An evaluation was performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of December 31, 2020. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2020.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management's Annual Report on Internal Control Over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. Our internal control over financial reporting includes policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of assets that could have a material effect on our financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we evaluated the effectiveness of our internal control over financial reporting using the criteria set forth in the 2013 Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on our assessment and those criteria, our management concluded that our internal control over financial reporting was effective as of December 31, 2020.

The Company's independent registered public accounting firm, PricewaterhouseCoopers LLP, has audited the Company's internal control over financial reporting as of December 31, 2020. Their report appears on page 106 of this Annual Report on Form 10-K.

Item 9B. Other Information

None.

235

PART III

Item 10. Directors, Executive Officers and Corporate Governance

The information required by Item 10 is incorporated by reference to information to be included in our definitive Proxy Statement for our 2021 annual stockholders' meeting.

Our Board of Directors has established a Code of Business Conduct and Ethics that applies to our officers and directors and to our Manager's and certain of its affiliates' officers, directors and employees when such individuals are acting for us or on our behalf which is available on our website at www.ellingtonfinancial.com. Any waiver of our Code of Business Conduct and Ethics of our executive officers or directors may be made only by our Board or one of its committees.

We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K relating to amendments to or waivers from any provision of our Code of Business Conduct and Ethics applicable to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions and that relates to any element of the code of ethics definition enumerated in Item 406(b) of Regulation S-K by posting such information on our website at www.ellingtonfinancial.com under the, "For Our Shareholders—Corporate Governance" section of the website.

Item 11. Executive Compensation

The information required by Item 11 is incorporated by reference to information to be included in our definitive Proxy Statement for our 2021 annual stockholders' meeting.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters

The information required by Item 12 is incorporated by reference to information to be included in our definitive Proxy Statement for our 2021 annual stockholders' meeting.

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information required by Item 13 is incorporated by reference to information to be included in our definitive Proxy Statement for our 2021 annual stockholders' meeting.

Item 14. Principal Accountant Fees and Services

The information required by Item 14 is incorporated by reference to information to be included in our definitive Proxy Statement for our 2021 annual stockholders' meeting.

236

PART IV

Item 15. Exhibits and Financial Statement Schedules

(a) Documents filed as part of this report:

1.Financial Statements:

See Index to consolidated financial statements, included in Part II, Item 8 of this Annual Report on Form 10-K.

2. Schedules to Financial Statements:

Except as disclosed below, all other financial statement schedules have been omitted because they are either inapplicable or the information required is provided in our Financial Statements and Notes thereto, included in Part II, Item 8, of this Annual Report on Form 10-K.

Ellington Financial Inc.

Schedule IV—Mortgage Loans on Real Estate

December 31, 2020

Asset Type	Description	Number of Loans	Interest Rate	Maturity Date	Periodic Payment Terms	Prior Liens	Face Amount of Mortgages	Carrying Amount of Mortgages(1)(2)		Principal Amount of loans subject to delinquent principal or interest
Residential Mortgage Loans:								(In thousands)
Adjustable Rate Residential Mortgage Loan	$0–$249,999	39	2.00%–8.38%	11/30–8/57	n/a	n/a	n/a	$	4,464	$	2,617
Adjustable Rate Residential Mortgage Loan	$250,000–$499,999	31	2.00%–9.25%	12/36–2/60	n/a	n/a	n/a	9,634		8,029
Adjustable Rate Residential Mortgage Loan	$500,000–$749,999	16	3.00%–7.37%	7/35–9/55	n/a	n/a	n/a	8,193		7,773
Adjustable Rate Residential Mortgage Loan	$750,000–$999,999	3	3.38%–6.75%	5/36–9/48	n/a	n/a	n/a	2,223		2,675
Adjustable Rate Residential Mortgage Loan	$1,000,000–$1,249,999	1	6.99%	7/48	n/a	n/a	n/a	902		1,003
Adjustable Rate Residential Mortgage Loan	$1,250,000–$1,499,999	1	5.37%	1/50	n/a	n/a	n/a	1,343		—
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$0–$249,999	397	4.00%–9.99%	6/46–4/50	n/a	n/a	n/a	69,577		1,938
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$250,000–$499,999	419	4.25%–8.88%	4/46–2/60	n/a	n/a	n/a	142,200		4,988
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$500,000–$749,999	155	4.50%–8.75%	3/46–4/60	n/a	n/a	n/a	91,987		2,299
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$750,000–$999,999	71	4.13%–8.38%	3/46–10/59	n/a	n/a	n/a	60,871		4,441
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$1,000,000–$1,249,999	34	4.62%–7.63%	8/46–3/60	n/a	n/a	n/a	36,567		—
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$1,250,000–$1,499,999	21	4.50%–7.49%	11/46–2/60	n/a	n/a	n/a	29,582		2,894
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$1,500,000–$1,749,999	18	4.88%–7.00%	2/47–3/60	n/a	n/a	n/a	26,915		3,264
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$1,750,000–$1,999,999	5	4.75%–8.50%	11/48–12/59	n/a	n/a	n/a	9,520		—
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$2,250,000–$2,499,999	6	4.63%–5.99%	6/48–9/59	n/a	n/a	n/a	14,450		—
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$2,500,000–$2,749,999	3	4.99%–5.25%	7/49–11/59	n/a	n/a	n/a	7,996		—
Fixed Rate Residential Mortgage Loan	$0–$249,999	389	2.00%–14.00%	1/21–1/61	n/a	n/a	n/a	57,568		5,184
Fixed Rate Residential Mortgage Loan	$250,000–$499,999	251	3.50%–13.00%	1/21–1/61	n/a	n/a	n/a	87,013		3,829

237

Asset Type	Description	Number of Loans	Interest Rate	Maturity Date	Periodic Payment Terms	Prior Liens	Face Amount of Mortgages	Carrying Amount of Mortgages(1)(2)	Principal Amount of loans subject to delinquent principal or interest
Residential Mortgage Loans (Continued):								(In thousands)
Fixed Rate Residential Mortgage Loan	$500,000–$749,999	98	4.00%–20.00%	1/21–1/61	n/a	n/a	n/a	59,912	3,427
Fixed Rate Residential Mortgage Loan	$750,000–$999,999	49	4.50%–11.55%	1/21–11/60	n/a	n/a	n/a	42,823	3,553
Fixed Rate Residential Mortgage Loan	$1,000,000–$1,249,999	34	3.99%–9.50%	10/21–1/61	n/a	n/a	n/a	38,198	1,088
Fixed Rate Residential Mortgage Loan	$1,250,000–$1,499,999	19	4.24%–10.65%	9/21–12/60	n/a	n/a	n/a	26,481	—
Fixed Rate Residential Mortgage Loan	$1,500,000–$1,749,999	8	4.13%–8.99%	8/21–1/61	n/a	n/a	n/a	13,546	—
Fixed Rate Residential Mortgage Loan	$1,750,000–$1,999,999	4	3.88%–5.50%	11/50–1/61	n/a	n/a	n/a	7,874	—
Fixed Rate Residential Mortgage Loan	$2,000,000–$2,249,999	3	5.88%–6.50%	10/50–1/61	n/a	n/a	n/a	6,591	—
Fixed Rate Residential Mortgage Loan	$2,250,000–$2,499,999	3	5.99%–9.00%	9/21–12/50	n/a	n/a	n/a	7,308	—
Fixed Rate Residential Mortgage Loan	$2,500,000–$2,749,999	3	4.25%–5.25%	1/51–1/61	n/a	n/a	n/a	7,999	—
Fixed Rate Residential Mortgage Loan	$3,250,000–$3,499,000	1	6.13%	10/60	n/a	n/a	n/a	3,654	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$0–$249,999	260	4.63%–8.63%	1/47–9/60	n/a	n/a	n/a	44,822	176
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$250,000–$499,999	227	4.00%–8.38%	12/34–9/60	n/a	n/a	n/a	80,323	1,539
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$500,000–$749,999	107	4.50%–7.63%	11/47–9/60	n/a	n/a	n/a	65,494	3,792
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$750,000–$999,999	49	4.25%–8.13%	5/48–9/60	n/a	n/a	n/a	41,486	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$1,000,000–$1,249,999	18	4.50%–6.38%	5/48–9/60	n/a	n/a	n/a	19,603	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$1,250,000–$1,499,999	20	4.50%–6.38%	12/47–7/60	n/a	n/a	n/a	28,010	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$1,500,000–$1,749,999	3	4.50%–5.50%	11/47–8/60	n/a	n/a	n/a	4,882	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$1,750,000–$1,999,999	6	4.38%–6.38%	8/48–8/60	n/a	n/a	n/a	11,912	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$2,000,000–$2,249,999	3	5.12%–6.24%	4/50–4/59	n/a	n/a	n/a	6,829	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$2,250,000–$2,499,999	1	6.00%	1/59	n/a	n/a	n/a	2,508	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$2,500,000–$2,749,999	1	6.50%	12/60	n/a	n/a	n/a	2,782	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$3,000,000–$3,249,999	1	5.38%	5/49	n/a	n/a	n/a	3,027	—
Total Residential Mortgage Loans								1,187,069	64,509

238

Asset Type	Description	Number of Loans	Interest Rate	Maturity Date	Periodic Payment Terms	Prior Liens	Face Amount of Mortgages	Carrying Amount of Mortgages(1)(2)	Principal Amount of loans subject to delinquent principal or interest
Commercial Mortgage Loans:								(In thousands)
Adjustable Rate Commercial Mortgage Loan	$0–$4,999,999	10	3.37%–9.00%	1/21–10/37	n/a	n/a	n/a	28,692	3,983
Adjustable Rate Commercial Mortgage Loan	$5,000,000–$9,999,999	9	7.00%–8.50%	3/21–4/22	n/a	n/a	n/a	65,776	16,500
Adjustable Rate Commercial Mortgage Loan	$10,000,000–$14,999,999	5	8.00%–11.00%	10/21–3/22	n/a	n/a	n/a	58,999	23,750
Adjustable Rate Commercial Mortgage Loan	$15,000,000–$19,999,999	3	8.25%–9.00%	8/21–9/21	n/a	n/a	n/a	46,633	—
Adjustable Rate Commercial Mortgage Loan	$25,000,000–$29,999,999	1	7.10%	2/21	n/a	n/a	n/a	12,558	—
Fixed Rate Commercial Mortgage Loan	$5,000,000–$9,999,999	1	8.00%	3/21	n/a	n/a	n/a	373	—
Total Commercial Mortgage Loans								213,031	44,233
Total Mortgage Loans								1,400,100	108,742

(1)Aggregate cost for federal income tax purposes is $598.8 million for commercial and non-securitized residential mortgage loans. Excluded from this amount is the cost basis for federal income tax purposes of $801.3 million of securitized residential loans; such loans have been deemed to be sold for tax purposes but do not meet the requirements for true sale under U.S. GAAP.

(2)As of December 31, 2020, all of the Company's mortgage loans were carried at fair value. See Note 2 and Note 3 in the notes to our consolidated financial statements for the year ended December 31, 2020 for additional details.

The following table presents a roll-forward of the fair value of the Company's mortgage loans on real estate for the year ended December 31, 2020.

	Year Ended
	December 31, 2020		December 31, 2019
(In thousands)
Beginning Balance	$	1,206,962	$	692,131
Additions:
Purchases	716,241		837,502
Net unrealized gain	11,427		6,717
Net realized gain	—		3,878
Deductions:
Cost of mortgages sold	(28,613)		(28,805)
Collections of principal	(496,186)		(275,520)
Amortization of premium and (discounts)	(6,317)		(6,363)
Foreclosures	(3,384)		(22,578)
Net realized loss	(30)		—
Ending Balance	$	1,400,100	$	1,206,962

239

3. Exhibits:

Exhibit	Description
3.1	Certificate of Incorporation of Ellington Financial Inc. (incorporated by reference to the current report on Form 8-K (No. 001-34569), filed on March 4, 2019)
3.2	Bylaws of Ellington Financial Inc. (incorporated by reference to the current report on Form 8-K (No. 001-34569), filed on March 4, 2019)
3.3	Certificate of Designations of 6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock of Ellington Financial Inc. (incorporated by reference to the registration statement on Form 8-A filed on October 21, 2019)
4.1	Form of certificate representing the 6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock of Ellington Financial Inc. (incorporated herein by reference to Exhibit 4.1 of Ellington Financial Inc.’s Form 8-A filed on October 21, 2019).
4.2	Indenture, dated as of February 13, 2019, among EF Holdco Inc., EF Cayman Holdings Ltd., Ellington Financial LLC and Wilmington Trust, National Association, as trustee (incorporated by reference to the current report on Form 8-K (No. 001-34569), filed on February 13, 2019)
4.3	Form of EF Holdco Inc.’s and EF Cayman Holdings Ltd.’s 5.50% Senior Notes due 2022 (included in Exhibit 4.2)
4.4	Description of Securities Registered under Section 12 of the Exchange Act (incorporated by reference to the Annual Report on Form 10-K for the fiscal year ended December 31, 2019)
10.1†	Seventh Amended and Restated Management Agreement, by and between the Company, Ellington Financial Operating Partnership LLC and Ellington Financial Management LLC, dated as of March 13, 2018 (incorporated by reference to the Annual Report on Form 10-K for the fiscal year ended December 31, 2017)
10.2	Operating Agreement of Ellington Financial Operating Partnership LLC, by and between the Company, Ellington Financial Operating Partnership LLC and EMG Holdings, L.P., dated as of January 1, 2013 (incorporated by reference to the Annual Report on Form 10-K for the fiscal year ended December 31, 2012)
10.3	First Amendment to Limited Liability Company Operating Agreement of Ellington Financial Operating Partnership LLC, by and between the Company, Ellington Financial Operating Partnership LLC and EMG Holdings, L.P., dated as of January 1, 2013. (incorporated by reference to the Current Report on Form 8-K filed on October 22, 2019)
10.4†	2007 Incentive Plan for Individuals (incorporated by reference to the registration statement on Form S-11 (No. 333-160562), filed July 14, 2009, as amended)
10.5†	2007 Incentive Plan for Entities (incorporated by reference to the registration statement on Form S-11 (No. 333-160562), filed July 14, 2009, as amended)
10.6†	Ellington Financial LLC 2017 Equity Incentive Plan (incorporated by reference to the Current Report on Form 8-K filed on May 18, 2017)
10.7†	Form of LTIP Unit Award Agreement for Directors (incorporated by reference to the Annual Report on Form 10-K for the fiscal year ended December 31, 2011)
10.8†	Form of LTIP Unit Award Agreement for Individuals (incorporated by reference to the Annual Report on Form 10-K for the fiscal year ended December 31, 2011)
10.9†	Form of Individual LTIP Unit Award Agreement under 2017 Equity Incentive Plan (incorporated by reference to the Current Report on Form 8-K filed on May 18, 2017)
10.10†	Form of Non-Employee Director LTIP Unit Award Agreement under 2017 Equity Incentive Plan (incorporated by reference to the Current Report on Form 8-K filed on May 18, 2017)
10.11†	Form of OP LTIP Unit Award for Directors (incorporated by reference to Form 10-Q for the Quarter Ended September 30, 2019).
10.12†	Form of OP LTIP Unit Award for Officers (incorporated by reference to Form 10-Q for the Quarter Ended September 30, 2019).
10.13†	Form of Indemnity Agreement (incorporated by reference to the registration statement on Form S-11 (No. 333-160562), filed on September 3, 2009, as amended)
21.1	List of Subsidiaries
23.1	Consent of the Independent Registered Public Accounting Firm
24.1	Power of Attorney (included on Signature Page)

240

Exhibit	Description
(continued)
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes – Oxley Act of 2002
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes – Oxley Act of 2002
32.1*	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes – Oxley Act of 2002
32.2*	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes – Oxley Act of 2002
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

*    Furnished herewith. These certifications are not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

†    Management or compensatory plan or arrangement.

Item 16. Form 10-K Summary

None.

241

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		ELLINGTON FINANCIAL INC.
Date:	March 16, 2021	By:	/s/ LAURENCE PENN
			Laurence Penn Chief Executive Officer (Principal Executive Officer)

POWER OF ATTORNEY

We, the undersigned officers and directors of Ellington Financial Inc., hereby severally constitute Laurence Penn, Daniel Margolis, Jason Frank and JR Herlihy, and each of them singly, our true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names in the capacities indicated below, any and all amendments to this Annual Report on Form 10-K, and generally to do all such things in our names and in our capacities as officers and directors to enable Ellington Financial Inc. to comply with the provisions of the Securities Exchange Act of 1934, as amended, and all requirements of the SEC, hereby ratifying and confirming our signatures as they may be signed by our said attorneys, or any of them, to said Annual Report on Form 10-K and any and all amendments thereto.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and dates indicated.

Signature	Title	Date
/s/ LAURENCE PENN	Chief Executive Officer, President and Director (Principal Executive Officer)	March 16, 2021
LAURENCE PENN
/s/ JR HERLIHY	Chief Financial Officer (Principal Financial and Accounting Officer)	March 16, 2021
JR HERLIHY
/s/ LISA MUMFORD	Director	March 16, 2021
LISA MUMFORD
/s/ RONALD I. SIMON PH.D	Chairman of the Board	March 16, 2021
RONALD I. SIMON PH.D
	Director
THOMAS F. ROBARDS
/s/ EDWARD RESENDEZ	Director	March 16, 2021
EDWARD RESENDEZ
/s/ STEPHEN J. DANNHAUSER	Director	March 16, 2021
STEPHEN J. DANNHAUSER

242

EX-21.1

Exhibit 21.1

List of Subsidiaries of Ellington Financial Inc.

Name	State of Incorporation or Organization
EF Mortgage LLC	Delaware
EF Securities LLC	Delaware
EF CMO LLC	Delaware
Ellington Financial Operating Partnership LLC	Delaware
EF Corporate Holdings LLC	Delaware
EF MBS/ABS Holdings LLC	Delaware
EFQ LLC	Delaware
EF SBC 2013-1 LLC	Delaware
EF Holdco Inc.	Delaware
EF Cayman Holdings Ltd.	Cayman Islands
EF SBC 2013-1 REO Holdings LLC	Delaware
EF CH LLC	Delaware
Ellington Financial REIT	Maryland
EF Residential Loans LLC	Delaware
EF SBC 2015-2 LLC	Delaware
Ellington Financial REIT TRS LLC	Delaware
EF SBC 2015-1 LLC	Delaware
EF CH2 LLC	Delaware
EF CH3 LLC	Delaware
EF CH4 LLC	Delaware
EF NM 2015-1 LLC	Delaware
EF SBC 2016-1 LLC	Delaware
EF Holdco WRE Assets LLC	Delaware
EF Holdco RER Assets LLC	Delaware
EF Holdco AL Assets LLC	Delaware
EF Titan SBC 2016-1 LLC	Delaware
EF SBC FM Holdings LLC	Delaware
EF Edgewood SBC 2016-1 LLC	Delaware
EF Edgewood SBC 2018-1 LLC	Delaware
EF Mortgage Depositor LLC	Delaware
EF Mortgage Depositor II LLC	Delaware
EF Mortgage Depositor III LLC	Delaware
EF Holdco WRE Assets REO LLC	Delaware
Ellington Financial REIT Cayman Ltd.	Cayman Islands
Ellington Financial REIT QLH LLC	Delaware
Armstrong Securities Holdings LLC	Delaware
Armstrong Securities LLC	Connecticut
EF WH LLC	Delaware

EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on FormS-3 (No.333-237913) of Ellington Financial Inc. of our report dated March 16, 2021 relating to the financial statements, financial statement scheduleand the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

New York, New York

March 16, 2021

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Laurence Penn, certify that:

1. I have reviewed this Annual Report on Form 10-K of Ellington Financial Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	March 16, 2021
		/s/ Laurence Penn
		Laurence Penn
		Chief Executive Officer (Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, JR Herlihy, certify that:

1. I have reviewed this Annual Report on Form 10-K of Ellington Financial Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	March 16, 2021
		/s/ JR Herlihy
		JR Herlihy
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Ellington Financial Inc. (the “Company”) on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Laurence Penn, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	March 16, 2021	/s/ Laurence Penn
		Laurence Penn Chief Executive Officer (Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Ellington Financial Inc. (the “Company”) on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, JR Herlihy, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	March 16, 2021	/s/ JR Herlihy
		JR Herlihy Chief Financial Officer (Principal Financial and Accounting Officer)

XML

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 05, 2021	Jun. 30, 2020
Class of Stock [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2020
Document Transition Report	false
Entity File Number	001-34569
Entity Registrant Name	Ellington Financial Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-0489289
IcfrAuditorAttestationFlag	true
Entity Address, Address Line One	53 Forest Avenue
Entity Address, City or Town	Old Greenwich
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06870
City Area Code	203
Local Phone Number	698-1200
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 478,888,017
Entity Common Stock, Shares Outstanding		43,781,684
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Entity Central Index Key	0001411342
Current Fiscal Year End Date	--12-31
Common Stock
Class of Stock [Line Items]
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	EFC
Security Exchange Name	NYSE
Cumulative Redeemable Preferred Stock
Class of Stock [Line Items]
Title of 12(b) Security	6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
Trading Symbol	EFC PR A
Security Exchange Name	NYSE

XML

Condensed Consolidated Balance Sheet - USD ($) $ in Thousands		Dec. 31, 2020		Dec. 31, 2019		Dec. 31, 2018
Assets
Cash and cash equivalents		$ 111,647	[1]	$ 72,302	[1]	$ 44,656
Restricted cash		175	[1]	175	[1]	425
Securities, at fair value(1)(2)	[1],[2]	1,514,185		2,449,941
Loans, at fair value	[1],[2]	1,453,480		1,412,426
Investment in unconsolidated entities, at fair value	[1]	141,620		71,850
Real estate owned	[1],[2]	23,598		30,584
Investments, financial derivatives, and repurchase agreements:
Investments, at fair value (Cost - $2,970,306)						2,939,311
Reverse repurchase agreements		38,640		73,639		61,274
Total investments and financial derivatives						3,020,586
Financial derivatives—assets, at fair value		15,479		16,788		20,001
Receivables from Brokers-Dealers and Clearing Organizations						780,826
Interest Receivable						37,676
Due from brokers		63,147	[1]	79,829	[1]	71,794
Investment related receivables	[1]	49,317		123,120
Other assets		2,575	[1]	7,563	[1]	15,536
Total Assets		3,413,863		4,338,217		3,971,499
Investments and Financial Derivatives [Abstract]
Securities sold short, at fair value		38,642		73,409		850,577
Financial derivatives—liabilities, at fair value		24,553		27,621		20,806
Total investments and financial derivatives						871,383
Repurchase agreements		1,496,931	[1]	2,445,300	[1]	1,498,849
Due to brokers		5,059		2,197		5,553
Investment related payables		4,754	[1]	66,133	[1]	488,411
Other secured borrowings		51,062	[1]	150,334	[1]	114,100
Other secured borrowings, at fair value		754,921	[1]	594,396	[1]	297,948
Senior notes, net		85,561		85,298		85,035
Base management fee payable to affiliate		3,178		2,663		1,744
Incentive fee payable to affiliate		0		116
Dividends payable		5,738		6,978
Interest payable	[1]	3,233		7,320
Accounts payable and accrued expenses						5,723
Interest and Dividends Payable						7,159
Other Liabilities						424
Accrued expenses and other liabilities	[1]	18,659		7,753
Total Liabilities		2,492,291		3,469,518		3,376,329
Commitments and contingencies
ANALYSIS OF EQUITY:
Preferred stock, par value $0.001 per share, 100,000,000 shares authorized;6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable; 4,600,000 shares issued and outstanding ($115,000 liquidation preference)		111,034		111,034		0
Common stock, par value $0.001 per share, 100,000,000 shares authorized; 43,781,684 and 38,647,943 shares issued and outstanding, respectively		44		39		563,833
Additional paid-in-capital		915,658		821,747		0
Retained earnings (accumulated deficit)		(141,521)		(103,555)
Total Stockholders' Equity		885,215		829,265		563,833
Non-controlling interests		36,357	[1]	39,434	[1]	31,337
Total Equity		921,572		868,699		595,170
Total Liabilities and Equity		$ 3,413,863		$ 4,338,217		$ 3,971,499
PER SHARE INFORMATION:
Common shares						$ 18.92

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Condensed Consolidated Balance Sheet (Parenthetical) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Common shares	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, shares issued	43,781,684	38,647,943	29,796,601
Common stock, shares outstanding	43,781,684	38,647,943	29,796,601
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	100,000,000	100,000,000
Preferred Stock, Shares Issued	4,600,000	4,600,000
Preferred Stock, Shares Outstanding	4,600,000	4,600,000
Preferred Stock, Dividend Rate, Percentage	6.75%	6.75%
Preferred Stock, Liquidation Preference, Value	$ 115,000	$ 115,000
Investments, at fair value, Cost			$ 2,970,306,000
Financial derivative-assets, at fair value, Net Cost			22,526,000
Repurchase agreements, cost			61,274,000
Investments sold short, at fair value, Proceeds			844,604,000
Financial derivatives–assets, at fair value-Net Proceeds			19,019,000
Other secured borrowings, Proceeds			114,100,000
Other secured financing, at fair value-Proceeds			$ 298,706,000

XML

Condensed Consolidated Statement of Operations $ in Thousands	12 Months Ended
	Dec. 31, 2018 USD ($) $ / shares
Net Interest Income
Interest income	$ 131,027	[1]
Interest expense	(56,707)	[1]
Other income	4,014
Total investment income	135,041
Expenses
Base management fee to affiliate (Net of fee rebates)	7,573	[2]
Incentive Fee Expense	715
Other investment related expenses
Servicing expense	7,715
Debt issuance costs related to Other secured borrowings, at fair value	1,647	[3]
Other	7,592
Professional fees	3,902
Compensation expense	2,233
Administration fee expense	734
General Insurance Expense	487
Noninterest Expense Directors Fees	298
Share-based long term incentive plan unit expense	415
Other expenses	1,898
Total expenses	91,916
Net investment income	43,125
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total	49,911
Net income (loss) attributable to non-controlling interests	3,235
Net Income (Loss) Attributable to Common Stockholders	46,676
Realized Investment Gains (Losses) [Abstract]
Investments	25,421
Financial derivatives, excluding currency hedges	(2,639)
Financial derivatives-currency hedges	4,475
Foreign currency transactions	4,131
Total net realized gain (loss)	31,388
Unrealized Gain (Loss) on Derivatives and Commodity Contracts [Abstract]
Investments	(25,947)
Other Secured Borrowings	758
Financial Derivatives, excluding currency hedges	7,093
Financial Derivatives-currency hedges	565
Foreign currency translation	(7,071)
Net Unrealized Gain (Loss)	(24,602)
Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency	$ 6,786
Net Income (Loss) per Share of Common Stock:
Basic and Diluted (USD per share) | $ / shares	$ 1.52

[1] Includes interest income and interest expense of a consolidated securitization trust of $6.0 million and $3.6 million, respectively, for the year ended December 31, 2018. See Note 6 for further details on the Company's consolidated securitization trust.

[2] See Note 9 for further details on management fee rebates.

[3] Related to non-qualified mortgage securitization transactions. See Note 6 for further details.

XML

Condensed Consolidated Statement of Operations (Parenthetical) - USD ($) $ in Thousands	3 Months Ended				12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2018
Management Fee Expense, Rebates	$ 400	$ 400	$ 300	$ 300
Management fee rebate					$ 1,380
Interest Expense	16,083	15,678	13,383	11,562	56,707	[1]
Interest income	35,694	35,300	31,941	28,092	131,027	[1]
Consolidated Entities [Member]
Interest Expense	1,200	700	800	900	3,600
Interest income	$ 2,100	$ 1,300	$ 1,300	$ 1,300	$ 6,000

[1] Includes interest income and interest expense of a consolidated securitization trust of $6.0 million and $3.6 million, respectively, for the year ended December 31, 2018. See Note 6 for further details on the Company's consolidated securitization trust.

XML

Condensed Consolidated Statement of Changes in Equity - USD ($) $ in Thousands		Total		Total Stockholders' Equity		Common Stock	Additional Paid-in Capital	Retained Earnings/(Accumulated Deficit)	Non-controlling Interest		Preferred Stock [Member]	Preferred Stock [Member] Total Stockholders' Equity	Preferred Stock [Member] Preferred Stock [Member]	Common Stock		Common Stock Total Stockholders' Equity	Common Stock Common Stock	Common Stock Additional Paid-in Capital
Beginning balance (in shares) at Dec. 31, 2017		31,335,938
Beginning balance at Dec. 31, 2017		$ 620,961		$ 600,099					$ 20,862
CHANGE IN SHAREHOLDERS’ EQUITY RESULTING FROM OPERATIONS
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		49,911		46,676					3,235
Shares Issued As Payment of Incentive Fee		71		71
Contributions from non-controlling interests		21,532							21,532
Distributions to non-controlling interests		(23,853)							(23,853)
Adjustment to non-controlling interests		$ 0		(369)					369
Stock issued during period, shares, conversion of units		(3,334)
Repurchase of shares of common stock (in shares)		(1,547,148)
Repurchase of shares of common stock		$ (23,131)		(23,131)
Share-based long term incentive plan unit awards		$ 415		412					3
Ending balance (in shares) at Dec. 31, 2018		29,796,601				29,796,601
Ending balance at Dec. 31, 2018		$ 595,170		563,833		$ 0	$ 665,356	$ (101,523)	31,337
CHANGE IN SHAREHOLDERS’ EQUITY RESULTING FROM OPERATIONS
Dividends declared (in usd per share)		$ 1.64
Net investment income		$ 43,125
Total net realized gain (loss)		31,388
Net Unrealized Gain (Loss)		(24,602)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		49,911		46,676					3,235
Dividends		(50,736)	[1]	(50,388)	[1]				(348)	[1]				$ (49,576)
Share-based long term incentive plan unit redemption and distribution		0		(9,537)					9,537
Net increase (decrease) in equity from transactions		(75,702)		(82,942)					7,240
Stockholders' Equity, Period Increase (Decrease)		(25,791)		(36,266)					10,475
Preferred Stock, Value, Outstanding		0
Share conversion	[2]					$ 30	(30)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		$ 63,177		57,933				57,933	5,244
Stock Issued During Period, Shares, New Issues		8,855,000												8,855,000	[3]
Stock Issued During Period, Value, New Issues	[3]										$ 111,034	$ 111,034	$ 111,034	$ 156,328		$ 156,328	$ 9	$ 156,319
Shares Issued As Payment of Incentive Fee, Shares		0
Contributions from non-controlling interests		$ 27,650							27,650
Dividends	[4]	(59,824)		(58,499)				(58,499)	(1,325)
Dividends, Preferred Stock, Cash	[5]	(1,466)		(1,466)				(1,466)
Distributions to non-controlling interests		$ (23,063)							(23,063)
Adjustment to non-controlling interests				(392)			(392)		392
Stock issued during period, shares, conversion of units						47,167
Stock Issued During Period, Value, Conversion of Units				812			812		812
Repurchase of shares of common stock (in shares)		(50,825)				(50,825)
Repurchase of shares of common stock		$ (782)		(782)			(782)
Share-based long term incentive plan unit awards		$ 475		464			464		11
Ending balance (in shares) at Dec. 31, 2019		38,647,943				38,647,943
Ending balance at Dec. 31, 2019		$ 868,699		829,265		$ 39	821,747	(103,555)	39,434
CHANGE IN SHAREHOLDERS’ EQUITY RESULTING FROM OPERATIONS
Dividends declared (in usd per share)		$ 1.81
Preferred Stock, Dividends Per Share, Declared		$ 0.45938
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		$ 63,177		57,933				57,933	5,244
Dividends		(59,824)												$ (58,499)
Preferred Stock, Value, Outstanding		111,034
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		$ 28,377		25,008				25,008	3,369
Stock Issued During Period, Shares, New Issues		5,290,000												5,290,000	[3]
Stock Issued During Period, Value, New Issues	[3]													$ 95,292		95,292	5	95,287
Shares Issued As Payment of Incentive Fee, Shares		637												637
Shares Issued As Payment of Incentive Fee														$ 12		$ 12	$ 0	$ 12
Contributions from non-controlling interests		$ 8,270							8,270
Dividends	[4]	(56,023)		(55,211)				(55,211)	(812)
Dividends, Preferred Stock, Cash	[5]	(7,763)		(7,763)				(7,763)	0
Distributions to non-controlling interests		$ (12,958)							(12,958)
Adjustment to non-controlling interests				(1,480)			(1,480)		1,480
Stock issued during period, shares, conversion of units						133,154
Stock Issued During Period, Value, Conversion of Units				2,437			2,437		2,437
Repurchase of shares of common stock (in shares)		(290,050)				(290,050)
Repurchase of shares of common stock		$ (3,056)		(3,056)			(3,056)
Share-based long term incentive plan unit awards		$ 722		711			711		11
Ending balance (in shares) at Dec. 31, 2020		43,781,684				43,781,684
Ending balance at Dec. 31, 2020		$ 921,572		885,215		$ 44	$ 915,658	(141,521)	36,357
CHANGE IN SHAREHOLDERS’ EQUITY RESULTING FROM OPERATIONS
Dividends declared (in usd per share)		$ 1.26
Preferred Stock, Dividends Per Share, Declared		$ 1.265625
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		$ 28,377		$ 25,008				$ 25,008	$ 3,369
Dividends		(56,023)												$ (55,211)
Preferred Stock, Value, Outstanding		$ 111,034

[1] For the year ended December 31, 2018, dividends totaling $1.64 per common share and convertible unit outstanding, were declared.

[2] See Note 1 for further details on the share conversion.

[3] Net of underwriters' discounts and offering costs.

[4] For the years ended December 31, 2020 and 2019, dividends totaling $1.26 and $1.81, respectively, per share of common stock and convertible unit outstanding, were declared.

[5] For the years ended December 31, 2020 and 2019, dividends totaling $1.265625 and $0.45938, respectively, per share of preferred stock was declared.

XML

Condensed Consolidated Statement of Cash Flows $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($)		Dec. 31, 2019 USD ($)		Dec. 31, 2018 USD ($)
Statement of Cash Flows [Abstract]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 28,377		$ 63,177		$ 49,911
Reconciliation of the net increase (decrease) in equity resulting from operations to net cash provided by (used in) operating activities:
Amortization of premiums and accretion of discounts, net	41,681		48,132		45,895
Realized (gains) losses on securities and loans, net	5,960		12,785
Realized (gains) losses on financial derivatives, net	31,521		30,912
Realized (gains) losses on real estate owned, net	(15)		(2,327)
Unrealized (gains) losses on securities and loans, net	25,783		(54,478)
Unrealized (gains) losses on financial derivatives, net	(989)		5,338
Unrealized (gains) losses on real estate owned, net	649		1,279
Unrealized (gains) losses other, net	9,562		645
Realized (gains) losses other, net—foreign currency transaction	173		2,392		(4,131)
Unrealized (gains) losses other, net—foreign currency translation	(1,720)		(3,310)
Purchase of investments					(3,350,398)
Proceeds from disposition of investments					1,868,532
Proceeds from principal payments of investments					497,858
Repurchase of investments sold short					(2,457,148)
Payments on financial derivatives					(119,490)
Proceeds from financial derivatives					121,904
Amortization of deferred debt issuance costs	263		263		263
Shares Issued In Connection With Incentive Fee Payment	12		0		71
Share-based long term incentive plan unit expense	722		475		415
Interest income related to consolidated securitization trust	(21,800)		(16,034)		4,697	[1]
Interest expense related to consolidated securitization trust	21,020		15,136		4,313	[1]
Debt issuance costs related to Other secured borrowings, at fair value	(1,749)		(1,381)
(Earnings) losses from investments in unconsolidated entities	(37,933)		(10,209)
Repurchase agreements					94,675
(Increase) decrease in assets:
Increase decrease in interest and principal receivable	5,223		(15,449)
Receivable for securities sold and financial derivatives					(304,826)
Due from brokers, net					68,610
Interest and principal receivable					(7,988)
Other assets	1,077		(3,663)		28,234
Increase (decrease) in liabilities:
Due to brokers					3,832
Payable for securities purchased and financial derivatives					285,708
Base management fee payable to affiliate	515		919		(369)
Accounts payable and accrued expenses					1,838
Incentive fee payable to affiliate	(116)		116
Other liabilities					(17)
Interest and dividends payable					1,255
Increase (decrease) in interest payable	(3,798)		161
Increase (decrease) in accrued expenses and other liabilities	11,590		1,607
Net cash provided by (used in) operating activities	119,506		79,248		(494,181)
Cash Flows from Investing Activities:
Purchase of securities	(1,346,245)		(3,057,372)
Purchase of loans	(852,261)		(1,040,006)
Capital improvements of real estate owned	(153)		(240)
Proceeds from disposition of securities	1,888,099		1,838,182
Proceeds from disposition of loans	25,414		28,878
Contributions to investments in unconsolidated entities	(34,624)		(42,124)
Distributions from investments in unconsolidated entities	30,644		49,758
Proceeds from disposition of real estate owned	9,889		24,059
Proceeds from principal payments of securities	362,987		275,221
Proceeds from principal payments of loans	443,640		304,953
Proceeds from investments sold short	268,294		645,553		2,674,841
Repurchase of securities sold short	(310,559)		(650,576)
Payments on financial derivatives	(115,418)		(90,057)
Proceeds from financial derivatives	84,597		58,578
Payments made on reverse repurchase agreements	(7,586,769)		(7,050,581)
Proceeds from reverse repurchase agreements	7,622,670		7,038,216
Due from brokers, net	16,443		6,483
Due to brokers, net	619		(3,458)
Net cash provided by (used in) investing activities	507,267		(1,664,533)
Cash flows provided by (used in) financing activities:
Net proceeds from issuance of common stock	95,537	[2]	156,742	[2]
Offering costs paid	(253)		(712)
Repurchase of common stock	(3,056)		(782)		(23,131)
Dividends paid	(65,026)		(54,312)		(50,736)
Contributions from non-controlling interests	9,848		27,650		21,532
Distributions to non-controlling interests	(11,301)		(23,063)		(23,853)
Proceeds from issuance of securitized debt	57,863		97,642		100,010
Proceeds from issuance of Other secured borrowings	427,959		250,666		102,706
Repayments of Secured Debt	(112,253)		(62,608)
Principal payment on securitized debt	(67,325)		(61,408)		(43,819)
Debt issuance costs related to Other secured borrowings at fair value financing activities					(775)
Borrowings under repurchase agreements	4,138,940		9,047,746		8,078,468
Repayments of repurchase agreements	(5,059,445)		(7,862,227)		(7,668,798)
Due from brokers, net	49		(13,676)
Due to brokers, net	1,035		(355)
Net cash provided by (used in) financing activities	(587,428)		1,612,681		491,604
Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash	39,345		27,396		(2,577)
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	72,477		45,081		47,658
Cash, Cash Equivalents, and Restricted Cash, End of Period	111,822		72,477		45,081
Supplemental disclosure of cash flow information:
Interest paid	65,751		78,754		55,649
Dividends payable	5,738		6,978
Contribution from non-controlling interest (non-cash)	2,340		0		9,537
Distributions to non-controlling interests	(2,340)		0
Shares Issued In Connection With Incentive Fee Payment Non-Cash	12		0		71
Income tax paid	543		189
Share-based long term incentive plan unit awards (non-cash)	722		475		415
Transfers from mortgage loans to real estate owned (non-cash)	3,384		22,577
Transfers from mortgage loans to investments in non-consolidated entities (non-cash)	10,833		0
Purchase of investments (non-cash)	0		(2,975)		17,424
Contributions to investments in non-consolidated entities (non-cash)	(17,023)		0
Purchase of Loans Non Cash	6,670		0
Proceeds from issuance of Other secured borrowings (non-cash)	6,670		0
Proceeds from principal payments of investments (non-cash)	193,575		119,683		49,731
Proceeds from the disposition of loans (non-cash)	113,791		0
Repayments of repurchase agreement (non-cash)	(27,864)		(226,945)
Principal payments on Other secured borrowings, at fair value (non-cash)	(193,575)		(119,683)		(49,731)
Proceeds received from Other secured borrowings, at fair value (non-cash)	28,818		227,428		120,625
Repayment of senior notes (non-cash)	0		(86,000)
Issuance of senior notes (non-cash)	0		86,000
Realized gain or loss on investments, financial derivatives, and foreign currency transactions (excludes FX on cash)					(25,368)
Total Net Unrealized Gain Loss On Investments, Other Secured Borrowings, Financial Derivatives, and Foreign Currency Translation (excluding FX on cash)					26,318
Debt issuance costs related to Other secured borrowings, at fair value	3,894		3,536		1,647	[1]
Aggregate To Be Announced Trade Activity Buys Sells Non Cash					29,752,907
Proceeds from the Disposition of Investments Non Cash					17,424
Repayments of reverse repurchase agreements non cash					(120,136)
Debt issuance costs related to Other secured borrowings at fair value non cash					(872)
Share based long term incentive plan unit redemption non cash					$ (9,537)
Proceeds from Issuance of Preferred Stock and Preference Stock	0		111,378
Distributions from investments in unconsolidated entities	0		2,975
Principal payments on Other secured borrowings (non-cash)	$ (96,480)		$ 0

[1] Related to non-qualified mortgage securitization transactions. See Note 6 for further details.

[2] Net of underwriters' discounts.

XML

Consolidated Condensed Schedule of Investments (Cash Equivalents) - Cash equivalents shares in Thousands, $ in Thousands	Dec. 31, 2018 USD ($) shares
Schedule of Investments [Line Items]
Money Market Funds, at Carrying Value	$ 12,460
Investment Owned, Percent of Net Assets	2.09%
Money Market Funds, at Cost	$ 12,460
Various Money Market Funds [Member]
Schedule of Investments [Line Items]
Investment Owned, Balance, Shares | shares	12,460
Money Market Funds, at Carrying Value	$ 12,460
Various Money Market Funds [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	2.31%
Various Money Market Funds [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	2.34%

XML

Consolidated Condensed Schedule of Investments (Long Investments) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2018 USD ($) property shares	Dec. 31, 2020 USD ($) property	Dec. 31, 2019 USD ($) property
Schedule of Investments [Line Items]
Unpaid Principal Balance		$ 1,417,054	$ 1,387,733
Fair Value	$ 2,939,311
Number of Real Estate Properties | property	20	13	15
Investments, at fair value, Cost	$ 2,970,306
PercentageCollaterallizedByGNRCMOCertificates	100.00%
Non-performing loans, maturity date not applicable	$ 47,300
Mortgage Loans in Process of Foreclosure, Amount	$ 9,100
Unrated But Agency Guaranteed [Member]
Schedule of Investments [Line Items]
Long Investment Holdings Percent Of Equity by Rating	243.66%
Long Investment Aaa Rating [Member]
Schedule of Investments [Line Items]
Long Investment Holdings Percent Of Equity by Rating	0.01%
Long Investment Aa Rating [Member]
Schedule of Investments [Line Items]
Long Investment Holdings Percent Of Equity by Rating	0.63%
Long Investment Arating [Member]
Schedule of Investments [Line Items]
Long Investment Holdings Percent Of Equity by Rating	4.73%
Long Investment Bbb Rating [Member]
Schedule of Investments [Line Items]
Long Investment Holdings Percent Of Equity by Rating	1.84%
Long Investment Bb Rating [Member]
Schedule of Investments [Line Items]
Long Investment Holdings Percent Of Equity by Rating	46.34%
Long Investment Unrated Rating [Member]
Schedule of Investments [Line Items]
Long Investment Holdings Percent Of Equity by Rating	196.65%
Related Party-Consumer Loans Titled in Name of Related Party
Schedule of Investments [Line Items]
Fair value of loans held in related party trust	$ 21,900	$ 44,500	$ 47,900
Purchasing Entity
Schedule of Investments [Line Items]
Fair value of loans held in related party trust	181,500	45,100	185,400
Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 884,870
Investment Owned, Percent of Net Assets	148.68%
Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 10,510
Investment Owned, Percent of Net Assets	1.77%
To Be Announced Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance			460,037
Fair Value	$ 474,860
Investment Owned, Percent of Net Assets	79.78%
Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 1,370,240
Investment Owned, Percent of Net Assets	230.23%
Investments, at fair value, Cost	$ 1,388,115
Principal And Interest Floating Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 60,971
Investment Owned, Percent of Net Assets	10.24%
Interest Only Floating Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 19,006
Investment Owned, Percent of Net Assets	3.19%
Agency Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 1,450,217
Investment Owned, Percent of Net Assets	243.66%
Investments, at fair value, Cost	$ 1,469,988
Principal And Interest Private Label Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 329,317
Investment Owned, Percent of Net Assets	55.33%
Investments, at fair value, Cost	$ 326,430
Interest Only Private Label Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 7,230
Investment Owned, Percent of Net Assets	1.22%
Investments, at fair value, Cost	$ 5,189
Other Private Label Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 0
Investment Owned, Percent of Net Assets	0.00%
Investments, at fair value, Cost	$ 0
Collateralized Mortgage Backed Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 1,786,764
Investment Owned, Percent of Net Assets	300.21%
Investments, at fair value, Cost	$ 1,801,607
CLOs
Schedule of Investments [Line Items]
Fair Value	$ 123,893
Investment Owned, Percent of Net Assets	20.82%
Investments, at fair value, Cost	$ 139,424
CLOs | Related Party CLO securitization [Member]
Schedule of Investments [Line Items]
Fair Value	50,800
Consumer loans and asset-backed securities backed by consumer loans
Schedule of Investments [Line Items]
Fair Value	$ 206,761
Investment Owned, Percent of Net Assets	34.74%
Investments, at fair value, Cost	$ 211,982
Corporate debt securities
Schedule of Investments [Line Items]
Fair Value	$ 22,392
Investment Owned, Percent of Net Assets	3.76%
Investments, at fair value, Cost	$ 24,268
Secured notes
Schedule of Investments [Line Items]
Fair Value	$ 10,917
Investment Owned, Percent of Net Assets	1.83%
Investments, at fair value, Cost	$ 12,138
Mortgage Loans [Member]
Schedule of Investments [Line Items]
Fair Value	$ 708,015
Investment Owned, Percent of Net Assets	118.96%
Investments, at fair value, Cost	$ 703,366
Real estate owned
Schedule of Investments [Line Items]
Fair Value	$ 34,500
Investment Owned, Percent of Net Assets	5.80%
Investments, at fair value, Cost	$ 35,371
Common stock
Schedule of Investments [Line Items]
Fair Value	$ 2,200
Investment Owned, Percent of Net Assets	0.37%
Investments, at fair value, Cost	$ 2,482
Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 43,793
Investment Owned, Percent of Net Assets	7.36%
Investments, at fair value, Cost	$ 39,592
U.S. Treasury securities
Schedule of Investments [Line Items]
Fair Value	$ 76
Investment Owned, Percent of Net Assets	0.01%
Investments, at fair value, Cost	$ 76
Long Investments [Member]
Schedule of Investments [Line Items]
Fair Value	$ 2,939,311
Investment Owned, Percent of Net Assets	493.86%
Investments, at fair value, Cost	$ 2,970,306
Private Label Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 336,547
Investment Owned, Percent of Net Assets	56.55%
Investments, at fair value, Cost	$ 331,619
Floating Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 79,977
Investment Owned, Percent of Net Assets	13.43%
Investments, at fair value, Cost	$ 81,873
Securitized residential mortgage loans
Schedule of Investments [Line Items]
Fair Value of Assets Transfered and Accounted for as Secured Borrowings	$ 314,200
Government National Mortgage Association [Member] | Long Investments [Member]
Schedule of Investments [Line Items]
Investment Owned, Percent of Net Assets	107.55%
Federal National Mortgage Association [Member] | Long Investments [Member]
Schedule of Investments [Line Items]
Investment Owned, Percent of Net Assets	93.99%
Federal Home Loan Mortgage Corporation [Member] | Long Investments [Member]
Schedule of Investments [Line Items]
Investment Owned, Percent of Net Assets	42.12%
Mortgage-related Commercial | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 1,100	$ 33,900	$ 17,300
North America [Member] | Principal And Interest Private Label Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 164,410
Investment Owned, Percent of Net Assets	27.62%
Investments, at fair value, Cost	$ 153,769
North America [Member] | CLOs
Schedule of Investments [Line Items]
Fair Value	$ 123,893
Investment Owned, Percent of Net Assets	20.82%
Investments, at fair value, Cost	$ 139,424
North America [Member] | Consumer loans and asset-backed securities backed by consumer loans
Schedule of Investments [Line Items]
Fair Value	$ 205,877
Investment Owned, Percent of Net Assets	34.59%
Investments, at fair value, Cost	$ 211,221
North America [Member] | Corporate debt securities
Schedule of Investments [Line Items]
Fair Value	$ 11,586
Investment Owned, Percent of Net Assets	1.95%
Investments, at fair value, Cost	$ 11,949
North America [Member] | Common stock
Schedule of Investments [Line Items]
Fair Value	$ 2,200
Investment Owned, Percent of Net Assets	0.37%
Investments, at fair value, Cost	$ 2,482
North America [Member] | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 43,789
Investment Owned, Percent of Net Assets	7.36%
Investments, at fair value, Cost	$ 39,587
North America [Member] | Various Issuer [Member] | CLOs
Schedule of Investments [Line Items]
Unpaid Principal Balance	269,224
Fair Value	$ 123,893
North America [Member] | Various Issuer [Member] | CLOs | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	0.00%
Investments maturity date	2019-01
North America [Member] | Various Issuer [Member] | CLOs | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	10.54%
Investments maturity date	2118-10
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 143,523
Investment Interest Rate	4.00%
Fair Value	$ 147,395
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2039-09
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-11
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 111,109
Investment Interest Rate	4.00%
Fair Value	$ 114,104
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2041-11
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-12
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 82,189
Investment Interest Rate	3.50%
Fair Value	$ 82,450
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2042-09
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-02
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 74,478
Investment Interest Rate	4.50%
Fair Value	$ 77,266
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2046-09
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2049-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 65,892
Investment Interest Rate	4.50%
Fair Value	$ 68,853
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2041-10
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-12
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 51,362
Investment Interest Rate	4.00%
Fair Value	$ 52,544
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2045-07
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-05
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 46,026
Investment Interest Rate	5.00%
Fair Value	$ 48,245
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2048-02
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-12
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 45,670
Investment Interest Rate	4.50%
Fair Value	$ 47,583
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2043-09
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-10
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Fifteen Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 42,663
Investment Interest Rate	3.50%
Fair Value	$ 43,241
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Fifteen Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2028-03
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Fifteen Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2032-03
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 38,420
Investment Interest Rate	5.00%
Fair Value	$ 40,652
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2035-10
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-08
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 32,106
Investment Interest Rate	3.50%
Fair Value	$ 32,253
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2042-12
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2047-12
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 25,082
Investment Interest Rate	3.50%
Fair Value	$ 25,185
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2042-01
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-03
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Five Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 21,807
Investment Interest Rate	5.50%
Fair Value	$ 23,207
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Five Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2048-04
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Five Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-12
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Fifteen Year) Three Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 10,899
Investment Interest Rate	3.00%
Fair Value	$ 10,895
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Fifteen Year) Three Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2030-04
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Fifteen Year) Three Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2032-09
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Fifteen Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 8,275
Investment Interest Rate	3.50%
Fair Value	$ 8,389
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Fifteen Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2028-09
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Fifteen Year) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2032-12
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Other) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 7,287
Investment Interest Rate	3.50%
Fair Value	$ 7,316
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Other) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2043-04
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Other) Three Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2046-09
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 6,096
Investment Interest Rate	5.00%
Fair Value	$ 6,423
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2044-07
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-10
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Fifteen Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 5,728
Investment Interest Rate	4.00%
Fair Value	$ 5,823
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Fifteen Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2026-06
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Fifteen Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2031-05
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Five Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 5,023
Investment Interest Rate	5.50%
Fair Value	$ 5,342
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Five Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2039-11
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Five Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-06
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Other) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 4,547
Investment Interest Rate	5.00%
Fair Value	$ 4,772
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Other) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2043-09
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Other) Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2044-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Other) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 4,394
Investment Interest Rate	4.00%
Fair Value	$ 4,478
Investments maturity date	2047-12
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Six Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 3,408
Investment Interest Rate	6.00%
Fair Value	$ 3,666
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Six Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2048-05
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Six Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-11
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Three Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,773
Investment Interest Rate	3.00%
Fair Value	$ 2,722
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Three Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2043-07
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Three Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2045-06
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Three Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,603
Investment Interest Rate	3.00%
Fair Value	$ 2,556
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Three Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2042-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Three Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2045-06
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Three Point Seven Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,508
Investment Interest Rate	3.75%
Fair Value	$ 2,537
Investments maturity date	2047-07
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Other) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,348
Investment Interest Rate	4.50%
Fair Value	$ 2,432
Investments maturity date	2044-05
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation (15 Year) 3 Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,343
Investment Interest Rate	3.00%
Fair Value	$ 2,342
Investments maturity date	2030-04
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation (15 Year) 3 Percent [Member] | To Be Announced Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 1,660
Investment Interest Rate	3.00%
Fair Value	$ 1,655
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Fifteen Year) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,177
Investment Interest Rate	4.50%
Fair Value	$ 2,265
Investments maturity date	2026-04
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Other) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,025
Investment Interest Rate	4.50%
Fair Value	$ 2,079
Investments maturity date	2041-05
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Twenty Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 1,478
Investment Interest Rate	4.00%
Fair Value	$ 1,526
Investments maturity date	2033-12
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Twenty Year) Four Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 976
Investment Interest Rate	4.50%
Fair Value	$ 1,021
Investments maturity date	2033-12
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Fifteen Year) Four Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 886
Investment Interest Rate	4.00%
Fair Value	$ 897
Investments maturity date	2029-02
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Six Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 651
Investment Interest Rate	6.00%
Fair Value	$ 697
Investments maturity date	2040-05
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Three Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 710
Investment Interest Rate	3.00%
Fair Value	$ 695
Investments maturity date	2042-11
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Six Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 588
Investment Interest Rate	6.00%
Fair Value	$ 631
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Six Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2039-09
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Six Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2040-02
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools (Thirty Year) Two Point Four Nine Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 524
Investment Interest Rate	2.49%
Fair Value	$ 496
Investments maturity date	2043-10
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools (Thirty Year) Three Point Two Eight Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 109
Investment Interest Rate	3.28%
Fair Value	$ 106
Investments maturity date	2042-06
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Four Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 17,505
Investment Interest Rate	4.00%
Fair Value	$ 2,828
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Four Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2045-02
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Four Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2045-06
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Four Point Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 10,446
Investment Interest Rate	4.50%
Fair Value	$ 1,223
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Four Point Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2020-12
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Four Point Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2044-06
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Six Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 4,768
Investment Interest Rate	6.00%
Fair Value	$ 978
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Six Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2038-06
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Six Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2039-08
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Four Point Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 5,949
Investment Interest Rate	4.50%
Fair Value	$ 808
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Four Point Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2039-06
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Four Point Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2044-07
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Five Point Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 3,401
Investment Interest Rate	5.50%
Fair Value	$ 749
Investments maturity date	2039-10
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Five Point Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 3,612
Investment Interest Rate	5.50%
Fair Value	$ 623
Investments maturity date	2043-11
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Three Point Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 3,642
Investment Interest Rate	3.50%
Fair Value	$ 515
Investments maturity date	2032-12
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Four Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 3,560
Investment Interest Rate	4.00%
Fair Value	$ 513
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Four Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2039-05
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Four Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2043-11
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,659
Investment Interest Rate	5.00%
Fair Value	$ 463
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2038-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2040-05
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 5,122
Investment Interest Rate	5.00%
Fair Value	$ 402
Investments maturity date	2038-11
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Five Point FIve Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 3,749
Investment Interest Rate	5.50%
Fair Value	$ 336
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Five Point FIve Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2039-01
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Five Point FIve Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2039-09
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Six Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 1,613
Investment Interest Rate	6.00%
Fair Value	$ 274
Investments maturity date	2040-01
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Four Point Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 1,463
Investment Interest Rate	4.50%
Fair Value	$ 254
Investments maturity date	2043-07
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Three Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,291
Investment Interest Rate	3.00%
Fair Value	$ 203
Investments maturity date	2041-09
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 3,043
Investment Interest Rate	5.00%
Fair Value	$ 181
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2037-05
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2041-05
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Four Point Seven Five Percent [Member] | Interest Only Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 842
Investment Interest Rate	4.75%
Fair Value	$ 160
Investments maturity date	2040-07
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association (30 Year) 5 Point 00 Percent [Member] | To Be Announced Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 299,455
Investment Interest Rate	5.00%
Fair Value	$ 311,515
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association (30 Year) 4 Point 00 Percent [Member] | To Be Announced Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 122,003
Investment Interest Rate	4.00%
Fair Value	$ 124,376
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation (30 Year) 3 Point 50 Percent [Member] | To Be Announced Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 21,540
Investment Interest Rate	3.50%
Fair Value	$ 21,529
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association (30 Year) 5 Point 50 Percent [Member] | To Be Announced Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 10,579
Investment Interest Rate	5.50%
Fair Value	$ 11,058
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association (30 Year) 3 Point 00 Percent [Member] | To Be Announced Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 4,800
Investment Interest Rate	3.00%
Fair Value	$ 4,727
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools [Member] | Principal And Interest Floating Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 52,532
Fair Value	$ 55,475
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools [Member] | Principal And Interest Floating Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	4.39%
Investments maturity date	2061-07
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association Pools [Member] | Principal And Interest Floating Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	4.67%
Investments maturity date	2067-12
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools [Member] | Principal And Interest Floating Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 3,515
Fair Value	$ 3,650
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools [Member] | Principal And Interest Floating Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	2.70%
Investments maturity date	2035-09
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association Pools [Member] | Principal And Interest Floating Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	4.69%
Investments maturity date	2045-05
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools [Member] | Principal And Interest Floating Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 1,808
Fair Value	$ 1,846
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools [Member] | Principal And Interest Floating Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	3.49%
Investments maturity date	2037-06
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools [Member] | Principal And Interest Floating Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	4.72%
Investments maturity date	2044-05
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association [Member] | Interest Only Floating Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 228,763
Fair Value	$ 10,772
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association [Member] | Interest Only Floating Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	0.38%
Investments maturity date	2031-06
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association [Member] | Interest Only Floating Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	5.64%
Investments maturity date	2066-10
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association [Member] | Interest Only Floating Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 70,568
Fair Value	$ 4,880
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association [Member] | Interest Only Floating Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	1.13%
Investments maturity date	2033-06
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association [Member] | Interest Only Floating Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	5.50%
Investments maturity date	2046-11
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation [Member] | Interest Only Floating Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 48,699
Fair Value	$ 3,256
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation [Member] | Interest Only Floating Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	1.55%
Investments maturity date	2036-03
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation [Member] | Interest Only Floating Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	4.19%
Investments maturity date	2044-01
North America [Member] | Mortgage-related Residential [Member] | Resecuritization of Government National Mortgage Association [Member] | Interest Only Floating Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 5,220
Investment Interest Rate	2.21%
Fair Value	$ 98
Investments maturity date	2060-08
North America [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Principal And Interest Private Label Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 227,479
Fair Value	$ 149,273
North America [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Principal And Interest Private Label Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	0.00%
Investments maturity date	2019-05
North America [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Principal And Interest Private Label Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	24.56%
Investments maturity date	2047-03
North America [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Interest Only Private Label Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 30,842
Fair Value	$ 3,941
North America [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Interest Only Private Label Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	0.00%
Investments maturity date	2030-12
North America [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Interest Only Private Label Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	2.00%
Investments maturity date	2047-09
North America [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Other Private Label Securities [Member]
Schedule of Investments [Line Items]
Investments maturity date	2037-06
North America [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Secured notes
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 17,608
Investment Interest Rate	5.00%
Fair Value	$ 10,917
Investments maturity date	2057-11
North America [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Mortgage Loans [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 493,248
Fair Value	$ 496,830
North America [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Mortgage Loans [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	2.00%
Investments maturity date	2019-03
North America [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Mortgage Loans [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	15.00%
Investments maturity date	2058-12
North America [Member] | Mortgage-related Residential [Member] | Non-Exchange Traded Preferred Equity Investment in Mortgage Originators [Member] | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 27,317
Investment Owned, Balance, Shares | shares	23
North America [Member] | Mortgage-related Residential [Member] | Non-Exchange Traded Equity Investment in Mortgage Originators [Member] | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 6,750
Investment Owned, Balance, Shares | shares	9,818
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Five Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 1,677
Investment Interest Rate	5.50%
Fair Value	$ 1,786
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Five Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2033-08
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation Pools (Thirty Year) Five Point Five Percent [Member] | Principal And Interest Fixed Rate Agency Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2048-05
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Principal And Interest Private Label Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 37,171
Fair Value	$ 15,137
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Principal And Interest Private Label Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	2.80%
Investments maturity date	2049-03
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Principal And Interest Private Label Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	3.29%
Investments maturity date	2061-05
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Interest Only Private Label Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 41,707
Fair Value	$ 3,289
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Interest Only Private Label Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	1.25%
Investments maturity date	2049-03
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Interest Only Private Label Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	2.00%
Investments maturity date	2061-05
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Other Private Label Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 0
Investment Interest Rate	0.00%
Fair Value	$ 0
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Other Private Label Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2045-07
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Other Private Label Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2061-05
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Mortgage Loans [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 235,459
Fair Value	$ 211,185
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Mortgage Loans [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	4.31%
Investments maturity date	2019-03
North America [Member] | Mortgage-related Commercial | Various Issuer [Member] | Mortgage Loans [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	12.74%
Investments maturity date	2037-10
North America [Member] | Mortgage-related Commercial | Non-controlling Interest in Mortgage-related Private Partnership | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 1,147
North America [Member] | Consumer [Member] | Various Issuer [Member] | Consumer loans and asset-backed securities backed by consumer loans
Schedule of Investments [Line Items]
Unpaid Principal Balance	233,602
Fair Value	$ 205,877
North America [Member] | Consumer [Member] | Various Issuer [Member] | Consumer loans and asset-backed securities backed by consumer loans | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	5.31%
Investments maturity date	2019-01
North America [Member] | Consumer [Member] | Various Issuer [Member] | Consumer loans and asset-backed securities backed by consumer loans | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	76.50%
Investments maturity date	2023-12
North America [Member] | Consumer [Member] | Various Issuer [Member] | Corporate debt securities
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 3,342
Investment Interest Rate	6.69%
Fair Value	$ 3,141
Investments maturity date	2027-01
North America [Member] | Consumer [Member] | Exchange Traded Equity [Member] | Common stock
Schedule of Investments [Line Items]
Fair Value	$ 25
Investment Owned, Balance, Shares | shares	24
North America [Member] | Consumer [Member] | Non-Exchange Traded Corporate Equity [Member] | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 0
Investment Owned, Balance, Shares | shares	1,540
North America [Member] | Consumer [Member] | Investment in unconsolidated entities | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 4,045
North America [Member] | Consumer [Member] | Non-Exchange Traded Preferred Equity Investment in Consumer Loan Originators [Member] [Domain] | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 3,000
Investment Owned, Balance, Shares | shares	3,000
North America [Member] | Communications [Member] | Various Issuer [Member] | Corporate debt securities
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 938
Investment Interest Rate	0.00%
Fair Value	$ 824
Investments maturity date	2022-05
North America [Member] | Communications [Member] | Non-Exchange Traded Corporate Equity [Member] | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 97
Investment Owned, Balance, Shares | shares	7
North America [Member] | Energy [Member] | Various Issuer [Member] | Corporate debt securities
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,080
Investment Interest Rate	4.63%
Fair Value	$ 1,877
Investments maturity date	2021-09
North America [Member] | Industrial Sector [Member] | Various Issuer [Member] | Corporate debt securities
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 1,755
Investment Interest Rate	3.75%
Fair Value	$ 1,742
Investments maturity date	2021-12
North America [Member] | Technology Sector [Member] | Various Issuer [Member] | Corporate debt securities
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 4,570
Fair Value	$ 4,002
North America [Member] | Technology Sector [Member] | Various Issuer [Member] | Corporate debt securities | Minimum
Schedule of Investments [Line Items]
Investments maturity date	2020-05
North America [Member] | Technology Sector [Member] | Various Issuer [Member] | Corporate debt securities | Maximum
Schedule of Investments [Line Items]
Investments maturity date	2022-05
North America [Member] | Financial [Member] | Exchange Traded Equity [Member] | Common stock
Schedule of Investments [Line Items]
Fair Value	$ 2,175
Investment Owned, Balance, Shares | shares	213
North America [Member] | Real estate-related [Member] | Single-Family Houses [Member] | Real estate owned
Schedule of Investments [Line Items]
Fair Value	$ 1,296
Number of Real Estate Properties | property	5
North America [Member] | Real estate-related [Member] | Commercial Property [Member] | Real estate owned
Schedule of Investments [Line Items]
Fair Value	$ 33,204
Number of Real Estate Properties | property	18
North America [Member] | Diversified [Member] | Non-Exchange Traded Corporate Equity [Member] | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 1,433
Investment Owned, Balance, Shares | shares	144
North America [Member] | Government Sector [Member] | U.S. Treasury Note, 2.75 Percent, Maturity Date 2023 04 [Member] | U.S. Treasury securities
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 75
Investment Interest Rate	2.75%
Fair Value	$ 76
Investments maturity date	2023-04
Europe [Member] | Principal And Interest Private Label Securities [Member]
Schedule of Investments [Line Items]
Fair Value	$ 164,907
Investment Owned, Percent of Net Assets	27.71%
Investments, at fair value, Cost	$ 172,661
Europe [Member] | Consumer loans and asset-backed securities backed by consumer loans
Schedule of Investments [Line Items]
Fair Value	$ 884
Investment Owned, Percent of Net Assets	0.15%
Investments, at fair value, Cost	$ 761
Europe [Member] | Corporate debt securities
Schedule of Investments [Line Items]
Fair Value	$ 10,806
Investment Owned, Percent of Net Assets	1.81%
Investments, at fair value, Cost	$ 12,319
Europe [Member] | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 4
Investment Owned, Percent of Net Assets	0.00%
Investments, at fair value, Cost	$ 5
Europe [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Principal And Interest Private Label Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	183,154
Fair Value	$ 149,425
Europe [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Principal And Interest Private Label Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	0.00%
Investments maturity date	2025-06
Europe [Member] | Mortgage-related Residential [Member] | Various Issuer [Member] | Principal And Interest Private Label Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	5.50%
Investments maturity date	2052-12
Europe [Member] | Mortgage-related Commercial | Various Issuer [Member] | Principal And Interest Private Label Securities [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 24,978
Fair Value	$ 15,482
Europe [Member] | Mortgage-related Commercial | Various Issuer [Member] | Principal And Interest Private Label Securities [Member] | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	0.38%
Investments maturity date	2020-10
Europe [Member] | Mortgage-related Commercial | Various Issuer [Member] | Principal And Interest Private Label Securities [Member] | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	4.29%
Investments maturity date	2045-08
Europe [Member] | Consumer [Member] | Various Issuer [Member] | Consumer loans and asset-backed securities backed by consumer loans
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 3,540
Investment Interest Rate	0.00%
Fair Value	$ 884
Investments maturity date	2030-12
Europe [Member] | Consumer [Member] | Various Issuer [Member] | Corporate debt securities
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 20,574
Investment Interest Rate	0.00%
Fair Value	$ 0
Investments maturity date	2019-12
Europe [Member] | Consumer [Member] | Non-Exchange Traded Corporate Equity [Member] | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 0
Investment Owned, Balance, Shares | shares	125
Europe [Member] | Technology Sector [Member] | Various Issuer [Member] | Corporate debt securities | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	0.00%
Europe [Member] | Technology Sector [Member] | Various Issuer [Member] | Corporate debt securities | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	4.38%
Europe [Member] | Financial [Member] | Various Issuer [Member] | Corporate debt securities
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 11,235
Fair Value	$ 10,806
Europe [Member] | Financial [Member] | Various Issuer [Member] | Corporate debt securities | Minimum
Schedule of Investments [Line Items]
Investment Interest Rate	0.00%
Investments maturity date	2020-10
Europe [Member] | Financial [Member] | Various Issuer [Member] | Corporate debt securities | Maximum
Schedule of Investments [Line Items]
Investment Interest Rate	16.00%
Investments maturity date	2022-11
Europe [Member] | Financial [Member] | Non-Exchange Traded Corporate Equity [Member] | Corporate equity securities
Schedule of Investments [Line Items]
Fair Value	$ 4
Investment Owned, Balance, Shares | shares	0

XML

Consolidated Condensed Schedule of Investments (Repurchase Agreements) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Schedule of Investments [Line Items]
Unpaid Principal Balance		$ 1,417,054	$ 1,387,733
Repurchase agreements, at fair value	$ 61,274	$ 38,640	$ 73,639
Repurchase agreements, cost	61,274
Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Repurchase agreements, at fair value	61,274
Repurchase agreements, cost	$ 61,274
Investment Owned, Percent of Net Assets	10.30%
JP Morgan Securities LLC Collateralized by Par Value $13,600 U.S. Treasury Note, Coupon 2.88%, Maturity Date 2021 11 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 13,854
Investment Interest Rate	(3.25%)
Repurchase agreements, at fair value	$ 13,854
Securities Collateralized By Par Value	$ 13,600
Coupon Rate On Underlying Collateral On Repurchase Agreement	2.88%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2021-11
Investments maturity date	2019-01
JP Morgan Securities LLC Collateralized by Par Value $10,451 U.S. Treasury Note, Coupon 2.88%, Maturity Date 2023 10 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 10,712
Investment Interest Rate	(3.15%)
Repurchase agreements, at fair value	$ 10,712
Securities Collateralized By Par Value	$ 10,451
Coupon Rate On Underlying Collateral On Repurchase Agreement	2.88%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2023-10
Investments maturity date	2019-01
JP Morgan Securities LLC Collateralized by Par Value $10,102 Sovereign Government Bond, Coupon 0.75%, Maturity Date 2021 07 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 10,365
Investment Interest Rate	(0.75%)
Repurchase agreements, at fair value	$ 10,365
Securities Collateralized By Par Value	$ 10,102
Coupon Rate On Underlying Collateral On Repurchase Agreement	0.75%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2021-07
Investments maturity date	2019-01
JP Morgan Securities LLC Collateralized by Par Value $9,161 Sovereign Government Bond, Coupon 2.75%, Maturity Date 2019 04 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 9,379
Investment Interest Rate	(0.65%)
Repurchase agreements, at fair value	$ 9,379
Securities Collateralized By Par Value	$ 9,161
Coupon Rate On Underlying Collateral On Repurchase Agreement	2.75%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2019-04
Investments maturity date	2019-01
JP Morgan Securities LLC Collateralized by Par Value $3,400 U.S. Treasury Note, Coupon 3.13%, Maturity Date 2028 11 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 3,562
Investment Interest Rate	(3.05%)
Repurchase agreements, at fair value	$ 3,562
Securities Collateralized By Par Value	$ 3,400
Coupon Rate On Underlying Collateral On Repurchase Agreement	3.13%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2028-11
Investments maturity date	2019-01
JP Morgan Securities LLC Collateralized by Par Value $2,800 U.S. Treasury Note, Coupon 2.88%, Maturity Date 2028 08 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,884
Investment Interest Rate	(2.95%)
Repurchase agreements, at fair value	$ 2,884
Securities Collateralized By Par Value	$ 2,800
Coupon Rate On Underlying Collateral On Repurchase Agreement	2.88%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2028-08
Investments maturity date	2019-01
Bank of America Securities Collateralized by Par Value $2,062 U.S. Treasury Note, Coupon 2.88%, Maturity Date 2023 11 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 2,098
Investment Interest Rate	(2.90%)
Repurchase agreements, at fair value	$ 2,098
Securities Collateralized By Par Value	$ 2,062
Coupon Rate On Underlying Collateral On Repurchase Agreement	2.88%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2023-11
Investments maturity date	2019-01
Bank of America Securities Collateralized by Par Value $1,939 U.S. Treasury Note, Coupon 2.75%, Maturity Date 2023 08 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 1,975
Investment Interest Rate	(2.90%)
Repurchase agreements, at fair value	$ 1,975
Securities Collateralized By Par Value	$ 1,939
Coupon Rate On Underlying Collateral On Repurchase Agreement	2.75%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2023-08
Investments maturity date	2019-01
Barclays Capital Inc Collateralized by Par Value $1,900 Exchange-Traded Corporate Debt, Coupon 5.95%, Maturity Date 2026 12 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 1,710
Investment Interest Rate	(1.65%)
Repurchase agreements, at fair value	$ 1,710
Securities Collateralized By Par Value	$ 1,900
Coupon Rate On Underlying Collateral On Repurchase Agreement	5.95%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2026-12
Investments maturity date	2019-01
Bank of America Securities Collateralized by Par Value $1,355 U.S. Treasury Note, Coupon 2.75%, Maturity Date 2023 04 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 1,369
Investment Interest Rate	(3.05%)
Repurchase agreements, at fair value	$ 1,369
Securities Collateralized By Par Value	$ 1,355
Coupon Rate On Underlying Collateral On Repurchase Agreement	2.75%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2023-04
Investments maturity date	2019-01
Morgan Stanley Collateralized by Par Value $1,000 Exchange-Traded Corporate Debt, Coupon 5.95%, Maturity Date 2026 12 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 957
Investment Interest Rate	(2.15%)
Repurchase agreements, at fair value	$ 957
Securities Collateralized By Par Value	$ 1,000
Coupon Rate On Underlying Collateral On Repurchase Agreement	5.95%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2026-12
Investments maturity date	2019-01
Barclays Capital Inc Collateralized by Par Value $1,200 Exchange-Traded Corporate Debt, Coupon 9.88%, Maturity Date 2024 02 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 797
Investment Interest Rate	(0.75%)
Repurchase agreements, at fair value	$ 797
Securities Collateralized By Par Value	$ 1,200
Coupon Rate On Underlying Collateral On Repurchase Agreement	9.88%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2024-02
Investments maturity date	2019-01
Barclays Capital Inc Collateralized by Par Value $800 Exchange-Traded Corporate Debt, Coupon 9.88%, Maturity Date 2024 02 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 531
Investment Interest Rate	(1.25%)
Repurchase agreements, at fair value	$ 531
Securities Collateralized By Par Value	$ 800
Coupon Rate On Underlying Collateral On Repurchase Agreement	9.88%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2024-02
Investments maturity date	2019-01
RBC Capital Markets LLC Collateralized by Par Value $500 Exchange-Traded Corporate Debt, Coupon 5.75%, Maturity Date 2022 10 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 525
Investment Interest Rate	(2.05%)
Repurchase agreements, at fair value	$ 525
Securities Collateralized By Par Value	$ 500
Coupon Rate On Underlying Collateral On Repurchase Agreement	5.75%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2022-10
Investments maturity date	2019-01
Bank of America Securities Collateralized by Par Value $463 U.S. Treasury Note, Coupon 2.63%, Maturity Date 2023 06 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 469
Investment Interest Rate	(3.05%)
Repurchase agreements, at fair value	$ 469
Securities Collateralized By Par Value	$ 463
Coupon Rate On Underlying Collateral On Repurchase Agreement	2.63%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2023-06
Investments maturity date	2019-01
Societe Generale Collateralized by Par Value $100 Exchange-Traded Corporate Debt, Coupon 5.95%, Maturity Date 2026 12 [Member] | Securities Purchased under Agreements to Resell [Member]
Schedule of Investments [Line Items]
Unpaid Principal Balance	$ 87
Investment Interest Rate	(1.85%)
Repurchase agreements, at fair value	$ 87
Securities Collateralized By Par Value	$ 100
Coupon Rate On Underlying Collateral On Repurchase Agreement	5.95%
Maturity Date Of Securities As Collateral On Repurchase Agreement1	2026-12
Investments maturity date	2019-01

XML

Consolidated Condensed Schedule of Investments (Investments Sold Short) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Investments Sold, Not yet Purchased [Line Items]
Securities sold short, at fair value	$ (850,577)	$ (38,642)	$ (73,409)
Investment Sold, Not yet Purchased, Sale Proceeds	(844,604)
TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal			$ (753,697)
Securities sold short, at fair value	$ (772,964)
Investment Sold, Not yet Purchased, Percent of Net Assets	(129.87%)
Investment Sold, Not yet Purchased, Sale Proceeds	$ (766,777)
Common stock
Investments Sold, Not yet Purchased [Line Items]
Securities sold short, at fair value	$ (16,933)
Investment Sold, Not yet Purchased, Percent of Net Assets	(2.84%)
Investment Sold, Not yet Purchased, Sale Proceeds	$ (17,164)
Corporate debt securities
Investments Sold, Not yet Purchased [Line Items]
Securities sold short, at fair value	$ (6,529)
Investment Sold, Not yet Purchased, Percent of Net Assets	(1.10%)
Investment Sold, Not yet Purchased, Sale Proceeds	$ (6,708)
Investments Sold Short
Investments Sold, Not yet Purchased [Line Items]
Securities sold short, at fair value	$ (850,577)
Investment Sold, Not yet Purchased, Percent of Net Assets	(142.91%)
Investment Sold, Not yet Purchased, Sale Proceeds	$ (844,604)
Government debt
Investments Sold, Not yet Purchased [Line Items]
Securities sold short, at fair value	$ (54,151)
Investment Sold, Not yet Purchased, Percent of Net Assets	(9.10%)
Investment Sold, Not yet Purchased, Sale Proceeds	$ (53,955)
Federal National Mortgage Association [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Investment Sold, Not yet Purchased, Percent of Net Assets	(66.31%)
Federal Home Loan Mortgage Corporation [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Investment Sold, Not yet Purchased, Percent of Net Assets	(22.71%)
Government National Mortgage Association [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Investment Sold, Not yet Purchased, Percent of Net Assets	(40.85%)
North America [Member] | US Government Debt Securities [Member]
Investments Sold, Not yet Purchased [Line Items]
Securities sold short, at fair value	$ (34,817)
Investment Sold, Not yet Purchased, Percent of Net Assets	(5.85%)
Investment Sold, Not yet Purchased, Sale Proceeds	$ (34,410)
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association (30 Year) 4 Point 50 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (156,590)
Investment Interest Rate	4.50%
Securities sold short, at fair value	$ (162,119)
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association (30 Year) 4 Point 50 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (117,590)
Investment Interest Rate	4.50%
Securities sold short, at fair value	$ (121,637)
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation (30 Year) 4 Point 00 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (107,397)
Investment Interest Rate	4.00%
Securities sold short, at fair value	$ (109,465)
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association (30 Year) 5 Point 00 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (87,817)
Investment Interest Rate	5.00%
Securities sold short, at fair value	$ (91,971)
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association (30 Year) 4 Point 00 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (86,893)
Investment Interest Rate	4.00%
Securities sold short, at fair value	$ (88,994)
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association (30 Year) 3 Point 50 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (76,912)
Investment Interest Rate	3.50%
Securities sold short, at fair value	$ (76,891)
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Government National Mortgage Association (30 Year) 3 Point 50 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (32,260)
Investment Interest Rate	3.50%
Securities sold short, at fair value	$ (32,484)
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association (15 Year) 3 Point 50 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (26,530)
Investment Interest Rate	3.50%
Securities sold short, at fair value	$ (26,859)
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Federal Home Loan Mortgage Corporation (30 Year) 4 Point 50 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (24,841)
Investment Interest Rate	4.50%
Securities sold short, at fair value	$ (25,707)
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association (30 Year) 3 Point 00 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (16,557)
Investment Interest Rate	3.00%
Securities sold short, at fair value	$ (16,153)
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association (15 Year) 3 Point 00 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (13,450)
Investment Interest Rate	3.00%
Securities sold short, at fair value	$ (13,426)
Investments maturity date	2019-01
North America [Member] | Mortgage-related Residential [Member] | Federal National Mortgage Association (30 Year) 5 Point 50 Percent [Member] | TBA - Fixed Rate Agency Securities Sold Short [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (6,860)
Investment Interest Rate	5.50%
Securities sold short, at fair value	$ (7,258)
Investments maturity date	2019-01
North America [Member] | Government Sector [Member] | U.S. Treasury Note, 2.88 Percent, Maturity Date 2021 11 [Member] [Domain] | US Government Debt Securities [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (13,600)
Investment Interest Rate	2.88%
Securities sold short, at fair value	$ (13,754)
Investments maturity date	2021-11
North America [Member] | Government Sector [Member] | U.S. Treasury Note, 2.88 Percent, Maturity Date 2023 10 [Member] [Domain] | US Government Debt Securities [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (10,451)
Investment Interest Rate	2.88%
Securities sold short, at fair value	$ (10,631)
Investments maturity date	2023-10
North America [Member] | Government Sector [Member] | U.S. Treasury Note, 3.13 Percent, Maturity Date 2028 11 [Member] [Domain] | US Government Debt Securities [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (3,400)
Investment Interest Rate	3.13%
Securities sold short, at fair value	$ (3,528)
Investments maturity date	2028-11
North America [Member] | Government Sector [Member] | U.S. Treasury Note, 2.88 Percent, Maturity Date 2028 08 [Member] | US Government Debt Securities [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (2,800)
Investment Interest Rate	2.88%
Securities sold short, at fair value	$ (2,844)
Investments maturity date	2028-08
North America [Member] | Government Sector [Member] | U.S. Treasury Note, 2.88 Percent, Maturity Date 2023 11 [Member] [Domain] | US Government Debt Securities [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (2,062)
Investment Interest Rate	2.88%
Securities sold short, at fair value	$ (2,098)
Investments maturity date	2023-11
North America [Member] | Government Sector [Member] | U.S. Treasury Note, 2.75 Percent, Maturity Date 2023 08 [Member] | US Government Debt Securities [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (1,939)
Investment Interest Rate	2.75%
Securities sold short, at fair value	$ (1,962)
Investments maturity date	2023-08
North America [Member] | Financial [Member] | Exchange Traded Equity [Member] | Common stock
Investments Sold, Not yet Purchased [Line Items]
Securities sold short, at fair value	$ (16,933)
Investment Sold, Not yet Purchased, Balance, Shares	(277)
North America [Member] | Financial [Member] | Various Issuer [Member] | Corporate debt securities
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (3,600)
Securities sold short, at fair value	$ (2,810)
North America [Member] | Financial [Member] | Various Issuer [Member] | Corporate debt securities | Minimum
Investments Sold, Not yet Purchased [Line Items]
Investment Interest Rate	4.70%
Investments maturity date	2026-12
North America [Member] | Financial [Member] | Various Issuer [Member] | Corporate debt securities | Maximum
Investments Sold, Not yet Purchased [Line Items]
Investment Interest Rate	5.95%
Investments maturity date	2027-06
North America [Member] | Communications [Member] | Various Issuer [Member] | Corporate debt securities
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (1,730)
Investment Interest Rate	4.25%
Securities sold short, at fair value	$ (1,734)
Investments maturity date	2023-09
North America [Member] | Consumer [Member] | Various Issuer [Member] | Corporate debt securities
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (500)
Investment Interest Rate	5.75%
Securities sold short, at fair value	$ (500)
Investments maturity date	2022-10
North America [Member] | Energy [Member] | Various Issuer [Member] | Corporate debt securities
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (2,000)
Investment Interest Rate	9.88%
Securities sold short, at fair value	$ (1,230)
Investments maturity date	2024-02
North America [Member] | Technology Sector [Member] | Various Issuer [Member] | Corporate debt securities
Investments Sold, Not yet Purchased [Line Items]
Current Principal	$ (288)
Investment Interest Rate	4.95%
Securities sold short, at fair value	$ (255)
Investments maturity date	2023-04
Europe [Member] | Debt Security, Government, Non-US [Member]
Investments Sold, Not yet Purchased [Line Items]
Securities sold short, at fair value	$ (19,334)
Investment Sold, Not yet Purchased, Percent of Net Assets	(3.25%)
Investment Sold, Not yet Purchased, Sale Proceeds	$ (19,545)
Europe [Member] | Government Sector [Member] | European Sovereign Bond [Member] | Debt Security, Government, Non-US [Member]
Investments Sold, Not yet Purchased [Line Items]
Current Principal	(19,006)
Securities sold short, at fair value	$ (19,334)
Europe [Member] | Government Sector [Member] | European Sovereign Bond [Member] | Debt Security, Government, Non-US [Member] | Minimum
Investments Sold, Not yet Purchased [Line Items]
Investment Interest Rate	0.75%
Investments maturity date	2019-04
Europe [Member] | Government Sector [Member] | European Sovereign Bond [Member] | Debt Security, Government, Non-US [Member] | Maximum
Investments Sold, Not yet Purchased [Line Items]
Investment Interest Rate	2.75%
Investments maturity date	2021-07

XML

Consolidated Condensed Schedule of Investments (Financial Derivatives) $ in Thousands	12 Months Ended
	Dec. 31, 2018 USD ($) contract	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Investment Holdings, Other than Securities [Line Items]
Financial derivatives–assets, at fair value-	$ 20,001	$ 15,479	$ 16,788
Derivative Liability	20,806	$ 24,553	$ 27,621
Financial derivative-assets, at fair value, Net Cost	22,526
Derivatives Proceeds	(19,019)
Financial Derivatives - Assets
Investment Holdings, Other than Securities [Line Items]
Financial derivatives–assets, at fair value-	$ 20,001
Investment Owned, Percent of Net Assets	3.36%
Financial derivative-assets, at fair value, Net Cost	$ 22,526
Financial Derivatives - Liabilities
Investment Holdings, Other than Securities [Line Items]
Derivative Liability	$ (20,806)
Investment Owned, Percent of Net Assets	(3.50%)
Derivatives Proceeds	$ (19,019)
Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member]
Investment Holdings, Other than Securities [Line Items]
Financial derivatives–assets, at fair value-	1,003
Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member]
Investment Holdings, Other than Securities [Line Items]
Financial derivatives–assets, at fair value-	1,470
Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative Liability	(2,482)
Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short | North America [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative Liability	(756)
Total return swaps | Financial Derivatives - Assets | Short | North America [Member]
Investment Holdings, Other than Securities [Line Items]
Financial derivatives–assets, at fair value-	1
Swap [Member] | Financial Derivatives - Assets
Investment Holdings, Other than Securities [Line Items]
Financial derivatives–assets, at fair value-	$ 19,995
Investment Owned, Percent of Net Assets	3.36%
Financial derivative-assets, at fair value, Net Cost	$ 22,524
Swap [Member] | Financial Derivatives - Liabilities
Investment Holdings, Other than Securities [Line Items]
Derivative Liability	$ (20,331)
Investment Owned, Percent of Net Assets	(3.42%)
Derivatives Proceeds	$ (19,019)
Options | Financial Derivatives - Assets
Investment Holdings, Other than Securities [Line Items]
Financial derivatives–assets, at fair value-	$ 0
Investment Owned, Percent of Net Assets	0.00%
Financial derivative-assets, at fair value, Net Cost	$ 2
US Treasury Note Futures [Member] | Short
Investment Holdings, Other than Securities [Line Items]
Number of contracts | contract	1,516
Futures | Financial Derivatives - Assets
Investment Holdings, Other than Securities [Line Items]
Financial derivatives–assets, at fair value-	$ 0
Investment Owned, Percent of Net Assets	0.00%
Futures | Financial Derivatives - Liabilities
Investment Holdings, Other than Securities [Line Items]
Derivative Liability	$ (355)
Investment Owned, Percent of Net Assets	(0.06%)
Forwards | Financial Derivatives - Assets
Investment Holdings, Other than Securities [Line Items]
Financial derivatives–assets, at fair value-	$ 6
Investment Owned, Percent of Net Assets	0.00%
Forwards | Financial Derivatives - Liabilities
Investment Holdings, Other than Securities [Line Items]
Derivative Liability	$ (120)
Investment Owned, Percent of Net Assets	(0.02%)
Recovery swaps | Financial Derivatives - Liabilities | Long | North America [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative Liability	$ (8)
Foreign Exchange Future [Member] | Short
Investment Holdings, Other than Securities [Line Items]
Number of contracts | contract	411
Credit Risk [Member] | Credit default swaps on corporate bond indices | Financial Derivatives - Assets | Long
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 47,815
Financial derivatives–assets, at fair value-	$ 733
Credit Risk [Member] | Credit default swaps on corporate bond indices | Financial Derivatives - Assets | Long | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2019-06
Credit Risk [Member] | Credit default swaps on corporate bond indices | Financial Derivatives - Assets | Long | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-06
Credit Risk [Member] | Credit default swaps on corporate bond indices | Financial Derivatives - Liabilities | Long
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 2,330
Derivative Liability	$ (1,467)
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bond indices | Financial Derivatives - Liabilities | Short
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (279,163)
Derivative Liability	$ (10,090)
Credit Risk [Member] | Credit default swaps on corporate bond indices | Financial Derivatives - Liabilities | Short | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2019-06
Credit Risk [Member] | Credit default swaps on corporate bond indices | Financial Derivatives - Liabilities | Short | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on asset-backed indices | Financial Derivatives - Assets | Long
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 689
Financial derivatives–assets, at fair value-	$ 7
Credit Risk [Member] | Credit default swaps on asset-backed indices | Financial Derivatives - Assets | Long | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2037-12
Credit Risk [Member] | Credit default swaps on asset-backed indices | Financial Derivatives - Assets | Short
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (56,207)
Financial derivatives–assets, at fair value-	$ 8,085
Credit Risk [Member] | Credit default swaps on asset-backed indices | Financial Derivatives - Assets | Short | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2046-05
Credit Risk [Member] | Credit default swaps on asset-backed indices | Financial Derivatives - Assets | Short | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2059-11
Credit Risk [Member] | Credit default swaps on asset-backed indices | Financial Derivatives - Liabilities | Long
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 14,838
Derivative Liability	$ (2,125)
Credit Risk [Member] | Credit default swaps on asset-backed indices | Financial Derivatives - Liabilities | Long | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2049-03
Credit Risk [Member] | Credit default swaps on asset-backed indices | Financial Derivatives - Liabilities | Long | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2060-11
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Basic Materials [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 4
Financial derivatives–assets, at fair value-	$ 0
Derivatives Maturity Date	2022-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Communications [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 3,090
Financial derivatives–assets, at fair value-	$ 18
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Communications [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2020-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Communications [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Consumer [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 10,655
Financial derivatives–assets, at fair value-	$ 868
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Consumer [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2020-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Consumer [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Financial [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 930
Financial derivatives–assets, at fair value-	$ 104
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Industrial Sector [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 485
Financial derivatives–assets, at fair value-	$ 13
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Energy [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2020-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Energy [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Technology Sector [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2020-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long | North America [Member] | Technology Sector [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Basic Materials [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2021-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Basic Materials [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Communications [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (906)
Financial derivatives–assets, at fair value-	$ 226
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Communications [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2021-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Communications [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Consumer [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (2,065)
Financial derivatives–assets, at fair value-	$ 30
Derivatives Maturity Date	2020-03
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Industrial Sector [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (2,074)
Financial derivatives–assets, at fair value-	25
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Energy [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	(7,610)
Financial derivatives–assets, at fair value-	$ 950
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Energy [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2019-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Energy [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Technology Sector [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (4,070)
Financial derivatives–assets, at fair value-	$ 239
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Technology Sector [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2020-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Short | North America [Member] | Technology Sector [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2022-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Basic Materials [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 2,000
Derivative Liability	$ (25)
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Communications [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 2,313
Derivative Liability	$ (396)
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Communications [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2022-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Communications [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Consumer [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 3,741
Derivative Liability	$ (62)
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Consumer [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2020-03
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Consumer [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2021-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Energy [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 5,144
Derivative Liability	$ (1,885)
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Energy [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2020-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Energy [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Technology Sector [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 1,953
Derivative Liability	$ (114)
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Technology Sector [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2020-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Long | North America [Member] | Technology Sector [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short | North America [Member] | Basic Materials [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (1,180)
Derivative Liability	$ (57)
Derivatives Maturity Date	2019-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short | North America [Member] | Communications [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (3,910)
Derivative Liability	$ (11)
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short | North America [Member] | Communications [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2019-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short | North America [Member] | Communications [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short | North America [Member] | Consumer [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (12,830)
Derivative Liability	$ (567)
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short | North America [Member] | Consumer [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2019-06
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short | North America [Member] | Consumer [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short | North America [Member] | Financial [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (930)
Derivative Liability	$ (104)
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short | North America [Member] | Industrial Sector [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (485)
Derivative Liability	$ (13)
Derivatives Maturity Date	2023-12
Credit Risk [Member] | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short | North America [Member] | Technology Sector [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (1,160)
Derivative Liability	$ (4)
Derivatives Maturity Date	2019-06
Credit Risk [Member] | Credit default swaps on asset-backed securities | Financial Derivatives - Assets | Short | North America [Member] | Mortgage-related Residential [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (3,186)
Financial derivatives–assets, at fair value-	$ 1,472
Credit Risk [Member] | Credit default swaps on asset-backed securities | Financial Derivatives - Assets | Short | North America [Member] | Mortgage-related Residential [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2035-06
Credit Risk [Member] | Credit default swaps on asset-backed securities | Financial Derivatives - Assets | Short | North America [Member] | Mortgage-related Residential [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2035-12
Credit Risk [Member] | Total return swaps | Financial Derivatives - Liabilities | Short
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (11,230)
Derivative Liability	$ (6)
Derivatives Maturity Date	2019-03
Credit Risk [Member] | Recovery swaps | Financial Derivatives - Liabilities | Long | North America [Member] | Consumer [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 2,600
Derivative Liability	$ (8)
Derivatives Maturity Date	2019-06
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Assets | Long
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 29,198
Financial derivatives–assets, at fair value-	$ 61
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Assets | Long | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2019-01
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Assets | Long | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2019-02
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Assets | Short
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (353,741)
Financial derivatives–assets, at fair value-	$ 7,163
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Assets | Short | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2020-03
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Assets | Short | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2045-12
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Liabilities | Long
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 113,809
Derivative Liability	$ (1,987)
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Liabilities | Long | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2021-06
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Liabilities | Long | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2029-01
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Liabilities | Short
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (71,672)
Derivative Liability	$ (1,406)
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Liabilities | Short | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2020-05
Interest Rate Risk [Member] | Interest rate swaps | Financial Derivatives - Liabilities | Short | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2028-11
Interest Rate Risk [Member] | Interest Rate Cap [Member] | Financial Derivatives - Assets | Long
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ 51,545
Financial derivatives–assets, at fair value-	$ 0
Derivatives Maturity Date	2019-05
Interest Rate Risk [Member] | US Treasury Note Futures [Member] | Financial Derivatives - Assets | Short
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (151,600)
Financial derivatives–assets, at fair value-	$ 0
Derivatives Maturity Date	2019-03
Interest Rate Risk [Member] | Interest Rate Swaps Variable rates only [Member] | Financial Derivatives - Liabilities | Short
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (12,900)
Derivative Liability	$ (4)
Derivatives Maturity Date	2019-06
Interest Rate Risk [Member] | Eurodollar futures | Financial Derivatives - Liabilities | Short
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (98,000)
Derivative Liability	$ (53)
Number Of Contracts Per Every $1,000,000 In Notional Value | contract	1
Interest Rate Risk [Member] | Eurodollar futures | Financial Derivatives - Liabilities | Short | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2019-03
Interest Rate Risk [Member] | Eurodollar futures | Financial Derivatives - Liabilities | Short | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2020-06
Interest Rate Risk [Member] | Foreign Exchange Future [Member] | Financial Derivatives - Liabilities | Short
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (47,931)
Derivative Liability	$ (302)
Derivatives Maturity Date	2019-03
Equity Market Risk [Member] | Total return swaps | Financial Derivatives - Assets | Short | North America [Member] | Financial [Member]
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (17,740)
Financial derivatives–assets, at fair value-	$ 1
Equity Market Risk [Member] | Total return swaps | Financial Derivatives - Assets | Short | North America [Member] | Financial [Member] | Minimum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2019-07
Equity Market Risk [Member] | Total return swaps | Financial Derivatives - Assets | Short | North America [Member] | Financial [Member] | Maximum
Investment Holdings, Other than Securities [Line Items]
Derivatives Maturity Date	2019-10
Currency risk [Member] | Forwards | Financial Derivatives - Assets | Short
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (802)
Financial derivatives–assets, at fair value-	$ 6
Derivatives Maturity Date	2019-03
Currency risk [Member] | Forwards | Financial Derivatives - Liabilities | Short
Investment Holdings, Other than Securities [Line Items]
Derivative notional	$ (16,497)
Derivative Liability	$ (120)
Derivatives Maturity Date	2019-03

XML

Organization and Investment Objective

12 Months Ended

Dec. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Investment Objective

Organization and Investment Objective

Ellington Financial Inc., formerly known as Ellington Financial LLC, was originally formed as a Delaware limited liability company on July 9, 2007 and commenced operations on August 17, 2007. On February 28, 2019, Ellington Financial LLC filed a certificate of conversion with the Secretary of State of the State of Delaware (the "Secretary") to convert from a Delaware limited liability company to a Delaware corporation (the "Conversion") and change its name to Ellington Financial Inc. The Conversion became effective on March 1, 2019, and upon effectiveness, each of Ellington Financial LLC's existing common shares representing limited liability company interests, no par value, converted into one issued and outstanding, fully paid and nonassessable share of common stock, $0.001 par value per share, of Ellington Financial Inc. In connection with the Conversion, Ellington Financial Inc.'s Board of Directors (the "Board of Directors") approved Ellington Financial Inc.'s Certificate of Incorporation (which was also filed with the Secretary) and Bylaws.

Ellington Financial Operating Partnership LLC (the "Operating Partnership"), a 98.7% owned consolidated subsidiary of Ellington Financial Inc., was formed as a Delaware limited liability company on December 14, 2012 and commenced operations on January 1, 2013. All of Ellington Financial Inc.'s operations and business activities are conducted through the Operating Partnership. Ellington Financial Inc., the Operating Partnership, and their consolidated subsidiaries are hereafter collectively referred to as the "Company." All intercompany accounts are eliminated in consolidation.

The Company conducts its operations to qualify and be taxed as a real estate investment trust, or "REIT," under the Internal Revenue Code of 1986, as amended (the "Code"), and has elected to be taxed as a corporation effective January 1, 2019. The Company has elected to be taxed as a REIT for U.S. federal income tax purposes. In anticipation of the Company's intended election to be taxed as a REIT under the Code beginning with its 2019 taxable year (the "REIT Election"), the Company implemented an internal restructuring as of December 31, 2018. As part of this restructuring, the Company moved certain of its non-REIT-qualifying investments and financial derivatives to taxable REIT subsidiaries or, "TRSs," and disposed of certain of its investments in non-REIT-qualifying investments and financial derivatives.

The Company invests in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, or "RMBS," commercial mortgage-backed securities, or "CMBS," consumer loans and asset-backed securities, or "ABS," including ABS backed by consumer loans, collateralized loan obligations, or "CLOs," non-mortgage- and mortgage-related derivatives, equity investments in loan origination companies, and other strategic investments.

Ellington Financial Management LLC (the "Manager") is an SEC-registered investment adviser that serves as the Manager to the Company pursuant to the terms of its Seventh Amended and Restated Management Agreement (the "Management Agreement"), which was approved by the Board of Directors effective March 13, 2018. The Manager is an affiliate of Ellington Management Group, L.L.C. ("Ellington"), an investment management firm that is registered as both an investment adviser and a commodity pool operator. In accordance with the terms of the Management Agreement, the Manager implements the investment strategy and manages the business and operations on a day-to-day basis for the Company and performs certain services for the Company, subject to oversight by the Board of Directors.

COVID-19 Impact

During the first quarter of 2020, there was a worldwide outbreak of a novel coronavirus disease, or "COVID-19." The outbreak was declared a pandemic by the World Health Organization and numerous countries, including the United States, have responded by instituting quarantines or lockdowns, imposing restrictions on travel, restrictions on the ability of individuals to assemble in groups, and restrictions on the ability of certain businesses to operate, all of which have resulted in significant disruptions in the U.S. and global economies. In mid-March 2020, adverse economic conditions related to the COVID-19 pandemic began to impact the Company's financial position and results of operations. The COVID-19 pandemic has contributed to volatility, dislocations in the financial markets, and illiquidity. As a result, during the first quarter of 2020 the Company received margin calls under its repurchase agreements that were higher than typical historical levels. During the remainder of 2020, prices for most credit assets, which are assets for which the principal and interest payments are not guaranteed by a U.S. government agency or a U.S. government-sponsored entity, stabilized, and market volatility subsided, and as a result our margin calls reverted to more typical levels. We satisfied all margin calls during the year ended December 31, 2020.

Actions by the U.S. Federal Reserve starting in the second half of March 2020 helped stabilize the market for certain assets, including RMBS for which the principal and interest payments are guaranteed by a U.S. government agency or a U.S. government-sponsored entity, or "Agency RMBS," and investment-grade corporate bonds, while other sectors, including non-investment-grade CMBS and CLOs, noticeably lagged. In light of the heightened levels of market volatility and systemic liquidity risk experienced during the first quarter of 2020, the Company proactively reduced the size of its Agency RMBS

portfolio, thereby bolstering its liquidity and lowering its leverage, and it maintained a smaller Agency RMBS portfolio through the rest of 2020. Beginning in the second quarter, the Company resumed making new credit and Agency RMBS investments, but continued to maintain a higher cash balance and lower debt-to-equity ratio than prior to the outbreak of COVID-19.

The Company's management team implemented business continuity plans, and the Company, the Manager, and Ellington continue to be fully operational in a largely work-from-home environment.

Organization and Investment Objective

Ellington Financial LLC was formed as a Delaware limited liability company on July 9, 2007 and commenced operations on August 17, 2007. Ellington Financial Operating Partnership LLC (the "Operating Partnership"), a 97.6% owned consolidated subsidiary of Ellington Financial LLC, was formed as a Delaware limited liability company on December 14, 2012 and commenced operations on January 1, 2013. All of the Company's operations and business activities are conducted through the Operating Partnership. Ellington Financial LLC, the Operating Partnership, and their consolidated subsidiaries are hereafter collectively referred to as the "Company." All intercompany accounts are eliminated in consolidation.

The Company invests in a diverse array of financial assets, including residential mortgage-backed securities, or "RMBS," commercial mortgage-backed securities, or "CMBS," residential and commercial mortgage loans, consumer loans and asset-backed securities, or "ABS," backed by consumer loans, collateralized loan obligations, or "CLOs," non-mortgage and mortgage-related derivatives, equity investments in loan origination companies, and other strategic investments.

Ellington Financial Management LLC ("EFM" or the "Manager") is an SEC-registered investment adviser and a registered commodity pool operator that serves as the Manager to the Company pursuant to the terms of its seventh amended and restated management agreement (the "Management Agreement"). EFM is an affiliate of Ellington Management Group, L.L.C., ("Ellington") an investment management firm that is registered as both an investment adviser and a commodity pool operator. In accordance with the terms of the Management Agreement, the Manager implements the investment strategy and manages the business and operations on a day-to-day basis for the Company and performs certain services for the Company, subject to oversight by the Company's Board of Directors ("Board of Directors").

XML

Significant Accounting Policies

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Significant Accounting Policies

Significant Accounting Policies

(A) Basis of Presentation: The Company's consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, or "U.S. GAAP," and Regulation S-X. The consolidated financial statements include the accounts of the Company, the Operating Partnership, its subsidiaries, and variable interest entities, or "VIEs," for which the Company is deemed to be the primary beneficiary. All intercompany balances and transactions have been eliminated. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and those differences could be material (particularly in light of the significant volatility, lack of pricing transparency, and market dislocations that have been caused by the COVID-19 pandemic, and associated responses to the pandemic). In management's opinion, all material adjustments considered necessary for a fair statement of the Company's consolidated financial statements have been included and are only of a normal recurring nature.

The Company adopted ASC 946, Financial Services—Investment Companies ("ASC 946") upon its commencement of operations in August 2007, and applied U.S. GAAP for investment companies. In connection with the Company's internal restructuring and the Company's intention to qualify as a REIT for the year ended December 31, 2019, the Company determined that, effective January 1, 2019, it no longer qualified for investment company accounting in accordance with ASC 946-10-25, and has prospectively discontinued its use. The Company elected the fair value option, or "FVO," for, and therefore the Company continued to measure at fair value, those of its assets and liabilities it had previously measured at fair value and for which such election is permitted, as provided for under ASC 825, Financial Instruments ("ASC 825"). Due to the prospective application of a change in accounting as required under ASC 946-10-25-2, the Company determined that the presentation of its consolidated financial statements for periods beginning after December 31, 2018 are not comparable to the consolidated financial statements previously prepared for prior periods for which the Company applied ASC 946. As a result, the Company has provided separate consolidated financial statements for applicable prior periods in Item 8 of this Annual Report on Form 10-K.

Reclassification and Presentation

Effective January 1, 2019, the Company prospectively discontinued its application of ASC 946. Upon its change in status, the following significant changes and elections were made:

•Investments in securities are now accounted for in accordance with ASC 320, Investments—Debt and Equity Securities ("ASC 320");

•The Company elected the FVO as provided for under ASC 825-10-25-4 for all eligible financial instruments for which the Company had previously measured at fair value, including investments in securities, loans, financial derivatives, and certain of the Company's secured borrowings. As a result, all changes in the fair value of such financial instruments will continue to be recorded in earnings on the Company's Consolidated Statement of Operations;

•Real estate owned, or "REO," is not eligible for the FVO election. As a result, REO is carried at the lower of cost or fair value. The Company's cost basis in any REO that was previously measured at fair value under ASC 946 was adjusted on January 1, 2019 to equal the fair value of such investment as of December 31, 2018;

•The Company elected not to designate its financial derivatives as hedging instruments in accordance with ASC 815, Derivatives and Hedging ("ASC 815"). As a result, all changes in the fair value of financial derivatives will continue to be recorded in earnings on the Company's Consolidated Statement of Operations;

•Forward settling to-be-announced mortgage-backed-securities, or "TBAs," are no longer classified as investments. TBAs will be classified as financial derivatives, with the difference between the forward contract price and the market value of the TBA position as of the reporting date included in Unrealized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations; and

•The Company is required to account for certain of its equity investments under ASC 323-10, Investments—Equity Method and Joint Ventures ("ASC 323-10"). The Company has elected the FVO for such equity investments and changes in fair value will be reported in Earnings (losses) from investments in unconsolidated entities, on the Consolidated Statement of Operations.

The discontinuation of the Company's application of ASC 946 prospectively changed the presentation of the Company's consolidated financial statements. The most significant changes were:

•The Consolidated Statement of Assets, Liabilities, and Equity has been changed to a Consolidated Balance Sheet;

•The Consolidated Condensed Schedule of Investments has been removed;

•The Consolidated Statement of Operations is no longer presented in the format required under ASC 946. The Company will present the Consolidated Statement of Operations as required under U.S. GAAP for operating companies. A Consolidated Statement of Other Comprehensive Income (Loss) will be presented, if and when applicable;

•The Consolidated Statement of Cash Flows has been changed, and now includes a section for investing activities;

•Certain footnotes have been changed to reflect conformity with applicable U.S. GAAP for operating companies;

•The Company re-evaluated its interests in all entities to determine whether they are variable interests, and re-evaluated its investments, including it investments in partially owned entities, to determine if they are VIEs, as required under ASC 810, Consolidation ("ASC 810"). The Company also re-evaluated consolidation considerations for all of its investments in VIEs and partially owned entities, as required under ASC 810. Applicable disclosures related to VIEs have been included in these notes to consolidated financial statements;

•Securities/loans sold under agreements to be repurchased at an agreed-upon price and date, which were formerly referred to as "reverse repurchase agreements," are now referred to as "repurchase agreements";

•Securities/loans purchased under agreements to resell at an agreed-upon price and date, which were formerly referred to as "repurchase agreements," are now referred to as "reverse repurchase agreements"; and

•The financial highlights disclosures, which are not required under U.S. GAAP for operating companies, have been removed.

(B) Valuation: The Company applies ASC 820-10, Fair Value Measurement ("ASC 820") to its holdings of financial instruments. ASC 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:

•Level 1—inputs to the valuation methodology are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Currently, the types of financial instruments the Company generally includes in this category are listed equities and exchange-traded derivatives;

•Level 2—inputs to the valuation methodology other than quoted prices included in Level 1 are observable for the asset or liability, either directly or indirectly. Currently, the types of financial instruments that the Company generally includes in this category are Agency RMBS, U.S. Treasury securities and sovereign debt, certain non-Agency RMBS, CMBS, CLOs, corporate debt, and actively traded derivatives such as interest rate swaps, foreign currency forwards, and other over-the-counter derivatives; and

•Level 3—inputs to the valuation methodology are unobservable and significant to the fair value measurement. The types of financial instruments that the Company generally includes in this category are certain RMBS, CMBS, CLOs, ABS, credit default swaps, or "CDS," on individual ABS, and total return swaps on distressed corporate debt, in each case where there is less price transparency. Also included in this category are residential and commercial mortgage loans, consumer loans, and private corporate debt and equity investments.

For certain financial instruments, the various inputs that management uses to measure fair value may fall into different levels of the fair value hierarchy. For each such financial instrument, the determination of which category within the fair value hierarchy is appropriate is based on the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the various inputs that management uses to measure fair value, with the highest priority given to inputs that are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets (Level 1), and the lowest priority given to inputs that are unobservable and significant to the fair value measurement (Level 3). The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. The Company may use valuation techniques consistent with the market and income approaches to measure the fair value of its financial instruments. The market approach uses third-party valuations and information obtained from market transactions involving identical or similar financial instruments. The income approach uses projections of the future economic benefit of an instrument to determine its fair value, such as in the discounted cash flow methodology. The inputs or methodology used for valuing financial instruments are not necessarily an indication of the risk associated with investing in these financial instruments. The leveling of each financial instrument is reassessed at the end of each period. Transfers between levels of the fair value hierarchy are assumed to occur at the end of the reporting period.

Summary Valuation Techniques

For financial instruments that are traded in an "active market," the best measure of fair value is the quoted market price. However, many of the Company's financial instruments are not traded in an active market. Therefore, management generally uses third-party valuations when available. If third-party valuations are not available, management uses other valuation techniques, such as the discounted cash flow methodology. The following are summary descriptions, for various categories of financial instruments, of the valuation methodologies management uses in determining fair value of the Company's financial instruments in such categories. Management utilizes such methodologies to assign a fair value (the estimated price that, in an orderly transaction at the valuation date, would be received to sell an asset, or paid to transfer a liability, as the case may be) to each such financial instrument.

For mortgage-backed securities, or "MBS," TBAs, CLOs, and corporate debt and equity, management seeks to obtain at least one third-party valuation, and often obtains multiple valuations when available. Management has been able to obtain third-party valuations on the vast majority of these instruments and expects to continue to solicit third-party valuations in the future. Management generally values each financial instrument at the average of third-party valuations received and not rejected as described below. Third-party valuations are not binding, management may adjust the valuations it receives (e.g., downward adjustments for odd lots), and management may challenge or reject a valuation when, based on its validation criteria, management determines that such valuation is unreasonable or erroneous. Furthermore, based on its validation criteria, management may determine that the average of the third-party valuations received for a given financial instrument does not result in what management believes to be the fair value of such instrument, and in such circumstances management may override this average with its own good faith valuation. The validation criteria may take into account output from management's own models, recent trading activity in the same or similar instruments, and valuations received from third parties. The use of proprietary models requires the use of a significant amount of judgment and the application of various assumptions including, but not limited to, assumptions concerning future prepayment rates and default rates. Given their relatively high level of price transparency, Agency RMBS pass-throughs are typically classified as Level 2. Non-Agency RMBS, CMBS, Agency interest only and inverse interest only RMBS, CLOs, and corporate bonds are generally classified as either Level 2 or Level 3 based on analysis of available market data and/or third-party valuations. The Company's investments in distressed corporate debt can be in the form of loans as well as total return swaps on loans. These investments, as well as related non-listed equity investments, are generally designated as Level 3 assets. Valuations for total return swaps are typically based on prices of the underlying loans received from third-party pricing services. Private equity investments are generally classified as Level 3. Furthermore, the methodology used by the third-party valuation providers is reviewed at least annually by management, so as to ascertain whether such providers are utilizing observable market data to determine the valuations that they provide.

For residential and commercial mortgage loans and consumer loans, management determines fair value by taking into account both external pricing data, which includes third-party valuations, and internal pricing models. Management has obtained third-party valuations on the majority of these investments and expects to continue to solicit third-party valuations in the future. In determining fair value for non-performing mortgage loans, management evaluates third-party valuations, if applicable, as well as management's estimates of the value of the underlying real estate, using information including general economic data, broker price opinions, or "BPOs," recent sales, property appraisals, and bids. In determining fair value for performing mortgage loans and consumer loans, management evaluates third-party valuations, if applicable, as well as discounted cash flows of the loans based on market assumptions. Cash flow assumptions typically include projected default and prepayment rates and loss severities, and may include adjustments based on appraisals and BPOs. Mortgage and consumer loans are classified as Level 3.

The Company has securitized certain mortgage loans that are not deemed "qualified mortgage," or "QM," loans under the rules of the Consumer Financial Protection Bureau, or "non-QM loans." The Company's securitized non-QM loans are held as part of a collateralized financing entity, or "CFE." A CFE is a VIE that holds financial assets, issues beneficial interests in those assets, and has no more than nominal equity, and for which the issued beneficial interests have contractual recourse only to the related assets of the CFE. ASC 810 allows the Company to elect to measure both the financial assets and financial liabilities of the CFE using the more observable of the fair value of the financial assets and the fair value of the financial liabilities of the CFE. The Company has elected the FVO for initial and subsequent recognition of the debt issued by its consolidated securitization trusts and has determined that each consolidated securitization trust meets the definition of a CFE; see Note 10 "Securitization Transactions—Residential Mortgage Loan Securitizations" for further discussion on the Company's securitization trusts. The Company has determined the inputs to the fair value measurement of the financial liabilities of each of its CFEs to be more observable than those of the financial assets and, as a result, has used the fair value of the financial liabilities of each of the CFEs to measure the fair value of the financial assets of each of the CFEs. The fair value of the debt issued by each CFE is typically valued using both external pricing data, which includes third-party valuations, and internal pricing models. The securitized non-QM loans, which are assets of the CFEs, are included in Loans, at fair value, on the Company's Consolidated Balance Sheet. The debt issued by the CFEs is included in Other secured borrowings, at fair value, on the Company's Consolidated Balance Sheet. Unrealized gains (losses) from changes in fair value of Other secured borrowings,

at fair value, are included in Other, net, on the Company's Consolidated Statement of Operations. The securitized non-QM loans and the debt issued by the Company's CFEs are both classified as Level 3.

For financial derivatives with greater price transparency, such as CDS on asset-backed indices, CDS on corporate indices, certain options on the foregoing, and total return swaps on publicly traded equities or indices, market-standard pricing sources are used to obtain valuations; these financial derivatives are generally classified as Level 2. Interest rate swaps, swaptions, and foreign currency forwards are typically valued based on internal models that use observable market data, including applicable interest rates and foreign currency rates in effect as of the measurement date; the model-generated valuations are then typically compared to counterparty valuations for reasonableness. These financial derivatives are also generally classified as Level 2. Financial derivatives with less price transparency, such as CDS on individual ABS, are generally valued based on internal models, and are classified as Level 3. In the case of CDS on individual ABS, the valuation process typically starts with an estimation of the value of the underlying ABS. In valuing its financial derivatives, the Company also considers the creditworthiness of both the Company and its counterparties, along with collateral provisions contained in each financial derivative agreement.

Investments in private operating entities, such as loan originators, are valued based on available metrics, such as relevant market multiples and comparable company valuations, company specific-financial data including actual and projected results, and independent third party valuation estimates. These investments are classified as Level 3.

The Company's repurchase and reverse repurchase agreements are carried at cost, which approximates fair value. Repurchase and reverse repurchase agreements are classified as Level 2, based on the adequacy of the collateral and their short term nature.

The Company's valuation process, including the application of validation criteria, is directed by the Manager's Valuation Committee (the "Valuation Committee"), and overseen by the Company's audit committee. The Valuation Committee includes senior level executives from various departments within the Manager, and each quarter, the Valuation Committee reviews and approves the valuations of the Company's financial instruments. The valuation process also includes a monthly review by the Company's third-party administrator. The goal of this review is to replicate various aspects of the Company's valuation process based on the Company's documented procedures.

Because of the inherent uncertainty of valuation, the estimated fair value of the Company's financial instruments may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to the Company's consolidated financial statements.

(C) Accounting for Securities: Purchases and sales of investments in securities are generally recorded on trade date, and realized and unrealized gains and losses are calculated based on identified cost. Investments in securities are recorded in accordance with ASC 320 or ASC 325-40, Beneficial Interests in Securitized Financial Assets ("ASC 325-40"). The Company generally classifies its securities as available-for-sale. The Company has chosen to elect the FVO pursuant to ASC 825 for its investments in securities. Electing the FVO allows the Company to record changes in fair value in the Consolidated Statement of Operations, as a component of Unrealized gains (losses) on securities and loans, net, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all investment activities will be recorded in a similar manner.

Many of the Company's investments in securities, such as MBS and CLOs, are issued by entities that are deemed to be VIEs. For the majority of such investments, the Company has determined it is not the primary beneficiary of such VIEs and therefore has not consolidated such VIEs. The Company's maximum risk of loss in these unconsolidated VIEs is generally limited to the fair value of the Company's investment in the VIE.

The Company evaluates its investments in interest only securities to determine whether they meet the requirements for classification as financial derivatives under ASC 815. For interest only securities, where the holder is entitled only to a portion of the interest payments made on the mortgages underlying certain MBS, and inverse interest only securities, which are interest only securities whose coupon has an inverse relationship to its benchmark rate, such as LIBOR, the Company has determined that such investments do not meet the requirements for treatment as financial derivatives and are classified as securities.

Periods after January 1, 2020—For periods subsequent to the Company's application of the principles of ASU 2016-13, Financial Instruments—Credit Losses ("ASU 2016-13"), as discussed below, the Company evaluates the cost basis of its investments in securities on at least a quarterly basis, under ASC 326-30, Financial Instruments—Credit Losses: Available-for-Sale Debt Securities ("ASC 326-30"). When the fair value of a security is less than its amortized cost basis as of the balance sheet date, the security's cost basis is considered impaired. The Company must evaluate the decline in the fair value of the impaired security and determine whether such decline resulted from a credit loss or non-credit related factors. In its assessment of whether a credit loss exists, the Company compares the present value of estimated future cash flows of the impaired security

with the amortized cost basis of such security. The estimated future cash flows reflect those that a "market participant" would use and typically include assumptions related to fluctuations in interest rates, prepayment speeds, default rates, collateral performance, and the timing and amount of projected credit losses, as well incorporating observations of current market developments and events. Cash flows are discounted at an interest rate equal to the current yield used to accrete interest income. If the present value of estimated future cash flows is less than the amortized cost basis of the security, an expected credit loss exists and is included in Unrealized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations. If it is determined as of the financial reporting date that all or a portion of a security's cost basis is not collectible, then the Company will recognize a realized loss to the extent of the adjustment to the security's cost basis. This adjustment to the amortized cost basis of the security is reflected in Net realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

Periods prior to January 1, 2020—For periods prior to the Company's adoption of ASU 2016-13, the Company evaluated the cost basis of its investments in securities for other-than-temporary impairment, or "OTTI," on at least a quarterly basis.

When the fair value of a security was less than its amortized cost basis as of the balance sheet date, the security's cost basis was considered impaired, and the impairment was designated as either temporary or other-than-temporary. When a security's cost basis was impaired, an OTTI was considered to have occurred if (i) the Company intended to sell the security, (ii) it was more likely than not that the Company would have been required to sell the security before recovery of its amortized cost basis, or (iii) the Company did not expect to recover the security's amortized cost basis, even if the Company did not intend to sell the security and it was not more likely than not that the Company would have been required to sell the security. Additionally, for securities accounted for under ASC 325-40, an impairment of the cost basis was recorded when there was an adverse change in the expected cash flows to be received and the fair value of the security was less than its carrying amount. Any resulting OTTI adjustments made to the cost basis of the security were reflected in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

(D) Accounting for Loans: The Company's loan portfolio primarily consists of residential mortgage, commercial mortgage, and consumer loans. The Company's loans are accounted for under ASC 310-10, Receivables, and are classified as held-for-investment when the Company has the intent and ability to hold such loans for the foreseeable future or to maturity/payoff. When the Company has the intent to sell loans, such loans will be classified as held-for-sale. Mortgage loans held-for-sale are accounted for under ASC 948-310, Financial services—mortgage banking. The Company may aggregate its loans into pools based on common risk characteristics at purchase. The Company has chosen to elect the FVO pursuant to ASC 825 for its loan portfolios. Loans are recorded at fair value on the Consolidated Balance Sheet and changes in fair value are recorded in earnings on the Consolidated Statement of Operations as a component of Unrealized gains (losses) on securities and loans, net. The Company generates income from fees on certain loans, generally commercial mortgage loans, that it originates and holds for investment, including origination and exit fees. Such fee income is recorded when earned and included in Other, net on the Consolidated Statement of Operations. Transfers between held-for-investment and held-for-sale occur once the Company's intent to sell the loans changes.

For residential and commercial mortgage loans, the Company generally accrues interest payments. Such loans are typically moved to non-accrual status if the loan becomes 90 days or more delinquent. The Company does not accrue interest payments on its consumer loans; interest payments are recorded upon receipt. Once consumer loans are more than 120 days past due, the Company will generally charge off such loans. The Company evaluates its charged-off loans and determines collectibility, if any, on such loans.

The Company evaluates the collectibility of both interest and principal on each of its loan investments and whether the cost basis of the loan is impaired. A loan's cost basis is impaired when, based on current information and market developments, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. When a loan's cost basis is impaired, the Company does not record an allowance for loan loss as it elected the FVO on all of its loan investments.

Periods after January 1, 2020—For periods subsequent to the Company's application of the principles of ASU 2016-13, in its assessment of whether a credit loss exists, the Company compares the present value of the amount expected to be collected on the impaired loan with the amortized cost basis of such loan. If the present value of the amount expected to be collected on the impaired loan is less than the amortized cost basis of such loan, an expected credit loss exists and is included in Unrealized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations. If it is determined as of the financial reporting date that all or a portion of a loan's cost basis is not collectible, then the Company will recognize a realized loss to the extent of the adjustment to the loan's cost basis. This adjustment to the amortized cost basis of the loan is reflected in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

Periods prior to January 1, 2020—For periods prior to the Company's application of the principles of ASU 2016-13, the Company recognized impairments through an adjustment to the amortized cost basis; the Company recognized a realized loss in the period such adjustment was made, which is included in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

(E) Interest Income: The Company amortizes premiums and accretes discounts on its debt securities. Coupon interest income on fixed-income investments is generally accrued based on the outstanding principal balance or notional value and the current coupon rate.

For debt securities that are deemed to be of high credit quality at the time of purchase (generally Agency RMBS, exclusive of interest only securities), premiums and discounts are amortized/accreted into interest income over the life of such securities using the effective interest method. For such securities whose cash flows vary depending on prepayments, an effective yield retroactive to the time of purchase is periodically recomputed based on actual prepayments and changes in projected prepayment activity, and a catch-up adjustment, or "Catch-up Premium Amortization Adjustment," is made to amortization to reflect the cumulative impact of the change in effective yield.

For debt securities (generally non-Agency RMBS, CMBS, ABS, CLOs, and interest only securities) that are deemed not to be of high credit quality at the time of purchase, interest income is recognized based on the effective interest method. For purposes of estimating future expected cash flows, management uses assumptions including, but not limited to, assumptions for future prepayment rates, default rates, and loss severities (each of which may in turn incorporate various macro-economic assumptions, such as future housing prices, GDP growth rates, and unemployment rates). These assumptions are re-evaluated not less than quarterly. Changes in projected cash flows may result in prospective changes in the yield/interest income recognized on such securities based on the updated expected future cash flows.

For each loan purchased with the expectation that both interest and principal will be paid in full, the Company generally amortizes or accretes any premium or discount over the life of the loan utilizing the effective interest method. However, based on current information and market developments, the Company re-assesses the collectibility of interest and principal, and generally designates a loan as in non-accrual status either when any payments have become 90 or more days past due, or when, in the opinion of management, it is probable that the Company will be unable to collect either interest or principal in full. Once a loan is designated as in non-accrual status, as long as principal is still expected to be collectible in full, interest payments are recorded as interest income only when received (i.e., under the cash basis method); accruals of interest income are only resumed when the loan becomes contractually current and performance is demonstrated to be resumed. However, if principal is not expected to be collectible in full, the cost recovery method is used (i.e., no interest income is recognized, and all payments received—whether contractually interest or principal—are applied to cost).

Periods after January 1, 2020—Certain of the Company's debt securities and loans, at the date of acquisition, have experienced or are expected to experience more-than-insignificant deterioration in credit quality since origination. For periods subsequent to the Company's application of the principles of ASU 2016-13, if at the date of acquisition for a particular asset the Company projects a significant difference between contractual cash flows and expected cash flows, it establishes an initial estimate for credit losses as an upward adjustment to the acquisition cost of the asset for the purpose of calculating interest income using the effective yield method.

Periods prior to January 1, 2020—Prior to the Company's application of the principles of ASU 2016-13, for each loan acquired that had evidence of credit deterioration since origination and the expectation that either principal or interest would not be paid in full, interest income was generally recognized using the effective interest method for so long as the cash flows could be reasonably estimated. Here, instead of amortizing the purchase discount (i.e., the excess of the unpaid principal balance over the purchase price) over the life of the loan, the Company effectively amortized the accretable yield (i.e., the excess of the Company's estimate of the total cash flows to be collected over the life of the loan over the purchase price). Not less than quarterly, the Company updated its estimate of the cash flows expected to be collected over the life of the loan, and applied revised yields prospectively.

In estimating future cash flows on the Company's debt securities, there are a number of assumptions that are subject to significant uncertainties and contingencies, including, in the case of MBS, assumptions relating to prepayment rates, default rates, loan loss severities, and loan repurchases. These estimates require the use of a significant amount of judgment.

(F) Investments in unconsolidated entities: The Company has made and may in the future make non-controlling equity investments in various entities, such as loan originators. Such investments are generally in the form of preferred and/or common equity, or membership interests. In certain cases, the Company can exercise significant influence over the entity (e.g. by having representation on the entity's board of directors) but the requirements for consolidation under ASC 810 are not met; in such cases the Company is required to account for such equity investments under ASC 323-10. The Company has chosen to elect the FVO pursuant to ASC 825 for its investments in unconsolidated entities, which, in management's view, more appropriately

reflects the results of operations for a particular reporting period, as all investment activities will be recorded in a similar manner. The period change in fair value of the Company's investments in unconsolidated entities is recorded on the Consolidated Statement of Operations in Earnings (losses) from investments in unconsolidated entities.

(G) REO: When the Company obtains possession of real property in connection with a foreclosure or similar action, the Company de-recognizes the associated mortgage loan according to ASU 2014-04, Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure ("ASU 2014-04"). Under the provisions of ASU 2014-04, the Company is deemed to have received physical possession of real estate property collateralizing a mortgage loan when it obtains legal title to the property upon completion of a foreclosure or when the borrower conveys all interest in the property to it through a deed in lieu of foreclosure or similar legal agreement. The Company's initial cost basis in REO is equal to the fair value of the real estate associated with the foreclosed mortgage loan, less expected costs to sell. REO valuations are reflected at the lower of cost or fair value. The fair value of such REO is typically based on management's estimates which generally use information including general economic data, BPOs, recent sales, property appraisals, and bids, and takes into account the expected costs to sell the property. REO recorded at fair value on a non-recurring basis are classified as Level 3.

(H) Securities Sold Short: The Company may purchase or engage in short sales of U.S. Treasury securities and sovereign debt to mitigate the potential impact of changes in interest rates and/or foreign exchange rates on the performance of its portfolio. When the Company sells securities short, it typically satisfies its security delivery settlement obligation by borrowing or purchasing the security sold short from the same or a different counterparty. When borrowing a security sold short from a counterparty, the Company generally is required to deliver cash or securities to such counterparty as collateral for the Company's obligation to return the borrowed security. The Company has chosen to elect the FVO pursuant to ASC 825 for its securities sold short. Electing the FVO allows the Company to record changes in fair value in the Consolidated Statement of Operations, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all securities activities will be recorded in a similar manner. As such, securities sold short are recorded at fair value on the Consolidated Balance Sheet and the period change in fair value is recorded in current period earnings on the Consolidated Statement of Operations as a component of Unrealized gains (losses) on securities and loans, net. A realized gain or loss will be recognized upon the termination of a short sale if the market price is less or greater than the original sale price. Such realized gain or loss is recorded on the Company's Consolidated Statement of Operations in Realized gains (losses) on securities and loans, net.

(I) Financial Derivatives: The Company enters into various types of financial derivatives subject to its investment guidelines, which include restrictions associated with maintaining qualification as a REIT. The Company's financial derivatives are predominantly subject to bilateral collateral arrangements or clearing in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the "Dodd-Frank Act." The Company may be required to deliver or receive cash or securities as collateral upon entering into derivative transactions. In addition, changes in the value of derivative transactions may require the Company or the counterparty to post or receive additional collateral. In the case of cleared derivatives, the clearinghouse becomes the Company's counterparty and a futures commission merchant acts as an intermediary between the Company and the clearinghouse with respect to all facets of the related transaction, including the posting and receipt of required collateral. Cash collateral received by the Company is included in Due to brokers, on the Consolidated Balance Sheet. Conversely, cash collateral posted by the Company is included in Due from brokers, on the Consolidated Balance Sheet. The types of derivatives primarily utilized by the Company are swaps, TBAs, futures, options, and forwards.

Swaps: The Company may enter into various types of swaps, including interest rate swaps, credit default swaps, and total return swaps. The primary risk associated with the Company's interest rate swap activity is interest rate risk. The primary risk associated with the Company's credit default swaps and total return swaps is credit risk.

The Company is subject to interest rate risk exposure in the normal course of pursuing its investment objectives. Primarily to help mitigate interest rate risk, the Company enters into interest rate swaps. Interest rate swaps are contractual agreements whereby one party pays a floating interest rate on a notional principal amount and receives a fixed-rate payment on the same notional principal, or vice versa, for a fixed period of time. Interest rate swaps change in value with movements in interest rates. The Company also enters into interest rate swaps whereby the Company pays one floating rate and receives a different floating rate, or "basis swaps."

The Company enters into credit default swaps. A credit default swap is a contract under which one party agrees to compensate another party for the financial loss associated with the occurrence of a "credit event" in relation to a "reference amount" or notional value of a "reference asset" (usually a bond, loan, or an index or basket of bonds or loans). The definition of a credit event may vary from contract to contract. A credit event may occur (i) when the reference asset (or underlying asset, in the case of a reference asset that is an index or basket) fails to make scheduled principal or interest payments to its holders, (ii) with respect to credit default swaps referencing mortgage/asset-backed securities and indices, when the reference asset (or underlying asset, in the case of a reference asset that is an index or basket) is downgraded below a certain rating level, or

(iii) with respect to credit default swaps referencing corporate entities and indices, upon the bankruptcy of the obligor of the reference asset (or underlying obligor, in the case of a reference asset that is an index). The Company typically writes (sells) protection to take a "long" position with respect to the underlying reference assets, or purchases (buys) protection to take a "short" position with respect to the underlying reference assets or to hedge exposure to other investment holdings.

The Company enters into total return swaps in order to take a "long" or "short" position with respect to an underlying reference asset. The Company is subject to market price volatility of the underlying reference asset. A total return swap involves commitments to pay interest in exchange for a market-linked return based on a notional value. To the extent that the total return of the corporate debt, security, group of securities or index underlying the transaction exceeds or falls short of the offsetting interest obligation, the Company will receive a payment from or make a payment to the counterparty.

Swaps change in value with movements in interest rates, credit quality, or total return of the reference securities. During the term of swap contracts, changes in value are recognized as unrealized gains or losses on the Consolidated Statement of Operations. When a contract is terminated, the Company realizes a gain or loss equal to the difference between the proceeds from (or cost of) the closing transaction and the Company's basis in the contract, if any. Periodic payments or receipts required by swap agreements are recorded as unrealized gains or losses when accrued and realized gains or losses when received or paid. Upfront payments paid and/or received by the Company to open swap contracts are recorded as an asset and/or liability on the Consolidated Balance Sheet and are recorded as a realized gain or loss on the termination date.

TBA Securities: The Company transacts in the forward settling TBA market. A TBA position is a forward contract for the purchase ("long position") or sale ("short position") of Agency RMBS at a predetermined price, face amount, issuer, coupon, and maturity on an agreed-upon future delivery date. For each TBA contract and delivery month, a uniform settlement date for all market participants is determined by the Securities Industry and Financial Markets Association. The specific Agency RMBS to be delivered into the contract at the settlement date are not known at the time of the transaction. The Company typically does not take delivery of TBAs, but rather enters into offsetting transactions and settles the associated receivable and payable balances with its counterparties. The Company uses TBAs to mitigate interest rate risk, usually by taking short positions. The Company also invests in TBAs as a means of acquiring additional exposure to Agency RMBS, or for speculative purposes, including holding long positions.

TBAs are accounted for by the Company as financial derivatives. The difference between the forward contract price and the market value of the TBA position as of the reporting date is included in Unrealized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations.

Futures Contracts: A futures contract is an exchange-traded agreement to buy or sell an asset for a set price on a future date. The Company enters into Eurodollar and/or U.S. Treasury security futures contracts to hedge its interest rate risk. The Company may also enter into various other futures contracts, including equity index futures and foreign currency futures. Initial margin deposits are made upon entering into futures contracts and can generally be either in the form of cash or securities. During the period the futures contract is open, changes in the value of the contract are recognized as unrealized gains or losses by marking-to-market to reflect the current market value of the contract. Variation margin payments are made or received periodically, depending upon whether unrealized losses or gains are incurred. When the contract is closed, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Options: The Company may purchase or write put or call options contracts or enter into swaptions. The Company enters into options contracts typically to help mitigate overall market, credit, or interest rate risk depending on the type of options contract. However, the Company also enters into options contracts from time to time for speculative purposes. When the Company purchases an options contract, the option asset is initially recorded at an amount equal to the premium paid, if any, and is subsequently marked-to-market. Premiums paid for purchasing options contracts that expire unexercised are recognized on the expiration date as realized losses. If an options contract is exercised, the premium paid is subtracted from the proceeds of the sale or added to the cost of the purchase to determine whether the Company has realized a gain or loss on the related transaction. When the Company writes an options contract, the option liability is initially recorded at an amount equal to the premium received, if any, and is subsequently marked-to-market. Premiums received for writing options contracts that expire unexercised are recognized on the expiration date as realized gains. If an options contract is exercised, the premium received is subtracted from the cost of the purchase or added to the proceeds of the sale to determine whether the Company has realized a gain or loss on the related investment transaction. When the Company enters into a closing transaction, the Company will realize a gain or loss depending upon whether the amount from the closing transaction is greater or less than the premiums paid or received. The Company may also enter into options contracts that contain forward-settling premiums. In this case, no money is exchanged upfront. Instead, the agreed-upon premium is paid by the buyer upon expiration of the option, regardless of whether or not the option is exercised.

Forward Currency Contracts: A forward currency contract is an agreement between two parties to purchase or sell a specific quantity of currency with the delivery and settlement at a specific future date and exchange rate. During the period the forward currency contract is open, changes in the value of the contract are recognized as unrealized gains or losses. When the contract is settled, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Financial derivative assets are included in Financial derivatives—assets, at fair value, on the Consolidated Balance Sheet. Financial derivative liabilities are included in Financial derivatives—liabilities, at fair value, on the Consolidated Balance Sheet. The Company has chosen to elect the FVO pursuant to ASC 825 for its financial derivatives. Electing the FVO allows the Company to record changes in fair value in the Consolidated Statement of Operations, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all securities activities will be recorded in a similar manner. Changes in unrealized gains and losses on financial derivatives are included in Unrealized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations. Realized gains and losses on financial derivatives are included in Realized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations.

(J) Cash and Cash Equivalents: Cash and cash equivalents include cash and short term investments with original maturities of three months or less at the date of acquisition. Cash and cash equivalents typically include amounts held in interest bearing overnight accounts and amounts held in money market funds, and these balances generally exceed insured limits. The Company holds its cash at institutions that it believes to be highly creditworthy. Restricted cash represents cash that the Company can use only for specific purposes. See Note 18 for further discussion of restricted cash balances.

(K) Repurchase Agreements: The Company enters into repurchase agreements with third-party broker-dealers whereby it sells securities under agreements to be repurchased at an agreed-upon price and date. The Company accounts for repurchase agreements as collateralized borrowings, with the initial sale price representing the amount borrowed, and with the future repurchase price consisting of the amount borrowed plus interest, at the implied interest rate of the repurchase agreement, on the amount borrowed over the term of the repurchase agreement. The interest rate on a repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. When the Company enters into a repurchase agreement, the lender establishes and maintains an account containing cash and/or securities having a value not less than the repurchase price, including accrued interest, of the repurchase agreement. Repurchase agreements are carried at their contractual amounts, which approximate fair value as the debt is short-term in nature.

(L) Reverse Repurchase Agreements: The Company enters into reverse repurchase agreement transactions whereby it purchases securities under agreements to resell at an agreed-upon price and date. In general, securities received pursuant to reverse repurchase agreements are delivered to counterparties of short sale transactions. The interest rate on a reverse repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. Assets held pursuant to reverse repurchase agreements are reflected as assets on the Consolidated Balance Sheet. Reverse repurchase agreements are carried at their contractual amounts, which approximates fair value due to their short-term nature.

Repurchase and reverse repurchase agreements that are conducted with the same counterparty may be reported on a net basis if they meet the requirements of ASC 210-20, Balance Sheet Offsetting. There are no repurchase and reverse repurchase agreements reported on a net basis in the Company's consolidated financial statements.

(M) Transfers of Financial Assets: The Company enters into transactions whereby it transfers financial assets to third parties. Upon such a transfer of financial assets, the Company will sometimes retain or acquire interests in the related assets. The Company evaluates transferred assets pursuant to ASC 860-10, Transfers of Financial Assets, or "ASC 860-10," which requires that a determination be made as to whether a transferor has surrendered control over transferred financial assets. That determination must consider the transferor's continuing involvement in the transferred financial asset, including all arrangements or agreements made contemporaneously with, or in contemplation of, the transfer, even if they were not entered into at the time of the transfer. When a transfer of financial assets does not qualify as a sale, ASC 860-10 requires the transfer to be accounted for as a secured borrowing with a pledge of collateral. ASC 860-10 is a standard that requires the Company to exercise significant judgment in determining whether a transaction should be recorded as a "sale" or a "financing."

(N) Variable Interest Entities: VIEs are entities in which: (i) the equity investors do not have the characteristics of a controlling financial interest, or (ii) there is insufficient equity to permit the entity to finance its activities without additional subordinated financial support from other parties. Consolidation of a VIE is required by the entity that is deemed to be the primary beneficiary of the VIE. The Company evaluates all of its interests in VIEs for consolidation under ASC 810. The primary beneficiary is generally the party with both (i) the power to direct the activities of the VIE that most significantly

impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant to the VIE.

When the Company has an interest in an entity that has been determined to be a VIE, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The Company will only consolidate a VIE for which it has concluded it is the primary beneficiary. To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE's economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes (i) identifying the activities that most significantly impact the VIE's economic performance; and (ii) identifying which party, if any, has power over those activities. To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, it considers all of its economic interests, including debt and/or equity investments, as well as other arrangements deemed to be variable interests in the VIE. These assessments to determine whether the Company is the primary beneficiary require significant judgment. In instances where the Company and its related parties have interests in a VIE, the Company considers whether there is a single party in the related party group that meets the criteria to be deemed the primary beneficiary. If one party within the related party group meets such criteria, that reporting entity would be deemed to be the primary beneficiary of the VIE and no further analysis is needed. If no party within the related party group on its own meets the criteria to be deemed the primary beneficiary, but the related party group as a whole meets such criteria, the determination of the primary beneficiary within the related party group requires significant judgment. The Company performs analysis, which is based upon qualitative as well as quantitative factors, such as the relationship of the VIE to each of the members of the related party group, as well as the significance of the VIE's activities to those members, with the objective of determining which party is most closely associated with the VIE.

The Company performs ongoing reassessments of (i) whether any entities previously evaluated have become VIEs, based on certain events, and therefore subject to assessment to determine whether consolidation is appropriate, and (ii) whether changes in the facts and circumstances regarding the Company's involvement with a VIE causes its consolidation conclusion regarding the VIE to change. See Note 9 and Note 13 for further information on the Company's consolidated VIEs.

The Company's maximum amount at risk is generally limited to the Company's investment in the VIE. The Company is generally not contractually required to provide and has not provided any form of financial support to the VIEs.

The Company holds beneficial interests in certain securitization trusts that are considered VIEs. The beneficial interests in these securitization trusts are represented by certificates issued by the trusts. The securitization trusts have been structured as pass-through entities that receive principal and interest payments on the underlying collateral and distribute those payments to the certificate holders, which include both third-party investors and the Company. The certificates held by the Company typically include some or all of the most subordinated tranches. The assets held by the trusts are restricted in that they can only be used to fulfill the obligations of the related trust. In certain cases, the design and structure of the securitization trust is such that the Company effectively retains control of the assets as well as the activities that most significantly impact the economic performance of the trust. In such cases, the Company is determined to be the primary beneficiary, and the Company consolidates the trust and all intercompany transactions are eliminated in consolidation. In cases where the Company does not effectively retain control of the assets of, or have the power to direct the activities that most significantly impact the economic performance of, the related trust, it does not consolidate the trust. See Note 10 for further discussion of the Company's securitization trusts.

(O) Offering Costs/Underwriters' Discount: Offering costs and underwriters' discount are generally charged against stockholders' equity upon the completion of a capital raise. Offering costs typically include legal, accounting, and other fees associated with the cost of raising capital.

(P) Debt Issuance Costs: Debt issuance costs associated with debt for which the Company has elected the FVO are expensed at the issuance of the debt, and are included in Investment related expenses—Other on the Consolidated Statement of Operations. Costs associated with the issuance of debt for which the Company has not elected the FVO are deferred and amortized over the life of the debt, which approximates the effective interest rate method, and are included in Interest expense on the Consolidated Statement of Operations. Deferred debt issuance costs are presented on the Consolidated Balance Sheet as a direct deduction from the related debt liability, unless such deferred debt issuance costs are associated with borrowing facilities that are expected to have a future benefit, such as giving the Company the ability to access additional borrowings over the contractual term of the debt, in which case such deferred debt issuance costs are included in Other assets on the Consolidated Balance Sheet. Debt issuance costs include legal and accounting fees, purchasers' or underwriters' discount, as well as other fees associated with the cost of the issuance of the related debt.

(Q) Expenses: Expenses are recognized as incurred on the Consolidated Statement of Operations.

(R) Investment Related Expenses: Investment related expenses consist of expenses directly related to specific financial instruments. Such expenses generally include dividend expense on common stock sold short, servicing fees and corporate and escrow advances on mortgage and consumer loans, and various other expenses and fees related directly to the Company's financial instruments. The Company has elected the FVO for its investments, and as a result all investment related expenses are expensed as incurred and included in Investment related expenses on the Consolidated Statement of Operations.

(S) Investment Related Receivables: Investment related receivables on the Company's Consolidated Balance Sheet includes receivables for securities sold and interest and principal receivable on securities and loans.

(T) Long Term Incentive Plan Units: Long term incentive plan units of the Operating Partnership ("OP LTIP Units") have been issued to certain Ellington personnel dedicated or partially dedicated to the Company, certain of the Company's directors, as well as the Manager. Costs associated with OP LTIP Units issued to dedicated or partially dedicated personnel, or to the Company's directors, are measured as of the grant date based on the Company's closing stock price on the New York Stock Exchange and are amortized over the vesting period in accordance with ASC 718-10, Compensation—Stock Compensation. The vesting periods for OP LTIP Units are typically one year from issuance for non-executive directors, and are typically one year to two years from issuance for dedicated or partially dedicated personnel.

(U) Non-controlling interests: Non-controlling interests include interests in the Operating Partnership represented by units convertible into shares of the Company's common stock ("Convertible Non-controlling Interests"). Convertible Non-controlling Interests include both the OP LTIP Units and those common units ("OP Units") of the Operating Partnership not held by the Company (collectively, the "Convertible Non-controlling Interest Units"). Non-controlling interests also include the interests of joint venture partners in certain of our consolidated subsidiaries. The joint venture partners' interests are not convertible into shares of the Company's common stock. The Company adjusts the Convertible Non-controlling Interests to align their carrying value with their share of total outstanding Operating Partnership units, including both the OP Units held by the Company and the Convertible Non-controlling Interests. Any such adjustments are reflected in Adjustment to non-controlling interests, on the Consolidated Statement of Changes in Equity. See Note 15 for further discussion of non-controlling interests.

(V) Dividends: Dividends payable on shares of common stock and Convertible Non-controlling Interest Units are recorded on the declaration date.

(W) Shares Repurchased: Shares of common stock that are repurchased by the Company subsequent to issuance are immediately retired upon settlement and decrease the total number of shares of common stock issued and outstanding. The cost of such repurchases is charged against Additional paid-in-capital on the Company's Consolidated Balance Sheet.

(X) Earnings Per Share ("EPS"): Basic EPS is computed using the two class method by dividing net income (loss) after adjusting for the impact of Convertible Non-controlling Interests which are participating securities, by the weighted average number of shares of common stock outstanding calculated including Convertible Non-controlling Interests. Because the Company's Convertible Non-controlling Interests are participating securities, they are included in the calculation of both basic and diluted EPS.

(Y) Foreign Currency: The functional currency of the Company is U.S. dollars. Assets and liabilities denominated in foreign currencies are remeasured into U.S. dollars at current exchange rates at the following dates: (i) assets, liabilities, and unrealized gains/losses—at the valuation date; and (ii) income, expenses, and realized gains/losses—at the accrual/transaction date. The Company isolates the portion of realized and change in unrealized gain (loss) resulting from changes in foreign currency exchange rates on investments and financial derivatives from the fluctuations arising from changes in fair value of investments and financial derivatives held. Changes in realized and change in unrealized gain (loss) due to foreign currency are included in Other, net, on the Consolidated Statement of Operations.

The Company's reporting currency is U.S. Dollars. If the Company has investments in unconsolidated entities that have a functional currency other than U.S. Dollars, the fair value is translated to U.S. dollars using the current exchange rate at the valuation date. The cumulative translation adjustment, if any, associated with the Company's investments in unconsolidated entities is recorded in accumulated other comprehensive income (loss), a component of consolidated stockholders' equity.

(Z) Income Taxes: The Company has elected to be taxed as a REIT under Sections 856 through 860 of the Code. As a REIT, the Company is generally not subject to corporate-level federal and state income tax on net income it distributes to its stockholders within the prescribed timeframes. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including distributing at least 90% of its annual taxable income to stockholders. Even if the Company qualifies as a REIT, it may be subject to certain federal, state, local and foreign taxes on its income and property, and to federal income and excise taxes on its undistributed taxable income. If the Company fails to qualify as a REIT, and does not qualify for

certain statutory relief provisions, it will be subject to U.S. federal, state, and local income taxes and may be precluded from qualifying as a REIT for the four taxable years following the year in which the Company fails to qualify as a REIT.

As a REIT, if the Company fails to distribute in any calendar year (subject to specific timing rules for certain dividends paid in January) at least the sum of (i) 85% of its ordinary income for such year, (ii) 95% of its capital gain net income for such year, and (iii) any undistributed taxable income from the prior year, the Company would be subject to a non-deductible 4% excise tax on the excess of such required distribution over the sum of (i) the amounts actually distributed and (ii) the amounts of income retained and on which the Company has paid corporate income tax.

The Company elected to treat certain domestic and foreign subsidiaries as TRSs, and may in the future elect to treat other current or future subsidiaries as TRSs. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. A domestic TRS may, but is not required to, declare dividends to the Company; such dividends will be included in the Company's taxable income/(loss) and may necessitate a distribution to the Company's stockholders. Conversely, if the Company retains earnings at the level of a domestic TRS, such earnings will increase the book equity of the consolidated entity. A domestic TRS is subject to U.S. federal, state, and local corporate income taxes. The Company has elected and may elect in the future to treat certain of its foreign corporate subsidiaries as TRSs and, accordingly, taxable income generated by these TRSs may not be subject to U.S. federal, state, and local corporate income taxation, but generally will be included in the Company's income on a current basis as Subpart F income, whether or not distributed. However, certain of the Company's foreign subsidiaries may be subject to income taxes in the relevant foreign jurisdictions. The Company's financial results are generally not expected to reflect provisions for current or deferred income taxes, except for any activities conducted through one or more TRSs that are subject to corporate income taxation.

The Company follows the authoritative guidance on accounting for and disclosure of uncertainty on tax positions, which requires management to determine whether a tax position of the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For uncertain tax positions, the tax benefit to be recognized is measured as the largest amount of benefit that is more than 50% likely to be realized upon ultimate settlement. The Company did not have any unrecognized tax benefits resulting from tax positions related to the current period or its open tax years. In the normal course of business, the Company may be subject to examination by federal, state, local, and foreign jurisdictions, where applicable, for the current period and its open tax years. The Company may take positions with respect to certain tax issues which depend on legal interpretation of facts or applicable tax regulations. Should the relevant tax regulators successfully challenge any of such positions, the Company might be found to have a tax liability that has not been recorded in the accompanying consolidated financial statements. Also, management's conclusions regarding the authoritative guidance may be subject to review and adjustment at a later date based on changing tax laws, regulations, and interpretations thereof.

(AA) Recent Accounting Pronouncements: In August 2018, the Financial Accounting Standards Board, or "FASB," issued ASU 2018-13, Fair Value Measurement—Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement ("ASU 2018-13"). This amends ASC 820 to remove or modify various current disclosure requirements related to fair value measurement. Additionally, ASU 2018-13 requires certain additional disclosures around fair value measurement. ASU 2018-13 is effective for annual periods beginning after December 15, 2019 and interim periods within those years, with early adoption permitted. Entities are permitted to early adopt any removed or modified disclosures and delay adoption of the additional disclosures until their effective date. The adoption of ASU 2018-13 did not have a material impact on the Company's consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, which introduced a new model related to the accounting for credit losses on financial assets subject to credit losses and measured at amortized cost and certain off-balance sheet credit exposures. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2016-13 amends the guidance which required an OTTI charge only when fair value is below the amortized cost of an asset. The length of time the fair value of an available-for-sale debt security has been below the amortized cost will no longer impact the determination of whether a credit loss exists; as a result, there is no longer an other-than-temporary impairment model. In addition, credit losses on available-for-sale debt securities will now be limited to the difference between the security's amortized cost basis and its fair value. This new debt security model will also require the use of an allowance to record estimated credit losses. While generally not applicable for financial assets for which the fair value option has been elected, the Company has applied the principles of ASU 2016-13 as described above. The adoption of ASU 2016-13 did not have a material impact on the Company's consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform—Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"), which provides optional guidance for a limited period meant to ease the potential burden in accounting for, or recognizing the effects of, reform to LIBOR and certain other reference rates. The

standard is effective for all entities beginning on March 12, 2020 and may be elected over time. However, ASU 2020-04 is only applicable to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform, and that were entered into or evaluated prior to January 1, 2023. The Company is currently evaluating the impact that the adoption of ASU 2020-04 would have on its consolidated financial statements.

2. Significant Accounting Policies

(A) Basis of Presentation: The Company's consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, or "U.S. GAAP," for investment companies, ASC 946, Financial Services—Investment Companies ("ASC 946"). The Company has determined that it meets the definition of an investment company under ASC 946. ASC 946 requires, among other things, that investments be reported at fair value in the financial statements. Additionally under ASC 946 the Company generally will not consolidate its interest in any company other than in its subsidiaries that qualify as investment companies under ASC 946. The consolidated financial statements include the accounts of the Company, the Operating Partnership, and its subsidiaries. They also include certain securitization trusts which are designed to facilitate specific financing activities of the Company and represent a direct extension of the Company's business activities. All intercompany balances and transactions have been eliminated. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and those differences could be material.

(B) Valuation: The Company applies ASC 820-10, Fair Value Measurement ("ASC 820-10"), to its holdings of financial instruments. ASC 820-10 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:

•Level 1—inputs to the valuation methodology are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Currently, the types of financial instruments the Company generally includes in this category are listed equities, exchange-traded derivatives, and cash equivalents;

•Level 2—inputs to the valuation methodology other than quoted prices included in Level 1 are observable for the asset or liability, either directly or indirectly. Currently, the types of financial instruments that the Company generally includes in this category are Agency RMBS, U.S. Treasury securities and sovereign debt, certain non-Agency RMBS and CMBS, CLOs, and corporate debt, and actively traded derivatives, such as interest rate swaps and foreign currency forwards, and certain other over-the-counter derivatives; and

•Level 3—inputs to the valuation methodology are unobservable and significant to the fair value measurement. The types of financial instruments that the Company generally includes in this category are certain RMBS, CMBS, and CLOs, ABS, credit default swaps, or "CDS," on individual ABS, distressed corporate debt, and total return swaps on distressed corporate debt, in each case where there is less price transparency. Also included in this category are residential and commercial mortgage loans, consumer loans, non-listed equities, private corporate debt and equity investments, secured notes, and Other secured borrowings, at fair value.

For certain financial instruments, the various inputs that management uses to measure fair value for such financial instrument may fall into different levels of the fair value hierarchy. In such cases, the determination of which category within the fair value hierarchy is appropriate for such financial instrument is based on the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the various inputs that management uses to measure fair value with the highest priority to inputs that are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets (Level 1) and the lowest priority to inputs that are unobservable and significant to the fair value measurement (Level 3). The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. The Company may use valuation techniques consistent with the market and income approaches to measure the fair value of its assets and liabilities. The market approach uses third-party valuations and information obtained from market transactions involving identical or similar assets or liabilities. The income approach uses projections of the future economic benefit of an instrument to determine its fair value, such as in the discounted cash flow methodology. The inputs or methodology used for valuing financial instruments are not necessarily an indication of the risk associated with investing in these financial instruments. The leveling of each financial instrument is reassessed at the end of each period.

Summary Valuation Techniques

For financial instruments that are traded in an "active market," the best measure of fair value is the quoted market price. However, many of the Company's financial instruments are not traded in an active market. Therefore, management generally uses third-party valuations when available. If third-party valuations are not available, management uses other valuation techniques, such as the discounted cash flow methodology. The following are summary descriptions, for various categories of financial instruments, of the valuation methodologies management uses in determining fair value of the Company's financial instruments in such categories. Management utilizes such methodologies to assign a good faith fair value (the estimated price that, in an orderly transaction at the valuation date, would be received to sell an asset, or paid to transfer a liability, as the case may be) to each such financial instrument.

For mortgage-backed securities, or "MBS," including To Be Announced MBS, or "TBAs," CLOs, and distressed and non-distressed corporate debt and equity, management seeks to obtain at least one third-party valuation, and often obtains multiple valuations when available. Management has been able to obtain third-party valuations on the vast majority of these instruments and expects to continue to solicit third-party valuations in the future. Management generally values each financial instrument at the average of third-party valuations received and not rejected as described below. Third-party valuations are not binding, and while management generally does not adjust the valuations it receives, management may challenge or reject a valuation when, based on its validation criteria, management determines that such valuation is unreasonable or erroneous. Furthermore, based on its validation criteria, management may determine that the average of the third-party valuations received for a given instrument does not result in what management believes to be the fair value of such instrument, and in such circumstances management may override this average with its own good faith valuation. The validation criteria may take into account output from management's own models, recent trading activity in the same or similar instruments, and valuations received from third parties. The use of proprietary models requires the use of a significant amount of judgment and the application of various assumptions including, but not limited to, assumptions concerning future prepayment rates and default rates. Valuations for fixed-rate RMBS pass-throughs issued by a U.S. government agency or government-sponsored enterprise are typically based on observable pay-up data (pay-ups are price premiums for specified categories of fixed-rate pools relative to their TBA counterparts) or models that use observable market data, such as interest rates and historical prepayment speeds, and are validated against third-party valuations. Given their relatively high level of price transparency, Agency RMBS pass-throughs are typically designated as Level 2 assets. Non-Agency MBS, Agency interest only and inverse interest only RMBS, and CLOs are generally classified as either Level 2 or Level 3 based on analysis of available market data and/or third-party valuations. The Company's investments in distressed corporate debt can be in the form of loans as well as total return swaps on loans. These investments, as well as related non-listed equity investments, are generally designated as Level 3 assets. Valuations for total return swaps are typically based on prices of the underlying loans received from widely used third-party pricing services. Investments in non-distressed corporate bonds are generally also valued based on prices received from third-party pricing services, and many of these bonds, because they are very liquid with readily observable data, are generally classified as Level 2 holdings. Furthermore, the methodology used by the third-party valuation providers is reviewed at least annually by management, so as to ascertain whether such providers are utilizing observable market data to determine the valuations that they provide.

For residential and commercial mortgage loans, consumer loans, and real estate owned properties, or "REO," management determines fair value by taking into account both external pricing data, when available, and internal pricing models. Non-performing mortgage loans and REO are typically valued based on management's estimates of the value of the underlying real estate, using information including general economic data, broker price opinions, or "BPOs," recent sales, property appraisals, and bids. Performing mortgage loans and consumer loans are typically valued using discounted cash flows based on market assumptions. Cash flow assumptions typically include projected default and prepayment rates and loss severities, and may

include adjustments based on appraisals and BPOs. Mortgage and consumer loans and REO properties are classified as Level 3 assets.

Securitized mortgage loans that are not deemed "qualified mortgage," or "QM," loans under the rules of the Consumer Financial Protection Bureau, or "non-QM loans," are held as part of a collateralized financing entity, or "CFE." A CFE is a variable interest entity, or "VIE," that holds financial assets, issues beneficial interests in those assets, and has no more than nominal equity, and for which the issued beneficial interests have contractual recourse only to the related assets of the CFE. ASC 810, Consolidation ("ASC 810"), allows the Company to elect to measure both the financial assets and financial liabilities of the CFE using the more observable of the fair value of the financial assets and the fair value of the financial liabilities of the CFE. The Company has elected the fair value option for initial and subsequent recognition of the debt issued by its consolidated securitization trust and has determined such trust meets the definition of a CFE; see Note 6 for further discussion on the Company's securitization trusts. The Company has determined the inputs to the fair value measurement of the financial liabilities of its CFE to be more observable than those of the financial assets and, as a result, has used the fair value of the financial liabilities of the CFE to measure the fair value of the financial assets of the CFE. The fair value of the debt issued by the CFE is typically valued using discounted cash flows and other market data. The securitized non-QM loans, which are assets of the CFE, are included in Investments, at fair value on the Company's Consolidated Statement of Assets, Liabilities, and Equity. The debt issued by the CFE is included in Other secured borrowings, at fair value, on the Company's Consolidated Statement of Assets, Liabilities, and Equity. The securitized non-QM loans and the debt issued by the Company's CFE are both designated as Level 3 financial instruments.

For financial derivatives with greater price transparency, such as CDS on asset-backed indices, CDS on corporate indices, certain options on the foregoing, and total return swaps on publicly traded equities, market-standard pricing sources are used to obtain valuations; these financial derivatives are generally designated as Level 2 instruments. Interest rate swaps, swaptions, and foreign currency forwards are typically valued based on internal models that use observable market data, including applicable interest rates and foreign currency rates in effect as of the measurement date; the model-generated valuations are then typically compared to counterparty valuations for reasonableness. These financial derivatives are also generally designated as Level 2 instruments. Financial derivatives with less price transparency, such as CDS on individual ABS, are generally valued based on internal models, and are typically designated as Level 3 instruments. In the case of CDS on individual ABS, the valuation process typically starts with an estimation of the value of the underlying ABS. In valuing its derivatives, the Company also considers the creditworthiness of both the Company and its counterparties, along with collateral provisions contained in each derivative agreement.

Investments in private operating entities, such as loan originators, are valued based on available metrics, such as relevant market multiples and comparable company valuations, company specific-financial data including actual and projected results and independent third party valuation estimates. These investments are designated as Level 3 assets.

The Company's repurchase agreements are carried at fair value based on their contractual amounts as the debt is short-term in nature. The Company's reverse repurchase agreements are carried at cost, which approximates fair value. Repurchase and reverse repurchase agreements are classified as Level 2 assets and liabilities based on the adequacy of the collateral and their short term nature.

The Company's valuation process, including the application of validation criteria, is overseen by the Manager's Valuation Committee ("Valuation Committee"). The Valuation Committee includes senior level executives from various departments within the Manager, and each quarter, the Valuation Committee reviews and approves the valuations of the Company's investments. The valuation process also includes a monthly review by the Company's third-party administrator. The goal of this review is to replicate various aspects of the Company's valuation process based on the Company's documented procedures.

Because of the inherent uncertainty of valuation, the estimated fair value of the Company's financial instruments may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to the Company's consolidated financial statements.

(C) Purchase and Sales of Investments and Investment Income: Purchases and sales of investments are generally recorded on trade date, and realized and unrealized gains and losses are calculated based on identified cost. The Company amortizes premiums and accretes discounts on its debt investments. Coupon interest income on fixed-income investments is generally accrued based on the outstanding principal balance or notional value and the current coupon interest rate.

For Agency RMBS and debt securities that are deemed to be of high credit quality at the time of purchase, premiums and discounts are amortized into interest income over the life of such securities using the effective interest method. For securities whose cash flows vary depending on prepayments, an effective yield retroactive to the time of purchase is periodically recomputed based on actual prepayments and changes in projected prepayment activity, and a catch-up adjustment is made to amortization to reflect the cumulative impact of the change in effective yield.

For debt securities (including non-Agency MBS) that are deemed not to be of high credit quality at the time of purchase, interest income is recognized based on the effective interest method. For purposes of determining the effective interest rate, management estimates the future expected cash flows of its investment holdings based on assumptions including, but not limited to, assumptions for future prepayment rates, default rates, and loss severities (each of which may in turn incorporate various macro-economic assumptions, such as future housing prices). These assumptions are re-evaluated not less than quarterly. Principal write-offs are generally treated as realized losses. Changes in projected cash flows, as applied to the current amortized cost of the security, may result in a prospective change in the yield/interest income recognized on such securities.

For each loan purchased with the expectation that both interest and principal will be paid in full, the Company generally amortizes or accretes any premium or discount over the life of the loan utilizing the effective interest method. However, on at least a quarterly basis based on current information and events, the Company re-assesses the collectibility of interest and principal, and designates a loan as impaired either when any payments have become 90 or more days past due, or when, in the opinion of management, it is probable that the Company will be unable to collect either interest or principal in full. Once a loan is designated as impaired, as long as principal is still expected to be collectible in full, interest payments are recorded as interest income only when received (i.e., under the cash basis method); accruals of interest income are only resumed when the loan becomes contractually current and performance is demonstrated to be resumed. However, if principal is not expected to be collectible in full, the cost recovery method is used (i.e., no interest income is recognized, and all payments received—whether contractually interest or principal—are applied to cost).

For each loan purchased with evidence of credit deterioration since origination and the expectation that either principal or interest will not be paid in full, interest income is generally recognized using the effective interest method for as long as the cash flows can be reasonably estimated. Here, instead of amortizing the purchase discount (i.e., the excess of the unpaid principal balance over the purchase price) over the life of the loan, the Company effectively amortizes the accretable yield (i.e., the excess of the Company's estimate of the total cash flows to be collected over the life of the loan over the purchase price). Not less than quarterly, the Company updates its estimate of the cash flows expected to be collected over the life of the loan, and revised yields are prospectively applied. To the extent that cash flows cannot be reasonably estimated, these loans are generally accounted for under the cost recovery method.

For certain groups of consumer loans that the Company considers as having sufficiently homogeneous characteristics, the Company aggregates such loans into pools, and accounts for each such pool as a single asset. The pool is then treated analogously to a debt security deemed not to be of high credit quality, in that (i) the aggregate premium or discount for the pool is amortized or accreted into interest income based on the pool's effective interest rate; (ii) the effective interest rate is determined based on the net expected cash flows of the pool, taking into account estimates of prepayments, defaults, and loss severities; and (iii) estimates are updated not less than quarterly and revised yields are prospectively applied.

In estimating future cash flows on the Company's debt investments, there are a number of assumptions that will be subject to significant uncertainties and contingencies, including, in the case of MBS, assumptions relating to prepayment rates, default rates, loan loss severities, and loan repurchases. These estimates require the use of a significant amount of judgment.

The Company receives dividend income on certain of its equity investments and rental income on certain of its REO properties. These items of income are included on the Consolidated Statement of Operations in, "Other income."

(D) Cash and Cash Equivalents: Cash and cash equivalents include cash and short term investments with original maturities of three months or less at the date of acquisition. Cash and cash equivalents typically include amounts held in an interest bearing overnight account and amounts held in money market funds, and these balances generally exceed insured limits. The Company holds its cash at institutions that it believes to be highly creditworthy. Restricted cash represents cash that the Company can use only for specific purposes. The Company's investments in money market funds are included in the Consolidated Condensed Schedule of Investments. See Note 15 for further discussion of restricted cash balances.

(E) Financial Derivatives: The Company enters into various types of financial derivatives. The Company's financial derivatives are predominantly subject to bilateral collateral arrangements or clearing in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. The Company may be required to deliver or receive cash or securities as collateral upon entering into derivative transactions. In addition, changes in the relative value of derivative transactions may require the Company or the counterparty to post or receive additional collateral. In the case of cleared derivatives, the clearinghouse becomes the Company's counterparty and a futures commission merchant acts as an intermediary between the Company and the clearinghouse with respect to all facets of the related transaction, including the posting and receipt of required collateral. Cash collateral received by the Company is reflected on the Consolidated Statement of Assets, Liabilities, and Equity as "Due to Brokers." Conversely, cash collateral posted by the Company is reflected as "Due from Brokers" on the Consolidated Statement of Assets, Liabilities, and Equity. The major types of derivatives utilized by the Company are swaps, futures, options, and forwards.

Swaps: The Company may enter into various types of swaps, including interest rate swaps, credit default swaps, and total return swaps. The primary risk associated with the Company's interest rate swap activity is interest rate risk. The primary risk associated with the Company's credit default swaps is credit risk and the primary risks associated with the Company's total return swap activity are equity market risk and credit risk.

The Company is subject to interest rate risk exposure in the normal course of pursuing its investment objectives. Primarily to help mitigate interest rate risk, the Company enters into interest rate swaps. Interest rate swaps are contractual agreements whereby one party pays a floating interest rate on a notional principal amount and receives a fixed-rate payment on the same notional principal, or vice versa, for a fixed period of time. Interest rate swaps change in value with movements in interest rates.

The Company enters into credit default swaps. A credit default swap is a contract under which one party agrees to compensate another party for the financial loss associated with the occurrence of a "credit event" in relation to a "reference amount" or notional value of a credit obligation (usually a bond, loan, or a basket of bonds or loans). The definition of a credit event may vary from contract to contract. A credit event may occur (i) when the underlying reference asset(s) fails to make scheduled principal or interest payments to its holders, (ii) with respect to credit default swaps referencing mortgage/asset-backed securities and indices, when the underlying reference obligation is downgraded below a certain rating level, or (iii) with respect to credit default swaps referencing corporate entities and indices, upon the bankruptcy of the underlying reference obligor. The Company typically writes (sells) protection to take a "long" position or purchases (buys) protection to take a "short" position with respect to underlying reference assets or to hedge exposure to other investment holdings.

The Company enters into total return swaps in order to take a "long" or "short" position with respect to an underlying reference asset. The Company is subject to market price volatility of the underlying reference asset. A total return swap involves commitments to pay interest in exchange for a market-linked return based on a notional value. To the extent that the total return of the corporate debt, security, group of securities or index underlying the transaction exceeds or falls short of the offsetting interest obligation, the Company will receive a payment from or make a payment to the counterparty.

Swaps change in value with movements in interest rates, credit quality, or total return of the reference securities. During the term of swap contracts, changes in value are recognized as unrealized gains or losses. When a contract is terminated, the Company realizes a gain or loss equal to the difference between the proceeds from (or cost of) the closing transaction and the Company's basis in the contract, if any. Periodic payments or receipts required by swap agreements are recorded as unrealized gains or losses when accrued and realized gains or losses when received or paid. Upfront payments paid and/or received by the Company to open swap contracts are recorded as an asset and/or liability on the Consolidated Statement of Assets, Liabilities, and Equity and are recorded as a realized gain or loss on the termination date.

Futures Contracts: A futures contract is an exchange-traded agreement to buy or sell an asset for a set price on a future date. The Company enters into Eurodollar and/or U.S. Treasury security futures contracts to hedge its interest rate risk. The Company may also enter into various other futures contracts, including equity index futures and foreign currency futures. Initial margin deposits are made upon entering into futures contracts and can generally be either in the form of cash or securities. During the period the futures contract is open, changes in the value of the contract are recognized as unrealized gains or losses by marking-to-market to reflect the current market value of the contract. Variation margin payments are made or received periodically, depending upon whether unrealized losses or gains are incurred. When the contract is closed, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Options: The Company may purchase or write put or call options contracts or enter into swaptions. The Company enters into options contracts typically to help mitigate overall market, credit, or interest rate risk depending on the type of options contract. However, the Company also enters into options contracts from time to time for speculative purposes. When the Company purchases an options contract, the option asset is initially recorded at an amount equal to the premium paid, if any, and is subsequently marked-to-market. Premiums paid for purchasing options contracts that expire unexercised are recognized on the expiration date as realized losses. If an options contract is exercised, the premium paid is subtracted from the proceeds of the sale or added to the cost of the purchase to determine whether the Company has realized a gain or loss on the related transaction. When the Company writes an options contract, the option liability is initially recorded at an amount equal to the premium received, if any, and is subsequently marked-to-market. Premiums received for writing options contracts that expire unexercised are recognized on the expiration date as realized gains. If an options contract is exercised, the premium received is subtracted from the cost of the purchase or added to the proceeds of the sale to determine whether the Company has realized a gain or loss on the related investment transaction. When the Company enters into a closing transaction, the Company will realize a gain or loss depending upon whether the amount from the closing transaction is greater or less than the premiums paid or received. The Company may also enter into options contracts that contain forward-settling premiums. In this case, no money

is exchanged upfront. Instead the agreed-upon premium is paid by the buyer upon expiration of the option, regardless of whether or not the option is exercised.

Forward Currency Contracts: A forward currency contract is an agreement between two parties to purchase or sell a specific quantity of currency with the delivery and settlement at a specific future date and exchange rate. During the period the forward currency contract is open, changes in the value of the contract are recognized as unrealized gains or losses. When the contract is settled, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Commitments to Purchase Residential Mortgage Loans: The Company has entered into forward purchase commitments under flow agreements, whereby the Company commits to purchasing the loans based on pre-defined underwriting guidelines and at stated interest rates. Actual loan purchases are contingent upon successful loan closings. These commitments to purchase mortgage loans are classified as derivatives on the Company's Consolidated Statement of Assets, Liabilities, and Equity and are, therefore, recorded as assets or liabilities measured at fair value. Until the purchase commitment expires or the underlying loan closes, changes in the estimated fair value of such commitments are recognized as unrealized gains or losses in the Consolidated Statement of Operations.

Financial derivatives disclosed on the Consolidated Condensed Schedule of Investments include: credit default swaps on asset-backed securities, credit default swaps on asset-backed indices, credit default swaps on corporate bond indices, credit default swaps on corporate bonds, interest rate swaps, total return swaps, futures contracts, foreign currency forwards, options contracts.

Financial derivative assets are included in Financial derivatives—assets, at fair value on the Consolidated Statement of Assets, Liabilities, and Equity. Financial derivative liabilities are included in Financial derivatives—liabilities, at fair value on the Consolidated Statement of Assets, Liabilities, and Equity. In addition, financial derivative contracts are summarized by type on the Consolidated Condensed Schedule of Investments.

(F) Investments Sold Short: When the Company sells securities short, it typically satisfies its security delivery settlement obligation by obtaining the security sold short from the same or a different counterparty. The Company generally is required to deliver cash or securities as collateral to the counterparty for the Company's obligation to return the borrowed security. The amount by which the market value of the obligation falls short of or exceeds the proceeds from the short sale is treated as an unrealized gain or loss, respectively. A realized gain or loss will be recognized upon the termination of a short sale if the market price is less or greater than the proceeds originally received.

(G) Reverse Repurchase Agreements: The Company enters into reverse repurchase agreements with third-party broker-dealers whereby it sells securities under agreements to be repurchased at an agreed-upon price and date. The Company accounts for reverse repurchase agreements as collateralized borrowings, with the initial sale price representing the amount borrowed, and with the future repurchase price consisting of the amount borrowed plus interest, at the implied interest rate of the reverse repurchase agreement, on the amount borrowed over the term of the reverse repurchase agreement. The interest rate on a reverse repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. When the Company enters into a reverse repurchase agreement, the lender establishes and maintains an account containing cash and/or securities having a value not less than the repurchase price, including accrued interest, of the reverse repurchase agreement. Reverse repurchase agreements are carried at their contractual amounts, which approximate fair value as the debt is short-term in nature.

(H) Repurchase Agreements: The Company enters into repurchase agreement transactions whereby it purchases securities under agreements to resell at an agreed-upon price and date. In general, securities received pursuant to repurchase agreements are delivered to counterparties of short sale transactions. The interest rate on a repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. Assets held pursuant to repurchase agreements are reflected as assets on the Consolidated Statement of Assets, Liabilities, and Equity. Repurchase agreements are carried at fair value based on their contractual amounts as the debt is short-term in nature.

Repurchase and reverse repurchase agreements that are conducted with the same counterparty may be reported on a net basis if they meet the requirements of ASC 210-20, Balance Sheet Offsetting. There are no repurchase and reverse repurchase agreements reported on a net basis in the Company's consolidated financial statements.

(I) Transfers of Financial Assets: The Company enters into transactions whereby it transfers financial assets to third parties. Upon such a transfer of financial assets, the Company will sometimes retain or acquire interests in the related assets. The Company evaluates transferred assets pursuant to ASC 860-10, Transfers of Financial Assets, or "ASC 860-10," which requires that a determination be made as to whether a transferor has surrendered control over transferred financial assets. That

determination must consider the transferor's continuing involvement in the transferred financial asset, including all arrangements or agreements made contemporaneously with, or in contemplation of, the transfer, even if they were not entered into at the time of the transfer. When a transfer of financial assets does not qualify as a sale, ASC 860-10 requires the transfer to be accounted for as a secured borrowing with a pledge of collateral. ASC 860-10 is a standard that requires the Company to exercise significant judgment in determining whether a transaction should be recorded as a "sale" or a "financing."

(J) When-Issued/Delayed Delivery Securities: The Company may purchase or sell securities on a when-issued or delayed delivery basis. Securities purchased or sold on a when-issued basis are traded for delivery beyond the normal settlement date at a stated price or yield, and no income accrues to the purchaser prior to settlement. Purchasing or selling securities on a when-issued or delayed delivery basis involves the risk that the market price or yield at the time of settlement may be lower or higher than the agreed-upon price or yield, in which case a realized loss may be incurred.

The Company transacts in the forward settling TBA market. The Company typically does not take delivery of TBAs, but rather settles the associated receivable and payable with its trading counterparties on a net basis. Transactions with the same counterparty for the same TBA that result in a reduction of the position are treated as extinguished. The market value of the securities that the Company is required to purchase pursuant to a TBA transaction may decline below the agreed-upon purchase price. Conversely, the market value of the securities that the Company is required to sell pursuant to a TBA transaction may increase above the agreed upon sale price. As part of its TBA activities, the Company may "roll" its TBA positions, whereby the Company may sell (buy) securities for delivery (receipt) in an earlier month and simultaneously contract to repurchase (sell) similar, but not identical, securities at an agreed-upon price on a fixed date in a later month (with the later-month price typically lower than the earlier-month price). The Company accounts for its TBA transactions (including those related to TBA rolls) as purchases and sales.

(K) REO: When the Company obtains possession of real property in connection with a foreclosure or similar action, the Company de-recognizes the associated mortgage loan according to ASU 2014-04, Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure ("ASU 2014-04"). Under the provisions of ASU 2014-04, the Company is deemed to have received physical possession of real estate property collateralizing a mortgage loan when it obtains legal title to the property upon completion of a foreclosure or when the borrower conveys all interest in the property to it through a deed in lieu of foreclosure or similar legal agreement. The Company holds all REO at fair value.

(L) Investments in Operating Entities: The Company has made and may in the future make non-controlling investments in operating entities such as loan originators. Investments in such operating entities may be in the form of preferred and/or common equity, debt, or some other form of investment. The Company carries its investments in such entities at fair value. In cases where the operating entity provides services to the Company, the Company is required to use the equity method of accounting.

(M) Variable Interest Entities: VIEs are entities in which: (i) the equity investors do not have the characteristics of a controlling financial interest, or (ii) there is insufficient equity to permit the entity to finance its activities without additional subordinated financial support from other parties. The Company holds beneficial interests in securitization trusts that are considered VIEs. The beneficial interests in these securitization trusts are represented by certificates issued by the trusts. The securitization trusts have been structured as pass-through entities that receive principal and interest payments on the underlying collateral and distribute those payments to the certificate holders, which include both third-party investors and the Company. The certificates held by the Company typically include some or all of the most subordinated tranches. The assets held by the trusts are restricted in that they can only be used to fulfill the obligations of the related trust. In certain cases the design and structure of the securitization trust is such that the Company effectively retains control of the assets as well as the activities that most significantly impact the economic performance of the trust; in such cases the trust is considered a direct extension of the Company's business, and the Company consolidates the trust. In cases where the Company does not effectively retain control of the assets of, or the activities that most significantly impact the economic performance of, the related trust, it does not consolidate the trust. See Note 6 for further discussion of the Company's securitization trusts.

(N) Offering Costs/Underwriters' Discount: Offering costs and underwriters' discount are charged against shareholders' equity. Offering costs typically include legal, accounting, printing, and other fees associated with the cost of raising capital.

(O) Debt Issuance Costs: Debt issuance costs associated with debt for which the Company has elected the fair value option are expensed at the issuance of the debt, and are included in Other investment related expenses on the Consolidated Statement of Operations. Costs associated with the issuance of debt for which the Company has not elected the fair value option are amortized over the life of the debt, which approximates the effective interest rate method, and are included in Interest expense on the Consolidated Statement of Operations. Deferred debt issuance costs are presented on the Consolidated Statement of Assets, Liabilities, and Equity as a direct deduction from the related debt liability, unless such deferred debt issuance costs are associated with borrowing facilities that are expected to have a future benefit, such as giving the Company

the ability to access additional borrowings over the contractual term of the debt, in which case such deferred debt issuance costs are included in Other Assets on Consolidated Statement of Assets, Liabilities, and Equity. Debt issuance costs include legal and accounting fees, purchasers' or underwriters' discount, as well as other fees associated with the cost of the issuance of the related debt.

(P) Expenses: Expenses are recognized as incurred on the Consolidated Statement of Operations.

(Q) Other Investment Related Expenses: Other investment related expenses consist of expenses directly related to specific financial instruments. Such expenses generally include dividend expense on common stock sold short, servicing fees and corporate and escrow advances on mortgage and consumer loans, and various other expenses and fees related directly to the Company's financial instruments. Other investment related expenses are recognized as incurred on the Consolidated Statement of Operations; dividend expense on common stock sold short is recognized on the ex-dividend date.

(R) LTIP Units: Long term incentive plan units of the Company ("LTIP Units") and long term incentive plan units of the Operating Partnership ("OP LTIP Units") have been issued to the Company's dedicated or partially dedicated personnel and certain of its directors as well as the Manager. Costs associated with LTIP Units and OP LTIP Units issued to dedicated or partially dedicated personnel, or to its directors, are measured as of the grant date based on the closing stock price on the New York Stock Exchange and are amortized over the vesting period in accordance with ASC 718-10, Compensation—Stock Compensation. The vesting periods for LTIP Units and OP LTIP Units are typically one year from issuance for directors, and are typically one year to two years from issuance for dedicated or partially dedicated personnel.

(S) Non-controlling interests: Non-controlling interests include interests in the Operating Partnership represented by units convertible into the Company's common shares ("Convertible Non-controlling Interests"). Convertible Non-controlling Interests include both the OP LTIP Units and those common units ("OP Units") of the Operating Partnership not held by the Company. Non-controlling interests also include the interests of joint venture partners in certain of our consolidated subsidiaries. The joint venture partners' interests are not convertible into the Company's common shares. The Company adjusts the Convertible Non-controlling Interests to align their carrying value with their share of total outstanding Operating Partnership units, including both the OP Units held by the Company and the Convertible Non-controlling Interests. Any such adjustments are reflected in "Adjustment to non-controlling interest" on the Consolidated Statement of Changes in Equity. See Note 11 for further discussion of non-controlling interests.

(T) Dividends: Dividends payable by the Company are recorded on the ex-dividend date. Dividends are typically declared and paid on a quarterly basis in arrears.

(U) Shares Repurchased: Common shares that are repurchased by the Company subsequent to issuance are immediately retired upon settlement and decrease the total number of shares outstanding and issued.

(V) Earnings Per Share ("EPS"): Basic EPS is computed using the two class method by dividing net increase (decrease) in shareholders' equity resulting from operations after adjusting for the impact of LTIP Units which are participating securities, by the weighted average number of common shares outstanding calculated including LTIP Units. Because the Company's LTIP Units are participating securities, they are included in the calculation of basic and diluted EPS. Convertible Non-controlling Interests are also participating securities and, accordingly, are included in the calculation of both basic and diluted EPS.

(W) Foreign Currency: Assets and liabilities denominated in foreign currencies are translated into U.S. dollars at current exchange rates at the following dates: (i) assets, liabilities, and unrealized gains/losses—at the valuation date; and (ii) income, expenses, and realized gains/losses—at the accrual/transaction date. The Company isolates the portion of realized and change in unrealized gain (loss) resulting from changes in foreign currency exchange rates on investments and financial derivatives from the fluctuations arising from changes in fair value of investments and financial derivatives held. Changes in realized and change in unrealized gain (loss) due to foreign currency are included in Foreign currency transactions and Foreign currency translation, respectively, on the Consolidated Statement of Operations.

(X) Income Taxes: The Company is treated as a partnership for U.S. federal income tax purposes. Certain of the Company's subsidiaries are not consolidated for U.S. federal income tax purposes, but are also treated as partnerships. In general, partnerships are not subject to entity-level tax on their income, but the income of a partnership is taxable to its owners on a flow-through basis. In addition, certain subsidiaries of the Company have elected to be treated as corporations for U.S. federal income tax purposes, and one has elected to be taxed as a real estate investment trust, or "REIT."

The Company follows the authoritative guidance on accounting for and disclosure of uncertainty on tax positions, which requires management to determine whether a tax position of the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For uncertain tax positions, the tax benefit to be recognized is measured as the largest amount

of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company did not have any additions to unrecognized tax benefits resulting from tax positions related either to the current period or to 2017, 2016, or 2015 (its open tax years), and no reductions resulting from tax positions of prior years or due to settlements, and thus had no unrecognized tax benefits or reductions since inception. The Company does not expect any change in unrecognized tax benefits within the next fiscal year. There were no amounts accrued for tax penalties or interest as of or during the periods presented in these consolidated financial statements.

The Company may take positions with respect to certain tax issues which depend on legal interpretation of facts or applicable tax regulations. Should the relevant tax regulators successfully challenge any of such positions, the Company might be found to have a tax liability that has not been recorded in the accompanying consolidated financial statements. Also, management's conclusions regarding ASC 740-10 may be subject to review and adjustment at a later date based on factors including, but not limited to, further implementation guidance from the Financial Accounting Standards Board, or "FASB," and ongoing analyses of tax laws, regulations and interpretations thereof.

(Y) Recent Accounting Pronouncements: In August 2018, the Financial Accounting Standards Board, or "FASB," issued ASU 2018-13, Fair Value Measurement—Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement ("ASU 2018-13"). This amends ASC 820, Fair Value Measurement, to remove or modify various current disclosure requirements related to fair value measurement. Additionally ASU 2018-13 requires certain additional disclosures around fair value measurement. ASU 2018-13 is effective for annual periods beginning after December 15, 2019 and interim periods within those years, with early adoption permitted. Entities are permitted to early adopt any removed or modified disclosures and delay adoption of the additional disclosures until their effective date. The Company has elected to early adopt the removal and modification of various disclosure requirements in accordance with ASU 2018-13; early adoption has not had a material impact on the Company's consolidated financial statements. The Company has elected not to early adopt the additional disclosure requirements. The adoption of additional disclosures, as required under ASU 2018-13, is not expected to have a material impact on the Company's consolidated financial statements.

In June 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation—Improvements to Nonemployee Share-Based Payment Accounting ("ASU 2018-07"). This amends ASC 718, Compensation—Stock Compensation, to simplify several aspects of accounting for nonemployee share-based payment transactions. ASU 2018-07 is effective for annual periods beginning after December 15, 2019 and interim periods beginning after December 15, 2020, with early adoption permitted. The adoption of ASU 2018-07 is not expected to have a material impact on the Company's consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows—Restricted Cash ("ASU 2016-18"). This amends ASC 230, Statement of Cash Flows, to require that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash and restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. ASU 2016-18 became effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU 2016-18 did not have a material impact on the Company's consolidated financial statements.

XML

Valuation

12 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Valuation

Valuation

The tables below reflect the value of the Company's Level 1, Level 2, and Level 3 financial instruments that are measured at fair value on a recurring basis as of December 31, 2020 and 2019:

December 31, 2020:

Description	Level 1		Level 2		Level 3		Total
	(In thousands)
Assets:
Securities, at fair value:
Agency RMBS	$	—	$	947,780	$	11,663	$	959,443
Non-Agency RMBS	—		76,276		127,838		204,114
CMBS	—		54,505		63,148		117,653
CLOs	—		70,171		111,100		181,271
Asset-backed securities, backed by consumer loans	—		—		44,925		44,925
Corporate debt securities	—		1,107		4,082		5,189
Corporate equity securities	—		—		1,590		1,590
Loans, at fair value:
Residential mortgage loans	—		—		1,187,069		1,187,069
Commercial mortgage loans	—		—		213,031		213,031
Consumer loans	—		—		47,525		47,525
Corporate loans	—		—		5,855		5,855
Investment in unconsolidated entities, at fair value	—		—		141,620		141,620
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	—		—		347		347
Credit default swaps on asset-backed indices	—		2,184		—		2,184
Credit default swaps on corporate bond indices	—		3,420		—		3,420
Interest rate swaps	—		8,519		—		8,519
TBAs	—		962		—		962
Total return swaps	—		—		9		9
Warrants	—		36		—		36
Futures	2		—		—		2
Total assets	$	2	$	1,164,960	$	1,959,802	$	3,124,764

Description	Level 1		Level 2		Level 3		Total
(continued)	(In thousands)
Liabilities:
Securities sold short, at fair value:
Government debt	$	—	$	(38,424)	$	—	$	(38,424)
Corporate debt securities	—		(218)		—		(218)
Financial derivatives–liabilities, at fair value:
Credit default swaps on asset-backed indices	—		(130)		—		(130)
Credit default swaps on corporate bonds	—		(747)		—		(747)
Credit default swaps on corporate bond indices	—		(6,438)		—		(6,438)
Interest rate swaps	—		(15,174)		—		(15,174)
TBAs	—		(925)		—		(925)
Futures	(376)		—		—		(376)
Forwards	—		(279)		—		(279)
Total return swaps	—		—		(484)		(484)
Other secured borrowings, at fair value	—		—		(754,921)		(754,921)
Total liabilities	$	(376)	$	(62,335)	$	(755,405)	$	(818,116)

December 31, 2019:

Description	Level 1		Level 2		Level 3		Total
	(In thousands)
Assets:
Securities, at fair value:
Agency RMBS	$	—	$	1,917,059	$	19,904	$	1,936,963
Non-Agency RMBS	—		76,969		89,581		166,550
CMBS	—		95,063		29,805		124,868
CLOs	—		125,464		44,979		170,443
Asset-backed securities, backed by consumer loans	—		—		48,610		48,610
Corporate debt securities	—		—		1,113		1,113
Corporate equity securities	—		—		1,394		1,394
Loans, at fair value:
Residential mortgage loans	—		—		932,203		932,203
Commercial mortgage loans	—		—		274,759		274,759
Consumer loans	—		—		186,954		186,954
Corporate loans	—		—		18,510		18,510
Investment in unconsolidated entities, at fair value	—		—		71,850		71,850
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	—		—		993		993
Credit default swaps on asset-backed indices	—		3,319		—		3,319
Credit default swaps on corporate bonds	—		2		—		2
Credit default swaps on corporate bond indices	—		5,599		—		5,599
Interest rate swaps	—		5,468		—		5,468
TBAs	—		596		—		596
Total return swaps	—		—		620		620
Futures	148		—		—		148
Forwards	—		43		—		43
Total assets	$	148	$	2,229,582	$	1,721,275	$	3,951,005

Description	Level 1		Level 2		Level 3		Total
(continued)	(In thousands)
Liabilities:
Securities sold short, at fair value:
Government debt	$	—	$	(72,938)	$	—	$	(72,938)
Corporate debt securities	—		(471)		—		(471)
Financial derivatives–liabilities, at fair value:
Credit default swaps on asset-backed indices	—		(250)		—		(250)
Credit default swaps on corporate bonds	—		(1,693)		—		(1,693)
Credit default swaps on corporate bond indices	—		(14,524)		—		(14,524)
Interest rate swaps	—		(8,719)		—		(8,719)
TBAs	—		(1,012)		—		(1,012)
Futures	(45)		—		—		(45)
Forwards	—		(169)		—		(169)
Total return swaps	—		(773)		(436)		(1,209)
Other secured borrowings, at fair value	—		—		(594,396)		(594,396)
Total liabilities	$	(45)	$	(100,549)	$	(594,832)	$	(695,426)

The following tables identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2020 and 2019:

December 31, 2020:

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
	(In thousands)
Non-Agency RMBS	$	70,619	Market Quotes	Non Binding Third-Party Valuation	$	9.53		$	204.61		$	85.70
	57,219		Discounted Cash Flows
	127,838			Yield(1)	0.7		%	52.6		%	7.4		%
				Projected Collateral Prepayments	—		%	99.1		%	45.3		%
				Projected Collateral Losses	0.4		%	72.6		%	18.4		%
				Projected Collateral Recoveries	—		%	79.1		%	16.8		%
Non-Agency CMBS	53,199		Market Quotes	Non Binding Third-Party Valuation	$	4.79		$	98.00		$	65.20
	9,949		Discounted Cash Flows
	63,148			Yield	3.7		%	26.3		%	8.7		%
				Projected Collateral Prepayments	—		%	—		%	—		%
				Projected Collateral Losses	0.7		%	10.7		%	3.6		%
				Projected Collateral Recoveries	72.4		%	96.1		%	90.6		%
CLOs	102,910		Market Quotes	Non Binding Third-Party Valuation	$	2.00		$	330.00		$	88.66
	8,190		Discounted Cash Flows
	111,100			Yield	3.4		%	35.4		%	10.5		%
				Projected Collateral Prepayments	41.2		%	97.7		%	65.7		%
				Projected Collateral Losses	1.7		%	28.9		%	11.2		%
				Projected Collateral Recoveries	0.6		%	15.2		%	7.9		%
Agency interest only RMBS	4,844		Market Quotes	Non Binding Third-Party Valuation	$	1.91		$	18.91		$	8.38
	6,819		Option Adjusted Spread ("OAS")
	11,663			LIBOR OAS(2)(3)	297			2,886			914
				Projected Collateral Prepayments	8.3		%	100.0		%	75.9		%
ABS backed by consumer loans	97		Market Quotes	Non Binding Third-Party Valuation	$	96.51		$	98.43		$	97.33
	44,828		Discounted Cash Flows
	44,925			Yield	12.6		%	27.5		%	15.6		%
				Projected Collateral Prepayments	0.0		%	11.6		%	7.7		%
				Projected Collateral Losses	1.0		%	21.1		%	17.1		%
Corporate debt and equity	5,672		Discounted Cash Flows	Yield	8.1		%	10.8		%	9.7		%
Performing and re-performing residential mortgage loans	338,265		Discounted Cash Flows	Yield	2.5		%	28.5		%	5.4		%
	15,659		Recent Transactions	Transaction Price	$	60.00		$	103.88		$	103.44
	353,924

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
(continued)	(In thousands)
Securitized residential mortgage loans(4)(5)	$	783,162	Market Quotes	Non Binding Third-Party Valuation	$	5.34		$	105.61		$	100.22
	18,182		Discounted Cash Flows
	801,343			Yield	—		%	38.7		%	4.4		%
Non-performing residential mortgage loans	31,802		Discounted Cash Flows	Yield	1.2		%	41.0		%	12.1		%
				Recovery Amount	0.9		%	1713.0		%	30.6		%
				Months to Resolution	0.0			106.6			30.0
Performing commercial mortgage loans	181,545		Discounted Cash Flows	Yield	3.7		%	9.7		%	8.1		%
Non-performing commercial mortgage loans	31,486		Discounted Cash Flows	Yield	8.6		%	14.6		%	10.8		%
				Recovery Amount	100.0		%	102.4		%	100.8		%
				Months to Resolution	1.8			5.8			3.7
Consumer loans	47,525		Discounted Cash Flows	Yield	7.8		%	28.1		%	11.2		%
				Projected Collateral Prepayments	0.0		%	36.0		%	17.3		%
				Projected Collateral Losses	0.9		%	86.6		%	9.4		%
Corporate loans	5,855		Market Quotes	Non Binding Third-Party Valuation	$	100.00		$	100.00		$	100.00
				Yield	21.1		%	21.1		%	21.1		%
Investment in unconsolidated entities	141,620		Enterprise Value	Equity Price-to-Book(6)	1.0x			6.2x			1.4x
Total return swaps—asset	9		Discounted Cash Flows	Yield	22.0		%	22.0		%	22.0		%
Credit default swaps on asset-backed securities	347		Net Discounted Cash Flows	Projected Collateral Prepayments	32.7		%	39.7		%	38.1		%
				Projected Collateral Losses	6.6		%	10.8		%	8.9		%
				Projected Collateral Recoveries	13.9		%	18.1		%	15.6		%
Total return swaps—liability	(484)		Discounted Cash Flows	Yield	16.8%			16.8%			16.8%
Other secured borrowings, at fair value(4)	(754,921)		Market Quotes	Non Binding Third-Party Valuation	$	85.37		$	105.61		$	102.04
				Yield	1.6%			3.0%			2.6%
				Projected Collateral Prepayments	—%			75.3%			48.7%

(1)For the range minimum, the range maximum, and the weighted average yield, excludes non-Agency RMBS with a negative yield, with a total fair value of $0.3 million. Including these securities the weighted average yield was 7.3%.

(2)Shown in basis points.

(3)For range minimum, range maximum, and the weighted average of LIBOR OAS, excludes Agency interest only securities with a negative LIBOR OAS, with a total fair value of $4.5 million. Including these securities the weighted average was 396 basis points.

(4)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFEs as discussed in Note 2.

(5)Includes $26.4 million of non-performing securitized residential mortgage loans.

(6)Represents an estimation of where market participants might value an enterprise on a price-to-book basis.

December 31, 2019(1):

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
	(In thousands)
Non-Agency RMBS	$	38,754	Market Quotes	Non Binding Third-Party Valuation	$	6.68		$	144.79		$	86.21
	50,827		Discounted Cash Flows
	89,581			Yield(2)	0.5		%	65.1		%	8.1		%
				Projected Collateral Prepayments	0.8		%	76.5		%	53.1		%
				Projected Collateral Losses	0.1		%	48.9		%	17.7		%
				Projected Collateral Recoveries	—		%	32.4		%	6.5		%
Non-Agency CMBS	29,630		Market Quotes	Non Binding Third-Party Valuation	$	5.08		$	80.72		$	64.73
	175		Discounted Cash Flows
	29,805			Yield	3.7		%	15.7		%	7.6		%
				Projected Collateral Prepayments	—		%	100.0		%	0.6		%
				Projected Collateral Losses	—		%	3.0		%	0.2		%
				Projected Collateral Recoveries	—		%	10.6		%	2.0		%
CLOs	38,220		Market Quotes	Non Binding Third-Party Valuation	$	40.00		$	96.00		$	73.98
	6,759		Discounted Cash Flows
	44,979			Yield	3.2		%	41.9		%	14.0		%
				Projected Collateral Prepayments	48.5		%	88.3		%	83.2		%
				Projected Collateral Losses	4.7		%	36.4		%	8.8		%
				Projected Collateral Recoveries	3.7		%	15.1		%	5.7		%
Agency interest only RMBS	3,753		Market Quotes	Non Binding Third-Party Valuation	$	1.36		$	16.61		$	5.11
	16,151		Option Adjusted Spread ("OAS")
	19,904			LIBOR OAS(3)(4)	93			3,527			583
				Projected Collateral Prepayments	12.3		%	100.0		%	70.5		%
ABS backed by consumer loans	139		Market Quotes	Non Binding Third-Party Valuation	$	95.47		$	96.78		$	96.12
	48,471		Discounted Cash Flows
	48,610			Yield	3.8		%	34.2		%	12.7		%
				Projected Collateral Prepayments	0.0		%	11.2		%	9.7		%
				Projected Collateral Losses	0.6		%	18.0		%	15.4		%
Corporate debt and equity	2,507		Discounted Cash Flows	Yield	7.2		%	10.0		%	8.8		%
Performing and re-performing residential mortgage loans	289,672		Discounted Cash Flows	Yield	0.4		%	19.5		%	6.3		%
Securitized residential mortgage loans(5)(6)	621,762		Market Quotes	Non Binding Third-Party Valuation	$	2.56		$	100.45		$	98.23
	6,653		Discounted Cash Flows
	628,415			Yield	3.2		%	4.3		%	3.6		%

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
(Continued)	(In thousands)
Non-performing residential mortgage loans	$	14,116	Discounted Cash Flows	Yield	1.0		%	26.6		%	9.2		%
				Recovery Amount	28.0		%	464.3		%	94.3		%
				Months to Resolution	1.1			165.4			56.3
Performing commercial mortgage loans	248,214		Discounted Cash Flows	Yield	7.7		%	16.6		%	8.8		%
Non-performing commercial mortgage loans	26,545		Discounted Cash Flows	Yield	9.8		%	14.7		%	12.4		%
				Recovery Amount	100.0		%	100.0		%	100.0		%
				Months to Resolution	1.1			23.0			11.4
Consumer loans	186,954		Discounted Cash Flows	Yield	6.7		%	19.6		%	9.4		%
				Projected Collateral Prepayments	0.0		%	44.2		%	16.0		%
				Projected Collateral Losses	3.7		%	84.5		%	8.6		%
Corporate loans	6,010		Market Quotes	Non Binding Third-Party Valuation	$	100.00		$	100.00		$	100.00
	12,500		Discounted Cash Flows
	18,510			Yield	15.0		%	21.0		%	17.8		%
Investment in unconsolidated entities	71,850		Enterprise Value	Equity Price-to-Book(7)	1.0x			4.7x			1.4x
Total return swaps—asset	620		Discounted Cash Flows	Yield	8.5		%	27.7		%	11.5		%
Credit default swaps on asset-backed securities	993		Net Discounted Cash Flows	Projected Collateral Prepayments	35.4		%	42.0		%	37.3		%
				Projected Collateral Losses	4.2		%	12.4		%	10.2		%
				Projected Collateral Recoveries	10.0		%	18.2		%	15.3		%
Total return swaps—liability	(436)		Discounted Cash Flows	Yield	27.7%			27.7%			27.7%
Other secured borrowings, at fair value(5)	(594,396)		Market Quotes	Non Binding Third-Party Valuation	97.77			100.45			100.61
				Yield	2.9%			4.0%			3.3%
				Projected Collateral Prepayments	—%			96.6%			57.2%

(1)Conformed to current period presentation.

(2)For the range minimum, the range maximum, and the weighted average yield, excludes non-Agency RMBS with a negative yield, with a total fair value of $0.6 million. Including these securities the weighted average yield was 8.0%.

(3)Shown in basis points.

(4)For range minimum, range maximum, and the weighted average of LIBOR OAS, excludes Agency interest only securities with a negative LIBOR OAS, with a total fair value of $0.3 million. Including these securities the weighted average was 576 basis points.

(5)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFEs as discussed in Note 2.

(6)Includes $1.5 million of non-performing securitized residential mortgage loans.

(7)Represent an estimation of where market participants might value an enterprise on a price-to-book basis.

Third-party non-binding valuations are validated by comparing such valuations to internally generated prices based on the Company's models and, when available, to recent trading activity in the same or similar instruments.

For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread ("LIBOR OAS") valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to

(b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset. The Company considers the expected timeline to resolution in the determination of fair value for its non-performing commercial and residential mortgage loans.

Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, for instruments subject to prepayments and credit losses, such as non-Agency RMBS and consumer loans and ABS backed by consumer loans, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such credit default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.

The tables below includes a roll-forward of the Company's financial instruments for the years ended December 31, 2020 and 2019 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.

Year Ended December 31, 2020

(In thousands)	Beginning Balance as of  December 31, 2019		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/Payments(1)		Sales/Issuances(2)		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of  December 31, 2020
Assets:
Securities, at fair value:
Agency RMBS	$	19,904	$	(7,903)	$	722	$	3,175	$	8,307	$	(5,046)	$	1,083	$	(8,579)	$	11,663
Non-Agency RMBS	89,581		1,557		1,009		(1,283)		64,362		(40,841)		17,425		(3,972)		127,838
CMBS	29,805		813		62		(2,477)		52,915		(38,553)		20,583		—		63,148
CLOs	44,979		2,185		(8,862)		(13,132)		48,120		(6,747)		53,052		(8,495)		111,100
Asset-backed securities backed by consumer loans	48,610		(4,986)		(138)		(1,245)		30,899		(28,215)		—		—		44,925
Corporate debt securities	1,113		—		914		1,068		5,668		(4,681)		—		—		4,082
Corporate equity securities	1,394		—		7		(165)		366		(12)		—		—		1,590
Loans, at fair value:
Residential mortgage loans	932,203		(6,445)		(165)		11,593		594,397		(344,514)		—		—		1,187,069
Commercial mortgage loans	274,759		128		135		(166)		121,844		(183,669)		—		—		213,031
Consumer loans	186,954		(24,586)		(4,843)		(2,891)		141,245		(248,354)		—		—		47,525
Corporate loan	18,510		—		—		—		1,445		(14,100)		—		—		5,855
Investments in unconsolidated entities, at fair value	71,850		—		424		37,509		61,589		(29,752)		—		—		141,620
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	993		—		(5,451)		5,402		24		(621)		—		—		347
Total return swaps	620		—		288		(611)		126		(414)		—		—		9
Total assets, at fair value	$	1,721,275	$	(39,237)	$	(15,898)	$	36,777	$	1,131,307	$	(945,519)	$	92,143	$	(21,046)	$	1,959,802
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps	$	(436)	$	—	$	(551)	$	(48)	$	592	$	(41)	$	—	$	—	$	(484)
Other secured borrowings, at fair value	(594,396)		—		—		(9,576)		305,828		(456,777)		—		—		(754,921)
Total liabilities, at fair value	$	(594,832)	$	—	$	(551)	$	(9,624)	$	306,420	$	(456,818)	$	—	$	—	$	(755,405)

(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities.

(2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities.

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at December 31, 2020, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2020. For Level 3 financial instruments held by the Company at December 31, 2020, change in net unrealized gain (loss) of $(33.3) million, $8.6 million, $37.1 million, $0.5 million, $(0.5) million, and $(9.6) million, for the year ended December 31, 2020 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively.

At December 31, 2020, the Company transferred $21.0 million of assets from Level 3 to Level 2 and $92.1 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

Year Ended December 31, 2019

(In thousands)	Beginning Balance as of  January 1, 2019		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/ Payments(1)		Sales/ Issuances(2)		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of  December 31, 2019
Assets:
Securities, at fair value:
Agency RMBS	$	7,293	$	(3,464)	$	(1,787)	$	808	$	13,818	$	(1,306)	$	5,370	$	(828)	$	19,904
Non-Agency RMBS	91,291		270		5,636		(3,654)		21,512		(33,664)		15,354		(7,164)		89,581
CMBS	803		16		180		(246)		31,464		(5,271)		2,859		—		29,805
CLOs	14,915		(268)		(3,190)		2,329		25,531		(5,112)		11,984		(1,210)		44,979
Asset-backed securities backed by consumer loans	22,800		(2,520)		(891)		873		42,137		(13,789)		—		—		48,610
Corporate debt securities	6,318		22		(1,341)		188		11,024		(15,098)		—		—		1,113
Corporate equity securities	1,534		—		(1,807)		205		1,462		—		—		—		1,394
Loans, at fair value:
Residential mortgage loans	496,830		(6,081)		1,466		8,800		661,813		(230,625)		—		—		932,203
Commercial mortgage loans	195,301		(282)		2,412		(2,083)		175,689		(96,278)		—		—		274,759
Consumer loans	183,961		(28,521)		(6,291)		3,000		183,994		(149,189)		—		—		186,954
Corporate loan	—		36		—		(36)		18,510		—		—		—		18,510
Investment in unconsolidated entities, at fair value	72,298		—		1,545		8,664		42,173		(52,830)		—		—		71,850
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	1,472		—		528		(479)		33		(561)		—		—		993
Total return swaps	—		—		160		620		—		(160)		—		—		620
Total assets, at fair value	$	1,094,816	$	(40,792)	$	(3,380)	$	18,989	$	1,229,160	$	(603,883)	$	35,567	$	(9,202)	$	1,721,275
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps	$	—	$	—	$	(15)	$	(436)	$	15	$	—	$	—	$	—	$	(436)
Other secured borrowings, at fair value	(297,948)		—		—		(502)		182,291		(478,237)		—		—		(594,396)
Total liabilities, at fair value	$	(297,948)	$	—	$	(15)	$	(938)	$	182,306	$	(478,237)	$	—	$	—	$	(594,832)

(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities.

(2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities.

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3

financial instruments held by the Company at December 31, 2019, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2019. For Level 3 financial instruments held by the Company at December 31, 2019, change in net unrealized gain (loss) of $2.4 million, $11.5 million, $5.2 million, $0.1 million, $(0.4) million, and $0.1 million, for the year ended December 31, 2019 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively.

At December 31, 2019, the Company transferred $9.2 million of assets from Level 3 to Level 2 and $35.6 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

The following table summarizes the estimated fair value of all other financial instruments not measured at fair value on a recurring basis as of December 31, 2020 and 2019:

	As of
	December 31, 2020				December 31, 2019
(In thousands)	Fair Value		Carrying Value		Fair Value		Carrying Value
Other financial instruments
Assets:
Cash and cash equivalents	$	111,647	$	111,647	$	72,302	$	72,302
Restricted cash	175		175		175		175
Due from brokers	63,147		63,147		79,829		79,829
Reverse repurchase agreements	38,640		38,640		73,639		73,639
Liabilities:
Repurchase agreements	1,496,931		1,496,931		2,445,300		2,445,300
Other secured borrowings	51,062		51,062		150,334		150,334
Senior notes, net	86,000		85,561		88,365		85,298
Due to brokers	5,059		5,059		2,197		2,197

Cash and cash equivalents generally includes cash held in interest bearing overnight accounts, for which fair value equals the carrying value, and investments which are liquid in nature, such as investments in money market accounts or U.S. Treasury Bills, for which fair value equals the carrying value; such assets are considered Level 1. Restricted cash includes cash held in a segregated account for which fair value equals the carrying value; such assets are considered Level 1. Due from brokers and Due to brokers include collateral transferred to or received from counterparties, along with receivables and payables for open and/or closed derivative positions. These receivables and payables are short term in nature and any collateral transferred consists primarily of cash; fair value of these items is approximated by carrying value and such items are considered Level 1. The Company's reverse repurchase agreements, repurchase agreements, and other secured borrowings are carried at cost, which approximates fair value due to their short term nature. Reverse repurchase agreements, repurchase agreements, and other secured borrowings are classified as Level 2 based on the adequacy of the collateral and their short term nature. Senior notes, net are considered Level 3 liabilities given the relative unobservability of the most significant inputs to valuation estimation as well as the lack of trading activity of these instruments. As of December 31, 2020 and 2019, the estimated fair value of the Company's Senior notes was based on a third-party valuation.

Valuation

The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2018:

Description	Level 1		Level 2		Level 3		Total
	(In thousands)
Assets:
Cash equivalents	$	12,460	$	—	$	—	$	12,460
Investments, at fair value-
Agency residential mortgage-backed securities	$	—	$	1,442,924	$	7,293	$	1,450,217
U.S. Treasury securities	—		76		—		76
Private label residential mortgage-backed securities	—		211,348		91,291		302,639
Private label commercial mortgage-backed securities	—		33,105		803		33,908
Commercial mortgage loans	—		—		211,185		211,185
Residential mortgage loans	—		—		496,830		496,830
Collateralized loan obligations	—		108,978		14,915		123,893
Consumer loans and asset-backed securities backed by consumer loans	—		—		206,761		206,761
Corporate debt	—		16,074		6,318		22,392
Secured notes	—		—		10,917		10,917
Real estate owned	—		—		34,500		34,500
Common stock	2,200		—		—		2,200
Corporate equity investments	—		—		43,793		43,793
Total investments, at fair value	2,200		1,812,505		1,124,606		2,939,311
Financial derivatives–assets, at fair value-
Credit default swaps on asset-backed securities	—		—		1,472		1,472
Credit default swaps on corporate bond indices	—		733		—		733
Credit default swaps on corporate bonds	—		2,473		—		2,473
Credit default swaps on asset-backed indices	—		8,092		—		8,092
Total return swaps	—		1		—		1
Interest rate swaps	—		7,224		—		7,224
Forwards	—		6		—		6
Total financial derivatives–assets, at fair value	—		18,529		1,472		20,001
Repurchase agreements, at fair value	—		61,274		—		61,274
Total investments, financial derivatives–assets, and repurchase agreements, at fair value	$	2,200	$	1,892,308	$	1,126,078	$	3,020,586
Liabilities:
Investments sold short, at fair value-
Agency residential mortgage-backed securities	$	—	$	(772,964)	$	—	$	(772,964)
Government debt	—		(54,151)		—		(54,151)
Corporate debt	—		(6,529)		—		(6,529)
Common stock	(16,933)		—		—		(16,933)
Total investments sold short, at fair value	(16,933)		(833,644)		—		(850,577)

Description	Level 1		Level 2		Level 3		Total
(continued)	(In thousands)
Financial derivatives–liabilities, at fair value-
Credit default swaps on corporate bond indices	$	—	$	(11,557)	$	—	$	(11,557)
Credit default swaps on corporate bonds	—		(3,246)		—		(3,246)
Credit default swaps on asset-backed indices	—		(2,125)		—		(2,125)
Interest rate swaps	—		(3,397)		—		(3,397)
Total return swaps	—		(6)		—		(6)
Futures	(355)		—		—		(355)
Forwards	—		(120)		—		(120)
Total financial derivatives–liabilities, at fair value	(355)		(20,451)		—		(20,806)
Other secured borrowings, at fair value	—		—		(297,948)		(297,948)
Total investments sold short, financial derivatives–liabilities, and other secured borrowings, at fair value	$	(17,288)	$	(854,095)	$	(297,948)	$	(1,169,331)

The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2018:

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
	(In thousands)
Private label residential mortgage-backed securities	$	36,945	Market Quotes	Non Binding Third-Party Valuation	$	17.42		$	178.00		$	78.31
Collateralized loan obligations	5,828		Market Quotes	Non Binding Third-Party Valuation	2.64			375.00			167.78
Corporate debt, non-exchange traded corporate equity, and secured notes	13,976		Market Quotes	Non Binding Third-Party Valuation	9.69			91.00			59.18
Private label commercial mortgage-backed securities	576		Market Quotes	Non Binding Third-Party Valuation	5.93			6.36			6.14
Agency interest only residential mortgage-backed securities	744		Market Quotes	Non Binding Third-Party Valuation	1.70			9.12			5.64
Private label residential mortgage-backed securities	54,346		Discounted Cash Flows	Yield	3.5		%	66.1		%	10.7		%
				Projected Collateral Prepayments	16.0		%	92.1		%	50.4		%
				Projected Collateral Losses	0.0		%	23.1		%	8.7		%
				Projected Collateral Recoveries	1.5		%	14.6		%	7.3		%
				Projected Collateral Scheduled Amortization	6.1		%	61.8		%	33.6		%
											100.0		%
Private label commercial mortgage-backed securities	227		Discounted Cash Flows	Yield	3.4		%	3.4		%	3.4		%
				Projected Collateral Losses	2.0		%	2.0		%	2.0		%
				Projected Collateral Recoveries	6.6		%	6.6		%	6.6		%
				Projected Collateral Scheduled Amortization	91.4		%	91.4		%	91.4		%
											100.0		%
Corporate debt and non-exchange traded corporate equity	4,793		Discounted Cash Flows	Yield	17.5		%	17.5		%	17.5		%

(continued)	Fair Value		Valuation  Technique	Unobservable Input	Range				Weighted Average
Description					Min		Max
	(In thousands)
Collateralized loan obligations	$	9,087	Discounted Cash Flows	Yield	12.6	%	103.1	%	26.7	%
				Projected Collateral Prepayments	8.1	%	88.4	%	65.2	%
				Projected Collateral Losses	3.7	%	40.8	%	13.5	%
				Projected Collateral Recoveries	4.2	%	38.0	%	11.9	%
				Projected Collateral Scheduled Amortization	3.5	%	13.5	%	9.4	%
									100.0	%
Consumer loans and asset-backed securities backed by consumer loans	206,761		Discounted Cash Flows	Yield	7.0	%	18.3	%	8.5	%
				Projected Collateral Prepayments	0.0	%	45.9	%	33.5	%
				Projected Collateral Losses	2.6	%	84.8	%	9.1	%
				Projected Collateral Scheduled Amortization	15.2	%	96.6	%	57.4	%
									100.0	%
Performing commercial mortgage loans	163,876		Discounted Cash Flows	Yield	8.0	%	22.5	%	9.6	%
Non-performing commercial mortgage loans and commercial real estate owned	80,513		Discounted Cash Flows	Yield	9.6	%	27.4	%	13.2	%
				Months to Resolution	3.0		16.0		7.9
Performing residential mortgage loans	171,367		Discounted Cash Flows	Yield	2.7	%	12.9	%	6.0	%
Securitized residential mortgage loans(1)	314,202		Discounted Cash Flows	Yield	4.3	%	4.6	%	4.6	%
Non-performing residential mortgage loans and residential real estate owned	12,557		Discounted Cash Flows	Yield	4.3	%	25.1	%	11.3	%
				Months to Resolution(2)	1.9		42.2		27.8
Credit default swaps on asset-backed securities	1,472		Net Discounted Cash Flows	Projected Collateral Prepayments	33.6	%	42.0	%	36.5	%
				Projected Collateral Losses	11.1	%	15.6	%	12.8	%
				Projected Collateral Recoveries	10.3	%	18.7	%	15.8	%
				Projected Collateral Scheduled Amortization	32.0	%	36.5	%	34.9	%
									100.0	%
Agency interest only residential mortgage-backed securities	6,549		Option Adjusted Spread ("OAS")	LIBOR OAS(3)	211		3,521		677
				Projected Collateral Prepayments	37.7	%	100.0	%	66.2	%
				Projected Collateral Scheduled Amortization	0.0	%	62.3	%	33.8	%
									100.0	%
Non-exchange traded common equity investment in mortgage-related entity	6,750		Enterprise Value	Equity Price-to-Book(4)	3.3x		3.3x		3.3x
Non-exchange traded preferred equity investment in mortgage-related entity	27,317		Enterprise Value	Equity Price-to-Book(4)	1.1x		1.1x		1.1x
Non-exchange traded preferred equity investment in loan origination entity	3,000		Recent Transactions	Transaction Price	N/A		N/A		N/A
Non-controlling equity interest in limited liability company	5,192		Discounted Cash Flows	Yield(5)	12.9%		16.1%		15.4%
Other secured borrowings, at fair value(1)	(297,948)		Discounted Cash Flows	Yield	3.9%		4.4%		4.3%

(1)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFE as discussed in Note 2.

(2)Excludes certain loans that are re-performing.

(3)Shown in basis points.

(4)Represent an estimation of where market participants might value an enterprise on a price-to-book basis.

(5)Represents the significant unobservable inputs used to fair value the financial instruments of the limited liability company. The fair value of such financial instruments is the largest component of the valuation of the limited liability company as a whole.

Third-party non-binding valuations are validated by comparing such valuations to internally generated prices based on the Company's models and to recent trading activity in the same or similar instruments.

For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread ("OAS") valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to (b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset. The Company considers the expected timeline to resolution in the determination of fair value for its non-performing commercial and residential mortgage loans.

Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, for instruments subject to prepayments and credit losses, such as non-Agency RMBS and consumer loans and ABS backed by consumer loans, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such credit default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.

The tables below include a roll-forward of the Company's financial instruments for the year ended December 31, 2018 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.

Level 3—Fair Value Measurement Using Significant Unobservable Inputs:

Year Ended December 31, 2018

(In thousands)	Ending Balance as of  December 31, 2017		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/ Payments		Sales/ Issuances		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of  December 31, 2018
Assets:
Investments, at fair value-
Agency residential mortgage-backed securities	$	6,173	$	(2,233)	$	(10)	$	175	$	2,753	$	(1,169)	$	2,616	$	(1,012)	$	7,293
Private label residential mortgage-backed securities	101,297		383		1,838		(2,135)		75,685		(78,487)		7,074		(14,364)		91,291
Private label commercial mortgage-backed securities	12,347		(243)		2,229		2,120		1,481		(16,896)		—		(235)		803
Commercial mortgage loans	108,301		790		1,146		1,944		149,053		(50,049)		—		—		211,185
Residential mortgage loans	182,472		(1,965)		1,011		(34)		402,235		(86,889)		—		—		496,830
Collateralized loan obligations	24,911		(351)		317		(2,268)		33,549		(33,115)		3,959		(12,087)		14,915
Consumer loans and asset-backed securities backed by consumer loans	135,258		(29,320)		8,415		(1,092)		228,354		(134,854)		—		—		206,761
Corporate debt	23,947		56		241		(964)		7,665		(17,688)		—		(6,939)		6,318
Secured notes	—		870		—		(1,221)		11,268		—		—		—		10,917
Real estate owned	26,277		—		(653)		(1,003)		12,793		(2,914)		—		—		34,500
Corporate equity investments	37,465		—		1,671		8,299		12,708		(16,350)		—		—		43,793
Total investments, at fair value	658,448		(32,013)		16,205		3,821		937,544		(438,411)		13,649		(34,637)		1,124,606
Financial derivatives–assets, at fair value-
Credit default swaps on asset-backed securities	3,140		—		(687)		715		102		(1,798)		—		—		1,472
Total financial derivatives– assets, at fair value	3,140		—		(687)		715		102		(1,798)		—		—		1,472
Total investments and financial derivatives–assets, at fair value	$	661,588	$	(32,013)	$	15,518	$	4,536	$	937,646	$	(440,209)	$	13,649	$	(34,637)	$	1,126,078
Liabilities:
Other secured borrowings, at fair value	$	(125,105)	$	—	$	—	$	758	$	49,731	$	(223,332)	$	—	$	—	$	(297,948)
Total other secured borrowings, at fair value	$	(125,105)	$	—	$	—	$	758	$	49,731	$	(223,332)	$	—	$	—	$	(297,948)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at December 31, 2018, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2018. For Level 3 financial instruments held by the Company at December 31, 2018, change in net unrealized gain (loss) of $5.3 million, $(0.6) million, and $0.8 million, for the year ended December 31, 2018 relate to investments, financial derivatives–assets, and other secured borrowings, at fair value, respectively.

At December 31, 2018, the Company transferred $34.6 million of securities from Level 3 to Level 2 and $13.6 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

Not included in the disclosures above are the Company's other financial instruments, which are carried at cost and include, Cash, Due from brokers, Due to brokers, Reverse repurchase agreements, Other secured borrowings, and the Company's unsecured long-term debt, or the "Senior Notes," which is reflected on the Consolidated Statement of Assets,

Liabilities, and Equity in Senior notes, net. Cash includes cash held in various accounts including an interest bearing overnight account for which fair value equals the carrying value; such assets are considered Level 1 assets. Due from brokers and Due to brokers include collateral transferred to or received from counterparties, along with receivables and payables for open and/or closed derivative positions. These receivables and payables are short term in nature and any collateral transferred consists primarily of cash; carrying value of these items approximates fair value and such items are considered Level 1 assets and liabilities. The Company's reverse repurchase agreements and Other secured borrowings are carried at cost, which approximates fair value due to their short term nature. Reverse repurchase agreements and Other secured borrowings are considered Level 2 assets and liabilities based on the adequacy of the associated collateral and their short term nature. The Company estimates the fair value of the Senior Notes at $86.0 million as of December 31, 2018. The Senior Notes are considered Level 3 liabilities given the relative unobservability of the most significant inputs to valuation estimation as well as the lack of trading activity of these instruments.

XML

Investment in Securities

12 Months Ended

Dec. 31, 2020

Investments, Debt and Equity Securities [Abstract]

Investment in Securities

Investment in Securities

The Company's securities portfolio primarily consists of Agency RMBS, non-Agency RMBS, CMBS, CLOs, ABS backed by consumer loans, and corporate debt and equity. The following tables detail the Company's investment in securities as of December 31, 2020 and 2019.

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Current Principal		Unamortized Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon(1)		Yield		Life (Years)(2)
Long:
Agency RMBS:
15-year fixed-rate mortgages	$	67,875	$	2,543	$	70,418	$	1,832	$	(36)	$	72,214	3.30	%	1.83	%	3.24
20-year fixed-rate mortgages	50,131		3,097		53,228		182		—		53,410		2.57	%	1.08	%	4.46
30-year fixed-rate mortgages	626,021		30,738		656,759		25,765		(444)		682,080		3.99	%	2.35	%	4.17
Adjustable rate mortgages	6,171		159		6,330		124		—		6,454		3.66	%	2.27	%	3.42
Reverse mortgages	89,383		5,152		94,535		3,123		(29)		97,629		3.97	%	2.37	%	4.60
Interest only securities	n/a		n/a		43,406		5,808		(1,558)		47,656		3.36	%	10.01	%	4.85
Non-Agency RMBS	321,842		(131,083)		190,759		15,880		(5,549)		201,090		3.15	%	6.40	%	5.46
CMBS	188,085		(61,763)		126,322		1,655		(16,910)		111,067		2.71	%	7.47	%	8.09
Non-Agency interest only securities	n/a		n/a		8,123		1,792		(305)		9,610		1.17	%	18.85	%	3.49
CLOs	n/a		n/a		208,907		2,563		(30,199)		181,271		3.67	%	8.50	%	3.50
ABS backed by consumer loans	69,646		(24,936)		44,710		221		(6)		44,925		11.95	%	18.57	%	1.11
Corporate debt	27,083		(23,187)		3,896		1,296		(3)		5,189		2.13	%	6.75	%	3.10
Corporate equity	n/a		n/a		1,604		376		(390)		1,590		n/a		n/a		n/a
Total Long	1,446,237		(199,280)		1,508,997		60,617		(55,429)		1,514,185		3.84	%	4.88	%	4.45
Short:
Corporate debt	(200)		(1)		(201)		—		(17)		(218)		5.09	%	4.67	%	6.42
European sovereign bonds	(37,804)		3,163		(34,641)		—		(3,783)		(38,424)		0.23	%	0.06	%	3.11
Total Short	(38,004)		3,162		(34,842)		—		(3,800)		(38,642)		0.26	%	0.09	%	3.13
Total	$	1,408,233	$	(196,118)	$	1,474,155	$	60,617	$	(59,229)	$	1,475,543	3.92	%	4.77	%	4.49

(1)Weighted average coupon represents the weighted average coupons of the securities, rather than, in the case of collateralized securities, the coupon rates or loan rates on the underlying collateral.

(2)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Current Principal		Unamortized Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon(1)		Yield		Life (Years)(2)
Long:
Agency RMBS:
15-year fixed-rate mortgages	$	314,636	$	6,369	$	321,005	$	2,604	$	(203)	$	323,406	3.05	%	2.28	%	3.05
20-year fixed-rate mortgages	804		49		853		24		—		877		4.62	%	2.99	%	4.80
30-year fixed-rate mortgages	1,358,762		64,846		1,423,608		13,821		(2,830)		1,434,599		4.20	%	2.95	%	6.63
Adjustable rate mortgages	9,651		315		9,966		90		(54)		10,002		3.99	%	2.03	%	4.09
Reverse mortgages	122,670		8,133		130,803		2,023		(26)		132,800		4.43	%	2.78	%	6.67
Interest only securities	n/a		n/a		34,044		1,624		(389)		35,279		2.81	%	9.27	%	3.86
Non-Agency RMBS	274,353		(122,685)		151,668		12,549		(1,081)		163,136		3.41	%	7.25	%	5.31
CMBS	185,417		(67,961)		117,456		2,990		(480)		119,966		3.31	%	6.62	%	8.94
Non-Agency interest only securities	n/a		n/a		6,517		1,817		(18)		8,316		1.10	%	8.18	%	4.14
CLOs	n/a		n/a		169,238		4,219		(3,014)		170,443		5.05	%	9.62	%	4.75
ABS backed by consumer loans	67,080		(19,154)		47,926		1,596		(912)		48,610		12.17	%	14.00	%	1.22
Corporate debt	22,125		(21,241)		884		229		—		1,113		—	%	—	%	0.33
Corporate equity	n/a		n/a		1,242		152		—		1,394		n/a		n/a		n/a
Total Long	2,355,498		(151,329)		2,415,210		43,738		(9,007)		2,449,941		4.15	%	4.09	%	5.88
Short:
Corporate debt	(450)		(6)		(456)		—		(15)		(471)		5.44	%	5.21	%	4.90
U.S. Treasury securities	(63,140)		381		(62,759)		63		(298)		(62,994)		1.76	%	1.87	%	6.11
European sovereign bonds	(9,759)		133		(9,626)		—		(318)		(9,944)		0.77	%	0.12	%	1.58
Total Short	(73,349)		508		(72,841)		63		(631)		(73,409)		1.65	%	1.66	%	5.49
Total	$	2,282,149	$	(150,821)	$	2,342,369	$	43,801	$	(9,638)	$	2,376,532	4.23	%	4.01	%	5.90

(1)Weighted average coupon represents the weighted average coupons of the securities, rather than, in the case of collateralized securities, the coupon rates or loan rates on the underlying collateral.

(2)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

The following tables detail weighted average life of the Company's Agency RMBS as of December 31, 2020 and 2019.

December 31, 2020:

($ in thousands)	Agency RMBS						Agency Interest Only Securities
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(2)		Fair Value		Amortized Cost		Weighted Average Coupon(2)
Less than three years	$	139,059	$	135,844	4.15	%	$	8,143	$	7,314	3.99	%
Greater than three years and less than seven years	770,173		742,946		3.79	%	32,669		29,362		3.74	%
Greater than seven years and less than eleven years	2,555		2,480		3.01	%	5,165		5,063		1.04	%
Greater than eleven years	—		—		—	%	1,679		1,667		0.83	%
Total	$	911,787	$	881,270	3.84	%	$	47,656	$	43,406	3.36	%

(1)Expected average lives of RMBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

December 31, 2019:

($ in thousands)	Agency RMBS						Agency Interest Only Securities
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(2)		Fair Value		Amortized Cost		Weighted Average Coupon(2)
Less than three years	$	188,593	$	187,099	3.39	%	$	9,011	$	8,611	3.35	%
Greater than three years and less than seven years	961,839		953,031		4.25	%	25,334		24,512		2.66	%
Greater than seven years and less than eleven years	713,862		708,805		3.89	%	934		921		1.90	%
Greater than eleven years	37,390		37,300		3.51	%	—		—		—	%
Total	$	1,901,684	$	1,886,235	4.02	%	$	35,279	$	34,044	2.81	%

(1)Expected average lives of RMBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

The following tables detail weighted average life of the Company's long non-Agency RMBS, CMBS, and CLOs and other securities as of December 31, 2020 and 2019.

December 31, 2020:

($ in thousands)	Non-Agency RMBS and CMBS						Non-Agency IOs						CLOs and Other Securities(2)
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)
Less than three years	$	58,350	$	54,339	3.39	%	$	5,163	$	3,754	0.92	%	$	89,235	$	90,869	7.73	%
Greater than three years and less than seven years	114,815		109,161		3.45	%	4,447		4,369		1.37	%	139,830		163,670		3.69	%
Greater than seven years and less than eleven years	109,519		123,782		2.74	%	—		—		—	%	2,320		2,974		1.14	%
Greater than eleven years	29,473		29,799		1.46	%	—		—		—	%	—		—		—	%
Total	$	312,157	$	317,081	2.98	%	$	9,610	$	8,123	1.17	%	$	231,385	$	257,513	5.09	%

(1)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Other Securities includes asset-backed securities, backed by consumer loans and corporate debt.

(3)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

December 31, 2019:

($ in thousands)	Non-Agency RMBS and CMBS						Non-Agency IOs						CLOs and Other Securities(2)
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)
Less than three years	$	50,120	$	48,213	2.73	%	$	439	$	401	1.37	%	$	54,446	$	54,090	11.11	%
Greater than three years and less than seven years	87,436		79,326		4.42	%	7,877		6,116		1.08	%	157,384		155,651		5.38	%
Greater than seven years and less than eleven years	127,533		123,924		3.31	%	—		—		—	%	8,336		8,307		—	%
Greater than eleven years	18,013		17,661		0.81	%	—		—		—	%	—		—		—	%
Total	$	283,102	$	269,124	3.37	%	$	8,316	$	6,517	1.10	%	$	220,166	$	218,048	6.60	%

(1)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Other Securities includes asset-backed securities, backed by consumer loans, corporate debt, and U.S. Treasury securities.

(3)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

The following tables detail the components of interest income by security type for the years ended December 31, 2020 and 2019:

	Year Ended
(In thousands)	December 31, 2020						December 31, 2019
Security Type	Coupon Interest		Net Amortization		Interest Income		Coupon Interest		Net Amortization		Interest Income
Agency RMBS	$	59,987	$	(31,975)	$	28,012	$	62,103	$	(24,731)	$	37,372
Non-Agency RMBS and CMBS	15,257		5,775		21,032		13,855		2,782		16,637
CLOs	14,103		3,529		17,632		15,857		(1,599)		14,258
Other securities(1)	11,545		(4,986)		6,559		7,157		(2,468)		4,689
Total	$	100,892	$	(27,657)	$	73,235	$	98,972	$	(26,016)	$	72,956

(1)Other securities includes ABS backed by consumer loans, corporate debt securities, and U.S. Treasury securities.

For the years ended December 31, 2020 and 2019, the Catch-Up Premium Amortization Adjustment was $(4.5) million and $(4.7) million, respectively.

The following tables present proceeds from sales and the resulting realized gains and (losses) of the Company's securities for the years ended December 31, 2020 and 2019.

	Year Ended
(In thousands)	December 31, 2020								December 31, 2019(1)
Security Type	Proceeds(2)		Gross Realized Gains		Gross Realized Losses(3)		Net Realized Gain (Loss)		Proceeds(2)		Gross Realized Gains		Gross Realized Losses(3)		Net Realized Gain (Loss)
Agency RMBS	$	1,439,413	$	16,260	$	(3,481)	$	12,779	$	1,010,251	$	9,006	$	(2,254)	$	6,752
Non-Agency RMBS and CMBS	145,323		13,692		(4,187)		9,505		184,725		12,552		(4,869)		7,683
CLOs	46,632		1,122		(4,251)		(3,129)		62,063		1,286		(816)		470
Other securities(4)	188,152		1,662		(9)		1,653		636,886		1,113		2		1,115
Total	$	1,819,520	$	32,736	$	(11,928)	$	20,808	$	1,893,925	$	23,957	$	(7,937)	$	16,020

(1)Conformed to current period presentation.

(2)Includes proceeds on sales of securities not yet settled as of period end.

(3)Excludes realized losses of $(17.7) million and $(28.7) million, for the years ended December 31, 2020 and 2019, respectively, related to adjustments to the cost basis of certain securities for which the Company has determined all or a portion of such securities cost basis to be uncollectible.

(4)Other securities includes ABS backed by consumer loans, corporate debt and equity, exchange-traded equity, and U.S. Treasury securities.

The following table presents the fair value and gross unrealized losses of our long securities, excluding those where there are expected credit losses as of the balance sheet date in relation to such securities' cost bases, by length of time that such securities have been in an unrealized loss position at December 31, 2020.

December 31, 2020:

(In thousands)	Less than 12 Months				Greater than 12 Months				Total
Security Type	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Agency RMBS	$	126,926	$	(981)	$	832	$	(44)	$	127,758	$	(1,025)
Non-Agency RMBS and CMBS	20,474		(2,616)		2,599		(348)		23,073		(2,964)
CLOs	5,279		(753)		1,196		(1,131)		6,475		(1,884)
Other securities(1)	1,107		(8)		—		—		1,107		(8)
Total	$	153,786	$	(4,358)	$	4,627	$	(1,523)	$	158,413	$	(5,881)

(1)Other securities includes ABS backed by consumer loans and corporate debt and equity securities.

The following table presents the fair value and gross unrealized losses of our long securities by length of time that such securities have been in an unrealized loss position at December 31, 2019.

December 31, 2019:

(In thousands)	Less than 12 Months				Greater than 12 Months				Total
Security Type	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Agency RMBS	$	328,968	$	(1,503)	$	125,095	$	(1,999)	$	454,063	$	(3,502)
Non-Agency RMBS and CMBS	88,495		(880)		27,218		(699)		115,713		(1,579)
CLOs	37,354		(1,911)		9,245		(1,103)		46,599		(3,014)
Other securities(1)	16,562		(852)		1,380		(60)		17,942		(912)
Total	$	471,379	$	(5,146)	$	162,938	$	(3,861)	$	634,317	$	(9,007)

(1)Other securities includes ABS backed by consumer loans, corporate debt and equity, and U.S. Treasury securities.

As described in Note 2, the Company evaluates the cost basis of its securities for impairment on at least a quarterly basis. As of December 31, 2020, the Company had expected future credit losses, which it tracks for purposes of calculating interest income, of $24.9 million related to adverse changes in estimated future cash flows on its securities, primarily due to the economic impact of the COVID-19 pandemic. Certain of the Company's securities, at the date of acquisition, have experienced or are expected to experience more-than-insignificant deterioration in credit quality since origination and the Company has established an initial estimate for credit losses on such securities; as of December 31, 2020, the estimated credit losses on such securities was $2.6 million. As of December 31, 2020, the Company determined for certain securities that a portion of such securities cost basis is not collectible; for the year ended December 31, 2020, the Company recognized realized losses on these securities of $(17.7) million, which are reflected in Net realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

For the year ended December 31, 2019, the Company recognized an impairment charge of $28.7 million on the cost basis of its securities, which is included in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

XML

Investment in Loans

12 Months Ended

Dec. 31, 2020

Receivables [Abstract]

Investment in Loans

Investment in Loans

The Company invests in various types of loans, such as residential mortgage, commercial mortgage, consumer, and corporate loans. As discussed in Note 2, the Company has elected the FVO for its investments in loans. The following table is a summary of the Company's investments in loans as of December 31, 2020 and 2019:

	As of
(In thousands)	December 31, 2020				December 31, 2019
Loan Type	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
Residential mortgage loans	$	1,150,303	$	1,187,069	$	911,705	$	932,203
Commercial mortgage loans	212,716		213,031		277,870		274,759
Consumer loans	48,180		47,525		179,743		186,954
Corporate loans	5,855		5,855		18,415		18,510
Total	$	1,417,054	$	1,453,480	$	1,387,733	$	1,412,426

The Company is subject to credit risk in connection with its investments in loans. The two primary components of credit risk are default risk, which is the risk that a borrower fails to make scheduled principal and interest payments, and severity risk, which is the risk of loss upon a borrower default on a mortgage loan or other secured or unsecured loan. Severity risk includes the risk of loss of value of the property or other asset, if any, securing the loan, as well as the risk of loss associated with taking over the property or other asset, if any, including foreclosure costs. Credit risk in our loan portfolio can be amplified by exogenous shocks impacting our borrowers such as man-made or natural disasters, including the COVID-19 pandemic.

The following table provides details, by accrual status, for loans that are 90 days or more past due as of December 31, 2020 and 2019:

	As of
	December 31, 2020				December 31, 2019
(In thousands)	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
90 days or more past due—non-accrual status
Residential mortgage loans	$	64,509	$	60,381	$	22,092	$	19,401
Commercial mortgage loans	44,233		44,052		28,936		26,545
Consumer loans	1,015		930		5,633		5,225

Residential Mortgage Loans

The tables below detail certain information regarding the Company's residential mortgage loans as of December 31, 2020 and 2019.

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield		Life (Years)(1)
Residential mortgage loans, held-for-investment(2)	$	1,150,303	$	14,263	$	1,164,566	$	27,892	$	(5,389)	$	1,187,069	6.19	%	5.60	%	1.90

(1)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

(2)Includes $801.3 million of non-QM loans that have been securitized and are held in consolidated securitization trusts. Such loans had $24.8 million and $(0.1) million of gross unrealized gains and gross unrealized losses, respectively; such unrealized gains (losses) are included on the Company's Consolidated Statement of Operations in Unrealized gains (losses) on securities and loans, net. See Residential Mortgage Loan Securitizations in Note 10 for additional information.

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield		Life (Years)(1)
Residential mortgage loans, held-for-investment(2)	$	911,705	$	9,354	$	921,059	$	13,082	$	(1,938)	$	932,203	6.44	%	5.79	%	1.90

(1)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

(2)Includes $628.4 million of non-QM loans that have been securitized and are held in consolidated securitization trusts. Such loans had $11.3 million and $(0.1) million of gross unrealized gains and gross unrealized losses, respectively; such unrealized gains (losses) are included on the Company's Consolidated Statement of Operations in Unrealized gains (losses) on securities and loans, net. See Residential Mortgage Loan Securitizations in Note 10 for additional information.

The table below summarizes the geographic distribution of the real estate collateral underlying the Company's residential mortgage loans as a percentage of total outstanding unpaid principal balance as of December 31, 2020 and 2019:

Property Location by U.S. State	December 31, 2020		December 31, 2019
California	43.1	%	46.6	%
Florida	14.8	%	11.9	%
Texas	10.2	%	11.9	%
Colorado	3.1	%	3.2	%
Massachusetts	2.6	%	2.9	%
Oregon	2.2	%	2.2	%
Arizona	2.0	%	2.4	%
Nevada	1.9	%	1.6	%
Illinois	1.8	%	1.7	%
Utah	1.7	%	1.9	%
New York	1.6	%	1.3	%
Washington	1.4	%	1.6	%
New Jersey	1.4	%	1.1	%
Georgia	1.3	%	0.7	%
North Carolina	1.1	%	0.8	%
Maryland	1.0	%	1.1	%
Other	8.8	%	7.1	%
	100.0	%	100.0	%

The following table presents information on the Company's residential mortgage loans by re-performing or non-performing status, as of December 31, 2020 and 2019.

	As of
	December 31, 2020				December 31, 2019
(In thousands)	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
Re-performing	$	18,120	$	16,741	$	27,663	$	25,323
Non-performing	62,009		58,169		17,757		15,580

As described in Note 2, the Company evaluates the cost basis of its residential mortgage loans for impairment on at least a quarterly basis. At December 31, 2020, the Company had expected future credit losses, which it tracks for purposes of calculating interest income, of $2.2 million related to adverse changes in estimated future cash flows on its residential mortgage loans, primarily due to the economic impact of the COVID-19 pandemic. Certain of the Company's residential mortgage loans, at the date of acquisition, have experienced or are expected to experience more-than-insignificant deterioration in credit quality since origination and the Company has established an initial estimate for credit losses on such loans; as of December 31, 2020, the estimated credit losses on such loans was $0.2 million. The Company has determined for certain of its residential mortgage loans that a portion of such loans' cost basis is not collectible; for the year ended December 31, 2020, the Company recognized realized losses on these loans of $(0.8) million, which are reflected in Net realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

For the year ended December 31, 2019, the Company recognized an impairment charge of $0.9 million on the cost basis of its residential mortgage loans, which is included in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

As of December 31, 2020 and 2019, the Company had residential mortgage loans that were in the process of foreclosure with a fair value of $14.9 million and $10.9 million, respectively.

Commercial Mortgage Loans

The tables below detail certain information regarding the Company's commercial mortgage loans as of December 31, 2020 and 2019:

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield(1)		Life (Years)(2)
Commercial mortgage loans, held-for-investment	$	212,716	$	290	$	213,006	$	479	$	(454)	$	213,031	8.38	%	8.28	%	0.62

(1)Excludes non-performing commercial mortgage loans, in non-accrual status, with a fair value of $31.5 million.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield(1)		Life (Years)(2)
Commercial mortgage loans, held-for-investment	$	277,870	$	(3,302)	$	274,568	$	253	$	(62)	$	274,759	7.65	%	8.58	%	1.07

(1)Excludes commercial mortgage loans, held at par in non-accrual status, with a fair value of $10.7 million.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

The table below summarizes the geographic distribution of the real estate collateral underlying the Company's commercial mortgage loans as a percentage of total outstanding unpaid principal balance as of December 31, 2020 and 2019:

Property Location by U.S. State	December 31, 2020		December 31, 2019
Florida	23.8	%	31.7	%
New York	15.2	%	17.7	%
Connecticut	11.2	%	8.2	%
Missouri	7.9	%	4.6	%
Ohio	7.3	%	—	%
California	5.9	%	—	%
Massachusetts	6.1	%	4.7	%
New Jersey	5.8	%	13.3	%
Arizona	4.3	%	3.8	%
Virginia	4.2	%	6.8	%
Indiana	2.8	%	2.1	%
North Carolina	2.2	%	1.8	%
Nevada	1.9	%	1.5	%
Tennessee	—	%	1.5	%
Illinois	1.4	%	1.2	%
Other	—	%	1.1	%
	100.0	%	100.0	%

As of December 31, 2020, the Company had three non-performing commercial mortgage loans with an unpaid principal balance and fair value of $31.8 million and $31.5 million, respectively. As of December 31, 2019, the Company had three non-performing commercial mortgage loans with an unpaid principal balance and fair value of $28.9 million and $26.5 million, respectively.

As described in Note 2, the Company evaluates the cost basis of its commercial mortgage loans for impairment on at least a quarterly basis. At December 31, 2020, the expected future credit losses, which it tracks for purposes of calculating interest income, of $0.4 million related to adverse changes in estimated future cash flows on its commercial mortgage loans. For the year ended December 31, 2019, the Company did not recognize any impairment charge on the cost basis of its commercial mortgage loans.

As of December 31, 2020 the Company had one commercial mortgage loan with a fair value of $10.5 million that was in the process of foreclosure. As of December 31, 2019, the Company had two commercial mortgage loans with a fair value of $16.0 million that were in the process of foreclosure.

Consumer Loans

The tables below detail certain information regarding the Company's consumer loans as of December 31, 2020 and 2019:

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value(1)		Life (Years)(2)	Delinquency (Days)
Consumer loans, held-for-investment	$	48,180	$	72	$	48,252	$	1,160	$	(1,887)	$	47,525	1.04	7

(1)Includes $0.6 million of charged-off loans for which the Company has determined that it is probable the servicer will be able to collect principal and interest.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value(1)		Life (Years)(2)	Delinquency (Days)
Consumer loans, held-for-investment	$	179,743	$	5,027	$	184,770	$	2,561	$	(377)	$	186,954	0.82	4

(1)Includes $0.6 million of charged-off loans for which the Company has determined that it is probable the servicer will be able to collect principal and interest.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

The table below provides details on the delinquency status as a percentage of total unpaid principal balance of the Company's consumer loans, which the Company uses as an indicator of credit quality, as of December 31, 2020 and 2019:

Days Past Due	December 31, 2020		December 31, 2019
Current	90.4	%	95.3	%
30-59 Days	3.4	%	2.1	%
60-89 Days	3.3	%	1.4	%
90-119 Days	2.8	%	1.2	%
>120 Days	0.1	%	—	%
	100.0	%	100.0	%

During the years ended December 31, 2020 and 2019, the Company charged off $20.9 million and $19.0 million, respectively, of unpaid principal balance of consumer loans that were greater than 120 days delinquent. As of both December 31, 2020 and 2019, the Company held charged-off consumer loans with an aggregate fair value of $0.6 million for which the Company has determined that it is probable the servicer will be able to collect principal and interest.

As described in Note 2, the Company evaluates the cost basis of its consumer loans for impairment on at least a quarterly basis. At December 31, 2020, the Company had expected future credit losses, which it tracks for purposes of calculating interest income, of $2.9 million on its consumer loans. The Company has determined for certain of its consumer loans that a portion of such loans' cost basis is not collectible; for the year ended December 31, 2020, the Company recognized realized losses on these loans of $3.2 million.

For the year ended December 31, 2019, the Company recognized an impairment charge of $6.3 million on the cost basis of its consumer loan pools, which is included in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

Corporate Loans

The tables below detail certain information regarding the Company's corporate loans as of December 31, 2020 and 2019:

December 31, 2020:

					Weighted Average
($ in thousands)	Unpaid Principal Balance		Fair Value		Rate		Remaining Term (Years)
Corporate loans, held-for-investment(1)	$	5,855	$	5,855	20.00	%	1.75

(1)See Note 21 for further details on the Company's unfunded commitments related to certain of its corporate loans.

December 31, 2019:

					Weighted Average
($ in thousands)	Unpaid Principal Balance		Fair Value		Rate		Remaining Term (Years)
Corporate loans, held-for-investment(1)(2)	$	18,415	$	18,510	17.62	%	0.87

(1)See Note 13 for further details on the Company's transactions involving a loan originator in which the Company also holds an equity investment.

(2)See Note 21 for further details on the Company's unfunded commitments related to certain of its corporate loans.

XML

Investments in Unconsolidated Entities

12 Months Ended

Dec. 31, 2020

Equity Method Investments and Joint Ventures [Abstract]

Investments in Unconsolidated Entities

Investments in Unconsolidated EntitiesThe Company has various equity investments in entities where it has the ability to exert significant influence over such entity, but does not control such entity. In these cases the criteria for consolidation have not been met and the Company is required to account for such investments under ASC 323-10; the Company has elected the FVO for its investments in unconsolidated entities. As of December 31, 2020 and 2019, the Company's investments in unconsolidated entities had an aggregate fair value of $141.6 million and $71.9 million, respectively, which is included on the Consolidated Balance Sheet in Investments in unconsolidated entities, at fair value. For the years ended December 31, 2020 and 2019, the Company recognized $37.9 million and $10.2 million, respectively, in Earnings (losses) from investments in unconsolidated entities, on its Consolidated Statement of Operations, primarily related to its investment in loan originators. As of December 31, 2020 and 2019, the Company had non-controlling equity interests in three loan originators with an aggregate fair value of $79.5 million and $40.6 million, respectively. Certain of the entities that the Company accounts for under ASC 323-10 are deemed to be VIEs, and the maximum amount at risk is generally limited to the Company's investment in the VIE. As of December 31, 2020 and 2019, the fair value of the Company's investments in unconsolidated entities that have been deemed to be VIEs was $13.6 million and $28.5 million.

The following table provides details about the Company's investments in unconsolidated entities as of December 31, 2020 and 2019:

		Percentage Ownership of Unconsolidated Entity
Investment in Unconsolidated Entity	Form of Investment	December 31, 2020	December 31, 2019
Longbridge Financial, LLC(1)	Preferred shares	49.7%	49.7%
LendSure Mortgage Corp.(1)(2)	Common shares	49.9%	49.9%
Elizon TCG SBC 2017-1(1)	Membership Interest	36.0%	—%
Jepson Holdings Limited(1)	Membership Interest	30.1%	30.1%
Elizon DB 2015-1 LLC(1)(3)(4)	Membership Interest	8.9%	3.5%
Elizon AFG 2018-1 LLC(1)(3)(5)	Membership Interest	—%	13.4%
Other(6)(7)	Various	7.4%–56.3%	7.7%–51.0%

(1)See Note 13 for additional details on the Company's related party transactions.

(2)Excludes investment in warrants convertible into non-voting common shares; including such warrants the Company's additional non-voting stake in the entity was 15.0% as of December 31, 2020. See Note 13 Related Party Transactions—Transactions Involving Certain Loan Originators for additional information.

(3)The Company has evaluated this entity and determined that it meets the definition of a VIE. The Company evaluated its interest in the VIE and determined that the Company does not have the power to direct the activities of the VIE and does not have control of the underlying assets, where applicable. As a result, the Company determined that it is not the primary beneficiary of this VIE and therefore has not consolidated the VIE.

(4)As discussed in Note 13 Related Party Transactions—Participation in Multi-Borrower Financing Facilities, the Company and the Affiliated Entities (as defined in Note 13) each consolidate their segregated silos of the Joint Entity (as defined in Note 13). The Company's effective percentage ownership before the effects of consolidation of both its and the Affiliated Entities' respective segregated silos of the Joint Entity, was 58.2% and 70.4% as of December 31, 2020 and 2019, respectively.

(5)As discussed in Note 13 Related Party Transactions—Participation in Multi-Borrower Financing Facilities, the Company and the Affiliated Entities each consolidate their segregated silos of the Joint Entity. The Company's effective percentage ownership before the effects of consolidation of both its and the Affiliated Entities' respective segregated silos of the Joint Entity, was 48.7% as of December 31, 2019.

(6)Includes interest in Consumer Risk Retention Vehicle, as defined in Note 10—Participation in Multi-Seller Consumer Loan Securitization. The Company has evaluated this entity and determined that it does not meet the definition of a VIE. The Company evaluated its interest in the entity under the voting interest model outlined in ASC 810, and has determined that the Company does not control this entity. As a result, the Company has not consolidated the entity. See Note 10 for additional details on the Company's securitization transactions.

(7)Includes interest in warehouse facilities; see Note 13—Participation in CLO Transactions, for additional details.

The following table provides a summary of the combined financial position of the unconsolidated entities as of December 31, 2020 and 2019, in which the Company has an investment:

	December 31, 2020		December 31, 2019
	(In thousands)
Assets
Investments in securities, loans, MSRs, and REO(1)	$	424,475	$	560,949
Other assets	117,746		65,580
Total assets	$	542,221	$	626,529
Liabilities
Borrowings	$	215,792	$	387,910
Other liabilities	30,801		28,134
Total liabilities	246,593		416,044
Equity	295,628		210,485
Total liabilities and equity	$	542,221	$	626,529

(1)Includes investments carried as the lower of cost or fair value as well as investments where the unconsolidated entity has elected the FVO.

The following table provides a summary of the combined results of operations of the unconsolidated entities as of December 31, 2020 and 2019, in which the Company has an investment:

	Year Ended December 31, 2020		Year Ended December 31, 2019
			(In thousands)
Net Interest Income
Interest income	$	10,935	$	30,587
Interest expense	(9,243)		(13,316)
Total net interest income	1,692		17,271
Other Income (Loss)
Realized and unrealized gains (losses) on securities, loans, MSRs, and REO, net	44,362		40,901
Other, net	44,031		31,848
Total other income (loss)	88,393		72,749
Total expenses	65,492		58,018
Net income (loss) before income tax expense	24,593		32,002
Income tax expense (benefit)	776		979
Net Income (Loss)	$	23,817	$	31,023

XML

Real Estate Owned

12 Months Ended

Dec. 31, 2020

Real Estate Owned, Disclosure of Detailed Components [Abstract]

Real Estate Owned

Real Estate Owned

As discussed in Note 2, the Company obtains possession of REO as a result of foreclosures on the associated mortgage loans. The following tables detail activity in the Company's carrying value of REO for the years ended December 31, 2020 and 2019:

	Year Ended
	December 31, 2020			December 31, 2019
	Number of Properties	Carrying Value		Number of Properties	Carrying Value
		(In thousands)			(In thousands)
Beginning Balance (December 31, 2019 and January 1, 2019, respectively)	15	$	30,584	20	$	30,778
Transfers from mortgage loans	10	3,384		8	22,577
Capital expenditures and other adjustments to cost		191			240
Adjustments to record at the lower of cost or fair value		(1,053)			(1,002)
Disposals	(12)	(9,508)		(13)	(22,009)
Ending Balance (December 31, 2020 and 2019, respectively)	13	$	23,598	15	$	30,584

During the year ended December 31, 2020, the Company sold twelve REO properties, realizing a net gain (loss) of approximately $15 thousand. During the year ended December 31, 2019, the Company sold thirteen REO properties, realizing a net gain (loss) of approximately $2.3 million. Such realized gains (losses) are included in Realized gains (losses) on real estate owned, net, on the Company's Consolidated Statement of Operations. As of December 31, 2020 and 2019 all of the Company's REO had been obtained as a result of obtaining physical possession through foreclosure. As of December 31, 2020 and 2019, the Company had REO measured at fair value on a non-recurring basis of $22.4 million and $19.4 million, respectively.

XML

To Be Announced RMBS

12 Months Ended

Dec. 31, 2020

To Be Announced RMBS [Abstract]

To Be Announced RMBS

To Be Announced RMBS

In addition to investing in pools of Agency RMBS, the Company transacts in the forward settling TBA market. Pursuant to these TBA transactions, the Company agrees to purchase or sell, for future delivery, Agency RMBS with certain principal and interest terms and certain types of underlying collateral, but the particular Agency RMBS to be delivered is not identified until shortly before the TBA settlement date. TBAs are liquid and have quoted market prices and represent the most actively traded class of MBS. The Company accounts for its TBAs as purchases and sales and uses TBAs primarily for hedging purposes, typically in the form of short positions. However, the Company may also invest in TBAs for speculative purposes, including holding long positions. Overall, the Company typically holds a net short position.

The Company does not generally take delivery of TBAs; rather, it settles the associated receivable and payable with its trading counterparties on a net basis. Transactions with the same counterparty for the same TBA that result in a reduction of the position are treated as extinguished. The fair value of the Company's long positions in TBA contracts are reflected on the Consolidated Condensed Schedule of Investments under TBA–Fixed-Rate Agency Securities and the fair value of the Company's positions in TBA contracts sold short are reflected on the Consolidated Condensed Schedule of Investments under TBA–Fixed-Rate Agency Securities Sold Short. The payables and receivables related to the Company's TBA securities are included on the Consolidated Statement of Assets, Liabilities, and Equity in Payable for securities purchased and Receivable for securities sold, respectively.

The below table details TBA assets, liabilities, and the respective related payables and receivables as of December 31, 2018:

(In thousands)	As of December 31, 2018
Assets:
TBA securities, at fair value (Current principal: $460,037)	$	474,860
Receivable for securities sold relating to unsettled TBA sales	766,574
Liabilities:
TBA securities sold short, at fair value (Current principal: -$753,697)	$	(772,964)
Payable for securities purchased relating to unsettled TBA purchases	(473,386)
Net short TBA securities, at fair value	(298,104)

XML

Financial Derivatives

12 Months Ended

Dec. 31, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Derivatives

Financial Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages certain risks associated with its investments and borrowings, including interest rate, credit, liquidity, and foreign exchange rate risk primarily by managing the amount, sources, and duration of its investments and borrowings, and through the use of derivative financial instruments. The Company's derivative financial instruments are used to manage differences in the amount, timing, and duration of its known or expected cash receipts and its known or expected cash payments principally related to its investments and borrowings.

The following table details the fair value of the Company's holdings of financial derivatives as of December 31, 2020 and 2019:

	December 31, 2020		December 31, 2019
(In thousands)
Financial derivatives–assets, at fair value:
TBA securities purchase contracts	$	961	$	90
TBA securities sale contracts	1		506
Fixed payer interest rate swaps	125		3,914
Fixed receiver interest rate swaps	8,394		1,554
Credit default swaps on asset-backed securities	347		993
Credit default swaps on asset-backed indices	2,184		3,319
Credit default swaps on corporate bonds	—		2
Credit default swaps on corporate bond indices	3,420		5,599
Total return swaps	9		620
Futures	2		148
Forwards	—		43
Warrants	36		—
Total financial derivatives–assets, at fair value	15,479		16,788
Financial derivatives–liabilities, at fair value:
TBA securities sale contracts	$	(925)	$	(1,012)
Fixed payer interest rate swaps	(15,109)		(8,513)
Fixed receiver interest rate swaps	(65)		(206)
Credit default swaps on asset-backed indices	(130)		(250)
Credit default swaps on corporate bonds	(747)		(1,693)
Credit default swaps on corporate bond indices	(6,438)		(14,524)
Total return swaps	(484)		(1,209)
Futures	(376)		(45)
Forwards	(279)		(169)
Total financial derivatives–liabilities, at fair value	(24,553)		(27,621)
Total	$	(9,074)	$	(10,833)

Interest Rate Swaps

The following tables provide information about the Company's fixed payer interest rate swaps as of December 31, 2020 and 2019:

December 31, 2020:

					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	17,500	$	(231)	2.75	%	0.24	%	0.22
2022	96,533		(1,535)		1.19		0.22		1.14
2023	146,012		(4,770)		1.50		0.23		2.42
2025	66,503		(1,034)		0.73		0.21		4.75
2026	11,216		(458)		1.23		0.25		5.50
2027	9,732		60		0.49		0.24		6.48
2028	16,644		(2,169)		2.39		0.24		7.32
2029	22,744		(2,289)		1.94		0.23		8.61
2030	13,015		(369)		1.13		0.22		9.29
2035	500		15		0.78		0.09		14.81
2036	1,100		(47)		1.45		0.25		15.13
2040	500		20		0.90		0.09		19.82
2049	5,796		(2,208)		2.89		0.23		28.02
2050	500		31		0.98		0.09		29.82
Total	$	408,295	$	(14,984)	1.39	%	0.23	%	3.82

December 31, 2019:

					Weighted Average
Maturity	Notional Amount(1)		Fair Value(1)		Pay Rate(2)(3)		Receive Rate(2)		Remaining Years to Maturity(4)
	(In thousands)
2020	$	68,607	$	(234)	1.74	%	1.93	%	0.24
2021	268,929		(419)		1.73		1.95		1.64
2022	31,350		9		1.65		1.93		2.14
2023	101,012		(1,265)		2.06		1.91		3.29
2024	13,000		99		1.56		1.89		4.90
2025	12,800		(24)		n/a		n/a		5.22
2026	59,902		1,946		1.24		1.94		6.50
2028	32,942		(1,634)		2.40		1.93		8.34
2029	136,838		(2,018)		2.02		1.96		9.61
2030	685		(32)		2.38		1.90		10.90
2036	1,100		87		1.45		1.94		16.14
2049	5,796		(1,114)		2.89		2.09		29.03
Total	$	732,961	$	(4,599)	1.83	%	1.94	%	4.31

(1)Includes forward-starting interest rate swaps with a notional amount of $20.9 million and fair value of $(41) thousand.

(2)Excludes forward-starting interest rate swaps.

(3)Including forward-starting interest rate swaps the total weighted average pay rate was 1.83%.

(4)Includes forward-starting interest rate swaps, all of which start within six months of period end.

The following tables provide information about the Company's fixed receiver interest rate swaps as of December 31, 2020 and 2019:

December 31, 2020:

					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	12,950	$	205	0.24	%	1.75	%	0.71
2022	103,974		1,413		0.22		1.07		1.48
2023	48,657		2,209		0.24		2.00		2.26
2024	86,342		4,567		0.22		1.65		3.73
2035	500		(14)		0.09		0.74		14.81
2040	500		(20)		0.09		0.84		19.82
2050	500		(31)		0.09		0.90		29.82
Total	$	253,423	$	8,329	0.22	%	1.48	%	2.48

December 31, 2019:

					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	181,950	$	(49)	1.89	%	1.67	%	1.84
2022	53,974		441		1.91		1.85		2.17
2023	48,657		709		1.92		2.00		3.26
2024	11,342		306		2.09		2.33		4.23
2029	9,800		(59)		1.91		1.78		9.77
Total	$	305,723	$	1,348	1.91	%	1.78	%	2.47

Credit Default Swaps

The following table provides information about the Company's credit default swaps as of December 31, 2020 and 2019:

	As of
	December 31, 2020					December 31, 2019
Type(1)	Notional		Fair Value		Weighted Average Remaining Term (Years)	Notional		Fair Value		Weighted Average Remaining Term (Years)
($ in thousands)
Asset:
Long:
Credit default swaps on asset-backed indices	$	395	$	5	16.99	$	695	$	10	23.80
Credit default swaps on corporate bonds	—		—		—	430		2		0.47
Credit default swaps on corporate bond indices	67,779		3,296		2.52	130,707		5,547		2.42
Short:
Credit default swaps on asset-backed securities	(957)		347		14.70	(2,640)		993		15.63
Credit default swaps on asset-backed indices	(12,888)		2,179		39.61	(63,515)		3,309		38.40
Credit default swaps on corporate bond indices	(2,173)		124		2.97	(1,997)		52		3.97
Liability:
Long:
Credit default swaps on asset-backed indices	479		(130)		32.36	344		(145)		29.35
Short:
Credit default swaps on asset-backed indices	(1)		—		29.00	(4,501)		(105)		40.31
Credit default swaps on corporate bonds	(8,400)		(747)		4.17	(10,800)		(1,693)		3.92
Credit default swaps on corporate bond indices	(110,624)		(6,438)		2.78	(250,088)		(14,524)		2.51
	$	(66,390)	$	(1,364)	10.25	$	(201,365)	$	(6,554)	14.88

(1)Long notional represents contracts where the Company has written protection and short notional represents contracts where the Company has purchased protection.

Futures

The following table provides information about the Company's long and short positions in futures as of December 31, 2020 and 2019:

	As of
	December 31, 2020					December 31, 2019
Description	Notional Amount		Fair Value		Remaining Months to Expiration	Notional Amount		Fair Value		Remaining Months to Expiration
	(In thousands)					(In thousands)
Assets:
Short Contracts:
U.S. Treasury futures	$	(300)	$	2	2.70	$	—	$	—	—
Liabilities:
Long Contracts:
U.S. Treasury futures	1,900		(9)		2.70	—		—		—
Short Contracts:
U.S. Treasury futures	(178,200)		(367)		2.94	(16,000)		148		2.77
Eurodollar futures	—		—		—	(14,000)		(45)		4.05
Total, net	$	(176,600)	$	(374)	2.94	$	(30,000)	$	103	3.37

Warrants

The following table provides information about the Company's warrants contracts to purchase shares as of December 31, 2020 and 2019:

	December 31, 2020				As of December, 31, 2019
Description	Number of Shares Underlying Warrant	Fair Value		Remaining Years to Expiration	Number of Shares Underlying Warrant	Fair Value		Remaining Years to Expiration
	(In thousands)				(In thousands)
Warrants	1,897	$	36	2.40	1,515	$	—	2.82

TBAs

The Company transacts in the forward settling TBA market. Pursuant to these TBA transactions, the Company agrees to purchase or sell, for future delivery, Agency RMBS with certain principal and interest terms and certain types of underlying collateral, but the particular Agency RMBS to be delivered is not identified until shortly before the TBA settlement date. TBAs are generally liquid, have quoted market prices, and represent the most actively traded class of MBS. The Company uses TBAs to mitigate interest rate risk, usually by taking short positions. The Company also invests in TBAs as a means of acquiring additional exposure to Agency RMBS, or for investment purposes, including holding long positions.

The Company does not generally take delivery of TBAs; rather, it settles the associated receivable and payable with its trading counterparties on a net basis. Transactions with the same counterparty for the same TBA that result in a reduction of the position are treated as extinguished.

As of December 31, 2020 and 2019, the Company had outstanding TBA purchase and sale contracts as follows:

	December 31, 2020								December 31, 2019
TBA Securities	Notional Amount(1)		Cost Basis(2)		Market Value(3)		Net Carrying Value(4)		Notional Amount(1)		Cost Basis(2)		Market Value(3)		Net Carrying Value(4)
(In thousands)
Purchase contracts:
Assets	$	149,990	$	155,008	$	155,969	$	961	$	40,100	$	40,585	$	40,675	$	90
Liabilities	—		—		—		—		—		—		—		—
	149,990		155,008		155,969		961		40,100		40,585		40,675		90
Sale contracts:
Assets	(4,400)		(4,765)		(4,764)		1		(319,981)		(332,080)		(331,574)		506
Liabilities	(499,667)		(531,034)		(531,959)		(925)		(773,749)		(806,568)		(807,580)		(1,012)
	(504,067)		(535,799)		(536,723)		(924)		(1,093,730)		(1,138,648)		(1,139,154)		(506)
Total TBA securities, net	$	(354,077)	$	(380,791)	$	(380,754)	$	37	$	(1,053,630)	$	(1,098,063)	$	(1,098,479)	$	(416)

(1)Notional amount represents the principal balance of the underlying Agency RMBS.

(2)Cost basis represents the forward price to be paid (received) for the underlying Agency RMBS.

(3)Market value represents the current market value of the underlying Agency RMBS (on a forward delivery basis) as of period end.

(4)Net carrying value represents the difference between the market value of the TBA contract as of period end and the cost basis, and is reported in Financial derivatives-assets, at fair value and Financial derivatives-liabilities, at fair value on the Consolidated Balance Sheet.

Gains and losses on the Company's derivative contracts for the years ended December 31, 2020 and 2019 are summarized in the tables below:

Year Ended December 31, 2020:

Derivative Type	Primary  Risk Exposure	Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps		Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)		Net Realized Gains (Losses) on Financial Derivatives(1)		Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps		Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)		Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)
(In thousands)
Interest rate swaps	Interest Rate	$	(2,038)	$	(17,060)	$	(19,098)	$	219	$	(6,597)	$	(6,378)
Credit default swaps on asset-backed securities	Credit			(5,452)		(5,452)				5,402		5,402
Credit default swaps on asset-backed indices	Credit			6,486		6,486				2,691		2,691
Credit default swaps on corporate bond indices	Credit			1,502		1,502				(712)		(712)
Credit default swaps on corporate bonds	Credit			285		285				486		486
Total return swaps	Credit			(2,057)		(2,057)				114		114
TBAs	Interest Rate			(4,624)		(4,624)				454		454
Futures	Interest Rate			(7,447)		(7,447)				(477)		(477)
Forwards	Currency			(1,004)		(1,004)				(153)		(153)
Warrants	Equity Market/Credit			—		—				(377)		(377)
Options	Credit			(100)		(100)				—		—
Total		$	(2,038)	$	(29,471)	$	(31,509)	$	219	$	831	$	1,050

(1)Includes realized gain/(loss) on transactions involving foreign-currency-denominated financial derivatives in the amount of $12 thousand for the year ended December 31, 2020, which is included on the Consolidated Statement of Operations in Other, net.

(2)Includes foreign currency remeasurement on financial derivatives in the amount of $61 thousand for the year ended December 31, 2020, which is included on the Consolidated Statement of Operations in Other, net.

Year Ended December 31, 2019:

Derivative Type	Primary  Risk Exposure	Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps		Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)		Net Realized Gains (Losses) on Financial Derivatives(1)		Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps		Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)		Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)
(In thousands)
Interest rate swaps	Interest Rate	$	1,695	$	(876)	$	819	$	(764)	$	(5,778)	$	(6,542)
Credit default swaps on asset-backed securities	Credit			528		528				(479)		(479)
Credit default swaps on asset-backed indices	Credit			(1,883)		(1,883)				(1,848)		(1,848)
Credit default swaps on corporate bond indices	Credit			(5,262)		(5,262)				(1,364)		(1,364)
Credit default swaps on corporate bonds	Credit			(708)		(708)				1,007		1,007
Total return swaps	Equity Market/Credit			(1,460)		(1,460)				(584)		(584)
TBAs	Interest Rate			(15,755)		(15,755)				4,026		4,026
Futures	Interest Rate/Currency			(7,924)		(7,924)				458		458
Forwards	Currency			813		813				(12)		(12)
Options	Interest Rate			(35)		(35)				1		1
Total		$	1,695	$	(32,562)	$	(30,867)	$	(764)	$	(4,573)	$	(5,337)

(1)Includes realized gain/(loss) on transactions involving foreign-currency-denominated financial derivatives in the amount of $45 thousand for the year ended December 31, 2019, which is included on the Consolidated Statement of Operations in Other, net.

(2)Includes foreign currency remeasurement on financial derivatives in the amount of $1 thousand for the year ended December 31, 2019, which is included on the Consolidated Statement of Operations in Other, net.

The table below details the average notional values of the Company's financial derivatives, using absolute value of month end notional values, for the years ended December 31, 2020 and 2019:

Derivative Type	Year Ended December 31, 2020		Year Ended December 31, 2019
(In thousands)
Interest rate swaps	$	1,009,110	$	731,941
TBAs	713,634		973,331
Credit default swaps	277,990		399,316
Total return swaps	6,975		39,434
Futures	149,538		167,708
Options	1,500		19,825
Forwards	26,413		30,930
Warrants	1,570		2,222

From time to time the Company enters into credit derivative contracts for which the Company sells credit protection ("written credit derivatives"). As of December 31, 2020 and 2019, all of the Company's open written credit derivatives were credit default swaps on either mortgage/asset-backed indices (ABX and CMBX indices) or corporate bond indices (CDX), collectively referred to as credit indices, or on individual corporate bonds, for which the Company receives periodic payments at fixed rates from credit protection buyers, and is obligated to make payments to the credit protection buyer upon the occurrence of a "credit event" with respect to underlying reference assets.

Written credit derivatives held by the Company at December 31, 2020 and 2019 are summarized below:

Credit Derivatives	December 31, 2020		December 31, 2019
(In thousands)
Fair Value of Written Credit Derivatives, Net	$	3,171	$	5,414
Fair Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties (1)	—		(3,248)
Notional Value of Written Credit Derivatives (2)	68,653		132,176
Notional Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties (1)	—		(81,637)

(1)Offsetting transactions with third parties include purchased credit derivatives which have the same reference obligation.

(2)The notional value is the maximum amount that a seller of credit protection would be obligated to pay, and a buyer of credit protection would receive, upon occurrence of a "credit event." Movements in the value of credit default swap transactions may require the Company or the counterparty to post or receive collateral. Amounts due or owed under credit derivative contracts with an International Swaps and Derivatives Association, or "ISDA," counterparty may be offset against amounts due or owed on other credit derivative contracts with the same ISDA counterparty. As a result, the notional value of written credit derivatives involving a particular underlying reference asset or index has been reduced (but not below zero) by the notional value of any contracts where the Company has purchased credit protection on the same reference asset or index with the same ISDA counterparty.

A credit default swap on a credit index or a corporate bond typically terminates at the stated maturity date in the case of corporate indices or bonds, or, in the case of ABX and CMBX indices, the date that all of the reference assets underlying the index are paid off in full, retired, or otherwise cease to exist. Implied credit spreads may be used to determine the market value of such contracts and are reflective of the cost of buying/selling credit protection. Higher spreads would indicate a greater likelihood that a seller will be obligated to perform (i.e., make protection payments) under the contract. In situations where the credit quality of the underlying reference assets has deteriorated, the percentage of notional values that would be paid up front to enter into a new such contract ("points up front") is frequently used as an indication of credit risk. Credit protection sellers entering the market in such situations would expect to be paid points up front corresponding to the approximate fair value of the contract. For the Company's written credit derivatives that were outstanding at December 31, 2020 and 2019, implied credit spreads on such contracts ranged between 40.0 and 274.8 basis points and 10.9 and 440.0 basis points, respectively. Excluded from these spread ranges are contracts outstanding for which the individual spread is greater than 2,000 basis points. The Company believes that these contracts would be quoted based on estimated points up front. The total fair value of contracts with individual implied credit spreads in excess of 2,000 basis points was $(0.1) million as of both December 31, 2020 and December 31, 2019. Estimated points up front on these contracts as of December 31, 2020 ranged between 56.2 and 85.2 and as of December 31, 2019 estimated points up front on these contracts was 57.0. Total net up-front payments (paid) or received relating to written credit derivatives outstanding at December 31, 2020 and 2019 were $(2.0) million and $(3.3) million, respectively.

Financial Derivatives

Gains and losses on the Company's derivative contracts for the year ended December 31, 2018 are summarized in the table below:

		Year Ended December 31, 2018
Derivative Type	Primary Risk Exposure	Net Realized Gain/(Loss)(1)		Change in Net Unrealized Gain/(Loss)(2)
(In thousands)
Credit default swaps on asset-backed securities	Credit	$	(687)	$	715
Credit default swaps on asset-backed indices	Credit	(2,293)		2,013
Credit default swaps on corporate bond indices	Credit	(1,983)		3,540
Credit default swaps on corporate bonds	Credit	2,993		(2,648)
Total return swaps	Equity Market/Credit	3,844		(5)
Interest rate swaps	Interest Rate	(985)		3,648
Futures	Interest Rate/Currency	162		108
Forwards	Currency	923		359
Options	Interest Rate/ Equity Market	(63)		77
Total		$	1,911	$	7,807

(1)Includes gain/(loss) on foreign currency transactions on derivatives in the amount of $0.1 million for the year ended December 31, 2018, which is included on the Consolidated Statement of Operations in Realized gain (loss) on foreign currency transactions.

(2)Includes foreign currency translation on derivatives in the amount of $0.1 million for the year ended December 31, 2018, which is included on the Consolidated Statement of Operations in Change in net unrealized gain (loss) on foreign currency translation.

The table below details the average notional values of the Company's financial derivatives, using absolute value of month end notional values, for the year ended December 31, 2018:

Derivative Type	Year Ended December 31, 2018
	(In thousands)
Interest rate swaps	$	1,059,756
Credit default swaps	566,805
Total return swaps	53,603
Futures	201,295
Options	99,891
Forwards	45,522

From time to time the Company enters into credit derivative contracts for which the Company sells credit protection ("written credit derivatives"). As of December 31, 2018 all of the Company's open written credit derivatives were credit default swaps on either mortgage/asset-backed indices (ABX and CMBX indices) or corporate bond indices (CDX), collectively referred to as credit indices, or on individual corporate bonds, for which the Company receives periodic payments at fixed rates from credit protection buyers, and is obligated to make payments to the credit protection buyer upon the occurrence of a "credit event" with respect to underlying reference assets.

Written credit derivatives held by the Company at December 31, 2018 are summarized below:

Credit Derivatives	December 31, 2018
(In thousands)
Fair Value of Written Credit Derivatives, Net	$	(4,339)
Fair Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties(1)	(284)
Notional Value of Written Credit Derivatives (2)	98,586
Notional Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties (1)	(41,134)

(1)Offsetting transactions with third parties include purchased credit derivatives which have the same reference obligation.

(2)The notional value is the maximum amount that a seller of credit protection would be obligated to pay, and a buyer of credit protection would receive, upon occurrence of a "credit event." Movements in the value of credit default swap transactions may require the Company or the counterparty to post or receive collateral. Amounts due or owed under credit derivative contracts with an International Swaps and Derivatives Association, or "ISDA," counterparty may be offset against amounts due or owed on other credit derivative contracts with the same ISDA counterparty. As a result, the notional value of written credit derivatives involving a particular underlying reference asset or index has been reduced (but not below zero) by the notional value of any contracts where the Company has purchased credit protection on the same reference asset or index with the same ISDA counterparty.

A credit default swap on a credit index or a corporate bond typically terminates at the stated maturity date in the case of corporate indices or bonds, or, in the case of ABX and CMBX indices, the date that all of the reference assets underlying the index are paid off in full, retired, or otherwise cease to exist. Implied credit spreads may be used to determine the market value of such contracts and are reflective of the cost of buying/selling credit protection. Higher spreads would indicate a greater likelihood that a seller will be obligated to perform (i.e., make protection payments) under the contract. In situations where the credit quality of the underlying reference assets has deteriorated, the percentage of notional values that would be paid up front to enter into a new such contract ("points up front") is frequently used as an indication of credit risk. Credit protection sellers entering the market in such situations would expect to be paid points up front corresponding to the approximate fair value of the contract. For the Company's written credit derivatives that were outstanding at December 31, 2018, implied credit spreads on such contracts ranged between 42.6 and 815.1 basis points. Excluded from this spread range are contracts outstanding for which the individual spread is greater than 2,000 basis points. The Company believes that these contracts would be quoted based on estimated points up front. The total fair value of contracts with individual implied credit spreads in excess of 2,000 basis points was $(1.0) million as of December 31, 2018. Estimated points up front on these contracts as of December 31, 2018 ranged between 36.9 and 75.2 points. Total net up-front payments (paid) or received relating to written credit derivatives outstanding at December 31, 2018 were $(2.0) million.

XML

Consolidated VIEs

12 Months Ended

Dec. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Consolidated VIEs

Consolidated VIEs

As discussed in Note 2, the Company has interests in entities that it has determined to be VIEs. The following table summarizes the assets and liabilities of the Company's consolidated VIEs that are included on the Company's Consolidated Balance Sheet as of December 31, 2020 and 2019.

(In thousands)	December 31, 2020 (1)		December 31, 2019 (1)
Assets
Cash and cash equivalents	$	701	$	6,016
Restricted cash	175		175
Securities, at fair value	44,523		47,923
Loans, at fair value	1,435,067		1,393,916
Investments in unconsolidated entities, at fair value	6,345		5,641
Real estate owned	23,598		30,584
Investment related receivables	24,824		28,668
Other assets	2,001		6,191
Total Assets	$	1,537,234	$	1,519,114
Liabilities
Repurchase agreements	$	275,019	$	302,791
Investment related payables	—		3,275
Other secured borrowings	51,062		150,334
Other secured borrowings, at fair value	754,921		594,396
Interest payable	776		1,247
Accrued expenses and other liabilities	1,103		2,279
Total Liabilities	1,082,881		1,054,322
Total Stockholders' Equity	430,554		440,394
Non-controlling interests	23,799		24,400
Total Equity	454,353		464,794
Total Liabilities and Equity	$	1,537,234	$	1,519,116

(1)See Note 10 and Note 13 for additional information on the Company's consolidated VIEs.

XML

Securitization Transactions

12 Months Ended

Dec. 31, 2020

Securitization Transactions [Abstract]

Securitization Transactions

Securitization Transactions

Participation in CLO Transactions

Since June 2017, an affiliate of Ellington has sponsored four CLO securitization transactions (the "Ellington-sponsored CLO Securitizations"), collateralized by corporate loans and managed by an affiliate of Ellington (the "CLO Manager"). Ellington, the Company, several other affiliates of Ellington, and in certain cases, third parties, participated in the Ellington-sponsored CLO Securitizations (collectively, the "CLO Co-Participants").

Pursuant to each Ellington-sponsored CLO Securitization, a newly formed securitization trust (each a "CLO Issuer") issued various classes of notes, which were in turn sold to unrelated third parties and the applicable CLO Co-Participants.

The CLO Issuers are each deemed to be a VIE. The Company evaluates its interests in the CLO Issuers under ASC 810, and while the Company retains credit risk in each of the securitization trusts through its beneficial ownership of a portion of the subordinated interests of each of the securitization trusts, which are the first to absorb credit losses on the securitized assets, the Company does not retain control of these assets or the power to direct the activities of the CLO Issuers that most significantly impact the CLO Issuers' economic performance. As a result, the Company determined that it is not the primary beneficiary of the CLO Issuers, and therefore the Company has not consolidated the CLO Issuers. The Company's maximum amount at risk is limited to the Company's investment in each of the CLO Issuers. As of December 31, 2020 and 2019, the fair value of the Company's investment in the notes issued by the CLO Issuers was $17.3 million and $39.7 million, respectively.

See Note 13 for further details on the Company's participation in CLO transactions.

Residential Mortgage Loan Securitizations

Since November 2017, the Company, through certain wholly owned subsidiaries (each, a "Sponsor"), has sponsored several securitizations of non-QM loans. In each case, the applicable Sponsor transferred a pool of non-QM loans (each, a Collateral Pool") to a wholly owned entity (each, a "Depositor") and on the closing date such loans were deposited into newly created securitization trusts (collectively, the "Issuing Entities"). Pursuant to the securitizations, the Issuing Entities issued various classes of mortgage pass-through certificates (the "Certificates") which are backed by the cash flows from the underlying non-QM loans.

Under the Dodd-Frank Act, sponsors of securitizations are generally required to retain at least 5% of the economic interest in the credit risk of the securitized assets (the "Risk Retention Rules"). In order to comply with the Risk Retention Rules, in each securitization, the applicable Sponsor purchased and intends to hold, at a minimum, the requisite amount of the most subordinated classes of Certificates and the excess cash flow certificates. The applicable Sponsor also purchased the Certificates entitled to excess servicing fees in each securitization, while the remaining classes of Certificates were purchased by unrelated parties.

Notwithstanding that the Certificates carry final scheduled distribution dates of October 25, 2047 or later, the applicable Depositor may, at its sole option, purchase all of the outstanding Certificates (an "Optional Redemption") following the earlier of (1) the applicable anniversary of the closing date (typically two or three years) of the respective securitization or (2) the date on which the aggregate unpaid principal balance of the applicable Collateral Pool has declined below 30% of the aggregate unpaid principal balance of the applicable Collateral Pool as of the date as of which such loans were originally transferred to the applicable Issuing Entity. The purchase price that the Depositor is required to pay in connection with an Optional Redemption is equal to the sum of the unpaid principal balance of each class of Certificates as of the redemption date and any accrued and unpaid interest thereon. In light of these Optional Redemption rights held by the applicable Depositor, the transfers of non-QM loans to each of the Issuing Entities do not qualify as sales under ASC 860-10.

In the event that certain breaches of representations or warranties are discovered with respect to any underlying non-QM loans, the Company could be required to repurchase or replace such loans.

Each Sponsor also serves as the servicing administrator of its respective securitization, for which it is entitled to receive a monthly fee equal to one-twelfth of the product of (a) 0.03% and (b) the unpaid principal balance of the underlying non-QM loans as of the first day of the related due period. Each Sponsor in its role as servicing administrator provides direction and consent for certain loss mitigation activities to the third-party servicer of the underlying non-QM loans. In certain circumstances, the servicing administrator will be required to reimburse the servicer for principal and interest advances and servicing advances made by the servicer.

In light of the Company's retained interests in each of the securitizations, together with the Optional Redemption rights and the Company's ability to direct the third-party servicer regarding certain loss mitigation activities, the Company is deemed to be the primary beneficiary of the Issuing Entities, which are VIEs, and has consolidated the Issuing Entities. Interest income from these loans and the expenses related to the servicing of these loans are included in Interest income and Investment related expenses—Servicing expense, respectively, on the Consolidated Statement of Operations.

The Issuing Entities each meet the definition of a CFE as defined in Note 2, and as a result the assets of each of the Issuing Entities have been valued using the fair value of the liabilities of the respective Issuing Entity, as such liabilities have been assessed to be more observable than such assets.

The debt of the Issuing Entities is included in Other secured borrowings, at fair value, on the Consolidated Balance Sheet and is shown net of the Certificates held by the Company. In November 2020, the Company exercised its Optional Redemption right with respect to Ellington Financial Mortgage Trust 2018-1. In November 2019, the Company exercised its Optional Redemption right with respect to Ellington Financial Mortgage Trust 2017-1.

The following table details the Company's outstanding consolidated residential mortgage loan securitizations:

Issuing Entity	Closing Date	Principal Balance of Loans Transferred to the Depositor		Total Face Amount of Certificates Issued
		(In thousands)
Ellington Financial Mortgage Trust 2019-1	6/19	$	226,913	$	226,913	(1)
Ellington Financial Mortgage Trust 2019-2	11/19	267,255		267,255		(2)
Ellington Financial Mortgage Trust 2020-1	6/20	259,273		259,273		(3)
Ellington Financial Mortgage Trust 2020-2	11/20	219,732		219,732		(4)

(1)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 6.1% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.2 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(2)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 6.4% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.7 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(3)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 8.0% of the fair value of all Certificates issued. Additionally, the Sponsor purchased another subordinated class of Certificates with an aggregate value equal to 3.5% of the fair value of all Certificates issued as of the settlement date. Finally, the Sponsor also purchased, for an aggregate purchase price of $1.9 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(4)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 7.6% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.4 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

The following table details the assets and liabilities of the consolidated securitization trusts included in the Company's Consolidated Balance Sheet as of December 31, 2020 and 2019:

(In thousands)	December 31, 2020		December 31, 2019
Assets:
Loans, at fair value	$	801,343	$	628,415
Real estate owned	—		658
Investment related receivables	15,544		10,409
Liabilities:
Other secured borrowings, at fair value	754,921		594,396

Participation in Multi-Seller Consumer Loan Securitization

In November 2020, the Company participated in a securitization whereby the Company, together with another entity managed by Ellington (the "Consumer Co-Participant"), sold consumer loans with an aggregate unpaid principal balance of approximately $205.1 million to a newly formed securitization trust (the "Consumer Securitization Issuer"). Of the $205.1 million in loans sold to the Consumer Securitization Issuer, the Company's share was 56.3% while the Consumer Co-Participant's share was 43.7%. The transfer was accounted for as a sale in accordance with ASC 860-10. Pursuant to the securitization, the Consumer Securitization Issuer issued senior and subordinated notes in the principal amounts of $158.4 million and $35.2 million, respectively. Trust certificates representing beneficial ownership of the Issuer were also issued. In connection with the transaction, and through a jointly owned newly formed entity (the "Consumer Risk Retention Vehicle"), the Company and the Consumer Co-Participant acquired certain of the subordinated notes as well as the trust certificates in the Issuer. The Company and the co-participant acquired 56.3% and 43.7%, respectively, of the interests in the Consumer Risk Retention Vehicle. As of December 31, 2020, the Company's total interest in the Consumer Risk Retention Vehicle, for which the Company has elected the FVO, was 56.3% or $19.1 million, and is included on the Consolidated Balance Sheet in Investments in unconsolidated entities, at fair value.

The notes and trust certificates issued by the Consumer Securitization Issuer are backed by the cash flows from the underlying consumer loans. If there are breaches of representations and warranties with respect to any underlying consumer loans, the Company could, under certain circumstances, be required to repurchase or replace such loans. Absent such breaches, the Company has no obligation to repurchase or replace any underlying consumer loans that become delinquent or otherwise default. In addition, another affiliate of Ellington acts as the administrator for the securitization and is paid a monthly fee for its services.

The Consumer Securitization Issuer is deemed to be a VIE. The Company has evaluated its interest in the Consumer Securitization Issuer under ASC 810, and while the Company retains credit risk in the securitization trust through its beneficial ownership of most of the subordinated interests of the securitization trust, which are the first to absorb credit losses on the securitized assets, neither the Company nor the Consumer Risk Retention Vehicle retains control of these assets or the power to direct the activities of the Consumer Securitization Issuer that most significantly impact the Consumer Securitization Issuer's economic performance. As a result, the Company determined that neither the Company nor the Consumer Risk Retention Vehicle is the primary beneficiary of the Consumer Securitization Issuer, and therefore the Company has not consolidated the Consumer Securitization Issuer. Additionally, the Company evaluated its interest in the Consumer Risk Retention Vehicle, which does not meet the criteria to be deemed a VIE, under the voting interest model provided by ASC 810 and determined the Company does not control the Consumer Risk Retention Vehicle. As a result, the Company has not consolidated the Consumer Risk Retention Vehicle.Securitization Transactions

Participation in Multi-Seller Consumer Loan Securitization

In August 2016, the Company participated in a securitization transaction whereby the Company, together with another entity managed by Ellington (the "co-participant"), sold consumer loans with an aggregate unpaid principal balance of approximately $124 million to a newly formed securitization trust (the "Issuer"). Of the $124 million in loans sold to the Issuer, the Company's share was 51% while the co-participant's share was 49%. The transfer was accounted for as a sale in accordance with ASC 860-10. As a result of the sale the Company recognized a realized loss in the amount of $(0.1) million. Pursuant to the securitization, the Issuer issued senior and subordinated notes in the principal amount of $87 million and $18.7 million, respectively. Trust certificates representing beneficial ownership of the Issuer were also issued. In connection with the transaction, and through a jointly owned newly formed entity (the "Acquiror"), the Company and the co-participant acquired all of the subordinated notes as well as the trust certificates in the Issuer. The Company and the co-participant acquired 51% and 49%, respectively, of the interests in the Acquiror. During 2017, at the co-participant's direction, the Acquiror sold the portion of the subordinated notes beneficially owned by the co-participant, and in 2018, the Acquiror sold the remaining portion of the subordinated notes which were beneficially owned by the Company, and as a result as of December 31, 2018, the Company's total interest in the Acquiror was approximately 62%. The Company's interest in the Acquiror is accounted for as a beneficial interest and is included on the Consolidated Condensed Schedule of Investments in Corporate Equity Investments.

The notes and trust certificates issued by the Issuer are backed by the cash flows from the underlying consumer loans. If there are breaches of representations and warranties with respect to any underlying consumer loans, the Company could, under certain circumstances, be required to purchase or replace such loans. Absent such breaches, the Company has no obligation to repurchase or replace any underlying consumer loans that become delinquent or otherwise default. Cash flows collected on the underlying consumer loans are distributed to service providers to the trust, noteholders, and trust certificate holders in accordance with the contractual priority of payments. In addition, another affiliate of Ellington (the "Administrator"), acts as the administrator for the securitization and is paid a monthly fee for its services.

While the Company retains credit risk in the securitization trust through its beneficial ownership of the most subordinated interests of the securitization trust, which are the first to absorb credit losses on the securitized assets, the Company does not retain control of these assets or the power to direct the activities of the Issuer that most significantly impact the Issuer's economic performance. See Note 9 for further details on the Company's participation in the multi-seller consumer loan securitization.

Participation in CLO Transactions

Since June 2017, an affiliate of Ellington sponsored three CLO securitization transactions (the "CLO I Securitization," the "CLO II Securitization," and the "CLO III Securitization"; collectively, the "Ellington-sponsored CLO Securitizations"), collateralized by corporate loans and managed by an affiliate of Ellington (the "CLO Manager"). Ellington, the Company,

several other affiliates of Ellington, and, in the case of the CLO II Securitization and the CLO III Securitization, several third parties, participated in the Ellington-sponsored CLO Securitizations (collectively, the "CLO Co-Participants").

Pursuant to each Ellington-sponsored CLO Securitization, a newly formed securitization trust (the "CLO I Issuer," the "CLO II Issuer," and the "CLO III Issuer"; collectively, the "CLO Issuers") issued various classes of notes, which were in turn sold to unrelated third parties and the applicable CLO Co-Participants. The notes issued by each CLO Issuer are backed by the cash flows from the underlying corporate loans (including loans to be purchased during a reinvestment period); these cash flows are applied in accordance with the contractual priority of payments.

In the case of the CLO I Securitization, the Company and one CLO Co-Participant transferred corporate loans with a fair value of approximately $62.0 million and $141.7 million, respectively, to the CLO I Issuer in exchange for cash. The Company has no obligation to repurchase or replace securitized corporate loans that subsequently become delinquent or are otherwise in default, and the transfer by the Company was accounted for as a sale in accordance with ASC 860-10. As a result of the sale, the Company recognized a realized gain in the amount of $0.2 million.

In the case of the CLO II Securitization and the CLO III Securitization, the Company, along with certain other CLO Co-Participants, advanced funds in the form of loans (the "Advances") to the applicable CLO Issuers prior to the CLO pricing date to enable it to establish warehouse facilities for the purpose of acquiring the assets to be securitized. Pursuant to their terms, the Advances are required to be repaid at the closing of the respective securitization.

In each Ellington-sponsored CLO Securitization, the Company and each of the applicable CLO Co-Participants purchased various classes of notes issued by the corresponding CLO Issuer. In accordance with the Company's accounting policy for recording certain investment transactions on trade date, these purchases were recorded on the CLO pricing date rather than the CLO closing date. In addition, in the case of each of the CLO I Securitization and the CLO II Securitization, the Company and the CLO Co-Participants also funded a newly formed entity (the "CLO I Risk Retention Vehicle" and the "CLO II Risk Retention Vehicle") to purchase a sufficient portion of the unsecured subordinated notes issued by the applicable CLO Issuer so as to comply with risk retention rules (the "Risk Retention Rules") under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as further described below.

With respect to each Ellington-sponsored CLO Securitization, the Company subsequently sold a portion of the notes that it had originally purchased. As of December 31, 2018, the Company did not have an ownership interest in the CLO I Risk Retention Vehicle.

Under the Risk Retention Rules, sponsors of securitizations are generally required to retain at least 5% of the economic interest in the credit risk of the securitized assets. However, in February 2018, the U.S. Court of Appeals for the District of Columbia Circuit, or the "Court of Appeals," ruled that open-market CLO securitizations are exempt from the Risk Retention Rules, as long as certain requirements are met, and in April 2018 the Court of Appeals gave effect to this ruling. As a result, Risk Retention Rules no longer apply to managers of open-market CLOs, and those managers are now permitted to sell the interests in existing open-market CLOs that were originally retained in order to comply with the Risk Retention Rules, as long as those securitizations meet the requirements for exemption. After the decision by the Court of Appeals, the CLO Manager determined that the CLO II Securitization met the requirements for exemption from the Risk Retention Rules and subsequently distributed, in-kind, the subordinated notes held in the CLO II Risk Retention Vehicle to the CLO Co-Participants pro rata based on each CLO Co-Participant's respective ownership percentage of the CLO II Risk Retention Vehicle. The subordinated notes distributed to the Company from the CLO II Risk Retention Vehicle had a face amount of $5.6 million. Such notes had a fair value of $4.3 million as of December 31, 2018 and are included on the Company's Consolidated Condensed Schedule of Investments in Collateralized Loan Obligations and in the table below. The Manager of CLO III Securitization was not required to establish a risk retention vehicle because the transaction closed subsequent to the effectiveness of the ruling by the Court of Appeals.

In August 2018, the CLO I Issuer optionally redeemed all of the notes issued by the CLO I Securitization. Simultaneously with this optional redemption, the CLO I Issuer issued various classes of new notes, which were in turn sold to unrelated third parties and to the applicable CLO Co-Participants ("the Reset CLO I Securitization"). These new notes are backed by the cash flows from the underlying corporate loans (including loans to be purchased during a reinvestment period); these cash flows are applied in accordance with the contractual priority of payments. The CLO Manager determined that the Reset CLO I Securitization met the requirements for exemption from the Risk Retention Rules. As a result, the CLO Manager commenced liquidation of the CLO I Risk Retention Vehicle, and all of the liquidation proceeds have been distributed to the applicable CLO Co-Participants. As of December 31, 2018, the Company has received $5.7 million in liquidation proceeds from the CLO I Risk Retention Vehicle.

While the Company retains credit risk in each of the Ellington-sponsored CLO Securitizations through its beneficial ownership of the most subordinated interests of each of the securitization trusts, which are the first to absorb credit losses on the

securitized assets, the Company does not retain control of these assets nor does it have the power to direct the activities of the CLO Issuers that most significantly impact the CLO Issuers' economic performance.

The following table details the Company's investments in notes issued by the Ellington-sponsored CLO Securitizations:

CLO Issuer(1)	CLO Pricing Date	CLO Closing Date	Total Face Amount of Notes Issued		Face Amount of Notes Initially Purchased			Aggregate Purchase Price		Notes Held(2) as of
										December 31, 2018
($ in thousands)
CLO I Issuer(3)(4)	5/17	6/17	$	373,550	$	36,606	(5)	$	35,926	$	—
CLO I Issuer(4)	8/18	8/18	461,840		36,579		(5)	25,622		16,973		(6)
CLO II Issuer	12/17	1/18	452,800		18,223		(7)	16,621		14,721		(6)
CLO III Issuer	6/18	7/18	407,100		35,480		(7)	32,394		19,071		(8)

(1)

(1)The Company does not have the power to direct the activities of the CLO Issuers that most significantly impact their economic performance.

(2)Included on the Company's Consolidated Condensed Schedule of Investments in Collateralized Loan Obligations.

(3)Excludes the Company's equity investment in the CLO I Risk Retention Vehicle, as discussed above.

(4)In August 2018, the notes originally issued by the CLO I Issuer in 2017 were fully redeemed, and the CLO I Issuer simultaneously issued new notes in conjunction with this full redemption.

(5)The Company purchased secured and unsecured subordinated notes.

(6)Includes secured and unsecured subordinated notes.

(7)The Company purchased secured senior and secured and unsecured subordinated notes.

(8)Includes secured senior and secured and unsecured subordinated notes.

See Note 9 for further details on the Company's participation in CLO transactions.

Residential Mortgage Loan Securitizations

Since November 2017, the Company, through its wholly owned subsidiary, Ellington Financial REIT TRS LLC (the "Sponsor"), has sponsored two securitizations of non-QM loans. In each case, the Sponsor transferred non-QM loans to a wholly owned, newly created entity (the "Depositor") and on the closing date such loans were deposited into newly created securitization trusts (Ellington Financial Mortgage Trust 2017-1 and Ellington Financial Mortgage Trust 2018-1, collectively the "Issuing Entities"). Pursuant to the securitizations, the Issuing Entities issued various classes of mortgage pass-through certificates (the "Certificates") which are backed by the cash flows from the underlying non-QM loans. As detailed further in the table below, in order to comply with the Risk Retention Rules, in each securitization the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates. The Sponsor also purchased the Certificates entitled to excess servicing fees in each securitization, while the remaining classes of Certificates were purchased by unrelated parties.

The Certificates issued in November 2017 and 2018 have final scheduled distribution dates of October 25, 2047 and October 25, 2058, respectively. However, the Depositor may, with respect to each securitization, at its sole option, purchase all of the outstanding Certificates (an "Optional Redemption") following the earlier of (1) the two year anniversary of the closing date of such securitization or (2) the date on which the aggregate unpaid principal balance of the underlying non-QM loans has declined below 30% of the aggregate unpaid principal balance of the underlying non-QM loans as of the date as of which such loans were originally transferred to the applicable Issuing Entity. The purchase price that the Depositor is required to pay in connection with an Optional Redemption is equal to the sum of the unpaid principal balance of each class of Certificates as of the redemption date and any accrued and unpaid interest thereon. In light of these Optional Redemption rights held by the Depositor, the transfers of non-QM loans to each of the Issuing Entities do not qualify as sales under ASC 860, Transfers and Servicing.

In the event that certain breaches of representations or warranties are discovered with respect to any underlying non-QM loans, the Company could be required to repurchase or replace such loans.

The Sponsor also serves as the servicing administrator of each securitization and as such, is entitled to receive a monthly fee equal to one-twelfth of the product of (a) 0.03% and (b) the unpaid principal balance of the underlying non-QM loans as of the first day of the related due period. The Sponsor in its role as servicing administrator provides direction and consent for certain loss mitigation activities to the third-party servicer of the underlying non-QM loans. In certain circumstances, the servicing administrator will be required to reimburse the servicer for principal and interest advances and servicing advances made by the servicer.

In light of the Company's retained interests in each of the securitizations, together with the Optional Redemption rights and the Company's ability to direct the third-party servicer regarding certain loss mitigation activities, the Issuing Entities are

deemed to be an extension of the Company's business. The non-QM loans held by the Issuing Entities are included on the Consolidated Condensed Schedule of Investments in Mortgage Loans. Interest income from these loans and the expenses related to the servicing of these loans are included in Interest income and Other investment related expenses—Servicing expense, respectively, on the Consolidated Statement of Operations.

The Issuing Entities each meet the definition of a CFE as defined in Note 2, and as a result the assets of the Issuing Entities have been valued using the fair value of the liabilities of the Issuing Entities, as such liabilities have been assessed to be more observable than such assets.

The debt of the Issuing Entities is included in Other secured borrowings, at fair value on the Consolidated Statement of Assets, Liabilities, and Equity and is shown net of the Certificates held by the Company.

The following table details the residential mortgage loan securitizations:

Issuing Entity	Closing Date	Principal Balance of Loans Transferred to the Depositor		Total Face Amount of Certificates Issued
		(In thousands)
Ellington Financial Mortgage Trust 2017-1	11/15/2017	$	141,233	$	141,233	(1)
Ellington Financial Mortgage Trust 2018-1	11/13/2018	232,518		232,518		(2)

(1)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value equal to 5.1% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $0.7 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(2)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value equal to 5.7% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.3 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

The following table details the assets and liabilities of the consolidated securitization trusts included in the Company's Consolidated Statement of Assets, Liabilities, and Equity as of December 31, 2018:

	As of
(In thousands)	December 31, 2018
Assets:
Investments, at fair value	$	314,202
Interest and dividends receivable	3,527
Liabilities:
Interest and dividends payable	103
Other secured borrowings, at fair value	297,948

Borrowings

Borrowings

Secured Borrowings

The Company's secured borrowings consist of repurchase agreements, Other secured borrowings, and Other secured borrowings, at fair value. As of December 31, 2020 and 2019, the Company's total secured borrowings were $2.3 billion and $3.2 billion, respectively.

Repurchase Agreements

The Company enters into repurchase agreements. A repurchase agreement involves the sale of an asset to a counterparty together with a simultaneous agreement to repurchase the transferred asset or similar asset from such counterparty at a future date. The Company accounts for its repurchase agreements as collateralized borrowings, with the transferred assets effectively serving as collateral for the related borrowing. The Company's repurchase agreements typically range in term from 30 to 180 days, although the Company also has repurchase agreements that provide for longer or shorter terms. The principal economic terms of each repurchase agreement—such as loan amount, interest rate, and maturity date—are typically negotiated on a transaction-by-transaction basis. Other terms and conditions, such as those relating to events of default, are typically governed under the Company's master repurchase agreements. Absent an event of default, the Company maintains beneficial ownership of the transferred securities during the term of the repurchase agreement and receives the related principal and interest payments. Interest rates on these borrowings are generally fixed based on prevailing rates corresponding to the terms of the borrowings, and for most repurchase agreements, interest is generally paid at the termination of the repurchase agreement, at which time the Company may enter into a new repurchase agreement at prevailing market rates with the same counterparty, repay that counterparty and possibly negotiate financing terms with a different counterparty, or choose to no longer finance the related asset. Some repurchase agreements provide for periodic payments of interest, such as monthly payments. In response to a decline in the fair value of the transferred securities, whether as a result of changes in market conditions, security paydowns, or other factors, repurchase agreement counterparties will typically make a margin call, whereby the Company will be required to post additional securities and/or cash as collateral with the counterparty in order to re-establish the agreed-upon collateralization requirements. In the event of increases in fair value of the transferred securities, the Company can generally require the counterparty to post collateral with it in the form of cash or securities. The Company is generally permitted to sell or re-pledge any securities posted by the counterparty as collateral; however, upon termination of the repurchase agreement, or other circumstance in which the counterparty is no longer required to post such margin, the Company must return to the counterparty the same security that had been posted.

At any given time, the Company seeks to have its outstanding borrowings under repurchase agreements with several different counterparties in order to reduce the exposure to any single counterparty. The Company had outstanding borrowings under repurchase agreements with 24 counterparties as of December 31, 2020 as compared to 28 counterparties as of December 31, 2019.

As of December 31, 2020, remaining days to maturity on the Company's open repurchase agreements ranged from 4 days to 516 days. Interest rates on the Company's open repurchase agreements ranged from 0.20% to 5.00% as of December 31, 2020. As of December 31, 2019, remaining days to maturity on the Company's open repurchase agreements ranged from 2 days to 882 days. Interest rates on the Company's open repurchase agreements ranged from 0.15% to 5.20% as of December 31, 2019.

The following table details the Company's outstanding borrowings under repurchase agreements for Agency RMBS and credit assets (which can include non-Agency RMBS, CMBS, CLOs, consumer loans, corporate debt, residential mortgage loans, and commercial mortgage loans and REO), by remaining maturity as of December 31, 2020 and 2019:

	December 31, 2020					December 31, 2019
			Weighted Average					Weighted Average
Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity
Agency RMBS:	(In thousands)					(In thousands)
30 Days or Less	$	265,556	0.28	%	17	$	511,996	2.08	%	17
31-60 Days	385,141		0.25	%	44	744,387		1.93	%	47
61-90 Days	174,586		0.28	%	70	594,738		1.96	%	76
91-120 Days	—		—	%	—	10,270		2.24	%	93
121-150 Days	2,692		0.27	%	126	—		—	%	—
151-180 Days	59,857		0.32	%	162	3,082		2.67	%	171
181-360 Days	34,030		0.32	%	252	—		—	%	—
Total Agency RMBS	921,862		0.27	%	57	1,864,473		1.98	%	48
Credit:
30 Days or Less	37,795		2.11	%	17	16,549		3.38	%	25
31-60 Days	84,554		2.23	%	50	104,491		3.14	%	48
61-90 Days	152,426		2.11	%	75	138,837		3.03	%	73
91-120 Days	89,931		2.47	%	106	—		—	%	—
121-150 Days	66,412		4.75	%	125	7,460		3.89	%	123
151-180 Days	11,063		2.27	%	165	31,498		3.87	%	173
181-360 Days	38,640		2.90	%	289	186,661		3.80	%	250
> 360 Days	94,248		2.99	%	447	95,331		4.52	%	678
Total Credit Assets	575,069		2.69	%	155	580,827		3.61	%	229
Total	$	1,496,931	1.20	%	94	$	2,445,300	2.37	%	91

Repurchase agreements involving underlying investments that the Company sold prior to period end, for settlement following period end, are shown using their original maturity dates even though such repurchase agreements may be expected to be terminated early upon settlement of the sale of the underlying investment.

As of December 31, 2020 and 2019, the fair value of investments transferred as collateral under outstanding borrowings under repurchase agreements was $1.831 billion and $2.763 billion, respectively. Collateral transferred under outstanding borrowings under repurchase agreements as of December 31, 2020 and 2019 include investments in the amount of $1.4 million and $64.7 million, respectively, that were sold prior to period end but for which such sale had not yet settled. In addition, as of December 31, 2020 the Company posted net cash collateral of $28.9 million to its counterparties. As of December 31, 2019, the Company posted net cash collateral of $31.0 million, as well as posting additional securities with a fair value of $0.2 million, to its counterparties.

Amount at risk represents the excess, if any, for each counterparty of the fair value of collateral held by such counterparty over the amounts outstanding under repurchase agreements. As of both December 31, 2020 and 2019, there was no single counterparty for which the amount at risk relating to our repurchase agreements was greater than 10% of total equity.

Other Secured Borrowings

In February 2018, the Company entered into agreements to finance a portfolio of unsecured loans through a recourse secured borrowing facility. The facility has a term ending in February 2021. The facility accrues interest on a floating-rate basis. As of December 31, 2020 and 2019, the Company had outstanding borrowings under this facility in the amount of $8.7 million and $16.0 million, respectively, which is included under the caption Other secured borrowings, on the Company's Consolidated Balance Sheet. The effective interest rate, inclusive of related deferred financing costs, was 2.30% and 3.85% as of December 31, 2020 and 2019. As of December 31, 2020 and 2019, the fair value of unsecured loans collateralizing this borrowing was $11.5 million and $22.3 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of December 31, 2020, the Company was in compliance with all of its covenants.

The Company has a non-recourse secured borrowing facility that is used to finance a portfolio of unsecured loans. The facility included a reinvestment period ending in February 2021 (or earlier following an early amortization event), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. Following the reinvestment period, the facility will begin to amortize based on the collections from the underlying loans. The facility accrues interest on a floating rate basis. As of December 31, 2020 and 2019, the Company had outstanding borrowings under this facility in the amount of $7.0 million and $102.5 million, respectively, which is included under the caption Other secured borrowings, on the Company's Consolidated Balance Sheet. The effective interest rate on this facility, inclusive of related deferred financing costs, was 2.25% and 4.01%, as of December 31, 2020 and 2019, respectively. As of December 31, 2020 and 2019, the fair value of unsecured loans collateralizing this borrowing was $31.8 million and $144.1 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of December 31, 2020, the Company was in compliance with all of its covenants.

In December 2019, the Company entered into an agreement to finance a portfolio of ABS backed by consumer loans through a recourse secured borrowing facility. The facility includes a revolving borrowing period ending in June 2021 (or earlier following a trigger event), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. Following the revolving borrowing period, the facility amortizes, with a final termination date in June 2023. The facility accrues interest on a floating rate basis. As of December 31, 2020 and 2019, the Company had outstanding borrowings under this facility in the amount of $28.7 million and $31.8 million, respectively, which is included under the caption Other secured borrowings, on the Company's Consolidated Balance Sheet.The effective interest rate on this facility, inclusive of related deferred financing costs, was 5.22% and 5.23% as of December 31, 2020 and 2019, respectively. As of December 31, 2020 and 2019, the fair value of ABS backed by consumer loans collateralizing this borrowing was $44.5 million and $47.9 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of December 31, 2020, the Company was in compliance with all of its covenants.

The Company has completed securitization transactions, as discussed in Note 10, whereby it financed portfolios of non-QM loans. As of December 31, 2020 and 2019, the fair value of the Company's outstanding liabilities associated with these securitization transactions was $754.9 million and $594.4 million, respectively, representing the fair value of the securitization trust certificates held by third parties as of such date, and is included on the Company's Consolidated Balance Sheet in Other secured borrowings, at fair value. The weighted average coupon of the Certificates held by third parties was 2.43% and 3.19% as of December 31, 2020 and 2019, respectively. As of December 31, 2020, the fair value of non-QM loans held in the consolidated securitization trusts was $801.3 million. As of December 31, 2019, the fair value of non-QM loans and the carrying value of REO was $629.1 million.

In March 2020, the Company entered into a participation agreement with an unrelated third-party, the "Junior Participant," whereby the Company transferred to the Junior Participant an interest in a small balance commercial mortgage loan, the "Partial Loan," (together with the Company's interest, the "Whole Commercial Loan"). The Partial Loan is subordinate to the interest in the loan held by the Company. In accordance with ASC 860-10, the Partial Loan transferred to the Junior Participant does not meet the definition of a participating interest and, as a result, the Company does not recognize the transfer of the Partial Loan to the Junior Participant as a sale. The Company has recorded the Whole Commercial Loan in Loans, at fair value, on the Consolidated Balance Sheet. As of December 31, 2020, the fair value of the Whole Commercial Loan was $17.3 million. The Company's liability to the Junior Participant as of December 31, 2020 was $6.7 million and is included in Other secured borrowings on the Company's Consolidated Balance Sheet. Under the terms of the participation agreement, the Junior Participant is entitled to a portion of the cashflows of the underlying commercial mortgage loan.

Unsecured Borrowings

Senior Notes

On August 18, 2017, the Company issued $86.0 million in aggregate principal amount of unsecured senior notes (the "Old Senior Notes"). The total net proceeds to the Company from the issuance of the Old Senior Notes was approximately $84.7 million, after deducting debt issuance costs. The Old Senior Notes had an interest rate of 5.25%, subject to adjustment based on changes in the ratings, if any, of the Old Senior Notes. On February 13, 2019, in connection with the REIT Election, the Company exchanged all $86.0 million in principal amount of the Old Senior Notes for new unsecured long-term debt jointly and severally co-issued by certain of its consolidated subsidiaries and fully guaranteed by the Company (the "Senior Notes"). At any time, the Company is permitted to add others of its consolidated subsidiaries as co-issuers of the Senior Notes. The Senior Notes bear interest at a rate of 5.50%, subject to adjustment based on changes, if any, in the ratings of the Senior Notes. Interest on the Senior Notes is payable semi-annually in arrears on March 1 and September 1 of each year. The Senior Notes mature on September 1, 2022. The Company may redeem the Senior Notes, at its option, in whole or in part, prior to March 1, 2022 at a price equal to 100% of the principal amount thereof, plus the applicable "make-whole" premium as of the applicable date of redemption. At any time on or after March 1, 2022, the Company may redeem the Senior Notes, in whole or in part, at a redemption price equal to 100% of the aggregate principal amount of the Senior Notes to be redeemed, plus accrued and unpaid

interest. The Senior Notes are carried at amortized cost. There are a number of covenants, including several financial covenants, associated with the Senior Notes. As of both December 31, 2020 and 2019, the Company was in compliance with all of its covenants.

The Company amortizes debt issuance costs over the life of the associated debt; the amortized portion of debt issuance costs is included in Interest expense on the Consolidated Statement of Operations. The Senior Notes have an effective interest rate of 5.80%, inclusive of debt issuance costs.

The Senior Notes are unsecured and are effectively subordinated to secured indebtedness of the Company, to the extent of the value of the collateral securing such indebtedness.

Schedule of Principal Repayments

The following table details the Company's principal repayment schedule, over the next 5 years, for outstanding borrowings as of December 31, 2020:

Year	Repurchase Agreements(1)		Other Secured Borrowings(2)		Senior Notes(1)		Total
(In thousands)
Next Twelve Months	$	1,402,683	$	370,933	$	—	$	1,773,616
Year 2	94,248		236,976		86,000		417,224
Year 3	—		221,269		—		221,269
Year 4	—		—		—		—
Year 5	—		—		—		—
Total	$	1,496,931	$	829,178	$	86,000	$	2,412,109

(1)Reflects the Company's contractual principal repayment dates.

(2)Includes $778.1 million of expected principal repayments related to the Company's consolidated residential mortgage loan securitizations, which are projected based upon the underlying assets' expected repayments and may be prior to the stated contractual maturities.

Borrowings

Secured Borrowings

The Company's secured borrowings consist of reverse repurchase agreements, Other secured borrowings, and Other secured borrowings, at fair value. As of December 31, 2018 the Company's total secured borrowings were $1.911 billion.

Reverse Repurchase Agreements

The Company enters into reverse repurchase agreements. A reverse repurchase agreement involves the sale of an asset to a counterparty together with a simultaneous agreement to repurchase the transferred asset or similar asset from such counterparty at a future date. The Company accounts for its reverse repurchase agreements as collateralized borrowings, with the transferred assets effectively serving as collateral for the related borrowing. The Company's reverse repurchase agreements typically range in term from 30 to 180 days, although the Company also has reverse repurchase agreements that provide for longer or shorter terms. The principal economic terms of each reverse repurchase agreement—such as loan amount, interest rate, and maturity date—are typically negotiated on a transaction-by-transaction basis. Other terms and conditions, such as those relating to events of default, are typically governed under the Company's master repurchase agreements. Absent an event of default, the Company maintains beneficial ownership of the transferred securities during the term of the reverse repurchase agreement and receives the related principal and interest payments. Interest rates on these borrowings are generally fixed based on prevailing rates corresponding to the terms of the borrowings, and for most reverse repurchase agreements, interest is generally paid at the termination of the reverse repurchase agreement, at which time the Company may enter into a new reverse repurchase agreement at prevailing market rates with the same counterparty, repay that counterparty and possibly negotiate

financing terms with a different counterparty, or choose to no longer finance the related asset. Some reverse repurchase agreements provide for periodic payments of interest, such as monthly payments. In response to a decline in the fair value of the transferred securities, whether as a result of changes in market conditions, security paydowns, or other factors, reverse repurchase agreement counterparties will typically make a margin call, whereby the Company will be required to post additional securities and/or cash as collateral with the counterparty in order to re-establish the agreed-upon collateralization requirements. In the event of increases in fair value of the transferred securities, the Company can generally require the counterparty to post collateral with it in the form of cash or securities. The Company is generally permitted to sell or re-pledge any securities posted by the counterparty as collateral; however, upon termination of the reverse repurchase agreement, or other circumstance in which the counterparty is no longer required to post such margin, the Company must return to the counterparty the same security that had been posted.

At any given time, the Company seeks to have its outstanding borrowings under reverse repurchase agreements with several different counterparties in order to reduce the exposure to any single counterparty. The Company had outstanding borrowings under reverse repurchase agreements with 23 counterparties as of December 31, 2018.

At December 31, 2018, approximately 21% of open reverse repurchase agreements were with one counterparty. As of December 31, 2018 remaining days to maturity on the Company's open reverse repurchase agreements ranged from 2 days to 871 days. Interest rates on the Company's open reverse repurchase agreements ranged from 0.23% to 6.07% as of December 31, 2018.

The following table details the Company's outstanding borrowings under reverse repurchase agreements for Agency RMBS, credit assets (which include non-Agency MBS, CLOs, consumer loans, corporate debt, residential mortgage loans, and commercial mortgage loans and REO), and U.S. Treasury securities, by remaining maturity as of December 31, 2018:

(In thousands)	December 31, 2018
			Weighted Average
Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity
Agency RMBS:
30 Days or Less	$	245,956	2.46	%	17
31-60 Days	415,379		2.58	%	46
61-90 Days	255,421		2.74	%	76
91-120 Days	506		3.31	%	91
Total Agency RMBS	917,262		2.59	%	47
Credit:
30 Days or Less	30,426		2.55	%	22
31-60 Days	189,937		3.32	%	48
61-90 Days	93,202		3.21	%	74
121-150 Days	26,222		4.60	%	123
151-180 Days	9,491		4.64	%	166
181-360 Days	91,730		4.54	%	316
> 360 Days	140,306		5.15	%	636
Total Credit Assets	581,314		3.98	%	240
U.S. Treasury Securities:
30 Days or Less	273		3.10	%	2
Total U.S. Treasury Securities	273		3.10	%	2
Total	$	1,498,849	3.13	%	122

Reverse repurchase agreements involving underlying investments that the Company sold prior to period end, for settlement following period end, are shown using their original maturity dates even though such reverse repurchase agreements may be expected to be terminated early upon settlement of the sale of the underlying investment.

As of December 31, 2018, the fair value of investments transferred as collateral under outstanding borrowings under reverse repurchase agreements was $1.79 billion. Collateral transferred under outstanding borrowings as of December 31, 2018 include investments in the amount of $86.7 million that were sold prior to period end but for which such sale had not yet

settled. In addition the Company posted net cash collateral of $17.0 million and additional securities with a fair value of $0.2 million as of December 31, 2018 to its counterparties.

As of December 31, 2018, there were no counterparties for which the amount at risk relating to our repurchase agreements was greater than 10% of total equity.

Other Secured Borrowings

In February 2018, the Company entered into agreements to finance a portfolio of unsecured loans through a recourse secured borrowing facility. The facility includes a one year revolving period (or earlier following an early amortization event or event of default), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. After the revolving period ends, the facility has a two-year term ending in February 2021. The facility accrues interest on a floating rate basis. As of December 31, 2018, the Company had outstanding borrowings under this facility in the amount of $13.2 million which is included under the caption Other secured borrowings, on the Company's Consolidated Statement of Assets, Liabilities, and Equity, and the effective interest rate, inclusive of related deferred financing costs, was 4.72%. As of December 31, 2018, the fair value of unsecured loans collateralizing this borrowing was $20.3 million.

In December 2017, the Company amended its non-recourse secured borrowing facility that is used to finance a portfolio of unsecured loans. The facility includes a reinvestment period ending in December 2019 (or earlier following an early amortization event), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. Following the reinvestment period, the facility will begin to amortize based on the collections from the underlying loans. The facility accrues interest on a floating rate basis. As of December 31, 2018 the Company had outstanding borrowings under this facility in the amount of $101.0 million which is included under the caption Other secured borrowings, on the Company's Consolidated Statement of Assets, Liabilities, and Equity, and the effective interest rate on this facility, inclusive of related deferred financing costs, was 4.68% as of December 31, 2018. As of December 31, 2018 the fair value of unsecured loans collateralizing this borrowing was $149.0 million.

The Company has completed securitization transactions, as discussed in Note 6, whereby it financed portfolios of non-QM loans. As of December 31, 2018 the fair value of the Company's outstanding liabilities associated with these securitization transactions were $297.9 million, representing the fair value of the securitization trust certificates held by third parties as of such date, and is included on Company's Consolidated Statement of Assets, Liabilities, and Equity in Other Secured Borrowings, at fair value. The weighted average coupon on the Certificates held by third parties was 3.72% as of December 31, 2018. As of December 31, 2018 the fair value of non-QM loans held in the securitization trusts were $314.2 million.

Unsecured Borrowings

Senior Notes

On August 18, 2017, the Company issued $86.0 million in aggregate principal amount of Senior Notes. The total net proceeds to the Company from the issuance of the Senior Notes was approximately $84.7 million, after deducting debt issuance costs. The Senior Notes bear an interest rate of 5.25%, subject to adjustment based on changes in the ratings, if any, of the Senior Notes. Interest on the Senior notes is payable semi-annually in arrears on March 1 and September 1 of each year. The Senior Notes mature on September 1, 2022. The Company may redeem the Senior Notes, at its option, in whole or in part, prior to March 1, 2022 at a price equal to 100% of the principal amount thereof, plus the applicable "make-whole" premium as of the applicable date of redemption. At any time on or after March 1, 2022, the Company may redeem the Senior Notes, in whole or in part, at a redemption price equal to 100% of the aggregate principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest. The Senior Notes are carried at amortized cost. There are a number of covenants, including several financial covenants, associated with the Senior Notes. As of December 31, 2018 the Company was in compliance with all of its covenants.

The Company amortizes debt issuance costs over the life of the associated debt; the amortized portion of debt issuance costs is included in Interest expense on the Consolidated Statement of Operations. The Senior Notes have an effective interest rate of 5.55%, inclusive of debt issuance costs.

The Senior Notes are unsecured and are effectively subordinated to secured indebtedness of the Company, to the extent of the value of the collateral securing such indebtedness.

Schedule of Principal Repayments

The following table details the Company's principal repayment schedule for outstanding borrowings as of December 31, 2018:

Year	Reverse Repurchase Agreements(1)		Other Secured Borrowings(2)		Senior Notes(1)		Total
(In thousands)
2019	$	1,358,542	$	194,135	$	—	$	1,552,677
2020	78,530		205,198		—		283,728
2021	61,776		13,150		—		74,926
2022	—		—		86,000		86,000
2023	—		—		—		—
Total	$	1,498,848	$	412,483	$	86,000	$	1,997,331

(1)Reflects the Company's contractual principal repayment dates.

(2)Reflects the Company's expected principal repayment dates.

XML

Borrowings

12 Months Ended

Dec. 31, 2020

Debt Disclosure [Abstract]

Borrowings

Borrowings

Secured Borrowings

The Company's secured borrowings consist of repurchase agreements, Other secured borrowings, and Other secured borrowings, at fair value. As of December 31, 2020 and 2019, the Company's total secured borrowings were $2.3 billion and $3.2 billion, respectively.

Repurchase Agreements

The Company enters into repurchase agreements. A repurchase agreement involves the sale of an asset to a counterparty together with a simultaneous agreement to repurchase the transferred asset or similar asset from such counterparty at a future date. The Company accounts for its repurchase agreements as collateralized borrowings, with the transferred assets effectively serving as collateral for the related borrowing. The Company's repurchase agreements typically range in term from 30 to 180 days, although the Company also has repurchase agreements that provide for longer or shorter terms. The principal economic terms of each repurchase agreement—such as loan amount, interest rate, and maturity date—are typically negotiated on a transaction-by-transaction basis. Other terms and conditions, such as those relating to events of default, are typically governed under the Company's master repurchase agreements. Absent an event of default, the Company maintains beneficial ownership of the transferred securities during the term of the repurchase agreement and receives the related principal and interest payments. Interest rates on these borrowings are generally fixed based on prevailing rates corresponding to the terms of the borrowings, and for most repurchase agreements, interest is generally paid at the termination of the repurchase agreement, at which time the Company may enter into a new repurchase agreement at prevailing market rates with the same counterparty, repay that counterparty and possibly negotiate financing terms with a different counterparty, or choose to no longer finance the related asset. Some repurchase agreements provide for periodic payments of interest, such as monthly payments. In response to a decline in the fair value of the transferred securities, whether as a result of changes in market conditions, security paydowns, or other factors, repurchase agreement counterparties will typically make a margin call, whereby the Company will be required to post additional securities and/or cash as collateral with the counterparty in order to re-establish the agreed-upon collateralization requirements. In the event of increases in fair value of the transferred securities, the Company can generally require the counterparty to post collateral with it in the form of cash or securities. The Company is generally permitted to sell or re-pledge any securities posted by the counterparty as collateral; however, upon termination of the repurchase agreement, or other circumstance in which the counterparty is no longer required to post such margin, the Company must return to the counterparty the same security that had been posted.

At any given time, the Company seeks to have its outstanding borrowings under repurchase agreements with several different counterparties in order to reduce the exposure to any single counterparty. The Company had outstanding borrowings under repurchase agreements with 24 counterparties as of December 31, 2020 as compared to 28 counterparties as of December 31, 2019.

As of December 31, 2020, remaining days to maturity on the Company's open repurchase agreements ranged from 4 days to 516 days. Interest rates on the Company's open repurchase agreements ranged from 0.20% to 5.00% as of December 31, 2020. As of December 31, 2019, remaining days to maturity on the Company's open repurchase agreements ranged from 2 days to 882 days. Interest rates on the Company's open repurchase agreements ranged from 0.15% to 5.20% as of December 31, 2019.

The following table details the Company's outstanding borrowings under repurchase agreements for Agency RMBS and credit assets (which can include non-Agency RMBS, CMBS, CLOs, consumer loans, corporate debt, residential mortgage loans, and commercial mortgage loans and REO), by remaining maturity as of December 31, 2020 and 2019:

	December 31, 2020					December 31, 2019
			Weighted Average					Weighted Average
Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity
Agency RMBS:	(In thousands)					(In thousands)
30 Days or Less	$	265,556	0.28	%	17	$	511,996	2.08	%	17
31-60 Days	385,141		0.25	%	44	744,387		1.93	%	47
61-90 Days	174,586		0.28	%	70	594,738		1.96	%	76
91-120 Days	—		—	%	—	10,270		2.24	%	93
121-150 Days	2,692		0.27	%	126	—		—	%	—
151-180 Days	59,857		0.32	%	162	3,082		2.67	%	171
181-360 Days	34,030		0.32	%	252	—		—	%	—
Total Agency RMBS	921,862		0.27	%	57	1,864,473		1.98	%	48
Credit:
30 Days or Less	37,795		2.11	%	17	16,549		3.38	%	25
31-60 Days	84,554		2.23	%	50	104,491		3.14	%	48
61-90 Days	152,426		2.11	%	75	138,837		3.03	%	73
91-120 Days	89,931		2.47	%	106	—		—	%	—
121-150 Days	66,412		4.75	%	125	7,460		3.89	%	123
151-180 Days	11,063		2.27	%	165	31,498		3.87	%	173
181-360 Days	38,640		2.90	%	289	186,661		3.80	%	250
> 360 Days	94,248		2.99	%	447	95,331		4.52	%	678
Total Credit Assets	575,069		2.69	%	155	580,827		3.61	%	229
Total	$	1,496,931	1.20	%	94	$	2,445,300	2.37	%	91

Repurchase agreements involving underlying investments that the Company sold prior to period end, for settlement following period end, are shown using their original maturity dates even though such repurchase agreements may be expected to be terminated early upon settlement of the sale of the underlying investment.

As of December 31, 2020 and 2019, the fair value of investments transferred as collateral under outstanding borrowings under repurchase agreements was $1.831 billion and $2.763 billion, respectively. Collateral transferred under outstanding borrowings under repurchase agreements as of December 31, 2020 and 2019 include investments in the amount of $1.4 million and $64.7 million, respectively, that were sold prior to period end but for which such sale had not yet settled. In addition, as of December 31, 2020 the Company posted net cash collateral of $28.9 million to its counterparties. As of December 31, 2019, the Company posted net cash collateral of $31.0 million, as well as posting additional securities with a fair value of $0.2 million, to its counterparties.

Amount at risk represents the excess, if any, for each counterparty of the fair value of collateral held by such counterparty over the amounts outstanding under repurchase agreements. As of both December 31, 2020 and 2019, there was no single counterparty for which the amount at risk relating to our repurchase agreements was greater than 10% of total equity.

Other Secured Borrowings

In February 2018, the Company entered into agreements to finance a portfolio of unsecured loans through a recourse secured borrowing facility. The facility has a term ending in February 2021. The facility accrues interest on a floating-rate basis. As of December 31, 2020 and 2019, the Company had outstanding borrowings under this facility in the amount of $8.7 million and $16.0 million, respectively, which is included under the caption Other secured borrowings, on the Company's Consolidated Balance Sheet. The effective interest rate, inclusive of related deferred financing costs, was 2.30% and 3.85% as of December 31, 2020 and 2019. As of December 31, 2020 and 2019, the fair value of unsecured loans collateralizing this borrowing was $11.5 million and $22.3 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of December 31, 2020, the Company was in compliance with all of its covenants.

The Company has a non-recourse secured borrowing facility that is used to finance a portfolio of unsecured loans. The facility included a reinvestment period ending in February 2021 (or earlier following an early amortization event), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. Following the reinvestment period, the facility will begin to amortize based on the collections from the underlying loans. The facility accrues interest on a floating rate basis. As of December 31, 2020 and 2019, the Company had outstanding borrowings under this facility in the amount of $7.0 million and $102.5 million, respectively, which is included under the caption Other secured borrowings, on the Company's Consolidated Balance Sheet. The effective interest rate on this facility, inclusive of related deferred financing costs, was 2.25% and 4.01%, as of December 31, 2020 and 2019, respectively. As of December 31, 2020 and 2019, the fair value of unsecured loans collateralizing this borrowing was $31.8 million and $144.1 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of December 31, 2020, the Company was in compliance with all of its covenants.

In December 2019, the Company entered into an agreement to finance a portfolio of ABS backed by consumer loans through a recourse secured borrowing facility. The facility includes a revolving borrowing period ending in June 2021 (or earlier following a trigger event), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. Following the revolving borrowing period, the facility amortizes, with a final termination date in June 2023. The facility accrues interest on a floating rate basis. As of December 31, 2020 and 2019, the Company had outstanding borrowings under this facility in the amount of $28.7 million and $31.8 million, respectively, which is included under the caption Other secured borrowings, on the Company's Consolidated Balance Sheet.The effective interest rate on this facility, inclusive of related deferred financing costs, was 5.22% and 5.23% as of December 31, 2020 and 2019, respectively. As of December 31, 2020 and 2019, the fair value of ABS backed by consumer loans collateralizing this borrowing was $44.5 million and $47.9 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of December 31, 2020, the Company was in compliance with all of its covenants.

The Company has completed securitization transactions, as discussed in Note 10, whereby it financed portfolios of non-QM loans. As of December 31, 2020 and 2019, the fair value of the Company's outstanding liabilities associated with these securitization transactions was $754.9 million and $594.4 million, respectively, representing the fair value of the securitization trust certificates held by third parties as of such date, and is included on the Company's Consolidated Balance Sheet in Other secured borrowings, at fair value. The weighted average coupon of the Certificates held by third parties was 2.43% and 3.19% as of December 31, 2020 and 2019, respectively. As of December 31, 2020, the fair value of non-QM loans held in the consolidated securitization trusts was $801.3 million. As of December 31, 2019, the fair value of non-QM loans and the carrying value of REO was $629.1 million.

In March 2020, the Company entered into a participation agreement with an unrelated third-party, the "Junior Participant," whereby the Company transferred to the Junior Participant an interest in a small balance commercial mortgage loan, the "Partial Loan," (together with the Company's interest, the "Whole Commercial Loan"). The Partial Loan is subordinate to the interest in the loan held by the Company. In accordance with ASC 860-10, the Partial Loan transferred to the Junior Participant does not meet the definition of a participating interest and, as a result, the Company does not recognize the transfer of the Partial Loan to the Junior Participant as a sale. The Company has recorded the Whole Commercial Loan in Loans, at fair value, on the Consolidated Balance Sheet. As of December 31, 2020, the fair value of the Whole Commercial Loan was $17.3 million. The Company's liability to the Junior Participant as of December 31, 2020 was $6.7 million and is included in Other secured borrowings on the Company's Consolidated Balance Sheet. Under the terms of the participation agreement, the Junior Participant is entitled to a portion of the cashflows of the underlying commercial mortgage loan.

Unsecured Borrowings

Senior Notes

On August 18, 2017, the Company issued $86.0 million in aggregate principal amount of unsecured senior notes (the "Old Senior Notes"). The total net proceeds to the Company from the issuance of the Old Senior Notes was approximately $84.7 million, after deducting debt issuance costs. The Old Senior Notes had an interest rate of 5.25%, subject to adjustment based on changes in the ratings, if any, of the Old Senior Notes. On February 13, 2019, in connection with the REIT Election, the Company exchanged all $86.0 million in principal amount of the Old Senior Notes for new unsecured long-term debt jointly and severally co-issued by certain of its consolidated subsidiaries and fully guaranteed by the Company (the "Senior Notes"). At any time, the Company is permitted to add others of its consolidated subsidiaries as co-issuers of the Senior Notes. The Senior Notes bear interest at a rate of 5.50%, subject to adjustment based on changes, if any, in the ratings of the Senior Notes. Interest on the Senior Notes is payable semi-annually in arrears on March 1 and September 1 of each year. The Senior Notes mature on September 1, 2022. The Company may redeem the Senior Notes, at its option, in whole or in part, prior to March 1, 2022 at a price equal to 100% of the principal amount thereof, plus the applicable "make-whole" premium as of the applicable date of redemption. At any time on or after March 1, 2022, the Company may redeem the Senior Notes, in whole or in part, at a redemption price equal to 100% of the aggregate principal amount of the Senior Notes to be redeemed, plus accrued and unpaid

interest. The Senior Notes are carried at amortized cost. There are a number of covenants, including several financial covenants, associated with the Senior Notes. As of both December 31, 2020 and 2019, the Company was in compliance with all of its covenants.

The Company amortizes debt issuance costs over the life of the associated debt; the amortized portion of debt issuance costs is included in Interest expense on the Consolidated Statement of Operations. The Senior Notes have an effective interest rate of 5.80%, inclusive of debt issuance costs.

The Senior Notes are unsecured and are effectively subordinated to secured indebtedness of the Company, to the extent of the value of the collateral securing such indebtedness.

Schedule of Principal Repayments

The following table details the Company's principal repayment schedule, over the next 5 years, for outstanding borrowings as of December 31, 2020:

Year	Repurchase Agreements(1)		Other Secured Borrowings(2)		Senior Notes(1)		Total
(In thousands)
Next Twelve Months	$	1,402,683	$	370,933	$	—	$	1,773,616
Year 2	94,248		236,976		86,000		417,224
Year 3	—		221,269		—		221,269
Year 4	—		—		—		—
Year 5	—		—		—		—
Total	$	1,496,931	$	829,178	$	86,000	$	2,412,109

(1)Reflects the Company's contractual principal repayment dates.

(2)Includes $778.1 million of expected principal repayments related to the Company's consolidated residential mortgage loan securitizations, which are projected based upon the underlying assets' expected repayments and may be prior to the stated contractual maturities.

Borrowings

Secured Borrowings

The Company's secured borrowings consist of reverse repurchase agreements, Other secured borrowings, and Other secured borrowings, at fair value. As of December 31, 2018 the Company's total secured borrowings were $1.911 billion.

Reverse Repurchase Agreements

The Company enters into reverse repurchase agreements. A reverse repurchase agreement involves the sale of an asset to a counterparty together with a simultaneous agreement to repurchase the transferred asset or similar asset from such counterparty at a future date. The Company accounts for its reverse repurchase agreements as collateralized borrowings, with the transferred assets effectively serving as collateral for the related borrowing. The Company's reverse repurchase agreements typically range in term from 30 to 180 days, although the Company also has reverse repurchase agreements that provide for longer or shorter terms. The principal economic terms of each reverse repurchase agreement—such as loan amount, interest rate, and maturity date—are typically negotiated on a transaction-by-transaction basis. Other terms and conditions, such as those relating to events of default, are typically governed under the Company's master repurchase agreements. Absent an event of default, the Company maintains beneficial ownership of the transferred securities during the term of the reverse repurchase agreement and receives the related principal and interest payments. Interest rates on these borrowings are generally fixed based on prevailing rates corresponding to the terms of the borrowings, and for most reverse repurchase agreements, interest is generally paid at the termination of the reverse repurchase agreement, at which time the Company may enter into a new reverse repurchase agreement at prevailing market rates with the same counterparty, repay that counterparty and possibly negotiate

financing terms with a different counterparty, or choose to no longer finance the related asset. Some reverse repurchase agreements provide for periodic payments of interest, such as monthly payments. In response to a decline in the fair value of the transferred securities, whether as a result of changes in market conditions, security paydowns, or other factors, reverse repurchase agreement counterparties will typically make a margin call, whereby the Company will be required to post additional securities and/or cash as collateral with the counterparty in order to re-establish the agreed-upon collateralization requirements. In the event of increases in fair value of the transferred securities, the Company can generally require the counterparty to post collateral with it in the form of cash or securities. The Company is generally permitted to sell or re-pledge any securities posted by the counterparty as collateral; however, upon termination of the reverse repurchase agreement, or other circumstance in which the counterparty is no longer required to post such margin, the Company must return to the counterparty the same security that had been posted.

At any given time, the Company seeks to have its outstanding borrowings under reverse repurchase agreements with several different counterparties in order to reduce the exposure to any single counterparty. The Company had outstanding borrowings under reverse repurchase agreements with 23 counterparties as of December 31, 2018.

At December 31, 2018, approximately 21% of open reverse repurchase agreements were with one counterparty. As of December 31, 2018 remaining days to maturity on the Company's open reverse repurchase agreements ranged from 2 days to 871 days. Interest rates on the Company's open reverse repurchase agreements ranged from 0.23% to 6.07% as of December 31, 2018.

The following table details the Company's outstanding borrowings under reverse repurchase agreements for Agency RMBS, credit assets (which include non-Agency MBS, CLOs, consumer loans, corporate debt, residential mortgage loans, and commercial mortgage loans and REO), and U.S. Treasury securities, by remaining maturity as of December 31, 2018:

(In thousands)	December 31, 2018
			Weighted Average
Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity
Agency RMBS:
30 Days or Less	$	245,956	2.46	%	17
31-60 Days	415,379		2.58	%	46
61-90 Days	255,421		2.74	%	76
91-120 Days	506		3.31	%	91
Total Agency RMBS	917,262		2.59	%	47
Credit:
30 Days or Less	30,426		2.55	%	22
31-60 Days	189,937		3.32	%	48
61-90 Days	93,202		3.21	%	74
121-150 Days	26,222		4.60	%	123
151-180 Days	9,491		4.64	%	166
181-360 Days	91,730		4.54	%	316
> 360 Days	140,306		5.15	%	636
Total Credit Assets	581,314		3.98	%	240
U.S. Treasury Securities:
30 Days or Less	273		3.10	%	2
Total U.S. Treasury Securities	273		3.10	%	2
Total	$	1,498,849	3.13	%	122

Reverse repurchase agreements involving underlying investments that the Company sold prior to period end, for settlement following period end, are shown using their original maturity dates even though such reverse repurchase agreements may be expected to be terminated early upon settlement of the sale of the underlying investment.

As of December 31, 2018, the fair value of investments transferred as collateral under outstanding borrowings under reverse repurchase agreements was $1.79 billion. Collateral transferred under outstanding borrowings as of December 31, 2018 include investments in the amount of $86.7 million that were sold prior to period end but for which such sale had not yet

settled. In addition the Company posted net cash collateral of $17.0 million and additional securities with a fair value of $0.2 million as of December 31, 2018 to its counterparties.

As of December 31, 2018, there were no counterparties for which the amount at risk relating to our repurchase agreements was greater than 10% of total equity.

Other Secured Borrowings

In February 2018, the Company entered into agreements to finance a portfolio of unsecured loans through a recourse secured borrowing facility. The facility includes a one year revolving period (or earlier following an early amortization event or event of default), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. After the revolving period ends, the facility has a two-year term ending in February 2021. The facility accrues interest on a floating rate basis. As of December 31, 2018, the Company had outstanding borrowings under this facility in the amount of $13.2 million which is included under the caption Other secured borrowings, on the Company's Consolidated Statement of Assets, Liabilities, and Equity, and the effective interest rate, inclusive of related deferred financing costs, was 4.72%. As of December 31, 2018, the fair value of unsecured loans collateralizing this borrowing was $20.3 million.

In December 2017, the Company amended its non-recourse secured borrowing facility that is used to finance a portfolio of unsecured loans. The facility includes a reinvestment period ending in December 2019 (or earlier following an early amortization event), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. Following the reinvestment period, the facility will begin to amortize based on the collections from the underlying loans. The facility accrues interest on a floating rate basis. As of December 31, 2018 the Company had outstanding borrowings under this facility in the amount of $101.0 million which is included under the caption Other secured borrowings, on the Company's Consolidated Statement of Assets, Liabilities, and Equity, and the effective interest rate on this facility, inclusive of related deferred financing costs, was 4.68% as of December 31, 2018. As of December 31, 2018 the fair value of unsecured loans collateralizing this borrowing was $149.0 million.

The Company has completed securitization transactions, as discussed in Note 6, whereby it financed portfolios of non-QM loans. As of December 31, 2018 the fair value of the Company's outstanding liabilities associated with these securitization transactions were $297.9 million, representing the fair value of the securitization trust certificates held by third parties as of such date, and is included on Company's Consolidated Statement of Assets, Liabilities, and Equity in Other Secured Borrowings, at fair value. The weighted average coupon on the Certificates held by third parties was 3.72% as of December 31, 2018. As of December 31, 2018 the fair value of non-QM loans held in the securitization trusts were $314.2 million.

Unsecured Borrowings

Senior Notes

On August 18, 2017, the Company issued $86.0 million in aggregate principal amount of Senior Notes. The total net proceeds to the Company from the issuance of the Senior Notes was approximately $84.7 million, after deducting debt issuance costs. The Senior Notes bear an interest rate of 5.25%, subject to adjustment based on changes in the ratings, if any, of the Senior Notes. Interest on the Senior notes is payable semi-annually in arrears on March 1 and September 1 of each year. The Senior Notes mature on September 1, 2022. The Company may redeem the Senior Notes, at its option, in whole or in part, prior to March 1, 2022 at a price equal to 100% of the principal amount thereof, plus the applicable "make-whole" premium as of the applicable date of redemption. At any time on or after March 1, 2022, the Company may redeem the Senior Notes, in whole or in part, at a redemption price equal to 100% of the aggregate principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest. The Senior Notes are carried at amortized cost. There are a number of covenants, including several financial covenants, associated with the Senior Notes. As of December 31, 2018 the Company was in compliance with all of its covenants.

The Company amortizes debt issuance costs over the life of the associated debt; the amortized portion of debt issuance costs is included in Interest expense on the Consolidated Statement of Operations. The Senior Notes have an effective interest rate of 5.55%, inclusive of debt issuance costs.

The Senior Notes are unsecured and are effectively subordinated to secured indebtedness of the Company, to the extent of the value of the collateral securing such indebtedness.

Schedule of Principal Repayments

The following table details the Company's principal repayment schedule for outstanding borrowings as of December 31, 2018:

Year	Reverse Repurchase Agreements(1)		Other Secured Borrowings(2)		Senior Notes(1)		Total
(In thousands)
2019	$	1,358,542	$	194,135	$	—	$	1,552,677
2020	78,530		205,198		—		283,728
2021	61,776		13,150		—		74,926
2022	—		—		86,000		86,000
2023	—		—		—		—
Total	$	1,498,848	$	412,483	$	86,000	$	1,997,331

(1)Reflects the Company's contractual principal repayment dates.

(2)Reflects the Company's expected principal repayment dates.

XML

Income Taxes

12 Months Ended

Dec. 31, 2020

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The Company has elected to be taxed as a REIT under the Code. A REIT is generally not subject to U.S. federal, state, and local income tax on the portion of its income that is distributed to its owners if it distributes at least 90% of its REIT taxable income within the prescribed time frames, determined without regard to the deduction for dividends paid and excluding any net capital gains. The Company intends to operate in a manner which will allow it to continue to meet the requirements for qualification as a REIT. Accordingly, Ellington Financial Inc. does not believe that it will be subject to U.S. federal, state, and local income tax on the portion of its net taxable income that is distributed to its stockholders as long as certain asset, income, and share ownership tests are met.

Cash dividends declared by the Company that do not exceed its current or accumulated earnings and profits will be considered ordinary income to stockholders for income tax purposes unless all or a portion of a dividend is designated by the Company as a capital gain dividend. Distributions in excess of the Company's current and accumulated earnings and profits will be characterized as return of capital or capital gains.

The following table details the tax characteristics of the Company's dividends declared on its shares of common and preferred stock for the years ended December 31, 2020 and 2019.

	Year Ended
Tax Characteristic	December 31, 2020		December 31, 2019
Ordinary income	58.2	%	85.0	%
Return of capital	37.9	%	9.4	%
Capital gains	3.9	%	5.6	%
	100.0	%	100.0	%

Certain foreign and domestic subsidiaries of the Company have elected to be treated as TRSs and therefore are taxed as corporations for U.S. federal, state, and local income tax purposes. To the extent that those entities incur, or are expected to incur, U.S. federal, state, or local income taxes, or foreign income taxes, such taxes are recorded in the Company's consolidated financial statements.

In response to the negative economic impact of the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act, or the "CARES Act," was signed into law on March 27, 2020, and provided for significant stimulus spending and included numerous tax provisions. As of December 31, 2020, there was no material impact on the Company's tax provision as a result of the CARES Act; however, the Company continues to monitor and evaluate the impact of the CARES Act and other COVID-19-related legislation.

The Company accounts for income taxes in accordance with ASC 740, Income Taxes, or "ASC 740." Deferred income taxes reflect the net tax effects of temporary differences that may exist between the carrying amounts of assets and liabilities under U.S. GAAP and the carrying amounts used for income tax purposes. For the years ended December 31, 2020 and 2019, the Company recorded an income tax expense of $11.4 million and $1.6 million, respectively. The increase in income tax expense for the year ended December 31, 2020, was primarily due to an increase in deferred tax liabilities related to unrealized gains on investments held in a domestic TRS.

The following table summarizes the Company's income tax provision for the years ended December 31, 2020 and 2019.

	As of
(In thousands)	December 31, 2020		December 31, 2019
Current income tax provision
Federal	$	38	$	185
State	602		293
Total current income tax provision, net	640		478
Deferred income tax provision
Federal	6,638		1,080
State	4,099		—
Total deferred income tax provision, net	10,737		1,080
Total income tax provision	$	11,377	$	1,558

The following table details the components of the Company's net deferred tax asset (liability) at December 31, 2020 and 2019.

	As of
(In thousands)	December 31, 2020		December 31, 2019
Deferred tax asset
Net operating loss available for carry-back and carry-forward	$	1,937	$	3,907
Basis difference for investments	1,481		669
Valuation allowance	—		(157)
Deferred tax asset	3,419		4,419
Deferred tax liability
Basis difference for investments	(15,525)		(5,484)
Deferred tax liability	(15,525)		(5,484)
Net deferred tax asset (liability)	$	(12,106)	$	(1,065)

The following table details the reconciliation between the Company's U.S. federal and state statutory income tax rate and the effective tax rate for the years ended December 31, 2020 and 2019.

	Year Ended
	December 31, 2020		December 31, 2019
Federal statutory rate	21.00	%	21.00	%
State statutory rate, net of federal benefit	11.83	%	0.45	%
Income attributable to non-controlling interests	(1.78)	%	(1.28)	%
REIT earnings not subject to corporate taxes	(2.43)	%	(17.76)	%
Effective tax rate	28.62	%	2.41	%

Income TaxesThe Company has certain subsidiaries that have elected to be treated as corporations for U.S. federal, state, and local income tax purposes. The Company accounts for income taxes in accordance with ASC 740, Income Taxes. Deferred income taxes reflect the net tax effects of temporary differences that may exist between the carrying amounts of assets and liabilities under U.S. GAAP and the amounts used for income tax purposes. As of December 31, 2018, one of the Company's domestic TRS's had a net operating loss carry-forward, resulting in a gross deferred tax asset, which has been fully reserved through a valuation allowance.

XML

Related Party Transactions

12 Months Ended

Dec. 31, 2020

Related Party Transactions [Abstract]

Related Party Transactions

Related Party Transactions

The Company is party to the Management Agreement (which may be amended from time to time), pursuant to which the Manager manages the assets, operations, and affairs of the Company, in consideration of which the Company pays the Manager management and incentive fees. The descriptions of the Base Management Fees and Incentive Fees are detailed below.

Base Management Fees

The Operating Partnership pays the Manager 1.50% per annum of total equity of the Operating Partnership calculated in accordance with U.S. GAAP as of the end of each fiscal quarter (before deductions for base management fees and incentive fees payable with respect to such fiscal quarter), provided that total equity is adjusted to exclude one-time events pursuant to changes in U.S. GAAP, as well as non-cash charges after discussion between the Manager and the Company's independent directors, and approval by a majority of the Company's independent directors in the case of non-cash charges.

Pursuant to the Management Agreement, if the Company invests at issuance in the equity of any collateralized debt obligation that is managed, structured, or originated by Ellington or one of its affiliates, or if the Company invests in any other investment fund or other investment for which Ellington or one of its affiliates receives management, origination, or structuring fees, then, unless agreed otherwise by a majority of the Company's independent directors, the base management and incentive fees payable by the Company to its Manager will be reduced by an amount equal to the applicable portion (as described in the Management Agreement) of any such management, origination, or structuring fees.

For the year ended December 31, 2020, the total base management fee incurred was $11.5 million, consisting of $12.6 million of total gross base management fee incurred, less $1.1 million of management fee rebates. For the year ended December 31, 2019, the total base management fee incurred was $8.0 million consisting of $10.0 million of total gross base management fee incurred, less $2.0 million of management fee rebates. See "—Participation in CLO Transactions" below for details on management fee rebates.

Incentive Fees

The Manager is entitled to receive a quarterly incentive fee equal to the positive excess, if any, of (i) the product of (A) 25% and (B) the excess of (1) Adjusted Net Income (described below) for the Incentive Calculation Period (which means such fiscal quarter and the immediately preceding three fiscal quarters) over (2) the sum of the Hurdle Amounts (described below) for the Incentive Calculation Period, over (ii) the sum of the incentive fees already paid or payable for each fiscal quarter in the Incentive Calculation Period preceding such fiscal quarter.

For purposes of calculating the incentive fee, "Adjusted Net Income" for the Incentive Calculation Period means the net increase in equity from operations of the Operating Partnership, after all base management fees but before any incentive fees for such period, and excluding any non-cash equity compensation expenses for such period, as reduced by any Loss Carryforward (as described below) as of the end of the fiscal quarter preceding the Incentive Calculation Period.

For purposes of calculating the incentive fee, the "Loss Carryforward" as of the end of any fiscal quarter is calculated by determining the excess, if any, of (1) the Loss Carryforward as of the end of the immediately preceding fiscal quarter over (2) the Company's net increase in equity from operations (expressed as a positive number) or net decrease in equity from operations (expressed as a negative number) of the Operating Partnership for such fiscal quarter. As of both December 31, 2020 and 2019, there was no Loss Carryforward.

For purposes of calculating the incentive fee, the "Hurdle Amount" means, with respect to any fiscal quarter, the product of (i) one-fourth of the greater of (A) 9% and (B) 3% plus the 10-year U.S. Treasury rate for such fiscal quarter, (ii) the sum of (A) the weighted average gross proceeds per share of all common stock and OP Unit issuances since inception of the Company and up to the end of such fiscal quarter, with each issuance weighted by both the number of shares of common stock and OP Units issued in such issuance and the number of days that such issued shares of common stock and OP Units were outstanding during such fiscal quarter, using a first-in first-out basis of accounting (i.e. attributing any share of common stock and OP Unit repurchases to the earliest issuances first) and (B) the result obtained by dividing (I) retained earnings attributable to shares of common stock and OP Units at the beginning of such fiscal quarter by (II) the average number of shares of common stock and OP Units outstanding for each day during such fiscal quarter, and (iii) the sum of (x) the average number of shares of common stock and long term incentive plan units of the Company outstanding for each day during such fiscal quarter, and (y) the average number of Convertible Non-controlling Interests outstanding for each day during such fiscal quarter. For purposes of determining the Hurdle Amount, issuances of common stock, and Convertible Non-controlling Interests (a) as equity incentive awards, (b) to the Manager as part of its base management fee or incentive fee and (c) to the Manager or any of its affiliates in privately negotiated transactions, are excluded from the calculation. The payment of the incentive fee will be in a combination

of shares of common stock and cash, provided that at least 10% of any quarterly payment will be made in shares of common stock.

The Company did not accrue an incentive fee for the year ended December 31, 2020, since on a rolling four quarter basis, the Company's income did not exceed the prescribed hurdle amount. Total incentive fee incurred for the year ended December 31, 2019 was $0.1 million.

Termination Fees

The Management Agreement requires the Company to pay a termination fee to the Manager in the event of (1) the Company's termination or non-renewal of the Management Agreement without cause or (2) the Company's termination of the Management Agreement based on unsatisfactory performance by the Manager that is materially detrimental to the Company or (3) the Manager's termination of the Management Agreement upon a default by the Company in the performance of any material term of the Management Agreement. Such termination fee will be equal to the amount of three times the sum of (i) the average annual quarterly base management fee amounts paid or payable with respect to the two 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal and (ii) the average annual quarterly incentive fee amounts paid or payable with respect to the two 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal.

Expense Reimbursement

Under the terms of the Management Agreement the Company is required to reimburse the Manager for operating expenses related to the Company that are incurred by the Manager, including expenses relating to legal, accounting, due diligence, other services, and all other costs and expenses. The Company's reimbursement obligation is not subject to any dollar limitation. Expenses will be reimbursed in cash within 60 days following delivery of the expense statement by the Manager; provided, however, that such reimbursement may be offset by the Manager against amounts due to the Company from the Manager. The Company will not reimburse the Manager for the salaries and other compensation of the Manager's personnel except that the Company will be responsible for expenses incurred by the Manager in employing certain dedicated or partially dedicated personnel as further described below.

The Company reimburses the Manager for the allocable share of the compensation, including, without limitation, wages, salaries, and employee benefits paid or reimbursed, as approved by the Compensation Committee of the Board of Directors to certain dedicated or partially dedicated personnel who spend all or a portion of their time managing the Company's affairs, based upon the percentage of time devoted by such personnel to the Company's affairs. In their capacities as officers or personnel of the Manager or its affiliates, such personnel will devote such portion of their time to the Company's affairs as is necessary to enable the Company to operate its business.

For the years ended December 31, 2020 and 2019, the Company reimbursed the Manager $9.9 million and $10.9 million, respectively, for previously incurred operating expenses. As of December 31, 2020 and 2019, the outstanding payable to the Manager for operating expenses was $2.5 million and $2.0 million, respectively, which are included in Accrued expenses and other liabilities on the Consolidated Balance Sheet.

Transactions Involving Certain Loan Originators

As of December 31, 2020 and 2019, the loan originators in which the Company holds equity investments represent related parties. Transactions that have been entered into with these related party mortgage originators are summarized below.

The Company is a party to a mortgage loan purchase and sale flow agreement, with a mortgage originator in which the Company holds a non-controlling equity investment, whereby the Company purchases residential mortgage loans that satisfy certain specified criteria. The Company has also provided a $5.0 million line of credit to the mortgage originator. Under the terms of this line of credit, the Company has agreed to make advances to the mortgage originator solely for the purpose of funding specifically identified residential mortgage loans designated for sale to the Company. To the extent the advances are drawn by the mortgage originator, it must pay interest, at a rate of 15% per annum, on the outstanding balance of each advance from the date the advance is made until such advance is repaid in full. The mortgage originator is required to repay advances in full no later than two business days following the date that the Company purchases the related residential mortgage loans from the mortgage originator. As of both December 31, 2020 and December 31, 2019, there were no advances outstanding. The Company has also entered into two agreements whereby it guarantees the performance of such mortgage originator under third-party master repurchase agreements. See Note 21, Commitments and Contingencies, for further information on the Company's guarantees of the third-party borrowing arrangements. Additionally, in August 2020, the Company entered into a commitment agreement whereby the Company committed to purchase $150 million of residential mortgage loans that meet specified criteria, or the "Commitment Agreement." As of December 31, 2020, the Company had purchased the entire $150 million of eligible

residential mortgage loans under the terms of the Commitment Agreement. In connection with the Commitment Agreement, the Company also entered into an agreement whereby the Company would be entitled to receive warrants proportionally as it satisfied its purchase commitment under the Commitment Agreement to purchase a maximum of 9.329 million shares of non-voting common stock. As of December 31, 2020, the Company has received warrants for the maximum 9.329 million shares; such warrants have a fair value of $3.6 million as of December 31, 2020 and are included in Investments in unconsolidated entities on the Consolidated Balance Sheet.

The Company, through a related party of Ellington, or the "Loan Purchaser," is a party to a consumer loan purchase and sale flow agreement with a consumer loan originator in which the Company holds an investment in preferred stock and warrants to purchase additional preferred stock, whereby the Loan Purchaser purchases consumer loans that satisfy certain specified criteria. The Company has investments in participation certificates related to consumer loans titled in the name of the Loan Purchaser. Through its participation certificates, the Company has beneficial interests in the loan cash flows, net of servicing-related fees and expenses. The total fair value of the Company's participation certificates was $44.5 million and $47.9 million as of December 31, 2020 and 2019, respectively.

In May 2019 the Company entered into a note purchase agreement whereby it agreed to lend up to $5.0 million to a mortgage originator ("the Initial Note") in which the Company also holds a non-controlling equity investment. The Initial Note carried an interest rate of 15% per annum on the outstanding balance. In July and December 2019, the Company amended the note purchase agreement whereby it agreed to lend an additional $5.0 million and $2.5 million, respectively, (the "Additional Notes") to the mortgage originator. The Additional Notes each carried an interest rate of 18% per annum. As of December 31, 2019, the aggregate outstanding balance on the Initial Note and the Additional Notes was $12.5 million. In January 2020, the Initial Note and the Additional Notes were repaid. The Initial Note and the Additional Notes are classified as Corporate loans and included in Loans, at fair value on the Consolidated Balance Sheet.

Consumer, Residential, and Commercial Loan Transactions with Affiliates

The Company purchases certain of its consumer loans through an affiliate, or the "Purchasing Entity." The Purchasing Entity has entered into purchase agreements, open-ended in duration, with third party consumer loan originators whereby it has agreed to purchase eligible consumer loans. The amount of loans purchased under these purchase agreements is dependent on, among other factors, the amount of loans originated in any given period by the selling originators. The Company and certain other affiliates of Ellington have entered into agreements with the Purchasing Entity whereby the Company and each of those other affiliates of Ellington have agreed to purchase their allocated portion (subject to monthly determination based on available capital and other factors) of the eligible loans acquired by the Purchasing Entity under each purchase agreement. Immediately after the Purchasing Entity purchases beneficial interests in the loans, the Company and other affiliates of Ellington purchase such beneficial interests from the Purchasing Entity, at the same price paid by the Purchasing Entity. During the years ended December 31, 2020 and 2019, the Company purchased loans under these agreements with an aggregate principal balance of $115.7 million and $134.4 million, respectively. As of December 31, 2020 and 2019, the estimated remaining contingent purchase obligations of the Company under these purchase agreements was approximately $13.0 million and $287.1 million, respectively, in principal balance.

The Company's beneficial interests in the consumer loans purchased through the Purchasing Entity are evidenced by participation certificates issued by trusts that hold legal title to the loans. These trusts are owned by a related party of Ellington and were established to hold such loans. Through its participation certificates, the Company participates in the cash flows of the underlying loans held by each trust. The total amount of consumer loans underlying the Company's participation certificates and held in the related party trusts was $45.1 million and $185.4 million as of December 31, 2020 and 2019, respectively.

The Company has beneficial interests in residential mortgage loans and REO held in a trust owned by a related party of Ellington. Through these beneficial interests, the Company participates in the cash flows of the underlying loans held by such trust. The total amount of residential mortgage loans and REO underlying the Company's beneficial interests and held in the related party trust was $387.4 million and $304.8 million as of December 31, 2020 and 2019, respectively.

The Company is a co-investor in certain small balance commercial mortgage loans with several other investors, including an unrelated third party and various affiliates of Ellington. These loans are beneficially owned by a consolidated subsidiary of the Company. As of December 31, 2020 and 2019, the aggregate fair value of the small balance commercial loans was $34.0 million and $29.5 million, respectively. As of December 31, 2020, the non-controlling interests held by the unrelated third party and the Ellington affiliates were $4.1 million and $8.9 million, respectively. As of December 31, 2019, the non-controlling interests held by the unrelated third party and the Ellington affiliates were $3.6 million and $7.0 million, respectively. As of December 31, 2019, the Company had a payable to an Ellington affiliate in the amount of $0.7 million, which is included in Accrued expenses and other liabilities on the Consolidated Balance Sheet. The Company did not have any payables to or receivables from the Ellington affiliates as of December 31, 2020.

The Company is also a co-investor in certain small balance commercial mortgage loans and REO with other investors, including various unrelated third parties and various affiliates of Ellington. Each co-investor in a particular loan has an interest in the limited liability company that owns such loan or REO. As of December 31, 2020 and 2019, the aggregate fair value of the Company's investments in the jointly owned limited liability companies was approximately $33.9 million and $17.3 million, respectively. Such investments are included in Investments in unconsolidated entities, on the Consolidated Balance Sheet.

The consumer, residential mortgage, and certain commercial mortgage loans that are the subject of the foregoing loan transactions are held in trusts, each of which the Company has determined to be a VIE. The Company has evaluated each of these VIEs and determined that the Company has the power to direct the activities of each VIE that most significantly impact such VIE's economic performance and the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. As a result the Company has determined it is the primary beneficiary of each of these VIEs and has consolidated each VIE.

Equity Investment in Unconsolidated Entity

The Company was a co-investor, together with other affiliates of Ellington, in Jepson Holdings Limited, the parent of an entity (the "Right Holder Entity") that held a call right (the "Call Right") to a European mortgage loan securitization (the "Initial Securitization"). The Right Holder Entity issued notes (the "Right Holder Notes") to the Company and its affiliates, and to an unrelated third party.

In March 2019, the Right Holder Entity assigned the Call Right to a newly formed entity, which exercised the Call Right and re-securitized the underlying European mortgage loan assets of the Initial Securitization through a new securitization trust (the "New Securitization"). In exchange for assigning the Call Right, the Right Holder Entity received a combination of (i) cash and (ii) certain notes issued by the New Securitization (the "New Securitization Notes"). The Right Holder Entity fully repaid the unrelated third party's Right Holder Note with a combination of cash and New Securitization Notes. The Right Holder Notes held by the Company and its affiliates were also fully repaid with cash and New Securitization Notes. Certain of the New Securitization Notes were distributed to the Company and its affiliates on a pro rata basis. The Right Holder Entity is expected to continue to hold certain of the New Securitization Notes in order to comply with European risk retention rules. As of December 31, 2020 and 2019, the Company's equity investment in Jepson Holdings Limited had a fair value of $1.8 million and $1.9 million, respectively. See Note 6 for additional details on this equity investment.

Participation in Multi-Borrower Financing Facilities

The Company is a co-participant with certain other entities managed by Ellington or its affiliates (the "Affiliated Entities") in various entities (each, a "Joint Entity"), which were formed in order to facilitate the financing of small balance commercial mortgage loans, residential mortgage loans, and REO (collectively, the "Mortgage Loan and REO Assets"), through repurchase agreements. Each Joint Entity has a master repurchase agreement with a particular financing counterparty.

In connection with the financing of the Mortgage Loan and REO Assets under repurchase agreements, each of the Company and the Affiliated Entities transferred certain of their respective Mortgage Loan and REO Assets to one of the Joint Entities in exchange for its pro rata share of the financing proceeds that the respective Joint Entity received from the financing counterparty. While the Company's Mortgage Loan and REO Assets were transferred to the Joint Entity, the Company's Mortgage Loan and REO Assets and the related debt were not derecognized for financial reporting purposes, in accordance with ASC 860-10, because the Company continued to retain the risks and rewards of ownership of its Mortgage Loan and REO Assets. As of December 31, 2020 and 2019, the Joint Entities had aggregate outstanding issued debt under the repurchase agreements in the amount of $192.3 million and $350.6 million, respectively. The Company's segregated silo of this debt as of December 31, 2020 and 2019 was $116.1 million and $174.4 million, respectively, and is included under the caption Repurchase agreements on the Company's Consolidated Balance Sheet. To the extent that there is a default under the repurchase agreements, all of the assets of each respective Joint Entity, including those beneficially owned by any non-defaulting owners of such Joint Entity, could be used to satisfy the outstanding obligations under such repurchase agreement. As of both December 31, 2020 and 2019, no party to any of the repurchase agreements was in default.

Each of the Joint Entities has been determined to be a VIE. The Company has evaluated each of these VIEs and determined that it continued to retain the risks and rewards of ownership of certain of the Mortgage Loan and REO Assets, where such Mortgage Loan and REO Assets and the related debt are segregated for the Company and each of the Affiliated Entities. On account of the segregation of certain of each co-participant's assets and liabilities within each of the Joint Entities, as well as the retention by each co-participant of control over its segregated Mortgage Loan and REO Assets within the Joint Entities, the Company has determined that it is the primary beneficiary of, and has consolidated its segregated silo of assets and liabilities within, each of the Joint Entities. See Note 9 and Note 11 for additional information.

Participation in CLO Transactions

As discussed in Note 10, the Company participated in a number of CLO securitization transactions, all managed by the CLO Manager.

The CLO Manager is entitled to receive management and incentive fees in accordance with the respective management agreements between the CLO Manager and the respective CLO Issuers. In accordance with the Management Agreement, the Manager rebates to the Company the portion of the management fees payable by each CLO Issuer to the CLO Manager that are allocable to the Company's participating interest in the unsecured subordinated notes issued by such CLO Issuer. For the years ended December 31, 2020 and 2019, the amount of such management fee rebates was $1.1 million and $2.0 million, respectively.

In addition, from time to time, the Company along with various other affiliates of Ellington, and in certain cases various third parties, advance funds in the form of loans ("Initial Funding Loans") to securitization vehicles to enable them to establish warehouse facilities for the purpose of acquiring the assets to be securitized. Pursuant to the terms of the warehouse facilities and the Initial Funding Loans, the applicable securitization trust is required, at the closing of each respective CLO securitization, first to repay the warehouse facility, then to repay the Initial Funding Loans, and then to distribute interest earned, net of any necessary reserves and/or interest expense, and the aggregate realized or unrealized gains, if any, on assets purchased into the warehouse facility. In the event that such CLO securitization fails to close, the assets held by the respective securitization vehicle would, subject to a cure period, be liquidated. As of December 31, 2020 and 2019, the Company's investment in such warehouse facilities was $6.1 million and $8.1 million, respectively, which are included on the Consolidated Balance Sheet in Investments in unconsolidated entities.

During the years ended December 31, 2020 and 2019, the Company purchased various underperforming corporate debt and equity securities from certain of the Ellington-sponsored CLO Securitizations at market prices determined through the procedures set forth in the indentures of the respective Ellington-sponsored CLO Securitization. The total amount of such debt and equity securities purchased during the years ended December 31, 2020 and 2019 was $1.6 million and $8.8 million, respectively.

Related Party Transactions

The Company is party to a Management Agreement (which may be amended from time to time), pursuant to which the Manager manages the assets, operations, and affairs of the Company, in consideration of which the Company pays the Manager management and incentive fees. Effective March 13, 2018, the Board of Directors approved a Seventh Amended and Restated Management Agreement between the Company and the Manager. The descriptions of the Base Management Fees and Incentive Fees are detailed below.

Base Management Fees

The Operating Partnership pays the Manager 1.50% per annum of total equity of the Operating Partnership calculated in accordance with U.S. GAAP as of the end of each fiscal quarter (before deductions for base management fees and incentive fees payable with respect to such fiscal quarter), provided that total equity is adjusted to exclude one-time events pursuant to changes in U.S. GAAP, as well as non-cash charges after discussion between the Manager and the Company's independent directors, and approval by a majority of the Company's independent directors in the case of non-cash charges.

Pursuant to the Company's management agreement, if the Company invests at issuance in the equity of any collateralized debt obligation that is managed, structured, or originated by Ellington or one of its affiliates, or if the Company invests in any other investment fund or other investment for which Ellington or one of its affiliates receives management, origination, or structuring fees, then, unless agreed otherwise by a majority of the Company's independent directors, the base management and incentive fees payable by the Company to its Manager will be reduced by an amount equal to the applicable portion (as described in the management agreement) of any such management, origination, or structuring fees.

Summary information—For the year ended December 31, 2018 the total base management fee incurred, net of fee rebates, was $7.6 million.

Incentive Fees

The Manager is entitled to receive a quarterly incentive fee equal to the positive excess, if any, of (i) the product of (A) 25% and (B) the excess of (1) Adjusted Net Income (described below) for the Incentive Calculation Period (which means such fiscal quarter and the immediately preceding three fiscal quarters) over (2) the sum of the Hurdle Amounts (described below) for the Incentive Calculation Period, over (ii) the sum of the incentive fees already paid or payable for each fiscal quarter in the Incentive Calculation Period preceding such fiscal quarter.

For purposes of calculating the incentive fee, "Adjusted Net Income" for the Incentive Calculation Period means the net increase in equity from operations of the Operating Partnership, after all base management fees but before any incentive fees for such period, and excluding any non-cash equity compensation expenses for such period, as reduced by any Loss Carryforward (as described below) as of the end of the fiscal quarter preceding the Incentive Calculation Period.

For purposes of calculating the incentive fee, the "Loss Carryforward" as of the end of any fiscal quarter is calculated by determining the excess, if any, of (1) the Loss Carryforward as of the end of the immediately preceding fiscal quarter over (2) the Company's net increase in equity from operations (expressed as a positive number) or net decrease in equity from operations (expressed as a negative number) of the Operating Partnership for such fiscal quarter. As of December 31, 2018, there was a Loss Carryforward of $2.1 million.

For purposes of calculating the incentive fee, the "Hurdle Amount" means, with respect to any fiscal quarter, the product of (i) one-fourth of the greater of (A) 9% and (B) 3% plus the 10-year U.S. Treasury rate for such fiscal quarter, (ii) the sum of (A) the weighted average gross proceeds per share of all common share and OP Unit issuances since inception of the Company and up to the end of such fiscal quarter, with each issuance weighted by both the number of shares and OP Units issued in such issuance and the number of days that such issued shares and OP Units were outstanding during such fiscal quarter, using a first-in first-out basis of accounting (i.e. attributing any share and OP Unit repurchases to the earliest issuances first) and (B) the result obtained by dividing (I) retained earnings attributable to common shares and OP Units at the beginning of such fiscal quarter by (II) the average number of common shares and OP Units outstanding for each day during such fiscal quarter, (iii) the sum of (x) the average number of common shares and LTIP Units outstanding for each day during such fiscal quarter, and (y) the average number of OP Units and OP LTIP Units outstanding for each day during such fiscal quarter. For purposes of determining the Hurdle Amount, issuances of common shares, OP LTIP Units, and OP Units (a) as equity incentive awards, (b) to the Manager as part of its base management fee or incentive fee and (c) to the Manager or any of its affiliates in privately negotiated transactions, are excluded from the calculation. The payment of the incentive fee will be in a combination of common shares and cash, provided that at least 10% of any quarterly payment will be made in common shares.

Summary information—Total incentive fee incurred for the year ended December 31, 2018 was $0.7 million.

Termination Fees

The Management Agreement requires the Company to pay a termination fee to the Manager in the event of (1) the Company's termination or non-renewal of the Management Agreement without cause or (2) the Company's termination of the Management Agreement based on unsatisfactory performance by the Manager that is materially detrimental to the Company or (3) the Manager's termination of the Management Agreement upon a default by the Company in the performance of any material term of the Management Agreement. Such termination fee will be equal to the amount of three times the sum of (i) the average annual Quarterly Base Management Fee Amounts paid or payable with respect to the two 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal and (ii) the average annual Quarterly Incentive Fee Amounts paid or payable with respect to the two 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal.

Expense Reimbursement

Under the terms of the Management Agreement the Company is required to reimburse the Manager for operating expenses related to the Company that are incurred by the Manager, including expenses relating to legal, accounting, due diligence, other services, and all other costs and expenses. The Company's reimbursement obligation is not subject to any dollar limitation. Expenses will be reimbursed in cash within 60 days following delivery of the expense statement by the Manager; provided, however, that such reimbursement may be offset by the Manager against amounts due to the Company from the Manager. The Company will not reimburse the Manager for the salaries and other compensation of the Manager's personnel except that the Company will be responsible for expenses incurred by the Manager in employing certain dedicated or partially dedicated personnel as further described below.

The Company reimburses the Manager for the allocable share of the compensation, including, without limitation, wages, salaries, and employee benefits paid or reimbursed, as approved by the Compensation Committee of the Board of Directors to certain dedicated or partially dedicated personnel who spend all or a portion of their time managing the Company's affairs, based upon the percentage of time devoted by such personnel to the Company's affairs. In their capacities as officers or personnel of the Manager or its affiliates, such personnel will devote such portion of their time to the Company's affairs as is necessary to enable the Company to operate its business.

For the year ended December 31, 2018 the Company reimbursed the Manager $6.5 million for previously incurred operating and compensation expenses.

Equity Investments in Certain Mortgage Originators

As of December 31, 2018, the mortgage originators in which the Company holds equity investments represent related parties. Transactions that have been entered into with these related party mortgage originators are summarized below.

The Company is a party to a mortgage loan purchase and sale flow agreement, with a mortgage originator in which the Company holds an investment in common stock, whereby the Company purchases residential mortgage loans that satisfy certain specified criteria. The Company has also provided a $5.0 million line of credit to the mortgage originator. Under the terms of this line of credit, the Company has agreed to make advances to the mortgage originator solely for the purpose of funding specifically identified residential mortgage loans designated for sale to the Company. To the extent the advances are drawn by the mortgage originator, it must pay interest, at a rate of 15% per annum, on the outstanding balance of each advance from the date the advance is made until such advance is repaid in full. The mortgage originator is required to repay advances in full no later than two business days following the date the Company purchases the related residential mortgage loans from the mortgage originator. As of December 31, 2018, there were no advances outstanding. The Company has also entered into two agreements whereby it guarantees the performance of such mortgage originator under third-party borrowing arrangements. See Note 17, Commitments and Contingencies, for further information on the Company's guarantees of the third-party borrowing arrangements.

Consumer, Residential, and Commercial Loan Transactions with Affiliates

The Company, through a related party of Ellington, or the "Loan Purchaser," is a beneficiary to a consumer loan purchase and sale flow agreement whereby the Loan Purchaser purchases consumer loans that satisfy certain specified criteria. The Company has investments in participation certificates related to consumer loans titled in the name of the Loan Purchaser. Through its participation certificates, the Company has beneficial interests in the loan cash flows, net of servicing-related fees and expenses. The total fair value of the Company's beneficial interests in the net cash flows was $21.9 million as of December 31, 2018 and is included on the Company's Consolidated Condensed Schedule of Investments in Consumer Loans and Asset-backed Securities backed by Consumer Loans. In addition, the Company also holds an investment in preferred stock and warrants to purchase additional preferred stock of the consumer loan originator that sells consumer loans to the Loan Purchaser.

The Company purchases certain of its consumer loans through an affiliate, or the "Purchasing Entity." The Purchasing Entity has entered into purchase agreements, open-ended in duration, with third party consumer loan originators whereby it has agreed to purchase eligible consumer loans. The amount of loans purchased under these purchase agreements is dependent on, among other factors, the amount of loans originated in any given period by the selling originators. The Company and other affiliates of Ellington have entered into agreements with the Purchasing Entity whereby the Company and each of the affiliates have agreed to purchase their allocated portion (subject to monthly determination based on available capital and other factors) of the eligible loans acquired by the Purchasing Entity under each purchase agreement. Immediately after the Purchasing Entity purchases beneficial interests in the loans, the Company and other affiliates purchase such beneficial interests from the Purchasing Entity, at the same price paid by the Purchasing Entity. During the year ended December 31, 2018, the Company purchased loans under these agreements with an aggregate principal balance of $166.3 million. As of December 31, 2018, the estimated remaining contingent purchase obligations of the Company under these purchase agreements was approximately $263.5 million in principal balance.

The Company's beneficial interests in the consumer loans purchased through the Purchasing Entity are evidenced by participation certificates issued by trusts that hold legal title to the loans. These trusts are owned by a related party of Ellington and were established to hold such loans. Through its participation certificates, the Company participates in the cash flows of the underlying loans held by each trust. The total amount of consumer loans held in the related party trusts, for which the Company has participating interests in the net cash flows, was $181.5 million as of December 31, 2018 and is included on the Company's Consolidated Condensed Schedule of Investments in Consumer Loans and Asset-backed Securities backed by Consumer Loans.

The Company has investments in participation certificates related to residential mortgage loans and REO held in a trust owned by another related party of Ellington. Through its participation certificates, the Company participates in the cash flows of the underlying loans held by such trust. The total amount of residential mortgage loans and REO held in the related party trust, for which the Company has participating interests in the net cash flows, and the residential mortgage loans previously held in the related party trust that now reside in the securitization trusts as described in Note 6 was $498.1 million as of December 31, 2018 and is included on the Company's Consolidated Condensed Schedule of Investments in Mortgage Loans as well as Real Estate Owned.

The Company is a co-investor in certain small balance commercial mortgage loans with several other investors, including an unrelated third party and various affiliates of Ellington. These loans are beneficially owned by a consolidated subsidiary of

the Company. As of December 31, 2018, the aggregate fair value of these loans was $25.3 million and the non-controlling interests held by the unrelated third party and the various Ellington affiliates were $1.4 million and $4.1 million, respectively.

The Company is also a co-investor in certain small balance commercial mortgage loans with other investors, including unrelated third parties and various affiliates of Ellington. Each co-investor has an interest in a limited liability company that owns the loans. As of December 31, 2018 the Company's ownership percentage of the jointly owned limited liability company was approximately 15% and had a fair value of $1.1 million, which is included on the Company's Consolidated Condensed Schedule of Investments in Corporate Equity Investments.

The Company is also a co-investor, together with other affiliates of Ellington, in the parent of an entity (the "Holding Entity"), that holds a call right to a securitization. The Holding Entity issued notes to the Company and its affiliates, and to an unrelated third party. As of December 31, 2018 the notes held by the Company had a fair value of $10.9 million, which are included on the Company's Consolidated Condensed Schedule of Investments in Secured Notes.

Participation in Multi-Borrower Financing Facilities

The Company is a co-participant with certain other entities managed by Ellington (the "Affiliated Entities") in two entities (each, a "Jointly Owned Entity"), which were formed in order to facilitate the financing of small balance commercial mortgage loans and REO (collectively, "SBC Assets"). Each Jointly Owned Entity has a reverse repurchase agreement with a particular financing counterparty.

From time to time, when the Company and/or the Affiliated Entities wish to finance an SBC Asset through one of the Jointly Owned Entities, Ellington submits such SBC Asset for approval to the financing counterparty for such Jointly Owned Entity. Upon obtaining such approval, the Company and/or the Affiliated Entities, as the case may be, transfers such SBC Assets to the Jointly Owned Entity in exchange for its pro rata share of the financing proceeds that the Jointly Owned Entity receives from the financing counterparty. While the Company transferred certain SBC Assets to the Jointly Owned Entities, such SBC Assets and the related debt were not derecognized for financial reporting purposes, in accordance with ASC 860-10, because the Company continued to retain the risks and rewards of ownership of its SBC Assets. As of December 31, 2018 , the Jointly Owned Entities have outstanding issued debt under the reverse repurchase agreements in the amount of $149.0 million. The Company's portion of this debt as of December 31, 2018 was $77.0 million and is included under the caption Reverse repurchase agreements on the Company's Consolidated Statement of Assets, Liabilities, and Equity. To the extent that there is a default under one of these reverse repurchase agreements, all of the assets of the applicable Jointly Owned Entity, including those assets beneficially owned by any non-defaulting owners of such Jointly Owned Entity, could be used to satisfy the outstanding obligations under such reverse repurchase agreement. As of December 31, 2018, no party to either of the reverse repurchase agreements was in default. There was no receivable from the Jointly Owned Entities as of December 31, 2018.

Multi-Seller Consumer Loan Securitization

In December 2016, in order to facilitate the financing of the Company's share of the subordinated note held by the Acquiror, the Company entered into a repurchase agreement with the Acquiror (the "Acquiror Repurchase Agreement") whereby the Company's share of the subordinated note held by the Acquiror was transferred to the Company as collateral under the Acquiror Repurchase Agreement. The Company then re-hypothecated this collateral to a third-party lending institution pursuant to a reverse repurchase agreement (the "Reverse Agreement"). The Acquiror Repurchase Agreement is included on the Company's Consolidated Statement of Assets, Liabilities and Equity under the caption, Repurchase agreements, at fair value and on its Consolidated Condensed Schedule of Investments. The Company's obligation under the Reverse Agreement is included on its Consolidated Statement of Assets, Liabilities and Equity under the caption, Reverse repurchase agreements. In December 2018, the Acquiror sold the Company's share of the subordinated note, and as a result as of December 31, 2018 there were no amounts outstanding amounts under the Acquiror Repurchase Agreement or the Reverse Agreement. See Note 6 for details of the Company's participation in the multi-seller consumer loan securitization.

Participation in CLO Transactions

As discussed in Note 6, the Company participated in various CLO securitization transactions, all managed by the CLO Manager.

The CLO Manager is entitled to receive management and incentive fees in accordance with the respective management agreements between the CLO Manager and the respective CLO Issuers. In accordance with the Company's Management Agreement, the Manager rebates to the Company the portion of the management fees payable by each CLO Issuer to the CLO Manager that are allocable to the Company's participating interest in the unsecured subordinated notes issued by such CLO Issuer. For the year ended December 31, 2018 the amount of such fee rebates was $1.4 million, respectively.

In addition, from time to time, the Company along with various other affiliates of Ellington, and in certain cases various third parties, advance funds in the form of loans ("Initial Funding Loans") to securitization vehicles to enable them to establish warehouse facilities for the purpose of acquiring the assets to be securitized. Pursuant to the terms of the warehouse facilities and the Initial Funding Loans, the applicable securitization trust is required, at the closing of each respective CLO securitization, first to repay the warehouse facility, then to repay the Initial Funding Loans, and then to distribute interest earned, net of any necessary reserves and/or interest expense, and the aggregate realized or unrealized gains, if any, on assets purchased into the warehouse facility. In the event that such CLO securitization fails to close, the assets held by the respective securitization vehicle would, subject to a cure period, be liquidated. As of December 31, 2018 the Company's loan receivable related to the warehouse facility in operation at such time was in the amount of $11.6 million and is included on the Consolidated Statement of Assets, Liabilities and Equity in Other assets. Each loan receivable from these warehouse facilities is considered a Level 3 asset and its carrying value approximates fair value due to its short term nature and the adequacy of the assets acquired into the warehouse.

In July 2018, the Company purchased two loans from the CLO I Securitization, at the fair market price. The loans purchased by the Company had a face amount of $2.9 million. The Company subsequently sold one of the loans and the remaining loan had a fair value of $1.6 million at December 31, 2018 and is included on the Company's Consolidated Condensed Schedule of Investments in Corporate Debt.

XML

Long-Term Incentive Plan Units

12 Months Ended

Dec. 31, 2020

Share-based Payment Arrangement [Abstract]

Long-Term Incentive Plan Units

Long-Term Incentive Plan Units

OP LTIP Units subject to the Company's incentive plans are generally exercisable by the holder at any time after vesting. Each OP LTIP Unit is convertible into an OP Unit on a one-for-one basis. Subject to certain conditions, the OP Units are redeemable by the holder for an equivalent number of shares of common stock of the Company or for the cash value of such shares of common stock, at the Company's election. Costs associated with the OP LTIP Units issued under the Company's incentive plans are measured as of the grant date and expensed ratably over the vesting period. Total expense associated with OP LTIP Units issued under the Company's incentive plans for the years ended December 31, 2020 and 2019 was $0.7 million and $0.5 million, respectively.

On March 4, 2020, the Company's Board of Directors authorized the issuance of 14,811 OP LTIP Units to certain of Ellington's personnel dedicated to the Company pursuant to the Company's 2017 Equity Incentive Plan.

On September 10, 2020, the Company's Board of Directors authorized the issuance of 22,840 OP LTIP Units to certain of its directors pursuant to the Company's 2017 Equity Incentive Plan.

On December 17, 2020, the Company's Board of Directors authorized the issuance of 32,809 OP LTIP Units to certain of Ellington's personnel dedicated to the Company pursuant to the Company's 2017 Equity Incentive Plan.

The below table details unvested OP LTIP Units as of December 31, 2020:

Grant Recipient	Number of OP LTIP Units Granted	Grant Date	Vesting Date(1)
Directors:
	22,840	September 10, 2020	September 9, 2021
Dedicated or partially dedicated personnel:
	10,067	December 13, 2019	December 13, 2021
	18,211	December 17, 2020	December 17, 2021
	9,834	March 4, 2020	December 31, 2021
	14,598	December 17, 2020	December 17, 2022
Total unvested OP LTIP Units at December 31, 2020	75,550

(1)Date at which such OP LTIP Units will vest and become non-forfeitable.

The following tables summarize issuance and exercise activity of OP LTIP Units for the years ended December 31, 2020 and 2019:

	Year Ended
	December 31, 2020			December 31, 2019
	Manager	Director/ Employee	Total	Manager	Director/ Employee	Total
OP LTIP Units Outstanding (December 31, 2019 and January 1, 2019, respectively)	365,518	180,198	545,716	375,000	146,371	521,371
Granted	—	70,460	70,460	—	37,437	37,437
Exercised	—	(3,638)	(3,638)	(9,482)	(3,610)	(13,092)
OP LTIP Units Outstanding (December 31, 2020 and 2019, respectively)	365,518	247,020	612,538	365,518	180,198	545,716
OP LTIP Units Unvested and Outstanding (December 31, 2020 and 2019, respectively)	—	75,550	75,550	—	46,128	46,128
OP LTIP Units Vested and Outstanding (December 31, 2020 and 2019, respectively)	365,518	171,470	536,988	365,518	134,070	499,588

There were an aggregate of 1,761,212 and 1,832,309 shares of common stock of the Company underlying awards, including OP LTIP Units, available for future issuance under the Company's 2017 Equity Incentive Plan as of December 31, 2020 and 2019, respectively.

Long-Term Incentive Plan Units

LTIP Units and OP LTIP Units held pursuant to the Company's incentive plans are generally exercisable by the holder at any time after vesting. Each LTIP Unit is convertible into one common share. Each OP LTIP Unit is convertible into an OP Unit on a one-for-one basis. Subject to certain conditions, the OP Units are redeemable by the holder for an equivalent number of common shares of the Company or for the cash value of such common shares, at the Company's election. Costs associated with the LTIP Units and the OP LTIP Units issued under the Company's incentive plans are measured as of the grant date and expensed ratably over the vesting period. Total expense associated with LTIP Units and OP LTIP Units issued under the Company's incentive plans for the year ended December 31, 2018 was $0.4 million.

On March 7, 2018, the Company's Board of Directors authorized the issuance of 1,723 LTIP Units to certain of its partially dedicated employees pursuant to the Company's 2017 Equity Incentive Plan. These LTIP Units will vest and become non-forfeitable on March 7, 2019.

On September 12, 2018, the Company's Board of Directors authorized the issuance of 14,440 LTIP Units to certain of its directors pursuant to the Company's 2017 Equity Incentive Plan. These LTIP Units will vest and become non-forfeitable on September 11, 2019.

On December 11, 2018, the Company's Board of Directors authorized the issuance of 17,383 OP LTIP Units to certain of its partially dedicated employees pursuant to the Company's 2017 Equity Incentive Plan. These OP LTIP Units will vest and become non-forfeitable on December 11, 2019 with respect to 8,692 OP LTIP Units and December 11, 2020 with respect to 8,691 OP LTIP Units.

On December 31, 2018, the Company redeemed all 503,988 outstanding LTIP Units which it had originally issued under its incentive plans, with each LTIP unitholder receiving in exchange an equal number of OP LTIP Units (the "Redemption Transaction").

The below table details unvested OP LTIP Units as of December 31, 2018:

Grant Recipient	Number of OP LTIP Units	Grant Date	Vesting Date(1)
Directors:
	14,440	September 12, 2018	September 11, 2019
Partially dedicated employees:
	8,692	December 11, 2018	December 11, 2019
	8,691	December 11, 2018	December 11, 2020
	1,723	March 7, 2018	March 7, 2019
	5,886	December 12, 2017	December 12, 2019
Total unvested OP LTIP Units at December 31, 2018	39,432

(1)Date at which such OP LTIP Units will vest and become non-forfeitable.

The following table summarizes issuance and exercise activity of LTIP Units and OP LTIP Units for the year ended December 31, 2018:

	Year Ended December 31, 2018
	Manager	Director/ Employee	Total
LTIP Units and OP LTIP Units Outstanding (December 31, 2017)	375,000	116,159	491,159
Granted	—	33,546	33,546
Exercised	—	(3,334)	(3,334)
LTIP Units and OP LTIP Units Outstanding (December 31, 2018)	375,000	146,371	521,371
LTIP Units and OP LTIP Units Vested and Outstanding (December 31, 2018)	375,000	106,939	481,939

As of December 31, 2018, there were an aggregate of 1,874,223 common shares underlying awards, including OP LTIP Units, available for future issuance under the Company's 2017 Equity Incentive Plan.

XML

Non-controlling Interests

12 Months Ended

Dec. 31, 2020

Noncontrolling Interest [Abstract]

Non-controlling Interests

Non-controlling Interests

Operating Partnership

Non-controlling interests include the Convertible Non-controlling Interests in the Operating Partnership owned by an affiliate of our Manager, our directors, and certain current and former Ellington employees and their related parties. On December 31, 2018, the Company redeemed 503,988 outstanding long term incentive plan units of the Company and exchanged them on a one-for-one basis for OP LTIP Units. Income allocated to Convertible Non-controlling Interests is based on the non-controlling interest owners' ownership percentage of the Operating Partnership during the period, calculated using a daily weighted average of all shares of common stock of the Company and Convertible Non-controlling Interests outstanding during the period. Holders of Convertible Non-controlling Interests are entitled to receive the same distributions that holders of shares of common stock of the Company receive. Convertible Non-controlling Interests are non-voting with respect to matters as to which holders of common stock of the Company are entitled to vote.

On March 2, 2020, certain related parties of current Ellington employees converted 129,516 OP Units into shares of common stock.

As December 31, 2020, the Convertible Non-controlling Interests consisted of the outstanding 612,538 OP LTIP Units and 48,409 OP Units, and represented an interest of approximately 1.3% in the Operating Partnership. As December 31, 2019, the Convertible Non-controlling Interests consisted of the outstanding 545,716 OP LTIP Units and 177,925 OP Units, and represented an interest of approximately 1.6% in the Operating Partnership. As of December 31, 2020 and 2019, non-controlling interests related to all outstanding Convertible Non-controlling Interests was $11.7 million and $13.4 million, respectively.

Joint Venture Interests

Non-controlling interests also include the interests of joint venture partners in various consolidated subsidiaries of the Company. These subsidiaries hold the Company's investments in certain commercial mortgage loans and REO. The joint venture partners participate in the income, expense, gains and losses of such subsidiaries as set forth in the related operating agreements of the subsidiaries. The joint venture partners make capital contributions to the subsidiaries as new approved investments are purchased by the subsidiaries, and are generally entitled to distributions when investments are sold or otherwise disposed of. As of December 31, 2020 and 2019, the joint venture partners' interests in subsidiaries of the Company were $24.5 million and $25.9 million, respectively.

The joint venture partners' interests are not convertible into shares of common stock of the Company or OP Units, nor are the joint venture partners entitled to receive distributions that holders of shares of common stock of the Company receive.

Non-controlling Interests

Operating Partnership

Non-controlling interests include the Convertible Non-controlling Interests in the Operating Partnership owned by an affiliate of our Manager, our directors, and certain current and former Ellington employees and their related parties. These interests consist of OP Units and OP LTIP Units. On January 1, 2013, 212,000 OP Units were purchased by the initial non-controlling interest member. On December 11, 2018, the Company issued 17,383 OP LTIP Units to certain officers of the Company. On December 31, 2018, the Company redeemed 503,988 LTIP Units and distributed 503,988 OP LTIP Units to non-controlling interest members pursuant to the Redemption Transaction. Income allocated to these non-controlling interests is based on the non-controlling interest owners' ownership percentage of the Operating Partnership during the quarter, calculated using a daily weighted average of all common shares and convertible units outstanding during the quarter. Holders of OP Units and OP LTIP Units are entitled to receive the same distributions that holders of common shares receive, and OP Units are convertible into common shares on a one-for-one basis, subject to specified limitations. Each OP LTIP Unit is convertible into an OP Unit on a one-for-one basis. OP Units and OP LTIP Units are non-voting with respect to matters as to which common shareholders are entitled to vote. As December 31, 2018, the Convertible Non-controlling Interests consisted of the outstanding 521,371 OP LTIP Units and 212,000 OP Units, and represented an interest of approximately 2.4% in the Operating Partnership. As of December 31, 2018 non-controlling interests related to the outstanding 521,371 OP LTIP Units and the outstanding 212,000 OP Units was $13.9 million.

Joint Venture Interests

Non-controlling interests also include the interests of joint venture partners in various consolidated subsidiaries of the Company. The subsidiaries hold the Company's investments in certain commercial mortgage loans and REO. These joint venture partners participate in the income, expense, gains and losses of such subsidiaries as set forth in the related operating agreements of the subsidiaries. These joint venture partners make capital contributions to the subsidiaries as new approved investments are purchased by the subsidiaries, and are generally entitled to distributions when investments are sold or otherwise disposed of. As of December 31, 2018 these joint venture partners' interests in subsidiaries of the Company were $17.3 million.

These joint venture partners' interests are not convertible into common shares of the Company or OP Units, nor are these joint venture partners entitled to receive distributions that holders of common shares of the Company receive.

Share-based Payment Arrangement

Long-Term Incentive Plan Units

OP LTIP Units subject to the Company's incentive plans are generally exercisable by the holder at any time after vesting. Each OP LTIP Unit is convertible into an OP Unit on a one-for-one basis. Subject to certain conditions, the OP Units are redeemable by the holder for an equivalent number of shares of common stock of the Company or for the cash value of such shares of common stock, at the Company's election. Costs associated with the OP LTIP Units issued under the Company's incentive plans are measured as of the grant date and expensed ratably over the vesting period. Total expense associated with OP LTIP Units issued under the Company's incentive plans for the years ended December 31, 2020 and 2019 was $0.7 million and $0.5 million, respectively.

On March 4, 2020, the Company's Board of Directors authorized the issuance of 14,811 OP LTIP Units to certain of Ellington's personnel dedicated to the Company pursuant to the Company's 2017 Equity Incentive Plan.

On September 10, 2020, the Company's Board of Directors authorized the issuance of 22,840 OP LTIP Units to certain of its directors pursuant to the Company's 2017 Equity Incentive Plan.

On December 17, 2020, the Company's Board of Directors authorized the issuance of 32,809 OP LTIP Units to certain of Ellington's personnel dedicated to the Company pursuant to the Company's 2017 Equity Incentive Plan.

The below table details unvested OP LTIP Units as of December 31, 2020:

Grant Recipient	Number of OP LTIP Units Granted	Grant Date	Vesting Date(1)
Directors:
	22,840	September 10, 2020	September 9, 2021
Dedicated or partially dedicated personnel:
	10,067	December 13, 2019	December 13, 2021
	18,211	December 17, 2020	December 17, 2021
	9,834	March 4, 2020	December 31, 2021
	14,598	December 17, 2020	December 17, 2022
Total unvested OP LTIP Units at December 31, 2020	75,550

(1)Date at which such OP LTIP Units will vest and become non-forfeitable.

The following tables summarize issuance and exercise activity of OP LTIP Units for the years ended December 31, 2020 and 2019:

	Year Ended
	December 31, 2020			December 31, 2019
	Manager	Director/ Employee	Total	Manager	Director/ Employee	Total
OP LTIP Units Outstanding (December 31, 2019 and January 1, 2019, respectively)	365,518	180,198	545,716	375,000	146,371	521,371
Granted	—	70,460	70,460	—	37,437	37,437
Exercised	—	(3,638)	(3,638)	(9,482)	(3,610)	(13,092)
OP LTIP Units Outstanding (December 31, 2020 and 2019, respectively)	365,518	247,020	612,538	365,518	180,198	545,716
OP LTIP Units Unvested and Outstanding (December 31, 2020 and 2019, respectively)	—	75,550	75,550	—	46,128	46,128
OP LTIP Units Vested and Outstanding (December 31, 2020 and 2019, respectively)	365,518	171,470	536,988	365,518	134,070	499,588

There were an aggregate of 1,761,212 and 1,832,309 shares of common stock of the Company underlying awards, including OP LTIP Units, available for future issuance under the Company's 2017 Equity Incentive Plan as of December 31, 2020 and 2019, respectively.

Long-Term Incentive Plan Units

LTIP Units and OP LTIP Units held pursuant to the Company's incentive plans are generally exercisable by the holder at any time after vesting. Each LTIP Unit is convertible into one common share. Each OP LTIP Unit is convertible into an OP Unit on a one-for-one basis. Subject to certain conditions, the OP Units are redeemable by the holder for an equivalent number of common shares of the Company or for the cash value of such common shares, at the Company's election. Costs associated with the LTIP Units and the OP LTIP Units issued under the Company's incentive plans are measured as of the grant date and expensed ratably over the vesting period. Total expense associated with LTIP Units and OP LTIP Units issued under the Company's incentive plans for the year ended December 31, 2018 was $0.4 million.

On March 7, 2018, the Company's Board of Directors authorized the issuance of 1,723 LTIP Units to certain of its partially dedicated employees pursuant to the Company's 2017 Equity Incentive Plan. These LTIP Units will vest and become non-forfeitable on March 7, 2019.

On September 12, 2018, the Company's Board of Directors authorized the issuance of 14,440 LTIP Units to certain of its directors pursuant to the Company's 2017 Equity Incentive Plan. These LTIP Units will vest and become non-forfeitable on September 11, 2019.

On December 11, 2018, the Company's Board of Directors authorized the issuance of 17,383 OP LTIP Units to certain of its partially dedicated employees pursuant to the Company's 2017 Equity Incentive Plan. These OP LTIP Units will vest and become non-forfeitable on December 11, 2019 with respect to 8,692 OP LTIP Units and December 11, 2020 with respect to 8,691 OP LTIP Units.

On December 31, 2018, the Company redeemed all 503,988 outstanding LTIP Units which it had originally issued under its incentive plans, with each LTIP unitholder receiving in exchange an equal number of OP LTIP Units (the "Redemption Transaction").

The below table details unvested OP LTIP Units as of December 31, 2018:

Grant Recipient	Number of OP LTIP Units	Grant Date	Vesting Date(1)
Directors:
	14,440	September 12, 2018	September 11, 2019
Partially dedicated employees:
	8,692	December 11, 2018	December 11, 2019
	8,691	December 11, 2018	December 11, 2020
	1,723	March 7, 2018	March 7, 2019
	5,886	December 12, 2017	December 12, 2019
Total unvested OP LTIP Units at December 31, 2018	39,432

(1)Date at which such OP LTIP Units will vest and become non-forfeitable.

The following table summarizes issuance and exercise activity of LTIP Units and OP LTIP Units for the year ended December 31, 2018:

	Year Ended December 31, 2018
	Manager	Director/ Employee	Total
LTIP Units and OP LTIP Units Outstanding (December 31, 2017)	375,000	116,159	491,159
Granted	—	33,546	33,546
Exercised	—	(3,334)	(3,334)
LTIP Units and OP LTIP Units Outstanding (December 31, 2018)	375,000	146,371	521,371
LTIP Units and OP LTIP Units Vested and Outstanding (December 31, 2018)	375,000	106,939	481,939

As of December 31, 2018, there were an aggregate of 1,874,223 common shares underlying awards, including OP LTIP Units, available for future issuance under the Company's 2017 Equity Incentive Plan.

XML

Equity

12 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Common Stock Capitalization

Equity

Preferred Stock

The Company has authorized 100,000,000 shares of preferred stock, $0.001 par value per share. As of both December 31, 2020 and 2019, there were 4,600,000 shares of 6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, $0.001 par value per share ("Series A Preferred Stock") outstanding.

The Company's Series A Preferred Stock ranks senior to its common stock and Convertible Non-controlling Interests with respect to the payment of dividends and the distribution of assets upon a voluntary or involuntary liquidation, dissolution or winding up of the Company. Additionally, the Company's Series A Preferred Stock has no stated maturity and is not subject to any sinking fund or mandatory redemption. The Series A Preferred Stock is not redeemable by the Company prior to October 30, 2024, except under circumstances where it is necessary to allow the Company to maintain its qualification as a REIT for U.S. federal income tax purposes and except in certain instances upon the occurrence of a change of control. Holders of the Company's Series A Preferred Stock generally do not have any voting rights.

Holders of the Series A Preferred Stock are entitled to receive cumulative cash dividends (i) from and including the original issue date to, but excluding, October 30, 2024, at a fixed rate equal to 6.750% per annum of the $25.00 per share liquidation preference and (ii) from and including October 30, 2024, at a floating rate equal to three-month LIBOR plus a spread of 5.196% per annum of the $25.00 per share liquidation preference. Dividends are payable quarterly in arrears on or about the 30th day of each January, April, July, and October, commencing with the first dividend payment on January 30, 2020, which the Board of Directors declared in December 2019. As of December 31, 2020 and 2019, the total amount of cumulative preferred dividends in arrears was $1.3 million and $1.5 million, respectively.

Common Stock

The Company has authorized 100,000,000 shares of common stock, $0.001 par value per share. The Board of Directors may authorize the issuance of additional shares, subject to the approval of the holders of at least a majority of the shares of common stock then outstanding present in person or represented by proxy at a meeting of the stockholders. As of December 31, 2020 and 2019, there were 43,781,684 and 38,647,943, respectively, shares of common stock outstanding.

On January 24, 2020, the Company completed a follow-on offering of 5,290,000 shares of its common stock, of which 690,000 shares were issued pursuant to the exercise of the underwriters' option. The issuance and sale of the 5,290,000 shares of common stock generated net proceeds, after underwriters' discount and offering costs, of $95.3 million.

The following table summarizes issuance, repurchase, and other activity with respect to the Company's common stock for the years ended December 31, 2020 and 2019:

	Year Ended
	December 31, 2020	December 31, 2019
Shares of Common Stock Outstanding (12/31/2019 and 1/1/2019, respectively)	38,647,943	29,796,601
Share Activity:
Shares of common stock issued	5,290,000	8,855,000
Shares of common stock issued in connection with incentive fee payment	637	—
Shares of common stock repurchased	(290,050)	(50,825)
OP LTIP Units exercised	—	13,092
OP Units exercised	133,154	34,075
Shares of Common Stock Outstanding (12/31/2020 and 12/31/2019, respectively)	43,781,684	38,647,943

If all Convertible Non-controlling Interests that have been previously issued were to become fully vested and exchanged for shares of common stock as of December 31, 2020 and 2019, the Company's issued and outstanding shares of common stock would increase to 44,442,631 and 39,371,584 shares, respectively.

On June 13, 2018, the Board of Directors approved the adoption of a share repurchase program under which the Company is authorized to repurchase up to 1.55 million shares of common stock. The program, which is open-ended in duration, allows the Company to make repurchases from time to time on the open market or in negotiated transactions, including under Rule 10b5-1 plans. Repurchases are at the Company's discretion, subject to applicable law, share availability, price and financial performance, among other considerations. During the year ended December 31, 2020, the Company repurchased 290,050 shares at an average price per share of $10.54 and a total cost of $3.1 million. During the year ended December 31, 2019, the Company repurchased 50,825 shares at an average price per share of $15.39 and a total cost of $0.8 million. From inception of the current repurchase plan through December 31, 2020, the Company repurchased 701,965 shares at an average price per share of $13.36 and a total cost of $9.4 million.

Common Share Capitalization

During the year ended December 31, 2018 the Board of Directors authorized dividends totaling $1.64 per share. Total dividends paid during the year ended December 31, 2018 were $50.7 million, respectively.

The following table summarizes issuance, repurchase, and other activity with respect to the Company's common shares for the year ended December 31, 2018:

	Year Ended December 31, 2018
Common Shares Outstanding (December 31, 2017)	31,335,938
Share Activity:
Shares repurchased	(1,547,148)

Director LTIP Units exercised	3,334
Shares issued in connection with incentive fee payment	4,477
Common Shares Outstanding (December 31, 2018)	29,796,601

If all LTIP Units, OP LTIP Units, and OP Units that have been previously issued were to become fully vested and exchanged for common shares as of December 31, 2018 the Company's issued and outstanding common shares would increase to 30,529,972.

On June 13, 2018, the Company's Board of Directors approved the adoption of a share repurchase program under which the Company is authorized to repurchase up to 1.55 million common shares. The program, which is open-ended in duration, allows the Company to make repurchases from time to time on the open market or in negotiated transactions, including under Rule 10b5-1 plans. Repurchases are at the Company's discretion, subject to applicable law, share availability, price and its financial performance, among other considerations. This program superseded the program that was previously adopted on February 6, 2018. During the year ended December 31, 2018, the Company repurchased 1,547,148 common shares at an average price per share of $14.95 and a total cost of $23.1 million. As of December 31, 2018, the Company had repurchased 361,090 common shares at an average price per share of $15.34 and a total cost of $5.5 million under the current share repurchase program.

XML

Earnings Per Share

12 Months Ended

Dec. 31, 2020

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

The components of the computation of basic and diluted EPS are as follows:

	Year Ended
(In thousands except share amounts)	December 31, 2020		December 31, 2019
Net income (loss) attributable to common stockholders	$	17,245	$	56,467
Add: Net income (loss) attributable to Convertible Non-controlling Interests(1)	(3)		1,305
Net income (loss) attributable to common stockholders and Convertible Non-controlling Interests	17,242		57,772
Dividends Paid:
Common stockholders	(55,211)		(58,499)
Convertible Non-controlling Interests	(812)		(1,325)
Total dividends paid to common stockholders and Convertible Non-controlling Interests	(56,023)		(59,824)
Undistributed (Distributed in excess of) earnings:
Common stockholders	(37,966)		(2,032)
Convertible Non-controlling Interests	(815)		(20)
Total undistributed (distributed in excess of) earnings attributable to common stockholders and Convertible Non-controlling Interests	$	(38,781)	$	(2,052)
Weighted average shares outstanding (basic and diluted):
Weighted average shares of common stock outstanding	43,486,336		32,067,768
Weighted average Convertible Non-controlling Interest Units outstanding	635,245		732,456
Weighted average shares of common stock and Convertible Non-controlling Interest Units outstanding	44,121,581		32,800,224
Basic earnings per share of common stock and Convertible Non-controlling Interest Unit:
Distributed	$	1.26	$	1.81
Undistributed (Distributed in excess of)	(0.87)		(0.05)
	$	0.39	$	1.76
Diluted earnings per share of common stock and Convertible Non-controlling Interest Unit:
Distributed	$	1.26	$	1.81
Undistributed (Distributed in excess of)	(0.87)		(0.05)
	$	0.39	$	1.76

(1)For the years ended December 31, 2020 and 2019, excludes net income (loss) of $3.4 million and $3.9 million, respectively, attributable to joint venture partners, which have non-participating interests as described in Note 15.

Earnings Per Share

The components of the computation of basic and diluted EPS were as follows:

	Year Ended December 31, 2018
(In thousands except share amounts)
Net increase (decrease) in shareholders' equity resulting from operations	$	46,676
Add: Net increase (decrease) in equity resulting from operations attributable to participating non-controlling interests(1)	319
Net increase (decrease) in equity resulting from operations related to common shares, LTIP Unit holders, and participating non-controlling interests	46,995
Net increase (decrease) in shareholders' equity resulting from operations available to common share and LTIP Unit holders:
Net increase (decrease) in shareholders' equity resulting from operations–common shares	45,922
Net increase (decrease) in shareholders' equity resulting from operations–LTIP Units	753
Dividends Paid:
Common shareholders	(49,576)
LTIP Unit holders	(812)
Non-controlling interests	(348)
Total dividends paid to common shareholders, LTIP Unit holders, and non-controlling interests	(50,736)
Undistributed (Distributed in excess of) earnings:
Common shareholders	(3,653)
LTIP Unit holders	(59)
Non-controlling interests	(29)
Total undistributed (distributed in excess of) earnings attributable to common shareholders, LTIP Unit holders, and non-controlling interests	$	(3,741)
Weighted average shares outstanding (basic and diluted):
Weighted average common shares outstanding	30,297,401
Weighted average participating LTIP Units	496,962
Weighted average non-controlling interest units	212,000
Basic earnings per common share:
Distributed	$	1.64
Undistributed (Distributed in excess of)	(0.12)
	$	1.52
Diluted earnings per common share:

Distributed	$	1.64
Undistributed (Distributed in excess of)	(0.12)
	$	1.52

(1)For the year ended December 31, 2018, excludes net increase (decrease) in equity resulting from operations of $2.9 million attributable to joint venture partners, which have non-participating interests as described in Note 11.

XML

Restricted Cash

12 Months Ended

Dec. 31, 2020

Restricted Cash and Investments [Abstract]

Restricted Cash

Restricted CashThe Company is required to maintain a specific cash balance in a segregated account pursuant to a flow consumer loan purchase and sale agreement. As of both December 31, 2020 and 2019, the Company's restricted cash balance related to the flow consumer loan purchase and sale agreement was $0.2 million.Restricted CashThe Company is required to maintain certain cash balances with counterparties and/or unrelated third parties for various activities and transactions.

The Company is required to maintain a specific cash balance in a segregated account pursuant to a flow consumer loan purchase and sale agreement. The Company is also required to maintain a specific minimum cash balance in connection with its subsidiary that holds various state mortgage origination licenses.

The below table details the Company's restricted cash balances included in Restricted cash on the Consolidated Statement of Assets, Liabilities, and Equity as of December 31, 2018.

	December 31, 2018
	(In thousands)
Restricted cash balance related to:
Minimum account balance required for regulatory purposes	$	250
Flow consumer loan purchase and sale agreement	175
Total	$	425

XML

Offsetting of Assets and Liabilities

12 Months Ended

Dec. 31, 2020

Offsetting of Assets and Liabilities [Abstract]

Offsetting of Assets and Liabilities

Offsetting of Assets and LiabilitiesThe Company generally records financial instruments at fair value as described in Note 2. Financial instruments are generally recorded on a gross basis on the Consolidated Balance Sheet. In connection with the vast majority of its derivative, reverse repurchase and repurchase agreements, and the related trading agreements, the Company and its counterparties are required to pledge collateral. Cash or other collateral is exchanged as required with each of the Company's counterparties in connection with open derivative positions, and reverse repurchase and repurchase agreements.

The following tables present information about certain assets and liabilities representing financial instruments as of December 31, 2020 and 2019. The Company has not entered into master netting agreements with any of its counterparties. Certain of the Company's reverse repurchase and repurchase agreements and financial derivative transactions are governed by underlying agreements that generally provide a right of net settlement, as well as a right of offset in the event of default or in the event of a bankruptcy of either party to the transaction.

December 31, 2020:

Description	Amount of Assets (Liabilities) Presented in the Consolidated Balance Sheet(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount
(In thousands)
Assets
Financial derivatives–assets	$	15,479	$	(12,579)	$	—	$	(1,404)	$	1,496
Reverse repurchase agreements	38,640		(38,640)		—		—		—
Liabilities
Financial derivatives–liabilities	(24,553)		12,579		—		10,694		(1,280)
Repurchase agreements	(1,496,931)		1,496,931		(28,884)		28,884		—

(1)In the Company's Consolidated Balance Sheet, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.

(2)For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's repurchase agreements as of December 31, 2020 was $1.8 billion. As of December 31, 2020, total cash collateral on financial derivative assets and liabilities excludes excess net cash collateral pledged (received) of $4.5 million and $10.3 million, respectively.

(3)When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a particular asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.

December 31, 2019:

Description	Amount of Assets (Liabilities) Presented in the Consolidated Balance Sheet(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount
(In thousands)
Assets
Financial derivatives–assets	$	16,788	$	(12,755)	$	—	$	(807)	$	3,226
Reverse repurchase agreements	73,639		(73,639)		—		—		—
Liabilities
Financial derivatives–liabilities	(27,621)		12,755		—		12,233		(2,633)
Repurchase agreements	(2,445,300)		73,639		2,340,656		31,005		—

(1)In the Company's Consolidated Balance Sheet, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.

(2)For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's repurchase agreements as of December 31, 2019 was $2.8 billion. As of December 31, 2019, total cash collateral on financial derivative assets and liabilities excludes excess net cash collateral pledged of $4.3 million and $23.4 million, respectively.

(3)When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a particular asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.

Offsetting of Assets and Liabilities

The Company records financial instruments at fair value as described in Note 2. All financial instruments are recorded on a gross basis on the Consolidated Statement of Assets, Liabilities, and Equity. In connection with the vast majority of its derivative, repurchase and reverse repurchase agreements, and the related trading agreements, the Company and its counterparties are required to pledge collateral. Cash or other collateral is exchanged as required with each of the Company's counterparties in connection with open derivative positions, and repurchase and reverse repurchase agreements.

The following tables present information about certain assets and liabilities representing financial instruments as of December 31, 2018. The Company has not entered into master netting agreements with any of its counterparties. Certain of the Company's repurchase and reverse repurchase agreements and financial derivative transactions are governed by underlying agreements that generally provide a right of offset in the event of default or in the event of a bankruptcy of either party to the transaction.

December 31, 2018:

Description	Amount of Assets (Liabilities) Presented in the Consolidated Statements of Assets, Liabilities, and Equity(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount
(In thousands)
Assets
Financial derivatives–assets	$	20,001	$	(10,910)	$	—	$	(2,514)	$	6,577
Repurchase agreements	61,274		(61,274)		—		—		—
Liabilities
Financial derivatives–liabilities	(20,806)		10,910		—		9,896		—
Reverse repurchase agreements	(1,498,849)		61,274		1,420,601		16,974		—

(1)

(1)In the Company's Consolidated Statement of Assets, Liabilities, and Equity, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.

(2)For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's reverse repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's reverse repurchase agreements as of December 31, 2018 were $1.79 billion. As of December 31, 2018 total cash collateral on financial derivative assets excludes excess net cash collateral pledged of $0.1 million. As of December 31, 2018 total cash collateral on financial derivative liabilities excludes excess cash collateral pledged of $16.4 million.

(3)When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a specific asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.

XML

Counterparty Risk

12 Months Ended

Dec. 31, 2020

Risks and Uncertainties [Abstract]

Counterparty Risk

Counterparty Risk

The Company is exposed to concentrations of counterparty risk. It seeks to mitigate such risk by diversifying its exposure among various counterparties, when appropriate. The following table summarizes the Company's exposure to counterparty risk as of December 31, 2020 and 2019.

December 31, 2020:

	Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)
	(In thousands)
Cash and cash equivalents	$	111,647	8	40.1	%
Collateral on repurchase agreements held by dealers(2)	1,860,059		24	15.3	%
Due from brokers	63,147		22	28.9	%
Receivable for securities sold(3)	1,416		2	94.5	%

(1)Each counterparty is a large creditworthy financial institution.

(2)Includes securities, loans, and REO as well as cash posted as collateral for repurchase agreements.

(3)Included in Investment related receivables on the Consolidated Balance Sheet.

December 31, 2019:

	Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)
	(In thousands)
Cash and cash equivalents	$	72,302	11	42.2	%
Collateral on repurchase agreements held by dealers(2)	2,793,696		28	13.8	%
Due from brokers	79,829		24	30.9	%
Receivable for securities sold(3)	69,995		5	62.3	%

(1)Each counterparty is a large creditworthy financial institution.

(2)Includes securities, loans, and REO as well as cash posted as collateral for repurchase agreements.

(3)Included in Investment related receivables on the Consolidated Balance Sheet.

Counterparty Risk

As of December 31, 2018, investments with an aggregate value of approximately $1.79 billion were held with dealers as collateral for various reverse repurchase agreements. The investments held as collateral include securities in the amount of $86.7 million that were sold prior to period end but for which such sale had not yet settled as of December 31, 2018.

The following table details the percentage of such collateral held by counterparties who hold greater than 15% of the aggregate $1.79 billion in collateral for various reverse repurchase agreements as of December 31, 2018. In addition to the below, unencumbered investments, on a settlement date basis, of approximately $13.3 million were held in custody at the Bank of New York Mellon Corporation as of December 31, 2018.

Dealer	% of Total Collateral on Reverse Repurchase Agreements
Royal Bank of Canada	19%

The following table details the percentage of collateral amounts held by dealers who hold greater than 15% of the Company's Due from Brokers, included as of December 31, 2018:

Dealer	% of Total Due from Brokers
Morgan Stanley	37%
J.P. Morgan Securities LLC	30%

The following table details the percentage of amounts held by dealers who hold greater than 15% of the Company's Receivable for securities sold as of December 31, 2018:

Dealer	% of Total Receivable for Securities Sold
J.P. Morgan Securities LLC	25%
Bank of America Securities	26%
CS First Boston Limited	34%

In addition, the Company held cash and cash equivalents of $44.7 million as of December 31, 2018. The below table details the concentration of cash and cash equivalents held by each counterparty:

Counterparty	As of December 31, 2018
Bank of New York Mellon Corporation	64%
Deutsche Bank Securities	5%
Bank of America Securities	2%
Morgan Stanley Institutional Liquidity Fund—Government Portfolio	10%
BlackRock Liquidity Funds FedFund Portfolio	9%
Goldman Sachs Financial Square Funds—Government Fund	9%
Lakeland Bank Inc.	1%

XML

Commitments and Contingencies

12 Months Ended

Dec. 31, 2020

Commitments and Contingencies Disclosure [Abstract]

Contingencies and Commitments

Commitments and Contingencies

The Company provides current directors and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the Company.

In the normal course of business the Company may also enter into contracts that contain a variety of representations, warranties, and general indemnifications. The Company's maximum exposure under these arrangements, including future claims that may be made against the Company that have not yet occurred, is unknown. The Company has not incurred any costs to defend lawsuits or settle claims related to these indemnification agreements. As of both December 31, 2020 and 2019, the Company has no liabilities recorded for these agreements.

The Company's maximum risk of loss from credit events on its securities (excluding Agency securities, which are guaranteed by the issuing government agency or government-sponsored enterprise), loans, and investments in unconsolidated entities is limited to the amount paid for such investment.

Commitments and Contingencies Related to Investments in Residential Mortgage Loans

In connection with certain of the Company's investments in residential mortgage loans, the Company has unfunded commitments in the amount of $4.7 million and $5.2 million as of December 31, 2020 and 2019, respectively.

Commitments and Contingencies Related to Investments in Mortgage Loan Originators

In connection with certain of its investments in mortgage loan originators, the Company has outstanding commitments and contingencies as described below.

As described in Note 13, the Company is party to a flow mortgage loan purchase and sale agreement with a mortgage loan originator. The Company has entered into two agreements whereby it guarantees the performance of this mortgage loan originator under master repurchase agreements. The Company's maximum guarantees are capped at $25.0 million. As of December 31, 2020 and 2019, the mortgage loan originator had $5.3 million and $0.4 million, respectively, of outstanding borrowings under the agreements guaranteed by the Company. The Company's obligations under these arrangements are deemed to be guarantees under ASC 460-10. The Company has elected the FVO for its guarantees, which are included in Accrued expenses and other liabilities on the Consolidated Balance Sheet. As of both December 31, 2020 and 2019, the estimated fair value of such guarantees was insignificant.

Commitments and Contingencies Related to Corporate Loans

The Company has investments in certain corporate loans whereby the borrowers can request additional funds under the respective agreements. As of December 31, 2020 and 2019 the Company had unfunded commitments related to such investments in the amount of $0.1 million and $1.9 million, respectively.

Commitments and Contingencies

The Company provides current directors and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the Company.

In the normal course of business the Company may also enter into contracts that contain a variety of representations,

warranties, and general indemnifications. The Company's maximum exposure under these arrangements, including future claims that may be made against the Company that have not yet occurred, is unknown. The Company has not incurred any costs to defend lawsuits or settle claims related to these indemnification agreements. As of December 31, 2018, the Company has no liabilities recorded for these agreements.

Commitments and Contingencies Related to Investments in Residential Mortgage Loans

In connection with certain of the Company's investments in residential mortgage loans, the Company has unfunded commitments in the amount of $1.0 million as of December 31, 2018.

Commitments and Contingencies Related to Investments in Mortgage Originators

In connection with certain of its investments in mortgage originators, the Company has outstanding commitments and contingencies as described below.

As described in Note 9, Related Party Transactions, the Company is party to a flow mortgage loan purchase and sale agreement with a mortgage originator. The Company has entered into two agreements whereby it guarantees the performance of this mortgage originator under master repurchase agreements. The Company's maximum guarantees are capped at $25.0 million. As of December 31, 2018 the mortgage originator had $2.9 million outstanding borrowings under these agreements guaranteed by the Company. The Company's obligation under these arrangements are deemed to be guarantees under ASC 460-10 and are carried at fair value and included in Other Liabilities on the Consolidated Statement of Assets, Liabilities, and Equity. As of December 31, 2018 the estimated fair value of such guarantees was zero.

XML

Condensed Quarterly Financial Data (Unaudited)

12 Months Ended

Dec. 31, 2020

Text Block [Abstract]

Quarterly Financial Information

Condensed Quarterly Financial Data (Unaudited)

Detailed below is unaudited quarterly financial data for the years ended December 31, 2020 and 2019.

	Three Month Period Ended
	March 31, 2020		June 30, 2020		September 30, 2020		December 31, 2020
(In thousands except per share amounts)
Net Interest Income
Interest income	$	52,108	$	39,281	$	43,075	$	39,067
Interest expense	(22,090)		(14,686)		(12,937)		(11,952)
Total net interest income	30,018		24,595		30,138		27,115
Other Income (Loss)
Realized gains (losses) on securities and loans, financial derivatives, and real estate owned, net	204		(27,927)		(192)		(9,551)
Unrealized gains (losses) on securities and loans, financial derivatives, and real estate owned, net	(144,079)		52,057		24,032		42,547
Other, net	1,679		(435)		(2,747)		(795)
Total other income (loss)	(142,196)		23,695		21,093		32,201
Expenses
Base management fee to affiliate (Net of fee rebates of $507, $145, $201, and $198, respectively)(1)	2,443		2,906		2,981		3,178
Incentive fee to affiliate	—		—		—		—
Investment related expenses:
Servicing expense	2,531		2,493		2,379		1,736
Debt issuance costs related to Other secured borrowings, at fair value	—		2,075		—		1,819
Other	1,423		707		1,199		1,782
Professional fees	1,277		1,333		1,209		1,186
Compensation expense	788		941		1,085		962
Other expenses	1,752		1,497		1,625		1,531
Total expenses	10,214		11,952		10,478		12,194
Net Income (Loss) before Income Tax Expense and Earnings from Investments in Unconsolidated Entities	(122,392)		36,338		40,753		47,122
Income tax expense (benefit)	(547)		1,542		2,494		7,888
Earnings from investments in unconsolidated entities	(6,497)		5,643		11,443		27,344
Net Income (Loss)	(128,342)		40,439		49,702		66,578
Net income (loss) attributable to non-controlling interests	(885)		1,220		1,559		1,475
Dividends on preferred stock	1,941		1,941		1,940		1,941
Net Income (Loss) Attributable to Common Stockholders	$	(129,398)	$	37,278	$	46,203	$	63,162
Net Income (Loss) per Share of Common Stock:
Basic and Diluted (2)	$	(3.04)	$	0.85	$	1.06	$	1.44

(1)See Note 13 for further details on management fee rebates.

(2)For the year ended December 31, 2020 the sum of EPS for the four quarters of the year does not equal EPS as calculated for the entire year (see Note 17) as a result of changes in the number of shares of common stock outstanding during the year due to both issuances and repurchases of shares of common stock, as EPS is calculated using average shares of common stock outstanding during the period.

	Three Month Period Ended
	March 31, 2019		June 30, 2019		September 30, 2019		December 31, 2019
(In thousands except per share amounts)
Net Interest Income
Interest income	$	36,016	$	38,547	$	39,985	$	45,353
Interest expense	(17,618)		(19,702)		(19,954)		(21,205)
Total net interest income	18,398		18,845		20,031		24,148
Other Income (Loss)
Realized gains (losses) on securities and loans, financial derivatives, and real estate owned, net	(16,950)		(12,327)		(4,827)		(7,266)
Unrealized gains (losses) on securities and loans, financial derivatives, and real estate owned, net	20,452		13,300		7,970		6,139
Other, net	2,002		1,808		539		1,001
Total other income (loss)	5,504		2,781		3,682		(126)
Expenses
Base management fee to affiliate (Net of fee rebates of $447, $508, $503, and $509, respectively)(1)	1,722		1,661		1,942		2,663
Incentive fee to affiliate	—		—		—		116
Investment related expenses:
Servicing expense	2,393		2,244		1,940		2,055
Debt issuance costs related to Other secured borrowings, at fair value	—		1,671		—		1,865
Other	1,083		1,238		1,347		1,941
Professional fees	1,956		1,178		698		1,021
Compensation expense	1,072		903		712		962
Other expenses	985		1,053		1,156		1,160
Total expenses	9,211		9,948		7,795		11,783
Net Income (Loss) before Income Tax Expense and Earnings from Investments in Unconsolidated Entities	14,691		11,678		15,918		12,239
Income tax expense (benefit)	—		376		2		1,180
Earnings from investments in unconsolidated entities	1,797		2,354		2,796		3,262
Net Income (Loss)	16,488		13,656		18,712		14,321
Net income (loss) attributable to non-controlling interests	1,080		1,012		1,419		1,733
Dividends on preferred stock	—		—		—		1,466
Net Income (Loss) Attributable to Common Stockholders	$	15,408	$	12,644	$	17,293	$	11,122
Net Income (Loss) per Share of Common Stock:
Basic and Diluted (2)	$	0.52	$	0.43	$	0.53	$	0.31

(1)See Note 13 for further details on management fee rebates.

(2)For the year ended December 31, 2019 the sum of EPS for the four quarters of the year does not equal EPS as calculated for the entire year (see Note 17) as a result of changes in the number of shares of common stock outstanding during the year due to issuances of shares of common stock, as EPS is calculated using average shares of common stock outstanding during the period.

Condensed Quarterly Financial Data (Unaudited)

Detailed below is unaudited quarterly financial data for the year ended December 31, 2018.

	Three Month Period Ended
	March 31, 2018		June 30, 2018		September 30, 2018		December 31, 2018
(In thousands except per share amounts)
INVESTMENT INCOME
Interest income(1)	$	28,092	$	31,941	$	35,300	$	35,694
Other income	716		1,094		1,046		1,157
Total investment income	28,808		33,035		36,346		36,851
EXPENSES
Base management fee to affiliate(2)	1,978		2,021		1,830		1,744
Incentive fee to affiliate	—		291		424		—
Interest expense(1)	11,562		13,383		15,678		16,083
Other investment related expenses	2,952		3,771		4,384		4,201
Other operating expenses	2,074		2,578		2,352		4,609
Total expenses	18,566		22,044		24,668		26,637
NET INVESTMENT INCOME	10,242		10,991		11,678		10,214
NET REALIZED AND CHANGE IN NET UNREALIZED GAIN (LOSS) ON INVESTMENTS, OTHER SECURED BORROWINGS, FINANCIAL DERIVATIVES, AND FOREIGN CURRENCY TRANSACTIONS/TRANSLATION
Net realized gain (loss) on investments, financial derivatives, and foreign currency transactions	13,051		(1,343)		10,102		9,578
Change in net unrealized gain (loss) on investments, other secured borrowings, financial derivatives, and foreign currency translation	(1,969)		12,536		(14,306)		(20,862)
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS, OTHER SECURED BORROWINGS, FINANCIAL DERIVATIVES, AND FOREIGN CURRENCY	11,082		11,193		(4,204)		(11,284)
NET INCREASE (DECREASE) IN EQUITY RESULTING FROM OPERATIONS	21,324		22,184		7,474		(1,070)
LESS: NET INCREASE IN EQUITY RESULTING FROM OPERATIONS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS	285		991		813		1,147
NET INCREASE (DECREASE) IN SHAREHOLDERS' EQUITY RESULTING FROM OPERATIONS	$	21,039	$	21,193	$	6,661	$	(2,217)
NET INCREASE (DECREASE) IN SHAREHOLDERS' EQUITY RESULTING FROM OPERATIONS PER SHARE:
Basic and Diluted (3)	$	0.67	$	0.69	$	0.22	$	(0.07)

(1)Includes interest income and interest expense of a consolidated securitization trust of $1.3 million and $0.9 million, respectively, for the three-month period ended March 31, 2018. Includes interest income and interest expense of a consolidated securitization trust of $1.3 million and $0.8 million, respectively, for the three-month period ended June 30, 2018. Includes interest income and interest expense of a consolidated securitization trust of $1.3 million and $0.7 million, respectively, for the three-month period ended September 30, 2018. Includes interest income and interest expense of a consolidated securitization trust of $2.1 million and $1.2 million, respectively, for the three-month period ended December 31, 2018. See Note 6 for further details on the Company's consolidated securitization trusts.

(2)Net of management fee rebate of $0.3 million, $0.3 million, $0.4 million, and $0.4 million, for the each of the three-month periods ended March 31, 2018, June 30, 2018, September 30, 2018, and December 31, 2018, respectively. See Note 9 for further details on management fee rebates.

(3)For the year ended December 31, 2018 the sum of EPS for the four quarters of the year does not equal EPS as calculated for the entire year (see Note 13) as a result of changes in shares during the year due to repurchases of common shares, as EPS is calculated using average shares outstanding during the period.

XML

Financial Highlights

12 Months Ended

Dec. 31, 2020

Investment Company, Financial Highlights [Abstract]

Investment Company, Financial Highlights

Financial Highlights

Results of Operations for a Share Outstanding Throughout the Periods:

	Year Ended December 31, 2018
Beginning Shareholders' Equity Per Share (December 31, 2017)	$	19.15
Net Investment Income	1.42
Net Realized/Unrealized Gains (Losses)	0.23
Results of Operations Attributable to Equity	1.65
Less: Results of Operations Attributable to Non-controlling Interests	(0.11)
Results of Operations Attributable to Shareholders' Equity(1)	1.54
Dividends Paid to Common Shareholders	(1.64)
Weighted Average Share Impact on Dividends Paid (2)	(0.03)
Accretive (Dilutive) Effect of Share Issuances (Net of Offering Costs), Share Repurchases, and Adjustments to Non-controlling Interest	(0.10)
Ending Shareholders' Equity Per Share (December 31, 2018)(3)	$	18.92
Shares Outstanding, end of period	29,796,601

(1)Calculated based on average common shares outstanding and can differ from the calculation for EPS (See Note 13).

(2)Per share impact on dividends paid relating to share issuances/repurchases during the period as well as dividends paid to LTIP and OP Unit holders.

(3)If all LTIP Units and OP Units previously issued were vested and exchanged for common shares as of December 31, 2018 shareholders' equity per share would be $18.92.

Total Return:

The Company calculates its total return two ways, one based on its reported net asset value and the other based on its publicly traded share price.

The following table illustrates the Company's total return for the periods presented based on net asset value:

Net Asset Value Based Total Return for a Shareholder: (1)

	Year Ended December 31, 2018(2)
Total Return	7.38%

(1)Total return is calculated assuming reinvestment of distributions at shareholders' equity per share during the period.

(2)The Company redeemed all 503,988 of its outstanding LTIP Units which it had originally issued under its incentive plans, with each LTIP unitholder receiving in exchange an equal number of OP LTIP Units. While this activity did not affect fully diluted net asset value per common share, it did cause a

1.66% decline in net asset value per common share. The Company's total return for the year ended December 31, 2018 before the effect of this activity was 9.19%.

Market Based Total Return for a Shareholder:

For the year ended December 31, 2018 the Company's market based total return based on the closing price as reported by the New York Stock Exchange was 17.30%. Calculation of market based total return assumes the reinvestment of dividends at the closing price as reported by the New York Stock Exchange as of the ex-date.

Net Investment Income Ratio to Average Equity: (1)

	Year Ended December 31, 2018
Net Investment Income	7.04%

(1)Average equity is calculated using month end values.

Expense Ratios to Average Equity: (1)

	Year Ended December 31, 2018
Operating expenses, before interest expense and other investment related expenses	(2.86)%
Incentive fee	(0.12)%
Interest expense and other investment related expenses	(12.03)%
Total Expenses	(15.01)%

(1)Average equity is calculated using month end values.

XML

Subsequent Events

12 Months Ended

Dec. 31, 2020

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

On January 8, 2021, the Board of Directors approved a dividend in the amount of $0.10 per share of common stock payable on February 25, 2021 to stockholders of record as of January 29, 2021 and a dividend in the amount of $0.421875 per share of Series A Preferred Stock payable on February 1, 2021 to stockholders of record as of January 19, 2021.

On February 5, 2021, the Board of Directors approved a dividend in the amount of $0.10 per share of common stock payable on March 25, 2021 to stockholders of record as of February 26, 2021.

Subsequent Events

On February 13, 2019, the Company announced that it will elect to be taxed as a REIT for U.S. federal income tax purposes for the taxable year ending December 31, 2019. To facilitate this planned election, it has elected to be taxed as a corporation for U.S. federal income tax purposes effective January 1, 2019.

Also on February 13, 2019, the Company exchanged $86 million of 5.50% Senior Notes due 2022 (the "New Senior Notes") for its existing 5.25% senior notes due 2022 (the "Existing Senior Notes"). The New Senior Notes were jointly and severally issued by two of the Company's subsidiaries and fully guaranteed by the Company. The indenture governing the New Senior Notes contains a number of covenants, including several financial covenants.

On February 14, 2019, the Company's Board of Directors approved a dividend in the amount of $0.41 per share payable on March 15, 2019 to shareholders of record as of March 1, 2019.

On February 28, 2019, the Company filed a certificate of conversion with the Secretary of State of the State of Delaware (the "Secretary of State") to convert from a Delaware limited liability company to a Delaware corporation (the "Conversion") and change its name to Ellington Financial Inc. (the "Corporation"). The Conversion became effective on March 1, 2019, and upon effectiveness, each of the Company's existing common shares representing limited liability company interests, no par value, converted into one issued and outstanding, fully paid and nonassessable share of common stock, $0.001 par value per share, of the Corporation. In connection with the Conversion, the Board approved the Company's Certificate of Incorporation, which the Company also filed with the Secretary of State, and the Company's Bylaws.

On March 11, 2019, the Company's Board of Directors approved a dividend in the amount of $0.14 per share payable on April 25, 2019 to stockholders of record as of March 29, 2019.

In connection with the Conversion and the Company's plan to qualify as a REIT for the year ending December 31, 2019, effective January 1, 2019 the Company no longer qualifies for investment company accounting in accordance with ASC 946 and will discontinue its use prospectively. The Company will continue to measure its qualifying assets and liabilities at fair value by electing the fair value option where applicable.

XML

SEC Schedule, Article 12-29, Mortgage Loans on Real Estate

12 Months Ended

Dec. 31, 2020

SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]

SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate

Ellington Financial Inc.

Schedule IV—Mortgage Loans on Real Estate

December 31, 2020

Asset Type	Description	Number of Loans	Interest Rate	Maturity Date	Periodic Payment Terms	Prior Liens	Face Amount of Mortgages	Carrying Amount of Mortgages(1)(2)		Principal Amount of loans subject to delinquent principal or interest
Residential Mortgage Loans:								(In thousands)
Adjustable Rate Residential Mortgage Loan	$0–$249,999	39	2.00%–8.38%	11/30–8/57	n/a	n/a	n/a	$	4,464	$	2,617
Adjustable Rate Residential Mortgage Loan	$250,000–$499,999	31	2.00%–9.25%	12/36–2/60	n/a	n/a	n/a	9,634		8,029
Adjustable Rate Residential Mortgage Loan	$500,000–$749,999	16	3.00%–7.37%	7/35–9/55	n/a	n/a	n/a	8,193		7,773
Adjustable Rate Residential Mortgage Loan	$750,000–$999,999	3	3.38%–6.75%	5/36–9/48	n/a	n/a	n/a	2,223		2,675
Adjustable Rate Residential Mortgage Loan	$1,000,000–$1,249,999	1	6.99%	7/48	n/a	n/a	n/a	902		1,003
Adjustable Rate Residential Mortgage Loan	$1,250,000–$1,499,999	1	5.37%	1/50	n/a	n/a	n/a	1,343		—
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$0–$249,999	397	4.00%–9.99%	6/46–4/50	n/a	n/a	n/a	69,577		1,938
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$250,000–$499,999	419	4.25%–8.88%	4/46–2/60	n/a	n/a	n/a	142,200		4,988
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$500,000–$749,999	155	4.50%–8.75%	3/46–4/60	n/a	n/a	n/a	91,987		2,299
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$750,000–$999,999	71	4.13%–8.38%	3/46–10/59	n/a	n/a	n/a	60,871		4,441
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$1,000,000–$1,249,999	34	4.62%–7.63%	8/46–3/60	n/a	n/a	n/a	36,567		—
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$1,250,000–$1,499,999	21	4.50%–7.49%	11/46–2/60	n/a	n/a	n/a	29,582		2,894
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$1,500,000–$1,749,999	18	4.88%–7.00%	2/47–3/60	n/a	n/a	n/a	26,915		3,264
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$1,750,000–$1,999,999	5	4.75%–8.50%	11/48–12/59	n/a	n/a	n/a	9,520		—
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$2,250,000–$2,499,999	6	4.63%–5.99%	6/48–9/59	n/a	n/a	n/a	14,450		—
Adjustable Rate Residential Mortgage Loan Held in Securitization Trust	$2,500,000–$2,749,999	3	4.99%–5.25%	7/49–11/59	n/a	n/a	n/a	7,996		—
Fixed Rate Residential Mortgage Loan	$0–$249,999	389	2.00%–14.00%	1/21–1/61	n/a	n/a	n/a	57,568		5,184
Fixed Rate Residential Mortgage Loan	$250,000–$499,999	251	3.50%–13.00%	1/21–1/61	n/a	n/a	n/a	87,013		3,829

Asset Type	Description	Number of Loans	Interest Rate	Maturity Date	Periodic Payment Terms	Prior Liens	Face Amount of Mortgages	Carrying Amount of Mortgages(1)(2)	Principal Amount of loans subject to delinquent principal or interest
Residential Mortgage Loans (Continued):								(In thousands)
Fixed Rate Residential Mortgage Loan	$500,000–$749,999	98	4.00%–20.00%	1/21–1/61	n/a	n/a	n/a	59,912	3,427
Fixed Rate Residential Mortgage Loan	$750,000–$999,999	49	4.50%–11.55%	1/21–11/60	n/a	n/a	n/a	42,823	3,553
Fixed Rate Residential Mortgage Loan	$1,000,000–$1,249,999	34	3.99%–9.50%	10/21–1/61	n/a	n/a	n/a	38,198	1,088
Fixed Rate Residential Mortgage Loan	$1,250,000–$1,499,999	19	4.24%–10.65%	9/21–12/60	n/a	n/a	n/a	26,481	—
Fixed Rate Residential Mortgage Loan	$1,500,000–$1,749,999	8	4.13%–8.99%	8/21–1/61	n/a	n/a	n/a	13,546	—
Fixed Rate Residential Mortgage Loan	$1,750,000–$1,999,999	4	3.88%–5.50%	11/50–1/61	n/a	n/a	n/a	7,874	—
Fixed Rate Residential Mortgage Loan	$2,000,000–$2,249,999	3	5.88%–6.50%	10/50–1/61	n/a	n/a	n/a	6,591	—
Fixed Rate Residential Mortgage Loan	$2,250,000–$2,499,999	3	5.99%–9.00%	9/21–12/50	n/a	n/a	n/a	7,308	—
Fixed Rate Residential Mortgage Loan	$2,500,000–$2,749,999	3	4.25%–5.25%	1/51–1/61	n/a	n/a	n/a	7,999	—
Fixed Rate Residential Mortgage Loan	$3,250,000–$3,499,000	1	6.13%	10/60	n/a	n/a	n/a	3,654	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$0–$249,999	260	4.63%–8.63%	1/47–9/60	n/a	n/a	n/a	44,822	176
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$250,000–$499,999	227	4.00%–8.38%	12/34–9/60	n/a	n/a	n/a	80,323	1,539
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$500,000–$749,999	107	4.50%–7.63%	11/47–9/60	n/a	n/a	n/a	65,494	3,792
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$750,000–$999,999	49	4.25%–8.13%	5/48–9/60	n/a	n/a	n/a	41,486	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$1,000,000–$1,249,999	18	4.50%–6.38%	5/48–9/60	n/a	n/a	n/a	19,603	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$1,250,000–$1,499,999	20	4.50%–6.38%	12/47–7/60	n/a	n/a	n/a	28,010	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$1,500,000–$1,749,999	3	4.50%–5.50%	11/47–8/60	n/a	n/a	n/a	4,882	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$1,750,000–$1,999,999	6	4.38%–6.38%	8/48–8/60	n/a	n/a	n/a	11,912	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$2,000,000–$2,249,999	3	5.12%–6.24%	4/50–4/59	n/a	n/a	n/a	6,829	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$2,250,000–$2,499,999	1	6.00%	1/59	n/a	n/a	n/a	2,508	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$2,500,000–$2,749,999	1	6.50%	12/60	n/a	n/a	n/a	2,782	—
Fixed Rate Residential Mortgage Loan Held in Securitization Trust	$3,000,000–$3,249,999	1	5.38%	5/49	n/a	n/a	n/a	3,027	—
Total Residential Mortgage Loans								1,187,069	64,509

Asset Type	Description	Number of Loans	Interest Rate	Maturity Date	Periodic Payment Terms	Prior Liens	Face Amount of Mortgages	Carrying Amount of Mortgages(1)(2)	Principal Amount of loans subject to delinquent principal or interest
Commercial Mortgage Loans:								(In thousands)
Adjustable Rate Commercial Mortgage Loan	$0–$4,999,999	10	3.37%–9.00%	1/21–10/37	n/a	n/a	n/a	28,692	3,983
Adjustable Rate Commercial Mortgage Loan	$5,000,000–$9,999,999	9	7.00%–8.50%	3/21–4/22	n/a	n/a	n/a	65,776	16,500
Adjustable Rate Commercial Mortgage Loan	$10,000,000–$14,999,999	5	8.00%–11.00%	10/21–3/22	n/a	n/a	n/a	58,999	23,750
Adjustable Rate Commercial Mortgage Loan	$15,000,000–$19,999,999	3	8.25%–9.00%	8/21–9/21	n/a	n/a	n/a	46,633	—
Adjustable Rate Commercial Mortgage Loan	$25,000,000–$29,999,999	1	7.10%	2/21	n/a	n/a	n/a	12,558	—
Fixed Rate Commercial Mortgage Loan	$5,000,000–$9,999,999	1	8.00%	3/21	n/a	n/a	n/a	373	—
Total Commercial Mortgage Loans								213,031	44,233
Total Mortgage Loans								1,400,100	108,742

(1)Aggregate cost for federal income tax purposes is $598.8 million for commercial and non-securitized residential mortgage loans. Excluded from this amount is the cost basis for federal income tax purposes of $801.3 million of securitized residential loans; such loans have been deemed to be sold for tax purposes but do not meet the requirements for true sale under U.S. GAAP.

(2)As of December 31, 2020, all of the Company's mortgage loans were carried at fair value. See Note 2 and Note 3 in the notes to our consolidated financial statements for the year ended December 31, 2020 for additional details.

The following table presents a roll-forward of the fair value of the Company's mortgage loans on real estate for the year ended December 31, 2020.

	Year Ended
	December 31, 2020		December 31, 2019
(In thousands)
Beginning Balance	$	1,206,962	$	692,131
Additions:
Purchases	716,241		837,502
Net unrealized gain	11,427		6,717
Net realized gain	—		3,878
Deductions:
Cost of mortgages sold	(28,613)		(28,805)
Collections of principal	(496,186)		(275,520)
Amortization of premium and (discounts)	(6,317)		(6,363)
Foreclosures	(3,384)		(22,578)
Net realized loss	(30)		—
Ending Balance	$	1,400,100	$	1,206,962

XML

Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2020

Assets Sold under Agreements to Repurchase [Line Items]

Basis of Presentation

Basis of Presentation: The Company's consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, or "U.S. GAAP," and Regulation S-X. The consolidated financial statements include the accounts of the Company, the Operating Partnership, its subsidiaries, and variable interest entities, or "VIEs," for which the Company is deemed to be the primary beneficiary. All intercompany balances and transactions have been eliminated. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and those differences could be material (particularly in light of the significant volatility, lack of pricing transparency, and market dislocations that have been caused by the COVID-19 pandemic, and associated responses to the pandemic). In management's opinion, all material adjustments considered necessary for a fair statement of the Company's consolidated financial statements have been included and are only of a normal recurring nature.The Company adopted ASC 946, Financial Services—Investment Companies ("ASC 946") upon its commencement of operations in August 2007, and applied U.S. GAAP for investment companies. In connection with the Company's internal restructuring and the Company's intention to qualify as a REIT for the year ended December 31, 2019, the Company determined that, effective January 1, 2019, it no longer qualified for investment company accounting in accordance with ASC 946-10-25, and has prospectively discontinued its use. The Company elected the fair value option, or "FVO," for, and therefore the Company continued to measure at fair value, those of its assets and liabilities it had previously measured at fair value and for which such election is permitted, as provided for under ASC 825, Financial Instruments ("ASC 825"). Due to the prospective application of a change in accounting as required under ASC 946-10-25-2, the Company determined that the presentation of its consolidated financial statements for periods beginning after December 31, 2018 are not comparable to the consolidated financial statements previously prepared for prior periods for which the Company applied ASC 946. As a result, the Company has provided separate consolidated financial statements for applicable prior periods in Item 8 of this Annual Report on Form 10-K.Basis of Presentation: The Company's consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, or "U.S. GAAP," for investment companies, ASC 946, Financial Services—Investment Companies ("ASC 946"). The Company has determined that it meets the definition of an investment company under ASC 946. ASC 946 requires, among other things, that investments be reported at fair value in the financial statements. Additionally under ASC 946 the Company generally will not consolidate its interest in any company other than in its subsidiaries that qualify as investment companies under ASC 946. The consolidated financial statements include the accounts of the Company, the Operating Partnership, and its subsidiaries. They also include certain securitization trusts which are designed to facilitate specific financing activities of the Company and represent a direct extension of the Company's business activities. All intercompany balances and transactions have been eliminated. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and those differences could be material.

Reclassification and Presentation

Reclassification and Presentation

Effective January 1, 2019, the Company prospectively discontinued its application of ASC 946. Upon its change in status, the following significant changes and elections were made:

•Investments in securities are now accounted for in accordance with ASC 320, Investments—Debt and Equity Securities ("ASC 320");

•The Company elected the FVO as provided for under ASC 825-10-25-4 for all eligible financial instruments for which the Company had previously measured at fair value, including investments in securities, loans, financial derivatives, and certain of the Company's secured borrowings. As a result, all changes in the fair value of such financial instruments will continue to be recorded in earnings on the Company's Consolidated Statement of Operations;

•Real estate owned, or "REO," is not eligible for the FVO election. As a result, REO is carried at the lower of cost or fair value. The Company's cost basis in any REO that was previously measured at fair value under ASC 946 was adjusted on January 1, 2019 to equal the fair value of such investment as of December 31, 2018;

•The Company elected not to designate its financial derivatives as hedging instruments in accordance with ASC 815, Derivatives and Hedging ("ASC 815"). As a result, all changes in the fair value of financial derivatives will continue to be recorded in earnings on the Company's Consolidated Statement of Operations;

•Forward settling to-be-announced mortgage-backed-securities, or "TBAs," are no longer classified as investments. TBAs will be classified as financial derivatives, with the difference between the forward contract price and the market value of the TBA position as of the reporting date included in Unrealized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations; and

•The Company is required to account for certain of its equity investments under ASC 323-10, Investments—Equity Method and Joint Ventures ("ASC 323-10"). The Company has elected the FVO for such equity investments and changes in fair value will be reported in Earnings (losses) from investments in unconsolidated entities, on the Consolidated Statement of Operations.

The discontinuation of the Company's application of ASC 946 prospectively changed the presentation of the Company's consolidated financial statements. The most significant changes were:

•The Consolidated Statement of Assets, Liabilities, and Equity has been changed to a Consolidated Balance Sheet;

•The Consolidated Condensed Schedule of Investments has been removed;

•The Consolidated Statement of Operations is no longer presented in the format required under ASC 946. The Company will present the Consolidated Statement of Operations as required under U.S. GAAP for operating companies. A Consolidated Statement of Other Comprehensive Income (Loss) will be presented, if and when applicable;

•The Consolidated Statement of Cash Flows has been changed, and now includes a section for investing activities;

•Certain footnotes have been changed to reflect conformity with applicable U.S. GAAP for operating companies;

•The Company re-evaluated its interests in all entities to determine whether they are variable interests, and re-evaluated its investments, including it investments in partially owned entities, to determine if they are VIEs, as required under ASC 810, Consolidation ("ASC 810"). The Company also re-evaluated consolidation considerations for all of its investments in VIEs and partially owned entities, as required under ASC 810. Applicable disclosures related to VIEs have been included in these notes to consolidated financial statements;

•Securities/loans sold under agreements to be repurchased at an agreed-upon price and date, which were formerly referred to as "reverse repurchase agreements," are now referred to as "repurchase agreements";

•Securities/loans purchased under agreements to resell at an agreed-upon price and date, which were formerly referred to as "repurchase agreements," are now referred to as "reverse repurchase agreements"; and

•The financial highlights disclosures, which are not required under U.S. GAAP for operating companies, have been removed.

Valuation

Valuation: The Company applies ASC 820-10, Fair Value Measurement ("ASC 820") to its holdings of financial instruments. ASC 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:

•Level 1—inputs to the valuation methodology are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Currently, the types of financial instruments the Company generally includes in this category are listed equities and exchange-traded derivatives;

•Level 2—inputs to the valuation methodology other than quoted prices included in Level 1 are observable for the asset or liability, either directly or indirectly. Currently, the types of financial instruments that the Company generally includes in this category are Agency RMBS, U.S. Treasury securities and sovereign debt, certain non-Agency RMBS, CMBS, CLOs, corporate debt, and actively traded derivatives such as interest rate swaps, foreign currency forwards, and other over-the-counter derivatives; and

•Level 3—inputs to the valuation methodology are unobservable and significant to the fair value measurement. The types of financial instruments that the Company generally includes in this category are certain RMBS, CMBS, CLOs, ABS, credit default swaps, or "CDS," on individual ABS, and total return swaps on distressed corporate debt, in each case where there is less price transparency. Also included in this category are residential and commercial mortgage loans, consumer loans, and private corporate debt and equity investments.

For certain financial instruments, the various inputs that management uses to measure fair value may fall into different levels of the fair value hierarchy. For each such financial instrument, the determination of which category within the fair value hierarchy is appropriate is based on the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the various inputs that management uses to measure fair value, with the highest priority given to inputs that are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets (Level 1), and the lowest priority given to inputs that are unobservable and significant to the fair value measurement (Level 3). The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. The Company may use valuation techniques consistent with the market and income approaches to measure the fair value of its financial instruments. The market approach uses third-party valuations and information obtained from market transactions involving identical or similar financial instruments. The income approach uses projections of the future economic benefit of an instrument to determine its fair value, such as in the discounted cash flow methodology. The inputs or methodology used for valuing financial instruments are not necessarily an indication of the risk associated with investing in these financial instruments. The leveling of each financial instrument is reassessed at the end of each period. Transfers between levels of the fair value hierarchy are assumed to occur at the end of the reporting period.

Summary Valuation Techniques

For financial instruments that are traded in an "active market," the best measure of fair value is the quoted market price. However, many of the Company's financial instruments are not traded in an active market. Therefore, management generally uses third-party valuations when available. If third-party valuations are not available, management uses other valuation techniques, such as the discounted cash flow methodology. The following are summary descriptions, for various categories of financial instruments, of the valuation methodologies management uses in determining fair value of the Company's financial instruments in such categories. Management utilizes such methodologies to assign a fair value (the estimated price that, in an orderly transaction at the valuation date, would be received to sell an asset, or paid to transfer a liability, as the case may be) to each such financial instrument.

For mortgage-backed securities, or "MBS," TBAs, CLOs, and corporate debt and equity, management seeks to obtain at least one third-party valuation, and often obtains multiple valuations when available. Management has been able to obtain third-party valuations on the vast majority of these instruments and expects to continue to solicit third-party valuations in the future. Management generally values each financial instrument at the average of third-party valuations received and not rejected as described below. Third-party valuations are not binding, management may adjust the valuations it receives (e.g., downward adjustments for odd lots), and management may challenge or reject a valuation when, based on its validation criteria, management determines that such valuation is unreasonable or erroneous. Furthermore, based on its validation criteria, management may determine that the average of the third-party valuations received for a given financial instrument does not result in what management believes to be the fair value of such instrument, and in such circumstances management may override this average with its own good faith valuation. The validation criteria may take into account output from management's own models, recent trading activity in the same or similar instruments, and valuations received from third parties. The use of proprietary models requires the use of a significant amount of judgment and the application of various assumptions including, but not limited to, assumptions concerning future prepayment rates and default rates. Given their relatively high level of price transparency, Agency RMBS pass-throughs are typically classified as Level 2. Non-Agency RMBS, CMBS, Agency interest only and inverse interest only RMBS, CLOs, and corporate bonds are generally classified as either Level 2 or Level 3 based on analysis of available market data and/or third-party valuations. The Company's investments in distressed corporate debt can be in the form of loans as well as total return swaps on loans. These investments, as well as related non-listed equity investments, are generally designated as Level 3 assets. Valuations for total return swaps are typically based on prices of the underlying loans received from third-party pricing services. Private equity investments are generally classified as Level 3. Furthermore, the methodology used by the third-party valuation providers is reviewed at least annually by management, so as to ascertain whether such providers are utilizing observable market data to determine the valuations that they provide.

For residential and commercial mortgage loans and consumer loans, management determines fair value by taking into account both external pricing data, which includes third-party valuations, and internal pricing models. Management has obtained third-party valuations on the majority of these investments and expects to continue to solicit third-party valuations in the future. In determining fair value for non-performing mortgage loans, management evaluates third-party valuations, if applicable, as well as management's estimates of the value of the underlying real estate, using information including general economic data, broker price opinions, or "BPOs," recent sales, property appraisals, and bids. In determining fair value for performing mortgage loans and consumer loans, management evaluates third-party valuations, if applicable, as well as discounted cash flows of the loans based on market assumptions. Cash flow assumptions typically include projected default and prepayment rates and loss severities, and may include adjustments based on appraisals and BPOs. Mortgage and consumer loans are classified as Level 3.

The Company has securitized certain mortgage loans that are not deemed "qualified mortgage," or "QM," loans under the rules of the Consumer Financial Protection Bureau, or "non-QM loans." The Company's securitized non-QM loans are held as part of a collateralized financing entity, or "CFE." A CFE is a VIE that holds financial assets, issues beneficial interests in those assets, and has no more than nominal equity, and for which the issued beneficial interests have contractual recourse only to the related assets of the CFE. ASC 810 allows the Company to elect to measure both the financial assets and financial liabilities of the CFE using the more observable of the fair value of the financial assets and the fair value of the financial liabilities of the CFE. The Company has elected the FVO for initial and subsequent recognition of the debt issued by its consolidated securitization trusts and has determined that each consolidated securitization trust meets the definition of a CFE; see Note 10 "Securitization Transactions—Residential Mortgage Loan Securitizations" for further discussion on the Company's securitization trusts. The Company has determined the inputs to the fair value measurement of the financial liabilities of each of its CFEs to be more observable than those of the financial assets and, as a result, has used the fair value of the financial liabilities of each of the CFEs to measure the fair value of the financial assets of each of the CFEs. The fair value of the debt issued by each CFE is typically valued using both external pricing data, which includes third-party valuations, and internal pricing models. The securitized non-QM loans, which are assets of the CFEs, are included in Loans, at fair value, on the Company's Consolidated Balance Sheet. The debt issued by the CFEs is included in Other secured borrowings, at fair value, on the Company's Consolidated Balance Sheet. Unrealized gains (losses) from changes in fair value of Other secured borrowings,

at fair value, are included in Other, net, on the Company's Consolidated Statement of Operations. The securitized non-QM loans and the debt issued by the Company's CFEs are both classified as Level 3.

For financial derivatives with greater price transparency, such as CDS on asset-backed indices, CDS on corporate indices, certain options on the foregoing, and total return swaps on publicly traded equities or indices, market-standard pricing sources are used to obtain valuations; these financial derivatives are generally classified as Level 2. Interest rate swaps, swaptions, and foreign currency forwards are typically valued based on internal models that use observable market data, including applicable interest rates and foreign currency rates in effect as of the measurement date; the model-generated valuations are then typically compared to counterparty valuations for reasonableness. These financial derivatives are also generally classified as Level 2. Financial derivatives with less price transparency, such as CDS on individual ABS, are generally valued based on internal models, and are classified as Level 3. In the case of CDS on individual ABS, the valuation process typically starts with an estimation of the value of the underlying ABS. In valuing its financial derivatives, the Company also considers the creditworthiness of both the Company and its counterparties, along with collateral provisions contained in each financial derivative agreement.

Investments in private operating entities, such as loan originators, are valued based on available metrics, such as relevant market multiples and comparable company valuations, company specific-financial data including actual and projected results, and independent third party valuation estimates. These investments are classified as Level 3.

The Company's repurchase and reverse repurchase agreements are carried at cost, which approximates fair value. Repurchase and reverse repurchase agreements are classified as Level 2, based on the adequacy of the collateral and their short term nature.

The Company's valuation process, including the application of validation criteria, is directed by the Manager's Valuation Committee (the "Valuation Committee"), and overseen by the Company's audit committee. The Valuation Committee includes senior level executives from various departments within the Manager, and each quarter, the Valuation Committee reviews and approves the valuations of the Company's financial instruments. The valuation process also includes a monthly review by the Company's third-party administrator. The goal of this review is to replicate various aspects of the Company's valuation process based on the Company's documented procedures.

Because of the inherent uncertainty of valuation, the estimated fair value of the Company's financial instruments may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to the Company's consolidated financial statements.

Valuation: The Company applies ASC 820-10, Fair Value Measurement ("ASC 820-10"), to its holdings of financial instruments. ASC 820-10 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:

•Level 1—inputs to the valuation methodology are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Currently, the types of financial instruments the Company generally includes in this category are listed equities, exchange-traded derivatives, and cash equivalents;

•Level 2—inputs to the valuation methodology other than quoted prices included in Level 1 are observable for the asset or liability, either directly or indirectly. Currently, the types of financial instruments that the Company generally includes in this category are Agency RMBS, U.S. Treasury securities and sovereign debt, certain non-Agency RMBS and CMBS, CLOs, and corporate debt, and actively traded derivatives, such as interest rate swaps and foreign currency forwards, and certain other over-the-counter derivatives; and

•Level 3—inputs to the valuation methodology are unobservable and significant to the fair value measurement. The types of financial instruments that the Company generally includes in this category are certain RMBS, CMBS, and CLOs, ABS, credit default swaps, or "CDS," on individual ABS, distressed corporate debt, and total return swaps on distressed corporate debt, in each case where there is less price transparency. Also included in this category are residential and commercial mortgage loans, consumer loans, non-listed equities, private corporate debt and equity investments, secured notes, and Other secured borrowings, at fair value.

For certain financial instruments, the various inputs that management uses to measure fair value for such financial instrument may fall into different levels of the fair value hierarchy. In such cases, the determination of which category within the fair value hierarchy is appropriate for such financial instrument is based on the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the various inputs that management uses to measure fair value with the highest priority to inputs that are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets (Level 1) and the lowest priority to inputs that are unobservable and significant to the fair value measurement (Level 3). The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. The Company may use valuation techniques consistent with the market and income approaches to measure the fair value of its assets and liabilities. The market approach uses third-party valuations and information obtained from market transactions involving identical or similar assets or liabilities. The income approach uses projections of the future economic benefit of an instrument to determine its fair value, such as in the discounted cash flow methodology. The inputs or methodology used for valuing financial instruments are not necessarily an indication of the risk associated with investing in these financial instruments. The leveling of each financial instrument is reassessed at the end of each period.

Summary Valuation Techniques

For financial instruments that are traded in an "active market," the best measure of fair value is the quoted market price. However, many of the Company's financial instruments are not traded in an active market. Therefore, management generally uses third-party valuations when available. If third-party valuations are not available, management uses other valuation techniques, such as the discounted cash flow methodology. The following are summary descriptions, for various categories of financial instruments, of the valuation methodologies management uses in determining fair value of the Company's financial instruments in such categories. Management utilizes such methodologies to assign a good faith fair value (the estimated price that, in an orderly transaction at the valuation date, would be received to sell an asset, or paid to transfer a liability, as the case may be) to each such financial instrument.

For mortgage-backed securities, or "MBS," including To Be Announced MBS, or "TBAs," CLOs, and distressed and non-distressed corporate debt and equity, management seeks to obtain at least one third-party valuation, and often obtains multiple valuations when available. Management has been able to obtain third-party valuations on the vast majority of these instruments and expects to continue to solicit third-party valuations in the future. Management generally values each financial instrument at the average of third-party valuations received and not rejected as described below. Third-party valuations are not binding, and while management generally does not adjust the valuations it receives, management may challenge or reject a valuation when, based on its validation criteria, management determines that such valuation is unreasonable or erroneous. Furthermore, based on its validation criteria, management may determine that the average of the third-party valuations received for a given instrument does not result in what management believes to be the fair value of such instrument, and in such circumstances management may override this average with its own good faith valuation. The validation criteria may take into account output from management's own models, recent trading activity in the same or similar instruments, and valuations received from third parties. The use of proprietary models requires the use of a significant amount of judgment and the application of various assumptions including, but not limited to, assumptions concerning future prepayment rates and default rates. Valuations for fixed-rate RMBS pass-throughs issued by a U.S. government agency or government-sponsored enterprise are typically based on observable pay-up data (pay-ups are price premiums for specified categories of fixed-rate pools relative to their TBA counterparts) or models that use observable market data, such as interest rates and historical prepayment speeds, and are validated against third-party valuations. Given their relatively high level of price transparency, Agency RMBS pass-throughs are typically designated as Level 2 assets. Non-Agency MBS, Agency interest only and inverse interest only RMBS, and CLOs are generally classified as either Level 2 or Level 3 based on analysis of available market data and/or third-party valuations. The Company's investments in distressed corporate debt can be in the form of loans as well as total return swaps on loans. These investments, as well as related non-listed equity investments, are generally designated as Level 3 assets. Valuations for total return swaps are typically based on prices of the underlying loans received from widely used third-party pricing services. Investments in non-distressed corporate bonds are generally also valued based on prices received from third-party pricing services, and many of these bonds, because they are very liquid with readily observable data, are generally classified as Level 2 holdings. Furthermore, the methodology used by the third-party valuation providers is reviewed at least annually by management, so as to ascertain whether such providers are utilizing observable market data to determine the valuations that they provide.

For residential and commercial mortgage loans, consumer loans, and real estate owned properties, or "REO," management determines fair value by taking into account both external pricing data, when available, and internal pricing models. Non-performing mortgage loans and REO are typically valued based on management's estimates of the value of the underlying real estate, using information including general economic data, broker price opinions, or "BPOs," recent sales, property appraisals, and bids. Performing mortgage loans and consumer loans are typically valued using discounted cash flows based on market assumptions. Cash flow assumptions typically include projected default and prepayment rates and loss severities, and may

include adjustments based on appraisals and BPOs. Mortgage and consumer loans and REO properties are classified as Level 3 assets.

Securitized mortgage loans that are not deemed "qualified mortgage," or "QM," loans under the rules of the Consumer Financial Protection Bureau, or "non-QM loans," are held as part of a collateralized financing entity, or "CFE." A CFE is a variable interest entity, or "VIE," that holds financial assets, issues beneficial interests in those assets, and has no more than nominal equity, and for which the issued beneficial interests have contractual recourse only to the related assets of the CFE. ASC 810, Consolidation ("ASC 810"), allows the Company to elect to measure both the financial assets and financial liabilities of the CFE using the more observable of the fair value of the financial assets and the fair value of the financial liabilities of the CFE. The Company has elected the fair value option for initial and subsequent recognition of the debt issued by its consolidated securitization trust and has determined such trust meets the definition of a CFE; see Note 6 for further discussion on the Company's securitization trusts. The Company has determined the inputs to the fair value measurement of the financial liabilities of its CFE to be more observable than those of the financial assets and, as a result, has used the fair value of the financial liabilities of the CFE to measure the fair value of the financial assets of the CFE. The fair value of the debt issued by the CFE is typically valued using discounted cash flows and other market data. The securitized non-QM loans, which are assets of the CFE, are included in Investments, at fair value on the Company's Consolidated Statement of Assets, Liabilities, and Equity. The debt issued by the CFE is included in Other secured borrowings, at fair value, on the Company's Consolidated Statement of Assets, Liabilities, and Equity. The securitized non-QM loans and the debt issued by the Company's CFE are both designated as Level 3 financial instruments.

For financial derivatives with greater price transparency, such as CDS on asset-backed indices, CDS on corporate indices, certain options on the foregoing, and total return swaps on publicly traded equities, market-standard pricing sources are used to obtain valuations; these financial derivatives are generally designated as Level 2 instruments. Interest rate swaps, swaptions, and foreign currency forwards are typically valued based on internal models that use observable market data, including applicable interest rates and foreign currency rates in effect as of the measurement date; the model-generated valuations are then typically compared to counterparty valuations for reasonableness. These financial derivatives are also generally designated as Level 2 instruments. Financial derivatives with less price transparency, such as CDS on individual ABS, are generally valued based on internal models, and are typically designated as Level 3 instruments. In the case of CDS on individual ABS, the valuation process typically starts with an estimation of the value of the underlying ABS. In valuing its derivatives, the Company also considers the creditworthiness of both the Company and its counterparties, along with collateral provisions contained in each derivative agreement.

Investments in private operating entities, such as loan originators, are valued based on available metrics, such as relevant market multiples and comparable company valuations, company specific-financial data including actual and projected results and independent third party valuation estimates. These investments are designated as Level 3 assets.

The Company's repurchase agreements are carried at fair value based on their contractual amounts as the debt is short-term in nature. The Company's reverse repurchase agreements are carried at cost, which approximates fair value. Repurchase and reverse repurchase agreements are classified as Level 2 assets and liabilities based on the adequacy of the collateral and their short term nature.

The Company's valuation process, including the application of validation criteria, is overseen by the Manager's Valuation Committee ("Valuation Committee"). The Valuation Committee includes senior level executives from various departments within the Manager, and each quarter, the Valuation Committee reviews and approves the valuations of the Company's investments. The valuation process also includes a monthly review by the Company's third-party administrator. The goal of this review is to replicate various aspects of the Company's valuation process based on the Company's documented procedures.

Because of the inherent uncertainty of valuation, the estimated fair value of the Company's financial instruments may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to the Company's consolidated financial statements.

Accounting for Securities

Accounting for Securities: Purchases and sales of investments in securities are generally recorded on trade date, and realized and unrealized gains and losses are calculated based on identified cost. Investments in securities are recorded in accordance with ASC 320 or ASC 325-40, Beneficial Interests in Securitized Financial Assets ("ASC 325-40"). The Company generally classifies its securities as available-for-sale. The Company has chosen to elect the FVO pursuant to ASC 825 for its investments in securities. Electing the FVO allows the Company to record changes in fair value in the Consolidated Statement of Operations, as a component of Unrealized gains (losses) on securities and loans, net, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all investment activities will be recorded in a similar manner.

Many of the Company's investments in securities, such as MBS and CLOs, are issued by entities that are deemed to be VIEs. For the majority of such investments, the Company has determined it is not the primary beneficiary of such VIEs and therefore has not consolidated such VIEs. The Company's maximum risk of loss in these unconsolidated VIEs is generally limited to the fair value of the Company's investment in the VIE.

The Company evaluates its investments in interest only securities to determine whether they meet the requirements for classification as financial derivatives under ASC 815. For interest only securities, where the holder is entitled only to a portion of the interest payments made on the mortgages underlying certain MBS, and inverse interest only securities, which are interest only securities whose coupon has an inverse relationship to its benchmark rate, such as LIBOR, the Company has determined that such investments do not meet the requirements for treatment as financial derivatives and are classified as securities.

Periods after January 1, 2020—For periods subsequent to the Company's application of the principles of ASU 2016-13, Financial Instruments—Credit Losses ("ASU 2016-13"), as discussed below, the Company evaluates the cost basis of its investments in securities on at least a quarterly basis, under ASC 326-30, Financial Instruments—Credit Losses: Available-for-Sale Debt Securities ("ASC 326-30"). When the fair value of a security is less than its amortized cost basis as of the balance sheet date, the security's cost basis is considered impaired. The Company must evaluate the decline in the fair value of the impaired security and determine whether such decline resulted from a credit loss or non-credit related factors. In its assessment of whether a credit loss exists, the Company compares the present value of estimated future cash flows of the impaired security

with the amortized cost basis of such security. The estimated future cash flows reflect those that a "market participant" would use and typically include assumptions related to fluctuations in interest rates, prepayment speeds, default rates, collateral performance, and the timing and amount of projected credit losses, as well incorporating observations of current market developments and events. Cash flows are discounted at an interest rate equal to the current yield used to accrete interest income. If the present value of estimated future cash flows is less than the amortized cost basis of the security, an expected credit loss exists and is included in Unrealized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations. If it is determined as of the financial reporting date that all or a portion of a security's cost basis is not collectible, then the Company will recognize a realized loss to the extent of the adjustment to the security's cost basis. This adjustment to the amortized cost basis of the security is reflected in Net realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

Periods prior to January 1, 2020—For periods prior to the Company's adoption of ASU 2016-13, the Company evaluated the cost basis of its investments in securities for other-than-temporary impairment, or "OTTI," on at least a quarterly basis.

When the fair value of a security was less than its amortized cost basis as of the balance sheet date, the security's cost basis was considered impaired, and the impairment was designated as either temporary or other-than-temporary. When a security's cost basis was impaired, an OTTI was considered to have occurred if (i) the Company intended to sell the security, (ii) it was more likely than not that the Company would have been required to sell the security before recovery of its amortized cost basis, or (iii) the Company did not expect to recover the security's amortized cost basis, even if the Company did not intend to sell the security and it was not more likely than not that the Company would have been required to sell the security. Additionally, for securities accounted for under ASC 325-40, an impairment of the cost basis was recorded when there was an adverse change in the expected cash flows to be received and the fair value of the security was less than its carrying amount. Any resulting OTTI adjustments made to the cost basis of the security were reflected in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

Accounting for Loans

Accounting for Loans: The Company's loan portfolio primarily consists of residential mortgage, commercial mortgage, and consumer loans. The Company's loans are accounted for under ASC 310-10, Receivables, and are classified as held-for-investment when the Company has the intent and ability to hold such loans for the foreseeable future or to maturity/payoff. When the Company has the intent to sell loans, such loans will be classified as held-for-sale. Mortgage loans held-for-sale are accounted for under ASC 948-310, Financial services—mortgage banking. The Company may aggregate its loans into pools based on common risk characteristics at purchase. The Company has chosen to elect the FVO pursuant to ASC 825 for its loan portfolios. Loans are recorded at fair value on the Consolidated Balance Sheet and changes in fair value are recorded in earnings on the Consolidated Statement of Operations as a component of Unrealized gains (losses) on securities and loans, net. The Company generates income from fees on certain loans, generally commercial mortgage loans, that it originates and holds for investment, including origination and exit fees. Such fee income is recorded when earned and included in Other, net on the Consolidated Statement of Operations. Transfers between held-for-investment and held-for-sale occur once the Company's intent to sell the loans changes.

For residential and commercial mortgage loans, the Company generally accrues interest payments. Such loans are typically moved to non-accrual status if the loan becomes 90 days or more delinquent. The Company does not accrue interest payments on its consumer loans; interest payments are recorded upon receipt. Once consumer loans are more than 120 days past due, the Company will generally charge off such loans. The Company evaluates its charged-off loans and determines collectibility, if any, on such loans.

The Company evaluates the collectibility of both interest and principal on each of its loan investments and whether the cost basis of the loan is impaired. A loan's cost basis is impaired when, based on current information and market developments, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. When a loan's cost basis is impaired, the Company does not record an allowance for loan loss as it elected the FVO on all of its loan investments.

Periods after January 1, 2020—For periods subsequent to the Company's application of the principles of ASU 2016-13, in its assessment of whether a credit loss exists, the Company compares the present value of the amount expected to be collected on the impaired loan with the amortized cost basis of such loan. If the present value of the amount expected to be collected on the impaired loan is less than the amortized cost basis of such loan, an expected credit loss exists and is included in Unrealized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations. If it is determined as of the financial reporting date that all or a portion of a loan's cost basis is not collectible, then the Company will recognize a realized loss to the extent of the adjustment to the loan's cost basis. This adjustment to the amortized cost basis of the loan is reflected in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

Periods prior to January 1, 2020—For periods prior to the Company's application of the principles of ASU 2016-13, the Company recognized impairments through an adjustment to the amortized cost basis; the Company recognized a realized loss in the period such adjustment was made, which is included in Realized gains (losses) on securities and loans, net, on the Consolidated Statement of Operations.

Interest Income

Interest Income: The Company amortizes premiums and accretes discounts on its debt securities. Coupon interest income on fixed-income investments is generally accrued based on the outstanding principal balance or notional value and the current coupon rate.

For debt securities that are deemed to be of high credit quality at the time of purchase (generally Agency RMBS, exclusive of interest only securities), premiums and discounts are amortized/accreted into interest income over the life of such securities using the effective interest method. For such securities whose cash flows vary depending on prepayments, an effective yield retroactive to the time of purchase is periodically recomputed based on actual prepayments and changes in projected prepayment activity, and a catch-up adjustment, or "Catch-up Premium Amortization Adjustment," is made to amortization to reflect the cumulative impact of the change in effective yield.

For debt securities (generally non-Agency RMBS, CMBS, ABS, CLOs, and interest only securities) that are deemed not to be of high credit quality at the time of purchase, interest income is recognized based on the effective interest method. For purposes of estimating future expected cash flows, management uses assumptions including, but not limited to, assumptions for future prepayment rates, default rates, and loss severities (each of which may in turn incorporate various macro-economic assumptions, such as future housing prices, GDP growth rates, and unemployment rates). These assumptions are re-evaluated not less than quarterly. Changes in projected cash flows may result in prospective changes in the yield/interest income recognized on such securities based on the updated expected future cash flows.

For each loan purchased with the expectation that both interest and principal will be paid in full, the Company generally amortizes or accretes any premium or discount over the life of the loan utilizing the effective interest method. However, based on current information and market developments, the Company re-assesses the collectibility of interest and principal, and generally designates a loan as in non-accrual status either when any payments have become 90 or more days past due, or when, in the opinion of management, it is probable that the Company will be unable to collect either interest or principal in full. Once a loan is designated as in non-accrual status, as long as principal is still expected to be collectible in full, interest payments are recorded as interest income only when received (i.e., under the cash basis method); accruals of interest income are only resumed when the loan becomes contractually current and performance is demonstrated to be resumed. However, if principal is not expected to be collectible in full, the cost recovery method is used (i.e., no interest income is recognized, and all payments received—whether contractually interest or principal—are applied to cost).

Periods after January 1, 2020—Certain of the Company's debt securities and loans, at the date of acquisition, have experienced or are expected to experience more-than-insignificant deterioration in credit quality since origination. For periods subsequent to the Company's application of the principles of ASU 2016-13, if at the date of acquisition for a particular asset the Company projects a significant difference between contractual cash flows and expected cash flows, it establishes an initial estimate for credit losses as an upward adjustment to the acquisition cost of the asset for the purpose of calculating interest income using the effective yield method.

Periods prior to January 1, 2020—Prior to the Company's application of the principles of ASU 2016-13, for each loan acquired that had evidence of credit deterioration since origination and the expectation that either principal or interest would not be paid in full, interest income was generally recognized using the effective interest method for so long as the cash flows could be reasonably estimated. Here, instead of amortizing the purchase discount (i.e., the excess of the unpaid principal balance over the purchase price) over the life of the loan, the Company effectively amortized the accretable yield (i.e., the excess of the Company's estimate of the total cash flows to be collected over the life of the loan over the purchase price). Not less than quarterly, the Company updated its estimate of the cash flows expected to be collected over the life of the loan, and applied revised yields prospectively.

In estimating future cash flows on the Company's debt securities, there are a number of assumptions that are subject to significant uncertainties and contingencies, including, in the case of MBS, assumptions relating to prepayment rates, default rates, loan loss severities, and loan repurchases. These estimates require the use of a significant amount of judgment.

Securities Transactions And Investment Income Policy [Policy Text Block]

Purchase and Sales of Investments and Investment Income: Purchases and sales of investments are generally recorded on trade date, and realized and unrealized gains and losses are calculated based on identified cost. The Company amortizes premiums and accretes discounts on its debt investments. Coupon interest income on fixed-income investments is generally accrued based on the outstanding principal balance or notional value and the current coupon interest rate. For Agency RMBS and debt securities that are deemed to be of high credit quality at the time of purchase, premiums and discounts are amortized into interest income over the life of such securities using the effective interest method. For securities whose cash flows vary depending on prepayments, an effective yield retroactive to the time of purchase is periodically recomputed based on actual prepayments and changes in projected prepayment activity, and a catch-up adjustment is made to amortization to reflect the cumulative impact of the change in effective yield.

For debt securities (including non-Agency MBS) that are deemed not to be of high credit quality at the time of purchase, interest income is recognized based on the effective interest method. For purposes of determining the effective interest rate, management estimates the future expected cash flows of its investment holdings based on assumptions including, but not limited to, assumptions for future prepayment rates, default rates, and loss severities (each of which may in turn incorporate various macro-economic assumptions, such as future housing prices). These assumptions are re-evaluated not less than quarterly. Principal write-offs are generally treated as realized losses. Changes in projected cash flows, as applied to the current amortized cost of the security, may result in a prospective change in the yield/interest income recognized on such securities.

For each loan purchased with the expectation that both interest and principal will be paid in full, the Company generally amortizes or accretes any premium or discount over the life of the loan utilizing the effective interest method. However, on at least a quarterly basis based on current information and events, the Company re-assesses the collectibility of interest and principal, and designates a loan as impaired either when any payments have become 90 or more days past due, or when, in the opinion of management, it is probable that the Company will be unable to collect either interest or principal in full. Once a loan is designated as impaired, as long as principal is still expected to be collectible in full, interest payments are recorded as interest income only when received (i.e., under the cash basis method); accruals of interest income are only resumed when the loan becomes contractually current and performance is demonstrated to be resumed. However, if principal is not expected to be collectible in full, the cost recovery method is used (i.e., no interest income is recognized, and all payments received—whether contractually interest or principal—are applied to cost).

For each loan purchased with evidence of credit deterioration since origination and the expectation that either principal or interest will not be paid in full, interest income is generally recognized using the effective interest method for as long as the cash flows can be reasonably estimated. Here, instead of amortizing the purchase discount (i.e., the excess of the unpaid principal balance over the purchase price) over the life of the loan, the Company effectively amortizes the accretable yield (i.e., the excess of the Company's estimate of the total cash flows to be collected over the life of the loan over the purchase price). Not less than quarterly, the Company updates its estimate of the cash flows expected to be collected over the life of the loan, and revised yields are prospectively applied. To the extent that cash flows cannot be reasonably estimated, these loans are generally accounted for under the cost recovery method.

For certain groups of consumer loans that the Company considers as having sufficiently homogeneous characteristics, the Company aggregates such loans into pools, and accounts for each such pool as a single asset. The pool is then treated analogously to a debt security deemed not to be of high credit quality, in that (i) the aggregate premium or discount for the pool is amortized or accreted into interest income based on the pool's effective interest rate; (ii) the effective interest rate is determined based on the net expected cash flows of the pool, taking into account estimates of prepayments, defaults, and loss severities; and (iii) estimates are updated not less than quarterly and revised yields are prospectively applied.

In estimating future cash flows on the Company's debt investments, there are a number of assumptions that will be subject to significant uncertainties and contingencies, including, in the case of MBS, assumptions relating to prepayment rates, default rates, loan loss severities, and loan repurchases. These estimates require the use of a significant amount of judgment.

The Company receives dividend income on certain of its equity investments and rental income on certain of its REO properties. These items of income are included on the Consolidated Statement of Operations in, "Other income."

Investments in Unconsolidated Entities

Investments in unconsolidated entities: The Company has made and may in the future make non-controlling equity investments in various entities, such as loan originators. Such investments are generally in the form of preferred and/or common equity, or membership interests. In certain cases, the Company can exercise significant influence over the entity (e.g. by having representation on the entity's board of directors) but the requirements for consolidation under ASC 810 are not met; in such cases the Company is required to account for such equity investments under ASC 323-10. The Company has chosen to elect the FVO pursuant to ASC 825 for its investments in unconsolidated entities, which, in management's view, more appropriately reflects the results of operations for a particular reporting period, as all investment activities will be recorded in a similar manner. The period change in fair value of the Company's investments in unconsolidated entities is recorded on the Consolidated Statement of Operations in Earnings (losses) from investments in unconsolidated entities.

REO

REO: When the Company obtains possession of real property in connection with a foreclosure or similar action, the Company de-recognizes the associated mortgage loan according to ASU 2014-04, Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure ("ASU 2014-04"). Under the provisions of ASU 2014-04, the Company is deemed to have received physical possession of real estate property collateralizing a mortgage loan when it obtains legal title to the property upon completion of a foreclosure or when the borrower conveys all interest in the property to it through a deed in lieu of foreclosure or similar legal agreement. The Company's initial cost basis in REO is equal to the fair value of the real estate associated with the foreclosed mortgage loan, less expected costs to sell. REO valuations are reflected at the lower of cost or fair value. The fair value of such REO is typically based on management's estimates which generally use information including general economic data, BPOs, recent sales, property appraisals, and bids, and takes into account the expected costs to sell the property. REO recorded at fair value on a non-recurring basis are classified as Level 3.REO: When the Company obtains possession of real property in connection with a foreclosure or similar action, the Company de-recognizes the associated mortgage loan according to ASU 2014-04, Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure ("ASU 2014-04"). Under the provisions of ASU 2014-04, the Company is deemed to have received physical possession of real estate property collateralizing a mortgage loan when it obtains legal title to the property upon completion of a foreclosure or when the borrower conveys all interest in the property to it through a deed in lieu of foreclosure or similar legal agreement. The Company holds all REO at fair value.

Securities Sold Short

Securities Sold Short: The Company may purchase or engage in short sales of U.S. Treasury securities and sovereign debt to mitigate the potential impact of changes in interest rates and/or foreign exchange rates on the performance of its portfolio. When the Company sells securities short, it typically satisfies its security delivery settlement obligation by borrowing or purchasing the security sold short from the same or a different counterparty. When borrowing a security sold short from a counterparty, the Company generally is required to deliver cash or securities to such counterparty as collateral for the Company's obligation to return the borrowed security. The Company has chosen to elect the FVO pursuant to ASC 825 for its securities sold short. Electing the FVO allows the Company to record changes in fair value in the Consolidated Statement of Operations, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all securities activities will be recorded in a similar manner. As such, securities sold short are recorded at fair value on the Consolidated Balance Sheet and the period change in fair value is recorded in current period earnings on the Consolidated Statement of Operations as a component of Unrealized gains (losses) on securities and loans, net. A realized gain or loss will be recognized upon the termination of a short sale if the market price is less or greater than the original sale price. Such realized gain or loss is recorded on the Company's Consolidated Statement of Operations in Realized gains (losses) on securities and loans, net.Investments Sold Short: When the Company sells securities short, it typically satisfies its security delivery settlement obligation by obtaining the security sold short from the same or a different counterparty. The Company generally is required to deliver cash or securities as collateral to the counterparty for the Company's obligation to return the borrowed security. The amount by which the market value of the obligation falls short of or exceeds the proceeds from the short sale is treated as an unrealized gain or loss, respectively. A realized gain or loss will be recognized upon the termination of a short sale if the market price is less or greater than the proceeds originally received.

Financial Derivatives

Financial Derivatives: The Company enters into various types of financial derivatives subject to its investment guidelines, which include restrictions associated with maintaining qualification as a REIT. The Company's financial derivatives are predominantly subject to bilateral collateral arrangements or clearing in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the "Dodd-Frank Act." The Company may be required to deliver or receive cash or securities as collateral upon entering into derivative transactions. In addition, changes in the value of derivative transactions may require the Company or the counterparty to post or receive additional collateral. In the case of cleared derivatives, the clearinghouse becomes the Company's counterparty and a futures commission merchant acts as an intermediary between the Company and the clearinghouse with respect to all facets of the related transaction, including the posting and receipt of required collateral. Cash collateral received by the Company is included in Due to brokers, on the Consolidated Balance Sheet. Conversely, cash collateral posted by the Company is included in Due from brokers, on the Consolidated Balance Sheet. The types of derivatives primarily utilized by the Company are swaps, TBAs, futures, options, and forwards.

Swaps: The Company may enter into various types of swaps, including interest rate swaps, credit default swaps, and total return swaps. The primary risk associated with the Company's interest rate swap activity is interest rate risk. The primary risk associated with the Company's credit default swaps and total return swaps is credit risk.

The Company is subject to interest rate risk exposure in the normal course of pursuing its investment objectives. Primarily to help mitigate interest rate risk, the Company enters into interest rate swaps. Interest rate swaps are contractual agreements whereby one party pays a floating interest rate on a notional principal amount and receives a fixed-rate payment on the same notional principal, or vice versa, for a fixed period of time. Interest rate swaps change in value with movements in interest rates. The Company also enters into interest rate swaps whereby the Company pays one floating rate and receives a different floating rate, or "basis swaps."

The Company enters into credit default swaps. A credit default swap is a contract under which one party agrees to compensate another party for the financial loss associated with the occurrence of a "credit event" in relation to a "reference amount" or notional value of a "reference asset" (usually a bond, loan, or an index or basket of bonds or loans). The definition of a credit event may vary from contract to contract. A credit event may occur (i) when the reference asset (or underlying asset, in the case of a reference asset that is an index or basket) fails to make scheduled principal or interest payments to its holders, (ii) with respect to credit default swaps referencing mortgage/asset-backed securities and indices, when the reference asset (or underlying asset, in the case of a reference asset that is an index or basket) is downgraded below a certain rating level, or

(iii) with respect to credit default swaps referencing corporate entities and indices, upon the bankruptcy of the obligor of the reference asset (or underlying obligor, in the case of a reference asset that is an index). The Company typically writes (sells) protection to take a "long" position with respect to the underlying reference assets, or purchases (buys) protection to take a "short" position with respect to the underlying reference assets or to hedge exposure to other investment holdings.

The Company enters into total return swaps in order to take a "long" or "short" position with respect to an underlying reference asset. The Company is subject to market price volatility of the underlying reference asset. A total return swap involves commitments to pay interest in exchange for a market-linked return based on a notional value. To the extent that the total return of the corporate debt, security, group of securities or index underlying the transaction exceeds or falls short of the offsetting interest obligation, the Company will receive a payment from or make a payment to the counterparty.

Swaps change in value with movements in interest rates, credit quality, or total return of the reference securities. During the term of swap contracts, changes in value are recognized as unrealized gains or losses on the Consolidated Statement of Operations. When a contract is terminated, the Company realizes a gain or loss equal to the difference between the proceeds from (or cost of) the closing transaction and the Company's basis in the contract, if any. Periodic payments or receipts required by swap agreements are recorded as unrealized gains or losses when accrued and realized gains or losses when received or paid. Upfront payments paid and/or received by the Company to open swap contracts are recorded as an asset and/or liability on the Consolidated Balance Sheet and are recorded as a realized gain or loss on the termination date.

TBA Securities: The Company transacts in the forward settling TBA market. A TBA position is a forward contract for the purchase ("long position") or sale ("short position") of Agency RMBS at a predetermined price, face amount, issuer, coupon, and maturity on an agreed-upon future delivery date. For each TBA contract and delivery month, a uniform settlement date for all market participants is determined by the Securities Industry and Financial Markets Association. The specific Agency RMBS to be delivered into the contract at the settlement date are not known at the time of the transaction. The Company typically does not take delivery of TBAs, but rather enters into offsetting transactions and settles the associated receivable and payable balances with its counterparties. The Company uses TBAs to mitigate interest rate risk, usually by taking short positions. The Company also invests in TBAs as a means of acquiring additional exposure to Agency RMBS, or for speculative purposes, including holding long positions.

TBAs are accounted for by the Company as financial derivatives. The difference between the forward contract price and the market value of the TBA position as of the reporting date is included in Unrealized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations.

Futures Contracts: A futures contract is an exchange-traded agreement to buy or sell an asset for a set price on a future date. The Company enters into Eurodollar and/or U.S. Treasury security futures contracts to hedge its interest rate risk. The Company may also enter into various other futures contracts, including equity index futures and foreign currency futures. Initial margin deposits are made upon entering into futures contracts and can generally be either in the form of cash or securities. During the period the futures contract is open, changes in the value of the contract are recognized as unrealized gains or losses by marking-to-market to reflect the current market value of the contract. Variation margin payments are made or received periodically, depending upon whether unrealized losses or gains are incurred. When the contract is closed, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Options: The Company may purchase or write put or call options contracts or enter into swaptions. The Company enters into options contracts typically to help mitigate overall market, credit, or interest rate risk depending on the type of options contract. However, the Company also enters into options contracts from time to time for speculative purposes. When the Company purchases an options contract, the option asset is initially recorded at an amount equal to the premium paid, if any, and is subsequently marked-to-market. Premiums paid for purchasing options contracts that expire unexercised are recognized on the expiration date as realized losses. If an options contract is exercised, the premium paid is subtracted from the proceeds of the sale or added to the cost of the purchase to determine whether the Company has realized a gain or loss on the related transaction. When the Company writes an options contract, the option liability is initially recorded at an amount equal to the premium received, if any, and is subsequently marked-to-market. Premiums received for writing options contracts that expire unexercised are recognized on the expiration date as realized gains. If an options contract is exercised, the premium received is subtracted from the cost of the purchase or added to the proceeds of the sale to determine whether the Company has realized a gain or loss on the related investment transaction. When the Company enters into a closing transaction, the Company will realize a gain or loss depending upon whether the amount from the closing transaction is greater or less than the premiums paid or received. The Company may also enter into options contracts that contain forward-settling premiums. In this case, no money is exchanged upfront. Instead, the agreed-upon premium is paid by the buyer upon expiration of the option, regardless of whether or not the option is exercised.

Forward Currency Contracts: A forward currency contract is an agreement between two parties to purchase or sell a specific quantity of currency with the delivery and settlement at a specific future date and exchange rate. During the period the forward currency contract is open, changes in the value of the contract are recognized as unrealized gains or losses. When the contract is settled, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Financial derivative assets are included in Financial derivatives—assets, at fair value, on the Consolidated Balance Sheet. Financial derivative liabilities are included in Financial derivatives—liabilities, at fair value, on the Consolidated Balance Sheet. The Company has chosen to elect the FVO pursuant to ASC 825 for its financial derivatives. Electing the FVO allows the Company to record changes in fair value in the Consolidated Statement of Operations, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all securities activities will be recorded in a similar manner. Changes in unrealized gains and losses on financial derivatives are included in Unrealized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations. Realized gains and losses on financial derivatives are included in Realized gains (losses) on financial derivatives, net, on the Consolidated Statement of Operations.

Financial Derivatives: The Company enters into various types of financial derivatives. The Company's financial derivatives are predominantly subject to bilateral collateral arrangements or clearing in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. The Company may be required to deliver or receive cash or securities as collateral upon entering into derivative transactions. In addition, changes in the relative value of derivative transactions may require the Company or the counterparty to post or receive additional collateral. In the case of cleared derivatives, the clearinghouse becomes the Company's counterparty and a futures commission merchant acts as an intermediary between the Company and the clearinghouse with respect to all facets of the related transaction, including the posting and receipt of required collateral. Cash collateral received by the Company is reflected on the Consolidated Statement of Assets, Liabilities, and Equity as "Due to Brokers." Conversely, cash collateral posted by the Company is reflected as "Due from Brokers" on the Consolidated Statement of Assets, Liabilities, and Equity. The major types of derivatives utilized by the Company are swaps, futures, options, and forwards.

Swaps: The Company may enter into various types of swaps, including interest rate swaps, credit default swaps, and total return swaps. The primary risk associated with the Company's interest rate swap activity is interest rate risk. The primary risk associated with the Company's credit default swaps is credit risk and the primary risks associated with the Company's total return swap activity are equity market risk and credit risk.

The Company is subject to interest rate risk exposure in the normal course of pursuing its investment objectives. Primarily to help mitigate interest rate risk, the Company enters into interest rate swaps. Interest rate swaps are contractual agreements whereby one party pays a floating interest rate on a notional principal amount and receives a fixed-rate payment on the same notional principal, or vice versa, for a fixed period of time. Interest rate swaps change in value with movements in interest rates.

The Company enters into credit default swaps. A credit default swap is a contract under which one party agrees to compensate another party for the financial loss associated with the occurrence of a "credit event" in relation to a "reference amount" or notional value of a credit obligation (usually a bond, loan, or a basket of bonds or loans). The definition of a credit event may vary from contract to contract. A credit event may occur (i) when the underlying reference asset(s) fails to make scheduled principal or interest payments to its holders, (ii) with respect to credit default swaps referencing mortgage/asset-backed securities and indices, when the underlying reference obligation is downgraded below a certain rating level, or (iii) with respect to credit default swaps referencing corporate entities and indices, upon the bankruptcy of the underlying reference obligor. The Company typically writes (sells) protection to take a "long" position or purchases (buys) protection to take a "short" position with respect to underlying reference assets or to hedge exposure to other investment holdings.

The Company enters into total return swaps in order to take a "long" or "short" position with respect to an underlying reference asset. The Company is subject to market price volatility of the underlying reference asset. A total return swap involves commitments to pay interest in exchange for a market-linked return based on a notional value. To the extent that the total return of the corporate debt, security, group of securities or index underlying the transaction exceeds or falls short of the offsetting interest obligation, the Company will receive a payment from or make a payment to the counterparty.

Swaps change in value with movements in interest rates, credit quality, or total return of the reference securities. During the term of swap contracts, changes in value are recognized as unrealized gains or losses. When a contract is terminated, the Company realizes a gain or loss equal to the difference between the proceeds from (or cost of) the closing transaction and the Company's basis in the contract, if any. Periodic payments or receipts required by swap agreements are recorded as unrealized gains or losses when accrued and realized gains or losses when received or paid. Upfront payments paid and/or received by the Company to open swap contracts are recorded as an asset and/or liability on the Consolidated Statement of Assets, Liabilities, and Equity and are recorded as a realized gain or loss on the termination date.

Futures Contracts: A futures contract is an exchange-traded agreement to buy or sell an asset for a set price on a future date. The Company enters into Eurodollar and/or U.S. Treasury security futures contracts to hedge its interest rate risk. The Company may also enter into various other futures contracts, including equity index futures and foreign currency futures. Initial margin deposits are made upon entering into futures contracts and can generally be either in the form of cash or securities. During the period the futures contract is open, changes in the value of the contract are recognized as unrealized gains or losses by marking-to-market to reflect the current market value of the contract. Variation margin payments are made or received periodically, depending upon whether unrealized losses or gains are incurred. When the contract is closed, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Options: The Company may purchase or write put or call options contracts or enter into swaptions. The Company enters into options contracts typically to help mitigate overall market, credit, or interest rate risk depending on the type of options contract. However, the Company also enters into options contracts from time to time for speculative purposes. When the Company purchases an options contract, the option asset is initially recorded at an amount equal to the premium paid, if any, and is subsequently marked-to-market. Premiums paid for purchasing options contracts that expire unexercised are recognized on the expiration date as realized losses. If an options contract is exercised, the premium paid is subtracted from the proceeds of the sale or added to the cost of the purchase to determine whether the Company has realized a gain or loss on the related transaction. When the Company writes an options contract, the option liability is initially recorded at an amount equal to the premium received, if any, and is subsequently marked-to-market. Premiums received for writing options contracts that expire unexercised are recognized on the expiration date as realized gains. If an options contract is exercised, the premium received is subtracted from the cost of the purchase or added to the proceeds of the sale to determine whether the Company has realized a gain or loss on the related investment transaction. When the Company enters into a closing transaction, the Company will realize a gain or loss depending upon whether the amount from the closing transaction is greater or less than the premiums paid or received. The Company may also enter into options contracts that contain forward-settling premiums. In this case, no money

is exchanged upfront. Instead the agreed-upon premium is paid by the buyer upon expiration of the option, regardless of whether or not the option is exercised.

Forward Currency Contracts: A forward currency contract is an agreement between two parties to purchase or sell a specific quantity of currency with the delivery and settlement at a specific future date and exchange rate. During the period the forward currency contract is open, changes in the value of the contract are recognized as unrealized gains or losses. When the contract is settled, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Commitments to Purchase Residential Mortgage Loans: The Company has entered into forward purchase commitments under flow agreements, whereby the Company commits to purchasing the loans based on pre-defined underwriting guidelines and at stated interest rates. Actual loan purchases are contingent upon successful loan closings. These commitments to purchase mortgage loans are classified as derivatives on the Company's Consolidated Statement of Assets, Liabilities, and Equity and are, therefore, recorded as assets or liabilities measured at fair value. Until the purchase commitment expires or the underlying loan closes, changes in the estimated fair value of such commitments are recognized as unrealized gains or losses in the Consolidated Statement of Operations.

Financial derivatives disclosed on the Consolidated Condensed Schedule of Investments include: credit default swaps on asset-backed securities, credit default swaps on asset-backed indices, credit default swaps on corporate bond indices, credit default swaps on corporate bonds, interest rate swaps, total return swaps, futures contracts, foreign currency forwards, options contracts.

Financial derivative assets are included in Financial derivatives—assets, at fair value on the Consolidated Statement of Assets, Liabilities, and Equity. Financial derivative liabilities are included in Financial derivatives—liabilities, at fair value on the Consolidated Statement of Assets, Liabilities, and Equity. In addition, financial derivative contracts are summarized by type on the Consolidated Condensed Schedule of Investments.

Cash and Cash Equivalents

Cash and Cash Equivalents: Cash and cash equivalents include cash and short term investments with original maturities of three months or less at the date of acquisition. Cash and cash equivalents typically include amounts held in interest bearing overnight accounts and amounts held in money market funds, and these balances generally exceed insured limits. The Company holds its cash at institutions that it believes to be highly creditworthy. Restricted cash represents cash that the Company can use only for specific purposes. See Note 18 for further discussion of restricted cash balances.Cash and Cash Equivalents: Cash and cash equivalents include cash and short term investments with original maturities of three months or less at the date of acquisition. Cash and cash equivalents typically include amounts held in an interest bearing overnight account and amounts held in money market funds, and these balances generally exceed insured limits. The Company holds its cash at institutions that it believes to be highly creditworthy. Restricted cash represents cash that the Company can use only for specific purposes. The Company's investments in money market funds are included in the Consolidated Condensed Schedule of Investments. See Note 15 for further discussion of restricted cash balances.

Transfers of Financial Assets

Transfers of Financial Assets: The Company enters into transactions whereby it transfers financial assets to third parties. Upon such a transfer of financial assets, the Company will sometimes retain or acquire interests in the related assets. The Company evaluates transferred assets pursuant to ASC 860-10, Transfers of Financial Assets, or "ASC 860-10," which requires that a determination be made as to whether a transferor has surrendered control over transferred financial assets. That determination must consider the transferor's continuing involvement in the transferred financial asset, including all arrangements or agreements made contemporaneously with, or in contemplation of, the transfer, even if they were not entered into at the time of the transfer. When a transfer of financial assets does not qualify as a sale, ASC 860-10 requires the transfer to be accounted for as a secured borrowing with a pledge of collateral. ASC 860-10 is a standard that requires the Company to exercise significant judgment in determining whether a transaction should be recorded as a "sale" or a "financing."Transfers of Financial Assets: The Company enters into transactions whereby it transfers financial assets to third parties. Upon such a transfer of financial assets, the Company will sometimes retain or acquire interests in the related assets. The Company evaluates transferred assets pursuant to ASC 860-10, Transfers of Financial Assets, or "ASC 860-10," which requires that a determination be made as to whether a transferor has surrendered control over transferred financial assets. That determination must consider the transferor's continuing involvement in the transferred financial asset, including all arrangements or agreements made contemporaneously with, or in contemplation of, the transfer, even if they were not entered into at the time of the transfer. When a transfer of financial assets does not qualify as a sale, ASC 860-10 requires the transfer to be accounted for as a secured borrowing with a pledge of collateral. ASC 860-10 is a standard that requires the Company to exercise significant judgment in determining whether a transaction should be recorded as a "sale" or a "financing."

Variable Interest Entities

Variable Interest Entities: VIEs are entities in which: (i) the equity investors do not have the characteristics of a controlling financial interest, or (ii) there is insufficient equity to permit the entity to finance its activities without additional subordinated financial support from other parties. Consolidation of a VIE is required by the entity that is deemed to be the primary beneficiary of the VIE. The Company evaluates all of its interests in VIEs for consolidation under ASC 810. The primary beneficiary is generally the party with both (i) the power to direct the activities of the VIE that most significantly

impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant to the VIE.

When the Company has an interest in an entity that has been determined to be a VIE, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The Company will only consolidate a VIE for which it has concluded it is the primary beneficiary. To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE's economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes (i) identifying the activities that most significantly impact the VIE's economic performance; and (ii) identifying which party, if any, has power over those activities. To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, it considers all of its economic interests, including debt and/or equity investments, as well as other arrangements deemed to be variable interests in the VIE. These assessments to determine whether the Company is the primary beneficiary require significant judgment. In instances where the Company and its related parties have interests in a VIE, the Company considers whether there is a single party in the related party group that meets the criteria to be deemed the primary beneficiary. If one party within the related party group meets such criteria, that reporting entity would be deemed to be the primary beneficiary of the VIE and no further analysis is needed. If no party within the related party group on its own meets the criteria to be deemed the primary beneficiary, but the related party group as a whole meets such criteria, the determination of the primary beneficiary within the related party group requires significant judgment. The Company performs analysis, which is based upon qualitative as well as quantitative factors, such as the relationship of the VIE to each of the members of the related party group, as well as the significance of the VIE's activities to those members, with the objective of determining which party is most closely associated with the VIE.

The Company performs ongoing reassessments of (i) whether any entities previously evaluated have become VIEs, based on certain events, and therefore subject to assessment to determine whether consolidation is appropriate, and (ii) whether changes in the facts and circumstances regarding the Company's involvement with a VIE causes its consolidation conclusion regarding the VIE to change. See Note 9 and Note 13 for further information on the Company's consolidated VIEs.

The Company's maximum amount at risk is generally limited to the Company's investment in the VIE. The Company is generally not contractually required to provide and has not provided any form of financial support to the VIEs.

The Company holds beneficial interests in certain securitization trusts that are considered VIEs. The beneficial interests in these securitization trusts are represented by certificates issued by the trusts. The securitization trusts have been structured as pass-through entities that receive principal and interest payments on the underlying collateral and distribute those payments to the certificate holders, which include both third-party investors and the Company. The certificates held by the Company typically include some or all of the most subordinated tranches. The assets held by the trusts are restricted in that they can only be used to fulfill the obligations of the related trust. In certain cases, the design and structure of the securitization trust is such that the Company effectively retains control of the assets as well as the activities that most significantly impact the economic performance of the trust. In such cases, the Company is determined to be the primary beneficiary, and the Company consolidates the trust and all intercompany transactions are eliminated in consolidation. In cases where the Company does not effectively retain control of the assets of, or have the power to direct the activities that most significantly impact the economic performance of, the related trust, it does not consolidate the trust. See Note 10 for further discussion of the Company's securitization trusts.

Variable Interest Entities: VIEs are entities in which: (i) the equity investors do not have the characteristics of a controlling financial interest, or (ii) there is insufficient equity to permit the entity to finance its activities without additional subordinated financial support from other parties. The Company holds beneficial interests in securitization trusts that are considered VIEs. The beneficial interests in these securitization trusts are represented by certificates issued by the trusts. The securitization trusts have been structured as pass-through entities that receive principal and interest payments on the underlying collateral and distribute those payments to the certificate holders, which include both third-party investors and the Company. The certificates held by the Company typically include some or all of the most subordinated tranches. The assets held by the trusts are restricted in that they can only be used to fulfill the obligations of the related trust. In certain cases the design and structure of the securitization trust is such that the Company effectively retains control of the assets as well as the activities that most significantly impact the economic performance of the trust; in such cases the trust is considered a direct extension of the Company's business, and the Company consolidates the trust. In cases where the Company does not effectively retain control of the assets of, or the activities that most significantly impact the economic performance of, the related trust, it does not consolidate the trust. See Note 6 for further discussion of the Company's securitization trusts.

When-Issued/Delayed Delivery Securities

When-Issued/Delayed Delivery Securities: The Company may purchase or sell securities on a when-issued or delayed delivery basis. Securities purchased or sold on a when-issued basis are traded for delivery beyond the normal settlement date at a stated price or yield, and no income accrues to the purchaser prior to settlement. Purchasing or selling securities on a when-issued or delayed delivery basis involves the risk that the market price or yield at the time of settlement may be lower or higher than the agreed-upon price or yield, in which case a realized loss may be incurred.The Company transacts in the forward settling TBA market. The Company typically does not take delivery of TBAs, but rather settles the associated receivable and payable with its trading counterparties on a net basis. Transactions with the same counterparty for the same TBA that result in a reduction of the position are treated as extinguished. The market value of the securities that the Company is required to purchase pursuant to a TBA transaction may decline below the agreed-upon purchase price. Conversely, the market value of the securities that the Company is required to sell pursuant to a TBA transaction may increase above the agreed upon sale price. As part of its TBA activities, the Company may "roll" its TBA positions, whereby the Company may sell (buy) securities for delivery (receipt) in an earlier month and simultaneously contract to repurchase (sell) similar, but not identical, securities at an agreed-upon price on a fixed date in a later month (with the later-month price typically lower than the earlier-month price). The Company accounts for its TBA transactions (including those related to TBA rolls) as purchases and sales.

Investments in Operating Entities

Investments in Operating Entities: The Company has made and may in the future make non-controlling investments in operating entities such as loan originators. Investments in such operating entities may be in the form of preferred and/or common equity, debt, or some other form of investment. The Company carries its investments in such entities at fair value. In cases where the operating entity provides services to the Company, the Company is required to use the equity method of accounting.

Offering Costs/Underwriters' Discount

Offering Costs/Underwriters' Discount: Offering costs and underwriters' discount are generally charged against stockholders' equity upon the completion of a capital raise. Offering costs typically include legal, accounting, and other fees associated with the cost of raising capital. Offering Costs/Underwriters' Discount: Offering costs and underwriters' discount are charged against shareholders' equity. Offering costs typically include legal, accounting, printing, and other fees associated with the cost of raising capital.

Debt Issuance Costs

Debt Issuance Costs: Debt issuance costs associated with debt for which the Company has elected the FVO are expensed at the issuance of the debt, and are included in Investment related expenses—Other on the Consolidated Statement of Operations. Costs associated with the issuance of debt for which the Company has not elected the FVO are deferred and amortized over the life of the debt, which approximates the effective interest rate method, and are included in Interest expense on the Consolidated Statement of Operations. Deferred debt issuance costs are presented on the Consolidated Balance Sheet as a direct deduction from the related debt liability, unless such deferred debt issuance costs are associated with borrowing facilities that are expected to have a future benefit, such as giving the Company the ability to access additional borrowings over the contractual term of the debt, in which case such deferred debt issuance costs are included in Other assets on the Consolidated Balance Sheet. Debt issuance costs include legal and accounting fees, purchasers' or underwriters' discount, as well as other fees associated with the cost of the issuance of the related debt. Debt Issuance Costs: Debt issuance costs associated with debt for which the Company has elected the fair value option are expensed at the issuance of the debt, and are included in Other investment related expenses on the Consolidated Statement of Operations. Costs associated with the issuance of debt for which the Company has not elected the fair value option are amortized over the life of the debt, which approximates the effective interest rate method, and are included in Interest expense on the Consolidated Statement of Operations. Deferred debt issuance costs are presented on the Consolidated Statement of Assets, Liabilities, and Equity as a direct deduction from the related debt liability, unless such deferred debt issuance costs are associated with borrowing facilities that are expected to have a future benefit, such as giving the Company the ability to access additional borrowings over the contractual term of the debt, in which case such deferred debt issuance costs are included in Other Assets on Consolidated Statement of Assets, Liabilities, and Equity. Debt issuance costs include legal and accounting fees, purchasers' or underwriters' discount, as well as other fees associated with the cost of the issuance of the related debt.

Expenses

Expenses: Expenses are recognized as incurred on the Consolidated Statement of Operations.Expenses: Expenses are recognized as incurred on the Consolidated Statement of Operations.

Investment Related Expenses

Investment Related Expenses: Investment related expenses consist of expenses directly related to specific financial instruments. Such expenses generally include dividend expense on common stock sold short, servicing fees and corporate and escrow advances on mortgage and consumer loans, and various other expenses and fees related directly to the Company's financial instruments. The Company has elected the FVO for its investments, and as a result all investment related expenses are expensed as incurred and included in Investment related expenses on the Consolidated Statement of Operations.Other Investment Related Expenses: Other investment related expenses consist of expenses directly related to specific financial instruments. Such expenses generally include dividend expense on common stock sold short, servicing fees and corporate and escrow advances on mortgage and consumer loans, and various other expenses and fees related directly to the Company's financial instruments. Other investment related expenses are recognized as incurred on the Consolidated Statement of Operations; dividend expense on common stock sold short is recognized on the ex-dividend date.

Investment Related Receivables [Policy Text Block]

Investment Related Receivables: Investment related receivables on the Company's Consolidated Balance Sheet includes receivables for securities sold and interest and principal receivable on securities and loans.

LTIP Units

Long Term Incentive Plan Units: Long term incentive plan units of the Operating Partnership ("OP LTIP Units") have been issued to certain Ellington personnel dedicated or partially dedicated to the Company, certain of the Company's directors, as well as the Manager. Costs associated with OP LTIP Units issued to dedicated or partially dedicated personnel, or to the Company's directors, are measured as of the grant date based on the Company's closing stock price on the New York Stock Exchange and are amortized over the vesting period in accordance with ASC 718-10, Compensation—Stock Compensation. The vesting periods for OP LTIP Units are typically one year from issuance for non-executive directors, and are typically one year to two years from issuance for dedicated or partially dedicated personnel.LTIP Units: Long term incentive plan units of the Company ("LTIP Units") and long term incentive plan units of the Operating Partnership ("OP LTIP Units") have been issued to the Company's dedicated or partially dedicated personnel and certain of its directors as well as the Manager. Costs associated with LTIP Units and OP LTIP Units issued to dedicated or partially dedicated personnel, or to its directors, are measured as of the grant date based on the closing stock price on the New York Stock Exchange and are amortized over the vesting period in accordance with ASC 718-10, Compensation—Stock Compensation. The vesting periods for LTIP Units and OP LTIP Units are typically one year from issuance for directors, and are typically one year to two years from issuance for dedicated or partially dedicated personnel.

Non-controlling interest

Non-controlling interests: Non-controlling interests include interests in the Operating Partnership represented by units convertible into shares of the Company's common stock ("Convertible Non-controlling Interests"). Convertible Non-controlling Interests include both the OP LTIP Units and those common units ("OP Units") of the Operating Partnership not held by the Company (collectively, the "Convertible Non-controlling Interest Units"). Non-controlling interests also include the interests of joint venture partners in certain of our consolidated subsidiaries. The joint venture partners' interests are not convertible into shares of the Company's common stock. The Company adjusts the Convertible Non-controlling Interests to align their carrying value with their share of total outstanding Operating Partnership units, including both the OP Units held by the Company and the Convertible Non-controlling Interests. Any such adjustments are reflected in Adjustment to non-controlling interests, on the Consolidated Statement of Changes in Equity. See Note 15 for further discussion of non-controlling interests.Non-controlling interests: Non-controlling interests include interests in the Operating Partnership represented by units convertible into the Company's common shares ("Convertible Non-controlling Interests"). Convertible Non-controlling Interests include both the OP LTIP Units and those common units ("OP Units") of the Operating Partnership not held by the Company. Non-controlling interests also include the interests of joint venture partners in certain of our consolidated subsidiaries. The joint venture partners' interests are not convertible into the Company's common shares. The Company adjusts the Convertible Non-controlling Interests to align their carrying value with their share of total outstanding Operating Partnership units, including both the OP Units held by the Company and the Convertible Non-controlling Interests. Any such adjustments are reflected in "Adjustment to non-controlling interest" on the Consolidated Statement of Changes in Equity. See Note 11 for further discussion of non-controlling interests.

Dividends

Dividends: Dividends payable on shares of common stock and Convertible Non-controlling Interest Units are recorded on the declaration date.Dividends: Dividends payable by the Company are recorded on the ex-dividend date. Dividends are typically declared and paid on a quarterly basis in arrears.

Shares Repurchased

Shares Repurchased: Shares of common stock that are repurchased by the Company subsequent to issuance are immediately retired upon settlement and decrease the total number of shares of common stock issued and outstanding. The cost of such repurchases is charged against Additional paid-in-capital on the Company's Consolidated Balance Sheet.Shares Repurchased: Common shares that are repurchased by the Company subsequent to issuance are immediately retired upon settlement and decrease the total number of shares outstanding and issued.

Earnings Per Share ("EPS")

Earnings Per Share ("EPS"): Basic EPS is computed using the two class method by dividing net income (loss) after adjusting for the impact of Convertible Non-controlling Interests which are participating securities, by the weighted average number of shares of common stock outstanding calculated including Convertible Non-controlling Interests. Because the Company's Convertible Non-controlling Interests are participating securities, they are included in the calculation of both basic and diluted EPS.Earnings Per Share ("EPS"): Basic EPS is computed using the two class method by dividing net increase (decrease) in shareholders' equity resulting from operations after adjusting for the impact of LTIP Units which are participating securities, by the weighted average number of common shares outstanding calculated including LTIP Units. Because the Company's LTIP Units are participating securities, they are included in the calculation of basic and diluted EPS. Convertible Non-controlling Interests are also participating securities and, accordingly, are included in the calculation of both basic and diluted EPS.

Foreign Currency

Foreign Currency: The functional currency of the Company is U.S. dollars. Assets and liabilities denominated in foreign currencies are remeasured into U.S. dollars at current exchange rates at the following dates: (i) assets, liabilities, and unrealized gains/losses—at the valuation date; and (ii) income, expenses, and realized gains/losses—at the accrual/transaction date. The Company isolates the portion of realized and change in unrealized gain (loss) resulting from changes in foreign currency exchange rates on investments and financial derivatives from the fluctuations arising from changes in fair value of investments and financial derivatives held. Changes in realized and change in unrealized gain (loss) due to foreign currency are included in Other, net, on the Consolidated Statement of Operations. The Company's reporting currency is U.S. Dollars. If the Company has investments in unconsolidated entities that have a functional currency other than U.S. Dollars, the fair value is translated to U.S. dollars using the current exchange rate at the valuation date. The cumulative translation adjustment, if any, associated with the Company's investments in unconsolidated entities is recorded in accumulated other comprehensive income (loss), a component of consolidated stockholders' equity.Foreign Currency: Assets and liabilities denominated in foreign currencies are translated into U.S. dollars at current exchange rates at the following dates: (i) assets, liabilities, and unrealized gains/losses—at the valuation date; and (ii) income, expenses, and realized gains/losses—at the accrual/transaction date. The Company isolates the portion of realized and change in unrealized gain (loss) resulting from changes in foreign currency exchange rates on investments and financial derivatives from the fluctuations arising from changes in fair value of investments and financial derivatives held. Changes in realized and change in unrealized gain (loss) due to foreign currency are included in Foreign currency transactions and Foreign currency translation, respectively, on the Consolidated Statement of Operations.

Income Taxes

Income Taxes: The Company has elected to be taxed as a REIT under Sections 856 through 860 of the Code. As a REIT, the Company is generally not subject to corporate-level federal and state income tax on net income it distributes to its stockholders within the prescribed timeframes. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including distributing at least 90% of its annual taxable income to stockholders. Even if the Company qualifies as a REIT, it may be subject to certain federal, state, local and foreign taxes on its income and property, and to federal income and excise taxes on its undistributed taxable income. If the Company fails to qualify as a REIT, and does not qualify for

certain statutory relief provisions, it will be subject to U.S. federal, state, and local income taxes and may be precluded from qualifying as a REIT for the four taxable years following the year in which the Company fails to qualify as a REIT.

As a REIT, if the Company fails to distribute in any calendar year (subject to specific timing rules for certain dividends paid in January) at least the sum of (i) 85% of its ordinary income for such year, (ii) 95% of its capital gain net income for such year, and (iii) any undistributed taxable income from the prior year, the Company would be subject to a non-deductible 4% excise tax on the excess of such required distribution over the sum of (i) the amounts actually distributed and (ii) the amounts of income retained and on which the Company has paid corporate income tax.

The Company elected to treat certain domestic and foreign subsidiaries as TRSs, and may in the future elect to treat other current or future subsidiaries as TRSs. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. A domestic TRS may, but is not required to, declare dividends to the Company; such dividends will be included in the Company's taxable income/(loss) and may necessitate a distribution to the Company's stockholders. Conversely, if the Company retains earnings at the level of a domestic TRS, such earnings will increase the book equity of the consolidated entity. A domestic TRS is subject to U.S. federal, state, and local corporate income taxes. The Company has elected and may elect in the future to treat certain of its foreign corporate subsidiaries as TRSs and, accordingly, taxable income generated by these TRSs may not be subject to U.S. federal, state, and local corporate income taxation, but generally will be included in the Company's income on a current basis as Subpart F income, whether or not distributed. However, certain of the Company's foreign subsidiaries may be subject to income taxes in the relevant foreign jurisdictions. The Company's financial results are generally not expected to reflect provisions for current or deferred income taxes, except for any activities conducted through one or more TRSs that are subject to corporate income taxation.

The Company follows the authoritative guidance on accounting for and disclosure of uncertainty on tax positions, which requires management to determine whether a tax position of the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For uncertain tax positions, the tax benefit to be recognized is measured as the largest amount of benefit that is more than 50% likely to be realized upon ultimate settlement. The Company did not have any unrecognized tax benefits resulting from tax positions related to the current period or its open tax years. In the normal course of business, the Company may be subject to examination by federal, state, local, and foreign jurisdictions, where applicable, for the current period and its open tax years. The Company may take positions with respect to certain tax issues which depend on legal interpretation of facts or applicable tax regulations. Should the relevant tax regulators successfully challenge any of such positions, the Company might be found to have a tax liability that has not been recorded in the accompanying consolidated financial statements. Also, management's conclusions regarding the authoritative guidance may be subject to review and adjustment at a later date based on changing tax laws, regulations, and interpretations thereof.

Income Taxes: The Company is treated as a partnership for U.S. federal income tax purposes. Certain of the Company's subsidiaries are not consolidated for U.S. federal income tax purposes, but are also treated as partnerships. In general, partnerships are not subject to entity-level tax on their income, but the income of a partnership is taxable to its owners on a flow-through basis. In addition, certain subsidiaries of the Company have elected to be treated as corporations for U.S. federal income tax purposes, and one has elected to be taxed as a real estate investment trust, or "REIT."The Company follows the authoritative guidance on accounting for and disclosure of uncertainty on tax positions, which requires management to determine whether a tax position of the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For uncertain tax positions, the tax benefit to be recognized is measured as the largest amount

of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company did not have any additions to unrecognized tax benefits resulting from tax positions related either to the current period or to 2017, 2016, or 2015 (its open tax years), and no reductions resulting from tax positions of prior years or due to settlements, and thus had no unrecognized tax benefits or reductions since inception. The Company does not expect any change in unrecognized tax benefits within the next fiscal year. There were no amounts accrued for tax penalties or interest as of or during the periods presented in these consolidated financial statements.

The Company may take positions with respect to certain tax issues which depend on legal interpretation of facts or applicable tax regulations. Should the relevant tax regulators successfully challenge any of such positions, the Company might be found to have a tax liability that has not been recorded in the accompanying consolidated financial statements. Also, management's conclusions regarding ASC 740-10 may be subject to review and adjustment at a later date based on factors including, but not limited to, further implementation guidance from the Financial Accounting Standards Board, or "FASB," and ongoing analyses of tax laws, regulations and interpretations thereof.

Recent Accounting Pronouncements

Recent Accounting Pronouncements: In August 2018, the Financial Accounting Standards Board, or "FASB," issued ASU 2018-13, Fair Value Measurement—Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement ("ASU 2018-13"). This amends ASC 820 to remove or modify various current disclosure requirements related to fair value measurement. Additionally, ASU 2018-13 requires certain additional disclosures around fair value measurement. ASU 2018-13 is effective for annual periods beginning after December 15, 2019 and interim periods within those years, with early adoption permitted. Entities are permitted to early adopt any removed or modified disclosures and delay adoption of the additional disclosures until their effective date. The adoption of ASU 2018-13 did not have a material impact on the Company's consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, which introduced a new model related to the accounting for credit losses on financial assets subject to credit losses and measured at amortized cost and certain off-balance sheet credit exposures. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2016-13 amends the guidance which required an OTTI charge only when fair value is below the amortized cost of an asset. The length of time the fair value of an available-for-sale debt security has been below the amortized cost will no longer impact the determination of whether a credit loss exists; as a result, there is no longer an other-than-temporary impairment model. In addition, credit losses on available-for-sale debt securities will now be limited to the difference between the security's amortized cost basis and its fair value. This new debt security model will also require the use of an allowance to record estimated credit losses. While generally not applicable for financial assets for which the fair value option has been elected, the Company has applied the principles of ASU 2016-13 as described above. The adoption of ASU 2016-13 did not have a material impact on the Company's consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform—Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"), which provides optional guidance for a limited period meant to ease the potential burden in accounting for, or recognizing the effects of, reform to LIBOR and certain other reference rates. The

standard is effective for all entities beginning on March 12, 2020 and may be elected over time. However, ASU 2020-04 is only applicable to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform, and that were entered into or evaluated prior to January 1, 2023. The Company is currently evaluating the impact that the adoption of ASU 2020-04 would have on its consolidated financial statements.Recent Accounting Pronouncements: In August 2018, the Financial Accounting Standards Board, or "FASB," issued ASU 2018-13, Fair Value Measurement—Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement ("ASU 2018-13"). This amends ASC 820, Fair Value Measurement, to remove or modify various current disclosure requirements related to fair value measurement. Additionally ASU 2018-13 requires certain additional disclosures around fair value measurement. ASU 2018-13 is effective for annual periods beginning after December 15, 2019 and interim periods within those years, with early adoption permitted. Entities are permitted to early adopt any removed or modified disclosures and delay adoption of the additional disclosures until their effective date. The Company has elected to early adopt the removal and modification of various disclosure requirements in accordance with ASU 2018-13; early adoption has not had a material impact on the Company's consolidated financial statements. The Company has elected not to early adopt the additional disclosure requirements. The adoption of additional disclosures, as required under ASU 2018-13, is not expected to have a material impact on the Company's consolidated financial statements.

In June 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation—Improvements to Nonemployee Share-Based Payment Accounting ("ASU 2018-07"). This amends ASC 718, Compensation—Stock Compensation, to simplify several aspects of accounting for nonemployee share-based payment transactions. ASU 2018-07 is effective for annual periods beginning after December 15, 2019 and interim periods beginning after December 15, 2020, with early adoption permitted. The adoption of ASU 2018-07 is not expected to have a material impact on the Company's consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows—Restricted Cash ("ASU 2016-18"). This amends ASC 230, Statement of Cash Flows, to require that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash and restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. ASU 2016-18 became effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU 2016-18 did not have a material impact on the Company's consolidated financial statements.

Financial Assets Sold under Agreement to Repurchase [Member]

Assets Sold under Agreements to Repurchase [Line Items]

Repurchase and Resale Agreements

Repurchase Agreements: The Company enters into repurchase agreements with third-party broker-dealers whereby it sells securities under agreements to be repurchased at an agreed-upon price and date. The Company accounts for repurchase agreements as collateralized borrowings, with the initial sale price representing the amount borrowed, and with the future repurchase price consisting of the amount borrowed plus interest, at the implied interest rate of the repurchase agreement, on the amount borrowed over the term of the repurchase agreement. The interest rate on a repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. When the Company enters into a repurchase agreement, the lender establishes and maintains an account containing cash and/or securities having a value not less than the repurchase price, including accrued interest, of the repurchase agreement. Repurchase agreements are carried at their contractual amounts, which approximate fair value as the debt is short-term in nature.Reverse Repurchase Agreements: The Company enters into reverse repurchase agreements with third-party broker-dealers whereby it sells securities under agreements to be repurchased at an agreed-upon price and date. The Company accounts for reverse repurchase agreements as collateralized borrowings, with the initial sale price representing the amount borrowed, and with the future repurchase price consisting of the amount borrowed plus interest, at the implied interest rate of the reverse repurchase agreement, on the amount borrowed over the term of the reverse repurchase agreement. The interest rate on a reverse repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. When the Company enters into a reverse repurchase agreement, the lender establishes and maintains an account containing cash and/or securities having a value not less than the repurchase price, including accrued interest, of the reverse repurchase agreement. Reverse repurchase agreements are carried at their contractual amounts, which approximate fair value as the debt is short-term in nature.

Securities Purchased under Agreements to Resell [Member]

Assets Sold under Agreements to Repurchase [Line Items]

Repurchase and Resale Agreements

Reverse Repurchase Agreements: The Company enters into reverse repurchase agreement transactions whereby it purchases securities under agreements to resell at an agreed-upon price and date. In general, securities received pursuant to reverse repurchase agreements are delivered to counterparties of short sale transactions. The interest rate on a reverse repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. Assets held pursuant to reverse repurchase agreements are reflected as assets on the Consolidated Balance Sheet. Reverse repurchase agreements are carried at their contractual amounts, which approximates fair value due to their short-term nature. Repurchase and reverse repurchase agreements that are conducted with the same counterparty may be reported on a net basis if they meet the requirements of ASC 210-20, Balance Sheet Offsetting. There are no repurchase and reverse repurchase agreements reported on a net basis in the Company's consolidated financial statements.Repurchase Agreements: The Company enters into repurchase agreement transactions whereby it purchases securities under agreements to resell at an agreed-upon price and date. In general, securities received pursuant to repurchase agreements are delivered to counterparties of short sale transactions. The interest rate on a repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. Assets held pursuant to repurchase agreements are reflected as assets on the Consolidated Statement of Assets, Liabilities, and Equity. Repurchase agreements are carried at fair value based on their contractual amounts as the debt is short-term in nature. Repurchase and reverse repurchase agreements that are conducted with the same counterparty may be reported on a net basis if they meet the requirements of ASC 210-20, Balance Sheet Offsetting. There are no repurchase and reverse repurchase agreements reported on a net basis in the Company's consolidated financial statements.

XML

Valuation (Tables)

12 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The tables below reflect the value of the Company's Level 1, Level 2, and Level 3 financial instruments that are measured at fair value on a recurring basis as of December 31, 2020 and 2019:

December 31, 2020:

Description	Level 1		Level 2		Level 3		Total
	(In thousands)
Assets:
Securities, at fair value:
Agency RMBS	$	—	$	947,780	$	11,663	$	959,443
Non-Agency RMBS	—		76,276		127,838		204,114
CMBS	—		54,505		63,148		117,653
CLOs	—		70,171		111,100		181,271
Asset-backed securities, backed by consumer loans	—		—		44,925		44,925
Corporate debt securities	—		1,107		4,082		5,189
Corporate equity securities	—		—		1,590		1,590
Loans, at fair value:
Residential mortgage loans	—		—		1,187,069		1,187,069
Commercial mortgage loans	—		—		213,031		213,031
Consumer loans	—		—		47,525		47,525
Corporate loans	—		—		5,855		5,855
Investment in unconsolidated entities, at fair value	—		—		141,620		141,620
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	—		—		347		347
Credit default swaps on asset-backed indices	—		2,184		—		2,184
Credit default swaps on corporate bond indices	—		3,420		—		3,420
Interest rate swaps	—		8,519		—		8,519
TBAs	—		962		—		962
Total return swaps	—		—		9		9
Warrants	—		36		—		36
Futures	2		—		—		2
Total assets	$	2	$	1,164,960	$	1,959,802	$	3,124,764

Description	Level 1		Level 2		Level 3		Total
(continued)	(In thousands)
Liabilities:
Securities sold short, at fair value:
Government debt	$	—	$	(38,424)	$	—	$	(38,424)
Corporate debt securities	—		(218)		—		(218)
Financial derivatives–liabilities, at fair value:
Credit default swaps on asset-backed indices	—		(130)		—		(130)
Credit default swaps on corporate bonds	—		(747)		—		(747)
Credit default swaps on corporate bond indices	—		(6,438)		—		(6,438)
Interest rate swaps	—		(15,174)		—		(15,174)
TBAs	—		(925)		—		(925)
Futures	(376)		—		—		(376)
Forwards	—		(279)		—		(279)
Total return swaps	—		—		(484)		(484)
Other secured borrowings, at fair value	—		—		(754,921)		(754,921)
Total liabilities	$	(376)	$	(62,335)	$	(755,405)	$	(818,116)

December 31, 2019:

Description	Level 1		Level 2		Level 3		Total
	(In thousands)
Assets:
Securities, at fair value:
Agency RMBS	$	—	$	1,917,059	$	19,904	$	1,936,963
Non-Agency RMBS	—		76,969		89,581		166,550
CMBS	—		95,063		29,805		124,868
CLOs	—		125,464		44,979		170,443
Asset-backed securities, backed by consumer loans	—		—		48,610		48,610
Corporate debt securities	—		—		1,113		1,113
Corporate equity securities	—		—		1,394		1,394
Loans, at fair value:
Residential mortgage loans	—		—		932,203		932,203
Commercial mortgage loans	—		—		274,759		274,759
Consumer loans	—		—		186,954		186,954
Corporate loans	—		—		18,510		18,510
Investment in unconsolidated entities, at fair value	—		—		71,850		71,850
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	—		—		993		993
Credit default swaps on asset-backed indices	—		3,319		—		3,319
Credit default swaps on corporate bonds	—		2		—		2
Credit default swaps on corporate bond indices	—		5,599		—		5,599
Interest rate swaps	—		5,468		—		5,468
TBAs	—		596		—		596
Total return swaps	—		—		620		620
Futures	148		—		—		148
Forwards	—		43		—		43
Total assets	$	148	$	2,229,582	$	1,721,275	$	3,951,005

Description	Level 1		Level 2		Level 3		Total
(continued)	(In thousands)
Liabilities:
Securities sold short, at fair value:
Government debt	$	—	$	(72,938)	$	—	$	(72,938)
Corporate debt securities	—		(471)		—		(471)
Financial derivatives–liabilities, at fair value:
Credit default swaps on asset-backed indices	—		(250)		—		(250)
Credit default swaps on corporate bonds	—		(1,693)		—		(1,693)
Credit default swaps on corporate bond indices	—		(14,524)		—		(14,524)
Interest rate swaps	—		(8,719)		—		(8,719)
TBAs	—		(1,012)		—		(1,012)
Futures	(45)		—		—		(45)
Forwards	—		(169)		—		(169)
Total return swaps	—		(773)		(436)		(1,209)
Other secured borrowings, at fair value	—		—		(594,396)		(594,396)
Total liabilities	$	(45)	$	(100,549)	$	(594,832)	$	(695,426)

The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2018:

Description	Level 1		Level 2		Level 3		Total
	(In thousands)
Assets:
Cash equivalents	$	12,460	$	—	$	—	$	12,460
Investments, at fair value-
Agency residential mortgage-backed securities	$	—	$	1,442,924	$	7,293	$	1,450,217
U.S. Treasury securities	—		76		—		76
Private label residential mortgage-backed securities	—		211,348		91,291		302,639
Private label commercial mortgage-backed securities	—		33,105		803		33,908
Commercial mortgage loans	—		—		211,185		211,185
Residential mortgage loans	—		—		496,830		496,830
Collateralized loan obligations	—		108,978		14,915		123,893
Consumer loans and asset-backed securities backed by consumer loans	—		—		206,761		206,761
Corporate debt	—		16,074		6,318		22,392
Secured notes	—		—		10,917		10,917
Real estate owned	—		—		34,500		34,500
Common stock	2,200		—		—		2,200
Corporate equity investments	—		—		43,793		43,793
Total investments, at fair value	2,200		1,812,505		1,124,606		2,939,311
Financial derivatives–assets, at fair value-
Credit default swaps on asset-backed securities	—		—		1,472		1,472
Credit default swaps on corporate bond indices	—		733		—		733
Credit default swaps on corporate bonds	—		2,473		—		2,473
Credit default swaps on asset-backed indices	—		8,092		—		8,092
Total return swaps	—		1		—		1
Interest rate swaps	—		7,224		—		7,224
Forwards	—		6		—		6
Total financial derivatives–assets, at fair value	—		18,529		1,472		20,001
Repurchase agreements, at fair value	—		61,274		—		61,274
Total investments, financial derivatives–assets, and repurchase agreements, at fair value	$	2,200	$	1,892,308	$	1,126,078	$	3,020,586
Liabilities:
Investments sold short, at fair value-
Agency residential mortgage-backed securities	$	—	$	(772,964)	$	—	$	(772,964)
Government debt	—		(54,151)		—		(54,151)
Corporate debt	—		(6,529)		—		(6,529)
Common stock	(16,933)		—		—		(16,933)
Total investments sold short, at fair value	(16,933)		(833,644)		—		(850,577)

Description	Level 1		Level 2		Level 3		Total
(continued)	(In thousands)
Financial derivatives–liabilities, at fair value-
Credit default swaps on corporate bond indices	$	—	$	(11,557)	$	—	$	(11,557)
Credit default swaps on corporate bonds	—		(3,246)		—		(3,246)
Credit default swaps on asset-backed indices	—		(2,125)		—		(2,125)
Interest rate swaps	—		(3,397)		—		(3,397)
Total return swaps	—		(6)		—		(6)
Futures	(355)		—		—		(355)
Forwards	—		(120)		—		(120)
Total financial derivatives–liabilities, at fair value	(355)		(20,451)		—		(20,806)
Other secured borrowings, at fair value	—		—		(297,948)		(297,948)
Total investments sold short, financial derivatives–liabilities, and other secured borrowings, at fair value	$	(17,288)	$	(854,095)	$	(297,948)	$	(1,169,331)

Schedule of Financial Instruments

The following table summarizes the estimated fair value of all other financial instruments not measured at fair value on a recurring basis as of December 31, 2020 and 2019:

	As of
	December 31, 2020				December 31, 2019
(In thousands)	Fair Value		Carrying Value		Fair Value		Carrying Value
Other financial instruments
Assets:
Cash and cash equivalents	$	111,647	$	111,647	$	72,302	$	72,302
Restricted cash	175		175		175		175
Due from brokers	63,147		63,147		79,829		79,829
Reverse repurchase agreements	38,640		38,640		73,639		73,639
Liabilities:
Repurchase agreements	1,496,931		1,496,931		2,445,300		2,445,300
Other secured borrowings	51,062		51,062		150,334		150,334
Senior notes, net	86,000		85,561		88,365		85,298
Due to brokers	5,059		5,059		2,197		2,197

Cash and cash equivalents generally includes cash held in interest bearing overnight accounts, for which fair value equals the carrying value, and investments which are liquid in nature, such as investments in money market accounts or U.S. Treasury Bills, for which fair value equals the carrying value; such assets are considered Level 1. Restricted cash includes cash held in a segregated account for which fair value equals the carrying value; such assets are considered Level 1. Due from brokers and Due to brokers include collateral transferred to or received from counterparties, along with receivables and payables for open and/or closed derivative positions. These receivables and payables are short term in nature and any collateral transferred consists primarily of cash; fair value of these items is approximated by carrying value and such items are considered Level 1. The Company's reverse repurchase agreements, repurchase agreements, and other secured borrowings are carried at cost, which approximates fair value due to their short term nature. Reverse repurchase agreements, repurchase agreements, and other secured borrowings are classified as Level 2 based on the adequacy of the collateral and their short term nature. Senior notes, net are considered Level 3 liabilities given the relative unobservability of the most significant inputs to valuation estimation as well as the lack of trading activity of these instruments. As of December 31, 2020 and 2019, the estimated fair value of the Company's Senior notes was based on a third-party valuation.

Schedule of Significant Unobservable Inputs, Qualitative Information

The following tables identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2020 and 2019:

December 31, 2020:

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
	(In thousands)
Non-Agency RMBS	$	70,619	Market Quotes	Non Binding Third-Party Valuation	$	9.53		$	204.61		$	85.70
	57,219		Discounted Cash Flows
	127,838			Yield(1)	0.7		%	52.6		%	7.4		%
				Projected Collateral Prepayments	—		%	99.1		%	45.3		%
				Projected Collateral Losses	0.4		%	72.6		%	18.4		%
				Projected Collateral Recoveries	—		%	79.1		%	16.8		%
Non-Agency CMBS	53,199		Market Quotes	Non Binding Third-Party Valuation	$	4.79		$	98.00		$	65.20
	9,949		Discounted Cash Flows
	63,148			Yield	3.7		%	26.3		%	8.7		%
				Projected Collateral Prepayments	—		%	—		%	—		%
				Projected Collateral Losses	0.7		%	10.7		%	3.6		%
				Projected Collateral Recoveries	72.4		%	96.1		%	90.6		%
CLOs	102,910		Market Quotes	Non Binding Third-Party Valuation	$	2.00		$	330.00		$	88.66
	8,190		Discounted Cash Flows
	111,100			Yield	3.4		%	35.4		%	10.5		%
				Projected Collateral Prepayments	41.2		%	97.7		%	65.7		%
				Projected Collateral Losses	1.7		%	28.9		%	11.2		%
				Projected Collateral Recoveries	0.6		%	15.2		%	7.9		%
Agency interest only RMBS	4,844		Market Quotes	Non Binding Third-Party Valuation	$	1.91		$	18.91		$	8.38
	6,819		Option Adjusted Spread ("OAS")
	11,663			LIBOR OAS(2)(3)	297			2,886			914
				Projected Collateral Prepayments	8.3		%	100.0		%	75.9		%
ABS backed by consumer loans	97		Market Quotes	Non Binding Third-Party Valuation	$	96.51		$	98.43		$	97.33
	44,828		Discounted Cash Flows
	44,925			Yield	12.6		%	27.5		%	15.6		%
				Projected Collateral Prepayments	0.0		%	11.6		%	7.7		%
				Projected Collateral Losses	1.0		%	21.1		%	17.1		%
Corporate debt and equity	5,672		Discounted Cash Flows	Yield	8.1		%	10.8		%	9.7		%
Performing and re-performing residential mortgage loans	338,265		Discounted Cash Flows	Yield	2.5		%	28.5		%	5.4		%
	15,659		Recent Transactions	Transaction Price	$	60.00		$	103.88		$	103.44
	353,924

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
(continued)	(In thousands)
Securitized residential mortgage loans(4)(5)	$	783,162	Market Quotes	Non Binding Third-Party Valuation	$	5.34		$	105.61		$	100.22
	18,182		Discounted Cash Flows
	801,343			Yield	—		%	38.7		%	4.4		%
Non-performing residential mortgage loans	31,802		Discounted Cash Flows	Yield	1.2		%	41.0		%	12.1		%
				Recovery Amount	0.9		%	1713.0		%	30.6		%
				Months to Resolution	0.0			106.6			30.0
Performing commercial mortgage loans	181,545		Discounted Cash Flows	Yield	3.7		%	9.7		%	8.1		%
Non-performing commercial mortgage loans	31,486		Discounted Cash Flows	Yield	8.6		%	14.6		%	10.8		%
				Recovery Amount	100.0		%	102.4		%	100.8		%
				Months to Resolution	1.8			5.8			3.7
Consumer loans	47,525		Discounted Cash Flows	Yield	7.8		%	28.1		%	11.2		%
				Projected Collateral Prepayments	0.0		%	36.0		%	17.3		%
				Projected Collateral Losses	0.9		%	86.6		%	9.4		%
Corporate loans	5,855		Market Quotes	Non Binding Third-Party Valuation	$	100.00		$	100.00		$	100.00
				Yield	21.1		%	21.1		%	21.1		%
Investment in unconsolidated entities	141,620		Enterprise Value	Equity Price-to-Book(6)	1.0x			6.2x			1.4x
Total return swaps—asset	9		Discounted Cash Flows	Yield	22.0		%	22.0		%	22.0		%
Credit default swaps on asset-backed securities	347		Net Discounted Cash Flows	Projected Collateral Prepayments	32.7		%	39.7		%	38.1		%
				Projected Collateral Losses	6.6		%	10.8		%	8.9		%
				Projected Collateral Recoveries	13.9		%	18.1		%	15.6		%
Total return swaps—liability	(484)		Discounted Cash Flows	Yield	16.8%			16.8%			16.8%
Other secured borrowings, at fair value(4)	(754,921)		Market Quotes	Non Binding Third-Party Valuation	$	85.37		$	105.61		$	102.04
				Yield	1.6%			3.0%			2.6%
				Projected Collateral Prepayments	—%			75.3%			48.7%

(1)For the range minimum, the range maximum, and the weighted average yield, excludes non-Agency RMBS with a negative yield, with a total fair value of $0.3 million. Including these securities the weighted average yield was 7.3%.

(2)Shown in basis points.

(3)For range minimum, range maximum, and the weighted average of LIBOR OAS, excludes Agency interest only securities with a negative LIBOR OAS, with a total fair value of $4.5 million. Including these securities the weighted average was 396 basis points.

(4)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFEs as discussed in Note 2.

(5)Includes $26.4 million of non-performing securitized residential mortgage loans.

(6)Represents an estimation of where market participants might value an enterprise on a price-to-book basis.

December 31, 2019(1):

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
	(In thousands)
Non-Agency RMBS	$	38,754	Market Quotes	Non Binding Third-Party Valuation	$	6.68		$	144.79		$	86.21
	50,827		Discounted Cash Flows
	89,581			Yield(2)	0.5		%	65.1		%	8.1		%
				Projected Collateral Prepayments	0.8		%	76.5		%	53.1		%
				Projected Collateral Losses	0.1		%	48.9		%	17.7		%
				Projected Collateral Recoveries	—		%	32.4		%	6.5		%
Non-Agency CMBS	29,630		Market Quotes	Non Binding Third-Party Valuation	$	5.08		$	80.72		$	64.73
	175		Discounted Cash Flows
	29,805			Yield	3.7		%	15.7		%	7.6		%
				Projected Collateral Prepayments	—		%	100.0		%	0.6		%
				Projected Collateral Losses	—		%	3.0		%	0.2		%
				Projected Collateral Recoveries	—		%	10.6		%	2.0		%
CLOs	38,220		Market Quotes	Non Binding Third-Party Valuation	$	40.00		$	96.00		$	73.98
	6,759		Discounted Cash Flows
	44,979			Yield	3.2		%	41.9		%	14.0		%
				Projected Collateral Prepayments	48.5		%	88.3		%	83.2		%
				Projected Collateral Losses	4.7		%	36.4		%	8.8		%
				Projected Collateral Recoveries	3.7		%	15.1		%	5.7		%
Agency interest only RMBS	3,753		Market Quotes	Non Binding Third-Party Valuation	$	1.36		$	16.61		$	5.11
	16,151		Option Adjusted Spread ("OAS")
	19,904			LIBOR OAS(3)(4)	93			3,527			583
				Projected Collateral Prepayments	12.3		%	100.0		%	70.5		%
ABS backed by consumer loans	139		Market Quotes	Non Binding Third-Party Valuation	$	95.47		$	96.78		$	96.12
	48,471		Discounted Cash Flows
	48,610			Yield	3.8		%	34.2		%	12.7		%
				Projected Collateral Prepayments	0.0		%	11.2		%	9.7		%
				Projected Collateral Losses	0.6		%	18.0		%	15.4		%
Corporate debt and equity	2,507		Discounted Cash Flows	Yield	7.2		%	10.0		%	8.8		%
Performing and re-performing residential mortgage loans	289,672		Discounted Cash Flows	Yield	0.4		%	19.5		%	6.3		%
Securitized residential mortgage loans(5)(6)	621,762		Market Quotes	Non Binding Third-Party Valuation	$	2.56		$	100.45		$	98.23
	6,653		Discounted Cash Flows
	628,415			Yield	3.2		%	4.3		%	3.6		%

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
(Continued)	(In thousands)
Non-performing residential mortgage loans	$	14,116	Discounted Cash Flows	Yield	1.0		%	26.6		%	9.2		%
				Recovery Amount	28.0		%	464.3		%	94.3		%
				Months to Resolution	1.1			165.4			56.3
Performing commercial mortgage loans	248,214		Discounted Cash Flows	Yield	7.7		%	16.6		%	8.8		%
Non-performing commercial mortgage loans	26,545		Discounted Cash Flows	Yield	9.8		%	14.7		%	12.4		%
				Recovery Amount	100.0		%	100.0		%	100.0		%
				Months to Resolution	1.1			23.0			11.4
Consumer loans	186,954		Discounted Cash Flows	Yield	6.7		%	19.6		%	9.4		%
				Projected Collateral Prepayments	0.0		%	44.2		%	16.0		%
				Projected Collateral Losses	3.7		%	84.5		%	8.6		%
Corporate loans	6,010		Market Quotes	Non Binding Third-Party Valuation	$	100.00		$	100.00		$	100.00
	12,500		Discounted Cash Flows
	18,510			Yield	15.0		%	21.0		%	17.8		%
Investment in unconsolidated entities	71,850		Enterprise Value	Equity Price-to-Book(7)	1.0x			4.7x			1.4x
Total return swaps—asset	620		Discounted Cash Flows	Yield	8.5		%	27.7		%	11.5		%
Credit default swaps on asset-backed securities	993		Net Discounted Cash Flows	Projected Collateral Prepayments	35.4		%	42.0		%	37.3		%
				Projected Collateral Losses	4.2		%	12.4		%	10.2		%
				Projected Collateral Recoveries	10.0		%	18.2		%	15.3		%
Total return swaps—liability	(436)		Discounted Cash Flows	Yield	27.7%			27.7%			27.7%
Other secured borrowings, at fair value(5)	(594,396)		Market Quotes	Non Binding Third-Party Valuation	97.77			100.45			100.61
				Yield	2.9%			4.0%			3.3%
				Projected Collateral Prepayments	—%			96.6%			57.2%

(1)Conformed to current period presentation.

(2)For the range minimum, the range maximum, and the weighted average yield, excludes non-Agency RMBS with a negative yield, with a total fair value of $0.6 million. Including these securities the weighted average yield was 8.0%.

(3)Shown in basis points.

(4)For range minimum, range maximum, and the weighted average of LIBOR OAS, excludes Agency interest only securities with a negative LIBOR OAS, with a total fair value of $0.3 million. Including these securities the weighted average was 576 basis points.

(5)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFEs as discussed in Note 2.

(6)Includes $1.5 million of non-performing securitized residential mortgage loans.

(7)Represent an estimation of where market participants might value an enterprise on a price-to-book basis.

The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2018:

	Fair Value		Valuation  Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
	(In thousands)
Private label residential mortgage-backed securities	$	36,945	Market Quotes	Non Binding Third-Party Valuation	$	17.42		$	178.00		$	78.31
Collateralized loan obligations	5,828		Market Quotes	Non Binding Third-Party Valuation	2.64			375.00			167.78
Corporate debt, non-exchange traded corporate equity, and secured notes	13,976		Market Quotes	Non Binding Third-Party Valuation	9.69			91.00			59.18
Private label commercial mortgage-backed securities	576		Market Quotes	Non Binding Third-Party Valuation	5.93			6.36			6.14
Agency interest only residential mortgage-backed securities	744		Market Quotes	Non Binding Third-Party Valuation	1.70			9.12			5.64
Private label residential mortgage-backed securities	54,346		Discounted Cash Flows	Yield	3.5		%	66.1		%	10.7		%
				Projected Collateral Prepayments	16.0		%	92.1		%	50.4		%
				Projected Collateral Losses	0.0		%	23.1		%	8.7		%
				Projected Collateral Recoveries	1.5		%	14.6		%	7.3		%
				Projected Collateral Scheduled Amortization	6.1		%	61.8		%	33.6		%
											100.0		%
Private label commercial mortgage-backed securities	227		Discounted Cash Flows	Yield	3.4		%	3.4		%	3.4		%
				Projected Collateral Losses	2.0		%	2.0		%	2.0		%
				Projected Collateral Recoveries	6.6		%	6.6		%	6.6		%
				Projected Collateral Scheduled Amortization	91.4		%	91.4		%	91.4		%
											100.0		%
Corporate debt and non-exchange traded corporate equity	4,793		Discounted Cash Flows	Yield	17.5		%	17.5		%	17.5		%

(continued)	Fair Value		Valuation  Technique	Unobservable Input	Range				Weighted Average
Description					Min		Max
	(In thousands)
Collateralized loan obligations	$	9,087	Discounted Cash Flows	Yield	12.6	%	103.1	%	26.7	%
				Projected Collateral Prepayments	8.1	%	88.4	%	65.2	%
				Projected Collateral Losses	3.7	%	40.8	%	13.5	%
				Projected Collateral Recoveries	4.2	%	38.0	%	11.9	%
				Projected Collateral Scheduled Amortization	3.5	%	13.5	%	9.4	%
									100.0	%
Consumer loans and asset-backed securities backed by consumer loans	206,761		Discounted Cash Flows	Yield	7.0	%	18.3	%	8.5	%
				Projected Collateral Prepayments	0.0	%	45.9	%	33.5	%
				Projected Collateral Losses	2.6	%	84.8	%	9.1	%
				Projected Collateral Scheduled Amortization	15.2	%	96.6	%	57.4	%
									100.0	%
Performing commercial mortgage loans	163,876		Discounted Cash Flows	Yield	8.0	%	22.5	%	9.6	%
Non-performing commercial mortgage loans and commercial real estate owned	80,513		Discounted Cash Flows	Yield	9.6	%	27.4	%	13.2	%
				Months to Resolution	3.0		16.0		7.9
Performing residential mortgage loans	171,367		Discounted Cash Flows	Yield	2.7	%	12.9	%	6.0	%
Securitized residential mortgage loans(1)	314,202		Discounted Cash Flows	Yield	4.3	%	4.6	%	4.6	%
Non-performing residential mortgage loans and residential real estate owned	12,557		Discounted Cash Flows	Yield	4.3	%	25.1	%	11.3	%
				Months to Resolution(2)	1.9		42.2		27.8
Credit default swaps on asset-backed securities	1,472		Net Discounted Cash Flows	Projected Collateral Prepayments	33.6	%	42.0	%	36.5	%
				Projected Collateral Losses	11.1	%	15.6	%	12.8	%
				Projected Collateral Recoveries	10.3	%	18.7	%	15.8	%
				Projected Collateral Scheduled Amortization	32.0	%	36.5	%	34.9	%
									100.0	%
Agency interest only residential mortgage-backed securities	6,549		Option Adjusted Spread ("OAS")	LIBOR OAS(3)	211		3,521		677
				Projected Collateral Prepayments	37.7	%	100.0	%	66.2	%
				Projected Collateral Scheduled Amortization	0.0	%	62.3	%	33.8	%
									100.0	%
Non-exchange traded common equity investment in mortgage-related entity	6,750		Enterprise Value	Equity Price-to-Book(4)	3.3x		3.3x		3.3x
Non-exchange traded preferred equity investment in mortgage-related entity	27,317		Enterprise Value	Equity Price-to-Book(4)	1.1x		1.1x		1.1x
Non-exchange traded preferred equity investment in loan origination entity	3,000		Recent Transactions	Transaction Price	N/A		N/A		N/A
Non-controlling equity interest in limited liability company	5,192		Discounted Cash Flows	Yield(5)	12.9%		16.1%		15.4%
Other secured borrowings, at fair value(1)	(297,948)		Discounted Cash Flows	Yield	3.9%		4.4%		4.3%

(1)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFE as discussed in Note 2.

(2)Excludes certain loans that are re-performing.

(3)Shown in basis points.

(4)Represent an estimation of where market participants might value an enterprise on a price-to-book basis.

(5)Represents the significant unobservable inputs used to fair value the financial instruments of the limited liability company. The fair value of such financial instruments is the largest component of the valuation of the limited liability company as a whole.

Fair Value Measurement Using Significant Unobservable Inputs

The tables below includes a roll-forward of the Company's financial instruments for the years ended December 31, 2020 and 2019 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.

Year Ended December 31, 2020

(In thousands)	Beginning Balance as of  December 31, 2019		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/Payments(1)		Sales/Issuances(2)		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of  December 31, 2020
Assets:
Securities, at fair value:
Agency RMBS	$	19,904	$	(7,903)	$	722	$	3,175	$	8,307	$	(5,046)	$	1,083	$	(8,579)	$	11,663
Non-Agency RMBS	89,581		1,557		1,009		(1,283)		64,362		(40,841)		17,425		(3,972)		127,838
CMBS	29,805		813		62		(2,477)		52,915		(38,553)		20,583		—		63,148
CLOs	44,979		2,185		(8,862)		(13,132)		48,120		(6,747)		53,052		(8,495)		111,100
Asset-backed securities backed by consumer loans	48,610		(4,986)		(138)		(1,245)		30,899		(28,215)		—		—		44,925
Corporate debt securities	1,113		—		914		1,068		5,668		(4,681)		—		—		4,082
Corporate equity securities	1,394		—		7		(165)		366		(12)		—		—		1,590
Loans, at fair value:
Residential mortgage loans	932,203		(6,445)		(165)		11,593		594,397		(344,514)		—		—		1,187,069
Commercial mortgage loans	274,759		128		135		(166)		121,844		(183,669)		—		—		213,031
Consumer loans	186,954		(24,586)		(4,843)		(2,891)		141,245		(248,354)		—		—		47,525
Corporate loan	18,510		—		—		—		1,445		(14,100)		—		—		5,855
Investments in unconsolidated entities, at fair value	71,850		—		424		37,509		61,589		(29,752)		—		—		141,620
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	993		—		(5,451)		5,402		24		(621)		—		—		347
Total return swaps	620		—		288		(611)		126		(414)		—		—		9
Total assets, at fair value	$	1,721,275	$	(39,237)	$	(15,898)	$	36,777	$	1,131,307	$	(945,519)	$	92,143	$	(21,046)	$	1,959,802
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps	$	(436)	$	—	$	(551)	$	(48)	$	592	$	(41)	$	—	$	—	$	(484)
Other secured borrowings, at fair value	(594,396)		—		—		(9,576)		305,828		(456,777)		—		—		(754,921)
Total liabilities, at fair value	$	(594,832)	$	—	$	(551)	$	(9,624)	$	306,420	$	(456,818)	$	—	$	—	$	(755,405)

(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities.

(2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities.

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at December 31, 2020, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2020. For Level 3 financial instruments held by the Company at December 31, 2020, change in net unrealized gain (loss) of $(33.3) million, $8.6 million, $37.1 million, $0.5 million, $(0.5) million, and $(9.6) million, for the year ended December 31, 2020 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively.

At December 31, 2020, the Company transferred $21.0 million of assets from Level 3 to Level 2 and $92.1 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

Year Ended December 31, 2019

(In thousands)	Beginning Balance as of  January 1, 2019		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/ Payments(1)		Sales/ Issuances(2)		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of  December 31, 2019
Assets:
Securities, at fair value:
Agency RMBS	$	7,293	$	(3,464)	$	(1,787)	$	808	$	13,818	$	(1,306)	$	5,370	$	(828)	$	19,904
Non-Agency RMBS	91,291		270		5,636		(3,654)		21,512		(33,664)		15,354		(7,164)		89,581
CMBS	803		16		180		(246)		31,464		(5,271)		2,859		—		29,805
CLOs	14,915		(268)		(3,190)		2,329		25,531		(5,112)		11,984		(1,210)		44,979
Asset-backed securities backed by consumer loans	22,800		(2,520)		(891)		873		42,137		(13,789)		—		—		48,610
Corporate debt securities	6,318		22		(1,341)		188		11,024		(15,098)		—		—		1,113
Corporate equity securities	1,534		—		(1,807)		205		1,462		—		—		—		1,394
Loans, at fair value:
Residential mortgage loans	496,830		(6,081)		1,466		8,800		661,813		(230,625)		—		—		932,203
Commercial mortgage loans	195,301		(282)		2,412		(2,083)		175,689		(96,278)		—		—		274,759
Consumer loans	183,961		(28,521)		(6,291)		3,000		183,994		(149,189)		—		—		186,954
Corporate loan	—		36		—		(36)		18,510		—		—		—		18,510
Investment in unconsolidated entities, at fair value	72,298		—		1,545		8,664		42,173		(52,830)		—		—		71,850
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	1,472		—		528		(479)		33		(561)		—		—		993
Total return swaps	—		—		160		620		—		(160)		—		—		620
Total assets, at fair value	$	1,094,816	$	(40,792)	$	(3,380)	$	18,989	$	1,229,160	$	(603,883)	$	35,567	$	(9,202)	$	1,721,275
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps	$	—	$	—	$	(15)	$	(436)	$	15	$	—	$	—	$	—	$	(436)
Other secured borrowings, at fair value	(297,948)		—		—		(502)		182,291		(478,237)		—		—		(594,396)
Total liabilities, at fair value	$	(297,948)	$	—	$	(15)	$	(938)	$	182,306	$	(478,237)	$	—	$	—	$	(594,832)

(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities.

(2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities.

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3

financial instruments held by the Company at December 31, 2019, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2019. For Level 3 financial instruments held by the Company at December 31, 2019, change in net unrealized gain (loss) of $2.4 million, $11.5 million, $5.2 million, $0.1 million, $(0.4) million, and $0.1 million, for the year ended December 31, 2019 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively.

At December 31, 2019, the Company transferred $9.2 million of assets from Level 3 to Level 2 and $35.6 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

The tables below include a roll-forward of the Company's financial instruments for the year ended December 31, 2018 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.

Level 3—Fair Value Measurement Using Significant Unobservable Inputs:

Year Ended December 31, 2018

(In thousands)	Ending Balance as of  December 31, 2017		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/ Payments		Sales/ Issuances		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of  December 31, 2018
Assets:
Investments, at fair value-
Agency residential mortgage-backed securities	$	6,173	$	(2,233)	$	(10)	$	175	$	2,753	$	(1,169)	$	2,616	$	(1,012)	$	7,293
Private label residential mortgage-backed securities	101,297		383		1,838		(2,135)		75,685		(78,487)		7,074		(14,364)		91,291
Private label commercial mortgage-backed securities	12,347		(243)		2,229		2,120		1,481		(16,896)		—		(235)		803
Commercial mortgage loans	108,301		790		1,146		1,944		149,053		(50,049)		—		—		211,185
Residential mortgage loans	182,472		(1,965)		1,011		(34)		402,235		(86,889)		—		—		496,830
Collateralized loan obligations	24,911		(351)		317		(2,268)		33,549		(33,115)		3,959		(12,087)		14,915
Consumer loans and asset-backed securities backed by consumer loans	135,258		(29,320)		8,415		(1,092)		228,354		(134,854)		—		—		206,761
Corporate debt	23,947		56		241		(964)		7,665		(17,688)		—		(6,939)		6,318
Secured notes	—		870		—		(1,221)		11,268		—		—		—		10,917
Real estate owned	26,277		—		(653)		(1,003)		12,793		(2,914)		—		—		34,500
Corporate equity investments	37,465		—		1,671		8,299		12,708		(16,350)		—		—		43,793
Total investments, at fair value	658,448		(32,013)		16,205		3,821		937,544		(438,411)		13,649		(34,637)		1,124,606
Financial derivatives–assets, at fair value-
Credit default swaps on asset-backed securities	3,140		—		(687)		715		102		(1,798)		—		—		1,472
Total financial derivatives– assets, at fair value	3,140		—		(687)		715		102		(1,798)		—		—		1,472
Total investments and financial derivatives–assets, at fair value	$	661,588	$	(32,013)	$	15,518	$	4,536	$	937,646	$	(440,209)	$	13,649	$	(34,637)	$	1,126,078
Liabilities:
Other secured borrowings, at fair value	$	(125,105)	$	—	$	—	$	758	$	49,731	$	(223,332)	$	—	$	—	$	(297,948)
Total other secured borrowings, at fair value	$	(125,105)	$	—	$	—	$	758	$	49,731	$	(223,332)	$	—	$	—	$	(297,948)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at December 31, 2018, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2018. For Level 3 financial instruments held by the Company at December 31, 2018, change in net unrealized gain (loss) of $5.3 million, $(0.6) million, and $0.8 million, for the year ended December 31, 2018 relate to investments, financial derivatives–assets, and other secured borrowings, at fair value, respectively.

At December 31, 2018, the Company transferred $34.6 million of securities from Level 3 to Level 2 and $13.6 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

XML

Investment in Securities (Tables)

12 Months Ended

Dec. 31, 2020

Investments, Debt and Equity Securities [Abstract]

Summary of Investment Holdings

The following tables detail the Company's investment in securities as of December 31, 2020 and 2019.

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Current Principal		Unamortized Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon(1)		Yield		Life (Years)(2)
Long:
Agency RMBS:
15-year fixed-rate mortgages	$	67,875	$	2,543	$	70,418	$	1,832	$	(36)	$	72,214	3.30	%	1.83	%	3.24
20-year fixed-rate mortgages	50,131		3,097		53,228		182		—		53,410		2.57	%	1.08	%	4.46
30-year fixed-rate mortgages	626,021		30,738		656,759		25,765		(444)		682,080		3.99	%	2.35	%	4.17
Adjustable rate mortgages	6,171		159		6,330		124		—		6,454		3.66	%	2.27	%	3.42
Reverse mortgages	89,383		5,152		94,535		3,123		(29)		97,629		3.97	%	2.37	%	4.60
Interest only securities	n/a		n/a		43,406		5,808		(1,558)		47,656		3.36	%	10.01	%	4.85
Non-Agency RMBS	321,842		(131,083)		190,759		15,880		(5,549)		201,090		3.15	%	6.40	%	5.46
CMBS	188,085		(61,763)		126,322		1,655		(16,910)		111,067		2.71	%	7.47	%	8.09
Non-Agency interest only securities	n/a		n/a		8,123		1,792		(305)		9,610		1.17	%	18.85	%	3.49
CLOs	n/a		n/a		208,907		2,563		(30,199)		181,271		3.67	%	8.50	%	3.50
ABS backed by consumer loans	69,646		(24,936)		44,710		221		(6)		44,925		11.95	%	18.57	%	1.11
Corporate debt	27,083		(23,187)		3,896		1,296		(3)		5,189		2.13	%	6.75	%	3.10
Corporate equity	n/a		n/a		1,604		376		(390)		1,590		n/a		n/a		n/a
Total Long	1,446,237		(199,280)		1,508,997		60,617		(55,429)		1,514,185		3.84	%	4.88	%	4.45
Short:
Corporate debt	(200)		(1)		(201)		—		(17)		(218)		5.09	%	4.67	%	6.42
European sovereign bonds	(37,804)		3,163		(34,641)		—		(3,783)		(38,424)		0.23	%	0.06	%	3.11
Total Short	(38,004)		3,162		(34,842)		—		(3,800)		(38,642)		0.26	%	0.09	%	3.13
Total	$	1,408,233	$	(196,118)	$	1,474,155	$	60,617	$	(59,229)	$	1,475,543	3.92	%	4.77	%	4.49

(1)Weighted average coupon represents the weighted average coupons of the securities, rather than, in the case of collateralized securities, the coupon rates or loan rates on the underlying collateral.

(2)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Current Principal		Unamortized Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon(1)		Yield		Life (Years)(2)
Long:
Agency RMBS:
15-year fixed-rate mortgages	$	314,636	$	6,369	$	321,005	$	2,604	$	(203)	$	323,406	3.05	%	2.28	%	3.05
20-year fixed-rate mortgages	804		49		853		24		—		877		4.62	%	2.99	%	4.80
30-year fixed-rate mortgages	1,358,762		64,846		1,423,608		13,821		(2,830)		1,434,599		4.20	%	2.95	%	6.63
Adjustable rate mortgages	9,651		315		9,966		90		(54)		10,002		3.99	%	2.03	%	4.09
Reverse mortgages	122,670		8,133		130,803		2,023		(26)		132,800		4.43	%	2.78	%	6.67
Interest only securities	n/a		n/a		34,044		1,624		(389)		35,279		2.81	%	9.27	%	3.86
Non-Agency RMBS	274,353		(122,685)		151,668		12,549		(1,081)		163,136		3.41	%	7.25	%	5.31
CMBS	185,417		(67,961)		117,456		2,990		(480)		119,966		3.31	%	6.62	%	8.94
Non-Agency interest only securities	n/a		n/a		6,517		1,817		(18)		8,316		1.10	%	8.18	%	4.14
CLOs	n/a		n/a		169,238		4,219		(3,014)		170,443		5.05	%	9.62	%	4.75
ABS backed by consumer loans	67,080		(19,154)		47,926		1,596		(912)		48,610		12.17	%	14.00	%	1.22
Corporate debt	22,125		(21,241)		884		229		—		1,113		—	%	—	%	0.33
Corporate equity	n/a		n/a		1,242		152		—		1,394		n/a		n/a		n/a
Total Long	2,355,498		(151,329)		2,415,210		43,738		(9,007)		2,449,941		4.15	%	4.09	%	5.88
Short:
Corporate debt	(450)		(6)		(456)		—		(15)		(471)		5.44	%	5.21	%	4.90
U.S. Treasury securities	(63,140)		381		(62,759)		63		(298)		(62,994)		1.76	%	1.87	%	6.11
European sovereign bonds	(9,759)		133		(9,626)		—		(318)		(9,944)		0.77	%	0.12	%	1.58
Total Short	(73,349)		508		(72,841)		63		(631)		(73,409)		1.65	%	1.66	%	5.49
Total	$	2,282,149	$	(150,821)	$	2,342,369	$	43,801	$	(9,638)	$	2,376,532	4.23	%	4.01	%	5.90

(1)Weighted average coupon represents the weighted average coupons of the securities, rather than, in the case of collateralized securities, the coupon rates or loan rates on the underlying collateral.

(2)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

Securities by Weighted Average Life

The following tables detail weighted average life of the Company's Agency RMBS as of December 31, 2020 and 2019.

December 31, 2020:

($ in thousands)	Agency RMBS						Agency Interest Only Securities
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(2)		Fair Value		Amortized Cost		Weighted Average Coupon(2)
Less than three years	$	139,059	$	135,844	4.15	%	$	8,143	$	7,314	3.99	%
Greater than three years and less than seven years	770,173		742,946		3.79	%	32,669		29,362		3.74	%
Greater than seven years and less than eleven years	2,555		2,480		3.01	%	5,165		5,063		1.04	%
Greater than eleven years	—		—		—	%	1,679		1,667		0.83	%
Total	$	911,787	$	881,270	3.84	%	$	47,656	$	43,406	3.36	%

(1)Expected average lives of RMBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

December 31, 2019:

($ in thousands)	Agency RMBS						Agency Interest Only Securities
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(2)		Fair Value		Amortized Cost		Weighted Average Coupon(2)
Less than three years	$	188,593	$	187,099	3.39	%	$	9,011	$	8,611	3.35	%
Greater than three years and less than seven years	961,839		953,031		4.25	%	25,334		24,512		2.66	%
Greater than seven years and less than eleven years	713,862		708,805		3.89	%	934		921		1.90	%
Greater than eleven years	37,390		37,300		3.51	%	—		—		—	%
Total	$	1,901,684	$	1,886,235	4.02	%	$	35,279	$	34,044	2.81	%

(1)Expected average lives of RMBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

The following tables detail weighted average life of the Company's long non-Agency RMBS, CMBS, and CLOs and other securities as of December 31, 2020 and 2019.

December 31, 2020:

($ in thousands)	Non-Agency RMBS and CMBS						Non-Agency IOs						CLOs and Other Securities(2)
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)
Less than three years	$	58,350	$	54,339	3.39	%	$	5,163	$	3,754	0.92	%	$	89,235	$	90,869	7.73	%
Greater than three years and less than seven years	114,815		109,161		3.45	%	4,447		4,369		1.37	%	139,830		163,670		3.69	%
Greater than seven years and less than eleven years	109,519		123,782		2.74	%	—		—		—	%	2,320		2,974		1.14	%
Greater than eleven years	29,473		29,799		1.46	%	—		—		—	%	—		—		—	%
Total	$	312,157	$	317,081	2.98	%	$	9,610	$	8,123	1.17	%	$	231,385	$	257,513	5.09	%

(1)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Other Securities includes asset-backed securities, backed by consumer loans and corporate debt.

(3)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

December 31, 2019:

($ in thousands)	Non-Agency RMBS and CMBS						Non-Agency IOs						CLOs and Other Securities(2)
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)
Less than three years	$	50,120	$	48,213	2.73	%	$	439	$	401	1.37	%	$	54,446	$	54,090	11.11	%
Greater than three years and less than seven years	87,436		79,326		4.42	%	7,877		6,116		1.08	%	157,384		155,651		5.38	%
Greater than seven years and less than eleven years	127,533		123,924		3.31	%	—		—		—	%	8,336		8,307		—	%
Greater than eleven years	18,013		17,661		0.81	%	—		—		—	%	—		—		—	%
Total	$	283,102	$	269,124	3.37	%	$	8,316	$	6,517	1.10	%	$	220,166	$	218,048	6.60	%

(1)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Other Securities includes asset-backed securities, backed by consumer loans, corporate debt, and U.S. Treasury securities.

(3)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

Investment Income

The following tables detail the components of interest income by security type for the years ended December 31, 2020 and 2019:

	Year Ended
(In thousands)	December 31, 2020						December 31, 2019
Security Type	Coupon Interest		Net Amortization		Interest Income		Coupon Interest		Net Amortization		Interest Income
Agency RMBS	$	59,987	$	(31,975)	$	28,012	$	62,103	$	(24,731)	$	37,372
Non-Agency RMBS and CMBS	15,257		5,775		21,032		13,855		2,782		16,637
CLOs	14,103		3,529		17,632		15,857		(1,599)		14,258
Other securities(1)	11,545		(4,986)		6,559		7,157		(2,468)		4,689
Total	$	100,892	$	(27,657)	$	73,235	$	98,972	$	(26,016)	$	72,956

(1)Other securities includes ABS backed by consumer loans, corporate debt securities, and U.S. Treasury securities.

Schedule of Realized Gain (Loss)

The following tables present proceeds from sales and the resulting realized gains and (losses) of the Company's securities for the years ended December 31, 2020 and 2019.

	Year Ended
(In thousands)	December 31, 2020								December 31, 2019(1)
Security Type	Proceeds(2)		Gross Realized Gains		Gross Realized Losses(3)		Net Realized Gain (Loss)		Proceeds(2)		Gross Realized Gains		Gross Realized Losses(3)		Net Realized Gain (Loss)
Agency RMBS	$	1,439,413	$	16,260	$	(3,481)	$	12,779	$	1,010,251	$	9,006	$	(2,254)	$	6,752
Non-Agency RMBS and CMBS	145,323		13,692		(4,187)		9,505		184,725		12,552		(4,869)		7,683
CLOs	46,632		1,122		(4,251)		(3,129)		62,063		1,286		(816)		470
Other securities(4)	188,152		1,662		(9)		1,653		636,886		1,113		2		1,115
Total	$	1,819,520	$	32,736	$	(11,928)	$	20,808	$	1,893,925	$	23,957	$	(7,937)	$	16,020

(1)Conformed to current period presentation.

(2)Includes proceeds on sales of securities not yet settled as of period end.

(3)Excludes realized losses of $(17.7) million and $(28.7) million, for the years ended December 31, 2020 and 2019, respectively, related to adjustments to the cost basis of certain securities for which the Company has determined all or a portion of such securities cost basis to be uncollectible.

(4)Other securities includes ABS backed by consumer loans, corporate debt and equity, exchange-traded equity, and U.S. Treasury securities.

Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value

The following table presents the fair value and gross unrealized losses of our long securities, excluding those where there are expected credit losses as of the balance sheet date in relation to such securities' cost bases, by length of time that such securities have been in an unrealized loss position at December 31, 2020.

December 31, 2020:

(In thousands)	Less than 12 Months				Greater than 12 Months				Total
Security Type	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Agency RMBS	$	126,926	$	(981)	$	832	$	(44)	$	127,758	$	(1,025)
Non-Agency RMBS and CMBS	20,474		(2,616)		2,599		(348)		23,073		(2,964)
CLOs	5,279		(753)		1,196		(1,131)		6,475		(1,884)
Other securities(1)	1,107		(8)		—		—		1,107		(8)
Total	$	153,786	$	(4,358)	$	4,627	$	(1,523)	$	158,413	$	(5,881)

(1)Other securities includes ABS backed by consumer loans and corporate debt and equity securities.

The following table presents the fair value and gross unrealized losses of our long securities by length of time that such securities have been in an unrealized loss position at December 31, 2019.

December 31, 2019:

(In thousands)	Less than 12 Months				Greater than 12 Months				Total
Security Type	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Agency RMBS	$	328,968	$	(1,503)	$	125,095	$	(1,999)	$	454,063	$	(3,502)
Non-Agency RMBS and CMBS	88,495		(880)		27,218		(699)		115,713		(1,579)
CLOs	37,354		(1,911)		9,245		(1,103)		46,599		(3,014)
Other securities(1)	16,562		(852)		1,380		(60)		17,942		(912)
Total	$	471,379	$	(5,146)	$	162,938	$	(3,861)	$	634,317	$	(9,007)

(1)Other securities includes ABS backed by consumer loans, corporate debt and equity, and U.S. Treasury securities.

XML

Investment in Loans (Tables)

12 Months Ended

Dec. 31, 2020

Receivables [Abstract]

Summary of Investments in Loans

The following table is a summary of the Company's investments in loans as of December 31, 2020 and 2019:

	As of
(In thousands)	December 31, 2020				December 31, 2019
Loan Type	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
Residential mortgage loans	$	1,150,303	$	1,187,069	$	911,705	$	932,203
Commercial mortgage loans	212,716		213,031		277,870		274,759
Consumer loans	48,180		47,525		179,743		186,954
Corporate loans	5,855		5,855		18,415		18,510
Total	$	1,417,054	$	1,453,480	$	1,387,733	$	1,412,426

The tables below detail certain information regarding the Company's residential mortgage loans as of December 31, 2020 and 2019.

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield		Life (Years)(1)
Residential mortgage loans, held-for-investment(2)	$	1,150,303	$	14,263	$	1,164,566	$	27,892	$	(5,389)	$	1,187,069	6.19	%	5.60	%	1.90

(1)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

(2)Includes $801.3 million of non-QM loans that have been securitized and are held in consolidated securitization trusts. Such loans had $24.8 million and $(0.1) million of gross unrealized gains and gross unrealized losses, respectively; such unrealized gains (losses) are included on the Company's Consolidated Statement of Operations in Unrealized gains (losses) on securities and loans, net. See Residential Mortgage Loan Securitizations in Note 10 for additional information.

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield		Life (Years)(1)
Residential mortgage loans, held-for-investment(2)	$	911,705	$	9,354	$	921,059	$	13,082	$	(1,938)	$	932,203	6.44	%	5.79	%	1.90

(1)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

(2)Includes $628.4 million of non-QM loans that have been securitized and are held in consolidated securitization trusts. Such loans had $11.3 million and $(0.1) million of gross unrealized gains and gross unrealized losses, respectively; such unrealized gains (losses) are included on the Company's Consolidated Statement of Operations in Unrealized gains (losses) on securities and loans, net. See Residential Mortgage Loan Securitizations in Note 10 for additional information.

The tables below detail certain information regarding the Company's commercial mortgage loans as of December 31, 2020 and 2019:

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield(1)		Life (Years)(2)
Commercial mortgage loans, held-for-investment	$	212,716	$	290	$	213,006	$	479	$	(454)	$	213,031	8.38	%	8.28	%	0.62

(1)Excludes non-performing commercial mortgage loans, in non-accrual status, with a fair value of $31.5 million.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield(1)		Life (Years)(2)
Commercial mortgage loans, held-for-investment	$	277,870	$	(3,302)	$	274,568	$	253	$	(62)	$	274,759	7.65	%	8.58	%	1.07

(1)Excludes commercial mortgage loans, held at par in non-accrual status, with a fair value of $10.7 million.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

The tables below detail certain information regarding the Company's consumer loans as of December 31, 2020 and 2019:

December 31, 2020:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value(1)		Life (Years)(2)	Delinquency (Days)
Consumer loans, held-for-investment	$	48,180	$	72	$	48,252	$	1,160	$	(1,887)	$	47,525	1.04	7

(1)Includes $0.6 million of charged-off loans for which the Company has determined that it is probable the servicer will be able to collect principal and interest.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

December 31, 2019:

							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value(1)		Life (Years)(2)	Delinquency (Days)
Consumer loans, held-for-investment	$	179,743	$	5,027	$	184,770	$	2,561	$	(377)	$	186,954	0.82	4

(1)Includes $0.6 million of charged-off loans for which the Company has determined that it is probable the servicer will be able to collect principal and interest.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

The tables below detail certain information regarding the Company's corporate loans as of December 31, 2020 and 2019:

December 31, 2020:

					Weighted Average
($ in thousands)	Unpaid Principal Balance		Fair Value		Rate		Remaining Term (Years)
Corporate loans, held-for-investment(1)	$	5,855	$	5,855	20.00	%	1.75

(1)See Note 21 for further details on the Company's unfunded commitments related to certain of its corporate loans.

December 31, 2019:

					Weighted Average
($ in thousands)	Unpaid Principal Balance		Fair Value		Rate		Remaining Term (Years)
Corporate loans, held-for-investment(1)(2)	$	18,415	$	18,510	17.62	%	0.87

(1)See Note 13 for further details on the Company's transactions involving a loan originator in which the Company also holds an equity investment.

(2)See Note 21 for further details on the Company's unfunded commitments related to certain of its corporate loans.

Financing Receivable, Past Due [Table Text Block]

The following table provides details, by accrual status, for loans that are 90 days or more past due as of December 31, 2020 and 2019:

	As of
	December 31, 2020				December 31, 2019
(In thousands)	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
90 days or more past due—non-accrual status
Residential mortgage loans	$	64,509	$	60,381	$	22,092	$	19,401
Commercial mortgage loans	44,233		44,052		28,936		26,545
Consumer loans	1,015		930		5,633		5,225

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

The table below summarizes the geographic distribution of the real estate collateral underlying the Company's residential mortgage loans as a percentage of total outstanding unpaid principal balance as of December 31, 2020 and 2019:

Property Location by U.S. State	December 31, 2020		December 31, 2019
California	43.1	%	46.6	%
Florida	14.8	%	11.9	%
Texas	10.2	%	11.9	%
Colorado	3.1	%	3.2	%
Massachusetts	2.6	%	2.9	%
Oregon	2.2	%	2.2	%
Arizona	2.0	%	2.4	%
Nevada	1.9	%	1.6	%
Illinois	1.8	%	1.7	%
Utah	1.7	%	1.9	%
New York	1.6	%	1.3	%
Washington	1.4	%	1.6	%
New Jersey	1.4	%	1.1	%
Georgia	1.3	%	0.7	%
North Carolina	1.1	%	0.8	%
Maryland	1.0	%	1.1	%
Other	8.8	%	7.1	%
	100.0	%	100.0	%

The table below summarizes the geographic distribution of the real estate collateral underlying the Company's commercial mortgage loans as a percentage of total outstanding unpaid principal balance as of December 31, 2020 and 2019:

Property Location by U.S. State	December 31, 2020		December 31, 2019
Florida	23.8	%	31.7	%
New York	15.2	%	17.7	%
Connecticut	11.2	%	8.2	%
Missouri	7.9	%	4.6	%
Ohio	7.3	%	—	%
California	5.9	%	—	%
Massachusetts	6.1	%	4.7	%
New Jersey	5.8	%	13.3	%
Arizona	4.3	%	3.8	%
Virginia	4.2	%	6.8	%
Indiana	2.8	%	2.1	%
North Carolina	2.2	%	1.8	%
Nevada	1.9	%	1.5	%
Tennessee	—	%	1.5	%
Illinois	1.4	%	1.2	%
Other	—	%	1.1	%
	100.0	%	100.0	%

The following table summarizes the Company's exposure to counterparty risk as of December 31, 2020 and 2019.

December 31, 2020:

	Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)
	(In thousands)
Cash and cash equivalents	$	111,647	8	40.1	%
Collateral on repurchase agreements held by dealers(2)	1,860,059		24	15.3	%
Due from brokers	63,147		22	28.9	%
Receivable for securities sold(3)	1,416		2	94.5	%

(1)Each counterparty is a large creditworthy financial institution.

(2)Includes securities, loans, and REO as well as cash posted as collateral for repurchase agreements.

(3)Included in Investment related receivables on the Consolidated Balance Sheet.

December 31, 2019:

	Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)
	(In thousands)
Cash and cash equivalents	$	72,302	11	42.2	%
Collateral on repurchase agreements held by dealers(2)	2,793,696		28	13.8	%
Due from brokers	79,829		24	30.9	%
Receivable for securities sold(3)	69,995		5	62.3	%

(1)Each counterparty is a large creditworthy financial institution.

(2)Includes securities, loans, and REO as well as cash posted as collateral for repurchase agreements.

(3)Included in Investment related receivables on the Consolidated Balance Sheet.

Financing Receivable Credit Quality Indicators [Table Text Block]

The following table presents information on the Company's residential mortgage loans by re-performing or non-performing status, as of December 31, 2020 and 2019.

	As of
	December 31, 2020				December 31, 2019
(In thousands)	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
Re-performing	$	18,120	$	16,741	$	27,663	$	25,323
Non-performing	62,009		58,169		17,757		15,580

Consumer Loans, Delinquency Status [Table Text Block]

The table below provides details on the delinquency status as a percentage of total unpaid principal balance of the Company's consumer loans, which the Company uses as an indicator of credit quality, as of December 31, 2020 and 2019:

Days Past Due	December 31, 2020		December 31, 2019
Current	90.4	%	95.3	%
30-59 Days	3.4	%	2.1	%
60-89 Days	3.3	%	1.4	%
90-119 Days	2.8	%	1.2	%
>120 Days	0.1	%	—	%
	100.0	%	100.0	%

XML

Investments in Unconsolidated Entities (Tables)

12 Months Ended

Dec. 31, 2020

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Investments in Unconsolidated Entities

The following table provides details about the Company's investments in unconsolidated entities as of December 31, 2020 and 2019:

		Percentage Ownership of Unconsolidated Entity
Investment in Unconsolidated Entity	Form of Investment	December 31, 2020	December 31, 2019
Longbridge Financial, LLC(1)	Preferred shares	49.7%	49.7%
LendSure Mortgage Corp.(1)(2)	Common shares	49.9%	49.9%
Elizon TCG SBC 2017-1(1)	Membership Interest	36.0%	—%
Jepson Holdings Limited(1)	Membership Interest	30.1%	30.1%
Elizon DB 2015-1 LLC(1)(3)(4)	Membership Interest	8.9%	3.5%
Elizon AFG 2018-1 LLC(1)(3)(5)	Membership Interest	—%	13.4%
Other(6)(7)	Various	7.4%–56.3%	7.7%–51.0%

(1)See Note 13 for additional details on the Company's related party transactions.

(2)Excludes investment in warrants convertible into non-voting common shares; including such warrants the Company's additional non-voting stake in the entity was 15.0% as of December 31, 2020. See Note 13 Related Party Transactions—Transactions Involving Certain Loan Originators for additional information.

(3)The Company has evaluated this entity and determined that it meets the definition of a VIE. The Company evaluated its interest in the VIE and determined that the Company does not have the power to direct the activities of the VIE and does not have control of the underlying assets, where applicable. As a result, the Company determined that it is not the primary beneficiary of this VIE and therefore has not consolidated the VIE.

(4)As discussed in Note 13 Related Party Transactions—Participation in Multi-Borrower Financing Facilities, the Company and the Affiliated Entities (as defined in Note 13) each consolidate their segregated silos of the Joint Entity (as defined in Note 13). The Company's effective percentage ownership before the effects of consolidation of both its and the Affiliated Entities' respective segregated silos of the Joint Entity, was 58.2% and 70.4% as of December 31, 2020 and 2019, respectively.

(5)As discussed in Note 13 Related Party Transactions—Participation in Multi-Borrower Financing Facilities, the Company and the Affiliated Entities each consolidate their segregated silos of the Joint Entity. The Company's effective percentage ownership before the effects of consolidation of both its and the Affiliated Entities' respective segregated silos of the Joint Entity, was 48.7% as of December 31, 2019.

(6)Includes interest in Consumer Risk Retention Vehicle, as defined in Note 10—Participation in Multi-Seller Consumer Loan Securitization. The Company has evaluated this entity and determined that it does not meet the definition of a VIE. The Company evaluated its interest in the entity under the voting interest model outlined in ASC 810, and has determined that the Company does not control this entity. As a result, the Company has not consolidated the entity. See Note 10 for additional details on the Company's securitization transactions.

(7)Includes interest in warehouse facilities; see Note 13—Participation in CLO Transactions, for additional details.

The following table provides a summary of the combined financial position of the unconsolidated entities as of December 31, 2020 and 2019, in which the Company has an investment:

	December 31, 2020		December 31, 2019
	(In thousands)
Assets
Investments in securities, loans, MSRs, and REO(1)	$	424,475	$	560,949
Other assets	117,746		65,580
Total assets	$	542,221	$	626,529
Liabilities
Borrowings	$	215,792	$	387,910
Other liabilities	30,801		28,134
Total liabilities	246,593		416,044
Equity	295,628		210,485
Total liabilities and equity	$	542,221	$	626,529

(1)Includes investments carried as the lower of cost or fair value as well as investments where the unconsolidated entity has elected the FVO.

The following table provides a summary of the combined results of operations of the unconsolidated entities as of December 31, 2020 and 2019, in which the Company has an investment:

	Year Ended December 31, 2020		Year Ended December 31, 2019
			(In thousands)
Net Interest Income
Interest income	$	10,935	$	30,587
Interest expense	(9,243)		(13,316)
Total net interest income	1,692		17,271
Other Income (Loss)
Realized and unrealized gains (losses) on securities, loans, MSRs, and REO, net	44,362		40,901
Other, net	44,031		31,848
Total other income (loss)	88,393		72,749
Total expenses	65,492		58,018
Net income (loss) before income tax expense	24,593		32,002
Income tax expense (benefit)	776		979
Net Income (Loss)	$	23,817	$	31,023

XML

Real Estate Owned (Tables)

12 Months Ended

Dec. 31, 2020

Real Estate Owned, Disclosure of Detailed Components [Abstract]

Schedule of Real Estate Owned

The following tables detail activity in the Company's carrying value of REO for the years ended December 31, 2020 and 2019:

	Year Ended
	December 31, 2020			December 31, 2019
	Number of Properties	Carrying Value		Number of Properties	Carrying Value
		(In thousands)			(In thousands)
Beginning Balance (December 31, 2019 and January 1, 2019, respectively)	15	$	30,584	20	$	30,778
Transfers from mortgage loans	10	3,384		8	22,577
Capital expenditures and other adjustments to cost		191			240
Adjustments to record at the lower of cost or fair value		(1,053)			(1,002)
Disposals	(12)	(9,508)		(13)	(22,009)
Ending Balance (December 31, 2020 and 2019, respectively)	13	$	23,598	15	$	30,584

XML

To Be Announced RMBS (Tables)

12 Months Ended

Dec. 31, 2020

To Be Announced RMBS [Abstract]

To Be Announced RMBS

The below table details TBA assets, liabilities, and the respective related payables and receivables as of December 31, 2018:

(In thousands)	As of December 31, 2018
Assets:
TBA securities, at fair value (Current principal: $460,037)	$	474,860
Receivable for securities sold relating to unsettled TBA sales	766,574
Liabilities:
TBA securities sold short, at fair value (Current principal: -$753,697)	$	(772,964)
Payable for securities purchased relating to unsettled TBA purchases	(473,386)
Net short TBA securities, at fair value	(298,104)

XML

Financial Derivatives (Tables)

12 Months Ended

Dec. 31, 2020

Dec. 31, 2018

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments

The following table details the fair value of the Company's holdings of financial derivatives as of December 31, 2020 and 2019:

	December 31, 2020		December 31, 2019
(In thousands)
Financial derivatives–assets, at fair value:
TBA securities purchase contracts	$	961	$	90
TBA securities sale contracts	1		506
Fixed payer interest rate swaps	125		3,914
Fixed receiver interest rate swaps	8,394		1,554
Credit default swaps on asset-backed securities	347		993
Credit default swaps on asset-backed indices	2,184		3,319
Credit default swaps on corporate bonds	—		2
Credit default swaps on corporate bond indices	3,420		5,599
Total return swaps	9		620
Futures	2		148
Forwards	—		43
Warrants	36		—
Total financial derivatives–assets, at fair value	15,479		16,788
Financial derivatives–liabilities, at fair value:
TBA securities sale contracts	$	(925)	$	(1,012)
Fixed payer interest rate swaps	(15,109)		(8,513)
Fixed receiver interest rate swaps	(65)		(206)
Credit default swaps on asset-backed indices	(130)		(250)
Credit default swaps on corporate bonds	(747)		(1,693)
Credit default swaps on corporate bond indices	(6,438)		(14,524)
Total return swaps	(484)		(1,209)
Futures	(376)		(45)
Forwards	(279)		(169)
Total financial derivatives–liabilities, at fair value	(24,553)		(27,621)
Total	$	(9,074)	$	(10,833)

Schedule of Interest Rate Derivatives [Table Text Block]

The following tables provide information about the Company's fixed payer interest rate swaps as of December 31, 2020 and 2019:

December 31, 2020:

					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	17,500	$	(231)	2.75	%	0.24	%	0.22
2022	96,533		(1,535)		1.19		0.22		1.14
2023	146,012		(4,770)		1.50		0.23		2.42
2025	66,503		(1,034)		0.73		0.21		4.75
2026	11,216		(458)		1.23		0.25		5.50
2027	9,732		60		0.49		0.24		6.48
2028	16,644		(2,169)		2.39		0.24		7.32
2029	22,744		(2,289)		1.94		0.23		8.61
2030	13,015		(369)		1.13		0.22		9.29
2035	500		15		0.78		0.09		14.81
2036	1,100		(47)		1.45		0.25		15.13
2040	500		20		0.90		0.09		19.82
2049	5,796		(2,208)		2.89		0.23		28.02
2050	500		31		0.98		0.09		29.82
Total	$	408,295	$	(14,984)	1.39	%	0.23	%	3.82

December 31, 2019:

					Weighted Average
Maturity	Notional Amount(1)		Fair Value(1)		Pay Rate(2)(3)		Receive Rate(2)		Remaining Years to Maturity(4)
	(In thousands)
2020	$	68,607	$	(234)	1.74	%	1.93	%	0.24
2021	268,929		(419)		1.73		1.95		1.64
2022	31,350		9		1.65		1.93		2.14
2023	101,012		(1,265)		2.06		1.91		3.29
2024	13,000		99		1.56		1.89		4.90
2025	12,800		(24)		n/a		n/a		5.22
2026	59,902		1,946		1.24		1.94		6.50
2028	32,942		(1,634)		2.40		1.93		8.34
2029	136,838		(2,018)		2.02		1.96		9.61
2030	685		(32)		2.38		1.90		10.90
2036	1,100		87		1.45		1.94		16.14
2049	5,796		(1,114)		2.89		2.09		29.03
Total	$	732,961	$	(4,599)	1.83	%	1.94	%	4.31

(1)Includes forward-starting interest rate swaps with a notional amount of $20.9 million and fair value of $(41) thousand.

(2)Excludes forward-starting interest rate swaps.

(3)Including forward-starting interest rate swaps the total weighted average pay rate was 1.83%.

(4)Includes forward-starting interest rate swaps, all of which start within six months of period end.

The following tables provide information about the Company's fixed receiver interest rate swaps as of December 31, 2020 and 2019:

December 31, 2020:

					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	12,950	$	205	0.24	%	1.75	%	0.71
2022	103,974		1,413		0.22		1.07		1.48
2023	48,657		2,209		0.24		2.00		2.26
2024	86,342		4,567		0.22		1.65		3.73
2035	500		(14)		0.09		0.74		14.81
2040	500		(20)		0.09		0.84		19.82
2050	500		(31)		0.09		0.90		29.82
Total	$	253,423	$	8,329	0.22	%	1.48	%	2.48

December 31, 2019:

					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	181,950	$	(49)	1.89	%	1.67	%	1.84
2022	53,974		441		1.91		1.85		2.17
2023	48,657		709		1.92		2.00		3.26
2024	11,342		306		2.09		2.33		4.23
2029	9,800		(59)		1.91		1.78		9.77
Total	$	305,723	$	1,348	1.91	%	1.78	%	2.47

Schedule of Credit Default Swaps [Table Text Block]

The following table provides information about the Company's credit default swaps as of December 31, 2020 and 2019:

	As of
	December 31, 2020					December 31, 2019
Type(1)	Notional		Fair Value		Weighted Average Remaining Term (Years)	Notional		Fair Value		Weighted Average Remaining Term (Years)
($ in thousands)
Asset:
Long:
Credit default swaps on asset-backed indices	$	395	$	5	16.99	$	695	$	10	23.80
Credit default swaps on corporate bonds	—		—		—	430		2		0.47
Credit default swaps on corporate bond indices	67,779		3,296		2.52	130,707		5,547		2.42
Short:
Credit default swaps on asset-backed securities	(957)		347		14.70	(2,640)		993		15.63
Credit default swaps on asset-backed indices	(12,888)		2,179		39.61	(63,515)		3,309		38.40
Credit default swaps on corporate bond indices	(2,173)		124		2.97	(1,997)		52		3.97
Liability:
Long:
Credit default swaps on asset-backed indices	479		(130)		32.36	344		(145)		29.35
Short:
Credit default swaps on asset-backed indices	(1)		—		29.00	(4,501)		(105)		40.31
Credit default swaps on corporate bonds	(8,400)		(747)		4.17	(10,800)		(1,693)		3.92
Credit default swaps on corporate bond indices	(110,624)		(6,438)		2.78	(250,088)		(14,524)		2.51
	$	(66,390)	$	(1,364)	10.25	$	(201,365)	$	(6,554)	14.88

(1)Long notional represents contracts where the Company has written protection and short notional represents contracts where the Company has purchased protection.

Schedule of Futures Contracts [Table Text Block]

The following table provides information about the Company's long and short positions in futures as of December 31, 2020 and 2019:

	As of
	December 31, 2020					December 31, 2019
Description	Notional Amount		Fair Value		Remaining Months to Expiration	Notional Amount		Fair Value		Remaining Months to Expiration
	(In thousands)					(In thousands)
Assets:
Short Contracts:
U.S. Treasury futures	$	(300)	$	2	2.70	$	—	$	—	—
Liabilities:
Long Contracts:
U.S. Treasury futures	1,900		(9)		2.70	—		—		—
Short Contracts:
U.S. Treasury futures	(178,200)		(367)		2.94	(16,000)		148		2.77
Eurodollar futures	—		—		—	(14,000)		(45)		4.05
Total, net	$	(176,600)	$	(374)	2.94	$	(30,000)	$	103	3.37

Schedule of Derivative Warrant Contracts [Table Text Block]

Warrants

The following table provides information about the Company's warrants contracts to purchase shares as of December 31, 2020 and 2019:

	December 31, 2020				As of December, 31, 2019
Description	Number of Shares Underlying Warrant	Fair Value		Remaining Years to Expiration	Number of Shares Underlying Warrant	Fair Value		Remaining Years to Expiration
	(In thousands)				(In thousands)
Warrants	1,897	$	36	2.40	1,515	$	—	2.82

Schedule of TBA securities [Table Text Block]

As of December 31, 2020 and 2019, the Company had outstanding TBA purchase and sale contracts as follows:

	December 31, 2020								December 31, 2019
TBA Securities	Notional Amount(1)		Cost Basis(2)		Market Value(3)		Net Carrying Value(4)		Notional Amount(1)		Cost Basis(2)		Market Value(3)		Net Carrying Value(4)
(In thousands)
Purchase contracts:
Assets	$	149,990	$	155,008	$	155,969	$	961	$	40,100	$	40,585	$	40,675	$	90
Liabilities	—		—		—		—		—		—		—		—
	149,990		155,008		155,969		961		40,100		40,585		40,675		90
Sale contracts:
Assets	(4,400)		(4,765)		(4,764)		1		(319,981)		(332,080)		(331,574)		506
Liabilities	(499,667)		(531,034)		(531,959)		(925)		(773,749)		(806,568)		(807,580)		(1,012)
	(504,067)		(535,799)		(536,723)		(924)		(1,093,730)		(1,138,648)		(1,139,154)		(506)
Total TBA securities, net	$	(354,077)	$	(380,791)	$	(380,754)	$	37	$	(1,053,630)	$	(1,098,063)	$	(1,098,479)	$	(416)

(1)Notional amount represents the principal balance of the underlying Agency RMBS.

(2)Cost basis represents the forward price to be paid (received) for the underlying Agency RMBS.

(3)Market value represents the current market value of the underlying Agency RMBS (on a forward delivery basis) as of period end.

(4)Net carrying value represents the difference between the market value of the TBA contract as of period end and the cost basis, and is reported in Financial derivatives-assets, at fair value and Financial derivatives-liabilities, at fair value on the Consolidated Balance Sheet.

Schedule of Gains and Losses on Derivative Contracts

Gains and losses on the Company's derivative contracts for the years ended December 31, 2020 and 2019 are summarized in the tables below:

Year Ended December 31, 2020:

Derivative Type	Primary  Risk Exposure	Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps		Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)		Net Realized Gains (Losses) on Financial Derivatives(1)		Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps		Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)		Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)
(In thousands)
Interest rate swaps	Interest Rate	$	(2,038)	$	(17,060)	$	(19,098)	$	219	$	(6,597)	$	(6,378)
Credit default swaps on asset-backed securities	Credit			(5,452)		(5,452)				5,402		5,402
Credit default swaps on asset-backed indices	Credit			6,486		6,486				2,691		2,691
Credit default swaps on corporate bond indices	Credit			1,502		1,502				(712)		(712)
Credit default swaps on corporate bonds	Credit			285		285				486		486
Total return swaps	Credit			(2,057)		(2,057)				114		114
TBAs	Interest Rate			(4,624)		(4,624)				454		454
Futures	Interest Rate			(7,447)		(7,447)				(477)		(477)
Forwards	Currency			(1,004)		(1,004)				(153)		(153)
Warrants	Equity Market/Credit			—		—				(377)		(377)
Options	Credit			(100)		(100)				—		—
Total		$	(2,038)	$	(29,471)	$	(31,509)	$	219	$	831	$	1,050

(1)Includes realized gain/(loss) on transactions involving foreign-currency-denominated financial derivatives in the amount of $12 thousand for the year ended December 31, 2020, which is included on the Consolidated Statement of Operations in Other, net.

(2)Includes foreign currency remeasurement on financial derivatives in the amount of $61 thousand for the year ended December 31, 2020, which is included on the Consolidated Statement of Operations in Other, net.

Year Ended December 31, 2019:

Derivative Type	Primary  Risk Exposure	Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps		Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)		Net Realized Gains (Losses) on Financial Derivatives(1)		Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps		Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)		Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)
(In thousands)
Interest rate swaps	Interest Rate	$	1,695	$	(876)	$	819	$	(764)	$	(5,778)	$	(6,542)
Credit default swaps on asset-backed securities	Credit			528		528				(479)		(479)
Credit default swaps on asset-backed indices	Credit			(1,883)		(1,883)				(1,848)		(1,848)
Credit default swaps on corporate bond indices	Credit			(5,262)		(5,262)				(1,364)		(1,364)
Credit default swaps on corporate bonds	Credit			(708)		(708)				1,007		1,007
Total return swaps	Equity Market/Credit			(1,460)		(1,460)				(584)		(584)
TBAs	Interest Rate			(15,755)		(15,755)				4,026		4,026
Futures	Interest Rate/Currency			(7,924)		(7,924)				458		458
Forwards	Currency			813		813				(12)		(12)
Options	Interest Rate			(35)		(35)				1		1
Total		$	1,695	$	(32,562)	$	(30,867)	$	(764)	$	(4,573)	$	(5,337)

(1)Includes realized gain/(loss) on transactions involving foreign-currency-denominated financial derivatives in the amount of $45 thousand for the year ended December 31, 2019, which is included on the Consolidated Statement of Operations in Other, net.

(2)Includes foreign currency remeasurement on financial derivatives in the amount of $1 thousand for the year ended December 31, 2019, which is included on the Consolidated Statement of Operations in Other, net.

Gains and losses on the Company's derivative contracts for the year ended December 31, 2018 are summarized in the table below:

		Year Ended December 31, 2018
Derivative Type	Primary Risk Exposure	Net Realized Gain/(Loss)(1)		Change in Net Unrealized Gain/(Loss)(2)
(In thousands)
Credit default swaps on asset-backed securities	Credit	$	(687)	$	715
Credit default swaps on asset-backed indices	Credit	(2,293)		2,013
Credit default swaps on corporate bond indices	Credit	(1,983)		3,540
Credit default swaps on corporate bonds	Credit	2,993		(2,648)
Total return swaps	Equity Market/Credit	3,844		(5)
Interest rate swaps	Interest Rate	(985)		3,648
Futures	Interest Rate/Currency	162		108
Forwards	Currency	923		359
Options	Interest Rate/ Equity Market	(63)		77
Total		$	1,911	$	7,807

(1)Includes gain/(loss) on foreign currency transactions on derivatives in the amount of $0.1 million for the year ended December 31, 2018, which is included on the Consolidated Statement of Operations in Realized gain (loss) on foreign currency transactions.

(2)Includes foreign currency translation on derivatives in the amount of $0.1 million for the year ended December 31, 2018, which is included on the Consolidated Statement of Operations in Change in net unrealized gain (loss) on foreign currency translation.

Derivative activity, volume

The table below details the average notional values of the Company's financial derivatives, using absolute value of month end notional values, for the years ended December 31, 2020 and 2019:

Derivative Type	Year Ended December 31, 2020		Year Ended December 31, 2019
(In thousands)
Interest rate swaps	$	1,009,110	$	731,941
TBAs	713,634		973,331
Credit default swaps	277,990		399,316
Total return swaps	6,975		39,434
Futures	149,538		167,708
Options	1,500		19,825
Forwards	26,413		30,930
Warrants	1,570		2,222

The table below details the average notional values of the Company's financial derivatives, using absolute value of month end notional values, for the year ended December 31, 2018:

Derivative Type	Year Ended December 31, 2018
	(In thousands)
Interest rate swaps	$	1,059,756
Credit default swaps	566,805
Total return swaps	53,603
Futures	201,295
Options	99,891
Forwards	45,522

Schedule of Credit Derivatives

Written credit derivatives held by the Company at December 31, 2020 and 2019 are summarized below:

Credit Derivatives	December 31, 2020		December 31, 2019
(In thousands)
Fair Value of Written Credit Derivatives, Net	$	3,171	$	5,414
Fair Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties (1)	—		(3,248)
Notional Value of Written Credit Derivatives (2)	68,653		132,176
Notional Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties (1)	—		(81,637)

(1)Offsetting transactions with third parties include purchased credit derivatives which have the same reference obligation.

(2)The notional value is the maximum amount that a seller of credit protection would be obligated to pay, and a buyer of credit protection would receive, upon occurrence of a "credit event." Movements in the value of credit default swap transactions may require the Company or the counterparty to post or receive collateral. Amounts due or owed under credit derivative contracts with an International Swaps and Derivatives Association, or "ISDA," counterparty may be offset against amounts due or owed on other credit derivative contracts with the same ISDA counterparty. As a result, the notional value of written credit derivatives involving a particular underlying reference asset or index has been reduced (but not below zero) by the notional value of any contracts where the Company has purchased credit protection on the same reference asset or index with the same ISDA counterparty.

Written credit derivatives held by the Company at December 31, 2018 are summarized below:

Credit Derivatives	December 31, 2018
(In thousands)
Fair Value of Written Credit Derivatives, Net	$	(4,339)
Fair Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties(1)	(284)
Notional Value of Written Credit Derivatives (2)	98,586
Notional Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties (1)	(41,134)

(1)Offsetting transactions with third parties include purchased credit derivatives which have the same reference obligation.

(2)The notional value is the maximum amount that a seller of credit protection would be obligated to pay, and a buyer of credit protection would receive, upon occurrence of a "credit event." Movements in the value of credit default swap transactions may require the Company or the counterparty to post or receive collateral. Amounts due or owed under credit derivative contracts with an International Swaps and Derivatives Association, or "ISDA," counterparty may be offset against amounts due or owed on other credit derivative contracts with the same ISDA counterparty. As a result, the notional value of written credit derivatives involving a particular underlying reference asset or index has been reduced (but not below zero) by the notional value of any contracts where the Company has purchased credit protection on the same reference asset or index with the same ISDA counterparty.

XML

Consolidated VIEs (Tables)

12 Months Ended

Dec. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Consolidated VIEs

The following table summarizes the assets and liabilities of the Company's consolidated VIEs that are included on the Company's Consolidated Balance Sheet as of December 31, 2020 and 2019.

(In thousands)	December 31, 2020 (1)		December 31, 2019 (1)
Assets
Cash and cash equivalents	$	701	$	6,016
Restricted cash	175		175
Securities, at fair value	44,523		47,923
Loans, at fair value	1,435,067		1,393,916
Investments in unconsolidated entities, at fair value	6,345		5,641
Real estate owned	23,598		30,584
Investment related receivables	24,824		28,668
Other assets	2,001		6,191
Total Assets	$	1,537,234	$	1,519,114
Liabilities
Repurchase agreements	$	275,019	$	302,791
Investment related payables	—		3,275
Other secured borrowings	51,062		150,334
Other secured borrowings, at fair value	754,921		594,396
Interest payable	776		1,247
Accrued expenses and other liabilities	1,103		2,279
Total Liabilities	1,082,881		1,054,322
Total Stockholders' Equity	430,554		440,394
Non-controlling interests	23,799		24,400
Total Equity	454,353		464,794
Total Liabilities and Equity	$	1,537,234	$	1,519,116

(1)See Note 10 and Note 13 for additional information on the Company's consolidated VIEs.

XML

Securitization Transactions (Tables)

12 Months Ended

Dec. 31, 2020

Securitization Transactions [Abstract]

Securitization Transactions

The following table details the Company's investments in notes issued by the Ellington-sponsored CLO Securitizations:

CLO Issuer(1)	CLO Pricing Date	CLO Closing Date	Total Face Amount of Notes Issued		Face Amount of Notes Initially Purchased			Aggregate Purchase Price		Notes Held(2) as of
										December 31, 2018
($ in thousands)
CLO I Issuer(3)(4)	5/17	6/17	$	373,550	$	36,606	(5)	$	35,926	$	—
CLO I Issuer(4)	8/18	8/18	461,840		36,579		(5)	25,622		16,973		(6)
CLO II Issuer	12/17	1/18	452,800		18,223		(7)	16,621		14,721		(6)
CLO III Issuer	6/18	7/18	407,100		35,480		(7)	32,394		19,071		(8)

(1)

(1)The Company does not have the power to direct the activities of the CLO Issuers that most significantly impact their economic performance.

(2)Included on the Company's Consolidated Condensed Schedule of Investments in Collateralized Loan Obligations.

(3)Excludes the Company's equity investment in the CLO I Risk Retention Vehicle, as discussed above.

(4)In August 2018, the notes originally issued by the CLO I Issuer in 2017 were fully redeemed, and the CLO I Issuer simultaneously issued new notes in conjunction with this full redemption.

(5)The Company purchased secured and unsecured subordinated notes.

(6)Includes secured and unsecured subordinated notes.

(7)The Company purchased secured senior and secured and unsecured subordinated notes.

(8)Includes secured senior and secured and unsecured subordinated notes.

Schedule of Residential Loan Securitizations

The following table details the Company's outstanding consolidated residential mortgage loan securitizations:

Issuing Entity	Closing Date	Principal Balance of Loans Transferred to the Depositor		Total Face Amount of Certificates Issued
		(In thousands)
Ellington Financial Mortgage Trust 2019-1	6/19	$	226,913	$	226,913	(1)
Ellington Financial Mortgage Trust 2019-2	11/19	267,255		267,255		(2)
Ellington Financial Mortgage Trust 2020-1	6/20	259,273		259,273		(3)
Ellington Financial Mortgage Trust 2020-2	11/20	219,732		219,732		(4)

(1)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 6.1% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.2 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(2)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 6.4% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.7 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(3)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 8.0% of the fair value of all Certificates issued. Additionally, the Sponsor purchased another subordinated class of Certificates with an aggregate value equal to 3.5% of the fair value of all Certificates issued as of the settlement date. Finally, the Sponsor also purchased, for an aggregate purchase price of $1.9 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(4)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 7.6% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.4 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

The following table details the residential mortgage loan securitizations:

Issuing Entity	Closing Date	Principal Balance of Loans Transferred to the Depositor		Total Face Amount of Certificates Issued
		(In thousands)
Ellington Financial Mortgage Trust 2017-1	11/15/2017	$	141,233	$	141,233	(1)
Ellington Financial Mortgage Trust 2018-1	11/13/2018	232,518		232,518		(2)

(1)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value equal to 5.1% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $0.7 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(2)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value equal to 5.7% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.3 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

Schedule of Assets and Liabilities of Consolidated Securitization Trusts

The following table details the assets and liabilities of the consolidated securitization trusts included in the Company's Consolidated Balance Sheet as of December 31, 2020 and 2019:

(In thousands)	December 31, 2020		December 31, 2019
Assets:
Loans, at fair value	$	801,343	$	628,415
Real estate owned	—		658
Investment related receivables	15,544		10,409
Liabilities:
Other secured borrowings, at fair value	754,921		594,396

The following table details the assets and liabilities of the consolidated securitization trusts included in the Company's Consolidated Statement of Assets, Liabilities, and Equity as of December 31, 2018:

	As of
(In thousands)	December 31, 2018
Assets:
Investments, at fair value	$	314,202
Interest and dividends receivable	3,527
Liabilities:
Interest and dividends payable	103
Other secured borrowings, at fair value	297,948

Schedule of Repurchase Agreements [Table Text Block]

The following table details the Company's outstanding borrowings under repurchase agreements for Agency RMBS and credit assets (which can include non-Agency RMBS, CMBS, CLOs, consumer loans, corporate debt, residential mortgage loans, and commercial mortgage loans and REO), by remaining maturity as of December 31, 2020 and 2019:

	December 31, 2020					December 31, 2019
			Weighted Average					Weighted Average
Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity
Agency RMBS:	(In thousands)					(In thousands)
30 Days or Less	$	265,556	0.28	%	17	$	511,996	2.08	%	17
31-60 Days	385,141		0.25	%	44	744,387		1.93	%	47
61-90 Days	174,586		0.28	%	70	594,738		1.96	%	76
91-120 Days	—		—	%	—	10,270		2.24	%	93
121-150 Days	2,692		0.27	%	126	—		—	%	—
151-180 Days	59,857		0.32	%	162	3,082		2.67	%	171
181-360 Days	34,030		0.32	%	252	—		—	%	—
Total Agency RMBS	921,862		0.27	%	57	1,864,473		1.98	%	48
Credit:
30 Days or Less	37,795		2.11	%	17	16,549		3.38	%	25
31-60 Days	84,554		2.23	%	50	104,491		3.14	%	48
61-90 Days	152,426		2.11	%	75	138,837		3.03	%	73
91-120 Days	89,931		2.47	%	106	—		—	%	—
121-150 Days	66,412		4.75	%	125	7,460		3.89	%	123
151-180 Days	11,063		2.27	%	165	31,498		3.87	%	173
181-360 Days	38,640		2.90	%	289	186,661		3.80	%	250
> 360 Days	94,248		2.99	%	447	95,331		4.52	%	678
Total Credit Assets	575,069		2.69	%	155	580,827		3.61	%	229
Total	$	1,496,931	1.20	%	94	$	2,445,300	2.37	%	91

The following table details the Company's outstanding borrowings under reverse repurchase agreements for Agency RMBS, credit assets (which include non-Agency MBS, CLOs, consumer loans, corporate debt, residential mortgage loans, and commercial mortgage loans and REO), and U.S. Treasury securities, by remaining maturity as of December 31, 2018:

(In thousands)	December 31, 2018
			Weighted Average
Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity
Agency RMBS:
30 Days or Less	$	245,956	2.46	%	17
31-60 Days	415,379		2.58	%	46
61-90 Days	255,421		2.74	%	76
91-120 Days	506		3.31	%	91
Total Agency RMBS	917,262		2.59	%	47
Credit:
30 Days or Less	30,426		2.55	%	22
31-60 Days	189,937		3.32	%	48
61-90 Days	93,202		3.21	%	74
121-150 Days	26,222		4.60	%	123
151-180 Days	9,491		4.64	%	166
181-360 Days	91,730		4.54	%	316
> 360 Days	140,306		5.15	%	636
Total Credit Assets	581,314		3.98	%	240
U.S. Treasury Securities:
30 Days or Less	273		3.10	%	2
Total U.S. Treasury Securities	273		3.10	%	2
Total	$	1,498,849	3.13	%	122

XML

Borrowings (Tables)

12 Months Ended

Dec. 31, 2020

Debt Disclosure [Abstract]

Schedule of Repurchase Agreements [Table Text Block]

The following table details the Company's outstanding borrowings under repurchase agreements for Agency RMBS and credit assets (which can include non-Agency RMBS, CMBS, CLOs, consumer loans, corporate debt, residential mortgage loans, and commercial mortgage loans and REO), by remaining maturity as of December 31, 2020 and 2019:

	December 31, 2020					December 31, 2019
			Weighted Average					Weighted Average
Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity
Agency RMBS:	(In thousands)					(In thousands)
30 Days or Less	$	265,556	0.28	%	17	$	511,996	2.08	%	17
31-60 Days	385,141		0.25	%	44	744,387		1.93	%	47
61-90 Days	174,586		0.28	%	70	594,738		1.96	%	76
91-120 Days	—		—	%	—	10,270		2.24	%	93
121-150 Days	2,692		0.27	%	126	—		—	%	—
151-180 Days	59,857		0.32	%	162	3,082		2.67	%	171
181-360 Days	34,030		0.32	%	252	—		—	%	—
Total Agency RMBS	921,862		0.27	%	57	1,864,473		1.98	%	48
Credit:
30 Days or Less	37,795		2.11	%	17	16,549		3.38	%	25
31-60 Days	84,554		2.23	%	50	104,491		3.14	%	48
61-90 Days	152,426		2.11	%	75	138,837		3.03	%	73
91-120 Days	89,931		2.47	%	106	—		—	%	—
121-150 Days	66,412		4.75	%	125	7,460		3.89	%	123
151-180 Days	11,063		2.27	%	165	31,498		3.87	%	173
181-360 Days	38,640		2.90	%	289	186,661		3.80	%	250
> 360 Days	94,248		2.99	%	447	95,331		4.52	%	678
Total Credit Assets	575,069		2.69	%	155	580,827		3.61	%	229
Total	$	1,496,931	1.20	%	94	$	2,445,300	2.37	%	91

The following table details the Company's outstanding borrowings under reverse repurchase agreements for Agency RMBS, credit assets (which include non-Agency MBS, CLOs, consumer loans, corporate debt, residential mortgage loans, and commercial mortgage loans and REO), and U.S. Treasury securities, by remaining maturity as of December 31, 2018:

(In thousands)	December 31, 2018
			Weighted Average
Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity
Agency RMBS:
30 Days or Less	$	245,956	2.46	%	17
31-60 Days	415,379		2.58	%	46
61-90 Days	255,421		2.74	%	76
91-120 Days	506		3.31	%	91
Total Agency RMBS	917,262		2.59	%	47
Credit:
30 Days or Less	30,426		2.55	%	22
31-60 Days	189,937		3.32	%	48
61-90 Days	93,202		3.21	%	74
121-150 Days	26,222		4.60	%	123
151-180 Days	9,491		4.64	%	166
181-360 Days	91,730		4.54	%	316
> 360 Days	140,306		5.15	%	636
Total Credit Assets	581,314		3.98	%	240
U.S. Treasury Securities:
30 Days or Less	273		3.10	%	2
Total U.S. Treasury Securities	273		3.10	%	2
Total	$	1,498,849	3.13	%	122

Schedule of Maturities of Long-term Debt [Table Text Block]

Schedule of Principal Repayments

The following table details the Company's principal repayment schedule, over the next 5 years, for outstanding borrowings as of December 31, 2020:

Year	Repurchase Agreements(1)		Other Secured Borrowings(2)		Senior Notes(1)		Total
(In thousands)
Next Twelve Months	$	1,402,683	$	370,933	$	—	$	1,773,616
Year 2	94,248		236,976		86,000		417,224
Year 3	—		221,269		—		221,269
Year 4	—		—		—		—
Year 5	—		—		—		—
Total	$	1,496,931	$	829,178	$	86,000	$	2,412,109

(1)Reflects the Company's contractual principal repayment dates.

(2)Includes $778.1 million of expected principal repayments related to the Company's consolidated residential mortgage loan securitizations, which are projected based upon the underlying assets' expected repayments and may be prior to the stated contractual maturities.

The following table details the Company's principal repayment schedule for outstanding borrowings as of December 31, 2018:

Year	Reverse Repurchase Agreements(1)		Other Secured Borrowings(2)		Senior Notes(1)		Total
(In thousands)
2019	$	1,358,542	$	194,135	$	—	$	1,552,677
2020	78,530		205,198		—		283,728
2021	61,776		13,150		—		74,926
2022	—		—		86,000		86,000
2023	—		—		—		—
Total	$	1,498,848	$	412,483	$	86,000	$	1,997,331

(1)Reflects the Company's contractual principal repayment dates.

(2)Reflects the Company's expected principal repayment dates.

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2020

Income Tax Disclosure [Abstract]

Cash Dividends, Tax Characteristic

The following table details the tax characteristics of the Company's dividends declared on its shares of common and preferred stock for the years ended December 31, 2020 and 2019.

	Year Ended
Tax Characteristic	December 31, 2020		December 31, 2019
Ordinary income	58.2	%	85.0	%
Return of capital	37.9	%	9.4	%
Capital gains	3.9	%	5.6	%
	100.0	%	100.0	%

Schedule of Components of Income Tax Expense (Benefit)

The following table summarizes the Company's income tax provision for the years ended December 31, 2020 and 2019.

	As of
(In thousands)	December 31, 2020		December 31, 2019
Current income tax provision
Federal	$	38	$	185
State	602		293
Total current income tax provision, net	640		478
Deferred income tax provision
Federal	6,638		1,080
State	4,099		—
Total deferred income tax provision, net	10,737		1,080
Total income tax provision	$	11,377	$	1,558

Schedule of Deferred Tax Assets and Liabilities

The following table details the components of the Company's net deferred tax asset (liability) at December 31, 2020 and 2019.

	As of
(In thousands)	December 31, 2020		December 31, 2019
Deferred tax asset
Net operating loss available for carry-back and carry-forward	$	1,937	$	3,907
Basis difference for investments	1,481		669
Valuation allowance	—		(157)
Deferred tax asset	3,419		4,419
Deferred tax liability
Basis difference for investments	(15,525)		(5,484)
Deferred tax liability	(15,525)		(5,484)
Net deferred tax asset (liability)	$	(12,106)	$	(1,065)

Schedule of Effective Income Tax Rate Reconciliation

The following table details the reconciliation between the Company's U.S. federal and state statutory income tax rate and the effective tax rate for the years ended December 31, 2020 and 2019.

	Year Ended
	December 31, 2020		December 31, 2019
Federal statutory rate	21.00	%	21.00	%
State statutory rate, net of federal benefit	11.83	%	0.45	%
Income attributable to non-controlling interests	(1.78)	%	(1.28)	%
REIT earnings not subject to corporate taxes	(2.43)	%	(17.76)	%
Effective tax rate	28.62	%	2.41	%

XML

Long-Term Incentive Plan Units (Tables)

12 Months Ended

Dec. 31, 2020

Share-based Payment Arrangement [Abstract]

Unvested LTIP Units

The below table details unvested OP LTIP Units as of December 31, 2020:

Grant Recipient	Number of OP LTIP Units Granted	Grant Date	Vesting Date(1)
Directors:
	22,840	September 10, 2020	September 9, 2021
Dedicated or partially dedicated personnel:
	10,067	December 13, 2019	December 13, 2021
	18,211	December 17, 2020	December 17, 2021
	9,834	March 4, 2020	December 31, 2021
	14,598	December 17, 2020	December 17, 2022
Total unvested OP LTIP Units at December 31, 2020	75,550

(1)Date at which such OP LTIP Units will vest and become non-forfeitable.

The below table details unvested OP LTIP Units as of December 31, 2018:

Grant Recipient	Number of OP LTIP Units	Grant Date	Vesting Date(1)
Directors:
	14,440	September 12, 2018	September 11, 2019
Partially dedicated employees:
	8,692	December 11, 2018	December 11, 2019
	8,691	December 11, 2018	December 11, 2020
	1,723	March 7, 2018	March 7, 2019
	5,886	December 12, 2017	December 12, 2019
Total unvested OP LTIP Units at December 31, 2018	39,432

(1)Date at which such OP LTIP Units will vest and become non-forfeitable.

Roll-Forward of Company's LTIP Units Outstanding

The following tables summarize issuance and exercise activity of OP LTIP Units for the years ended December 31, 2020 and 2019:

	Year Ended
	December 31, 2020			December 31, 2019
	Manager	Director/ Employee	Total	Manager	Director/ Employee	Total
OP LTIP Units Outstanding (December 31, 2019 and January 1, 2019, respectively)	365,518	180,198	545,716	375,000	146,371	521,371
Granted	—	70,460	70,460	—	37,437	37,437
Exercised	—	(3,638)	(3,638)	(9,482)	(3,610)	(13,092)
OP LTIP Units Outstanding (December 31, 2020 and 2019, respectively)	365,518	247,020	612,538	365,518	180,198	545,716
OP LTIP Units Unvested and Outstanding (December 31, 2020 and 2019, respectively)	—	75,550	75,550	—	46,128	46,128
OP LTIP Units Vested and Outstanding (December 31, 2020 and 2019, respectively)	365,518	171,470	536,988	365,518	134,070	499,588

The following table summarizes issuance and exercise activity of LTIP Units and OP LTIP Units for the year ended December 31, 2018:

	Year Ended December 31, 2018
	Manager	Director/ Employee	Total
LTIP Units and OP LTIP Units Outstanding (December 31, 2017)	375,000	116,159	491,159
Granted	—	33,546	33,546
Exercised	—	(3,334)	(3,334)
LTIP Units and OP LTIP Units Outstanding (December 31, 2018)	375,000	146,371	521,371
LTIP Units and OP LTIP Units Vested and Outstanding (December 31, 2018)	375,000	106,939	481,939

XML

Equity (Tables)

12 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Summary of Common Shares Outstanding

The following table summarizes issuance, repurchase, and other activity with respect to the Company's common stock for the years ended December 31, 2020 and 2019:

	Year Ended
	December 31, 2020	December 31, 2019
Shares of Common Stock Outstanding (12/31/2019 and 1/1/2019, respectively)	38,647,943	29,796,601
Share Activity:
Shares of common stock issued	5,290,000	8,855,000
Shares of common stock issued in connection with incentive fee payment	637	—
Shares of common stock repurchased	(290,050)	(50,825)
OP LTIP Units exercised	—	13,092
OP Units exercised	133,154	34,075
Shares of Common Stock Outstanding (12/31/2020 and 12/31/2019, respectively)	43,781,684	38,647,943

The following table summarizes issuance, repurchase, and other activity with respect to the Company's common shares for the year ended December 31, 2018:

	Year Ended December 31, 2018
Common Shares Outstanding (December 31, 2017)	31,335,938
Share Activity:
Shares repurchased	(1,547,148)

Director LTIP Units exercised	3,334
Shares issued in connection with incentive fee payment	4,477
Common Shares Outstanding (December 31, 2018)	29,796,601

XML

Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2020

Earnings Per Share [Abstract]

Computation Of Basic And Diluted EPS

The components of the computation of basic and diluted EPS are as follows:

	Year Ended
(In thousands except share amounts)	December 31, 2020		December 31, 2019
Net income (loss) attributable to common stockholders	$	17,245	$	56,467
Add: Net income (loss) attributable to Convertible Non-controlling Interests(1)	(3)		1,305
Net income (loss) attributable to common stockholders and Convertible Non-controlling Interests	17,242		57,772
Dividends Paid:
Common stockholders	(55,211)		(58,499)
Convertible Non-controlling Interests	(812)		(1,325)
Total dividends paid to common stockholders and Convertible Non-controlling Interests	(56,023)		(59,824)
Undistributed (Distributed in excess of) earnings:
Common stockholders	(37,966)		(2,032)
Convertible Non-controlling Interests	(815)		(20)
Total undistributed (distributed in excess of) earnings attributable to common stockholders and Convertible Non-controlling Interests	$	(38,781)	$	(2,052)
Weighted average shares outstanding (basic and diluted):
Weighted average shares of common stock outstanding	43,486,336		32,067,768
Weighted average Convertible Non-controlling Interest Units outstanding	635,245		732,456
Weighted average shares of common stock and Convertible Non-controlling Interest Units outstanding	44,121,581		32,800,224
Basic earnings per share of common stock and Convertible Non-controlling Interest Unit:
Distributed	$	1.26	$	1.81
Undistributed (Distributed in excess of)	(0.87)		(0.05)
	$	0.39	$	1.76
Diluted earnings per share of common stock and Convertible Non-controlling Interest Unit:
Distributed	$	1.26	$	1.81
Undistributed (Distributed in excess of)	(0.87)		(0.05)
	$	0.39	$	1.76

(1)For the years ended December 31, 2020 and 2019, excludes net income (loss) of $3.4 million and $3.9 million, respectively, attributable to joint venture partners, which have non-participating interests as described in Note 15.

The components of the computation of basic and diluted EPS were as follows:

	Year Ended December 31, 2018
(In thousands except share amounts)
Net increase (decrease) in shareholders' equity resulting from operations	$	46,676
Add: Net increase (decrease) in equity resulting from operations attributable to participating non-controlling interests(1)	319
Net increase (decrease) in equity resulting from operations related to common shares, LTIP Unit holders, and participating non-controlling interests	46,995
Net increase (decrease) in shareholders' equity resulting from operations available to common share and LTIP Unit holders:
Net increase (decrease) in shareholders' equity resulting from operations–common shares	45,922
Net increase (decrease) in shareholders' equity resulting from operations–LTIP Units	753
Dividends Paid:
Common shareholders	(49,576)
LTIP Unit holders	(812)
Non-controlling interests	(348)
Total dividends paid to common shareholders, LTIP Unit holders, and non-controlling interests	(50,736)
Undistributed (Distributed in excess of) earnings:
Common shareholders	(3,653)
LTIP Unit holders	(59)
Non-controlling interests	(29)
Total undistributed (distributed in excess of) earnings attributable to common shareholders, LTIP Unit holders, and non-controlling interests	$	(3,741)
Weighted average shares outstanding (basic and diluted):
Weighted average common shares outstanding	30,297,401
Weighted average participating LTIP Units	496,962
Weighted average non-controlling interest units	212,000
Basic earnings per common share:
Distributed	$	1.64
Undistributed (Distributed in excess of)	(0.12)
	$	1.52
Diluted earnings per common share:

Distributed	$	1.64
Undistributed (Distributed in excess of)	(0.12)
	$	1.52

(1)For the year ended December 31, 2018, excludes net increase (decrease) in equity resulting from operations of $2.9 million attributable to joint venture partners, which have non-participating interests as described in Note 11.

XML

Restricted Cash (Tables)

12 Months Ended

Dec. 31, 2020

Restricted Cash and Investments [Abstract]

Restrictions on Cash and Cash Equivalents

The below table details the Company's restricted cash balances included in Restricted cash on the Consolidated Statement of Assets, Liabilities, and Equity as of December 31, 2018.

	December 31, 2018
	(In thousands)
Restricted cash balance related to:
Minimum account balance required for regulatory purposes	$	250
Flow consumer loan purchase and sale agreement	175
Total	$	425

XML

Offsetting of Assets and Liabilities (Tables)

12 Months Ended

Dec. 31, 2020

Offsetting of Assets and Liabilities [Abstract]

Schedule of Offsetting of Assets and Liabilities

The following tables present information about certain assets and liabilities representing financial instruments as of December 31, 2020 and 2019. The Company has not entered into master netting agreements with any of its counterparties. Certain of the Company's reverse repurchase and repurchase agreements and financial derivative transactions are governed by underlying agreements that generally provide a right of net settlement, as well as a right of offset in the event of default or in the event of a bankruptcy of either party to the transaction.

December 31, 2020:

Description	Amount of Assets (Liabilities) Presented in the Consolidated Balance Sheet(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount
(In thousands)
Assets
Financial derivatives–assets	$	15,479	$	(12,579)	$	—	$	(1,404)	$	1,496
Reverse repurchase agreements	38,640		(38,640)		—		—		—
Liabilities
Financial derivatives–liabilities	(24,553)		12,579		—		10,694		(1,280)
Repurchase agreements	(1,496,931)		1,496,931		(28,884)		28,884		—

(1)In the Company's Consolidated Balance Sheet, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.

(2)For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's repurchase agreements as of December 31, 2020 was $1.8 billion. As of December 31, 2020, total cash collateral on financial derivative assets and liabilities excludes excess net cash collateral pledged (received) of $4.5 million and $10.3 million, respectively.

(3)When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a particular asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.

December 31, 2019:

Description	Amount of Assets (Liabilities) Presented in the Consolidated Balance Sheet(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount
(In thousands)
Assets
Financial derivatives–assets	$	16,788	$	(12,755)	$	—	$	(807)	$	3,226
Reverse repurchase agreements	73,639		(73,639)		—		—		—
Liabilities
Financial derivatives–liabilities	(27,621)		12,755		—		12,233		(2,633)
Repurchase agreements	(2,445,300)		73,639		2,340,656		31,005		—

(1)In the Company's Consolidated Balance Sheet, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.

(2)For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's repurchase agreements as of December 31, 2019 was $2.8 billion. As of December 31, 2019, total cash collateral on financial derivative assets and liabilities excludes excess net cash collateral pledged of $4.3 million and $23.4 million, respectively.

(3)When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a particular asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.

The following tables present information about certain assets and liabilities representing financial instruments as of December 31, 2018. The Company has not entered into master netting agreements with any of its counterparties. Certain of the Company's repurchase and reverse repurchase agreements and financial derivative transactions are governed by underlying agreements that generally provide a right of offset in the event of default or in the event of a bankruptcy of either party to the transaction.

December 31, 2018:

Description	Amount of Assets (Liabilities) Presented in the Consolidated Statements of Assets, Liabilities, and Equity(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount
(In thousands)
Assets
Financial derivatives–assets	$	20,001	$	(10,910)	$	—	$	(2,514)	$	6,577
Repurchase agreements	61,274		(61,274)		—		—		—
Liabilities
Financial derivatives–liabilities	(20,806)		10,910		—		9,896		—
Reverse repurchase agreements	(1,498,849)		61,274		1,420,601		16,974		—

(1)

(1)In the Company's Consolidated Statement of Assets, Liabilities, and Equity, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.

(2)For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's reverse repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's reverse repurchase agreements as of December 31, 2018 were $1.79 billion. As of December 31, 2018 total cash collateral on financial derivative assets excludes excess net cash collateral pledged of $0.1 million. As of December 31, 2018 total cash collateral on financial derivative liabilities excludes excess cash collateral pledged of $16.4 million.

(3)When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a specific asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.

XML

Counterparty Risk (Tables)

12 Months Ended

Dec. 31, 2020

Risks and Uncertainties [Abstract]

Schedules of Exposure to Counterparty Risk

The table below summarizes the geographic distribution of the real estate collateral underlying the Company's residential mortgage loans as a percentage of total outstanding unpaid principal balance as of December 31, 2020 and 2019:

Property Location by U.S. State	December 31, 2020		December 31, 2019
California	43.1	%	46.6	%
Florida	14.8	%	11.9	%
Texas	10.2	%	11.9	%
Colorado	3.1	%	3.2	%
Massachusetts	2.6	%	2.9	%
Oregon	2.2	%	2.2	%
Arizona	2.0	%	2.4	%
Nevada	1.9	%	1.6	%
Illinois	1.8	%	1.7	%
Utah	1.7	%	1.9	%
New York	1.6	%	1.3	%
Washington	1.4	%	1.6	%
New Jersey	1.4	%	1.1	%
Georgia	1.3	%	0.7	%
North Carolina	1.1	%	0.8	%
Maryland	1.0	%	1.1	%
Other	8.8	%	7.1	%
	100.0	%	100.0	%

The table below summarizes the geographic distribution of the real estate collateral underlying the Company's commercial mortgage loans as a percentage of total outstanding unpaid principal balance as of December 31, 2020 and 2019:

Property Location by U.S. State	December 31, 2020		December 31, 2019
Florida	23.8	%	31.7	%
New York	15.2	%	17.7	%
Connecticut	11.2	%	8.2	%
Missouri	7.9	%	4.6	%
Ohio	7.3	%	—	%
California	5.9	%	—	%
Massachusetts	6.1	%	4.7	%
New Jersey	5.8	%	13.3	%
Arizona	4.3	%	3.8	%
Virginia	4.2	%	6.8	%
Indiana	2.8	%	2.1	%
North Carolina	2.2	%	1.8	%
Nevada	1.9	%	1.5	%
Tennessee	—	%	1.5	%
Illinois	1.4	%	1.2	%
Other	—	%	1.1	%
	100.0	%	100.0	%

The following table summarizes the Company's exposure to counterparty risk as of December 31, 2020 and 2019.

December 31, 2020:

	Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)
	(In thousands)
Cash and cash equivalents	$	111,647	8	40.1	%
Collateral on repurchase agreements held by dealers(2)	1,860,059		24	15.3	%
Due from brokers	63,147		22	28.9	%
Receivable for securities sold(3)	1,416		2	94.5	%

(1)Each counterparty is a large creditworthy financial institution.

(2)Includes securities, loans, and REO as well as cash posted as collateral for repurchase agreements.

(3)Included in Investment related receivables on the Consolidated Balance Sheet.

December 31, 2019:

	Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)
	(In thousands)
Cash and cash equivalents	$	72,302	11	42.2	%
Collateral on repurchase agreements held by dealers(2)	2,793,696		28	13.8	%
Due from brokers	79,829		24	30.9	%
Receivable for securities sold(3)	69,995		5	62.3	%

(1)Each counterparty is a large creditworthy financial institution.

(2)Includes securities, loans, and REO as well as cash posted as collateral for repurchase agreements.

(3)Included in Investment related receivables on the Consolidated Balance Sheet.

Schedule Of Percentage Of Total Collateral On Reverse Repurchase Agreements [Table Text Block]

The following table details the percentage of such collateral held by counterparties who hold greater than 15% of the aggregate $1.79 billion in collateral for various reverse repurchase agreements as of December 31, 2018. In addition to the below, unencumbered investments, on a settlement date basis, of approximately $13.3 million were held in custody at the Bank of New York Mellon Corporation as of December 31, 2018.

Dealer	% of Total Collateral on Reverse Repurchase Agreements
Royal Bank of Canada	19%

% Of Total Deposits With Dealers Held As Collateral

The following table details the percentage of collateral amounts held by dealers who hold greater than 15% of the Company's Due from Brokers, included as of December 31, 2018:

Dealer	% of Total Due from Brokers
Morgan Stanley	37%
J.P. Morgan Securities LLC	30%

% Of Total Receivable For Securities Sold

The following table details the percentage of amounts held by dealers who hold greater than 15% of the Company's Receivable for securities sold as of December 31, 2018:

Dealer	% of Total Receivable for Securities Sold
J.P. Morgan Securities LLC	25%
Bank of America Securities	26%
CS First Boston Limited	34%

Schedule of Cash and Cash Equivalents

In addition, the Company held cash and cash equivalents of $44.7 million as of December 31, 2018. The below table details the concentration of cash and cash equivalents held by each counterparty:

Counterparty	As of December 31, 2018
Bank of New York Mellon Corporation	64%
Deutsche Bank Securities	5%
Bank of America Securities	2%
Morgan Stanley Institutional Liquidity Fund—Government Portfolio	10%
BlackRock Liquidity Funds FedFund Portfolio	9%
Goldman Sachs Financial Square Funds—Government Fund	9%
Lakeland Bank Inc.	1%

XML

Condensed Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2020

Text Block [Abstract]

Quarterly Financial Information

Detailed below is unaudited quarterly financial data for the year ended December 31, 2018.

	Three Month Period Ended
	March 31, 2018		June 30, 2018		September 30, 2018		December 31, 2018
(In thousands except per share amounts)
INVESTMENT INCOME
Interest income(1)	$	28,092	$	31,941	$	35,300	$	35,694
Other income	716		1,094		1,046		1,157
Total investment income	28,808		33,035		36,346		36,851
EXPENSES
Base management fee to affiliate(2)	1,978		2,021		1,830		1,744
Incentive fee to affiliate	—		291		424		—
Interest expense(1)	11,562		13,383		15,678		16,083
Other investment related expenses	2,952		3,771		4,384		4,201
Other operating expenses	2,074		2,578		2,352		4,609
Total expenses	18,566		22,044		24,668		26,637
NET INVESTMENT INCOME	10,242		10,991		11,678		10,214
NET REALIZED AND CHANGE IN NET UNREALIZED GAIN (LOSS) ON INVESTMENTS, OTHER SECURED BORROWINGS, FINANCIAL DERIVATIVES, AND FOREIGN CURRENCY TRANSACTIONS/TRANSLATION
Net realized gain (loss) on investments, financial derivatives, and foreign currency transactions	13,051		(1,343)		10,102		9,578
Change in net unrealized gain (loss) on investments, other secured borrowings, financial derivatives, and foreign currency translation	(1,969)		12,536		(14,306)		(20,862)
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS, OTHER SECURED BORROWINGS, FINANCIAL DERIVATIVES, AND FOREIGN CURRENCY	11,082		11,193		(4,204)		(11,284)
NET INCREASE (DECREASE) IN EQUITY RESULTING FROM OPERATIONS	21,324		22,184		7,474		(1,070)
LESS: NET INCREASE IN EQUITY RESULTING FROM OPERATIONS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS	285		991		813		1,147
NET INCREASE (DECREASE) IN SHAREHOLDERS' EQUITY RESULTING FROM OPERATIONS	$	21,039	$	21,193	$	6,661	$	(2,217)
NET INCREASE (DECREASE) IN SHAREHOLDERS' EQUITY RESULTING FROM OPERATIONS PER SHARE:
Basic and Diluted (3)	$	0.67	$	0.69	$	0.22	$	(0.07)

(1)Includes interest income and interest expense of a consolidated securitization trust of $1.3 million and $0.9 million, respectively, for the three-month period ended March 31, 2018. Includes interest income and interest expense of a consolidated securitization trust of $1.3 million and $0.8 million, respectively, for the three-month period ended June 30, 2018. Includes interest income and interest expense of a consolidated securitization trust of $1.3 million and $0.7 million, respectively, for the three-month period ended September 30, 2018. Includes interest income and interest expense of a consolidated securitization trust of $2.1 million and $1.2 million, respectively, for the three-month period ended December 31, 2018. See Note 6 for further details on the Company's consolidated securitization trusts.

(2)Net of management fee rebate of $0.3 million, $0.3 million, $0.4 million, and $0.4 million, for the each of the three-month periods ended March 31, 2018, June 30, 2018, September 30, 2018, and December 31, 2018, respectively. See Note 9 for further details on management fee rebates.

(3)For the year ended December 31, 2018 the sum of EPS for the four quarters of the year does not equal EPS as calculated for the entire year (see Note 13) as a result of changes in shares during the year due to repurchases of common shares, as EPS is calculated using average shares outstanding during the period.

XML

Financial Highlights (Tables)

12 Months Ended

Dec. 31, 2020

Investment Company, Financial Highlights [Abstract]

Schedule Of Shareholders Equity Per Share

Results of Operations for a Share Outstanding Throughout the Periods:

	Year Ended December 31, 2018
Beginning Shareholders' Equity Per Share (December 31, 2017)	$	19.15
Net Investment Income	1.42
Net Realized/Unrealized Gains (Losses)	0.23
Results of Operations Attributable to Equity	1.65
Less: Results of Operations Attributable to Non-controlling Interests	(0.11)
Results of Operations Attributable to Shareholders' Equity(1)	1.54
Dividends Paid to Common Shareholders	(1.64)
Weighted Average Share Impact on Dividends Paid (2)	(0.03)
Accretive (Dilutive) Effect of Share Issuances (Net of Offering Costs), Share Repurchases, and Adjustments to Non-controlling Interest	(0.10)
Ending Shareholders' Equity Per Share (December 31, 2018)(3)	$	18.92
Shares Outstanding, end of period	29,796,601

(1)Calculated based on average common shares outstanding and can differ from the calculation for EPS (See Note 13).

(2)Per share impact on dividends paid relating to share issuances/repurchases during the period as well as dividends paid to LTIP and OP Unit holders.

(3)If all LTIP Units and OP Units previously issued were vested and exchanged for common shares as of December 31, 2018 shareholders' equity per share would be $18.92.

Schedule Of Net Asset Based Total Return For Shareholders

The following table illustrates the Company's total return for the periods presented based on net asset value:

Net Asset Value Based Total Return for a Shareholder: (1)

	Year Ended December 31, 2018(2)
Total Return	7.38%

(1)Total return is calculated assuming reinvestment of distributions at shareholders' equity per share during the period.

(2)The Company redeemed all 503,988 of its outstanding LTIP Units which it had originally issued under its incentive plans, with each LTIP unitholder receiving in exchange an equal number of OP LTIP Units. While this activity did not affect fully diluted net asset value per common share, it did cause a

1.66% decline in net asset value per common share. The Company's total return for the year ended December 31, 2018 before the effect of this activity was 9.19%.

Schedule Of Net Investment Income Ratio To Average Equity

Net Investment Income Ratio to Average Equity: (1)

	Year Ended December 31, 2018
Net Investment Income	7.04%

(1)Average equity is calculated using month end values.

Schedule Of Expense Ratios to Average Equity

Expense Ratios to Average Equity: (1)

	Year Ended December 31, 2018
Operating expenses, before interest expense and other investment related expenses	(2.86)%
Incentive fee	(0.12)%
Interest expense and other investment related expenses	(12.03)%
Total Expenses	(15.01)%

(1)Average equity is calculated using month end values.

XML

Organization and Investment Objective (Details) - $ / shares	Dec. 31, 2020	Dec. 31, 2019	Feb. 28, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common shares	$ 0.001	$ 0.001	$ 0.001
Ellington Financial Operating Partnership LLC [Member] | Total Stockholders' Equity
Organization, Consolidation and Presentation of Financial Statements [Line Items]
Ownership Percentage	98.70%			97.60%

XML

Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2018
Significant Accounting Policies [Line Items]
Number of days to determine non-performance of loan	90 days
Long-Term Incentive Plan Units [Member] | Director [Member]
Significant Accounting Policies [Line Items]
Vesting period	1 year	1 year
Minimum | Long-Term Incentive Plan Units [Member] | Dedicated or partially dedicated personnel [Member]
Significant Accounting Policies [Line Items]
Vesting period	1 year	1 year
Maximum | Long-Term Incentive Plan Units [Member] | Dedicated or partially dedicated personnel [Member]
Significant Accounting Policies [Line Items]
Vesting period	2 years	2 years

XML

Valuation (Schedule of Financial Instruments) (Details) - USD ($) $ in Thousands		Dec. 31, 2020		Dec. 31, 2019		Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)	[1],[2]	$ 1,514,185		$ 2,449,941
Investment in unconsolidated entities, at fair value	[1]	141,620		71,850
Financial derivatives–assets, at fair value-		15,479		16,788		$ 20,001
Repurchase agreements, at fair value		38,640		73,639		61,274
Investments sold short, at fair value-		(38,642)		(73,409)		(850,577)
Financial derivatives–liabilities, at fair value-		(24,553)		(27,621)		(20,806)
Other secured borrowings, at fair value		(754,921)	[1]	(594,396)	[1]	(297,948)
Level 3 | Non-Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets		127,838		89,581
Level 3 | CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets		63,148		29,805
Level 3 | CLOs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets		111,100		44,979
Level 3 | Asset-backed securities, backed by consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets		44,925		48,610
Level 3 | Corporate loan [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets				18,510
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in unconsolidated entities, at fair value		141,620		71,850
Total assets		3,124,764		3,951,005		3,020,586
Other secured borrowings, at fair value		(754,921)		(594,396)
Total liabilities		(818,116)		(695,426)		(1,169,331)
Fair Value, Measurements, Recurring | Investments Sold Short
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						(850,577)
Fair Value, Measurements, Recurring | Investments Sold Short | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						(772,964)
Fair Value, Measurements, Recurring | Investments Sold Short | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-		(218)		(471)
Fair Value, Measurements, Recurring | Investments Sold Short | Government debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-		(38,424)		(72,938)		(54,151)
Fair Value, Measurements, Recurring | Investments Sold Short | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						(6,529)
Fair Value, Measurements, Recurring | Investments Sold Short | Common stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						(16,933)
Fair Value, Measurements, Recurring | Financial Derivatives - Liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-						(20,806)
Fair Value, Measurements, Recurring | Financial Derivatives - Liabilities | Credit default swaps on corporate bond indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(6,438)		(14,524)		(11,557)
Fair Value, Measurements, Recurring | Financial Derivatives - Liabilities | Credit default swaps on corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(747)		(1,693)		(3,246)
Fair Value, Measurements, Recurring | Financial Derivatives - Liabilities | Credit default swaps on asset-backed indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(130)		(250)		(2,125)
Fair Value, Measurements, Recurring | Financial Derivatives - Liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(15,174)		(8,719)		(3,397)
Fair Value, Measurements, Recurring | Financial Derivatives - Liabilities | TBA securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(925)		(1,012)
Fair Value, Measurements, Recurring | Financial Derivatives - Liabilities | Futures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(376)		(45)		(355)
Fair Value, Measurements, Recurring | Financial Derivatives - Liabilities | Forwards
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(279)		(169)		(120)
Fair Value, Measurements, Recurring | Financial Derivatives - Liabilities | Total return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(484)		(1,209)		(6)
Fair Value, Measurements, Recurring | Other secured borrowings, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other secured borrowings, at fair value						(297,948)
Fair Value, Measurements, Recurring | Cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents						12,460
Fair Value, Measurements, Recurring | Securities | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		959,443		1,936,963
Fair Value, Measurements, Recurring | Securities | Non-Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		204,114		166,550
Fair Value, Measurements, Recurring | Securities | CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		117,653		124,868
Fair Value, Measurements, Recurring | Securities | CLOs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		181,271		170,443
Fair Value, Measurements, Recurring | Securities | Asset-backed securities, backed by consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		44,925		48,610
Fair Value, Measurements, Recurring | Securities | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		5,189		1,113
Fair Value, Measurements, Recurring | Securities | Corporate equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		1,590		1,394
Fair Value, Measurements, Recurring | Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						2,939,311
Fair Value, Measurements, Recurring | Investments | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						1,450,217
Fair Value, Measurements, Recurring | Investments | Non-Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						302,639
Fair Value, Measurements, Recurring | Investments | CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						33,908
Fair Value, Measurements, Recurring | Investments | CLOs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						123,893
Fair Value, Measurements, Recurring | Investments | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						22,392
Fair Value, Measurements, Recurring | Investments | Corporate equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						43,793
Fair Value, Measurements, Recurring | Investments | Secured notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						10,917
Fair Value, Measurements, Recurring | Investments | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						76
Fair Value, Measurements, Recurring | Investments | Residential mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						496,830
Fair Value, Measurements, Recurring | Investments | Commercial mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						211,185
Fair Value, Measurements, Recurring | Investments | Consumer loans and asset-backed securities backed by consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						206,761
Fair Value, Measurements, Recurring | Investments | Real estate owned
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						34,500
Fair Value, Measurements, Recurring | Investments | Common stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						2,200
Fair Value, Measurements, Recurring | Loans | Residential mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		1,187,069		932,203
Fair Value, Measurements, Recurring | Loans | Commercial mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		213,031		274,759
Fair Value, Measurements, Recurring | Loans | Consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		47,525		186,954
Fair Value, Measurements, Recurring | Loans | Corporate loan [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		5,855		18,510
Fair Value, Measurements, Recurring | Financial Derivatives - Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-						20,001
Fair Value, Measurements, Recurring | Financial Derivatives - Assets | Credit default swaps on asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		347		993		1,472
Fair Value, Measurements, Recurring | Financial Derivatives - Assets | Credit default swaps on corporate bond indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		3,420		5,599		733
Fair Value, Measurements, Recurring | Financial Derivatives - Assets | Credit default swaps on corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-				2		2,473
Fair Value, Measurements, Recurring | Financial Derivatives - Assets | Credit default swaps on asset-backed indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		2,184		3,319		8,092
Fair Value, Measurements, Recurring | Financial Derivatives - Assets | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		8,519		5,468		7,224
Fair Value, Measurements, Recurring | Financial Derivatives - Assets | TBA securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		962		596
Fair Value, Measurements, Recurring | Financial Derivatives - Assets | Futures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		2		148
Fair Value, Measurements, Recurring | Financial Derivatives - Assets | Forwards
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-				43		6
Fair Value, Measurements, Recurring | Financial Derivatives - Assets | Total return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		9		620		1
Fair Value, Measurements, Recurring | Financial Derivatives - Assets | Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		36
Fair Value, Measurements, Recurring | Repurchase Agreements
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Repurchase agreements, at fair value						61,274
Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in unconsolidated entities, at fair value		0		0
Total assets		2		148		2,200
Other secured borrowings, at fair value		0		0
Total liabilities		(376)		(45)		(17,288)
Fair Value, Measurements, Recurring | Level 1 | Investments Sold Short
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						(16,933)
Fair Value, Measurements, Recurring | Level 1 | Investments Sold Short | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments Sold Short | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-		0		0
Fair Value, Measurements, Recurring | Level 1 | Investments Sold Short | Government debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Investments Sold Short | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments Sold Short | Common stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						(16,933)
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-						(355)
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Liabilities | Credit default swaps on corporate bond indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Liabilities | Credit default swaps on corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Liabilities | Credit default swaps on asset-backed indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Liabilities | TBA securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Liabilities | Futures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(376)		(45)		(355)
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Liabilities | Forwards
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Liabilities | Total return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Other secured borrowings, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other secured borrowings, at fair value						0
Fair Value, Measurements, Recurring | Level 1 | Cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents						12,460
Fair Value, Measurements, Recurring | Level 1 | Securities | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		0		0
Fair Value, Measurements, Recurring | Level 1 | Securities | Non-Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		0		0
Fair Value, Measurements, Recurring | Level 1 | Securities | CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		0		0
Fair Value, Measurements, Recurring | Level 1 | Securities | CLOs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		0		0
Fair Value, Measurements, Recurring | Level 1 | Securities | Asset-backed securities, backed by consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		0		0
Fair Value, Measurements, Recurring | Level 1 | Securities | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		0		0
Fair Value, Measurements, Recurring | Level 1 | Securities | Corporate equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		0		0
Fair Value, Measurements, Recurring | Level 1 | Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						2,200
Fair Value, Measurements, Recurring | Level 1 | Investments | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | Non-Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | CLOs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | Corporate equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | Secured notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | Residential mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | Commercial mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | Consumer loans and asset-backed securities backed by consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | Real estate owned
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Investments | Common stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						2,200
Fair Value, Measurements, Recurring | Level 1 | Loans | Residential mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		0		0
Fair Value, Measurements, Recurring | Level 1 | Loans | Commercial mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		0		0
Fair Value, Measurements, Recurring | Level 1 | Loans | Consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		0		0
Fair Value, Measurements, Recurring | Level 1 | Loans | Corporate loan [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-						0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Assets | Credit default swaps on asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Assets | Credit default swaps on corporate bond indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Assets | Credit default swaps on corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-				0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Assets | Credit default swaps on asset-backed indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Assets | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Assets | TBA securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Assets | Futures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		2		148
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Assets | Forwards
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-				0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Assets | Total return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 1 | Financial Derivatives - Assets | Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0
Fair Value, Measurements, Recurring | Level 1 | Repurchase Agreements
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Repurchase agreements, at fair value						0
Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in unconsolidated entities, at fair value		0		0
Total assets		1,164,960		2,229,582		1,892,308
Other secured borrowings, at fair value		0		0
Total liabilities		(62,335)		(100,549)		(854,095)
Fair Value, Measurements, Recurring | Level 2 | Investments Sold Short
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						(833,644)
Fair Value, Measurements, Recurring | Level 2 | Investments Sold Short | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						(772,964)
Fair Value, Measurements, Recurring | Level 2 | Investments Sold Short | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-		(218)		(471)
Fair Value, Measurements, Recurring | Level 2 | Investments Sold Short | Government debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-		(38,424)		(72,938)		(54,151)
Fair Value, Measurements, Recurring | Level 2 | Investments Sold Short | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						(6,529)
Fair Value, Measurements, Recurring | Level 2 | Investments Sold Short | Common stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						0
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-						(20,451)
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Liabilities | Credit default swaps on corporate bond indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(6,438)		(14,524)		(11,557)
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Liabilities | Credit default swaps on corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(747)		(1,693)		(3,246)
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Liabilities | Credit default swaps on asset-backed indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(130)		(250)		(2,125)
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(15,174)		(8,719)		(3,397)
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Liabilities | TBA securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(925)		(1,012)
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Liabilities | Futures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Liabilities | Forwards
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(279)		(169)		(120)
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Liabilities | Total return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		(773)		(6)
Fair Value, Measurements, Recurring | Level 2 | Other secured borrowings, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other secured borrowings, at fair value						0
Fair Value, Measurements, Recurring | Level 2 | Cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents						0
Fair Value, Measurements, Recurring | Level 2 | Securities | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		947,780		1,917,059
Fair Value, Measurements, Recurring | Level 2 | Securities | Non-Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		76,276		76,969
Fair Value, Measurements, Recurring | Level 2 | Securities | CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		54,505		95,063
Fair Value, Measurements, Recurring | Level 2 | Securities | CLOs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		70,171		125,464
Fair Value, Measurements, Recurring | Level 2 | Securities | Asset-backed securities, backed by consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		0		0
Fair Value, Measurements, Recurring | Level 2 | Securities | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		1,107		0
Fair Value, Measurements, Recurring | Level 2 | Securities | Corporate equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		0		0
Fair Value, Measurements, Recurring | Level 2 | Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						1,812,505
Fair Value, Measurements, Recurring | Level 2 | Investments | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						1,442,924
Fair Value, Measurements, Recurring | Level 2 | Investments | Non-Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						211,348
Fair Value, Measurements, Recurring | Level 2 | Investments | CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						33,105
Fair Value, Measurements, Recurring | Level 2 | Investments | CLOs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						108,978
Fair Value, Measurements, Recurring | Level 2 | Investments | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						16,074
Fair Value, Measurements, Recurring | Level 2 | Investments | Corporate equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 2 | Investments | Secured notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 2 | Investments | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						76
Fair Value, Measurements, Recurring | Level 2 | Investments | Residential mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 2 | Investments | Commercial mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 2 | Investments | Consumer loans and asset-backed securities backed by consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 2 | Investments | Real estate owned
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 2 | Investments | Common stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 2 | Loans | Residential mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		0		0
Fair Value, Measurements, Recurring | Level 2 | Loans | Commercial mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		0		0
Fair Value, Measurements, Recurring | Level 2 | Loans | Consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		0		0
Fair Value, Measurements, Recurring | Level 2 | Loans | Corporate loan [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		0		0
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-						18,529
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Assets | Credit default swaps on asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Assets | Credit default swaps on corporate bond indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		3,420		5,599		733
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Assets | Credit default swaps on corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-				2		2,473
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Assets | Credit default swaps on asset-backed indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		2,184		3,319		8,092
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Assets | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		8,519		5,468		7,224
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Assets | TBA securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		962		596
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Assets | Futures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Assets | Forwards
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-				43		6
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Assets | Total return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0		1
Fair Value, Measurements, Recurring | Level 2 | Financial Derivatives - Assets | Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		36
Fair Value, Measurements, Recurring | Level 2 | Repurchase Agreements
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Repurchase agreements, at fair value						61,274
Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in unconsolidated entities, at fair value		141,620		71,850
Total assets		1,959,802		1,721,275		1,126,078
Other secured borrowings, at fair value		(754,921)		(594,396)
Total liabilities		(755,405)		(594,832)		(297,948)
Fair Value, Measurements, Recurring | Level 3 | Investments Sold Short
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						0
Fair Value, Measurements, Recurring | Level 3 | Investments Sold Short | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						0
Fair Value, Measurements, Recurring | Level 3 | Investments Sold Short | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-		0		0
Fair Value, Measurements, Recurring | Level 3 | Investments Sold Short | Government debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 3 | Investments Sold Short | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						0
Fair Value, Measurements, Recurring | Level 3 | Investments Sold Short | Common stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments sold short, at fair value-						0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-						0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Liabilities | Credit default swaps on corporate bond indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Liabilities | Credit default swaps on corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Liabilities | Credit default swaps on asset-backed indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Liabilities | TBA securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Liabilities | Futures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Liabilities | Forwards
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Liabilities | Total return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–liabilities, at fair value-		(484)		(436)		0
Fair Value, Measurements, Recurring | Level 3 | Other secured borrowings, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other secured borrowings, at fair value						(297,948)
Fair Value, Measurements, Recurring | Level 3 | Cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents						0
Fair Value, Measurements, Recurring | Level 3 | Securities | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		11,663		19,904
Fair Value, Measurements, Recurring | Level 3 | Securities | Non-Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		127,838		89,581
Fair Value, Measurements, Recurring | Level 3 | Securities | CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		63,148		29,805
Fair Value, Measurements, Recurring | Level 3 | Securities | CLOs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		111,100		44,979
Fair Value, Measurements, Recurring | Level 3 | Securities | Asset-backed securities, backed by consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		44,925		48,610
Fair Value, Measurements, Recurring | Level 3 | Securities | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		4,082		1,113
Fair Value, Measurements, Recurring | Level 3 | Securities | Corporate equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities, at fair value(1)(2)		1,590		1,394
Fair Value, Measurements, Recurring | Level 3 | Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						1,124,606
Fair Value, Measurements, Recurring | Level 3 | Investments | Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						7,293
Fair Value, Measurements, Recurring | Level 3 | Investments | Non-Agency RMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						91,291
Fair Value, Measurements, Recurring | Level 3 | Investments | CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						803
Fair Value, Measurements, Recurring | Level 3 | Investments | CLOs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						14,915
Fair Value, Measurements, Recurring | Level 3 | Investments | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						6,318
Fair Value, Measurements, Recurring | Level 3 | Investments | Corporate equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						43,793
Fair Value, Measurements, Recurring | Level 3 | Investments | Secured notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						10,917
Fair Value, Measurements, Recurring | Level 3 | Investments | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 3 | Investments | Residential mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						496,830
Fair Value, Measurements, Recurring | Level 3 | Investments | Commercial mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						211,185
Fair Value, Measurements, Recurring | Level 3 | Investments | Consumer loans and asset-backed securities backed by consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						206,761
Fair Value, Measurements, Recurring | Level 3 | Investments | Real estate owned
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						34,500
Fair Value, Measurements, Recurring | Level 3 | Investments | Common stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, at fair value-						0
Fair Value, Measurements, Recurring | Level 3 | Loans | Residential mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		1,187,069		932,203
Fair Value, Measurements, Recurring | Level 3 | Loans | Commercial mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		213,031		274,759
Fair Value, Measurements, Recurring | Level 3 | Loans | Consumer loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		47,525		186,954
Fair Value, Measurements, Recurring | Level 3 | Loans | Corporate loan [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans, at fair value		5,855		18,510
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-						1,472
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Assets | Credit default swaps on asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		347		993		1,472
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Assets | Credit default swaps on corporate bond indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Assets | Credit default swaps on corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-				0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Assets | Credit default swaps on asset-backed indices
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Assets | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Assets | TBA securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Assets | Futures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Assets | Forwards
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-				0		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Assets | Total return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		9		$ 620		0
Fair Value, Measurements, Recurring | Level 3 | Financial Derivatives - Assets | Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial derivatives–assets, at fair value-		$ 0
Fair Value, Measurements, Recurring | Level 3 | Repurchase Agreements
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Repurchase agreements, at fair value						$ 0

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Valuation (Schedule of Significant Unobservable Inputs, Qualitative Information) (Details) - Level 3	12 Months Ended
	Dec. 31, 2020 USD ($) $ / shares	Dec. 31, 2019 USD ($) $ / shares	Dec. 31, 2018 USD ($)
Non-Agency RMBS
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 127,838,000	$ 89,581,000
Fair Value of Level 3 Assets, Negative Yield	$ 300,000	$ 600,000
Non-Agency RMBS | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair Value Inputs, Yield Including Negative	7.30%	8.00%
Non-Agency RMBS | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.007	0.005
Non-Agency RMBS | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.526	0.651
Non-Agency RMBS | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.074	0.081
Non-Agency RMBS | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0	0.008
Non-Agency RMBS | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.991	0.765
Non-Agency RMBS | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.453	0.531
Non-Agency RMBS | Measurement Input, Default Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.004	0.001
Non-Agency RMBS | Measurement Input, Default Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.726	0.489
Non-Agency RMBS | Measurement Input, Default Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.184	0.177
Non-Agency RMBS | Measurement Input, Projected Collateral Recoveries | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0	0
Non-Agency RMBS | Measurement Input, Projected Collateral Recoveries | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.791	0.324
Non-Agency RMBS | Measurement Input, Projected Collateral Recoveries | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.168	0.065
CMBS
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 63,148,000	$ 29,805,000
CMBS | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.037	0.037
CMBS | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.263	0.157
CMBS | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.087	0.076
CMBS | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0	0
CMBS | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0	1.000
CMBS | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0	0.006
CMBS | Measurement Input, Default Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.007	0
CMBS | Measurement Input, Default Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.107	0.030
CMBS | Measurement Input, Default Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.036	0.002
CMBS | Measurement Input, Projected Collateral Recoveries | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.724	0
CMBS | Measurement Input, Projected Collateral Recoveries | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.961	0.106
CMBS | Measurement Input, Projected Collateral Recoveries | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.906	0.020
Agency RMBS | Interest only securities
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 11,663,000	$ 19,904,000
Agency RMBS | Interest only securities | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.083	0.123
Agency RMBS | Interest only securities | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	1.000	1.000
Agency RMBS | Interest only securities | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.759	0.705
Corporate equity securities | Non-exchange traded preferred equity investment in loan origination entity
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 3,000,000
CLOs
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 111,100,000	$ 44,979,000
CLOs | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.034	0.032
CLOs | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.354	0.419
CLOs | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.105	0.140
CLOs | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.412	0.485
CLOs | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.977	0.883
CLOs | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.657	0.832
CLOs | Measurement Input, Default Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.017	0.047
CLOs | Measurement Input, Default Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.289	0.364
CLOs | Measurement Input, Default Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.112	0.088
CLOs | Measurement Input, Projected Collateral Recoveries | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.006	0.037
CLOs | Measurement Input, Projected Collateral Recoveries | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.152	0.151
CLOs | Measurement Input, Projected Collateral Recoveries | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.079	0.057
Asset-backed securities, backed by consumer loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 44,925,000	$ 48,610,000
Asset-backed securities, backed by consumer loans | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.126	0.038
Asset-backed securities, backed by consumer loans | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.275	0.342
Asset-backed securities, backed by consumer loans | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.156	0.127
Asset-backed securities, backed by consumer loans | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.000	0.000
Asset-backed securities, backed by consumer loans | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.116	0.112
Asset-backed securities, backed by consumer loans | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.077	0.097
Asset-backed securities, backed by consumer loans | Measurement Input, Default Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.010	0.006
Asset-backed securities, backed by consumer loans | Measurement Input, Default Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.211	0.180
Asset-backed securities, backed by consumer loans | Measurement Input, Default Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.171	0.154
Corporate loan [Member]
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value		$ 18,510,000
Corporate loan [Member] | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input		0.150
Corporate loan [Member] | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input		0.210
Corporate loan [Member] | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input		0.178
Total return swaps | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.220	0.085
Derivative Liability, Measurement Input	0.168	0.277
Total return swaps | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.220	0.277
Derivative Liability, Measurement Input	0.168	0.277
Total return swaps | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.220	0.115
Derivative Liability, Measurement Input	0.168	0.277
Valuation, Market Approach | Non-Agency RMBS
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 70,619,000	$ 38,754,000	$ 36,945,000
Valuation, Market Approach | Non-Agency RMBS | Measurement Input, Quoted Price | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			17.42
Securities, measurement input | $ / shares	9.53	6.68
Valuation, Market Approach | Non-Agency RMBS | Measurement Input, Quoted Price | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			178.00
Securities, measurement input | $ / shares	204.61	144.79
Valuation, Market Approach | Non-Agency RMBS | Measurement Input, Quoted Price | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			78.31
Securities, measurement input | $ / shares	85.70	86.21
Valuation, Market Approach | CMBS
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 53,199,000	$ 29,630,000	$ 576,000
Valuation, Market Approach | CMBS | Measurement Input, Quoted Price | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			5.93
Securities, measurement input | $ / shares	4.79	5.08
Valuation, Market Approach | CMBS | Measurement Input, Quoted Price | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			6.36
Securities, measurement input | $ / shares	98.00	80.72
Valuation, Market Approach | CMBS | Measurement Input, Quoted Price | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			6.14
Securities, measurement input | $ / shares	65.20	64.73
Valuation, Market Approach | Agency RMBS | Interest only securities
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 4,844,000	$ 3,753,000	$ 744,000
Valuation, Market Approach | Agency RMBS | Interest only securities | Measurement Input, Quoted Price | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			1.70
Securities, measurement input | $ / shares	1.91	1.36
Valuation, Market Approach | Agency RMBS | Interest only securities | Measurement Input, Quoted Price | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			9.12
Securities, measurement input | $ / shares	18.91	16.61
Valuation, Market Approach | Agency RMBS | Interest only securities | Measurement Input, Quoted Price | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			5.64
Securities, measurement input | $ / shares	8.38	5.11
Valuation, Market Approach | CLOs
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 102,910,000	$ 38,220,000	$ 5,828,000
Valuation, Market Approach | CLOs | Measurement Input, Quoted Price | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			2.64
Securities, measurement input | $ / shares	2.00	40.00
Valuation, Market Approach | CLOs | Measurement Input, Quoted Price | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			375.00
Securities, measurement input | $ / shares	330.00	96.00
Valuation, Market Approach | CLOs | Measurement Input, Quoted Price | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			167.78
Securities, measurement input | $ / shares	88.66	73.98
Valuation, Market Approach | Corporate debt, non-exchange traded corporate equity, and secured notes [Member]
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 13,976,000
Valuation, Market Approach | Corporate debt, non-exchange traded corporate equity, and secured notes [Member] | Measurement Input, Quoted Price | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			9.69
Valuation, Market Approach | Corporate debt, non-exchange traded corporate equity, and secured notes [Member] | Measurement Input, Quoted Price | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			91.00
Valuation, Market Approach | Corporate debt, non-exchange traded corporate equity, and secured notes [Member] | Measurement Input, Quoted Price | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			59.18
Valuation, Market Approach | Asset-backed securities, backed by consumer loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 97,000	$ 139,000
Valuation, Market Approach | Asset-backed securities, backed by consumer loans | Measurement Input, Quoted Price | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input | $ / shares	96.51	95.47
Valuation, Market Approach | Asset-backed securities, backed by consumer loans | Measurement Input, Quoted Price | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input | $ / shares	98.43	96.78
Valuation, Market Approach | Asset-backed securities, backed by consumer loans | Measurement Input, Quoted Price | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input | $ / shares	97.33	96.12
Valuation, Market Approach | Corporate loan [Member]
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 5,855,000	$ 6,010,000
Valuation, Market Approach | Corporate loan [Member] | Measurement Input, Quoted Price | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input | $ / shares	100.00	100.00
Valuation, Market Approach | Corporate loan [Member] | Measurement Input, Quoted Price | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input | $ / shares	100.00	100.00
Valuation, Market Approach | Corporate loan [Member] | Measurement Input, Quoted Price | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input | $ / shares	100.00	100.00
Valuation, Market Approach | Other secured borrowings, at fair value
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ (754,921,000)	$ (594,396,000)
Valuation, Market Approach | Other secured borrowings, at fair value | Measurement Input, Quoted Price | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt instrument, measurement input	85.37	97.77
Valuation, Market Approach | Other secured borrowings, at fair value | Measurement Input, Quoted Price | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt instrument, measurement input	105.61	100.45
Valuation, Market Approach | Other secured borrowings, at fair value | Measurement Input, Quoted Price | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt instrument, measurement input	102.04	100.61
Valuation, Market Approach | Other secured borrowings, at fair value | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt instrument, measurement input	0.016	0.029
Valuation, Market Approach | Other secured borrowings, at fair value | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt instrument, measurement input	0.030	0.040
Valuation, Market Approach | Other secured borrowings, at fair value | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt instrument, measurement input	0.026	0.033
Valuation, Market Approach | Other secured borrowings, at fair value | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt instrument, measurement input	0	0
Valuation, Market Approach | Other secured borrowings, at fair value | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt instrument, measurement input	0.753	0.966
Valuation, Market Approach | Other secured borrowings, at fair value | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt instrument, measurement input	0.487	0.572
Valuation, Income Approach | Non-Agency RMBS
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 57,219,000	$ 50,827,000	$ 54,346,000
Valuation, Income Approach | Non-Agency RMBS | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Total outstanding collateral			100.00%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			3.50%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			66.10%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			10.70%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			16.00%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			92.10%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			50.40%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Default Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			0.00%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Default Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			23.10%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Default Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			8.70%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Projected Collateral Recoveries | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			1.50%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Projected Collateral Recoveries | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			14.60%
Valuation, Income Approach | Non-Agency RMBS | Measurement Input, Projected Collateral Recoveries | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			7.30%
Valuation, Income Approach | Non-Agency RMBS | Measurement input, Projected Collateral Scheduled Amortization | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			6.10%
Valuation, Income Approach | Non-Agency RMBS | Measurement input, Projected Collateral Scheduled Amortization | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			61.80%
Valuation, Income Approach | Non-Agency RMBS | Measurement input, Projected Collateral Scheduled Amortization | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			33.60%
Valuation, Income Approach | CMBS
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	9,949,000	175,000	$ 227,000
Valuation, Income Approach | CMBS | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Total outstanding collateral			100.00%
Valuation, Income Approach | CMBS | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			3.40%
Valuation, Income Approach | CMBS | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			3.40%
Valuation, Income Approach | CMBS | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			3.40%
Valuation, Income Approach | CMBS | Measurement Input, Default Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			2.00%
Valuation, Income Approach | CMBS | Measurement Input, Default Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			2.00%
Valuation, Income Approach | CMBS | Measurement Input, Default Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			2.00%
Valuation, Income Approach | CMBS | Measurement Input, Projected Collateral Recoveries | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			6.60%
Valuation, Income Approach | CMBS | Measurement Input, Projected Collateral Recoveries | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			6.60%
Valuation, Income Approach | CMBS | Measurement Input, Projected Collateral Recoveries | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			6.60%
Valuation, Income Approach | CMBS | Measurement input, Projected Collateral Scheduled Amortization | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			91.40%
Valuation, Income Approach | CMBS | Measurement input, Projected Collateral Scheduled Amortization | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			91.40%
Valuation, Income Approach | CMBS | Measurement input, Projected Collateral Scheduled Amortization | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			91.40%
Valuation, Income Approach | Agency RMBS | Interest only securities
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	6,819,000	16,151,000	$ 6,549,000
Fair Value of Agency IOs, negative OAS measurement input	$ 4,500,000	$ 300,000
Valuation, Income Approach | Agency RMBS | Interest only securities | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			2.11%
Valuation, Income Approach | Agency RMBS | Interest only securities | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			35.21%
Valuation, Income Approach | Agency RMBS | Interest only securities | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			6.77%
Total outstanding collateral			100.00%
Valuation, Income Approach | Agency RMBS | Interest only securities | Measurement Input, LIBOR OAS | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.0297	0.0093
Valuation, Income Approach | Agency RMBS | Interest only securities | Measurement Input, LIBOR OAS | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.2886	0.3527
Valuation, Income Approach | Agency RMBS | Interest only securities | Measurement Input, LIBOR OAS | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.0914	0.0583
Valuation, Income Approach | Agency RMBS | Interest only securities | Net LIBOR OAS [Member] | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.0396	0.0576
Valuation, Income Approach | Agency RMBS | Interest only securities | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			37.70%
Valuation, Income Approach | Agency RMBS | Interest only securities | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			100.00%
Valuation, Income Approach | Agency RMBS | Interest only securities | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			66.20%
Valuation, Income Approach | Agency RMBS | Interest only securities | Measurement input, Projected Collateral Scheduled Amortization | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			0.00%
Valuation, Income Approach | Agency RMBS | Interest only securities | Measurement input, Projected Collateral Scheduled Amortization | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			62.30%
Valuation, Income Approach | Agency RMBS | Interest only securities | Measurement input, Projected Collateral Scheduled Amortization | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			33.80%
Valuation, Income Approach | Corporate Debt and non-exchange traded corporate equity [Member]
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 4,793,000
Valuation, Income Approach | Corporate Debt and non-exchange traded corporate equity [Member] | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			17.50%
Valuation, Income Approach | Corporate Debt and non-exchange traded corporate equity [Member] | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			17.50%
Valuation, Income Approach | Corporate Debt and non-exchange traded corporate equity [Member] | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			17.50%
Valuation, Income Approach | Corporate debt and equity
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 5,672,000	$ 2,507,000
Valuation, Income Approach | Corporate debt and equity | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.081	0.072
Valuation, Income Approach | Corporate debt and equity | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.108	0.100
Valuation, Income Approach | Corporate debt and equity | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.097	0.088
Valuation, Income Approach | CLOs
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 8,190,000	$ 6,759,000	$ 9,087,000
Valuation, Income Approach | CLOs | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Total outstanding collateral			100.00%
Valuation, Income Approach | CLOs | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			12.60%
Valuation, Income Approach | CLOs | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			103.10%
Valuation, Income Approach | CLOs | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			26.70%
Valuation, Income Approach | CLOs | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			8.10%
Valuation, Income Approach | CLOs | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			88.40%
Valuation, Income Approach | CLOs | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			65.20%
Valuation, Income Approach | CLOs | Measurement Input, Default Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			3.70%
Valuation, Income Approach | CLOs | Measurement Input, Default Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			40.80%
Valuation, Income Approach | CLOs | Measurement Input, Default Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			13.50%
Valuation, Income Approach | CLOs | Measurement Input, Projected Collateral Recoveries | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			4.20%
Valuation, Income Approach | CLOs | Measurement Input, Projected Collateral Recoveries | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			38.00%
Valuation, Income Approach | CLOs | Measurement Input, Projected Collateral Recoveries | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			11.90%
Valuation, Income Approach | CLOs | Measurement input, Projected Collateral Scheduled Amortization | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			3.50%
Valuation, Income Approach | CLOs | Measurement input, Projected Collateral Scheduled Amortization | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			13.50%
Valuation, Income Approach | CLOs | Measurement input, Projected Collateral Scheduled Amortization | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			9.40%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 206,761,000
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Total outstanding collateral			100.00%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			7.00%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			18.30%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			8.50%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			0.00%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			45.90%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			33.50%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement Input, Default Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			2.60%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement Input, Default Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			84.80%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement Input, Default Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			9.10%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement input, Projected Collateral Scheduled Amortization | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			15.20%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement input, Projected Collateral Scheduled Amortization | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			96.60%
Valuation, Income Approach | Consumer loans and asset-backed securities backed by consumer loans | Measurement input, Projected Collateral Scheduled Amortization | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			57.40%
Valuation, Income Approach | Asset-backed securities, backed by consumer loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	44,828,000	48,471,000
Valuation, Income Approach | Consumer loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 47,525,000	$ 186,954,000
Valuation, Income Approach | Consumer loans | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.078	0.067
Valuation, Income Approach | Consumer loans | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.281	0.196
Valuation, Income Approach | Consumer loans | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.112	0.094
Valuation, Income Approach | Consumer loans | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.000	0.000
Valuation, Income Approach | Consumer loans | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.360	0.442
Valuation, Income Approach | Consumer loans | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.173	0.160
Valuation, Income Approach | Consumer loans | Measurement Input, Default Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.009	0.037
Valuation, Income Approach | Consumer loans | Measurement Input, Default Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.866	0.845
Valuation, Income Approach | Consumer loans | Measurement Input, Default Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Securities, measurement input	0.094	0.086
Valuation, Income Approach | Corporate loan [Member]
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value		$ 12,500,000
Valuation, Income Approach | Corporate loan [Member] | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.211
Valuation, Income Approach | Corporate loan [Member] | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.211
Valuation, Income Approach | Corporate loan [Member] | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.211
Valuation, Income Approach | Performing commercial mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 163,876,000
Valuation, Income Approach | Performing commercial mortgage loans | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			8.00%
Valuation, Income Approach | Performing commercial mortgage loans | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			22.50%
Valuation, Income Approach | Performing commercial mortgage loans | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			9.60%
Valuation, Income Approach | Non-performing commercial mortgage loans and commercial real estate owned
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 80,513,000
Valuation, Income Approach | Non-performing commercial mortgage loans and commercial real estate owned | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time			3 months
Valuation, Income Approach | Non-performing commercial mortgage loans and commercial real estate owned | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time			16 months
Valuation, Income Approach | Non-performing commercial mortgage loans and commercial real estate owned | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time			7 months 27 days
Valuation, Income Approach | Non-performing commercial mortgage loans and commercial real estate owned | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			9.60%
Valuation, Income Approach | Non-performing commercial mortgage loans and commercial real estate owned | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			27.40%
Valuation, Income Approach | Non-performing commercial mortgage loans and commercial real estate owned | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			13.20%
Valuation, Income Approach | Performing residential mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 171,367,000
Valuation, Income Approach | Performing residential mortgage loans | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			2.70%
Valuation, Income Approach | Performing residential mortgage loans | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			12.90%
Valuation, Income Approach | Performing residential mortgage loans | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			6.00%
Valuation, Income Approach | Securitized residential mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 314,202,000
Valuation, Income Approach | Securitized residential mortgage loans | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			4.30%
Valuation, Income Approach | Securitized residential mortgage loans | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			4.60%
Valuation, Income Approach | Securitized residential mortgage loans | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			4.60%
Valuation, Income Approach | Non-performing residential mortgage loans and residential real estate owned
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 12,557,000
Valuation, Income Approach | Non-performing residential mortgage loans and residential real estate owned | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time			1 month 27 days
Valuation, Income Approach | Non-performing residential mortgage loans and residential real estate owned | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time			42 months 6 days
Valuation, Income Approach | Non-performing residential mortgage loans and residential real estate owned | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time			27 months 24 days
Valuation, Income Approach | Non-performing residential mortgage loans and residential real estate owned | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			4.30%
Valuation, Income Approach | Non-performing residential mortgage loans and residential real estate owned | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			25.10%
Valuation, Income Approach | Non-performing residential mortgage loans and residential real estate owned | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			11.30%
Valuation, Income Approach | Credit default swaps on asset-backed securities
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 347,000	$ 993,000	$ 1,472,000
Valuation, Income Approach | Credit default swaps on asset-backed securities | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Total outstanding collateral			100.00%
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement Input, Prepayment Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			33.60%
Derivative asset, measurement input	0.327	0.354
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement Input, Prepayment Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			42.00%
Derivative asset, measurement input	0.397	0.420
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement Input, Prepayment Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			36.50%
Derivative asset, measurement input	0.381	0.373
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement Input, Default Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			11.10%
Derivative asset, measurement input	0.066	0.042
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement Input, Default Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			15.60%
Derivative asset, measurement input	0.108	0.124
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement Input, Default Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			12.80%
Derivative asset, measurement input	0.089	0.102
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement Input, Projected Collateral Recoveries | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			10.30%
Derivative asset, measurement input	0.139	0.100
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement Input, Projected Collateral Recoveries | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			18.70%
Derivative asset, measurement input	0.181	0.182
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement Input, Projected Collateral Recoveries | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			15.80%
Derivative asset, measurement input	0.156	0.153
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement input, Projected Collateral Scheduled Amortization | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			32.00%
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement input, Projected Collateral Scheduled Amortization | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			36.50%
Valuation, Income Approach | Credit default swaps on asset-backed securities | Measurement input, Projected Collateral Scheduled Amortization | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			34.90%
Valuation, Income Approach | Total return swaps
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 9,000	$ 620,000
Fair value	(484,000)	(436,000)
Valuation, Income Approach | Investment in unconsolidated entities
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 5,192,000
Valuation, Income Approach | Investment in unconsolidated entities | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			12.90%
Valuation, Income Approach | Investment in unconsolidated entities | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			16.10%
Valuation, Income Approach | Investment in unconsolidated entities | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, percent			15.40%
Valuation, Income Approach | Other secured borrowings, at fair value
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ (297,948,000)
Valuation, Income Approach | Other secured borrowings, at fair value | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt, measurement input			3.90%
Valuation, Income Approach | Other secured borrowings, at fair value | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt, measurement input			4.40%
Valuation, Income Approach | Other secured borrowings, at fair value | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Debt, measurement input			4.30%
Enterprise Value | Investment in unconsolidated entities
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 141,620,000	$ 71,850,000
Enterprise Value | Corporate equity securities | Non-exchange traded common equity investment in mortgage-related entity
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 6,750,000
Enterprise Value | Corporate equity securities | Non-exchange traded common equity investment in mortgage-related entity | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			3.3
Enterprise Value | Corporate equity securities | Non-exchange traded common equity investment in mortgage-related entity | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			3.3
Enterprise Value | Corporate equity securities | Non-exchange traded common equity investment in mortgage-related entity | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			3.3
Enterprise Value | Corporate equity securities | Non-exchange traded preferred equity investment in mortgage-related entity
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value			$ 27,317,000
Enterprise Value | Corporate equity securities | Non-exchange traded preferred equity investment in mortgage-related entity | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			1.1
Enterprise Value | Corporate equity securities | Non-exchange traded preferred equity investment in mortgage-related entity | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			1.1
Enterprise Value | Corporate equity securities | Non-exchange traded preferred equity investment in mortgage-related entity | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input			1.1
measurement input equity multiple | Investment in unconsolidated entities | Measurement Input, Equity Price-to-Book | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Equity method investment, measurement input	1.0	1.0
measurement input equity multiple | Investment in unconsolidated entities | Measurement Input, Equity Price-to-Book | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Equity method investment, measurement input	6.2	4.7
measurement input equity multiple | Investment in unconsolidated entities | Measurement Input, Equity Price-to-Book | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Equity method investment, measurement input	1.4	1.4
Performing and/or Re-performing | Residential mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 353,924,000
Performing and/or Re-performing | Residential mortgage loans | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.025	0.004
Performing and/or Re-performing | Residential mortgage loans | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.285	0.195
Performing and/or Re-performing | Residential mortgage loans | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.054	0.063
Performing and/or Re-performing | Residential mortgage loans | Measurement Input, Offered Price | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	60.00
Performing and/or Re-performing | Residential mortgage loans | Measurement Input, Offered Price | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	103.88
Performing and/or Re-performing | Residential mortgage loans | Measurement Input, Offered Price | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	103.44
Performing and/or Re-performing | Valuation, Market Approach | Residential mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 15,659,000
Performing and/or Re-performing | Valuation, Income Approach | Commercial mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 181,545,000	$ 248,214,000
Performing and/or Re-performing | Valuation, Income Approach | Commercial mortgage loans | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.037	0.077
Performing and/or Re-performing | Valuation, Income Approach | Commercial mortgage loans | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.097	0.166
Performing and/or Re-performing | Valuation, Income Approach | Commercial mortgage loans | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.081	0.088
Performing and/or Re-performing | Valuation, Income Approach | Residential mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 338,265,000	$ 289,672,000
Securitized loans [Member] | Residential mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	801,343,000	628,415,000
Securitized loans [Member] | Valuation, Market Approach | Residential mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 783,162,000	$ 621,762,000
Securitized loans [Member] | Valuation, Market Approach | Residential mortgage loans | Measurement Input, Quoted Price | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	5.34	2.56
Securitized loans [Member] | Valuation, Market Approach | Residential mortgage loans | Measurement Input, Quoted Price | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	105.61	100.45
Securitized loans [Member] | Valuation, Market Approach | Residential mortgage loans | Measurement Input, Quoted Price | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	100.22	98.23
Securitized loans [Member] | Valuation, Income Approach | Residential mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 18,182,000	$ 6,653,000
Securitized loans [Member] | Valuation, Income Approach | Residential mortgage loans | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0	0.032
Securitized loans [Member] | Valuation, Income Approach | Residential mortgage loans | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.387	0.043
Securitized loans [Member] | Valuation, Income Approach | Residential mortgage loans | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.044	0.036
Securitized loans [Member] | Valuation, Income Approach | Residential mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 26,400,000	$ 1,500,000
Non-performing | Residential mortgage loans | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.012	0.010
Non-performing | Residential mortgage loans | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.410	0.266
Non-performing | Residential mortgage loans | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.121	0.092
Non-performing | Residential mortgage loans | Measurement Input recovery amount | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input, Recovery Amount	$ 0.009	$ 0.280
Non-performing | Residential mortgage loans | Measurement Input recovery amount | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input, Recovery Amount	17.130	4.643
Non-performing | Residential mortgage loans | Measurement Input recovery amount | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input, Recovery Amount	0.306	0.943
Non-performing | Valuation, Income Approach | Commercial mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 31,486,000	$ 26,545,000
Non-performing | Valuation, Income Approach | Commercial mortgage loans | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time	1 month 24 days	1 month 3 days
Non-performing | Valuation, Income Approach | Commercial mortgage loans | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time	5 months 24 days	23 months
Non-performing | Valuation, Income Approach | Commercial mortgage loans | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time	3 months 21 days	11 months 12 days
Non-performing | Valuation, Income Approach | Commercial mortgage loans | Measurement Input, Discount Rate | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.086	0.098
Non-performing | Valuation, Income Approach | Commercial mortgage loans | Measurement Input, Discount Rate | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.146	0.147
Non-performing | Valuation, Income Approach | Commercial mortgage loans | Measurement Input, Discount Rate | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input	0.108	0.124
Non-performing | Valuation, Income Approach | Commercial mortgage loans | Measurement Input recovery amount | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input, Recovery Amount	$ 1.000	$ 1.000
Non-performing | Valuation, Income Approach | Commercial mortgage loans | Measurement Input recovery amount | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input, Recovery Amount	1.024	1.000
Non-performing | Valuation, Income Approach | Commercial mortgage loans | Measurement Input recovery amount | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Loans, Measurement Input, Recovery Amount	1.008	1.000
Non-performing | Valuation, Income Approach | Residential mortgage loans
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Fair value	$ 31,802,000	$ 14,116,000
Non-performing | Valuation, Income Approach | Residential mortgage loans | Minimum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time	0 months	1 month 3 days
Non-performing | Valuation, Income Approach | Residential mortgage loans | Maximum
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time	106 months 18 days	165 months 12 days
Non-performing | Valuation, Income Approach | Residential mortgage loans | Weighted Average
Fair Value Measurements Inputs and Valuation Techniques [Line Items]
Investment, measurement input, recovery time	30 months	54 months 18 days

XML

Valuation (Significant Unobservable Inputs Rollforward) (Details) - Level 3 - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	$ 1,721,275	$ 1,094,816
Assets, Accreted Discounts/Amortized Premiums	(39,237)	(40,792)
Assets, Realized Gain (Loss)	(15,898)	(3,380)
Assets, Change In Net Unrealized Gain/(Loss)	36,777	18,989
Assets, Purchases	1,131,307	1,229,160
Assets, Sales	(945,519)	(603,883)
Assets, Transfers into Level 3	92,143	35,567
Assets, Transfers out of Level 3	(21,046)	(9,202)
Assets, Ending Balance	1,959,802	1,721,275	$ 1,094,816
Liabilities, Begining Balance	(594,832)	(297,948)	(125,105)
Liabilities, Accreted Discounts/Amortized Premiums	0	0	0
Liabilities, Realized Gain/(Loss)	(551)	(15)	0
Liabilities, Change In Net Unrealized Gain/(Loss)	(9,624)	(938)	758
Liabilities Purchases/Payments	306,420	182,306	49,731
Liabilities, Sales/Issuance	(456,818)	(478,237)	223,332
Liabilities, Transfers into Level 3	0	0	0
Liabilities, Transfers out of Level 3	0	0	0
Liabilities, Ending Balance	(755,405)	(594,832)	(297,948)
Other secured borrowings, at fair value
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, Begining Balance	(594,396)	(297,948)	(125,105)
Liabilities, Accreted Discounts/Amortized Premiums	0	0	0
Liabilities, Realized Gain/(Loss)	0	0	0
Liabilities, Change In Net Unrealized Gain/(Loss)	(9,576)	(502)	758
Liabilities, Payments	305,828	182,291	49,731
Liabilities, Issuances	(456,777)	(478,237)	(223,332)
Liabilities, Transfers into Level 3	0	0	0
Liabilities, Transfers out of Level 3	0	0	0
Liabilities, Ending Balance	(754,921)	(594,396)	(297,948)
Change in unrealized gains (losses), liabilities	(9,600)	100	800
Financial Derivatives - Liabilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Change in unrealized gains (losses), liabilities	(500)	(400)
Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Change in unrealized gain (loss), assets	(33,300)	2,400
Securities | Agency RMBS
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	19,904	7,293
Assets, Accreted Discounts/Amortized Premiums	(7,903)	(3,464)
Assets, Realized Gain (Loss)	722	(1,787)
Assets, Change In Net Unrealized Gain/(Loss)	3,175	808
Assets, Purchases	8,307	13,818
Assets, Sales	(5,046)	(1,306)
Assets, Transfers into Level 3	1,083	5,370
Assets, Transfers out of Level 3	(8,579)	(828)
Assets, Ending Balance	11,663	19,904	7,293
Securities | Non-Agency RMBS
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	89,581	91,291
Assets, Accreted Discounts/Amortized Premiums	1,557	270
Assets, Realized Gain (Loss)	1,009	5,636
Assets, Change In Net Unrealized Gain/(Loss)	(1,283)	(3,654)
Assets, Purchases	64,362	21,512
Assets, Sales	(40,841)	(33,664)
Assets, Transfers into Level 3	17,425	15,354
Assets, Transfers out of Level 3	(3,972)	(7,164)
Assets, Ending Balance	127,838	89,581	91,291
Securities | CMBS
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	29,805	803
Assets, Accreted Discounts/Amortized Premiums	813	16
Assets, Realized Gain (Loss)	62	180
Assets, Change In Net Unrealized Gain/(Loss)	(2,477)	(246)
Assets, Purchases	52,915	31,464
Assets, Sales	(38,553)	(5,271)
Assets, Transfers into Level 3	20,583	2,859
Assets, Transfers out of Level 3	0	0
Assets, Ending Balance	63,148	29,805	803
Securities | CLOs
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	44,979	14,915
Assets, Accreted Discounts/Amortized Premiums	2,185	(268)
Assets, Realized Gain (Loss)	(8,862)	(3,190)
Assets, Change In Net Unrealized Gain/(Loss)	(13,132)	2,329
Assets, Purchases	48,120	25,531
Assets, Sales	(6,747)	(5,112)
Assets, Transfers into Level 3	53,052	11,984
Assets, Transfers out of Level 3	(8,495)	(1,210)
Assets, Ending Balance	111,100	44,979	14,915
Securities | Asset-backed securities, backed by consumer loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	48,610	22,800
Assets, Accreted Discounts/Amortized Premiums	(4,986)	(2,520)
Assets, Realized Gain (Loss)	(138)	(891)
Assets, Change In Net Unrealized Gain/(Loss)	(1,245)	873
Assets, Purchases	30,899	42,137
Assets, Sales	(28,215)	(13,789)
Assets, Transfers into Level 3	0	0
Assets, Transfers out of Level 3	0	0
Assets, Ending Balance	44,925	48,610	22,800
Securities | Corporate debt securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	1,113	6,318
Assets, Accreted Discounts/Amortized Premiums	0	22
Assets, Realized Gain (Loss)	914	(1,341)
Assets, Change In Net Unrealized Gain/(Loss)	1,068	188
Assets, Purchases	5,668	11,024
Assets, Sales	(4,681)	(15,098)
Assets, Transfers into Level 3	0	0
Assets, Transfers out of Level 3	0	0
Assets, Ending Balance	4,082	1,113	6,318
Securities | Corporate equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	1,394	1,534
Assets, Accreted Discounts/Amortized Premiums	0	0
Assets, Realized Gain (Loss)	7	(1,807)
Assets, Change In Net Unrealized Gain/(Loss)	(165)	205
Assets, Purchases	366	1,462
Assets, Sales	(12)	0
Assets, Transfers into Level 3	0	0
Assets, Transfers out of Level 3	0	0
Assets, Ending Balance	1,590	1,394	1,534
Investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		1,124,606	658,448
Assets, Accreted Discounts/Amortized Premiums			(32,013)
Assets, Realized Gain (Loss)			16,205
Assets, Change In Net Unrealized Gain/(Loss)			3,821
Assets, Purchases			937,544
Assets, Sales			(438,411)
Assets, Transfers into Level 3			13,649
Assets, Transfers out of Level 3			(34,637)
Assets, Ending Balance			1,124,606
Change in unrealized gain (loss), assets			5,300
Investments | Agency RMBS
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		7,293	6,173
Assets, Accreted Discounts/Amortized Premiums			(2,233)
Assets, Realized Gain (Loss)			(10)
Assets, Change In Net Unrealized Gain/(Loss)			175
Assets, Purchases			2,753
Assets, Sales			(1,169)
Assets, Transfers into Level 3			2,616
Assets, Transfers out of Level 3			(1,012)
Assets, Ending Balance			7,293
Investments | Non-Agency RMBS
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		91,291	101,297
Assets, Accreted Discounts/Amortized Premiums			383
Assets, Realized Gain (Loss)			1,838
Assets, Change In Net Unrealized Gain/(Loss)			(2,135)
Assets, Purchases			75,685
Assets, Sales			(78,487)
Assets, Transfers into Level 3			7,074
Assets, Transfers out of Level 3			(14,364)
Assets, Ending Balance			91,291
Investments | CMBS
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		803	12,347
Assets, Accreted Discounts/Amortized Premiums			(243)
Assets, Realized Gain (Loss)			2,229
Assets, Change In Net Unrealized Gain/(Loss)			2,120
Assets, Purchases			1,481
Assets, Sales			(16,896)
Assets, Transfers into Level 3			0
Assets, Transfers out of Level 3			(235)
Assets, Ending Balance			803
Investments | CLOs
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		14,915	24,911
Assets, Accreted Discounts/Amortized Premiums			(351)
Assets, Realized Gain (Loss)			317
Assets, Change In Net Unrealized Gain/(Loss)			(2,268)
Assets, Purchases			33,549
Assets, Sales			(33,115)
Assets, Transfers into Level 3			3,959
Assets, Transfers out of Level 3			(12,087)
Assets, Ending Balance			14,915
Investments | Corporate debt securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		6,318	23,947
Assets, Accreted Discounts/Amortized Premiums			56
Assets, Realized Gain (Loss)			241
Assets, Change In Net Unrealized Gain/(Loss)			(964)
Assets, Purchases			7,665
Assets, Sales			(17,688)
Assets, Transfers into Level 3			0
Assets, Transfers out of Level 3			(6,939)
Assets, Ending Balance			6,318
Investments | Secured notes
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		10,917	0
Assets, Accreted Discounts/Amortized Premiums			870
Assets, Realized Gain (Loss)			0
Assets, Change In Net Unrealized Gain/(Loss)			(1,221)
Assets, Purchases			11,268
Assets, Sales			0
Assets, Transfers into Level 3			0
Assets, Transfers out of Level 3			0
Assets, Ending Balance			10,917
Investments | Corporate equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		43,793	37,465
Assets, Accreted Discounts/Amortized Premiums			0
Assets, Realized Gain (Loss)			1,671
Assets, Change In Net Unrealized Gain/(Loss)			8,299
Assets, Purchases			12,708
Assets, Sales			(16,350)
Assets, Transfers into Level 3			0
Assets, Transfers out of Level 3			0
Assets, Ending Balance			43,793
Investments | Residential mortgage loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		496,830	182,472
Assets, Accreted Discounts/Amortized Premiums			(1,965)
Assets, Realized Gain (Loss)			1,011
Assets, Change In Net Unrealized Gain/(Loss)			(34)
Assets, Purchases			402,235
Assets, Sales			(86,889)
Assets, Transfers into Level 3			0
Assets, Transfers out of Level 3			0
Assets, Ending Balance			496,830
Investments | Commercial mortgage loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance			108,301
Assets, Accreted Discounts/Amortized Premiums			790
Assets, Realized Gain (Loss)			1,146
Assets, Change In Net Unrealized Gain/(Loss)			1,944
Assets, Purchases			149,053
Assets, Sales			(50,049)
Assets, Transfers into Level 3			0
Assets, Transfers out of Level 3			0
Investments | Consumer loans and asset-backed securities backed by consumer loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		206,761	135,258
Assets, Accreted Discounts/Amortized Premiums			(29,320)
Assets, Realized Gain (Loss)			8,415
Assets, Change In Net Unrealized Gain/(Loss)			(1,092)
Assets, Purchases			228,354
Assets, Sales			(134,854)
Assets, Transfers into Level 3			0
Assets, Transfers out of Level 3			0
Assets, Ending Balance			206,761
Investments | Real estate owned
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		34,500	26,277
Assets, Accreted Discounts/Amortized Premiums			0
Assets, Realized Gain (Loss)			(653)
Assets, Change In Net Unrealized Gain/(Loss)			(1,003)
Assets, Purchases			12,793
Assets, Sales			(2,914)
Assets, Transfers into Level 3			0
Assets, Transfers out of Level 3			0
Assets, Ending Balance			34,500
Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Change in unrealized gain (loss), assets	8,600	11,500
Loans | Residential mortgage loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	932,203	496,830
Assets, Accreted Discounts/Amortized Premiums	(6,445)	(6,081)
Assets, Realized Gain (Loss)	(165)	1,466
Assets, Change In Net Unrealized Gain/(Loss)	11,593	8,800
Assets, Purchases	594,397	661,813
Assets, Sales	(344,514)	(230,625)
Assets, Transfers into Level 3	0	0
Assets, Transfers out of Level 3	0	0
Assets, Ending Balance	1,187,069	932,203	496,830
Loans | Commercial mortgage loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	274,759	195,301
Assets, Accreted Discounts/Amortized Premiums	128	(282)
Assets, Realized Gain (Loss)	135	2,412
Assets, Change In Net Unrealized Gain/(Loss)	(166)	(2,083)
Assets, Purchases	121,844	175,689
Assets, Sales	(183,669)	(96,278)
Assets, Transfers into Level 3	0	0
Assets, Transfers out of Level 3	0	0
Assets, Ending Balance	213,031	274,759	195,301
Loans | Consumer loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	186,954	183,961
Assets, Accreted Discounts/Amortized Premiums	(24,586)	(28,521)
Assets, Realized Gain (Loss)	(4,843)	(6,291)
Assets, Change In Net Unrealized Gain/(Loss)	(2,891)	3,000
Assets, Purchases	141,245	183,994
Assets, Sales	(248,354)	(149,189)
Assets, Transfers into Level 3	0	0
Assets, Transfers out of Level 3	0	0
Assets, Ending Balance	47,525	186,954	183,961
Loans | Corporate loan [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	18,510	0
Assets, Accreted Discounts/Amortized Premiums	0	36
Assets, Realized Gain (Loss)	0	0
Assets, Change In Net Unrealized Gain/(Loss)	0	(36)
Assets, Purchases	1,445	18,510
Assets, Sales	(14,100)	0
Assets, Transfers into Level 3	0	0
Assets, Transfers out of Level 3	0	0
Assets, Ending Balance	5,855	18,510	0
Investment in unconsolidated entities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	71,850	72,298
Assets, Accreted Discounts/Amortized Premiums	0	0
Assets, Realized Gain (Loss)	424	1,545
Assets, Change In Net Unrealized Gain/(Loss)	37,509	8,664
Assets, Purchases	61,589	42,173
Assets, Sales	(29,752)	(52,830)
Assets, Transfers into Level 3	0	0
Assets, Transfers out of Level 3	0	0
Assets, Ending Balance	141,620	71,850	72,298
Change in unrealized gain (loss), assets	37,100	5,200
Financial Derivatives - Assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		1,472	3,140
Assets, Accreted Discounts/Amortized Premiums			0
Assets, Realized Gain (Loss)			(687)
Assets, Change In Net Unrealized Gain/(Loss)			715
Assets, Purchases			102
Assets, Sales			(1,798)
Assets, Transfers into Level 3			0
Assets, Transfers out of Level 3			0
Assets, Ending Balance			1,472
Change in unrealized gain (loss), assets	500	100	(600)
Financial Derivatives - Assets | Total return swaps
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	620	0
Assets, Accreted Discounts/Amortized Premiums	0	0
Assets, Realized Gain (Loss)	288	160
Assets, Change In Net Unrealized Gain/(Loss)	(611)	620
Assets, Purchases	126	0
Assets, Sales	(414)	(160)
Assets, Transfers into Level 3	0	0
Assets, Transfers out of Level 3	0	0
Assets, Ending Balance	9	620	0
Financial Derivatives - Assets | Credit default swaps on asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance	993	1,472	3,140
Assets, Accreted Discounts/Amortized Premiums	0	0	0
Assets, Realized Gain (Loss)	(5,451)	528	(687)
Assets, Change In Net Unrealized Gain/(Loss)	5,402	(479)	715
Assets, Purchases	24	33	102
Assets, Sales	(621)	(561)	(1,798)
Assets, Transfers into Level 3	0	0	0
Assets, Transfers out of Level 3	0	0	0
Assets, Ending Balance	347	993	1,472
Financial Derivatives - Liabilities | Total return swaps
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, Begining Balance	(436)	0
Liabilities, Accreted Discounts/Amortized Premiums	0	0
Liabilities, Realized Gain/(Loss)	(551)	(15)
Liabilities, Change In Net Unrealized Gain/(Loss)	(48)	(436)
Liabilities, Payments	592	15
Liabilities, Issuances	(41)	0
Liabilities, Transfers into Level 3	0	0
Liabilities, Transfers out of Level 3	0	0
Liabilities, Ending Balance	$ (484)	(436)	0
Previous Accounting Guidance [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		1,126,078	661,588
Assets, Accreted Discounts/Amortized Premiums			(32,013)
Assets, Realized Gain (Loss)			15,518
Assets, Change In Net Unrealized Gain/(Loss)			4,536
Assets, Purchases			937,646
Assets, Sales			(440,209)
Assets, Transfers into Level 3			13,649
Assets, Transfers out of Level 3			(34,637)
Assets, Ending Balance			1,126,078
Previous Accounting Guidance [Member] | Investments | Commercial mortgage loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, Beginning Balance		$ 211,185
Assets, Ending Balance			$ 211,185

XML

Valuation (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term Debt, Fair Value			$ 86,000
Level 3 | Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in unrealized gains (losses)	$ (33,300)	$ 2,400
Level 3 | Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in unrealized gains (losses)	8,600	11,500
Level 3 | Investment in unconsolidated entities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in unrealized gains (losses)	37,100	5,200
Level 3 | Financial Derivatives - Assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in unrealized gains (losses)	500	100	(600)
Level 3 | Other secured borrowings, at fair value
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in unrealized gains (losses)	(9,600)	100	$ 800
Level 3 | Financial Derivatives - Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in unrealized gains (losses)	$ (500)	$ (400)

XML

Valuation (Fair Value of Other Financial Instruments) (Details) - USD ($) $ in Thousands	Dec. 31, 2020		Dec. 31, 2019		Dec. 31, 2018
Assets:
Cash and cash equivalents	$ 111,647	[1]	$ 72,302	[1]	$ 44,656
Restricted cash					425
Due from brokers	63,147	[1]	79,829	[1]	71,794
Repurchase agreements, at fair value	38,640		73,639		61,274
Liabilities:
Repurchase agreements	1,496,931	[1]	2,445,300	[1]	1,498,849
Other secured borrowings	51,062	[1]	150,334	[1]	114,100
Senior notes, net	85,561		85,298		85,035
Due to brokers	5,059		2,197		$ 5,553
Fair Value
Assets:
Cash and cash equivalents	111,647		72,302
Restricted cash	175		175
Due from brokers	63,147		79,829
Repurchase agreements, at fair value	38,640		73,639
Liabilities:
Repurchase agreements	1,496,931		2,445,300
Other secured borrowings	51,062		150,334
Senior notes, net	86,000		88,365
Due to brokers	5,059		2,197
Carrying Value
Assets:
Cash and cash equivalents	111,647		72,302
Restricted cash	175		175
Due from brokers	63,147		79,829
Repurchase agreements, at fair value	38,640		73,639
Liabilities:
Repurchase agreements	1,496,931		2,445,300
Other secured borrowings	51,062		150,334
Senior notes, net	85,561		85,298
Due to brokers	$ 5,059		$ 2,197

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

XML

Investment in Securities (Summary of Investment in Securities) (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Securities, Available-for-sale [Line Items]
Current Principal		$ 1,408,233	$ 2,282,149
Unamortized Premium (Discount)		(196,118)	(150,821)
Amortized Cost		1,474,155	2,342,369
Gross Unrealized Gains		60,617	43,801
Gross Unrealized Losses		(59,229)	(9,638)
Investment Owned At Fair Value, Net		1,475,543	2,376,532
Securities, at fair value(1)(2)	[1],[2]	1,514,185	2,449,941
Securities sold short, at fair value		$ (38,642)	$ (73,409)	$ (850,577)
Fair Value				$ 2,939,311
Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.92%	4.23%
Weighted Average Yield		4.77%	4.01%
Weighted average life		4 years 5 months 26 days	5 years 10 months 24 days
Long
Securities, Available-for-sale [Line Items]
Current Principal		$ 1,446,237	$ 2,355,498
Unamortized Premium (Discount)		(199,280)	(151,329)
Amortized Cost		1,508,997	2,415,210
Gross Unrealized Gains		60,617	43,738
Gross Unrealized Losses		(55,429)	(9,007)
Securities, at fair value(1)(2)		$ 1,514,185	$ 2,449,941
Long | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.84%	4.15%
Weighted Average Yield		4.88%	4.09%
Weighted average life		4 years 5 months 12 days	5 years 10 months 17 days
Long | 15-year fixed-rate mortgages
Securities, Available-for-sale [Line Items]
Current Principal		$ 67,875	$ 314,636
Unamortized Premium (Discount)		2,543	6,369
Amortized Cost		70,418	321,005
Gross Unrealized Gains		1,832	2,604
Gross Unrealized Losses		(36)	(203)
Securities, at fair value(1)(2)		$ 72,214	$ 323,406
Long | 15-year fixed-rate mortgages | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.30%	3.05%
Weighted Average Yield		1.83%	2.28%
Weighted average life		3 years 2 months 26 days	3 years 18 days
Long | 20-year fixed-rate mortgages
Securities, Available-for-sale [Line Items]
Current Principal		$ 50,131	$ 804
Unamortized Premium (Discount)		3,097	49
Amortized Cost		53,228	853
Gross Unrealized Gains		182	24
Gross Unrealized Losses		0	0
Securities, at fair value(1)(2)		$ 53,410	$ 877
Long | 20-year fixed-rate mortgages | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		2.57%	4.62%
Weighted Average Yield		1.08%	2.99%
Weighted average life		4 years 5 months 15 days	4 years 9 months 18 days
Long | 30-year fixed-rate mortgages
Securities, Available-for-sale [Line Items]
Current Principal		$ 626,021	$ 1,358,762
Unamortized Premium (Discount)		30,738	64,846
Amortized Cost		656,759	1,423,608
Gross Unrealized Gains		25,765	13,821
Gross Unrealized Losses		(444)	(2,830)
Securities, at fair value(1)(2)		$ 682,080	$ 1,434,599
Long | 30-year fixed-rate mortgages | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.99%	4.20%
Weighted Average Yield		2.35%	2.95%
Weighted average life		4 years 2 months 1 day	6 years 7 months 17 days
Long | Adjustable rate mortgages
Securities, Available-for-sale [Line Items]
Current Principal		$ 6,171	$ 9,651
Unamortized Premium (Discount)		159	315
Amortized Cost		6,330	9,966
Gross Unrealized Gains		124	90
Gross Unrealized Losses		0	(54)
Securities, at fair value(1)(2)		$ 6,454	$ 10,002
Long | Adjustable rate mortgages | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.66%	3.99%
Weighted Average Yield		2.27%	2.03%
Weighted average life		3 years 5 months 1 day	4 years 1 month 2 days
Long | Reverse mortgages
Securities, Available-for-sale [Line Items]
Current Principal		$ 89,383	$ 122,670
Unamortized Premium (Discount)		5,152	8,133
Amortized Cost		94,535	130,803
Gross Unrealized Gains		3,123	2,023
Gross Unrealized Losses		(29)	(26)
Securities, at fair value(1)(2)		$ 97,629	$ 132,800
Long | Reverse mortgages | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.97%	4.43%
Weighted Average Yield		2.37%	2.78%
Weighted average life		4 years 7 months 6 days	6 years 8 months 1 day
Long | Interest only securities
Securities, Available-for-sale [Line Items]
Amortized Cost		$ 43,406	$ 34,044
Gross Unrealized Gains		5,808	1,624
Gross Unrealized Losses		(1,558)	(389)
Securities, at fair value(1)(2)		$ 47,656	$ 35,279
Long | Interest only securities | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.36%	2.81%
Weighted Average Yield		10.01%	9.27%
Weighted average life		4 years 10 months 6 days	3 years 10 months 9 days
Long | Non-Agency RMBS
Securities, Available-for-sale [Line Items]
Current Principal		$ 321,842	$ 274,353
Unamortized Premium (Discount)		(131,083)	(122,685)
Amortized Cost		190,759	151,668
Gross Unrealized Gains		15,880	12,549
Gross Unrealized Losses		(5,549)	(1,081)
Securities, at fair value(1)(2)		$ 201,090	$ 163,136
Long | Non-Agency RMBS | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.15%	3.41%
Weighted Average Yield		6.40%	7.25%
Weighted average life		5 years 5 months 15 days	5 years 3 months 21 days
Long | CMBS
Securities, Available-for-sale [Line Items]
Current Principal		$ 188,085	$ 185,417
Unamortized Premium (Discount)		(61,763)	(67,961)
Amortized Cost		126,322	117,456
Gross Unrealized Gains		1,655	2,990
Gross Unrealized Losses		(16,910)	(480)
Securities, at fair value(1)(2)		$ 111,067	$ 119,966
Long | CMBS | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		2.71%	3.31%
Weighted Average Yield		7.47%	6.62%
Weighted average life		8 years 1 month 2 days	8 years 11 months 8 days
Long | Non-Agency IOs
Securities, Available-for-sale [Line Items]
Amortized Cost		$ 8,123	$ 6,517
Gross Unrealized Gains		1,792	1,817
Gross Unrealized Losses		(305)	(18)
Securities, at fair value(1)(2)		$ 9,610	$ 8,316
Long | Non-Agency IOs | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		1.17%	1.10%
Weighted Average Yield		18.85%	8.18%
Weighted average life		3 years 5 months 26 days	4 years 1 month 20 days
Long | CLOs
Securities, Available-for-sale [Line Items]
Amortized Cost		$ 208,907	$ 169,238
Gross Unrealized Gains		2,563	4,219
Gross Unrealized Losses		(30,199)	(3,014)
Securities, at fair value(1)(2)		$ 181,271	$ 170,443
Long | CLOs | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.67%	5.05%
Weighted Average Yield		8.50%	9.62%
Weighted average life		3 years 6 months	4 years 9 months
Long | Asset-backed securities, backed by consumer loans
Securities, Available-for-sale [Line Items]
Current Principal		$ 69,646	$ 67,080
Unamortized Premium (Discount)		(24,936)	(19,154)
Amortized Cost		44,710	47,926
Gross Unrealized Gains		221	1,596
Gross Unrealized Losses		(6)	(912)
Securities, at fair value(1)(2)		$ 44,925	$ 48,610
Long | Asset-backed securities, backed by consumer loans | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		11.95%	12.17%
Weighted Average Yield		18.57%	14.00%
Weighted average life		1 year 1 month 9 days	1 year 2 months 19 days
Long | Corporate debt securities
Securities, Available-for-sale [Line Items]
Current Principal		$ 27,083	$ 22,125
Unamortized Premium (Discount)		(23,187)	(21,241)
Amortized Cost		3,896	884
Gross Unrealized Gains		1,296	229
Gross Unrealized Losses		(3)	0
Securities, at fair value(1)(2)		$ 5,189	$ 1,113
Long | Corporate debt securities | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		2.13%	0.00%
Weighted Average Yield		6.75%	0.00%
Weighted average life		3 years 1 month 6 days	3 months 29 days
Long | Corporate equity securities
Securities, Available-for-sale [Line Items]
Amortized Cost		$ 1,604	$ 1,242
Securities, at fair value(1)(2)		1,590	1,394
Corporate equity, gross unrealized gains		376	152
Corporate equity, gross unrealized losses		(390)	0
Short
Securities, Available-for-sale [Line Items]
Current Principal		(38,004)	(73,349)
Unamortized Premium (Discount)		3,162	508
Investment Sold, Not yet Purchased, Sale Proceeds		(34,842)	(72,841)
Gross Unrealized Gains		0	63
Gross Unrealized Losses		(3,800)	(631)
Securities sold short, at fair value		$ (38,642)	$ (73,409)
Short | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		0.26%	1.65%
Weighted Average Yield		0.09%	1.66%
Weighted average life		3 years 1 month 17 days	5 years 5 months 26 days
Short | Corporate debt securities
Securities, Available-for-sale [Line Items]
Current Principal		$ (200)	$ (450)
Unamortized Premium (Discount)		(1)	(6)
Investment Sold, Not yet Purchased, Sale Proceeds		(201)	(456)
Gross Unrealized Gains		0	0
Gross Unrealized Losses		(17)	(15)
Securities sold short, at fair value		$ (218)	$ (471)
Short | Corporate debt securities | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		5.09%	5.44%
Weighted Average Yield		4.67%	5.21%
Weighted average life		6 years 5 months 1 day	4 years 10 months 24 days
Short | U.S. Treasury securities
Securities, Available-for-sale [Line Items]
Current Principal			$ (63,140)
Unamortized Premium (Discount)			381
Investment Sold, Not yet Purchased, Sale Proceeds			(62,759)
Gross Unrealized Gains			63
Gross Unrealized Losses			(298)
Securities sold short, at fair value			$ (62,994)
Short | U.S. Treasury securities | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon			1.76%
Weighted Average Yield			1.87%
Weighted average life			6 years 1 month 9 days
Short | European sovereign bonds
Securities, Available-for-sale [Line Items]
Current Principal		$ (37,804)	$ (9,759)
Unamortized Premium (Discount)		3,163	133
Investment Sold, Not yet Purchased, Sale Proceeds		(34,641)	(9,626)
Gross Unrealized Gains		0	0
Gross Unrealized Losses		(3,783)	(318)
Securities sold short, at fair value		$ (38,424)	$ (9,944)
Short | European sovereign bonds | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		0.23%	0.77%
Weighted Average Yield		0.06%	0.12%
Weighted average life		3 years 1 month 9 days	1 year 6 months 29 days

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Investment in Securities (Maturities of Securities) (Details) - USD ($) $ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)	[1],[2]	$ 1,514,185	$ 2,449,941
Amortized Cost		$ 1,474,155	$ 2,342,369
Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.92%	4.23%
Long
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 1,514,185	$ 2,449,941
Amortized Cost		$ 1,508,997	$ 2,415,210
Long | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.84%	4.15%
Long | Agency RMBS
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 911,787	$ 1,901,684
Amortized Cost		$ 881,270	$ 1,886,235
Long | Agency RMBS | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.84%	4.02%
Long | Agency RMBS | Less than three years [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 139,059	$ 188,593
Amortized Cost		$ 135,844	$ 187,099
Long | Agency RMBS | Less than three years [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		4.15%	3.39%
Long | Agency RMBS | Greater than three years less than seven years [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 770,173	$ 961,839
Amortized Cost		$ 742,946	$ 953,031
Long | Agency RMBS | Greater than three years less than seven years [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.79%	4.25%
Long | Agency RMBS | Greater than seven years less than eleven [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 2,555	$ 713,862
Amortized Cost		$ 2,480	$ 708,805
Long | Agency RMBS | Greater than seven years less than eleven [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.01%	3.89%
Long | Agency RMBS | Greater than eleven year [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 0	$ 37,390
Amortized Cost		$ 0	$ 37,300
Long | Agency RMBS | Greater than eleven year [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		0.00%	3.51%
Long | Agency RMBS | Interest only securities
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 47,656	$ 35,279
Amortized Cost		$ 43,406	$ 34,044
Long | Agency RMBS | Interest only securities | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.36%	2.81%
Long | Agency RMBS | Interest only securities | Less than three years [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 8,143	$ 9,011
Amortized Cost		$ 7,314	$ 8,611
Long | Agency RMBS | Interest only securities | Less than three years [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.99%	3.35%
Long | Agency RMBS | Interest only securities | Greater than three years less than seven years [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 32,669	$ 25,334
Amortized Cost		$ 29,362	$ 24,512
Long | Agency RMBS | Interest only securities | Greater than three years less than seven years [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.74%	2.66%
Long | Agency RMBS | Interest only securities | Greater than seven years less than eleven [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 5,165	$ 934
Amortized Cost		$ 5,063	$ 921
Long | Agency RMBS | Interest only securities | Greater than seven years less than eleven [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		1.04%	1.90%
Long | Agency RMBS | Interest only securities | Greater than eleven year [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 1,679	$ 0
Amortized Cost		$ 1,667	$ 0
Long | Agency RMBS | Interest only securities | Greater than eleven year [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		0.83%	0.00%
Long | Non-Agency RMBS and CMBS
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 312,157	$ 283,102
Amortized Cost		$ 317,081	$ 269,124
Long | Non-Agency RMBS and CMBS | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		2.98%	3.37%
Long | Non-Agency RMBS and CMBS | Less than three years [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 58,350	$ 50,120
Amortized Cost		$ 54,339	$ 48,213
Long | Non-Agency RMBS and CMBS | Less than three years [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.39%	2.73%
Long | Non-Agency RMBS and CMBS | Greater than three years less than seven years [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 114,815	$ 87,436
Amortized Cost		$ 109,161	$ 79,326
Long | Non-Agency RMBS and CMBS | Greater than three years less than seven years [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.45%	4.42%
Long | Non-Agency RMBS and CMBS | Greater than seven years less than eleven [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 109,519	$ 127,533
Amortized Cost		$ 123,782	$ 123,924
Long | Non-Agency RMBS and CMBS | Greater than seven years less than eleven [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		2.74%	3.31%
Long | Non-Agency RMBS and CMBS | Greater than eleven year [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 29,473	$ 18,013
Amortized Cost		$ 29,799	$ 17,661
Long | Non-Agency RMBS and CMBS | Greater than eleven year [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		1.46%	0.81%
Long | Non-Agency RMBS
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 201,090	$ 163,136
Amortized Cost		$ 190,759	$ 151,668
Long | Non-Agency RMBS | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.15%	3.41%
Long | Non-Agency RMBS | Interest only securities
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 9,610	$ 8,316
Amortized Cost		$ 8,123	$ 6,517
Long | Non-Agency RMBS | Interest only securities | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		1.17%	1.10%
Long | Non-Agency RMBS | Interest only securities | Less than three years [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 5,163	$ 439
Amortized Cost		$ 3,754	$ 401
Long | Non-Agency RMBS | Interest only securities | Less than three years [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		0.92%	1.37%
Long | Non-Agency RMBS | Interest only securities | Greater than three years less than seven years [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 4,447	$ 7,877
Amortized Cost		$ 4,369	$ 6,116
Long | Non-Agency RMBS | Interest only securities | Greater than three years less than seven years [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		1.37%	1.08%
Long | Non-Agency RMBS | Interest only securities | Greater than seven years less than eleven [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 0	$ 0
Amortized Cost		$ 0	$ 0
Long | Non-Agency RMBS | Interest only securities | Greater than seven years less than eleven [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		0.00%	0.00%
Long | Non-Agency RMBS | Interest only securities | Greater than eleven year [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 0	$ 0
Amortized Cost		$ 0	$ 0
Long | Non-Agency RMBS | Interest only securities | Greater than eleven year [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		0.00%	0.00%
Long | CLOs And Other Securities [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 231,385	$ 220,166
Amortized Cost		$ 257,513	$ 218,048
Long | CLOs And Other Securities [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		5.09%	6.60%
Long | CLOs And Other Securities [Member] | Less than three years [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 89,235	$ 54,446
Amortized Cost		$ 90,869	$ 54,090
Long | CLOs And Other Securities [Member] | Less than three years [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		7.73%	11.11%
Long | CLOs And Other Securities [Member] | Greater than three years less than seven years [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 139,830	$ 157,384
Amortized Cost		$ 163,670	$ 155,651
Long | CLOs And Other Securities [Member] | Greater than three years less than seven years [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		3.69%	5.38%
Long | CLOs And Other Securities [Member] | Greater than seven years less than eleven [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 2,320	$ 8,336
Amortized Cost		$ 2,974	$ 8,307
Long | CLOs And Other Securities [Member] | Greater than seven years less than eleven [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		1.14%	0.00%
Long | CLOs And Other Securities [Member] | Greater than eleven year [Member]
Securities, Available-for-sale [Line Items]
Securities, at fair value(1)(2)		$ 0	$ 0
Amortized Cost		$ 0	$ 0
Long | CLOs And Other Securities [Member] | Greater than eleven year [Member] | Weighted Average
Securities, Available-for-sale [Line Items]
Weighted Average Coupon		0.00%	0.00%

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Investment in Securities (Summary of Investment Income) (Details) - USD ($) $ in Thousands	3 Months Ended												12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Securities, Available-for-sale [Line Items]
Net Amortization													$ (41,681)	$ (48,132)	$ (45,895)
Interest Income	$ 39,067	$ 43,075	$ 39,281	$ 52,108	$ 45,353	$ 39,985	$ 38,547	$ 36,016	$ 35,694	$ 35,300	$ 31,941	$ 28,092	173,531	159,901	$ 131,027	[1]
Agency RMBS
Securities, Available-for-sale [Line Items]
Coupon Interest													59,987	62,103
Net Amortization													(31,975)	(24,731)
Interest Income													28,012	37,372
Non-Agency RMBS and CMBS
Securities, Available-for-sale [Line Items]
Coupon Interest													15,257	13,855
Net Amortization													5,775	2,782
Interest Income													21,032	16,637
CLOs
Securities, Available-for-sale [Line Items]
Coupon Interest													14,103	15,857
Net Amortization													3,529	(1,599)
Interest Income													17,632	14,258
Other Securities
Securities, Available-for-sale [Line Items]
Coupon Interest													11,545	7,157
Net Amortization													(4,986)	(2,468)
Interest Income													6,559	4,689
Securities Investment [Member]
Securities, Available-for-sale [Line Items]
Coupon Interest													100,892	98,972
Net Amortization													(27,657)	(26,016)
Interest Income													$ 73,235	$ 72,956

[1] Includes interest income and interest expense of a consolidated securitization trust of $6.0 million and $3.6 million, respectively, for the year ended December 31, 2018. See Note 6 for further details on the Company's consolidated securitization trust.

XML

Investment in Securities (Proceeds, Realized Gains (Losses) on Sales) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Securities, Available-for-sale [Line Items]
Available-for-sale securities Realizes Losses - adjustments to cost basis of certain securities	$ (17,700)	$ (28,700)
Proceeds	1,819,520	1,893,925
Available-for-sale Securities, Gross Realized Gains	32,736	23,957
Available-for-sale Securities, Gross Realized Losses	(11,928)	(7,937)
Available-for-sale Securities, Gross Realized Gain (Loss)	20,808	16,020
OTTI charge on securities		28,700
Agency RMBS
Securities, Available-for-sale [Line Items]
Proceeds	1,439,413	1,010,251
Available-for-sale Securities, Gross Realized Gains	16,260	9,006
Available-for-sale Securities, Gross Realized Losses	(3,481)	(2,254)
Available-for-sale Securities, Gross Realized Gain (Loss)	12,779	6,752
Non-Agency RMBS and CMBS
Securities, Available-for-sale [Line Items]
Proceeds	145,323	184,725
Available-for-sale Securities, Gross Realized Gains	13,692	12,552
Available-for-sale Securities, Gross Realized Losses	(4,187)	(4,869)
Available-for-sale Securities, Gross Realized Gain (Loss)	9,505	7,683
CLOs
Securities, Available-for-sale [Line Items]
Proceeds	46,632	62,063
Available-for-sale Securities, Gross Realized Gains	1,122	1,286
Available-for-sale Securities, Gross Realized Losses	(4,251)	(816)
Available-for-sale Securities, Gross Realized Gain (Loss)	(3,129)	470
Other Securities
Securities, Available-for-sale [Line Items]
Proceeds	188,152	636,886
Available-for-sale Securities, Gross Realized Gains	1,662	1,113
Available-for-sale Securities, Gross Realized Losses	(9)	2
Available-for-sale Securities, Gross Realized Gain (Loss)	$ 1,653	$ 1,115

XML

Investment in Securities (Unrealized Loss Positions Securities) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 Months	$ 153,786	$ 471,379
Unrealized Losses, Less than 12 Months	(4,358)	(5,146)
Fair Value, Greater than 12 Months	4,627	162,938
Unrealized Losses, Greater than 12 Months	(1,523)	(3,861)
Fair Value, Total	158,413	634,317
Unrealized Loss, Total	(5,881)	(9,007)
Agency RMBS
Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 Months	126,926	328,968
Unrealized Losses, Less than 12 Months	(981)	(1,503)
Fair Value, Greater than 12 Months	832	125,095
Unrealized Losses, Greater than 12 Months	(44)	(1,999)
Fair Value, Total	127,758	454,063
Unrealized Loss, Total	(1,025)	(3,502)
Non-Agency RMBS
Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 Months	20,474	88,495
Unrealized Losses, Less than 12 Months	(2,616)	(880)
Fair Value, Greater than 12 Months	2,599	27,218
Unrealized Losses, Greater than 12 Months	(348)	(699)
Fair Value, Total	23,073	115,713
Unrealized Loss, Total	(2,964)	(1,579)
CLOs
Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 Months	5,279	37,354
Unrealized Losses, Less than 12 Months	(753)	(1,911)
Fair Value, Greater than 12 Months	1,196	9,245
Unrealized Losses, Greater than 12 Months	(1,131)	(1,103)
Fair Value, Total	6,475	46,599
Unrealized Loss, Total	(1,884)	(3,014)
Other Securities
Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 Months	1,107	16,562
Unrealized Losses, Less than 12 Months	(8)	(852)
Fair Value, Greater than 12 Months	0	1,380
Unrealized Losses, Greater than 12 Months	0	(60)
Fair Value, Total	1,107	17,942
Unrealized Loss, Total	$ (8)	$ (912)

XML

Investment in Securities (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	$ 59,229	$ 9,638
Debt Securities, Available-for-sale, Allowance for Credit Loss	24,900
Debt Securities, Available-for-sale, Purchased with Credit Deterioration, Allowance for Credit Loss at Acquisition Date	2,600
Available-for-sale securities Realizes Losses - Write offs	(17,700)
Catch-up premium amortization adjustment	(4,500)	(4,700)
OTTI charge on securities		28,700
Long
Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	$ 55,429	$ 9,007

XML

Investment in Loans (Schedule of Investments in Loans) (Details) - USD ($) $ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current Principal/Notional Amount		$ 1,417,054	$ 1,387,733
Fair Value	[1],[2]	1,453,480	1,412,426
Residential mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current Principal/Notional Amount		1,150,303	911,705
Fair Value		1,187,069	932,203
Commercial mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current Principal/Notional Amount		212,716	277,870
Fair Value		213,031	274,759
Consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current Principal/Notional Amount		48,180	179,743
Fair Value		47,525	186,954
Corporate loan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current Principal/Notional Amount		5,855	18,415
Fair Value		$ 5,855	$ 18,510

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Investment in Loans (Schedule of 90 Days or More Past Due) (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		$ 1,417,054	$ 1,387,733
Loans, at fair value	[1],[2]	1,453,480	1,412,426
Proceeds from the disposition of loans (non-cash)		113,791	0
Commercial mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		212,716	277,870
Loans, at fair value		213,031	274,759
Residential mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		1,150,303	911,705
Loans, at fair value		1,187,069	932,203
Consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		48,180	179,743
Loans, at fair value		47,525	186,954
Non-accrual status [Member] | Commercial mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, at fair value			10,700
Non-accrual status [Member] | Commercial mortgage loans | 90 Days or More Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		44,233	28,936
Loans, at fair value		44,052	26,545
Non-accrual status [Member] | Residential mortgage loans | 90 Days or More Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		64,509	22,092
Loans, at fair value		60,381	19,401
Non-accrual status [Member] | Consumer loans | 90 Days or More Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		1,015	5,633
Loans, at fair value		$ 930	$ 5,225

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Investment in Loans (Schedule of Residential Mortgage Loans) (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		$ 1,417,054	$ 1,387,733
Unamortized Premium (Discount)		(196,118)	(150,821)
Amortized Cost				$ 2,970,306
Fair Value	[1],[2]	$ 1,453,480	$ 1,412,426
Weighted Average
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted Average Coupon		3.92%	4.23%
Weighted Average Yield		4.77%	4.01%
Weighted average life		4 years 5 months 26 days	5 years 10 months 24 days
Residential mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		$ 1,150,303	$ 911,705
Fair Value		1,187,069	932,203
Residential mortgage loans | Non-performing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		62,009	17,757
Fair Value		58,169	15,580
Consolidated securitization trusts [Member] | Residential mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gains		24,800	11,300
Losses		100	100
Loans held-for-investment [Member] | Residential mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		1,150,303	911,705
Unamortized Premium (Discount)		14,263	9,354
Amortized Cost		1,164,566	921,059
Gains		27,892	13,082
Losses		(5,389)	(1,938)
Fair Value		$ 1,187,069	$ 932,203
Loans held-for-investment [Member] | Residential mortgage loans | Weighted Average
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted Average Coupon		6.19%	6.44%
Weighted Average Yield		5.60%	5.79%
Weighted average life		1 year 10 months 24 days	1 year 10 months 24 days
Non-QM loan securitization | Residential mortgage loans | Consolidated Entities [Member] | Securitized loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair Value		$ 801,343	$ 628,415

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Investment in Loans (Schedule of Residential Mortgage Loans: Geographic Distribution) (Details) - Financing Receivables, Unpaid Principal Balance [Member] - Residential mortgage loans - Geographic Concentration Risk [Member]	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	100.00%	100.00%
CALIFORNIA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	43.10%	46.60%
Florida [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	14.80%	11.90%
Texas [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	10.20%	11.90%
Colorado [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	3.10%	3.20%
MASSACHUSETTS
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	2.60%	2.90%
MASSACHUSETTS
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	1.40%	1.60%
NEVADA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	1.90%	1.60%
OREGON
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	2.20%	2.20%
ARIZONA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	2.00%	2.40%
UTAH
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	1.70%	1.90%
Maryland [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	1.60%	1.30%
MARYLAND
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	1.00%	1.10%
NORTH CAROLINA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	1.10%	0.80%
NEW JERSEY
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	1.40%	1.10%
ILLINOIS
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	1.80%	1.70%
Other [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	8.80%	7.10%
GEORGIA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	1.30%	0.70%

XML

Investment in Loans Investment in Loans (Schedule of Residential Mortgage Loans: Performance) (Details) - USD ($) $ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		$ 1,417,054	$ 1,387,733
Loans, at fair value	[1],[2]	1,453,480	1,412,426
Residential mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		1,150,303	911,705
Loans, at fair value		1,187,069	932,203
Residential mortgage loans | Performing Financial Instruments [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		18,120	27,663
Loans, at fair value		16,741	25,323
Residential mortgage loans | Non-performing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		62,009	17,757
Loans, at fair value		$ 58,169	$ 15,580

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Investment in Loans (Narrative) (Details) $ in Thousands		12 Months Ended
		Dec. 31, 2020 USD ($) loan	Dec. 31, 2019 USD ($) loan	Dec. 31, 2018 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, at fair value	[1],[2]	$ 1,453,480	$ 1,412,426
Mortgage Loans in Process of Foreclosure, Amount				$ 9,100
Unpaid Principal Balance		1,417,054	1,387,733
Residential mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, at fair value		1,187,069	932,203
Impairment Losses, Recognized in Earnings			900
Mortgage Loans in Process of Foreclosure, Amount		14,900	10,900
Unpaid Principal Balance		1,150,303	911,705
Residential mortgage loans | Non-performing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, at fair value		58,169	15,580
Unpaid Principal Balance		62,009	17,757
Commercial mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, at fair value		213,031	274,759
Losses		(454)	(62)
Financing Receivable, Allowance for Credit Loss		400
Mortgage Loans in Process of Foreclosure, Amount		10,500	16,000
Unpaid Principal Balance		$ 212,716	$ 277,870
Number of mortgage loans in process of foreclosure		1	2
Commercial mortgage loans | Non-performing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, at fair value		$ 31,500	$ 26,500
Number of loans | loan		3	3
Unpaid Principal Balance		$ 31,800	$ 28,900
Consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, at fair value		47,525	186,954
Losses		(1,887)	(377)
Impairment Losses, Recognized in Earnings			6,300
Unpaid Principal Balance		48,180	179,743
Delinquent loans, charged off		20,900	19,000
Fair value of charged-off loans		600	600
Financing Receivable, Allowance for Credit Loss		2,900
Corporate loan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, at fair value		5,855	18,510
Unpaid Principal Balance		5,855	18,415
Loans held-for-investment [Member] | Residential mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, at fair value		1,187,069	932,203
Losses		(5,389)	(1,938)
Financing Receivable, Allowance for Credit Loss		2,200
Financing Receivable, Purchased with Credit Deterioration, Allowance for Credit Loss at Acquisition Date		200
Unpaid Principal Balance		1,150,303	$ 911,705
Realized Losses, Write offs on loans		(800)
Loans held-for-investment [Member] | Consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Realized Losses, Write offs on loans		$ 3,200

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Investment in Loans (Schedule of Commercial Mortgage Loans) (Details) (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		$ 1,417,054	$ 1,387,733
Unamortized Premium (Discount)		(196,118)	(150,821)
Investments, at fair value, Cost				$ 2,970,306
Loans, at fair value	[1],[2]	$ 1,453,480	$ 1,412,426
Mortgage Loans in Process of Foreclosure, Amount				$ 9,100
Weighted Average
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted Average Coupon		3.92%	4.23%
Weighted Average Yield		4.77%	4.01%
Weighted average life		4 years 5 months 26 days	5 years 10 months 24 days
Commercial mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		$ 212,716	$ 277,870
Unamortized Premium (Discount)		290	(3,302)
Investments, at fair value, Cost		213,006	274,568
Gains		479	253
Losses		(454)	(62)
Loans, at fair value		$ 213,031	$ 274,759
Number of mortgage loans in process of foreclosure		1	2
Mortgage Loans in Process of Foreclosure, Amount		$ 10,500	$ 16,000
Commercial mortgage loans | Non-performing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		31,800	28,900
Loans, at fair value		$ 31,500	$ 26,500
Commercial mortgage loans | Weighted Average
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted Average Coupon		8.38%	7.65%
Weighted Average Yield		8.28%	8.58%
Weighted average life		7 months 13 days	1 year 25 days
Non-accrual status [Member] | Commercial mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, at fair value			$ 10,700
Non-accrual status [Member] | Commercial mortgage loans | Non-performing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, at fair value		$ 31,500

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Investment in Loans (Schedule of Commercial Loans: Geographic Distribution) (Details) - Financing Receivables, Unpaid Principal Balance [Member] - Geographic Concentration Risk [Member] - Commercial mortgage loans	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	100.00%	100.00%
Florida [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	23.80%	31.70%
NEW YORK
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	15.20%	17.70%
Virginia [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	4.20%	6.80%
CONNECTICUT
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	11.20%	8.20%
MASSACHUSETTS
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	5.80%	13.30%
NORTH CAROLINA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	7.90%	4.60%
CALIFORNIA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	5.90%	0.00%
MASSACHUSETTS
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	6.10%	4.70%
ARIZONA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	4.30%	3.80%
Indiana [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	2.80%	2.10%
PENNSYLVANIA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	2.20%	1.80%
NEVADA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	1.90%	1.50%
Tennessee [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	0.00%	1.50%
ILLINOIS
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	1.40%	1.20%
Other [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	0.00%	1.10%
OHIO
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of Total Outstanding Unpaid Principal Balance	7.30%	0.00%

XML

Investment in Loans (Schedule of Consumer Loans) (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		$ 1,417,054	$ 1,387,733
Unamortized Premium (Discount)		(196,118)	(150,821)
Investments, at fair value, Cost				$ 2,970,306
Loans, at fair value	[1],[2]	$ 1,453,480	$ 1,412,426
Weighted Average
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted average life		4 years 5 months 26 days	5 years 10 months 24 days
Consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair value of charged-off loans		$ 600	$ 600
Unpaid Principal Balance		48,180	179,743
Unamortized Premium (Discount)		72	5,027
Investments, at fair value, Cost		48,252	184,770
Gains		1,160	2,561
Losses		(1,887)	(377)
Loans, at fair value		$ 47,525	$ 186,954
Consumer loans | Weighted Average
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted average life		1 year 14 days	9 months 25 days
Delinquency (Days)		7 days	4 days

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Investment in Loans (Schedule of Consumer Loans: Delinquency Status) (Details) - Consumer loans	Dec. 31, 2020	Dec. 31, 2019
Financing Receivable, Past Due [Line Items]
Percent past due	100.00%	100.00%
Financial Asset, 1 to 29 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Percent past due	90.40%	95.30%
30 to 59 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Percent past due	3.40%	2.10%
60 to 89 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Percent past due	3.30%	1.40%
90-119 Days or More Past Due [Member]
Financing Receivable, Past Due [Line Items]
Percent past due	2.80%	1.20%
Financing Receivables, Equal to Greater than 120 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Percent past due	0.10%	0.00%

XML

Investment in Loans Investment in Loans (Schedule of Corporate Loans) (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		$ 1,417,054	$ 1,387,733
Loans, at fair value	[1],[2]	1,453,480	1,412,426
Corporate loan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance		5,855	18,415
Loans, at fair value		$ 5,855	$ 18,510
Weighted Average
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted Average Coupon		3.92%	4.23%
Weighted average life		4 years 5 months 26 days	5 years 10 months 24 days
Weighted Average | Corporate loan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted Average Coupon		20.00%	17.62%
Weighted average life		1 year 9 months	10 months 13 days

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Investments in Unconsolidated Entities (Details) - USD ($) $ in Thousands		3 Months Ended								12 Months Ended
		Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Schedule of Equity Method Investments [Line Items]
Investment in unconsolidated entities, at fair value	[1]	$ 141,620				$ 71,850				$ 141,620	$ 71,850
Earnings (losses) from investments in unconsolidated entities		27,344	$ 11,443	$ 5,643	$ (6,497)	3,262	$ 2,796	$ 2,354	$ 1,797	37,933	10,209
Investment in Loan Originator
Schedule of Equity Method Investments [Line Items]
Investment in unconsolidated entities, at fair value		79,500				40,600				79,500	40,600
Variable Interest Entity, Not Primary Beneficiary
Schedule of Equity Method Investments [Line Items]
Investment in unconsolidated entities, at fair value		$ 13,600				$ 28,500				$ 13,600	$ 28,500

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

XML

Investments in Unconsolidated Entities Schedule of Ownership of Investments in Unconsolidated Entities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Summarized Financial Information, Net Income (Loss)	$ 23,817	$ 31,023
Longbridge Financial LLC [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	49.70%	49.70%
LendSure Mortgage Corp [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	49.90%	49.90%
LendSure Mortgage Corp [Member] | Nonvoting Common Stock [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	15.00%
Jepson Holdings Limited
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	30.10%	30.10%
Elizon AFG 2018-1 LLC [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	0.00%	13.40%
Effective Ownership Percentage	58.20%	70.40%
Elizon TCG SBC 2017-1
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	36.00%	0.00%
Elizon DB 2015-1 LLC [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	8.90%	3.50%
Effective Ownership Percentage		48.70%
Minimum | Other Equity Method Investments [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	7.40%	7.70%
Maximum | Other Equity Method Investments [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	56.30%	51.00%

XML

Investments in Unconsolidated Entities Summarized Financial Information Financial Condition (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Schedule of Equity Method Investments [Line Items]
Equity Method Investments, Summarized Financial Information, Investments	$ 424,475	$ 560,949
Equity Method Investments, Summarized Financial Information, Other assets	117,746	65,580
Equity Method Investment, Summarized Financial Information, Assets	542,221	626,529
Equity Method Investment, Summarized Financial Information, Borrowings	215,792	387,910
Equity Method Investment, Summarized Financial Information, Other liabilities	30,801	28,134
Equity Method Investment, Summarized Financial Information, Liabilities	246,593	416,044
Equity Method Investment Summarized Financial Information, Equity	295,628	210,485
Equity Method Investment, Summarized Financial Information, Liabilities and Equity	$ 542,221	$ 626,529

XML

Investments in Unconsolidated Entities Summarized Financial Information Results of Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investment, Summarized Financial Information, Interest Income	$ 10,935	$ 30,587
Equity Method Investment, Summarized Financial Information, Interest expense	(9,243)	(13,316)
Equity Method Investment, Summarized Financial Information, Net interest income	1,692	17,271
Equity Method Investment, Summarized Financial Information, Realized and unrealized gain (loss) on investments	44,362	40,901
Equity Method Investment, Summarized Financial Information, Other, net	44,031	31,848
Equity Method Investment, Summarized Financial Information, Total other income (loss)	88,393	72,749
Equity Method Investment, Summarized Financial Information, Expenses	65,492	58,018
Equity Method Investment, Summarized Financial Information, Net income (loss) before income tax	24,593	32,002
Equity Method Investment, Summarized Financial Information, Tax expense (benefit)	776	979
Equity Method Investment, Summarized Financial Information, Net Income (Loss)	$ 23,817	$ 31,023

XML

Real Estate Owned (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($) property	Dec. 31, 2019 USD ($) property
Real Estate Owned, Disclosure of Detailed Components [Abstract]
Real Estate Acquired Through Foreclosure, Disposals, Number Of Properties | property	12	13
Realized Gain (Loss) on Sale of Properties	$ 15	$ 2,300
REO, fair value	$ 22,400	$ 19,400

XML

Real Estate Owned Schedule of Real Estate Owned Activity (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($) property	Dec. 31, 2019 USD ($) property
Number of Properties
Beginning Balance | property	15	20
Transfers from mortgage loans | property	10	8
Disposals | property	(12)	(13)
Ending Balance | property	13	15
Carrying Value
Beginning Balance	$ 30,584	$ 30,778
Transfers from mortgage loans	3,384	22,577
Capital expenditures and other adjustments to cost	191	240
Adjustments to record at the lower of cost or fair value	(1,053)	(1,002)
Disposals	(9,508)	(22,009)
Ending Balance	$ 23,598	$ 30,584

XML

To Be Announced RMBS (Details) - USD ($) $ in Thousands	Dec. 31, 2020		Dec. 31, 2019		Dec. 31, 2018
To Be Announced Securities [Line Items]
Fair Value					$ 2,939,311
Unpaid Principal Balance	$ 1,417,054		$ 1,387,733
Investments sold short, at fair value-	(38,642)		(73,409)		(850,577)
Payable for securities purchased relating to unsettled TBA purchases	(4,754)	[1]	(66,133)	[1]	(488,411)
Net short TBA securities, at fair value	$ (1,475,543)		(2,376,532)
To Be Announced Fixed Rate Agency Securities [Member]
To Be Announced Securities [Line Items]
Fair Value					474,860
Unpaid Principal Balance			460,037
Receivable for securities sold relating to unsettled TBA sales					766,574
TBA - Fixed Rate Agency Securities Sold Short [Member]
To Be Announced Securities [Line Items]
Investments sold short, at fair value-					(772,964)
Current Principal			$ (753,697)
Payable for securities purchased relating to unsettled TBA purchases					(473,386)
Net short TBA securities, at fair value					$ (298,104)

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

XML

Financial Derivatives (Schedule of Financial Derivatives) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	$ 15,479	$ 16,788	$ 20,001
Financial derivatives–liabilities, at fair value-	(24,553)	(27,621)	$ (20,806)
Total	(9,074)	(10,833)
TBA Securities, Purchase Contracts [Member]
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	961	90
TBA Securities, Sale Contracts [Member]
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	1	506
Financial derivatives–liabilities, at fair value-	(925)	(1,012)
Interest rate swaps | Short
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	125	3,914
Financial derivatives–liabilities, at fair value-	(15,109)	(8,513)
Interest rate swaps | Long
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	8,394	1,554
Financial derivatives–liabilities, at fair value-	(65)	(206)
Credit default swaps on asset-backed securities
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	347	993
Credit default swaps on asset-backed indices
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	2,184	3,319
Financial derivatives–liabilities, at fair value-	(130)	(250)
Credit default swaps on corporate bonds
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	0	2
Financial derivatives–liabilities, at fair value-	(747)	(1,693)
Credit default swaps on corporate bond indices
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	3,420	5,599
Financial derivatives–liabilities, at fair value-	(6,438)	(14,524)
Total return swaps
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	9	620
Financial derivatives–liabilities, at fair value-	(484)	(1,209)
Futures
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	2	148
Financial derivatives–liabilities, at fair value-	(376)	(45)
Futures | Short
Derivatives, Fair Value [Line Items]
Total	(374)	103
Forwards
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	0	43
Financial derivatives–liabilities, at fair value-	(279)	(169)
Warrants
Derivatives, Fair Value [Line Items]
Financial derivatives–assets, at fair value-	$ 36	$ 0

XML

Financial Derivatives (Interest Rate Swaps) (Details) - Interest rate swaps - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Long
Derivative [Line Items]
Notional Amount	$ 253,423	$ 305,723
Fair Value	8,329	1,348
Long | 2021 [Member]
Derivative [Line Items]
Notional Amount	12,950	181,950
Fair Value	205	(49)
Long | 2022 [Member]
Derivative [Line Items]
Notional Amount	103,974	53,974
Fair Value	1,413	441
Long | 2023 [Member]
Derivative [Line Items]
Notional Amount	48,657	48,657
Fair Value	2,209	709
Long | 2024 [Member]
Derivative [Line Items]
Notional Amount	86,342	11,342
Fair Value	4,567	306
Long | 2029 [Member]
Derivative [Line Items]
Notional Amount		9,800
Fair Value		$ (59)
Long | 2035
Derivative [Line Items]
Notional Amount	500
Fair Value	(14)
Long | 2040
Derivative [Line Items]
Notional Amount	500
Fair Value	(20)
Long | 2050
Derivative [Line Items]
Notional Amount	500
Fair Value	$ (31)
Long | Weighted Average
Derivative [Line Items]
Pay Rate	1.48%	1.78%
Receive Rate	0.22%	1.91%
Remaining Years to Maturity	2 years 5 months 23 days	2 years 5 months 19 days
Long | Weighted Average | 2021 [Member]
Derivative [Line Items]
Pay Rate	1.75%	1.67%
Receive Rate	0.24%	1.89%
Remaining Years to Maturity	8 months 15 days	1 year 10 months 2 days
Long | Weighted Average | 2022 [Member]
Derivative [Line Items]
Pay Rate	1.07%	1.85%
Receive Rate	0.22%	1.91%
Remaining Years to Maturity	1 year 5 months 23 days	2 years 2 months 1 day
Long | Weighted Average | 2023 [Member]
Derivative [Line Items]
Pay Rate	2.00%	2.00%
Receive Rate	0.24%	1.92%
Remaining Years to Maturity	2 years 3 months 3 days	3 years 3 months 3 days
Long | Weighted Average | 2024 [Member]
Derivative [Line Items]
Pay Rate	1.65%	2.33%
Receive Rate	0.22%	2.09%
Remaining Years to Maturity	3 years 8 months 23 days	4 years 2 months 23 days
Long | Weighted Average | 2029 [Member]
Derivative [Line Items]
Pay Rate		1.78%
Receive Rate		1.91%
Remaining Years to Maturity		9 years 9 months 7 days
Long | Weighted Average | 2035
Derivative [Line Items]
Pay Rate	0.74%
Receive Rate	0.09%
Remaining Years to Maturity	14 years 9 months 21 days
Long | Weighted Average | 2040
Derivative [Line Items]
Pay Rate	0.84%
Receive Rate	0.09%
Remaining Years to Maturity	19 years 9 months 25 days
Long | Weighted Average | 2050
Derivative [Line Items]
Pay Rate	0.90%
Receive Rate	0.09%
Remaining Years to Maturity	29 years 9 months 25 days
Short
Derivative [Line Items]
Notional Amount	$ 408,295	$ 732,961
Fair Value	(14,984)	(4,599)
Short | 2020 [Member]
Derivative [Line Items]
Notional Amount		68,607
Fair Value		(234)
Short | 2021 [Member]
Derivative [Line Items]
Notional Amount	17,500	268,929
Fair Value	(231)	(419)
Short | 2022 [Member]
Derivative [Line Items]
Notional Amount	96,533	31,350
Fair Value	(1,535)	9
Short | 2023 [Member]
Derivative [Line Items]
Notional Amount	146,012	101,012
Fair Value	(4,770)	(1,265)
Short | 2024 [Member]
Derivative [Line Items]
Notional Amount		13,000
Fair Value		99
Short | 2025 [Member]
Derivative [Line Items]
Notional Amount	66,503	12,800
Fair Value	(1,034)	(24)
Short | 2027 [Member]
Derivative [Line Items]
Notional Amount	9,732
Fair Value	60
Short | 2026 [Member]
Derivative [Line Items]
Notional Amount	11,216	59,902
Fair Value	(458)	1,946
Short | 2028 [Member]
Derivative [Line Items]
Notional Amount	16,644	32,942
Fair Value	(2,169)	(1,634)
Short | 2029 [Member]
Derivative [Line Items]
Notional Amount	22,744	136,838
Fair Value	(2,289)	(2,018)
Short | 2030 [Member]
Derivative [Line Items]
Notional Amount	13,015	685
Fair Value	(369)	(32)
Short | 2035
Derivative [Line Items]
Notional Amount	500
Fair Value	15
Short | 2036 [Member]
Derivative [Line Items]
Notional Amount	1,100	1,100
Fair Value	(47)	87
Short | 2040
Derivative [Line Items]
Notional Amount	500
Fair Value	20
Short | 2049 [Member]
Derivative [Line Items]
Notional Amount	5,796	5,796
Fair Value	(2,208)	$ (1,114)
Short | 2050
Derivative [Line Items]
Notional Amount	500
Fair Value	$ 31
Short | Weighted Average
Derivative [Line Items]
Pay Rate	1.39%	1.83%
Receive Rate	0.23%	1.94%
Remaining Years to Maturity	3 years 9 months 25 days	4 years 3 months 21 days
Short | Weighted Average | 2020 [Member]
Derivative [Line Items]
Pay Rate		1.74%
Receive Rate		1.93%
Remaining Years to Maturity		2 months 26 days
Short | Weighted Average | 2021 [Member]
Derivative [Line Items]
Pay Rate	2.75%	1.73%
Receive Rate	0.24%	1.95%
Remaining Years to Maturity	2 months 19 days	1 year 7 months 20 days
Short | Weighted Average | 2022 [Member]
Derivative [Line Items]
Pay Rate	1.19%	1.65%
Receive Rate	0.22%	1.93%
Remaining Years to Maturity	1 year 1 month 20 days	2 years 1 month 20 days
Short | Weighted Average | 2023 [Member]
Derivative [Line Items]
Pay Rate	1.50%	2.06%
Receive Rate	0.23%	1.91%
Remaining Years to Maturity	2 years 5 months 1 day	3 years 3 months 14 days
Short | Weighted Average | 2024 [Member]
Derivative [Line Items]
Pay Rate		1.56%
Receive Rate		1.89%
Remaining Years to Maturity		4 years 10 months 24 days
Short | Weighted Average | 2025 [Member]
Derivative [Line Items]
Pay Rate	0.73%
Receive Rate	0.21%
Remaining Years to Maturity	4 years 9 months	5 years 2 months 19 days
Short | Weighted Average | 2027 [Member]
Derivative [Line Items]
Pay Rate	0.49%
Receive Rate	0.24%
Remaining Years to Maturity	6 years 5 months 23 days
Short | Weighted Average | 2026 [Member]
Derivative [Line Items]
Pay Rate	1.23%	1.24%
Receive Rate	0.25%	1.94%
Remaining Years to Maturity	5 years 6 months	6 years 6 months
Short | Weighted Average | 2028 [Member]
Derivative [Line Items]
Pay Rate	2.39%	2.40%
Receive Rate	0.24%	1.93%
Remaining Years to Maturity	7 years 3 months 25 days	8 years 4 months 2 days
Short | Weighted Average | 2029 [Member]
Derivative [Line Items]
Pay Rate	1.94%	2.02%
Receive Rate	0.23%	1.96%
Remaining Years to Maturity	8 years 7 months 9 days	9 years 7 months 9 days
Short | Weighted Average | 2030 [Member]
Derivative [Line Items]
Pay Rate	1.13%	2.38%
Receive Rate	0.22%	1.90%
Remaining Years to Maturity	9 years 3 months 14 days	10 years 10 months 24 days
Short | Weighted Average | 2035
Derivative [Line Items]
Pay Rate	0.78%
Receive Rate	0.09%
Remaining Years to Maturity	14 years 9 months 21 days
Short | Weighted Average | 2036 [Member]
Derivative [Line Items]
Pay Rate	1.45%	1.45%
Receive Rate	0.25%	1.94%
Remaining Years to Maturity	15 years 1 month 17 days	16 years 1 month 20 days
Short | Weighted Average | 2040
Derivative [Line Items]
Pay Rate	0.90%
Receive Rate	0.09%
Remaining Years to Maturity	19 years 9 months 25 days
Short | Weighted Average | 2049 [Member]
Derivative [Line Items]
Pay Rate	2.89%	2.89%
Receive Rate	0.23%	2.09%
Remaining Years to Maturity	28 years 7 days	29 years 10 days
Short | Weighted Average | 2050
Derivative [Line Items]
Pay Rate	0.98%
Receive Rate	0.09%
Remaining Years to Maturity	29 years 9 months 25 days
Forward-starting interest rate swap [Member] | Short
Derivative [Line Items]
Notional Amount		$ 20,900
Fair Value		$ (41)
Derivative fixed interest rate including forward-starting swaps		1.83%

XML

Financial Derivatives (Credit Default Swaps) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Financial derivatives–assets, at fair value-	$ 15,479	$ 16,788	$ 20,001
Financial derivatives–liabilities, at fair value-	(24,553)	(27,621)	$ (20,806)
Fair Value	9,074	10,833
Credit default swaps on asset-backed indices
Derivative [Line Items]
Financial derivatives–assets, at fair value-	2,184	3,319
Financial derivatives–liabilities, at fair value-	(130)	(250)
Credit default swaps on asset-backed indices | Financial Derivatives - Assets | Long
Derivative [Line Items]
Notional Amount	(395)	(695)
Financial derivatives–assets, at fair value-	5	10
Credit default swaps on asset-backed indices | Financial Derivatives - Assets | Short
Derivative [Line Items]
Notional Amount	(12,888)	(63,515)
Financial derivatives–assets, at fair value-	2,179	3,309
Credit default swaps on asset-backed indices | Financial Derivatives - Liabilities | Long
Derivative [Line Items]
Notional Amount	(479)	(344)
Financial derivatives–liabilities, at fair value-	(130)	(145)
Credit default swaps on asset-backed indices | Financial Derivatives - Liabilities | Short
Derivative [Line Items]
Notional Amount	(1)	(4,501)
Financial derivatives–liabilities, at fair value-	0	(105)
Credit default swaps on asset-backed securities
Derivative [Line Items]
Financial derivatives–assets, at fair value-	347	993
Credit default swaps on asset-backed securities | Financial Derivatives - Assets | Short
Derivative [Line Items]
Notional Amount	(957)	(2,640)
Financial derivatives–assets, at fair value-	347	993
Credit default swaps on corporate bonds
Derivative [Line Items]
Financial derivatives–assets, at fair value-	0	2
Financial derivatives–liabilities, at fair value-	(747)	(1,693)
Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long
Derivative [Line Items]
Notional Amount	0	(430)
Financial derivatives–assets, at fair value-	0	2
Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short
Derivative [Line Items]
Notional Amount	(8,400)	(10,800)
Financial derivatives–liabilities, at fair value-	(747)	(1,693)
Credit default swaps
Derivative [Line Items]
Notional Amount	(66,390)	(201,365)
Fair Value	1,364	6,554
Credit default swaps on corporate bond indices
Derivative [Line Items]
Financial derivatives–assets, at fair value-	3,420	5,599
Financial derivatives–liabilities, at fair value-	(6,438)	(14,524)
Credit default swaps on corporate bond indices | Financial Derivatives - Assets | Long
Derivative [Line Items]
Notional Amount	(67,779)	(130,707)
Financial derivatives–assets, at fair value-	3,296	5,547
Credit default swaps on corporate bond indices | Financial Derivatives - Assets | Short
Derivative [Line Items]
Notional Amount	(2,173)	(1,997)
Financial derivatives–assets, at fair value-	124	52
Credit default swaps on corporate bond indices | Financial Derivatives - Liabilities | Short
Derivative [Line Items]
Notional Amount	(110,624)	(250,088)
Financial derivatives–liabilities, at fair value-	$ (6,438)	$ (14,524)
Weighted Average | Credit default swaps on asset-backed indices | Financial Derivatives - Assets | Long
Derivative [Line Items]
Remaining Years to Maturity	16 years 11 months 26 days	23 years 9 months 18 days
Weighted Average | Credit default swaps on asset-backed indices | Financial Derivatives - Assets | Short
Derivative [Line Items]
Remaining Years to Maturity	39 years 7 months 9 days	38 years 4 months 24 days
Weighted Average | Credit default swaps on asset-backed indices | Financial Derivatives - Liabilities | Long
Derivative [Line Items]
Remaining Years to Maturity	32 years 4 months 9 days	29 years 4 months 6 days
Weighted Average | Credit default swaps on asset-backed indices | Financial Derivatives - Liabilities | Short
Derivative [Line Items]
Remaining Years to Maturity	29 years	40 years 3 months 21 days
Weighted Average | Credit default swaps on asset-backed securities | Financial Derivatives - Assets | Short
Derivative [Line Items]
Remaining Years to Maturity	14 years 8 months 12 days	15 years 7 months 17 days
Weighted Average | Credit default swaps on corporate bonds | Financial Derivatives - Assets | Long
Derivative [Line Items]
Remaining Years to Maturity	0 days	5 months 19 days
Weighted Average | Credit default swaps on corporate bonds | Financial Derivatives - Liabilities | Short
Derivative [Line Items]
Remaining Years to Maturity	4 years 2 months 1 day	3 years 11 months 1 day
Weighted Average | Credit default swaps
Derivative [Line Items]
Remaining Years to Maturity	10 years 3 months	14 years 10 months 17 days
Weighted Average | Credit default swaps on corporate bond indices | Financial Derivatives - Assets | Long
Derivative [Line Items]
Remaining Years to Maturity	2 years 6 months 7 days	2 years 5 months 1 day
Weighted Average | Credit default swaps on corporate bond indices | Financial Derivatives - Assets | Short
Derivative [Line Items]
Remaining Years to Maturity	2 years 11 months 19 days	3 years 11 months 19 days
Weighted Average | Credit default swaps on corporate bond indices | Financial Derivatives - Liabilities | Short
Derivative [Line Items]
Remaining Years to Maturity	2 years 9 months 10 days	2 years 6 months 3 days

XML

Financial Derivatives (Futures) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Fair Value	$ (9,074)	$ (10,833)
Short | Futures
Derivative [Line Items]
Notional Amount	176,600	30,000
Fair Value	$ (374)	$ 103
Remaining Years to Maturity	2 months 26 days	3 months 10 days
Financial Derivatives - Liabilities | Short | U.S. Treasury futures
Derivative [Line Items]
Notional Amount	$ 178,200	$ 16,000
Fair Value	$ (367)	$ 148
Remaining Years to Maturity	2 months 26 days	2 months 23 days
Financial Derivatives - Liabilities | Short | Eurodollar futures
Derivative [Line Items]
Notional Amount	$ 0	$ 14,000
Fair Value	$ 0	$ (45)
Remaining Years to Maturity	0 years	4 months 2 days
Financial Derivatives - Liabilities | Long | U.S. Treasury futures
Derivative [Line Items]
Notional Amount	$ 1,900	$ 0
Fair Value	$ (9)	$ 0
Remaining Years to Maturity	2 months 19 days	0 years
Financial Derivatives - Assets | Short | U.S. Treasury futures
Derivative [Line Items]
Notional Amount	$ 300	$ 0
Fair Value	$ 2	$ 0
Remaining Years to Maturity	2 months 19 days	0 years

XML

Financial Derivatives (TBAs) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Financial derivatives–assets, at fair value-	$ 15,479	$ 16,788	$ 20,001
Derivative Liability	24,553	27,621	$ 20,806
Derivative Assets (Liabilities), at Fair Value, Net	(9,074)	(10,833)
TBA securities
Derivative [Line Items]
Notional Amount	(354,077)	(1,053,630)
Derivative, Cost Basis	(380,791)	(1,098,063)
Market Value Underlying	(380,754)	(1,098,479)
Derivative Assets (Liabilities), at Fair Value, Net	37	(416)
TBA securities | Long
Derivative [Line Items]
Notional Amount	(149,990)	(40,100)
Derivative, Cost Basis	155,008	40,585
Market Value Underlying	155,969	40,675
Derivative Assets (Liabilities), at Fair Value, Net	961	90
TBA securities | Short
Derivative [Line Items]
Notional Amount	(504,067)	(1,093,730)
Derivative, Cost Basis	(535,799)	(1,138,648)
Market Value Underlying	(536,723)	(1,139,154)
Derivative Assets (Liabilities), at Fair Value, Net	(924)	(506)
Financial Derivatives - Assets | TBA securities | Long
Derivative [Line Items]
Notional Amount	(149,990)	(40,100)
Derivative, Cost Basis	155,008	40,585
Market Value Underlying	155,969	40,675
Financial derivatives–assets, at fair value-	961	90
Financial Derivatives - Assets | TBA securities | Short
Derivative [Line Items]
Notional Amount	(4,400)	(319,981)
Derivative, Cost Basis	(4,765)	(332,080)
Market Value Underlying	(4,764)	(331,574)
Financial derivatives–assets, at fair value-	1	506
Financial Derivatives - Liabilities | TBA securities | Long
Derivative [Line Items]
Notional Amount	0	0
Derivative, Cost Basis	0	0
Market Value Underlying	0	0
Derivative Liability	0	0
Financial Derivatives - Liabilities | TBA securities | Short
Derivative [Line Items]
Notional Amount	(499,667)	(773,749)
Derivative, Cost Basis	(531,034)	(806,568)
Market Value Underlying	(531,959)	(807,580)
Derivative Liability	$ (925)	$ (1,012)

XML

Financial Derivatives (Schedule of Gains and Losses on Derivative Contracts) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps	$ (2,038)	$ 1,695
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	(29,471)	(32,562)
Realized gains (losses) on financial derivatives, net	(31,509)	(30,867)	$ 1,911
Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps	219	(764)
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	831	(4,573)
Unrealized gains (losses) on financial derivatives, net	1,050	(5,337)	7,807
Foreign currency transactions	(173)	(2,392)	4,131
Foreign currency translation			(7,071)
Derivative [Member]
Derivative [Line Items]
Foreign currency transactions	12	45	100
Foreign currency translation	61	1	100
Interest rate swaps | Interest Rate Risk [Member]
Derivative [Line Items]
Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps	(2,038)	1,695
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	(17,060)	(876)
Realized gains (losses) on financial derivatives, net	(19,098)	819	(985)
Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps	219	(764)
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	(6,597)	(5,778)
Unrealized gains (losses) on financial derivatives, net	(6,378)	(6,542)	3,648
Credit default swaps on asset-backed securities | Credit Risk [Member]
Derivative [Line Items]
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	(5,452)	528
Realized gains (losses) on financial derivatives, net	(5,452)	528	(687)
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	5,402	(479)
Unrealized gains (losses) on financial derivatives, net	5,402	(479)	715
Credit default swaps on asset-backed indices | Credit Risk [Member]
Derivative [Line Items]
Realized gains (losses) on financial derivatives, net			(2,293)
Unrealized gains (losses) on financial derivatives, net			2,013
Credit default swaps on corporate bond indices | Credit Risk [Member]
Derivative [Line Items]
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	6,486	(1,883)
Realized gains (losses) on financial derivatives, net	6,486	(1,883)
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	2,691	(1,848)
Unrealized gains (losses) on financial derivatives, net	2,691	(1,848)
Credit default swaps on corporate bond indices | Credit Risk [Member]
Derivative [Line Items]
Realized gains (losses) on financial derivatives, net			(1,983)
Unrealized gains (losses) on financial derivatives, net			3,540
Credit default swaps on corporate bond indices | Credit Risk [Member]
Derivative [Line Items]
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	1,502	(5,262)
Realized gains (losses) on financial derivatives, net	1,502	(5,262)
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	(712)	(1,364)
Unrealized gains (losses) on financial derivatives, net	(712)	(1,364)
Credit default swaps on corporate bonds | Credit Risk [Member]
Derivative [Line Items]
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	285	(708)
Realized gains (losses) on financial derivatives, net	285	(708)	2,993
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	486	1,007
Unrealized gains (losses) on financial derivatives, net	486	1,007	(2,648)
Total return swaps | Equity Market/Credit Risk [Member]
Derivative [Line Items]
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	(2,057)	(1,460)
Realized gains (losses) on financial derivatives, net	(2,057)	(1,460)	3,844
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	114	(584)
Unrealized gains (losses) on financial derivatives, net	114	(584)	(5)
TBA securities | Interest Rate Risk [Member]
Derivative [Line Items]
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	(4,624)	(15,755)
Realized gains (losses) on financial derivatives, net	(4,624)	(15,755)
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	454	4,026
Unrealized gains (losses) on financial derivatives, net	454	4,026
Futures | Interest Rate/Currency Risk [Member]
Derivative [Line Items]
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	(7,447)	(7,924)
Realized gains (losses) on financial derivatives, net	(7,447)	(7,924)	162
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	(477)	458
Unrealized gains (losses) on financial derivatives, net	(477)	458	108
Forwards | Currency risk [Member]
Derivative [Line Items]
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	(1,004)	813
Realized gains (losses) on financial derivatives, net	(1,004)	813	923
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	(153)	(12)
Unrealized gains (losses) on financial derivatives, net	(153)	(12)	359
Warrants | Equity Market/Credit Risk [Member]
Derivative [Line Items]
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	0
Realized gains (losses) on financial derivatives, net	0
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	(377)
Unrealized gains (losses) on financial derivatives, net	(377)
Options | Interest Rate Risk [Member]
Derivative [Line Items]
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps		(35)
Realized gains (losses) on financial derivatives, net		(35)
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps		1
Unrealized gains (losses) on financial derivatives, net		$ 1
Options | Interest Rates/Equity Market Risk [Member]
Derivative [Line Items]
Realized gains (losses) on financial derivatives, net			(63)
Unrealized gains (losses) on financial derivatives, net			$ 77
Options | Credit [Member]
Derivative [Line Items]
Net Realized Gains (Losses) Other Than Periodic Settlements of Interest Rate Swaps	(100)
Realized gains (losses) on financial derivatives, net	(100)
Change in Net Unrealized Gains (Losses) Other Than on Accrued Periodic Settlements of Interest Rate Swaps	0
Unrealized gains (losses) on financial derivatives, net	$ 0

XML

Financial Derivatives (Schedule of Derivative Activity) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Interest rate swaps
Derivative [Line Items]
Average Monthly Notional	$ 1,009,110	$ 731,941	$ 1,059,756
TBA securities
Derivative [Line Items]
Average Monthly Notional	713,634	973,331
Credit default swaps
Derivative [Line Items]
Average Monthly Notional	277,990	399,316	566,805
Total return swaps
Derivative [Line Items]
Average Monthly Notional	6,975	39,434	53,603
Futures
Derivative [Line Items]
Average Monthly Notional	149,538	167,708	201,295
Options
Derivative [Line Items]
Average Monthly Notional	1,500	19,825	99,891
Forwards
Derivative [Line Items]
Average Monthly Notional	26,413	30,930	$ 45,522
Warrants
Derivative [Line Items]
Average Monthly Notional	$ 1,570	$ 2,222

XML

Financial Derivatives (Schedule of Credit Derivatives) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Credit Default Swap, Selling Protection [Member]
Credit Derivatives [Line Items]
Credit Risk Derivatives, at Fair Value, Net			$ 4,339
Fair Value	$ 3,171	$ 5,414
Notional value	68,653	132,176
Derivative notional			(98,586)
Credit Default Swap, Buying Protection [Member]
Credit Derivatives [Line Items]
Credit Risk Derivatives, at Fair Value, Net			284
Fair Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives	0	(3,248)
Notional value of purchased credit derivatives offsetting written credit derivatives	$ 0	$ (81,637)
Derivative notional			$ (41,134)

XML

Financial Derivatives (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Written credit derivative spread threshold	20.00%	20.00%	20.00%
Upfront points on written credit derivative in excess of threshold		57.0
Credit Default Swap, Selling Protection [Member]
Derivative [Line Items]
Credit risk derivative in excess of threshold, at fair value, net	$ (0.1)	$ (0.1)	$ (1.0)
Total net up-front payments received	$ (2.0)	$ (3.3)	$ (2.0)
Minimum
Derivative [Line Items]
Spread on written credit derivatives	4.00%	1.09%	4.26%
Upfront points on written credit derivative in excess of threshold	56.2		36.9
Maximum
Derivative [Line Items]
Spread on written credit derivatives	27.48%	44.00%	81.51%
Upfront points on written credit derivative in excess of threshold	85.2		75.2

XML

Financial Derivatives Schedule of Options Contracts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Financial derivatives–assets, at fair value-	$ 15,479	$ 16,788	$ 20,001
Put Option [Member]
Derivative [Line Items]
Remaining Years to Maturity	15 days

XML

Financial Derivatives Schedule of Warrant Contracts (Details) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Financial derivatives–assets, at fair value-	$ 15,479	$ 16,788	$ 20,001
Warrants
Derivative [Line Items]
Number of Shares Underlying Warrant Contracts	1,897	1,515
Financial derivatives–assets, at fair value-	$ 36	$ 0
Remaining Years to Maturity	2 years 4 months 24 days	2 years 9 months 25 days

XML

Consolidated VIEs (Details) - USD ($) $ in Thousands		Dec. 31, 2020		Dec. 31, 2019		Dec. 31, 2018	Dec. 31, 2017
Assets
Cash and cash equivalents		$ 111,647	[1]	$ 72,302	[1]	$ 44,656
Restricted cash		175	[1]	175	[1]	425
Securities, at fair value(1)(2)	[1],[2]	1,514,185		2,449,941
Loans, at fair value	[1],[2]	1,453,480		1,412,426
Investment in unconsolidated entities, at fair value	[1]	141,620		71,850
Real estate owned	[1],[2]	23,598		30,584
Due from brokers		63,147	[1]	79,829	[1]	71,794
Investment related receivables	[1]	49,317		123,120
Other assets		2,575	[1]	7,563	[1]	15,536
Total Assets		3,413,863		4,338,217		3,971,499
Liabilities
Repurchase agreements		1,496,931	[1]	2,445,300	[1]	1,498,849
Investment related payables		4,754	[1]	66,133	[1]	488,411
Other secured borrowings		51,062	[1]	150,334	[1]	114,100
Other secured borrowings, at fair value		754,921	[1]	594,396	[1]	297,948
Accounts payable and accrued expenses						5,723
Interest payable	[1]	3,233		7,320
Accrued expenses and other liabilities	[1]	18,659		7,753
Total Liabilities		2,492,291		3,469,518		3,376,329
Total Stockholders' Equity		885,215		829,265		563,833
Non-controlling interests		36,357	[1]	39,434	[1]	31,337
Total Equity		921,572		868,699		595,170	$ 620,961
Total Liabilities and Equity		3,413,863		4,338,217		$ 3,971,499
Primary Beneficiary
Assets
Cash and cash equivalents		701		6,016
Restricted cash		175		175
Securities, at fair value(1)(2)		44,523		47,923
Loans, at fair value		1,435,067		1,393,916
Investment in unconsolidated entities, at fair value		6,345		5,641
Real estate owned		23,598		30,584
Investment related receivables		24,824		28,668
Other assets		2,001		6,191
Total Assets		1,537,234		1,519,114
Liabilities
Repurchase agreements		275,019		302,791
Investment related payables		0		3,275
Other secured borrowings		51,062		150,334
Other secured borrowings, at fair value		754,921		594,396
Interest payable		776		1,247
Accrued expenses and other liabilities		1,103		2,279
Total Liabilities		1,082,881		1,054,322
Total Stockholders' Equity		430,554		440,394
Non-controlling interests		23,799		24,400
Total Equity		454,353		464,794
Total Liabilities and Equity		$ 1,537,234		$ 1,519,116

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Securitization Transactions Narrative (Details) - USD ($) $ in Thousands		1 Months Ended			12 Months Ended
		Nov. 30, 2020	May 31, 2017	Aug. 31, 2016	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Securitization Transactions [Line Items]
Securities, at fair value(1)(2)	[1],[2]				$ 1,514,185	$ 2,449,941
Face amount of notes distributed from Risk Retention Vehicle							$ 5,600
Proceeds received from equity investment in risk retention vehicle (liquidation)							$ 5,700
Minimum economic interest required to be retained							5.00%
Fair Value							$ 2,939,311
Investment in unconsolidated entities, at fair value	[1]				141,620	$ 71,850
CLO I Securitization [Member]
Securitization Transactions [Line Items]
Loss on securitization of financial assets			$ 200
Participation in Multi-Seller Consumer Loan Securitization [Member]
Securitization Transactions [Line Items]
Aggregate unpaid principal balance of loans sold		$ 205,100		$ 124,000
Company's share of loans sold		56.30%		51.00%
Co-participants share of loans sold		43.70%		49.00%
Loss on securitization of financial assets				$ (100)
Senior notes issued in securitization transaction		$ 158,400		87,000
Subordinated notes issued in securitization transaction		$ 35,200		$ 18,700
Company's initial percentage ownership of jointly owned entity		56.30%		51.00%
Affiliated co-participants initial percentage ownership of jointly owned entity		43.70%		49.00%
Investment in unconsolidated entities, at fair value					$ 19,100
Company's current percentage ownership of jointly owned entity					56.30%		62.00%
The Company [Member] | CLO I Securitization [Member]
Securitization Transactions [Line Items]
Corporate loans transferred into CLO securitization			62,000
Affiliated Entity [Member] | CLO I Securitization [Member]
Securitization Transactions [Line Items]
Corporate loans transferred into CLO securitization			$ 141,700
CLOs
Securitization Transactions [Line Items]
Fair Value							$ 123,893
CLOs | CLO I Securitization [Member]
Securitization Transactions [Line Items]
Fair Value							0
CLOs | Distributed from Risk Retention Vehicle [Member]
Securitization Transactions [Line Items]
Fair Value							$ 4,300
Non-QM loan securitization
Securitization Transactions [Line Items]
Threshold for exercising Optional Redemption					30.00%	30.00%
Percentage used to calculate servicing administrator fee					0.03%	0.03%

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Securitization Transactions (Schedule of CLO Securitization Transactions) (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2020
Securitization Transactions [Line Items]
Fair Value			$ 2,939,311
Securities, at fair value(1)(2)	[1],[2]	$ 2,449,941		$ 1,514,185
CLO I Securitization [Member]
Securitization Transactions [Line Items]
CLO Pricing Date		2017-05
CLO Closing Date			2017-06
Total Face Amount of Notes Issued			$ 373,550
Face Amount of Notes Initially Purchased			36,606
Aggregate Purchase Price of Notes Initially Purchased			$ 35,926
Reset CLO I Securitization [Member]
Securitization Transactions [Line Items]
CLO Pricing Date		2018-08
CLO Closing Date			2018-08
Total Face Amount of Notes Issued			$ 461,840
Face Amount of Notes Initially Purchased			36,579
Aggregate Purchase Price of Notes Initially Purchased			$ 25,622
CLO II Securitization [Member]
Securitization Transactions [Line Items]
CLO Pricing Date		2017-12
CLO Closing Date			2018-01
Total Face Amount of Notes Issued			$ 452,800
Face Amount of Notes Initially Purchased			18,223
Aggregate Purchase Price of Notes Initially Purchased			$ 16,621
CLO III Securitization [Member]
Securitization Transactions [Line Items]
CLO Pricing Date		2018-06
CLO Closing Date			2018-07
Total Face Amount of Notes Issued			$ 407,100
Face Amount of Notes Initially Purchased			35,480
Aggregate Purchase Price of Notes Initially Purchased			32,394
CLOs
Securitization Transactions [Line Items]
Fair Value			123,893
CLOs | CLO I Securitization [Member]
Securitization Transactions [Line Items]
Fair Value			0
CLOs | Related Party CLO securitization [Member]
Securitization Transactions [Line Items]
Fair Value			50,800
Securities, at fair value(1)(2)		$ 39,700		$ 17,300
CLOs | Reset CLO I Securitization [Member]
Securitization Transactions [Line Items]
Fair Value			16,973
CLOs | CLO II Securitization [Member]
Securitization Transactions [Line Items]
Fair Value			14,721
CLOs | CLO III Securitization [Member]
Securitization Transactions [Line Items]
Fair Value			$ 19,071

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Securitization Transactions (Schedule of Residential Loan Securitizations) (Details) - Non-QM loan securitization - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2018
November 2017 [Member]
Securitization Transactions [Line Items]
Total Face Amount of Certificates Issued		$ 141,233
Economic interest retained		5.10%
Purchase of certificates		$ 700
November 2018 [Member]
Securitization Transactions [Line Items]
Total Face Amount of Certificates Issued		$ 232,518
Economic interest retained		5.70%
Purchase of certificates		$ 1,300
June 2019 [Member]
Securitization Transactions [Line Items]
Total Face Amount of Certificates Issued	$ 226,913
Economic interest retained	6.10%
Purchase of certificates	$ 1,200
November 2019 [Member]
Securitization Transactions [Line Items]
Total Face Amount of Certificates Issued	$ 267,255
Economic interest retained	6.40%
Purchase of certificates	$ 1,700
June 2020 [Member]
Securitization Transactions [Line Items]
Total Face Amount of Certificates Issued	259,273
Purchase of certificates	1,900
November 2020
Securitization Transactions [Line Items]
Total Face Amount of Certificates Issued	219,732
Purchase of certificates	1,400
The Company [Member] | November 2017 [Member]
Securitization Transactions [Line Items]
Principal Balance of Loans Transferred to the Depositor		141,233
The Company [Member] | November 2018 [Member]
Securitization Transactions [Line Items]
Principal Balance of Loans Transferred to the Depositor		$ 232,518
The Company [Member] | June 2019 [Member]
Securitization Transactions [Line Items]
Principal Balance of Loans Transferred to the Depositor	226,913
The Company [Member] | November 2019 [Member]
Securitization Transactions [Line Items]
Principal Balance of Loans Transferred to the Depositor	267,255
The Company [Member] | June 2020 [Member]
Securitization Transactions [Line Items]
Principal Balance of Loans Transferred to the Depositor	259,273
The Company [Member] | November 2020
Securitization Transactions [Line Items]
Principal Balance of Loans Transferred to the Depositor	$ 219,732
Retained, non-risk retention [Member] | June 2020 [Member]
Securitization Transactions [Line Items]
Economic interest retained	3.50%
Retained, risk retention rules [Member] | June 2020 [Member]
Securitization Transactions [Line Items]
Economic interest retained	8.00%
Retained, risk retention rules [Member] | November 2020
Securitization Transactions [Line Items]
Economic interest retained	7.60%

XML

Securitization Transactions (Schedule of Assets and Liabilities Attributable to Consolidated VIEs) (Details) - USD ($) $ in Thousands		Dec. 31, 2020		Dec. 31, 2019		Dec. 31, 2018
Variable Interest Entity [Line Items]
Fair Value						$ 2,939,311
Interest and Dividends Payable						7,159
Other secured borrowings, at fair value		$ 754,921	[1]	$ 594,396	[1]	297,948
Loans, at fair value	[1],[2]	1,453,480		1,412,426
Real estate owned	[1],[2]	23,598		30,584
Investment related receivables	[1]	49,317		123,120
Residential mortgage loans
Variable Interest Entity [Line Items]
Loans, at fair value		1,187,069		932,203
Consolidated Entities [Member]
Variable Interest Entity [Line Items]
Fair Value						314,202
Interest and Dividends Receivable						3,527
Interest and Dividends Payable						103
Other secured borrowings, at fair value						$ 297,948
Consolidated Entities [Member] | Non-QM loan securitization
Variable Interest Entity [Line Items]
Other secured borrowings, at fair value		754,921		594,396
Investment related receivables		15,544		10,409
Consolidated Entities [Member] | Residential mortgage loans | Securitized loans [Member] | Non-QM loan securitization
Variable Interest Entity [Line Items]
Loans, at fair value		801,343		628,415
Real estate owned		$ 0		$ 658

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

(Schedule of Reverse Repurchase Agreements by Maturity) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($) counterparty		Dec. 31, 2019 USD ($) counterparty		Dec. 31, 2018 USD ($) counterparty
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	$ 1,496,931	[1]	$ 2,445,300	[1]	$ 1,498,849
Number of Counterparties with Outstanding Reverse Repurchase Agreements | counterparty	24		28		23
Total secured borrowings	$ 2,300,000		$ 3,200,000		$ 1,911,000
Agency RMBS
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	921,862		1,864,473		917,262
Agency RMBS | 30 Days or Less
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	265,556		511,996		245,956
Agency RMBS | 31-60 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	385,141		744,387		415,379
Agency RMBS | 61-90 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	174,586		594,738		255,421
Agency RMBS | 91-120 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	0		10,270		506
Agency RMBS | 151 to 180 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	59,857		3,082
Agency RMBS | More Than 360 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	34,030		0
Agency RMBS | 121-150 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	2,692		0
U.S. Treasury securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements					273
U.S. Treasury securities | 30 Days or Less
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements					273
Credit
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	575,069		580,827
Credit | 30 Days or Less
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	37,795		16,549		30,426
Credit | 31-60 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	84,554		104,491		189,937
Credit | 61-90 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	152,426		138,837		93,202
Credit | 91-120 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	89,931		0		26,222
Credit | 151 to 180 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	11,063		31,498		91,730
Credit | More Than 360 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	38,640		186,661		140,306
Credit | Total Credit Assets
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	94,248		95,331		581,314
Credit | 121-150 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	$ 66,412		$ 7,460		$ 9,491
Minimum
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	0.20%		0.15%		23.00%
Repurchase agreements, remaining days to maturity	4 days		2 days		2 days
Maximum
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	5.00%		5.20%		607.00%
Repurchase agreements, remaining days to maturity	516 days		882 days		871 days
Weighted Average
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	1.20%		2.37%		3.13%
Repurchase agreements, remaining days to maturity	94 days		91 days		122 days
Weighted Average | Agency RMBS
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	0.27%		1.98%		2.59%
Repurchase agreements, remaining days to maturity	57 days		48 days		47 days
Weighted Average | Agency RMBS | 30 Days or Less
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	0.28%		2.08%		2.46%
Repurchase agreements, remaining days to maturity	17 days		17 days		17 days
Weighted Average | Agency RMBS | 31-60 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	0.25%		1.93%		2.58%
Repurchase agreements, remaining days to maturity	44 days		47 days		46 days
Weighted Average | Agency RMBS | 61-90 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	0.28%		1.96%		2.74%
Repurchase agreements, remaining days to maturity	70 days		76 days		76 days
Weighted Average | Agency RMBS | 91-120 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	0.00%		2.24%		3.31%
Repurchase agreements, remaining days to maturity	0 days		93 days		91 days
Weighted Average | Agency RMBS | 151 to 180 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	0.32%		2.67%
Repurchase agreements, remaining days to maturity	162 days		171 days
Weighted Average | Agency RMBS | More Than 360 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	0.32%		0.00%
Repurchase agreements, remaining days to maturity	252 days		0 days
Weighted Average | Agency RMBS | 121-150 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	0.27%		0.00%
Repurchase agreements, remaining days to maturity	126 days		0 days
Weighted Average | U.S. Treasury securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate					3.10%
Repurchase agreements, remaining days to maturity					2 days
Weighted Average | U.S. Treasury securities | 30 Days or Less
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate					3.10%
Repurchase agreements, remaining days to maturity					2 days
Weighted Average | Credit
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	2.69%		3.61%
Repurchase agreements, remaining days to maturity	155 days		229 days
Weighted Average | Credit | 30 Days or Less
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	2.11%		3.38%		2.55%
Repurchase agreements, remaining days to maturity	17 days		25 days		22 days
Weighted Average | Credit | 31-60 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	2.23%		3.14%		3.32%
Repurchase agreements, remaining days to maturity	50 days		48 days		48 days
Weighted Average | Credit | 61-90 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	2.11%		3.03%		3.21%
Repurchase agreements, remaining days to maturity	75 days		73 days		74 days
Weighted Average | Credit | 91-120 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	2.47%		0.00%		4.60%
Repurchase agreements, remaining days to maturity	106 days		0 days		123 days
Weighted Average | Credit | 151 to 180 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	2.27%		3.87%		4.54%
Repurchase agreements, remaining days to maturity	165 days		173 days		316 days
Weighted Average | Credit | More Than 360 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	2.90%		3.80%		5.15%
Repurchase agreements, remaining days to maturity	289 days		250 days		636 days
Weighted Average | Credit | Total Credit Assets
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	2.99%		4.52%		3.98%
Repurchase agreements, remaining days to maturity	447 days		678 days		240 days
Weighted Average | Credit | 121-150 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Interest Rate	4.75%		3.89%		4.64%
Repurchase agreements, remaining days to maturity	125 days		123 days		166 days

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

XML

Borrowings (Schedule of Debt Repayments) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2018
Debt Instrument [Line Items]
Expected principal repayments related to consolidated residential mortgage loan securitizations	$ 778,100
Repurchase Agreements
Debt Instrument [Line Items]
Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months	1,402,683
Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two	94,248
2019 Scheduled Repayment of Principal		$ 1,358,542
2020 Scheduled Repayment of Principal	0	78,530
2021 Scheduled Repayment of Principal	0	61,776
Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five	0	0
Total Scheduled Repayment of Principal	1,496,931	1,498,848
Long-term Debt, Maturities, Repayments of Principal after Year Five		0
Other Secured Borrowings
Debt Instrument [Line Items]
Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months	370,933
Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two	236,976
2019 Scheduled Repayment of Principal		194,135
2020 Scheduled Repayment of Principal	221,269	205,198
2021 Scheduled Repayment of Principal	0	13,150
Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five	0	0
Total Scheduled Repayment of Principal	829,178	412,483
Long-term Debt, Maturities, Repayments of Principal after Year Five		0
Senior Notes
Debt Instrument [Line Items]
Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months	0
Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two	86,000
2019 Scheduled Repayment of Principal		0
2020 Scheduled Repayment of Principal	0	0
2021 Scheduled Repayment of Principal	0	0
Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five	0	86,000
Total Scheduled Repayment of Principal	86,000	86,000
Long-term Debt, Maturities, Repayments of Principal after Year Five		0
Total
Debt Instrument [Line Items]
Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months	1,773,616
Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two	417,224
2019 Scheduled Repayment of Principal		1,552,677
2020 Scheduled Repayment of Principal	221,269	283,728
2021 Scheduled Repayment of Principal	0	74,926
Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five	0	86,000
Total Scheduled Repayment of Principal	$ 2,412,109	1,997,331
Long-term Debt, Maturities, Repayments of Principal after Year Five		$ 0

XML

Borrowings (Details) $ in Thousands			12 Months Ended
	Feb. 13, 2019 USD ($)	Aug. 18, 2017 USD ($)	Dec. 31, 2020 USD ($) counterparty		Dec. 31, 2019 USD ($) counterparty		Dec. 31, 2018 USD ($) counterparty
Borrowings [Line Items]
Total secured borrowings			$ 2,300,000		$ 3,200,000		$ 1,911,000
Concentration Risk, Reverse Repurchase Agreements							2100.00%
Number of Counterparties With Concentration Risk, Reverse Repurchase Agreements | counterparty							1
Number of Counterparties with Outstanding Reverse Repurchase Agreements | counterparty			24		28		23
Financial Instruments transferred as collateral for repurchase agreements			$ 1,831,000		$ 2,763,000		$ 1,790,000
Collateral on repurchase agreements, unsettled sales			$ 1,400		64,700
Pledged Financial Instruments, Not Separately Reported, Securities For Repurchase Agreements Unsettled							$ 86,700
Repurchase Agreements amount at risk threshold			10.00%				10.00%
Other secured borrowings			$ 51,062	[1]	150,334	[1]	$ 114,100
Other secured borrowings, at fair value			$ 754,921	[1]	$ 594,396	[1]	297,948
Long-term Debt, Fair Value							$ 86,000
Minimum
Borrowings [Line Items]
Reverse Repurchase Agreements Maturity			30 days				30 days
Repurchase agreements, remaining days to maturity			4 days		2 days		2 days
Repurchase Agreements Interest Rate			0.20%		0.15%		23.00%
Maximum
Borrowings [Line Items]
Reverse Repurchase Agreements Maturity			180 days				180 days
Repurchase agreements, remaining days to maturity			516 days		882 days		871 days
Repurchase Agreements Interest Rate			5.00%		5.20%		607.00%
Reverse repurchase agreements
Borrowings [Line Items]
Cash collateral posted for securities sold under agreements to repurchase			$ 28,900		$ 31,000		$ 17,000
Security Owned and Pledged as Collateral, Fair Value					200		200
Securitized residential mortgage loans
Borrowings [Line Items]
Fair Value of Assets Transfered and Accounted for as Secured Borrowings			801,300		629,100
Secured borrowing recourse facility collateralized by unsecured loan portfolio
Borrowings [Line Items]
Other secured borrowings			$ 8,700		$ 16,000		$ 13,200
Debt Instrument, Interest Rate, Effective Rate			2.30%		3.85%
Debt Instrument, Interest Rate, Stated Percentage							4.72%
Secured borrowing recourse facility collateralized by unsecured loan portfolio | Unsecured loans
Borrowings [Line Items]
Fair Value of Assets Transfered and Accounted for as Secured Borrowings			$ 11,500		$ 22,300		$ 20,300
Non-QM loan securitization
Borrowings [Line Items]
Other secured borrowings					$ 594,400		$ 297,900
Debt Instrument, Interest Rate, Effective Rate			2.43%		3.19%
Debt Instrument, Interest Rate, Stated Percentage							3.72%
Secured borrowing facility collateralized by unsecured loan portfolio
Borrowings [Line Items]
Other secured borrowings			$ 7,000		$ 102,500		$ 101,000
Debt Instrument, Interest Rate, Effective Rate			2.25%		4.01%
Debt Instrument, Interest Rate, Stated Percentage							4.68%
Secured borrowing facility collateralized by unsecured loan portfolio | Unsecured loans
Borrowings [Line Items]
Fair Value of Assets Transfered and Accounted for as Secured Borrowings			$ 31,800		$ 144,100		$ 149,000
Secured borrowing facility collateralized by ABS backed by consumer loans [Member]
Borrowings [Line Items]
Other secured borrowings			$ 28,700		$ 31,800
Debt Instrument, Interest Rate, Effective Rate			5.22%		5.23%
Fair Value of Assets Transfered and Accounted for as Secured Borrowings			$ 44,500		$ 47,900
Commercial mortgage loans
Borrowings [Line Items]
Other secured borrowings			6,700
Fair Value of Assets Transfered and Accounted for as Secured Borrowings			$ 17,300
Senior Notes
Borrowings [Line Items]
Debt Instrument, Interest Rate, Effective Rate			5.80%
Debt Instrument, Face Amount	$ 86,000	$ 86,000
Proceeds from Debt, Net of Issuance Costs		$ 84,700
Debt Instrument, Interest Rate, Stated Percentage	5.50%	5.25%					5.55%
Redemption percentage	100.00%	100.00%
Debt Instrument, Maturity Date		Sep. 01, 2022

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

XML

Income Taxes Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income Tax Expense (Benefit)	$ 7,888	$ 2,494	$ 1,542	$ (547)	$ 1,180	$ 2	$ 376	$ 0	$ 11,377	$ 1,558

XML

Income Taxes Schedule of Tax Characteristics of Distributions (Details) (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Ordinary income	58.20%	85.00%
Return of capital	37.90%	9.40%
Capital gain	3.90%	5.60%
Total, percentage of dividends with tax characteristic	100.00%	100.00%

XML

Income Taxes Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Current Federal Tax Expense (Benefit)									$ 38	$ 185
Current State and Local Tax Expense (Benefit)									602	293
Current Income Tax Expense (Benefit)									640	478
Deferred Federal Income Tax Expense (Benefit)									6,638	1,080
Deferred Federal, State and Local, Tax Expense (Benefit)									4,099	0
Deferred Income Tax Expense (Benefit)									10,737	1,080
Income Tax Expense (Benefit)	$ 7,888	$ 2,494	$ 1,542	$ (547)	$ 1,180	$ 2	$ 376	$ 0	$ 11,377	$ 1,558

XML

Income Taxes Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Deferred Tax Assets, Operating Loss Carryforwards	$ 1,937	$ 3,907
Deferred Tax Assets, Investments	1,481	669
Deferred Tax Assets, Valuation Allowance	0	(157)
Deferred Tax Assets, Gross	3,419	4,419
Deferred Tax Liabilities, Investments	(15,525)	(5,484)
Deferred Tax Liabilities, Gross	(15,525)	(5,484)
Deferred Tax Liabilities, Net	$ (12,106)	$ (1,065)

XML

Income Taxes Reconciliation of Tax Rate to Effective Tax Rate (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%	21.00%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent	11.83%	0.45%
Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent	(1.78%)	(1.28%)
Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent	(2.43%)	(17.76%)
Effective Income Tax Rate Reconciliation, Percent	28.62%	2.41%

XML

Related Party Transactions (Details)		3 Months Ended														12 Months Ended
		Dec. 31, 2020 USD ($)		Sep. 30, 2020 USD ($)	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)		Sep. 30, 2019 USD ($)	Jun. 30, 2019 USD ($)	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Sep. 30, 2018 USD ($)	Jun. 30, 2018 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2020 USD ($) numberOfWarrants period		Dec. 31, 2019 USD ($)		Dec. 31, 2018 USD ($) period
Related Party Transaction [Line Items]
Annual base management fee percentage																1.50%		1.50%
Base management fee to affiliate		$ 3,178,000	[1]	$ 2,981,000	$ 2,906,000	$ 2,443,000	$ 2,663,000		$ 1,942,000	$ 1,661,000	$ 1,722,000	$ 1,744,000	$ 1,830,000	$ 2,021,000	$ 1,978,000	$ 11,508,000	[1]	$ 7,988,000	[1]	$ 7,573,000	[2]
Base management fee, gross																12,600,000		10,000,000.0
Management Fee Expense, Rebates												400,000	400,000	300,000	300,000	$ 1,051,000		1,967,000	[1]
Incentive fee rate																25.00%				25.00%
Incentive Fee, Loss Carryforward		0					0					2,100,000				$ 0		0		$ 2,100,000
Incentive fee hurdle rate fixed																9.00%				9.00%
Incentive fee hurdle rate floating																3.00%				3.00%
Incentive Fee Expense		0		$ 0	$ 0	$ 0	116,000		$ 0	$ 0	$ 0	0	$ 424,000	$ 291,000	$ 0	$ 0		$ 116,000		$ 715,000
Minimum percentage of incentive fee to be paid in share																10.00%				10.00%
Termination Fee, Number Of Periods | period																2				2
Termination Fee, Period																12 months				12 months
Expense Reimbursement Period																60 days		60 days
Expense Reimbursement - Manager																$ 9,900,000		$ 10,900,000		$ 6,500,000
Accounts payable and accrued expenses												5,723,000								5,723,000
Fair Value												2,939,311,000								2,939,311,000
Real estate owned	[3],[4]	23,598,000					30,584,000									23,598,000		30,584,000
Investment in unconsolidated entities, at fair value	[3]	141,620,000					71,850,000									141,620,000		71,850,000
Securities, at fair value(1)(2)	[3],[4]	1,514,185,000					2,449,941,000									1,514,185,000		2,449,941,000
Non-controlling interests		36,357,000	[3]				39,434,000	[3]				31,337,000				36,357,000	[3]	39,434,000	[3]	31,337,000
Accrued expenses and other liabilities	[3]	18,659,000					7,753,000									18,659,000		7,753,000
Reverse repurchase agreements		1,496,931,000					2,445,300,000					1,498,849,000				1,496,931,000		2,445,300,000		1,498,849,000
Management fee rebate																				1,380,000
Other assets		2,575,000	[3]				7,563,000	[3]				15,536,000				2,575,000	[3]	7,563,000	[3]	15,536,000
Face amount of investments purchased from related party																				$ 2,900,000
Management Fee, description																				The Operating Partnership pays the Manager 1.50% per annum of total equity of the Operating Partnership calculated in accordance with U.S. GAAP as of the end of each fiscal quarter (before deductions for base management fees and incentive fees payable with respect to such fiscal quarter), provided that total equity is adjusted to exclude one-time events pursuant to changes in U.S. GAAP, as well as non-cash charges after discussion between the Manager and the Company's independent directors, and approval by a majority of the Company's independent directors in the case of non-cash charges.
Incentive fee, description																				The Manager is entitled to receive a quarterly incentive fee equal to the positive excess, if any, of (i) the product of (A) 25% and (B) the excess of (1) Adjusted Net Income (described below) for the Incentive Calculation Period (which means such fiscal quarter and the immediately preceding three fiscal quarters) over (2) the sum of the Hurdle Amounts (described below) for the Incentive Calculation Period, over (ii) the sum of the incentive fees already paid or payable for each fiscal quarter in the Incentive Calculation Period preceding such fiscal quarter.For purposes of calculating the incentive fee, "Adjusted Net Income" for the Incentive Calculation Period means the net increase in equity from operations of the Operating Partnership, after all base management fees but before any incentive fees for such period, and excluding any non-cash equity compensation expenses for such period, as reduced by any Loss Carryforward (as described below) as of the end of the fiscal quarter preceding the Incentive Calculation Period.For purposes of calculating the incentive fee, the "Loss Carryforward" as of the end of any fiscal quarter is calculated by determining the excess, if any, of (1) the Loss Carryforward as of the end of the immediately preceding fiscal quarter over (2) the Company's net increase in equity from operations (expressed as a positive number) or net decrease in equity from operations (expressed as a negative number) of the Operating Partnership for such fiscal quarter. As of December 31, 2018, there was a Loss Carryforward of $2.1 million.For purposes of calculating the incentive fee, the "Hurdle Amount" means, with respect to any fiscal quarter, the product of (i) one-fourth of the greater of (A) 9% and (B) 3% plus the 10-year U.S. Treasury rate for such fiscal quarter, (ii) the sum of (A) the weighted average gross proceeds per share of all common share and OP Unit issuances since inception of the Company and up to the end of such fiscal quarter, with each issuance weighted by both the number of shares and OP Units issued in such issuance and the number of days that such issued shares and OP Units were outstanding during such fiscal quarter, using a first-in first-out basis of accounting (i.e. attributing any share and OP Unit repurchases to the earliest issuances first) and (B) the result obtained by dividing (I) retained earnings attributable to common shares and OP Units at the beginning of such fiscal quarter by (II) the average number of common shares and OP Units outstanding for each day during such fiscal quarter, (iii) the sum of (x) the average number of common shares and LTIP Units outstanding for each day during such fiscal quarter, and (y) the average number of OP Units and OP LTIP Units outstanding for each day during such fiscal quarter. For purposes of determining the Hurdle Amount, issuances of common shares, OP LTIP Units, and OP Units (a) as equity incentive awards, (b) to the Manager as part of its base management fee or incentive fee and (c) to the Manager or any of its affiliates in privately negotiated transactions, are excluded from the calculation. The payment of the incentive fee will be in a combination of common shares and cash, provided that at least 10% of any quarterly payment will be made in common shares.
Termination fee, description																				The Management Agreement requires the Company to pay a termination fee to the Manager in the event of (1) the Company's termination or non-renewal of the Management Agreement without cause or (2) the Company's termination of the Management Agreement based on unsatisfactory performance by the Manager that is materially detrimental to the Company or (3) the Manager's termination of the Management Agreement upon a default by the Company in the performance of any material term of the Management Agreement. Such termination fee will be equal to the amount of three times the sum of (i) the average annual Quarterly Base Management Fee Amounts paid or payable with respect to the two 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal and (ii) the average annual Quarterly Incentive Fee Amounts paid or payable with respect to the two 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal.
Unpaid Principal Balance		1,417,054,000					1,387,733,000									1,417,054,000		1,387,733,000
Related Party Transaction, Purchases from Related Party																1,600,000		8,800,000
Securities Collateral relating to Reverse Repurchase Agreements		1,800,000,000					2,800,000,000					1,790,000,000				1,800,000,000		2,800,000,000		$ 1,790,000,000
Commercial mortgage loans and REO
Related Party Transaction [Line Items]
Fair Value		34,000,000.0					29,500,000					25,300,000				34,000,000.0		29,500,000		25,300,000
Reverse repurchase agreements		116,100,000					174,400,000					77,000,000.0				116,100,000		174,400,000		77,000,000.0
Corporate equity securities
Related Party Transaction [Line Items]
Fair Value												43,793,000								43,793,000
Secured notes
Related Party Transaction [Line Items]
Fair Value												10,917,000								10,917,000
Corporate debt securities
Related Party Transaction [Line Items]
Fair Value												22,392,000								22,392,000
Affiliated Entity [Member]
Related Party Transaction [Line Items]
Accounts payable and accrued expenses	[3]	2,500,000					2,000,000.0									2,500,000		2,000,000.0
Affiliated Entity [Member] | Commercial mortgage loans and REO
Related Party Transaction [Line Items]
Accrued expenses and other liabilities	[3]						700,000											700,000
Mortgage Originator
Related Party Transaction [Line Items]
Warehouse facility, monetary amount		$ 5,000,000.0										$ 5,000,000.0				$ 5,000,000.0				$ 5,000,000.0
Interest rate		15.00%										15.00%				15.00%				15.00%
Advances made under warehouse facility		$ 0					0					$ 0				$ 0		0		$ 0
Loans purchased under commitment agreement																$ 150,000,000
Number of warrants purchased under commitment agreement | numberOfWarrants																9,329,000
Mortgage Originator | Warrants
Related Party Transaction [Line Items]
Investment in unconsolidated entities, at fair value		3,600,000														$ 3,600,000
Related Party-Consumer Loans Titled in Name of Related Party
Related Party Transaction [Line Items]
Fair value of loans held in related party trust		44,500,000					47,900,000					21,900,000				44,500,000		47,900,000		21,900,000
Purchasing Entity
Related Party Transaction [Line Items]
Fair value of loans held in related party trust		45,100,000					185,400,000					181,500,000				45,100,000		185,400,000		181,500,000
Consumer loans purchased through affiliate																115,700,000		134,400,000		166,300,000
Estimated remaining contingent purchase obligations		13,000,000.0					287,100,000					263,500,000				13,000,000.0		287,100,000		263,500,000
Related party trust - Residential Mortgage Loans and REO
Related Party Transaction [Line Items]
Fair value of loans held in related party trust		387,400,000					304,800,000					498,100,000				387,400,000		304,800,000		498,100,000
Related party mortgage originator (with flow mortgage loan purchase and sale agreement) [Member] | Non-Exchange Traded Equity Investment in Mortgage Originators [Member]
Related Party Transaction [Line Items]
Drawn down amount being guaranteed		5,300,000					400,000					2,900,000				5,300,000		400,000		2,900,000
Non-controlling interest of joint venture partner | Unrelated third party joint venture interest | Commercial mortgage loans and REO
Related Party Transaction [Line Items]
Non-controlling interests		4,100,000					3,600,000					1,400,000				4,100,000		3,600,000		1,400,000
Non-controlling interest of joint venture partner | Related party joint venture interest | Commercial mortgage loans and REO
Related Party Transaction [Line Items]
Non-controlling interests		8,900,000					7,000,000.0					4,100,000				8,900,000		7,000,000.0		4,100,000
Mortgage-related Commercial | Corporate equity securities
Related Party Transaction [Line Items]
Fair Value		33,900,000					17,300,000					$ 1,100,000				33,900,000		17,300,000		$ 1,100,000
Ownership percentage of limited liability company held as investment												15.00%								15.00%
Jepson Holdings Limited
Related Party Transaction [Line Items]
Investment in unconsolidated entities, at fair value		1,800,000					1,900,000									1,800,000		1,900,000
Corporate loan [Member]
Related Party Transaction [Line Items]
Unpaid Principal Balance		5,855,000					18,415,000									5,855,000		18,415,000
Corporate loan [Member] | Mortgage Originator
Related Party Transaction [Line Items]
Unpaid Principal Balance							12,500,000											12,500,000
Long
Related Party Transaction [Line Items]
Securities, at fair value(1)(2)		1,514,185,000					2,449,941,000									1,514,185,000		2,449,941,000
Long | Non-Agency RMBS
Related Party Transaction [Line Items]
Securities, at fair value(1)(2)		201,090,000					163,136,000									201,090,000		163,136,000
Loan receivable from affiliated entity related to warehouse facility
Related Party Transaction [Line Items]
Other assets		6,100,000					8,100,000					$ 11,600,000				6,100,000		8,100,000		$ 11,600,000
Participation in multi-borrower financing facility
Related Party Transaction [Line Items]
Outstanding debt of related party		$ 192,300,000					$ 350,600,000					149,000,000.0				192,300,000		$ 350,600,000		149,000,000.0
Investment purchased from related party | Corporate debt securities
Related Party Transaction [Line Items]
Fair Value												$ 1,600,000								$ 1,600,000
Maximum | Mortgage Originator
Related Party Transaction [Line Items]
Commitment to purchase loans																$ 150,000,000
Number of warrants available for purchase under commitment agreement | numberOfWarrants																9,329,000
Note Purchase Agreement May 2019 [Member] | Corporate loan [Member] | Mortgage Originator
Related Party Transaction [Line Items]
Investment Interest Rate		15.00%														15.00%
Note Purchase Agreement May 2019 [Member] | Maximum | Corporate loan [Member] | Mortgage Originator
Related Party Transaction [Line Items]
Note Agreement, Lending Amount Per Agreement		$ 5,000,000.0														$ 5,000,000.0
Note Purchase Agreement July 2019 [Member] | Corporate loan [Member] | Mortgage Originator
Related Party Transaction [Line Items]
Investment Interest Rate		18.00%														18.00%
Note Purchase Agreement July 2019 [Member] | Maximum | Corporate loan [Member] | Mortgage Originator
Related Party Transaction [Line Items]
Note Agreement, Lending Amount Per Agreement		$ 5,000,000.0														$ 5,000,000.0
Note Purchase Agreement December 2019 [Member] | Maximum | Corporate loan [Member] | Mortgage Originator
Related Party Transaction [Line Items]
Note Agreement, Lending Amount Per Agreement		$ 2,500,000														$ 2,500,000

[1] See Note 13 for further details on management fee rebates.

[2] See Note 9 for further details on management fee rebates.

[3] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[4] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

Long-Term Incentive Plan Units (Narrative) (Details) - USD ($) $ in Thousands							12 Months Ended
	Dec. 17, 2020	Sep. 10, 2020	Mar. 04, 2020	Dec. 12, 2018	Sep. 12, 2018	Mar. 07, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based long term incentive plan unit expense							$ 722	$ 475	$ 415
Capital shares reserved for future issuance (in shares)							1,761,212	1,832,309	1,874,223
Long-Term Incentive Plan Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period							3,638	13,092	3,334
Grants in Period (in shares)							75,550		39,432
Director [Member] | Long-Term Incentive Plan Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
LTIP Unit Grants in Period (in units)					14,440
Grants in Period (in shares)							22,840		14,440
Dedicated or partially dedicated personnel [Member] | Long-Term Incentive Plan Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
LTIP Unit Grants in Period (in units)	32,809	22,840	14,811	17,383		1,723
Manager [Member] | Long-Term Incentive Plan Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period							0	9,482	0
Vest December 11, 2019 [Member] | Dedicated or partially dedicated personnel [Member] | Long-Term Incentive Plan Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in Period (in shares)								8,692	8,692
Vest December 12, 2019 [Member] | Dedicated or partially dedicated personnel [Member] | Long-Term Incentive Plan Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in Period (in shares)									5,886
Vest December 11, 2020 [Member] | Dedicated or partially dedicated personnel [Member] | Long-Term Incentive Plan Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in Period (in shares)								8,691	8,691
Vest December 13, 2021 [Member] | Dedicated or partially dedicated personnel [Member] | Long-Term Incentive Plan Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in Period (in shares)							10,067
Non-controlling interest in Operating Partnership [Member] | Non-controlling Interest
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Operating Partnership LTIP Units Redeemed (in units)									503,988

XML

Long-Term Incentive Plan Units Long-Term Incentive Plan Units (Unvested LTIP Units) (Details) - Long-Term Incentive Plan Units [Member] - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Schedule of Unvested LTIP Units [Line Items]
Number of OP LTIP Units (in units)	75,550		39,432
Director [Member]
Schedule of Unvested LTIP Units [Line Items]
Number of OP LTIP Units (in units)	22,840		14,440
Grant Date	Sep. 10, 2020		Sep. 12, 2018
Vesting Date(1)	Sep. 09, 2021		Sep. 11, 2019
Vest December 13, 2021 [Member] | Dedicated or partially dedicated personnel [Member]
Schedule of Unvested LTIP Units [Line Items]
Number of OP LTIP Units (in units)	10,067
Grant Date	Dec. 13, 2019
Vesting Date(1)	Dec. 13, 2021
Vest December 11, 2019 [Member] | Dedicated or partially dedicated personnel [Member]
Schedule of Unvested LTIP Units [Line Items]
Number of OP LTIP Units (in units)		8,692	8,692
Grant Date			Dec. 11, 2018
Vesting Date(1)			Dec. 11, 2019
Vest December 11, 2020 [Member] | Dedicated or partially dedicated personnel [Member]
Schedule of Unvested LTIP Units [Line Items]
Number of OP LTIP Units (in units)		8,691	8,691
Grant Date			Dec. 11, 2018
Vesting Date(1)			Dec. 11, 2020
Vest March 7, 2019 [Member] | Dedicated or partially dedicated personnel [Member]
Schedule of Unvested LTIP Units [Line Items]
Number of OP LTIP Units (in units)			1,723
Grant Date			Mar. 07, 2018
Vesting Date(1)			Mar. 07, 2019
Vest December 12, 2019 [Member] | Dedicated or partially dedicated personnel [Member]
Schedule of Unvested LTIP Units [Line Items]
Number of OP LTIP Units (in units)			5,886
Grant Date			Dec. 12, 2017
Vesting Date(1)			Dec. 12, 2019
Vest December 17, 2021 | Dedicated or partially dedicated personnel [Member]
Schedule of Unvested LTIP Units [Line Items]
Number of OP LTIP Units (in units)	18,211
Grant Date	Dec. 17, 2020
Vesting Date(1)	Dec. 17, 2021
Vest December 31, 2021 [Member] | Dedicated or partially dedicated personnel [Member]
Schedule of Unvested LTIP Units [Line Items]
Number of OP LTIP Units (in units)	9,834
Grant Date	Mar. 04, 2020
Vesting Date(1)	Dec. 31, 2021
Vest December 17, 2022 | Dedicated or partially dedicated personnel [Member]
Schedule of Unvested LTIP Units [Line Items]
Number of OP LTIP Units (in units)	14,598
Grant Date	Dec. 17, 2020
Vesting Date(1)	Dec. 17, 2022

XML

Long-Term Incentive Plan Units (Roll-Forward of Company's LTIP Units Outstanding) (Details) - Long-Term Incentive Plan Units [Member] - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
LTIP Units Outstanding, beginning of period	545,716	521,371	491,159
Granted	70,460	37,437	33,546
Exercised	(3,638)	(13,092)	(3,334)
LTIP Units Outstanding, end of period	612,538	545,716	521,371
OP LTIP Units Unvested and Outstanding end of period	75,550	46,128
OP LTIP Units Vested and Outstanding end of period	536,988	499,588	481,939
Manager [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
LTIP Units Outstanding, beginning of period	365,518	375,000	375,000
Granted	0	0	0
Exercised	0	(9,482)	0
LTIP Units Outstanding, end of period	365,518	365,518	375,000
OP LTIP Units Unvested and Outstanding end of period	0	0
OP LTIP Units Vested and Outstanding end of period	365,518	365,518	375,000
Non-Manager [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
LTIP Units Outstanding, beginning of period	180,198	146,371	116,159
Granted	70,460	37,437	33,546
Exercised	(3,638)	(3,610)	(3,334)
LTIP Units Outstanding, end of period	247,020	180,198	146,371
OP LTIP Units Unvested and Outstanding end of period	75,550	46,128
OP LTIP Units Vested and Outstanding end of period	171,470	134,070	106,939

XML

Non-controlling Interests (Details) - USD ($) $ in Thousands				12 Months Ended
	Mar. 02, 2020	Dec. 12, 2018	Jan. 02, 2013	Dec. 31, 2020		Dec. 31, 2019		Dec. 31, 2018
Noncontrolling Interest [Line Items]
Non-controlling interests				$ 36,357	[1]	$ 39,434	[1]	$ 31,337
Non-controlling interest in Operating Partnership [Member] | Non-controlling Interest
Noncontrolling Interest [Line Items]
Operating Partnership LTIP Units Redeemed (in units)								503,988
Non-controlling interest of joint venture partner | Non-controlling Interest
Noncontrolling Interest [Line Items]
Non-controlling interests				$ 24,500		$ 25,900		$ 17,300
Operating Partnership Units [Member]
Noncontrolling Interest [Line Items]
Operating Partnership Units, converted during period	(129,516)
Operating Partnership | Non-controlling Interest
Noncontrolling Interest [Line Items]
Operating Partnership LTIP Units (in units)				612,538		545,716
Operating Partnership Units (in units)				48,409		177,925
Ownership Percentage				1.30%		1.60%
Noncontrolling Interest in Operating Partnerships				$ 11,700		$ 13,400
Operating Partnership | Non-controlling interest in Operating Partnership [Member] | Non-controlling Interest
Noncontrolling Interest [Line Items]
Operating Partnership Units Issued			212,000
Operating Partnership LTIP Units Issued (in units)		17,383
Operating Partnership LTIP Units Redeemed (in units)								503,988
Operating Partnership LTIP Units Distributed (in units)								503,988
Operating Partnership LTIP Units (in units)								521,371
Operating Partnership Units (in units)								212,000
Ownership Percentage								2.40%
Noncontrolling Interest in Operating Partnerships								$ 13,900

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

XML

Equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands		7 Months Ended	12 Months Ended			31 Months Ended
	Jan. 25, 2020	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2020	Jan. 24, 2020	Feb. 28, 2019	Jun. 13, 2018	Dec. 31, 2017
Subsidiary, Sale of Stock [Line Items]
Preferred Stock, Shares Issued			4,600,000	4,600,000		4,600,000
Proceeds from Issuance of Preferred Stock and Preference Stock			$ 0	$ 111,378
Preferred Stock, Dividend Rate, Percentage			6.75%	6.75%
Preferred Stock, Shares Outstanding			4,600,000	4,600,000		4,600,000
Preferred Stock, Shares Authorized			100,000,000	100,000,000		100,000,000
Preferred Stock, Par or Stated Value Per Share			$ 0.001	$ 0.001		$ 0.001
Preferred Stock, Liquidation Preference Per Share			$ 25.00			$ 25.00
Preferred Stock, Amount of Preferred Dividends in Arrears			$ 1,300	$ 1,500
Preferred Stock Dividend Rate Variable Rate Spread			5.196%
Common stock, shares authorized (in shares)		100,000,000	100,000,000	100,000,000	100,000,000	100,000,000
Common shares			$ 0.001	$ 0.001		$ 0.001		$ 0.001
Common stock, shares outstanding		29,796,601	43,781,684	38,647,943	29,796,601	43,781,684				31,335,938
Dividends declared (in usd per share)			$ 1.26	$ 1.81	$ 1.64
Dividends paid			$ (65,026)	$ (54,312)	$ (50,736)
Common shares issued and outstanding upon conversion of all convertible securities (in shares)		30,529,972	44,442,631	39,371,584	30,529,972	44,442,631
Number of shares authorized to be repurchased (in shares)									1,550,000
Shares repurchased (in shares)		361,090	290,050	50,825	1,547,148	701,965
Average price per share (USD per share)		$ 15.34	$ 10.54	$ 15.39		$ 13.36
Total cost		$ (5,500)	$ (3,056)	$ (782)	$ (23,131)	$ (9,400)
Stock Issued During Period, Shares, New Issues	5,290,000		5,290,000	8,855,000
Proceeds from issuance of shares, net							$ 95,300
Stock issued during period, shares, conversion of units					3,334
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, New Issues	690,000
OP LTIP Unit [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued during period, shares, conversion of units			0	13,092
Operating Partnership Units [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued during period, shares, conversion of units			133,154	34,075

XML

Equity (Summary of Common Stock Outstanding) (Details) - shares		7 Months Ended	12 Months Ended			31 Months Ended
	Jan. 25, 2020	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2020
Noncontrolling Interest [Line Items]
Common stock, shares outstanding		29,796,601	38,647,943	38,647,943	31,335,938	43,781,684
Shares repurchased (in shares)		361,090	290,050	50,825	1,547,148	701,965
Stock issued during period, shares, conversion of units					3,334
Shares issued in connection with incentive fee payment					4,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			38,647,943	29,796,601	31,335,938
Stock Issued During Period, Shares, New Issues	5,290,000		5,290,000	8,855,000
Shares Issued As Payment of Incentive Fee, Shares			637	0
Shares repurchased		(361,090)	(290,050)	(50,825)	(1,547,148)	(701,965)
Stock issued during period, shares, conversion of units					3,334
Shares issued in connection with incentive fee payment					4,477
Ending balance (in shares)		29,796,601	43,781,684	38,647,943	29,796,601	43,781,684
OP LTIP Unit [Member]
Noncontrolling Interest [Line Items]
Stock issued during period, shares, conversion of units			0	13,092
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued during period, shares, conversion of units			0	13,092
Operating Partnership Units [Member]
Noncontrolling Interest [Line Items]
Stock issued during period, shares, conversion of units			133,154	34,075
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued during period, shares, conversion of units			133,154	34,075

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended												12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Net increase (decrease) in shareholders' equity resulting from operations
Net income (loss) attributable to common stockholders	$ 63,162	$ 46,203	$ 37,278	$ (129,398)	$ 11,122	$ 17,293	$ 12,644	$ 15,408	$ (2,217)	$ 6,661	$ 21,193	$ 21,039	$ 17,245	$ 56,467	$ 46,676
Add: Net income (loss) attributable to Convertible Non-controlling Interests													(3)	1,305	319
Net income (loss) related to common stockholders and Convertible Non-controlling Interests													17,242	57,772	46,995
Dividends Paid:
Dividends													(56,023)	(59,824)	(50,736)	[1]
Undistributed (Distributed in excess of) earnings:
Total undistributed (distributed in excess of) earnings													$ (38,781)	$ (2,052)	$ (3,741)
Weighted average shares outstanding (basic and diluted):
Weighted average shares outstanding (basic and diluted) (in shares)													44,121,581	32,800,224
Basic earnings per share of common stock:
Distributed (in usd per share)													$ 1.26	$ 1.81	$ 1.64
Undistributed (Distributed in excess of) (in usd per share)													(0.87)	(0.05)	(0.12)
Basic earnings per common share (in usd per share)													0.39	1.76	1.52
Diluted earnings per share of common stock:
Distributed (in usd per share)													1.26	1.81	1.64
Undistributed (Distributed in excess of) (usd per share)													(0.87)	(0.05)	(0.12)
Diluted earnings per common share (in usd per share)													$ 0.39	$ 1.76	$ 1.52
Net increase (decrease) in equity resulting from operations													$ 3,400	$ 3,900	$ 2,900
Net increase (decrease) in equity resulting from operations													3,400	3,900	2,900
Common Stock
Net increase (decrease) in shareholders' equity resulting from operations
Net income (loss) attributable to common stockholders															45,922
Dividends Paid:
Dividends													(55,211)	(58,499)	(49,576)
Undistributed (Distributed in excess of) earnings:
Total undistributed (distributed in excess of) earnings													$ (37,966)	$ (2,032)	$ (3,653)
Weighted average shares outstanding (basic and diluted):
Weighted average shares outstanding (basic and diluted) (in shares)													43,486,336	32,067,768	30,297,401
Long-Term Incentive Plan Units [Member]
Net increase (decrease) in shareholders' equity resulting from operations
Net income (loss) attributable to common stockholders															$ 753
Dividends Paid:
Dividends															(812)
Undistributed (Distributed in excess of) earnings:
Total undistributed (distributed in excess of) earnings															$ (59)
Weighted average shares outstanding (basic and diluted):
Weighted average shares outstanding (basic and diluted) (in shares)															496,962
Non-controlling Interest
Dividends Paid:
Dividends													$ (812)	$ (1,325)	$ (348)
Undistributed (Distributed in excess of) earnings:
Total undistributed (distributed in excess of) earnings													$ (815)	$ (20)	$ (29)
Weighted average shares outstanding (basic and diluted):
Weighted average shares outstanding (basic and diluted) (in shares)													635,245	732,456	212,000

[1] For the year ended December 31, 2018, dividends totaling $1.64 per common share and convertible unit outstanding, were declared.

XML

(Schedule of Restricted Cash) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Restricted Cash [Line Items]
Restricted cash			$ 425
Flow consumer loan purchase and sale agreement
Restricted Cash [Line Items]
Restricted cash	$ 200	$ 200	175
Minimum Required Regulatory Balance [Member]
Restricted Cash [Line Items]
Restricted cash			$ 250

XML

Offsetting of Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Financial derivatives–assets
Financial derivatives–assets, at fair value-	$ 15,479	$ 16,788	$ 20,001
Financial Instruments Available for Offset	(12,579)	(12,755)	(10,910)
Cash Collateral (Received) Pledged	(1,404)	(807)	(2,514)
Net Amount	1,496	3,226	6,577
Reverse repurchase agreements
Repurchase agreements, at fair value	38,640	73,639	61,274
Financial Instruments Available for Offset	(38,640)	(73,639)	(61,274)
Cash Collateral (Received) Pledged	0	0	0
Net Amount	0	0	0
Repurchase agreements
Reverse repurchase agreements	(1,496,931)	(2,445,300)	(1,498,849)
Financial Instruments Available for Offset	1,496,931	73,639	61,274
Cash Collateral (Received) Pledged	28,884	31,005	16,974
Net Amount	0	0	0
Financial derivatives–liabilities
Financial derivatives–liabilities, at fair value-	(24,553)	(27,621)	(20,806)
Financial Instruments Available for Offset	12,579	12,755	10,910
Cash Collateral (Received) Pledged	10,694	12,233	9,896
Net Amount	(1,280)	(2,633)	0
Securities Collateral relating to Reverse Repurchase Agreements	1,800,000	2,800,000	1,790,000
Financial Derivatives - Assets
Financial derivatives–assets
Financial derivatives–assets, at fair value-			20,001
Financial Instruments Transferred or Pledged as Collateral	0	0	0
Financial derivatives–liabilities
Excess cash collateral	4,500	4,300	100
Securities Purchased under Agreements to Resell [Member]
Financial derivatives–assets
Financial Instruments Transferred or Pledged as Collateral	0	0	0
Reverse repurchase agreements
Repurchase agreements, at fair value			61,274
Financial Derivatives - Liabilities
Financial derivatives–assets
Financial Instruments Transferred or Pledged as Collateral	0	0	0
Financial derivatives–liabilities
Financial derivatives–liabilities, at fair value-			20,806
Excess cash collateral	10,300	23,400	16,400
Reverse repurchase agreements
Financial derivatives–assets
Financial Instruments Transferred or Pledged as Collateral	$ (28,884)	$ (2,340,656)	$ (1,420,601)

XML

Counterparty Risk (Exposure to Counterparty Risk) (Details) - Counterparty Risk [Member] $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($) counterparty	Dec. 31, 2019 USD ($) counterparty
Cash and Cash Equivalents [Member]
Concentration Risk [Line Items]
Amount of Exposure | $	$ 111,647	$ 72,302
Number of Counterparties with Exposure | counterparty	8	11
Percentage of Total Outstanding Unpaid Principal Balance	40.10%	42.20%
Collateral On Repurchase Agreements Held By Dealers [Member]
Concentration Risk [Line Items]
Amount of Exposure | $	$ 1,860,059	$ 2,793,696
Number of Counterparties with Exposure | counterparty	24	28
Percentage of Total Outstanding Unpaid Principal Balance	15.30%	13.80%
Due From Broker [Member]
Concentration Risk [Line Items]
Amount of Exposure | $	$ 63,147	$ 79,829
Number of Counterparties with Exposure | counterparty	22	24
Percentage of Total Outstanding Unpaid Principal Balance	28.90%	30.90%
Receivable For Securities Sold [Member]
Concentration Risk [Line Items]
Amount of Exposure | $	$ 1,416	$ 69,995
Number of Counterparties with Exposure | counterparty	2	5
Percentage of Total Outstanding Unpaid Principal Balance	94.50%	62.30%

XML

Counterparty Risk (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019		Dec. 31, 2018	Dec. 31, 2020
Risks and Uncertainties [Abstract]
Financial Instruments transferred as collateral for repurchase agreements	$ 2,763,000		$ 1,790,000	$ 1,831,000
Concentration risk threshold	15.00%		15.00%
Unencumbered investments held in custody			$ 13,300
Cash and cash equivalents	$ 72,302	[1]	44,656	$ 111,647	[1]
Pledged Financial Instruments, Not Separately Reported, Securities For Repurchase Agreements Unsettled			$ 86,700

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

XML

Counterparty Risk (% of Total Collateral on Reverse Repurchase Agreements) (Details)	Dec. 31, 2018
Royal Bank of Canada [Member]
Concentration Risk [Line Items]
Percentage of Total Collateral On Reverse Repurchase Agreements	19.00%

XML

Counterparty Risk (% of Due from Brokers) (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Concentration Risk [Line Items]
Concentration risk threshold	15.00%	15.00%
Morgan Stanley [Member]
Concentration Risk [Line Items]
% of Total Due from Brokers		37.00%
J.P. Morgan Securities LLC [Member]
Concentration Risk [Line Items]
% of Total Due from Brokers		30.00%

XML

Counterparty Risk (% of Total Receivable for Securities Sold) (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Concentration Risk [Line Items]
Concentration risk threshold	15.00%	15.00%
J.P. Morgan Securities LLC [Member]
Concentration Risk [Line Items]
% of Total Receivable for Securities Sold		25.00%
Bank of America Securities [Member]
Concentration Risk [Line Items]
% of Total Receivable for Securities Sold		26.00%
CS First Boston Limited [Member]
Concentration Risk [Line Items]
% of Total Receivable for Securities Sold		34.00%

XML

Counterparty Risk (Cash and Cash Equivalents) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	[1]	Dec. 31, 2019	[1]	Dec. 31, 2018
Concentration Risk [Line Items]
Cash and Cash Equivalents, at Carrying Value	$ 111,647		$ 72,302		$ 44,656
Bank of New York Mellon Corporation [Member]
Concentration Risk [Line Items]
Concentration risk percentage, cash and cash equivalents					64.00%
Deutsche Bank Securities [Member]
Concentration Risk [Line Items]
Concentration risk percentage, cash and cash equivalents					5.00%
Bank of America Securities [Member]
Concentration Risk [Line Items]
Concentration risk percentage, cash and cash equivalents					2.00%
Morgan Stanley Institutional Liquidity Fund - Government Portfolio [Member]
Concentration Risk [Line Items]
Concentration risk percentage, cash and cash equivalents					10.00%
BlackRock Liquidity Funds FedFund Portfolio, Institutional Class Shares [Member]
Concentration Risk [Line Items]
Concentration risk percentage, cash and cash equivalents					9.00%
Goldman Sachs Financial Square Funds - Government Fund [Member]
Concentration Risk [Line Items]
Concentration risk percentage, cash and cash equivalents					9.00%
US Bank N.A. [Member]
Concentration Risk [Line Items]
Concentration risk percentage, cash and cash equivalents					1.00%

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

XML

Commitments and Contingencies (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Other Commitments [Line Items]
Guarantor Obligations, Current Carrying Value			$ 1,000,000.0
Related party mortgage originator (with flow mortgage loan purchase and sale agreement) [Member] | Non-Exchange Traded Equity Investment in Mortgage Originators [Member]
Other Commitments [Line Items]
Maximum guarantees	$ 25,000,000.0
Drawn down amount being guaranteed	5,300,000	$ 400,000	2,900,000
Guarantor Obligations, Current Carrying Value			0
Guaranty Liabilities			$ 25,000,000.0
Residential mortgage loans
Other Commitments [Line Items]
Unfunded commitment	4,700,000	5,200,000
Corporate loan [Member]
Other Commitments [Line Items]
Unfunded commitment	$ 100,000	$ 1,900,000

XML

Condensed Quarterly Financial Data (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended													12 Months Ended
	Dec. 31, 2020		Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2020		Dec. 31, 2019		Dec. 31, 2018
Text Block [Abstract]
Interest income	$ 39,067		$ 43,075	$ 39,281	$ 52,108	$ 45,353	$ 39,985	$ 38,547	$ 36,016	$ 35,694	$ 35,300	$ 31,941	$ 28,092	$ 173,531		$ 159,901		$ 131,027	[1]
Interest expense	(11,952)		(12,937)	(14,686)	(22,090)	(21,205)	(19,954)	(19,702)	(17,618)	(16,083)	(15,678)	(13,383)	(11,562)	(61,665)		(78,479)		(56,707)	[1]
Interest Income (Expense), Net	27,115		30,138	24,595	30,018	24,148	20,031	18,845	18,398					111,866		81,422
Realized gains (losses) on securities and loans, financial derivatives, and real estate owned, net	(9,551)		(192)	(27,927)	204	(7,266)	(4,827)	(12,327)	(16,950)
Unrealized gains (losses) on securities and loans, financial derivatives, and real estate owned, net	42,547		24,032	52,057	(144,079)	6,139	7,970	13,300	20,452
Other, net	(795)		(2,747)	(435)	1,679	1,001	539	1,808	2,002					(2,298)		5,350
Noninterest Income	32,201		21,093	23,695	(142,196)	(126)	3,682	2,781	5,504					(65,207)		11,841
Base management fee to affiliate (Net of fee rebates)	3,178	[2]	2,981	2,906	2,443	2,663	1,942	1,661	1,722	1,744	1,830	2,021	1,978	11,508	[2]	7,988	[2]	7,573	[3]
Incentive Fee Expense	0		0	0	0	116	0	0	0	0	424	291	0	0		116		715
Servicing expense	1,736		2,379	2,493	2,531	2,055	1,940	2,244	2,393					9,139		8,632		7,715
Debt issuance costs related to Other secured borrowings, at fair value	1,819		0	2,075	0	1,865	0	1,671	0					3,894		3,536		1,647	[4]
Other	1,782		1,199	707	1,423	1,941	1,347	1,238	1,083					5,111		5,609		7,592
Professional fees	1,186		1,209	1,333	1,277	1,021	698	1,178	1,956					5,005		4,853		3,902
Compensation expense	962		1,085	941	788	962	712	903	1,072					3,776		3,649		2,233
Other expenses	1,531		1,625	1,497	1,752	1,160	1,156	1,053	985					6,405		4,354		1,898
Operating Expenses	12,194		10,478	11,952	10,214	11,783	7,795	9,948	9,211	26,637	24,668	22,044	18,566	44,838		38,737		91,916
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	47,122		40,753	36,338	(122,392)	12,239	15,918	11,678	14,691					1,821		54,526
Income Tax Expense (Benefit)	7,888		2,494	1,542	(547)	1,180	2	376	0					11,377		1,558
Earnings (losses) from investments in unconsolidated entities	27,344		11,443	5,643	(6,497)	3,262	2,796	2,354	1,797					37,933		10,209
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total	66,578		49,702	40,439	(128,342)	14,321	18,712	13,656	16,488	(1,070)	7,474	22,184	21,324	28,377		63,177		49,911
Net income (loss) attributable to non-controlling interests	1,475		1,559	1,220	(885)	1,733	1,419	1,012	1,080	1,147	813	991	285	3,369		5,244		3,235
Dividends on preferred stock	1,941		1,940	1,941	1,941	1,466	0	0	0					7,763		1,466
Net income (loss) attributable to common stockholders	$ 63,162		$ 46,203	$ 37,278	$ (129,398)	$ 11,122	$ 17,293	$ 12,644	$ 15,408	$ (2,217)	$ 6,661	$ 21,193	$ 21,039	$ 17,245		$ 56,467		$ 46,676
Basic and Diluted (USD per share)	$ 1.44		$ 1.06	$ 0.85	$ (3.04)	$ 0.31	$ 0.53	$ 0.43	$ 0.52	$ (0.07)	$ 0.22	$ 0.69	$ 0.67	$ 0.39		$ 1.76		$ 1.52
Other income										$ 1,157	$ 1,046	$ 1,094	$ 716					$ 4,014
Total investment income										36,851	36,346	33,035	28,808					135,041
Other investment related expenses										4,201	4,384	3,771	2,952
Other operating expenses										4,609	2,352	2,578	2,074
Net investment income										10,214	11,678	10,991	10,242					43,125
Realized gain or loss on investments, financial derivatives, and foreign currency transactions (excludes FX on cash)										9,578	10,102	(1,343)	13,051					25,368
Total Net Unrealized Gain Loss On Investments, Other Secured Borrowings, Financial Derivatives, and Foreign Currency Translation (excluding FX on cash)										(20,862)	(14,306)	12,536	(1,969)					26,318
Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency										(11,284)	(4,204)	11,193	11,082					6,786
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 66,578		$ 49,702	$ 40,439	$ (128,342)	$ 14,321	$ 18,712	$ 13,656	$ 16,488	(1,070)	7,474	22,184	21,324	$ 28,377		$ 63,177		$ 49,911
Management Fee Expense, Rebates										$ 400	$ 400	$ 300	$ 300	$ 1,051		$ 1,967	[2]

[1] Includes interest income and interest expense of a consolidated securitization trust of $6.0 million and $3.6 million, respectively, for the year ended December 31, 2018. See Note 6 for further details on the Company's consolidated securitization trust.

[2] See Note 13 for further details on management fee rebates.

[3] See Note 9 for further details on management fee rebates.

[4] Related to non-qualified mortgage securitization transactions. See Note 6 for further details.

XML

Financial Services, Investment Company (Details)	12 Months Ended
	Dec. 31, 2019
Investment Company, Financial Highlights [Abstract]
Market Based Total Return	1730.00%

XML

Schedule Of Shareholders Equity Per Share (Details) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Asset Value Per Share, Beginning Balance	$ 19.15
Net Investment Income	1.42
Net Realized/Unrealized Gains (Losses)	0.23
Results of Operations Attributable to Equity	1.65
Less: Results of Operations Attributable to Non-controlling Interests	(0.11)
Results of Operations Attributable to Shareholders' Equity	1.54
Divideds Paid Per Common Share	(1.64)
Weighted Average Share Impact on Dividends Paid	(0.03)
Accretive (Dilutive) Effect of Share Issuances (Net of Offering Costs), Share Repurchases, and Adjustments to Non-controlling interests	(0.10)
Net Asset Value Per Share, Ending Balance	$ 18.92
Common stock, shares outstanding	29,796,601	43,781,684	38,647,943	31,335,938
Shareholders Equity Per Share Upon Conversion Of All Convertible Units	$ 18.92

XML

Financial Highlights (Net Asset Value Based Total Return for a Shareholder) (Details)	12 Months Ended
	Dec. 31, 2018
Investment Company, Financial Highlights [Abstract]
Investment Company, Total Return after Incentive Fees	7.38%

XML

Financial Highlights (Net Investment Income Ratio to Average Equity) (Details)	12 Months Ended
	Dec. 31, 2018
Investment Company, Financial Highlights [Abstract]
Investment Company, Investment Income (Loss) Ratio	7.04%

XML

Financial Highlights (Expense Ratios to Average Equity) (Details)	12 Months Ended
	Dec. 31, 2018
Investment Company, Financial Highlights [Abstract]
Ratio Of Operating Expenses Before Incentive Fee, Interest Expense, and Other Investment Related Expenses To Average Equity	(2.86%)
Investment Company, Incentive Fee to Average Net Assets	(0.12%)
Ratio Of Interest and other investment related Expenses To Average Equity	(12.03%)
Investment Company, Expense Ratio after Incentive Allocation	(15.01%)

XML

Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Millions	Feb. 05, 2021	Jan. 08, 2021	Mar. 12, 2019	Feb. 15, 2019	Dec. 31, 2020	Dec. 31, 2019	Mar. 11, 2019	Feb. 28, 2019	Feb. 14, 2019	Feb. 13, 2019	Dec. 31, 2018	Aug. 18, 2017
Subsequent Event [Line Items]
Dividend Per Share (USD per share)							$ 0.14		$ 0.41
Declared date			Mar. 11, 2019	Feb. 14, 2019
Payment Date			Apr. 25, 2019	Mar. 15, 2019
Record Date			Mar. 29, 2019	Mar. 01, 2019
Common shares					$ 0.001	$ 0.001		$ 0.001
Senior Notes
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage										5.50%	5.55%	5.25%
Debt Instrument, Face Amount										$ 86.0		$ 86.0
Subsequent Event [Member]
Subsequent Event [Line Items]
Dividend Per Share (USD per share)	$ 0.10
Declared date	Feb. 05, 2021	Jan. 08, 2021
Payment Date	Mar. 25, 2021
Record Date	Feb. 26, 2021
Subsequent Event [Member] | Common Stock
Subsequent Event [Line Items]
Dividend Per Share (USD per share)		$ 0.10
Payment Date		Feb. 25, 2021
Record Date		Jan. 29, 2021
Subsequent Event [Member] | Preferred Stock [Member]
Subsequent Event [Line Items]
Dividend Per Share (USD per share)		$ 0.421875
Payment Date		Feb. 01, 2021
Record Date		Jan. 19, 2021

XML

SEC Schedule, Article 12-29, Mortgage Loans on Real Estate (Details) $ in Thousands		12 Months Ended
		Dec. 31, 2020 USD ($) loan	Dec. 31, 2019 USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Loans, at fair value	[1],[2]	$ 1,453,480	$ 1,412,426
Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		1,187,069
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		64,509
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		1,187,069
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		64,509
Loans, at fair value		1,187,069	932,203
Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		213,031
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		44,233
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		213,031
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		44,233
Loans, at fair value		213,031	274,759
Mortgage Loans [Member]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		1,400,100
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		108,742
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		1,400,100
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		108,742
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Federal Income Tax Basis		598,800
Securitized loans [Member] | Residential mortgage loans | Consolidated Entities [Member] | Non-QM loan securitization
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Loans, at fair value		$ 801,343	$ 628,415
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		39
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 4,464
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 2,617
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		39
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 4,464
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 2,617
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		2.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		2.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Nov. 01, 2030
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Aug. 01, 2057
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		31
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 9,634
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 8,029
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		31
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 9,634
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 8,029
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		2.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		2.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Dec. 01, 2036
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Feb. 01, 2060
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		16
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 8,193
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 7,773
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		16
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 8,193
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 7,773
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jul. 01, 2035
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.37%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.37%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Sep. 01, 2055
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 2,223
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 2,675
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 2,223
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 2,675
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		May 01, 2036
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.75%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.75%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Sep. 01, 2048
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,00,000 and $1,249,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 902
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 1,003
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 902
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 1,003
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jul. 01, 2048
Adjustable rate mortgages | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,250,000 and $1,499,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.37%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 1,343
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 1,343
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.37%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2050
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		397
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 69,577
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 1,938
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		397
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 69,577
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 1,938
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jun. 01, 2046
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Apr. 01, 2050
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		419
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 142,200
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 4,988
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		419
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 142,200
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 4,988
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Apr. 01, 2046
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.88%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.88%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Feb. 01, 2060
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		155
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 91,987
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 2,299
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		155
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 91,987
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 2,299
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Mar. 01, 2046
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.75%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.75%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Apr. 01, 2060
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		71
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 60,871
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 4,441
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		71
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 60,871
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 4,441
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.13%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.13%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Mar. 01, 2046
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Oct. 01, 2059
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,00,000 and $1,249,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		34
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 36,567
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		34
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 36,567
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,00,000 and $1,249,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.62%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.62%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Aug. 01, 2046
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,00,000 and $1,249,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.63%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.63%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Mar. 01, 2060
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,250,000 and $1,499,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		21
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 29,582
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 2,894
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		21
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 29,582
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 2,894
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,250,000 and $1,499,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Nov. 01, 2046
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,250,000 and $1,499,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.49%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.49%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Feb. 01, 2060
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,500,000 and $1,749,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		18
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 26,915
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,264
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		18
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 26,915
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,264
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,500,000 and $1,749,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.88%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.88%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Feb. 01, 2047
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,500,000 and $1,749,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Mar. 01, 2060
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,750,000 and $1,999,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		5
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 9,520
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		5
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 9,520
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,750,000 and $1,999,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.75%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.75%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Nov. 01, 2048
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,750,000 and $1,999,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Dec. 01, 2059
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,250,000 and $2,499,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		6
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 14,450
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		6
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 14,450
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,250,000 and $2,499,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.63%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.63%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jun. 01, 2048
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,250,000 and $2,499,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Sep. 01, 2059
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,500,000 and $2,749,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 7,996
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 7,996
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,500,000 and $2,749,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jul. 01, 2049
Adjustable rate mortgages | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,500,000 and $2,749,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Nov. 01, 2059
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		389
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 57,568
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 5,184
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		389
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 57,568
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 5,184
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		2.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		2.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2021
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		14.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		14.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2061
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		251
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 87,013
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,829
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		251
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 87,013
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,829
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2021
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		13.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		13.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2061
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		98
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 59,912
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,427
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		98
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 59,912
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,427
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2021
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		20.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		20.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2061
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		49
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 42,823
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,553
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		49
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 42,823
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,553
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2021
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		11.55%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		11.55%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Nov. 01, 2060
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,00,000 and $1,249,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		34
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 38,198
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 1,088
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		34
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 38,198
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 1,088
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,00,000 and $1,249,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Oct. 01, 2021
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,00,000 and $1,249,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2061
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,250,000 and $1,499,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		19
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 26,481
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		19
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 26,481
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,250,000 and $1,499,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.24%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.24%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Sep. 01, 2021
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,250,000 and $1,499,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		10.65%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		10.65%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Dec. 01, 2060
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,500,000 and $1,749,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		8
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 13,546
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		8
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 13,546
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,500,000 and $1,749,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.13%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.13%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Aug. 01, 2021
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,500,000 and $1,749,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2061
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,750,000 and $1,999,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		4
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 7,874
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		4
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 7,874
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,750,000 and $1,999,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.88%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.88%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Nov. 01, 2050
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,750,000 and $1,999,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2061
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,250,000 and $2,499,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 7,308
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 7,308
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,250,000 and $2,499,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.99%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Sep. 01, 2021
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,250,000 and $2,499,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Dec. 01, 2050
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,500,000 and $2,749,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 7,999
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 7,999
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,500,000 and $2,749,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2051
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,500,000 and $2,749,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2061
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,000,000 and $2,249,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 6,591
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 6,591
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,000,000 and $2,249,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.88%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.88%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Oct. 01, 2050
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,000,000 and $2,249,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2061
Fixed Rate Residential Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $3,250,000 and $3,499,000 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.13%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 3,654
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 3,654
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.13%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Oct. 01, 2060
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		260
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 44,822
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 176
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		260
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 44,822
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 176
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.63%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.63%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2047
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $250,000 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.63%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.63%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Sep. 01, 2060
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		227
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 80,323
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 1,539
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		227
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 80,323
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 1,539
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Dec. 01, 2034
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $250,000 and $499,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Sep. 01, 2060
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		107
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 65,494
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,792
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		107
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 65,494
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,792
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Nov. 01, 2047
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $500,000 and $749,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.63%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.63%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Sep. 01, 2060
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		49
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 41,486
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		49
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 41,486
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		May 01, 2048
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $750,000 and $999,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.13%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.13%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Sep. 01, 2060
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,00,000 and $1,249,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		18
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 19,603
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		18
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 19,603
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,00,000 and $1,249,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		May 01, 2048
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,00,000 and $1,249,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Sep. 01, 2060
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,250,000 and $1,499,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		20
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 28,010
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		20
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 28,010
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,250,000 and $1,499,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Dec. 01, 2047
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,250,000 and $1,499,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jul. 01, 2060
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,500,000 and $1,749,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 4,882
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 4,882
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,500,000 and $1,749,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Nov. 01, 2047
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,500,000 and $1,749,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Aug. 01, 2060
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,750,000 and $1,999,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		6
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 11,912
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		6
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 11,912
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,750,000 and $1,999,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		4.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Aug. 01, 2048
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,750,000 and $1,999,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Aug. 01, 2060
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,250,000 and $2,499,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 2,508
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 2,508
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2059
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,500,000 and $2,749,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 2,782
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 2,782
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Dec. 01, 2060
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,000,000 and $2,249,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 6,829
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 6,829
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,000,000 and $2,249,999 | Minimum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.12%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.12%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Apr. 01, 2050
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $2,000,000 and $2,249,999 | Maximum | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.24%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		6.24%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Apr. 01, 2059
Fixed Rate Residential Mortgage | Securitized loans [Member] | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $3,000,000 and $3,249,999 | Residential mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 3,027
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 3,027
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		5.38%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		May 01, 2049
Fixed Rate commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $5,000,000 and $9,999,000 | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 373
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 373
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Mar. 01, 2021
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $1,250,000 and $1,499,999 | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.10%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 12,558
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 12,558
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.10%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Feb. 01, 2021
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $5,000,000 | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		10
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 28,692
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,983
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		10
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 28,692
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 3,983
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $5,000,000 | Minimum | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.37%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		3.37%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Jan. 01, 2021
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans under $5,000,000 | Maximum | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Oct. 01, 2037
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $5,000,000 and $9,999,999 | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		9
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 65,776
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 16,500
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		9
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 65,776
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 16,500
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $5,000,000 and $9,999,999 | Minimum | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		7.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Mar. 01, 2021
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $5,000,000 and $9,999,999 | Maximum | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Apr. 01, 2022
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $10,000,000 and $14,999,999 | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		5
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 58,999
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 23,750
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		5
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 58,999
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 23,750
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $10,000,000 and $14,999,999 | Minimum | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Oct. 01, 2021
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $10,000,000 and $14,999,999 | Maximum | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		11.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		11.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Mar. 01, 2022
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $15,000,000 and $19,999,999 | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 46,633
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Number of Loans | loan		3
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages		$ 46,633
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans		$ 0
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $15,000,000 and $19,999,999 | Minimum | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		8.25%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Aug. 01, 2021
Adjustable Rate Commercial Mortgage | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans between $15,000,000 and $19,999,999 | Maximum | Commercial mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate		9.00%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Final Maturity Date		Sep. 01, 2021

[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

XML

SEC Schedule, Article 12-29, Mortgage Loans on Real Estate Roll Forward(Details) - Mortgage Loans [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Beginning Balance	$ 1,206,962	$ 692,131
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan	716,241	837,502
Net unrealized gains	11,427	6,717
Net realized gains	0	3,878
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Cost of Mortgage Sold	(28,613)	(28,805)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Collections of Principal	(496,186)	(275,520)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Amortization of Premium	(6,317)	(6,363)
Realized gains (losses) on securities and loans, net	(30)	0
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure	(3,384)	(22,578)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Ending Balance	$ 1,400,100	$ 1,206,962